PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gugliotti, LA; Feldheim, DL; Eaton, BE				Gugliotti, LA; Feldheim, DL; Eaton, BE			RNA-mediated metal-metal bond formation in the synthesis of hexagonal palladium nanoparticles	SCIENCE			English	Article							EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; DNA; SELECTION; LIGANDS; TEMPLATE; URIDINE; BINDING; GOLD	RNA sequences have been discovered that mediate the growth of hexagonal palladium nanoparticles. In vitro selection techniques were used to evolve an initial library of similar to10(14) unique RNA sequences through eight cycles of selection to yield several active sequence families. Of the five families, all representative members could form crystalline hexagonal palladium platelets. The palladium particle growth occurred in aqueous solution at ambient temperature, without any endogenous reducing agent, and at low concentrations of metal precursor (100 micromolar). Relative to metal precursor, the RNA concentration was significantly lower ( 1 micromolar), yet micrometer-size crystalline hexagonal palladium particles were formed rapidly (7.5 to 1 minutes).	N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Feldheim, DL (corresponding author), N Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.	dan_feldheim@ncsu.edu; bruce_eaton@ncsu.edu						Ahmadi TS, 1996, CHEM MATER, V8, P1161, DOI 10.1021/cm9601190; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; Dewey TM, 1996, NUCLEOS NUCLEOT, V15, P1611, DOI 10.1080/07328319608002461; DEWEY TM, 1995, J AM CHEM SOC, V117, P8474, DOI 10.1021/ja00137a027; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; ILLANGASEKARE M, 1995, SCIENCE, V267, P643, DOI 10.1126/science.7530860; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Joyce GF, 2002, NATURE, V420, P278, DOI 10.1038/420278a; Lohse PA, 1996, NATURE, V381, P442, DOI 10.1038/381442a0; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Mahtab R, 2000, J AM CHEM SOC, V122, P14, DOI 10.1021/ja9907156; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r; Nieuwlandt D, 2003, CHEMBIOCHEM, V4, P651, DOI 10.1002/cbic.200300610; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Sengle G, 2001, CHEM BIOL, V8, P459, DOI 10.1016/S1074-5521(01)00026-6; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tarasow TM, 1997, NATURE, V389, P54, DOI 10.1038/37950; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Walter J, 2000, ADV MATER, V12, P31, DOI 10.1002/(SICI)1521-4095(200001)12:1<31::AID-ADMA31>3.0.CO;2-N; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Whitling JM, 2000, ADV MATER, V12, P1377, DOI 10.1002/1521-4095(200009)12:18<1377::AID-ADMA1377>3.0.CO;2-X; Wiegand TW, 1997, CHEM BIOL, V4, P675, DOI 10.1016/S1074-5521(97)90223-4; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	27	160	165	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					850	852		10.1126/science.1095678	http://dx.doi.org/10.1126/science.1095678			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15087507				2022-12-28	WOS:000221243000037
J	Evans, T; Gulmezoglu, M; Pang, T				Evans, T; Gulmezoglu, M; Pang, T			Registering clinical trials: an essential role for WHO	LANCET			English	Editorial Material							HEALTH		WHO, Evidence & Informat Policy, CH-1211 Geneva, Switzerland; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Res Policy & Cooperat, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization; World Health Organization	Gulmezoglu, M (corresponding author), WHO, Evidence & Informat Policy, CH-1211 Geneva, Switzerland.	gulmezoglum@who.int						[Anonymous], INT STAND RAND CONTR; Bailey C, 2003, B WORLD HEALTH ORGAN, V81, P777; *CURR CONTR TRIALS, METAREGISTER CONTR T; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; *EDCTP, EUR DEV COUNTR CLIN; HOPEWELL S, 2004, COCHRANE LIB; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Lee JW, 2003, B WORLD HEALTH ORGAN, V81, P473; SCHERER RW, 2003, COCHRANE LIB; *WHO, PROGR MAP BEST REPR; *WHO, WHO LEADS DRIV INT C; 2004, COCHRANE LIB	12	31	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1413	1414		10.1016/S0140-6736(04)16136-9	http://dx.doi.org/10.1016/S0140-6736(04)16136-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121401				2022-12-28	WOS:000221130300005
J	Sakkers, R; Kok, D; Engelbert, R; van Dongen, A; Jansen, M; Pruijs, H; Verbout, A; Schweitzer, D; Uiterwaal, C				Sakkers, R; Kok, D; Engelbert, R; van Dongen, A; Jansen, M; Pruijs, H; Verbout, A; Schweitzer, D; Uiterwaal, C			Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study	LANCET			English	Article							INTRAVENOUS PAMIDRONATE; PEDIATRIC EVALUATION; DISABILITY; BISPHOSPHONATE; VALIDITY; THERAPY; MINERALIZATION; ADOLESCENTS; CHILDHOOD; INFUSION	Background Non-randomised studies have suggested beneficial effects of bisphosphonates in osteogenesis imperfecta. We assessed the effects of oral olpadronate in children with this disorder in a randomised double-blind placebo-controlled trial. Methods 34 children recruited from the Dutch national centre for osteogenesis imperfecta were randomly assigned olpadronate (10 mg/m(2) daily; n=16) or placebo (n=18) for 2 years. All children also received calcium and vitamin D Supplements. Primary endpoints were incident fractures of long bones and changes in bone mineral content (BMC), bone mineral density (BMD), and functional outcome. Anthropometry, vertebral height. and urinary markers of bone resorption were also studied. Analyses were by intention to treat. Findings Fracture follow-up was complete for all the children, including two who withdrew from the study (one from each group). Olpadronate treatment was associated with a 31% reduction in relative risk of fracture of long bones (hazard ratio 0.69 [95% Cl 0.52-0-91], p=0.01). The olpadronate group showed significantly greater increases than the placebo group in spinal BMC (difference between groups 2.24 g/year [0.20-4.29], p=0.03) and spinal BMD (difference between groups 0.054 g/cm(2) per year [0.012-0.096]. p=0.01). There were no detectable effects on functional outcome. anthropometrics, or vertebral height and no differences between the groups in changes in urinary markers of bone resorption. Interpretation Oral treatment with olpadronate at a daily dose of 10 mg/m(2) results in a reduction of fracture risk of long bones in children with osteogenesis imperfecta. However, the issue of whether bisphosphonates will alter the natural course of osteogenesis imperfecta remains unresolved. and further studies are needed.	Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Orthopaed Surg, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Phys Therapy, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Nucl Med, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; Reinier de Graaf Grp Hosp, Dept Internal Med & Endocrinol, Delft, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Reinier de Graaf Hospital	Sakkers, R (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Orthopaed Surg, KE 4-140-5,POB 85090, NL-3508 AB Utrecht, Netherlands.	r.sakkers@wkz.azu.nl						ADAMSON BB, 1993, LANCET, V342, P1459, DOI 10.1016/0140-6736(93)92935-M; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Astrom E, 2002, ARCH DIS CHILD, V86, P356, DOI 10.1136/adc.86.5.356; BACKMAN E, 1989, SCAND J REHABIL MED, V21, P105; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; BLAKE G, 1999, EVALUATION OSTEOPORO, P230; BLECK EE, 1981, CLIN ORTHOP RELAT R, V159, P111; Brumsen C, 1997, MEDICINE, V76, P266, DOI 10.1097/00005792-199707000-00005; Byers Peter H., 1993, P317; Custers JW, 2002, ARCH PHYS MED REHAB, V83, P1437, DOI 10.1053/apmr.2002.34831; Custers JWH, 2002, DISABIL REHABIL, V24, P250, DOI 10.1080/09638280110076036; DEVOGELAER JP, 1987, SKELETAL RADIOL, V16, P360, DOI 10.1007/BF00350961; Engelbert RHH, 1999, ARCH PHYS MED REHAB, V80, P896, DOI 10.1016/S0003-9993(99)90080-1; Engelbert RHH, 2000, J PEDIATR-US, V137, P397, DOI 10.1067/mpd.2000.107892; Falk MJ, 2003, PEDIATRICS, V111, P573, DOI 10.1542/peds.111.3.573; FELDMAN AB, 1990, PHYS THER, V70, P602, DOI 10.1093/ptj/70.10.602; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Gonzalez E, 2001, J PEDIATR ENDOCR MET, V14, P529; HUAUX JP, 1988, J PEDIATR ORTHOPED, V8, P71, DOI 10.1097/01241398-198801000-00017; LandsmeerBeker EA, 1997, EUR J PEDIATR, V156, P792, DOI 10.1007/s004310050715; Lee YS, 2001, EUR J PEDIATR, V160, P641, DOI 10.1007/s004310100844; Marini JC, 2003, NEW ENGL J MED, V349, P423, DOI 10.1056/NEJMp038103; Montpetit K, 2003, PEDIATRICS, V111, pE601, DOI 10.1542/peds.111.5.e601; Papapoulos Socrates E., 1996, P1209; Plotkin H, 2000, J CLIN ENDOCR METAB, V85, P1846, DOI 10.1210/jc.85.5.1846; Rauch F, 2003, J BONE MINER RES, V18, P610, DOI 10.1359/jbmr.2003.18.4.610; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110; Zacharin M, 2002, J PEDIATR ENDOCR MET, V15, P163; Zeitlin L, 2003, PEDIATRICS, V111, P1030, DOI 10.1542/peds.111.5.1030	30	152	157	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1427	1431		10.1016/S0140-6736(04)16101-1	http://dx.doi.org/10.1016/S0140-6736(04)16101-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121405				2022-12-28	WOS:000221130300009
J	van Steijn, JHM; van der Voort, PHJ				van Steijn, JHM; van der Voort, PHJ			Pneumoperitoneum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Ctr Leeuwarden, NL-8901 BR Leeuwarden, Netherlands	Medical Center Leeuwarden	van Steijn, JHM (corresponding author), Med Ctr Leeuwarden, NL-8901 BR Leeuwarden, Netherlands.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					E16	E16		10.1056/ENEJMicm020442	http://dx.doi.org/10.1056/ENEJMicm020442			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115846				2022-12-28	WOS:000221080300012
J	Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E				Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E			Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data	LANCET			English	Article							PHARMACEUTICAL-INDUSTRY; MAJOR DEPRESSION; CONTROLLED TRIAL; CHILDREN; ADOLESCENTS; DISORDER; FLUOXETINE; SERTRALINE; EFFICACY	Background Questions concerning the safety of selective serotonin reuptake inhibitors (SSRls) in the treatment of depression in children led us to compare and contrast published and unpublished data on the risks and benefits of these drugs. Methods We did a meta-analysis of data from randomised controlled trials that evaluated an SSRI versus placebo in participants aged 5-18 years and that were published in a peer-reviewed journal or were unpublished and included in a review by the Committee on Safety of Medicines. The following outcomes were included: remission, response to treatment, depressive symptom scores, serious adverse events, suicide-related behaviours, and discontinuation of treatment because of adverse events. Findings Data for two published trials suggest that fluoxetine has a favourable risk-benefit profile, and unpublished data lend support to this finding. Published results from one trial of paroxetine and two trials of sertraline suggest equivocal or weak positive risk-benefit profiles. However, in both cases, addition of unpublished data indicates that risks outweigh benefits. Data from unpublished trials of citalopram and venlafaxine show unfavourable risk-benefit profiles. Interpretation Published data suggest a favourable risk-benefit profile for some SSRIs; however, addition of unpublished data indicates that risks could outweigh benefits of these drugs (except fluoxetine) to treat depression in children and young people. Clinical guideline development and clinical decisions about treatment are largely dependent on an evidence base published in peer-reviewed journals. Non-publication of trials, for whatever reason, or the omission of important data from published trials, can lead to erroneous recommendations for treatment. Greater openness and transparency with respect to all intervention studies is needed.	UCL, Ctr Outcomes Res & Effectiveness, Subdept Clin Hlth Psychol, London WC1E 7HB, England; Royal Coll Psychiatrists, Res Unit, London SW1H 0HW, England; Univ Leeds, Sch Med, Acad Unit Child & Adolescent Mental Hlth, Leeds LS2 9JT, W Yorkshire, England; Pine Lodge Young Peoples Ctr, Chester, Cheshire, England	University of London; University College London; University of Leeds	Whittington, CJ (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, Subdept Clin Hlth Psychol, 1-19 Torrington Pl, London WC1E 7HB, England.	c.whittington@ucl.ac.uk	Whittington, Craig/B-1380-2008; Cottrell, David J/A-1211-2013	Whittington, Craig/0000-0002-1950-0334; Cottrell, David J/0000-0001-8674-0955; Fonagy, Peter/0000-0003-0229-0091				*ACNP, 2004, EX SUMM PREL REP TAS; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; ANDERSON RN, 2002, NATL VITAL STAT REP, V250, P1; COCHRANE COLLOBORATION, 2003, REV MAN REVMAN COMP; Committee on Safety of Medicines. Selective Serotonin Reuptake Inhibitors (SSRIs), SEL SER REUPT INH SS; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1129; COSTELLO EJ, 1989, J AM ACAD CHILD PSY, V28, P836, DOI 10.1097/00004583-198911000-00004; DUFF G, 2003, SELECTIVE SEROTONIN; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Garland EJ, 2004, CAN MED ASSOC J, V170, P489; HAZELL P, 2004, COCHRANE LIB; Herxheimer A, 2004, CAN MED ASSOC J, V170, P487; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; KAPCZINSKI F, 2004, COCHRANE LIB; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Khan KS, 2003, SYSTEMATIC REV SUPPO; Kondro W, 2004, CAN MED ASSOC J, V170, P783, DOI 10.1503/cmaj.1040213; LAUGHREN TP, 2004, FEBR 2 2004 M PSYCH; Lewinsohn PM, 1999, CLIN PSYCHOL REV, V19, P329, DOI 10.1016/S0272-7358(98)00055-5; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mandoki MW, 1997, PSYCHOPHARMACOL BULL, V33, P149; McPherson K, 2004, BRIT MED J, V328, P518, DOI 10.1136/bmj.328.7438.518; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; *MHRA, 2003, INT REP COMM SAF MED; *NAT I CLIN EV, 2004, GUID DEV METH INF NA; Ramchandani P, 2004, BRIT MED J, V328, P3, DOI 10.1136/bmj.328.7430.3; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; Wagner KD, 2003, J CHILD ADOL PSYCHOP, V13, pS53, DOI 10.1089/104454603322126340	29	708	716	5	115	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1341	1345		10.1016/S0140-6736(04)16043-1	http://dx.doi.org/10.1016/S0140-6736(04)16043-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814TF	15110490				2022-12-28	WOS:000220996300007
J	Lister, G; Fontan, JJP				Lister, G; Fontan, JJP			Can resuscitation jeopardize survival?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EPINEPHRINE		Univ Texas, SW Med Sch, Dept Pediat, Dallas, TX 75230 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Lister, G (corresponding author), Univ Texas, SW Med Sch, Dept Pediat, Dallas, TX 75230 USA.							Behringer W, 1998, ANN INTERN MED, V129, P450, DOI 10.7326/0003-4819-129-6-199809150-00004; CAIN SM, 1973, AM J PHYSIOL, V225, P1405, DOI 10.1152/ajplegacy.1973.225.6.1405; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; 1986, JAMA, V255, P2961	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1708	1709		10.1056/NEJMp048055	http://dx.doi.org/10.1056/NEJMp048055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102995				2022-12-28	WOS:000220947300003
J	McManus, JF; Francois, R; Gherardi, JM; Keigwin, LD; Brown-Leger, S				McManus, JF; Francois, R; Gherardi, JM; Keigwin, LD; Brown-Leger, S			Collapse and rapid resumption of Atlantic meridional circulation linked to deglacial climate changes	NATURE			English	Article							OCEAN THERMOHALINE CIRCULATION; SEA-LEVEL RECORD; RADIOCARBON AGE; DISCHARGES; RATES	The Atlantic meridional overturning circulation is widely believed to affect climate. Changes in ocean circulation have been inferred from records of the deep water chemical composition derived from sedimentary nutrient proxies(1), but their impact on climate is difficult to assess because such reconstructions provide insufficient constraints on the rate of overturning(2). Here we report measurements of Pa-231/(230) Th, a kinematic proxy for the meridional overturning circulation, in a sediment core from the subtropical North Atlantic Ocean. We find that the meridional overturning was nearly, or completely, eliminated during the coldest deglacial interval in the North Atlantic region, beginning with the catastrophic iceberg discharge Heinrich event H1, 17,500 yr ago, and declined sharply but briefly into the Younger Dryas cold event, about 12,700 yr ago. Following these cold events, the Pa-231/(230) Th record indicates that rapid accelerations of the meridional overturning circulation were concurrent with the two strongest regional warming events during deglaciation. These results confirm the significance of variations in the rate of the Atlantic meridional overturning circulation for abrupt climate changes.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	McManus, JF (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	jmcmanus@whoi.edu						BACON MP, 1982, J GEOPHYS RES-OCEANS, V87, P2045, DOI 10.1029/JC087iC03p02045; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BROECKER WS, 1979, J GEOPHYS RES-OC ATM, V84, P3218, DOI 10.1029/JC084iC06p03218; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Choi MS, 2001, MAR CHEM, V76, P99, DOI 10.1016/S0304-4203(01)00050-0; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; DUPLESSY JC, 1992, NATURE, V358, P485, DOI 10.1038/358485a0; Elliot M, 2002, QUATERNARY SCI REV, V21, P1153, DOI 10.1016/S0277-3791(01)00137-8; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; LEGRAND P, 1995, PALEOCEANOGRAPHY, V10, P1011, DOI 10.1029/95PA01455; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Marchal O, 2000, PALEOCEANOGRAPHY, V15, P625, DOI 10.1029/2000PA000496; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 1998, EARTH PLANET SC LETT, V155, P29, DOI 10.1016/S0012-821X(97)00201-X; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Ohkouchi N, 2002, SCIENCE, V298, P1224, DOI 10.1126/science.1075287; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Vidal L, 1997, EARTH PLANET SC LETT, V146, P13, DOI 10.1016/S0012-821X(96)00192-6; Waelbroeck C, 1998, PALEOCEANOGRAPHY, V13, P272, DOI 10.1029/98PA00071; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	33	1418	1482	21	451	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					834	837		10.1038/nature02494	http://dx.doi.org/10.1038/nature02494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103371				2022-12-28	WOS:000220952300034
J	Alotaibi, S; Kennedy, J; Tellier, R; Stephens, D; Banwell, B				Alotaibi, S; Kennedy, J; Tellier, R; Stephens, D; Banwell, B			Epstein-Barr virus in pediatric multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHETLAND ISLANDS; ANTIBODY-TITERS; NUCLEAR ANTIGEN; INFECTIONS; CHILDHOOD; HUMAN-HERPESVIRUS-6; DISEASE; ORKNEY	Context Infection with common viruses, particularly Epstein-Barr virus (EBV), has been postulated to contribute to the pathobiology of multiple sclerosis (MS). Detailed virological studies in pediatric MS have not been previously reported. Objective To evaluate whether children with MS are more likely to be seropositive for EBV or other common viruses than their healthy age-matched peers. Design, Setting, and Patients Case-control study of viral samples collected from March 1994 to February 2003 from 30 pediatric MS patients, 90 emergency department controls matched 3:1 with the MS patients by year of birth, and 53 healthy control children. Main Outcome Measures Archived serum samples were analyzed for the presence of IgG antibodies directed against EBV viral capsid antigens, nuclear antigens, and early antigens, cytomegalovirus, parvovirus B19, herpes simplex virus, and varicella zoster. Results Serological evidence for remote EBV infection was present in 83% of pediatric MS patients compared with 42% of emergency department and healthy controls (P<.001). Five pediatric MS patients were negative for all 3 EBV antigens. Pediatric MS patients were less likely than controls to have been exposed to herpes simplex virus (P=.003), while seropositivity for cytomegalovirus, parvovirus 1319, and varicella zoster did not differ between MS patients and controls. Conclusion These results suggest an association between EBV infection and pediatric MS.	Univ Toronto, Hosp Sick Children, Dept Paediat Neurol, Paediat Multiple Sclerosis Clin, Toronto, ON M5G 1X8, Canada; Al Sabah Hosp, Dept Pediat Neurol, Shuwaikh, Kuwait	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Al Sabah Hospital	Banwell, B (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat Neurol, Paediat Multiple Sclerosis Clin, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	brenda.banwell@sickkids.ca						Allen UD, 2001, BONE MARROW TRANSPL, V28, P473, DOI 10.1038/sj.bmt.1703153; Ascherio A, 2000, EPIDEMIOLOGY, V11, P220, DOI 10.1097/00001648-200003000-00023; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; BRAY PF, 1992, NEUROLOGY, V42, P278, DOI 10.1212/WNL.42.2.278; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; BRAY PF, 1992, NEUROLOGY, V42, P1798, DOI 10.1212/WNL.42.9.1798; CUOMO L, 1995, AIDS RES HUM RETROV, V11, P1241, DOI 10.1089/aid.1995.11.1241; DUQUETTE P, 1987, J PEDIATR-US, V111, P359, DOI 10.1016/S0022-3476(87)80454-7; EVANS AS, 1989, VIRAL INFECT HUMANS, P265; Ghezzi A, 1997, MULT SCLER, V3, P43, DOI 10.1177/135245859700300105; Granieri E, 1997, NEUROLOGY, V49, pS42, DOI 10.1212/WNL.49.2_Suppl_2.S42; Haahr S, 1997, LANCET, V349, P923, DOI 10.1016/S0140-6736(05)62698-0; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Knox KK, 2000, CLIN INFECT DIS, V31, P894, DOI 10.1086/318141; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Levin LI, 2003, JAMA-J AM MED ASSOC, V289, P1533, DOI 10.1001/jama.289.12.1533; Marrie RA, 2000, NEUROLOGY, V54, P2307, DOI 10.1212/WNL.54.12.2307; MARTIN JR, 1981, LANCET, V2, P777; MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSKANZER DC, 1980, J EPIDEMIOL COMMUN H, V34, P265, DOI 10.1136/jech.34.4.265; POSKANZER DC, 1980, J EPIDEMIOL COMMUN H, V34, P258, DOI 10.1136/jech.34.4.258; Swanborg RH, 2003, J NEUROIMMUNOL, V136, P1, DOI 10.1016/S0165-5728(02)00465-4; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8	24	175	177	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1875	1879		10.1001/jama.291.15.1875	http://dx.doi.org/10.1001/jama.291.15.1875			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100207				2022-12-28	WOS:000220871200029
J	Nunes, EV; Levin, FR				Nunes, EV; Levin, FR			Treatment of depression in patients with alcohol or other drug dependence - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							METHADONE-MAINTENANCE PATIENTS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; IMIPRAMINE TREATMENT; PHARMACOLOGICAL TREATMENT; FLUOXETINE TREATMENT; COCAINE ABSTINENCE; PROGNOSTIC-FACTOR; MAJOR DEPRESSION; ANTI-DEPRESSANTS	Context Depression and substance abuse are common and costly disorders that frequently-co-occur, but controversy about effective treatment for patients with both disorders persists. Objective To conduct a systematic review and meta-analysis to quantify the efficacy of antidepressant medications for treatment of combined depression and substance use disorders. Data Sources PubMed, MEDLINE, and Cochrane database search (1970-2003), using the keywords antidepressant treatment or treatment depressed in conjunction with each of the following alcohol dependence, benzodiazepine dependence, opiate dependence, cocaine dependence, marijuana dependence, and methadone; a search of bibliographies; and consultation with experts in the field. Study Selection Among inclusion criteria used for study selection were prospective, parallel group, double-blind, controlled clinical trials with random assignment to an antidepressant medication or placebo for which trial patients met standard diagnostic criteria for current alcohol or other drug use and a current unipolar depressive disorder. Of the more than 300 citations extracted, 44 were placebo-controlled clinical trials, 14 of which were selected for this analysis and included 848 patients: 5 studies of tricyclic antidepressants, 7 of selective serotonin re-uptake inhibitors, and 2 from other classes Data Extraction We independently screened the titles and abstracts of each citation, identified placebo-controlled trials of patients with both substance dependence and depression, applied the inclusion criteria, and reached consensus. Data on study methods, sample characteristics, and depression and substance use outcomes were extracted. The principal measure of effect size was the standardized difference between means on the Hamilton Depression Scale (HDS). Data Synthesis For the HDS score, the pooled effect size from the random-effects model was 0.38 (95% confidence interval, 0.18-0.58). Heterogeneity of effect on HDS across studies was significant (P <.02), and studies with low placebo response showed larger effects. Moderator analysis suggested that diagnostic methods and concurrent psychosocial interventions influenced outcome. Studies with larger depression effect sizes (>0.5) demonstrated favorable effects of medication on measures of quantity of substance use, but rates of sustained abstinence were low. Conclusions Antidepressant medication exerts a modest beneficial effect for patients with combined depressive- and substance-use disorders. It is not a stand-alone treatment, and concurrent therapy directly targeting the addiction is also indicated. More research is needed to understand variations in the strength of the effect, but the data suggest that care be exercised in the diagnosis of depression-either by observing depression to persist during at least a brief period of abstinence or through efforts by clinical history to screen out substance-related depressive symptoms.	New York State Psychiat Inst & Hosp, Depress Evaluat Serv, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Div Subst Abuse, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY USA	New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University	Nunes, EV (corresponding author), New York State Psychiat Inst & Hosp, Depress Evaluat Serv, 1051 Riverside Dr,Unit 51, New York, NY 10032 USA.	nunesed@pi.cpmc.columbia.ecu		Nunes, Edward/0000-0002-2055-3425	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009236, K02DA000465, K02DA000288] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALTAMURA AC, 1990, INT J CLIN PHARM RES, V10, P293; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; BATKI S, 1987, RES MONOGRAPH SERIES, V81, P292; Borenstein M., 1999, COMPREHENSIVE META A; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; BRADY KT, 1975, TXB SUBSTANCE ABUSE, P475; Brown RA, 1997, J CONSULT CLIN PSYCH, V65, P715, DOI 10.1037/0022-006X.65.5.715; BROWN SA, 1988, J STUD ALCOHOL, V49, P412, DOI 10.15288/jsa.1988.49.412; BUTTERWORTH AT, 1971, Q J STUD ALCOHOL, V32, P343; CARPENTER KM, IN PRESS DRUG ALCOHO; CARROLL KM, 1995, J NERV MENT DIS, V183, P251, DOI 10.1097/00005053-199504000-00012; CIRAULO DA, 1981, J CLIN PSYCHOPHARM, V1, P146, DOI 10.1097/00004714-198105000-00006; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Copas JB, 2001, STAT METHODS MED RES, V10, P251, DOI 10.1191/096228001678227776; Cornelius JR, 2000, ADDICT BEHAV, V25, P307, DOI 10.1016/S0306-4603(99)00065-9; Cornelius JR, 1997, PSYCHOPHARMACOL BULL, V33, P165; Cornelius JR, 1998, PSYCHOPHARMACOL BULL, V34, P117; CORNELIUS JR, 1995, PSYCHOPHARMACOL BULL, V31, P297; Cornelius JR, 1997, ARCH GEN PSYCHIAT, V54, P700; Cornelius JR, 1999, ADDICT BEHAV, V24, P111, DOI 10.1016/S0306-4603(98)00050-1; Dean AJ, 2002, J AFFECT DISORDERS, V72, P85, DOI 10.1016/S0165-0327(01)00419-0; DELEON G, 1973, ARCH GEN PSYCHIAT, V28, P131; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; FELDMAN HS, 1972, PSYCHOSOMATICS, V13, P41; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; GIANNINI AJ, 1986, J CLIN PHARMACOL, V26, P211, DOI 10.1002/j.1552-4604.1986.tb02936.x; Gonzalez G, 2003, AM J DRUG ALCOHOL AB, V29, P497, DOI 10.1081/ADA-120023455; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HASIN DS, 1988, DUAL DIAGNOSIS TREAT; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIGGINS ST, 1993, AM J PSYCHIAT, V150, P763; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KLEBER HD, 1983, ARCH GEN PSYCHIAT, V40, P649; KRANZLER H, 2002, 26 ANN M RES SOC ALC; KRANZLER HR, 1995, AM J PSYCHIAT, V152, P391; KRUPITSKY EM, 1993, DRUG ALCOHOL DEPEN, V33, P157, DOI 10.1016/0376-8716(93)90057-W; LEVIN FR, IN PRESS TXB SUBSANT; LEVY JC, 1989, AM J PSYCHIAT, V146, P1462; Liappas J, 2002, DRUG ALCOHOL DEPEN, V68, P215, DOI 10.1016/S0376-8716(02)00195-3; LIPSEY MW, 2003, APPL SOCIAL RES METH, V49; LISKOW BI, 1987, J STUD ALCOHOL, V48, P356, DOI 10.15288/jsa.1987.48.356; Margolin A, 1995, DRUG ALCOHOL DEPEN, V40, P125, DOI 10.1016/0376-8716(95)01198-6; MASON BJ, 1991, PSYCHOPHARMACOL BULL, V27, P155; Mason BJ, 1996, JAMA-J AM MED ASSOC, V275, P761, DOI 10.1001/jama.275.10.761; McGrath PJ, 1996, ARCH GEN PSYCHIAT, V53, P232; McLean P C, 1986, Psychiatr Pol, V20, P417; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moak DH, 2003, J CLIN PSYCHOPHARM, V23, P553, DOI 10.1097/01.jcp.0000095346.32154.41; MURPHY GE, 1992, ARCH GEN PSYCHIAT, V49, P459; NUNES E, 1994, J ADDICT DIS, V13, P13; Nunes EV, 1998, ARCH GEN PSYCHIAT, V55, P153, DOI 10.1001/archpsyc.55.2.153; NUNES EV, 1993, AM J PSYCHIAT, V150, P963; NUNES EV, 1995, DRUG ALCOHOL DEPEN, V39, P185, DOI 10.1016/0376-8716(95)01161-6; Petrakis I, 1998, DRUG ALCOHOL DEPEN, V50, P221, DOI 10.1016/S0376-8716(98)00032-5; Petrakis IL, 2003, J CLIN PSYCHIAT, V64, P865, DOI 10.4088/JCP.v64n0802; Pettinati HM, 2001, J CLIN PSYCHOPHARM, V21, P143, DOI 10.1097/00004714-200104000-00005; POWELL BJ, 1995, ALCOHOL CLIN EXP RES, V19, P462, DOI 10.1111/j.1530-0277.1995.tb01532.x; RASKIN A, 1969, J NERV MENT DIS, V148, P87, DOI 10.1097/00005053-196901000-00010; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; ROUNSAVILLE BJ, 1986, COMPR PSYCHIAT, V27, P480, DOI 10.1016/0010-440X(86)90036-2; Roy A, 1998, BIOL PSYCHIAT, V44, P633, DOI 10.1016/S0006-3223(97)00509-X; Roy-Byrne PP, 2000, J CLIN PSYCHOPHARM, V20, P129, DOI 10.1097/00004714-200004000-00003; SATEL SL, 1991, AM J PSYCHIAT, V148, P1712; Schmitz JM, 2001, DRUG ALCOHOL DEPEN, V63, P207, DOI 10.1016/S0376-8716(00)00208-8; SCHUCKIT MA, 1986, AM J PSYCHIAT, V143, P140; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHAW JA, 1975, AM J PSYCHIAT, V132, P641; SIRIS SG, 1992, PROG NEURO-PSYCHOPH, V16, P539, DOI 10.1016/0278-5846(92)90059-N; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; TITIEVSKY J, 1982, J CLIN PSYCHIAT, V43, P454; Tondo L, 1999, J CLIN PSYCHIAT, V60, P63; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; WEDDINGTON WW, 1990, ARCH GEN PSYCHIAT, V47, P861; WEISS RD, DUAL DIAGNOSIS TREAT; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; WILSON IC, 1970, PSYCHOSOMATICS, V11, P488; WOODY GE, 1982, ANN NY ACAD SCI, V398, P120, DOI 10.1111/j.1749-6632.1982.tb39485.x; WOODY GE, 1975, AM J PSYCHIAT, V132, P447; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; ZIEDONIS DM, 1991, PSYCHOPHARMACOL BULL, V27, P337	83	375	382	1	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1887	1896		10.1001/jama.291.15.1887	http://dx.doi.org/10.1001/jama.291.15.1887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812XC	15100209				2022-12-28	WOS:000220871200031
J	Marshall, T				Marshall, T			When measurements are misleading: modelling the effects of blood pressure misclassification in English population	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	T.P.Marshall@bham.ac.uk		Marshall, Tom/0000-0001-9277-5214				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1978, J Chronic Dis, V31, P651; *DEP HLTH, HLTH SURV ENGL 1998; Wood D, 1998, HEART, V80, pS1; Wright JM., 2000, 8 INT COCHR C	5	27	28	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					933	933		10.1136/bmj.328.7445.933	http://dx.doi.org/10.1136/bmj.328.7445.933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087340	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000220994400025
J	Coleman, SW; Patricelli, GL; Borgia, G				Coleman, SW; Patricelli, GL; Borgia, G			Variable female preferences drive complex male displays	NATURE			English	Article							BOWERBIRDS PTILONORHYNCHUS-VIOLACEUS; SATIN BOWERBIRD; MATE-CHOICE; CONSEQUENCES; QUALITY; SIGNALS	Complexity in male sexual displays is widely appreciated(1) but diversity in female mate choice has received little attention. Males of many species have sexual displays composed of multiple display traits, and females are thought to use these different traits in mate choice(1). Models of multiple display trait evolution suggest that these traits provide females with different kinds of information in different stages of the mate choice process(2), or function as redundant signals to improve the accuracy of mate assessment(3),(4). We suggest that complex male displays might also arise because of variation in female preferences for particular male display traits. The causes of female preference variation have received little attention(5-7), and the role of preference variation in shaping complex male displays is unclear. Here we show that in satin bowerbirds (Ptilonorhynchus violaceus) female mate choice is a multistage process, where females of different ages use different male display traits in successive stages. Age- and stage-specific female preferences may contribute to explaining the widespread occurrence of multifaceted male displays.	Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Coleman, SW (corresponding author), Univ Maryland, Behav Ecol Evolut & Systemat Program, College Pk, MD 20742 USA.	Coleman@umd.edu	Patricelli, Gail L/L-3730-2017	Borgia, Gerald/0000-0002-2669-9548; Patricelli, Gail/0000-0003-3397-8390				Andersson Malte, 1994; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; BORGIA G, 1986, ANIM BEHAV, V34, P727, DOI 10.1016/S0003-3472(86)80056-2; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Patricelli GL, 2004, BEHAV ECOL, V15, P297, DOI 10.1093/beheco/arh013; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; Uy JAC, 2001, P ROY SOC B-BIOL SCI, V268, P633, DOI 10.1098/rspb.2000.1413; Uy JAC, 2001, AM NAT, V158, P530, DOI 10.1086/323118; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6	18	183	184	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					742	745		10.1038/nature02419	http://dx.doi.org/10.1038/nature02419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085130				2022-12-28	WOS:000220823800037
J	Olszewski, TD; Erwin, DH				Olszewski, TD; Erwin, DH			Dynamic response of Permian brachiopod communities to long-term environmental change	NATURE			English	Article							SPECIES-ABUNDANCE; NEUTRAL THEORY; MODEL	The fossil record preserves numerous natural experiments that can shed light on the response of ecological communities to environmental change. However, directly observing the community dynamics of extinct organisms is not possible. As an alternative, neutral ecological models(1-3) suggest that species abundance distributions reflect dynamical processes like migration, competition, recruitment, and extinction. Live-dead comparisons suggest that such distributions can be faithfully preserved in the rock record(4). Here we use a maximum-likelihood approach to show that brachiopod (lamp shell) abundance distributions from four temporally distinct ecological landscapes from the Glass Mountains, Texas (of the Permian period), exhibit significant differences. Further, all four are better fitted by zero-sum multinomial distributions, characteristic of Hubbell's neutral model(2), than by log-normal distributions, as predicted by the traditional ecological null hypothesis(5). Using the neutral model as a guide, we suggest that sea level fluctuations spanning about 10 Myr altered the degrees of isolation and exchange among local communities within these ecological landscapes. Neither these long-term environmental changes nor higher-frequency sea level fluctuations resulted in wholesale extinction or major innovation within evolutionary lineages.	Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; Smithsonian Inst, Dept Paleobiol, NMNH, Washington, DC 20013 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Texas A&M University System; Texas A&M University College Station; Smithsonian Institution; Smithsonian National Museum of Natural History; The Santa Fe Institute	Olszewski, TD (corresponding author), Texas A&M Univ, Dept Geol & Geophys, 3115 TAMU, College Stn, TX 77843 USA.	tomo@geo.tamu.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614; Olszewski, Thomas/0000-0002-0179-6536				Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Carroll M, 2003, PALEOBIOLOGY, V29, P381, DOI 10.1666/0094-8373(2003)029<0381:QEOTIT>2.0.CO;2; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Cooper G.A., 1974, Smithsonian Contributions to Paleobiology, VNo. 15, P233; Cooper G.A., 1972, Smithsonian Contributions to Paleobiology, VNo. 14, P1; Cooper G.A., 1976, Smithsonian Contributions to Paleobiology, VNo. 21, P1923; Cooper G. A, 1977, Smithsonian Contributions to Paleobiology, VNo. 32, P3161; Cooper G.A., 1976, SMITHSON CONTRIB PAL, V24, P2609; Cooper G.A., 1975, SMITHSON CONTRIB PAL, V19, P795; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; HARRIS MT, 2000, SMITHSONIAN CONTRIBU, V32, P153; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; HUGHES RG, 1984, MAR ECOL PROG SER, V15, P1, DOI 10.3354/meps015001; Jin YG, 1997, EPISODES, V20, P10; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; May R.M., 1975, P81; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; ROHR D. M., 2000, SMITHSON CONTRIB EAR, V32, P5; ROUTLEDGE RD, 1980, J THEOR BIOL, V82, P547, DOI 10.1016/0022-5193(80)90177-0; Sarg J., 1999, ADV CARBONATE SEQUEN, P11, DOI 10.2110/pec.99.11.0011; SARG JF, 1986, LOWER MIDDLE GUADALU, P1; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; WARDLAW BR, 2000, SMITHSONIAN CONTRIBU, V32, P121; Wardlaw Bruce R., 2000, Smithsonian Contributions to the Earth Sciences, V32, P37	30	39	42	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					738	741		10.1038/nature02464	http://dx.doi.org/10.1038/nature02464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085129				2022-12-28	WOS:000220823800036
J	Brewer, HB				Brewer, HB			Increasing HDL cholesterol levels	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIGH-DENSITY-LIPOPROTEINS; ATHEROSCLEROSIS; TARGET		NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Brewer, HB (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.							Barter PJ, 2002, CURR OPIN LIPIDOL, V13, P285, DOI 10.1097/00041433-200206000-00008; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292	5	105	113	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1491	1494		10.1056/NEJMp048023	http://dx.doi.org/10.1056/NEJMp048023			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071124				2022-12-28	WOS:000220682000004
J	Matsuzaki, M; Misumi, O; Shin-I, T; Maruyama, S; Takahara, M; Miyagishima, SY; Mori, T; Nishida, K; Yagisawa, F; Nishida, K; Yoshida, Y; Nishimura, Y; Nakao, S; Kobayashi, T; Momoyama, Y; Higashiyama, T; Minoda, A; Sano, M; Nomoto, H; Oishi, K; Hayashi, H; Ohta, F; Nishizaka, S; Haga, S; Miura, S; Morishita, T; Kabeya, Y; Terasawa, K; Suzuki, Y; Ishii, Y; Asakawa, S; Takano, H; Ohta, N; Kuroiwa, H; Tanaka, K; Shimizu, N; Sugano, S; Sato, N; Nozaki, H; Ogasawara, N; Kohara, Y; Kuroiwa, T				Matsuzaki, M; Misumi, O; Shin-I, T; Maruyama, S; Takahara, M; Miyagishima, SY; Mori, T; Nishida, K; Yagisawa, F; Nishida, K; Yoshida, Y; Nishimura, Y; Nakao, S; Kobayashi, T; Momoyama, Y; Higashiyama, T; Minoda, A; Sano, M; Nomoto, H; Oishi, K; Hayashi, H; Ohta, F; Nishizaka, S; Haga, S; Miura, S; Morishita, T; Kabeya, Y; Terasawa, K; Suzuki, Y; Ishii, Y; Asakawa, S; Takano, H; Ohta, N; Kuroiwa, H; Tanaka, K; Shimizu, N; Sugano, S; Sato, N; Nozaki, H; Ogasawara, N; Kohara, Y; Kuroiwa, T			Genome sequence of the ultrasmall unicellular red alga Cyanidioschyzon merolae 10D	NATURE			English	Article							CHLOROPLAST DIVISION MACHINERY; MITOCHONDRIA; PLASTIDS; REVEALS; DYNAMIN; PROTEIN; GENES; PROLIFERATION; ENDOSYMBIOSIS; EUKARYOTES	Small, compact genomes of ultrasmall unicellular algae provide information on the basic and essential genes that support the lives of photosynthetic eukaryotes, including higher plants(1,2). Here we report the 16,520,305-base-pair sequence of the 20 chromosomes of the unicellular red alga Cyanidioschyzon merolae 10D as the first complete algal genome. We identified 5,331 genes in total, of which at least 86.3% were expressed. Unique characteristics of this genomic structure include: a lack of introns in all but 26 genes; only three copies of ribosomal DNA units that maintain the nucleolus; and two dynamin genes that are involved only in the division of mitochondria and plastids. The conserved mosaic origin of Calvin cycle enzymes in this red alga and in green plants supports the hypothesis of the existence of single primary plastid endosymbiosis. The lack of a myosin gene, in addition to the unexpressed actin gene, suggests a simpler system of cytokinesis. These results indicate that the C. merolae genome provides a model system with a simple gene composition for studying the origin, evolution and fundamental mechanisms of eukaryotic cells.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Shizuoka 4118540, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Univ, Fac Sci, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjyuku Ku, Tokyo 1608582, Japan; Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; National Agriculture & Food Research Organization - Japan; University of Tokyo; Saitama University; University of Tokyo; Keio University; Kumamoto University; Nara Institute of Science & Technology	Tanaka, K (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, 3-34-1 Nishiikebukuro, Tokyo 1718501, Japan.	mzaki@biol.s.u-tokyo.ac.jp; tsune@rikkyo.ne.jp	Tanaka, Kan/E-3724-2015; Minoda, Ayumi/GQB-3657-2022; Higashiyama, Tetsuya/C-2882-2012; Ogasawara, Naotake/B-7971-2011; Matsuzaki, Motomichi/D-4043-2016; Mori, Toshiyuki/F-8488-2013; Maruyama, Shinichiro/AAO-4764-2021	Tanaka, Kan/0000-0001-7560-7884; Minoda, Ayumi/0000-0003-1968-7984; Higashiyama, Tetsuya/0000-0002-7346-360X; Matsuzaki, Motomichi/0000-0001-5811-798X; Sato, Naoki/0000-0001-6230-0410; Miyagishima, Shin-ya/0000-0002-9111-0832; Takano, Hiroyoshi/0000-0003-4720-5057; Nozaki, Hisayoshi/0000-0002-9308-4498; Kabeya, Yukihiro/0000-0001-6328-0765; Nishimura, Yoshiki/0000-0001-8686-9206				Cavalier-Smith T, 2003, PHILOS T R SOC B, V358, P109, DOI 10.1098/rstb.2002.1194; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kuroiwa H, 2002, PLANTA, V215, P185, DOI 10.1007/s00425-002-0734-4; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Kuroiwa T, 1998, BIOESSAYS, V20, P344, DOI 10.1002/(SICI)1521-1878(199804)20:4<344::AID-BIES11>3.3.CO;2-L; Kuroiwa Tsuneyoshi, 1994, Cytologia (Tokyo), V59, P149; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; McFadden GI, 2003, P NATL ACAD SCI USA, V100, P3557, DOI 10.1073/pnas.0831049100; Miyagishima M, 1998, PROTOPLASMA, V201, P115, DOI 10.1007/BF01280718; Miyagishima S, 1999, PLANTA, V208, P326, DOI 10.1007/s004250050566; Miyagishima SY, 2003, TRENDS PLANT SCI, V8, P432, DOI 10.1016/S1360-1385(03)00193-6; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; Ohta N, 1997, J PLANT RES, V110, P235, DOI 10.1007/BF02509312; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; SURRIDGE D, 2003, NATURE, V422, P275; Takahara M, 2000, MOL GEN GENET, V264, P452, DOI 10.1007/s004380000307; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terui S, 1995, J PHYCOL, V31, P958, DOI 10.1111/j.0022-3646.1995.00958.x; Toda Kyoko, 1995, Cytologia (Tokyo), V60, P183; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zauner S, 2000, P NATL ACAD SCI USA, V97, P200, DOI 10.1073/pnas.97.1.200	31	805	842	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					653	657		10.1038/nature02398	http://dx.doi.org/10.1038/nature02398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071595	hybrid			2022-12-28	WOS:000220697200044
J	Nowak, MA; Sasaki, A; Taylor, C; Fudenberg, D				Nowak, MA; Sasaki, A; Taylor, C; Fudenberg, D			Emergence of cooperation and evolutionary stability in finite populations	NATURE			English	Article							TIT-FOR-TAT; STABLE STRATEGIES; GAMES	To explain the evolution of cooperation by natural selection has been a major goal of biologists since Darwin. Cooperators help others at a cost to themselves, while defectors receive the benefits of altruism without providing any help in return. The standard game dynamical formulation is the 'Prisoner's Dilemma'(1-11), in which two players have a choice between cooperation and defection. In the repeated game, cooperators using direct reciprocity cannot be exploited by defectors, but it is unclear how such cooperators can arise in the first place(12-15). In general, defectors are stable against invasion by cooperators. This understanding is based on traditional concepts of evolutionary stability and dynamics in infinite populations(16-20). Here we study evolutionary game dynamics in finite populations(21-25). We show that a single cooperator using a strategy like 'tit-for-tat' can invade a population of defectors with a probability that corresponds to a net selective advantage. We specify the conditions required for natural selection to favour the emergence of cooperation and define evolutionary stability in finite populations.	Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Math, Cambridge, MA 02138 USA; Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; MIT, Dept Math, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Harvard University; Kyushu University; Massachusetts Institute of Technology (MIT)	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008					AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Dugatkin L.A., 1997, COOPERATION ANIMALS; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; FICCI S, 2000, P 2000 GEN EV COMP C, P927; Fogel GB, 1998, ECOL MODEL, V109, P283, DOI 10.1016/S0304-3800(98)00068-4; FUDENBERG D, 1990, AM ECON REV, V80, P274; FUDENBERG D, 1992, J ECON THEORY, V57, P420, DOI 10.1016/0022-0531(92)90044-I; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammerstein P., 2003, GENETIC CULTURAL EVO; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Killingback T, 1998, J THEOR BIOL, V191, P335, DOI 10.1006/jtbi.1997.0602; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; MAY RM, 1987, NATURE, V327, P15, DOI 10.1038/327015a0; Maynard Smith J., 1982, pi; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; RILEY JG, 1979, J THEOR BIOL, V76, P109, DOI 10.1016/0022-5193(79)90365-5; SCHAFFER ME, 1988, J THEOR BIOL, V132, P469, DOI 10.1016/S0022-5193(88)80085-7; Schreiber SJ, 2001, SIAM J APPL MATH, V61, P2148, DOI 10.1137/S0036139999352857; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	31	888	923	16	301	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					646	650		10.1038/nature02414	http://dx.doi.org/10.1038/nature02414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071593	Green Submitted			2022-12-28	WOS:000220697200042
J	Vitiello, B; Swedo, S				Vitiello, B; Swedo, S			Antidepressant medications in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADOLESCENTS; DEPRESSION; FLUOXETINE; TRIAL		NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Vitiello, B (corresponding author), NIMH, Bethesda, MD 20892 USA.		Vitiello, Benedetto/AAC-1758-2022		NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002666, ZIAMH002666] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P1236, DOI 10.1001/archpsyc.60.12.1236; *PSYCH DRUGS ADV C, 2004, BRIEF INF	5	66	67	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1489	1491		10.1056/NEJMp038248	http://dx.doi.org/10.1056/NEJMp038248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810CI	15071123				2022-12-28	WOS:000220682000003
J	Fox, NC; Schott, JM				Fox, NC; Schott, JM			Imaging cerebral atrophy: normal ageing to Alzheimer's disease	LANCET			English	Review							MAGNETIC-RESONANCE IMAGES; HIPPOCAMPAL ATROPHY; COGNITIVE DECLINE; LONGITUDINAL MRI; BRAIN ATROPHY; TEMPORAL-LOBE; GRAY-MATTER; HUMAN LIFE; RATES; HEALTHY	Context With ageing populations, the prevalence of dementia, especially Alzheimer's disease, is set to soar. Alzheimer's disease is associated with progressive cerebral atrophy, which can be seen on MRI with high resolution. Longitudinal MRI could track disease progression and detect neurodegenerative diseases earlier to allow prompt and specific treatment. Such use of MRI requires accurate understanding of how brain changes in normal ageing differ from those in dementia. Starting point Recently, Henry Rusinek and colleagues, in a 6-year longitudinal MRI study of initially healthy elderly subjects, showed that an increased rate of atrophy in the medial temporal lobe predicted future cognitive decline with a specificity of 91% and sensitivity of 89% (Radiology 2003; 229: 691-96). Where next? As understanding of neurodegenerative diseases increases, specific disease-modifying treatments might become available. Serial MRI could help to determine the efficacy of such treatments, which would be expected to slow the rate of atrophy towards that of normal ageing, and might also detect the onset of neurodegeneration. The amount and pattern of excess atrophy might help to predict the underlying pathological process, allowing specific therapies to be started. As the precision of imaging improves, the ability to distinguish healthy ageing from degenerative dementia should improve.	Inst Neurol, Dementia Res Grp, London WC1N 3BG, England	University of London; University College London	Fox, NC (corresponding author), Inst Neurol, Dementia Res Grp, Queen Sq, London WC1N 3BG, England.	nfox@dementia.ion.ucl.ac.uk	Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009; Schott, Jonathan M/A-9065-2011	Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Schott, Jonathan M/0000-0003-2059-024X	Medical Research Council [G116/143] Funding Source: Medline; MRC [G116/143] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Blinkov SM., 1968, HUMAN BRAIN FIGURES; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; MILLER AKH, 1977, ANN HUM BIOL, V4, P253, DOI 10.1080/03014467700007142; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mueller EA, 1998, NEUROLOGY, V51, P1555, DOI 10.1212/WNL.51.6.1555; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schott JM, 2003, ANN NEUROL, V53, P181, DOI 10.1002/ana.10424; Silbert LC, 2003, NEUROLOGY, V61, P487, DOI 10.1212/01.WNL.0000079053.77227.14; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2003, J NEUROSCI, V23, P994	32	282	286	2	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					392	394		10.1016/S0140-6736(04)15441-X	http://dx.doi.org/10.1016/S0140-6736(04)15441-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15074306				2022-12-28	WOS:000188590900025
J	Hetzel, M; Hetzel, J; Arslandemir, C; Nussle, K; Schirrmeister, H				Hetzel, M; Hetzel, J; Arslandemir, C; Nussle, K; Schirrmeister, H			Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany; Univ Ulm, Dept Nucl Med, D-89069 Ulm, Germany; Univ Ulm, Dept Diagnost Radiol, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Hetzel, M (corresponding author), Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany.	martin.hetzel@medizin.uni-ulm.de						[Anonymous], 1997, AM J RESP CRIT CARE, V156, P320; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; MICHEL F, 1991, THORAX, V46, P469, DOI 10.1136/thx.46.7.469; Silvestri GA, 2003, CHEST, V123, p147S, DOI 10.1378/chest.123.1_suppl.147S	4	16	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1051	1052		10.1136/bmj.328.7447.1051	http://dx.doi.org/10.1136/bmj.328.7447.1051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117792	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000221174500017
J	Narasimhan, V; Brown, H; Pablos-Mendez, A; Adams, O; Dussault, G; Elzinga, G; Nordstrom, A; Habte, D; Jacobs, M; Solimano, G; Sewankambo, N; Wibulpolprasert, S; Evans, T; Chen, L				Narasimhan, V; Brown, H; Pablos-Mendez, A; Adams, O; Dussault, G; Elzinga, G; Nordstrom, A; Habte, D; Jacobs, M; Solimano, G; Sewankambo, N; Wibulpolprasert, S; Evans, T; Chen, L			Responding to the global human resources crisis	LANCET			English	Article								The global community is in the midst of a growing response to health crises in developing countries, which is focused on mobilising financial resources and increasing access to essential medicines. However, the response has yet to tackle the most important aspect of health-care systems-the people that make them work. Human resources for health-the personnel that deliver public-health, clinical, and environmental services-are in disarray and decline in much of the developing world, particularly in sub-Saharan Africa. The reasons behind this disorder are complex. For decades, efforts have focused on building training institutions. What is becoming increasingly clear, however, is that issues of supply, demand, and mobility (transnational, regional, and local) are central to the human-resource problem. Without substantial improvements in workforces, newly mobilised funds and commodities will not deliver on their promise. The global community needs to engage in four core strategies: raise the profile of the issue of human resources; improve the conceptual base and statistical evidence available to decision makers; collect, share, and learn from country experiences; and begin to formulate and enact policies at the country level that affect all aspects of the crisis.	Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Rockefeller Fdn, Hlth Equ, New York, NY USA; WHO, Hlth Serv Provis, CH-1211 Geneva, Switzerland; WHO, Gen Management & Adm, CH-1211 Geneva, Switzerland; WHO, Evidence & Informat Policy, CH-1211 Geneva, Switzerland; World Bank Inst, Washington, DC USA; Natl Inst Publ Hlth & Environm, Amsterdam, Netherlands; Univ Cape Town, Childrens Inst, ZA-7925 Cape Town, South Africa; Univ Chile, Sch Publ Hlth, Santiago, Chile; Makerere Univ, Fac Med, Kampala, Uganda; Minist Hlth, Bangkok, Thailand	Harvard University; World Health Organization; World Health Organization; World Health Organization; The World Bank; Netherlands National Institute for Public Health & the Environment; University of Cape Town; Universidad de Chile; Makerere University; Ministry of Public Health - Thailand	Narasimhan, V (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	vasant_narasimhan@ksg03.harvard.edu	Dussault, Gilles/I-8495-2012	Sewankambo, Nelson/0000-0001-9362-053X; Dussault, Gilles/0000-0002-5976-3454				*ACHAP, 2001, AFR COMPR HIV AIDS P; Adams O, 2000, ACHIEVING RIGHT BALA; *AFRO WORLD BANK, 2002, HUM RES AFR WORKSH S; Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; Chomitz K, 1998, 1888 WORLD BANK; COHEN D, 2002, 2 INT LAB ORG; *COMM SECR, COMM COD PRACT INT R; DOVLO D, 2003, BRAIN DRAIN RETENTIO; FAWFIK L, 2001, IMPACT HIV AIDS HLTH; Flexner A., 1910, FLEXNER REPORT; HAMMER J, 2001, 2547 WPS WORLD BANK; ILO, 1999, TERMS EMPL WORK COND; MARTINEAU T, 2002, BRIEFING NOTE INT MI; Martinez J, 1998, HEALTH POLICY PLANN, V13, P345, DOI 10.1093/heapol/13.4.345; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; Rigoli F, 2003, HUM RESOUR HEALTH, V1, P9, DOI DOI 10.1186/1478-4491-1-9; Salvatore C, 2000, GOVT EMPLOYMENT PAY; *WHO, DECL TRIPS AGR PUBL; *WHO, 2001, CAT WORLD MED SCH; Wibulpolprasert Suwit, 2003, Hum Resour Health, V1, P12, DOI 10.1186/1478-4491-1-12; World Bank, 1993, INV HLTH WORLD DEV R; *WORLD BANK, COSTS ATT MILL DEV G; World Health Organisation, 2002, WORLD HLTH STAT; 1915, WELCH ROSE REPORT SC; 2001, PUBLIC HLTH WORKFORC	25	179	182	3	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1469	1472		10.1016/S0140-6736(04)16108-4	http://dx.doi.org/10.1016/S0140-6736(04)16108-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121412				2022-12-28	WOS:000221130300022
J	Vinke, JG; Borgstein, J				Vinke, JG; Borgstein, J			Red ears as red herring	LANCET			English	Editorial Material									Erasmus MC, ENT Dept, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vinke, JG (corresponding author), Erasmus MC, ENT Dept, NL-3015 GD Rotterdam, Netherlands.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1421	1421		10.1016/S0140-6736(04)16099-6	http://dx.doi.org/10.1016/S0140-6736(04)16099-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121403	Bronze			2022-12-28	WOS:000221130300007
J	Petersen, CCH; Brecht, M; Hahn, TTG; Sakmann, B				Petersen, CCH; Brecht, M; Hahn, TTG; Sakmann, B			RETRACTED: Synaptic changes in layer 2/3 underlying map plasticity of developing barrel cortex (Retracted article. See vol 306, pg. 54, 2004)	SCIENCE			English	Article; Retracted Publication							EXPERIENCE-DEPENDENT PLASTICITY; CAT STRIATE CORTEX; VISUAL-CORTEX; IN-VIVO; HORIZONTAL CONNECTIONS; SENSORY DEPRIVATION; CORTICAL PLASTICITY; DENDRITIC SPINES; RESPONSES; SYNAPSES	The functional and anatomical rearrangements of cortical sensory maps accompanying changes in experience are not well understood. We examined in vivo and in vitro how the sensory map and underlying synaptic connectivity of the developing rat barrel cortex are altered when the sensory input to the cortex is partially deprived. In the nondeprived cortex, both the sensory responses and synaptic connectivity between columns were strengthened through an increase in the synaptic connection probability between L2/3 pyramids in adjacent columns. This was accompanied by a selective growth of L2/3 pyramid axonal arbors between spared columns. In contrast, deprived and nondeprived cortical columns became weakly connected in their L2/3 pyramid connections.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Ecole Polytech Fed Lausanne, Lab Sensory Proc Brain & Mind Inst, CH-1015 Lausanne, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	carl.petersen@epfl.ch		Brecht, Michael/0000-0002-5387-0953				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Haydon D., UNPUB; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Schierloh A, 2003, NEUROREPORT, V14, P1787, DOI 10.1097/00001756-200310060-00006; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	29	11	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					739	742		10.1126/science.1096750	http://dx.doi.org/10.1126/science.1096750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118164				2022-12-28	WOS:000221105300047
J	Foote, AD; Osborne, RW; Hoelzel, AR				Foote, AD; Osborne, RW; Hoelzel, AR			Environment - Whale-call response to masking boat noise	NATURE			English	Editorial Material							KILLER WHALES		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Whale Museum, Friday Harbor, WA 98250 USA	Durham University	Foote, AD (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	a.r.hoelzel@dur.ac.uk		Foote, Andrew/0000-0001-7384-1634				Bain David E., 1994, P243; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Heil P, 2003, P NATL ACAD SCI USA, V100, P6151, DOI 10.1073/pnas.1030017100; HOELZEL AR, 1993, ANIM BEHAV, V45, P581, DOI 10.1006/anbe.1993.1068; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; [No title captured]	8	182	191	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					910	910		10.1038/428910a	http://dx.doi.org/10.1038/428910a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118717	Bronze			2022-12-28	WOS:000221083000031
J	Heckmann, JG; Ganslandt, O				Heckmann, JG; Ganslandt, O			The Mount Fuji sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Erlangen, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Heckmann, JG (corresponding author), Univ Hosp Erlangen, D-91054 Erlangen, Germany.								0	29	30	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1881	1881		10.1056/NEJMicm020479	http://dx.doi.org/10.1056/NEJMicm020479			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115834				2022-12-28	WOS:000221080300011
J	Nagashima, K; Krot, AN; Yurimoto, H				Nagashima, K; Krot, AN; Yurimoto, H			Stardust silicates from primitive meteorites	NATURE			English	Article							CARBONACEOUS CHONDRITE; SILICON-CARBIDE; SOLAR-SYSTEM; GRAINS	Primitive chondritic meteorites contain material (presolar grains(1)), at the level of a few parts per million, that predates the formation of our Solar System. Astronomical observations(2) and the chemical composition of the Sun(3) both suggest that silicates must have been the dominant solids in the protoplanetary disk from which the planets of the Solar System formed, but no presolar silicates have been identified in chondrites(4-6). Here we report the in situ discovery of presolar silicate grains 0.1 - 1 mum in size in the matrices of two primitive carbonaceous chondrites. These grains are highly enriched in O-17 (delta(17)O(SMOW) > 100 - 400%), but have solar silicon isotopic compositions within analytical uncertainties, suggesting an origin in an oxygen-rich red giant or an asymptotic giant branch star(7,8). The estimated abundance of these presolar silicates ( 3 - 30 parts per million) is higher than reported for other types of presolar grains in meteorites(1), consistent with their ubiquity in the early Solar System, but is about two orders of magnitude lower than their abundance in anhydrous interplanetary dust particles(9). This result is best explained by the destruction of silicates during high-temperature processing in the solar nebula.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	Tokyo Institute of Technology; University of Hawaii System; University of Hawaii Manoa	Nagashima, K (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	kazu@geo.titech.ac.jp	Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Nagashima, Kazuhide/0000-0002-9322-3187				ALEXANDER CMO, 2001, LUNAR PLANET SCI, V32, P2191; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BISCHOFF A, 1991, METEORITICS, V26, P318; BRADLEY JP, 1986, SCIENCE, V231, P1542, DOI 10.1126/science.231.4745.1542; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Dai ZR, 2002, NATURE, V418, P157, DOI 10.1038/nature00897; Greshake A, 1997, GEOCHIM COSMOCHIM AC, V61, P437, DOI 10.1016/S0016-7037(96)00332-8; Hewins R. H., 1996, CHONDRULES PROTOPLAN, P3; Hoppe P, 1997, AIP CONF PROC, P27, DOI 10.1063/1.53314; Huss GR, 2003, GEOCHIM COSMOCHIM AC, V67, P4823, DOI 10.1016/j.gca.2003.07.019; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Jessberger EK, 2001, ASTR AST LI, P253; Krot AN, 2002, METEORIT PLANET SCI, V37, P1451, DOI 10.1111/j.1945-5100.2002.tb00805.x; KUNIHIRO T, UNPUB GEOCHIM COSMOC; Lugaro M, 1999, ASTROPHYS J, V527, P369, DOI 10.1086/308078; Messenger S, 2000, METEORIT PLANET SCI, V35, pA109; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Mostefaoui S, 2003, METEORIT PLANET SCI, V38, pA99, DOI 10.1111/j.1945-5100.2003.tb00289.x; NEWTON J, 1995, METEORITICS, V30, P47, DOI 10.1111/j.1945-5100.1995.tb01211.x; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Nittler LR, 2003, EARTH PLANET SC LETT, V209, P259, DOI 10.1016/S0012-821X(02)01153-6; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; Yurimoto L, 2003, APPL SURF SCI, V203, P793, DOI 10.1016/S0169-4332(02)00825-5	23	154	155	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					921	924		10.1038/nature02510	http://dx.doi.org/10.1038/nature02510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118720				2022-12-28	WOS:000221083000034
J	Slovut, DP; Olin, JW				Slovut, DP; Olin, JW			Current concepts - Fibromuscular dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTERNAL CAROTID-ARTERY; TRANS-LUMINAL ANGIOPLASTY; TRANSLUMINAL RENAL ANGIOPLASTY; NATURAL-HISTORY; RENOVASCULAR HYPERTENSION; BALLOON ANGIOPLASTY; CEREBRAL PROTECTION; BRACHIAL-ARTERY; FOLLOW-UP; DISEASE		CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Olin, JW (corresponding author), CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, 1 Gustave L Levy Pl,Box 1033, New York, NY 10029 USA.	jeffrey.olin@msnyuhealth.org						Airoldi F, 2000, AM J HYPERTENS, V13, P1210, DOI 10.1016/S0895-7061(00)01206-1; Al-Mubarak N, 2001, CIRCULATION, V104, P1999, DOI 10.1161/hc4201.099224; ANDERSON CA, 1995, J VASC SURG, V22, P207, DOI 10.1016/S0741-5214(95)70132-X; ARCHIBALD GR, 1988, AM J ROENTGENOL, V151, P593, DOI 10.2214/ajr.151.3.593; Arning C, 2001, VASA-J VASCULAR DIS, V30, P160; BAERT AL, 1990, CARDIOVASC INTER RAD, V13, P22, DOI 10.1007/BF02576933; BALLARD JL, 1995, ANN VASC SURG, V9, P390, DOI 10.1007/BF02139412; Baumgartner I, 1997, KIDNEY INT, V51, P798, DOI 10.1038/ki.1997.112; Begelman S M, 2000, Semin Vasc Surg, V13, P153; Begelman SM, 2000, CURR OPIN RHEUMATOL, V12, P41, DOI 10.1097/00002281-200001000-00007; BELAN A, 1982, CARDIOVASC INTER RAD, V5, P79, DOI 10.1007/BF02552082; Birrer M, 2002, EUR J VASC ENDOVASC, V23, P146, DOI 10.1053/ejvs.2001.1559; Bisschops RHC, 2001, J VASC INTERV RADIOL, V12, P757, DOI 10.1016/S1051-0443(07)61449-3; Bofinger A, 2001, J HUM HYPERTENS, V15, P185, DOI 10.1038/sj.jhh.1001144; BONELLI FS, 1995, MAYO CLIN PROC, V70, P1041, DOI 10.4065/70.11.1041; BROWN MM, 1992, NEUROL RES, V14, P159, DOI 10.1080/01616412.1992.11740040; Carman TL, 2001, UROL CLIN N AM, V28, P815, DOI 10.1016/S0094-0143(01)80036-7; Chiche L, 1997, ANN VASC SURG, V11, P496, DOI 10.1007/s100169900081; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CLUZEL P, 1994, RADIOLOGY, V193, P227, DOI 10.1148/radiology.193.1.8090896; COLLINS GJ, 1981, ANN SURG, V194, P89, DOI 10.1097/00000658-198107000-00016; COWDA MS, 2003, J AM COLL CARDIOL, V41, P1305; CRAGG AH, 1989, RADIOLOGY, V172, P145, DOI 10.1148/radiology.172.1.2662248; Cutts S, 2000, EUR J VASC ENDOVASC, V19, P667, DOI 10.1053/ejvs.1999.1007; D'Souza SJA, 1998, J PEDIATR-US, V132, P1016, DOI 10.1016/S0022-3476(98)70401-9; Davidson RA, 1996, AM J KIDNEY DIS, V28, P334, DOI 10.1016/S0272-6386(96)90489-8; de Fraissinette B, 2003, CARDIOVASC INTER RAD, V26, P46, DOI 10.1007/s00270-002-1797-0; DEMENDONCA WC, 1981, AM J CLIN PATHOL, V75, P749, DOI 10.1093/ajcp/75.5.749; DUBLIN AB, 1984, AM J NEURORADIOL, V5, P646; EDWARDS JM, 1992, J VASC SURG, V15, P604, DOI 10.1016/0741-5214(92)90004-R; EFFENEY DJ, 1983, AUST NZ J SURG, V53, P527, DOI 10.1111/j.1445-2197.1983.tb02502.x; Finsterer J, 2000, J NEUROL NEUROSUR PS, V69, P683, DOI 10.1136/jnnp.69.5.683; Flamm SD, 1998, INT J CARDIOL, V66, pS151, DOI 10.1016/S0167-5273(98)00163-6; FOMMEI E, 1993, EUR J NUCL MED, V20, P617; Funabashi N, 2003, Heart, V89, P639, DOI 10.1136/heart.89.6.639; GARRIDO E, 1981, SURG NEUROL, V16, P469, DOI 10.1016/0090-3019(81)90252-4; GONCHARENKO V, 1981, RADIOLOGY, V139, P45, DOI 10.1148/radiology.139.1.7208940; Grimbert P, 1998, ARCH MAL COEUR VAISS, V91, P1069; HAGG A, 1987, ACTA CHIR SCAND, V153, P15; Hamed RMA, 1997, J PEDIATR SURG, V32, P1379, DOI 10.1016/S0022-3468(97)90328-6; HARRISON EG, 1971, MAYO CLIN PROC, V46, P161; Henry M, 2002, J ENDOVASC THER, V9, P1, DOI 10.1583/1545-1550(2002)009<0001:BOCPDC>2.0.CO;2; Horie T, 2002, JPN HEART J, V43, P301, DOI 10.1536/jhj.43.301; Hudgins L B, 1982, J Tenn Med Assoc, V75, P733; INSALL RL, 1992, EUR J VASCULAR SURG, V6, P668, DOI 10.1016/S0950-821X(05)80849-7; JAFF MR, 1993, J VASC MED BIOL, V4, P223; Janzen J, 1999, HEART VESSELS, V14, P277, DOI 10.1007/BF03257239; JENSEN G, 1995, KIDNEY INT, V48, P1936, DOI 10.1038/ki.1995.494; KINCAID OW, 1968, AMER J ROENTGENOL RA, V104, P271, DOI 10.2214/ajr.104.2.271; Klow NE, 1998, ACTA RADIOL, V39, P594, DOI 10.3109/02841859809175483; Kojima A, 2002, CARDIOVASC SURG, V10, P157, DOI 10.1016/S0967-2109(01)00111-9; Krumme B, 1997, NEPHROL DIAL TRANSPL, V12, P1067, DOI 10.1093/ndt/12.5.1067; Leadbetter WF, 1938, J UROLOGY, V39, P611, DOI 10.1016/S0022-5347(17)71895-2; LUSCHER TF, 1987, MAYO CLIN PROC, V62, P931; LUSCHER TF, 1986, NEPHRON, V44, P109, DOI 10.1159/000184059; MANDKE JV, 1993, CATHETER CARDIO DIAG, V30, P30, DOI 10.1002/ccd.1810300108; Marcos HB, 2000, SEMIN NEPHROL, V20, P450; MARTIN EC, 1980, RADIOLOGY, V135, P27, DOI 10.1148/radiology.135.1.6127750; MCCORMAC.LJ, 1966, AM HEART J, V72, P188, DOI 10.1016/0002-8703(66)90442-X; MCCORMACK LJ, 1958, AM J PATHOL, V34, P582; MEANEY TF, 1968, RADIOLOGY, V91, P881, DOI 10.1148/91.5.881; METTINGER KL, 1982, STROKE, V13, P53, DOI 10.1161/01.STR.13.1.53; METTINGER KL, 1982, STROKE, V13, P46, DOI 10.1161/01.STR.13.1.46; MOREAU P, 1993, J CARDIOVASC SURG, V34, P465; Mounier-Vehier C, 2002, AM J KIDNEY DIS, V40, P1138, DOI 10.1053/ajkd.2002.36855; Napoli V, 2002, EUR RADIOL, V12, P796, DOI 10.1007/s003300101121; NOVICK AC, 1987, JAMA-J AM MED ASSOC, V257, P498, DOI 10.1001/jama.257.4.498; Ohki T, 2002, J VASC SURG, V36, P1175, DOI 10.1067/mva.2002.129488; Olin Jeffrey W., 2002, Cardiology Clinics, V20, P547, DOI 10.1016/S0733-8651(02)00091-7; OLIN JW, 1995, ANN INTERN MED, V122, P833, DOI 10.7326/0003-4819-122-11-199506010-00004; OLIN JW, 1991, CURR OPIN CARDIOL, V6, P768, DOI 10.1097/00001573-199110000-00017; Pannier-Moreau I, 1997, J HYPERTENS, V15, P1797, DOI 10.1097/00004872-199715120-00092; PLOUIN PF, 1993, HYPERTENSION, V21, P89, DOI 10.1161/01.HYP.21.1.89; QUNIBI WJ, 1979, SOUTHERN MED J, V72, P1481, DOI 10.1097/00007611-197911000-00043; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Radhi, 1998, Int J Angiol, V7, P215, DOI 10.1007/s005479900098; Reiher L, 2000, EUR J VASC ENDOVASC, V20, P556, DOI 10.1053/ejvs.2000.1201; ROSENBERGER A, 1976, RADIOLOGY, V118, P579, DOI 10.1148/118.3.579; Rubin GD, 2003, EUR J RADIOL, V45, pS42, DOI 10.1016/S0720-048X(03)00036-6; RYBKA SJ, 1983, J UROLOGY, V129, P798, DOI 10.1016/S0022-5347(17)52369-1; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; SANG CN, 1989, HYPERTENSION, V14, P472, DOI 10.1161/01.HYP.14.5.472; SCHIEVINK WI, 1994, STROKE, V25, P2492, DOI 10.1161/01.STR.25.12.2492; SCHIEVINK WI, 1989, NEUROSURGERY, V25, P482; SCHREIBER MJ, 1984, UROL CLIN N AM, V11, P383; SMITH LL, 1987, J VASC SURG, V6, P482, DOI 10.1067/mva.1987.avs0060482; SOS TA, 1983, NEW ENGL J MED, V309, P274, DOI 10.1056/NEJM198308043090504; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; STARR DS, 1981, STROKE, V12, P196, DOI 10.1161/01.STR.12.2.196; STEWART MT, 1986, J VASC SURG, V3, P305, DOI 10.1067/mva.1986.avs0030305; Stokes JB, 1996, ARCH INTERN MED, V156, P2611, DOI 10.1001/archinte.156.22.2611; Surowiec SM, 2003, ANN VASC SURG, V17, P650, DOI 10.1007/s10016-003-0070-6; Suzuki H, 1999, HEART, V82, P251, DOI 10.1136/hrt.82.2.251; TEGTMEYER CJ, 1991, CIRCULATION, V83, P155; TSAI FY, 1986, AM J NEURORADIOL, V7, P349; Van Damme H, 1999, ACTA CHIR BELG, V99, P163; VANDENDUNGEN JJAM, 1990, BRIT J SURG, V77, P396, DOI 10.1002/bjs.1800770413; vanJaarsveld BC, 1997, ARCH INTERN MED, V157, P1226, DOI 10.1001/archinte.157.11.1226; VERTRUYEN M, 1993, ACTA CHIR BELG, P249; WELCH EL, 1985, NEW YORK STATE J MED, V85, P115; WELLS RP, 1982, NEUROSURGERY, V10, P39, DOI 10.1227/00006123-198201000-00007; WESEN CA, 1986, AM J SURG, V151, P448, DOI 10.1016/0002-9610(86)90100-5; WESSELY Z, 1973, ARCH PATHOL, V96, P179; WILMS GE, 1985, CARDIOVASC INTER RAD, V8, P20, DOI 10.1007/BF02552635; Yamaguchi R, 1996, AM J GASTROENTEROL, V91, P1635; YOSHIDA T, 1994, CARDIOVASC INTER RAD, V17, P99	106	478	522	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1862	1871		10.1056/NEJMra032393	http://dx.doi.org/10.1056/NEJMra032393			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115832				2022-12-28	WOS:000221080300009
J	Sudo, K; Kishimoto, R; Tajima, Y; Matsumoto, A; Tashiro, K				Sudo, K; Kishimoto, R; Tajima, Y; Matsumoto, A; Tashiro, K			A paralysed thumb	LANCET			English	Editorial Material							MONOPARESIS; INFARCTION; KNOB		Sapporo City Gen Hosp, Dept Neurol, Sapporo, Hokkaido 0608648, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0608648, Japan	Sapporo City General Hospital; Hokkaido University	Sudo, K (corresponding author), Sapporo City Gen Hosp, Dept Neurol, Sapporo, Hokkaido 0608648, Japan.	kazumasa-sudo@hokkaido.med.or.jp						Kohno Y, 1999, CLIN IMAG, V23, P149, DOI 10.1016/S0899-7071(99)00126-6; Tei H, 1999, NEURORADIOLOGY, V41, P269, DOI 10.1007/s002340050745; TERAO Y, 1993, STROKE, V24, P2118, DOI 10.1161/01.STR.24.12.2118; WAXMAN SG, 2000, CORRELATIVE NEUROANA, P145; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	5	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1364	1364		10.1016/S0140-6736(04)16047-9	http://dx.doi.org/10.1016/S0140-6736(04)16047-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110494				2022-12-28	WOS:000220996300011
J	Damste, JSS; Muyzer, G; Abbas, B; Rampen, SW; Masse, G; Allard, WG; Belt, ST; Robert, JM; Rowland, SJ; Moldowan, JM; Barbanti, SM; Fago, FJ; Denisevich, P; Dahl, J; Trindade, LAF; Schouten, S				Damste, JSS; Muyzer, G; Abbas, B; Rampen, SW; Masse, G; Allard, WG; Belt, ST; Robert, JM; Rowland, SJ; Moldowan, JM; Barbanti, SM; Fago, FJ; Denisevich, P; Dahl, J; Trindade, LAF; Schouten, S			The rise of the rhizosolenid diatoms	SCIENCE			English	Article							HASLEA-OSTREARIA SIMONSEN; ORGANIC-CARBON BURIAL; ISOPRENOID ALKENES; FOSSIL RECORD; IDENTIFICATION; C-25; SETIGERA; SILICA; SEDIMENTS; PENTAENE	The 18S ribosomal DNA molecular phylogeny and lipid composition of over 120 marine diatoms showed that the capability to biosynthesize highly branched isoprenoid (HBI) alkenes is restricted to two specific phylogenetic clusters, which independently evolved in centric and pennate diatoms. The molecular record of C-25 HBI chemical fossils in a large suite of well-dated marine sediments and petroleum revealed that the older cluster, composed of rhizosolenid diatoms, evolved 91.5+/-1.5 million years ago (Upper Turonian), enabling an accurate dating of the pace of diatom evolution that is unprecedented. The rapid rise of the rhizosolenid diatoms probably resulted from a major reorganization of the nutrient budget in the mid-Cretaceous oceans, triggered by plate tectonics.	Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Delft Univ Technol, Dept Biotechnol, Environm Biotechnol Grp, NL-2628 BC Delft, Netherlands; Univ Plymouth, Sch Earth Ocean & Environm Sci, Petr & Environm Geochem Grp, Plymouth PL4 8AA, Devon, England; Univ Nantes, ISOmer, UPRESEA 2663, Fac Sci, F-44322 Nantes 3, France; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Petrobras Res Ctr, CENPES, BR-20132970 Rio De Janeiro, Brazil	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Delft University of Technology; University of Plymouth; Nantes Universite; Stanford University; Petrobras	Damste, JSS (corresponding author), Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, POB 59, NL-1790 AB Den Burg, Netherlands.	damste@nioz.nl	Muyzer, Gerard/ABE-5834-2020; Damste, Jaap S Sinninghe/F-6128-2011; Muyzer, Gerard/A-3161-2013	Muyzer, Gerard/0000-0002-2422-0732; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Rampen, Sebastiaan/0000-0002-1092-6363; Barbanti, Silvana/0000-0001-5682-9764				ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Belt ST, 2000, GEOCHIM COSMOCHIM AC, V64, P3839, DOI 10.1016/S0016-7037(00)00464-6; Belt ST, 2002, PHYTOCHEMISTRY, V59, P141, DOI 10.1016/S0031-9422(01)00444-7; Belt ST, 2001, ORG GEOCHEM, V32, P1169, DOI 10.1016/S0146-6380(01)00102-4; Belt ST, 1996, TETRAHEDRON LETT, V37, P4755, DOI 10.1016/0040-4039(96)00926-4; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; COOLEN MJL, UNPUB; Damste JSS, 2002, J LIPID RES, V43, P1641, DOI 10.1194/jlr.M200148-JLR200; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Damste JSS, 1999, ORG GEOCHEM, V30, P1581; Dixit S, 2001, MAR CHEM, V73, P333, DOI 10.1016/S0304-4203(00)00118-3; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Kemp AES, 1999, NATURE, V398, P57, DOI 10.1038/18001; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; Kuypers MMM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000569; KUYPERS MMM, 2001, GEOL ULTRAIECTINA; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; MOLDOWAN JM, 1994, SCIENCE, V265, P768, DOI 10.1126/science.265.5173.768; Pike J, 1999, GEOLOGY, V27, P311, DOI 10.1130/0091-7613(1999)027<0311:DMIGOC>2.3.CO;2; ROBSON JN, 1986, NATURE, V324, P561, DOI 10.1038/324561a0; Round F. E., 1990, DIATOMS BIOL MORPHOL; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; VOLKMAN JK, 1994, ORG GEOCHEM, V21, P407, DOI 10.1016/0146-6380(94)90202-X; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0	26	196	208	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					584	587		10.1126/science.1096806	http://dx.doi.org/10.1126/science.1096806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105500				2022-12-28	WOS:000220975100048
J	Ikegaya, Y; Aaron, G; Cossart, R; Aronov, D; Lampl, I; Ferster, D; Yuste, R				Ikegaya, Y; Aaron, G; Cossart, R; Aronov, D; Lampl, I; Ferster, D; Yuste, R			Synfire chains and cortical songs: Temporal modules of cortical activity	SCIENCE			English	Article							SEQUENCES; NEURONS; REPLAY; DYNAMICS; PATTERNS	How can neural activity propagate through cortical networks built with weak, stochastic synapses? We find precise repetitions of spontaneous patterns of synaptic inputs in neocortical neurons in vivo and in vitro. These patterns repeat after minutes, maintaining millisecond accuracy. Calcium imaging of slices reveals reactivation of sequences of cells during the occurrence of repeated intracellular synaptic patterns. The spontaneous activity drifts with time, engaging different cells. Sequences of active neurons have distinct spatial structures and are repeated in the same order over tens of seconds, revealing modular temporal dynamics. Higher order sequences are replayed with compressed timing.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Columbia University; Northwestern University	Yuste, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rmy5@columbia.edu	Cossart, Rosa/E-7674-2014; Cossart, Rosa/AAT-7934-2020	Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638; Lampl, Ilan/0000-0002-9380-0730; Ikegaya, Yuji/0000-0003-2260-8191				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M., 1991, CORTICONICS; BIENENSTOCK E, 1995, NETWORK-COMP NEURAL, V6, P179, DOI 10.1088/0954-898X/6/2/004; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grinvald A, 2003, BIOPOLYMERS, V68, P422, DOI 10.1002/bip.10273; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Llinas R. R., 2002, 1 VORTEX NEURONS SEL; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; NOTTEBOHM F, 1990, PHILOS T R SOC B, V329, P115, DOI 10.1098/rstb.1990.0156; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILBERBERG G, 2004, J PHYSL, P19; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; STEVENS CF, 1994, CURR BIOL, V4, P268, DOI 10.1016/S0960-9822(00)00062-2; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	31	604	613	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					559	564		10.1126/science.1093173	http://dx.doi.org/10.1126/science.1093173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105494				2022-12-28	WOS:000220975100041
J	Wright, IJ; Reich, PB; Westoby, M; Ackerly, DD; Baruch, Z; Bongers, F; Cavender-Bares, J; Chapin, T; Cornelissen, JHC; Diemer, M; Flexas, J; Garnier, E; Groom, PK; Gulias, J; Hikosaka, K; Lamont, BB; Lee, T; Lee, W; Lusk, C; Midgley, JJ; Navas, ML; Niinemets, U; Oleksyn, J; Osada, N; Poorter, H; Poot, P; Prior, L; Pyankov, VI; Roumet, C; Thomas, SC; Tjoelker, MG; Veneklaas, EJ; Villar, R				Wright, IJ; Reich, PB; Westoby, M; Ackerly, DD; Baruch, Z; Bongers, F; Cavender-Bares, J; Chapin, T; Cornelissen, JHC; Diemer, M; Flexas, J; Garnier, E; Groom, PK; Gulias, J; Hikosaka, K; Lamont, BB; Lee, T; Lee, W; Lusk, C; Midgley, JJ; Navas, ML; Niinemets, U; Oleksyn, J; Osada, N; Poorter, H; Poot, P; Prior, L; Pyankov, VI; Roumet, C; Thomas, SC; Tjoelker, MG; Veneklaas, EJ; Villar, R			The worldwide leaf economics spectrum	NATURE			English	Article							PHOTOSYNTHESIS-NITROGEN RELATIONS; LIFE-SPAN; USE EFFICIENCY; HIGH-RAINFALL; DRY MASS; AREA; NUTRIENT; PLANT; LEAVES; CARBON	Bringing together leaf trait data spanning 2,548 species and 175 sites we describe, for the first time at global scale, a universal spectrum of leaf economics consisting of key chemical, structural and physiological properties. The spectrum runs from quick to slow return on investments of nutrients and dry mass in leaves, and operates largely independently of growth form, plant functional type or biome. Categories along the spectrum would, in general, describe leaf economic variation at the global scale better than plant functional types, because functional types overlap substantially in their leaf traits. Overall, modulation of leaf traits and trait relationships by climate is surprisingly modest, although some striking and significant patterns can be seen. Reliable quantification of the leaf economics spectrum and its interaction with climate will prove valuable for modelling nutrient fluxes and vegetation boundaries under changing land-use and climate.	Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Simon Bolivar, Dept Estudios Ambientales, Caracas 1080, Venezuela; Wageningen Univ, Forest Ecol & Forest Management Grp, Dept Environm Sci, NL-6700 AH Wageningen, Netherlands; Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Vrije Univ Amsterdam, Inst Ecol Sci, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Zurich, Inst Umwelwissensch, Zurich, Switzerland; Univ Illes Balears, Dept Biol, Lab Fisiol Vegetal, Palma de Mallorca 07122, Illes Balears, Spain; Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, F-34293 Montpellier 5, France; Curtin Univ Technol, Dept Environm Biol, Perth, WA 6845, Australia; Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Univ Wisconsin, Dept Biol, Eau Claire, WI 54702 USA; Landcare Res, Dunedin, New Zealand; Univ Concepcion, Dept Bot, Concepcion, Chile; Univ Cape Town, Dept Bot, ZA-7701 Rondebosch, South Africa; Univ Tartu, Dept Plant Physiol, EE-51011 Tartu, Estonia; Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; Univ Tokyo, Nikko Bot Garden, Grad Sch Sci, Nikko, Tochigi 3211435, Japan; Univ Utrecht, NL-3508 TB Utrecht, Netherlands; Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; Charles Darwin Univ, Key Ctr Wildlife Management, Darwin, NT 0909, Australia; Ural State Univ, Ekaterinburg, Russia; Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada; Texas A&M Univ, Dept Forest Sci, College Stn, TX 77843 USA; Univ Cordoba, Area Ecol, E-14071 Cordoba, Spain	Macquarie University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Simon Bolivar University; Wageningen University & Research; Smithsonian Institution; Smithsonian Environmental Research Center; University of Alaska System; University of Alaska Fairbanks; Vrije Universiteit Amsterdam; University of Zurich; Universitat de les Illes Balears; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Curtin University; Tohoku University; University of Wisconsin System; Landcare Research - New Zealand; Universidad de Concepcion; University of Cape Town; University of Tartu; Polish Academy of Sciences; University of Tokyo; Utrecht University; University of Western Australia; Charles Darwin University; Ural Federal University; University of Toronto; Texas A&M University System; Texas A&M University College Station; Universidad de Cordoba	Wright, IJ (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	iwright@rna.bio.mq.edu.au	Hikosaka, Kouki/A-5415-2013; Ackerly, David/A-1247-2009; Tjoelker, Mark G/M-2413-2016; Niinemets, Ülo/A-3816-2008; Cavender-Bares, Jeannine/K-5716-2013; THOMAS, Sean C./B-6089-2008; Osada, Noriyuki/K-2946-2012; Gulías, Javier/N-7240-2013; Veneklaas, Erik J/C-8907-2009; Garnier, Eric/D-1650-2012; Wright, Ian J/G-4979-2012; Hikosaka, Kouki/AAH-4214-2019; Poot, Pieter/B-3457-2011; Villar, Rafael/F-7507-2010; Oleksyn, Jacek/AAR-2351-2020; Oleksyn, Jacek/I-4539-2012; Poorter, Hendrik/B-8062-2010; Prior, Lynda/A-7460-2012; Flexas, Jaume/C-1898-2012; Poorter, Hendrik/Y-2542-2019	Hikosaka, Kouki/0000-0003-1744-3775; Ackerly, David/0000-0002-1847-7398; Tjoelker, Mark G/0000-0003-4607-5238; Niinemets, Ülo/0000-0002-3078-2192; THOMAS, Sean C./0000-0002-0686-2483; Veneklaas, Erik J/0000-0002-7030-4056; Garnier, Eric/0000-0002-9392-5154; Wright, Ian J/0000-0001-8338-9143; Hikosaka, Kouki/0000-0003-1744-3775; Villar, Rafael/0000-0002-3895-9984; Poorter, Hendrik/0000-0001-9900-2433; Prior, Lynda/0000-0002-5511-2320; Flexas, Jaume/0000-0002-3069-175X; Poorter, Hendrik/0000-0001-9900-2433; Poot, Pieter/0000-0001-7721-0696; Westoby, Mark/0000-0001-7690-4530; Cavender-Bares, Jeannine/0000-0003-3375-9630; Oleksyn, Jacek/0000-0002-6576-3258; Lee, Tali/0000-0002-3933-6607; Lamont, Byron/0000-0001-9279-7149; Gulias, Javier/0000-0002-6685-4231; Reich, Peter/0000-0003-4424-662X				ACKERLY DD, 1995, OECOLOGIA, V101, P289, DOI 10.1007/BF00328814; BARRY RG, 1981, MOUNTAIN WEATHER CLI, P24; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Cannell MGR, 2000, ANN BOT-LONDON, V85, P45, DOI 10.1006/anbo.1999.0996; Choudhury BJ, 1997, REMOTE SENS ENVIRON, V61, P64, DOI 10.1016/S0034-4257(96)00241-6; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Evans JR, 2000, PHOTOSYNTHESIS PHYSL, P321, DOI DOI 10.1007/0-306-48137-5_14; Farquhar GD, 2002, SILVA FENN, V36, P625, DOI 10.14214/sf.530; Field C. H., 1986, EC FORM FUNCTION, P25; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; GOVNISH TJ, 1986, EC PLANT FORM FUNCTI; Green DS, 2001, TREE PHYSIOL, V21, P1341, DOI 10.1093/treephys/21.18.1341; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; HARPER JL, 1989, OECOLOGIA, V80, P53, DOI 10.1007/BF00789931; Hikosaka K, 1998, FUNCT ECOL, V12, P896, DOI 10.1046/j.1365-2435.1998.00272.x; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; KORNER C, 1999, ALPINE PLANT LIFE FU, pCH3; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Maximov NA., 1929, PLANT RELATION WATER; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; ORIANS GH, 1977, AM NAT, V111, P677, DOI 10.1086/283199; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; Peterson AG, 1999, OECOLOGIA, V118, P144, DOI 10.1007/s004420050712; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reich PB, 1998, OECOLOGIA, V114, P471, DOI 10.1007/s004420050471; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; REICH PB, 1994, OECOLOGIA, V97, P73, DOI 10.1007/BF00317910; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Sokal R.R., 2012, BIOMETRY; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Walters MB, 2000, ECOLOGY, V81, P1887, DOI 10.1890/0012-9658(2000)081[1887:SSNSAG]2.0.CO;2; Westoby M, 2000, AM NAT, V155, P649, DOI 10.1086/303346; Whittaker R.H., 1975, COMMUNITIES ECOSYSTE, P167; Wright IJ, 2003, AM NAT, V161, P98, DOI 10.1086/344920; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x	50	5338	5992	241	3450	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					821	827		10.1038/nature02403	http://dx.doi.org/10.1038/nature02403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103368	Green Published			2022-12-28	WOS:000220952300031
J	Slevogt, H; Tintelnot, K; Seybold, J; Suttorp, N				Slevogt, H; Tintelnot, K; Seybold, J; Suttorp, N			Lymphadenopathy in a pregnant woman from Brazil	LANCET			English	Editorial Material							PARACOCCIDIOIDOMYCOSIS		Humboldt Univ, Charite, Dept Internal Med Infect Dis, D-13353 Berlin, Germany; Robert Koch Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Slevogt, H (corresponding author), Humboldt Univ, Charite, Dept Internal Med Infect Dis, D-13353 Berlin, Germany.	hortense.slevogt@charite.de		Seybold, Joachim/0000-0003-1444-8976; Suttorp, Norbert/0000-0002-3958-1151				Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Luppi P, 2003, VACCINE, V21, P3352, DOI 10.1016/S0264-410X(03)00331-1; Manns BJ, 1996, CLIN INFECT DIS, V23, P1026, DOI 10.1093/clinids/23.5.1026; WANKE B, 1984, REV I MED TROP, V26, P205, DOI 10.1590/S0036-46651984000400004	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1282	1282		10.1016/S0140-6736(04)16001-7	http://dx.doi.org/10.1016/S0140-6736(04)16001-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094273				2022-12-28	WOS:000220904900010
J	Beer, MA; Tavazoie, S				Beer, MA; Tavazoie, S			Predicting gene expression from sequence	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; C-ELEGANS; BAYESIAN NETWORKS; CHROMOSOMAL DOMAINS; REGULATORY NETWORKS; PROMOTER ELEMENTS; STRESS-RESPONSE; TRANSCRIPTION; SKN-1; YEAST	We describe a systematic genome-wide approach for learning the complex combinatorial code underlying gene expression. Our probabilistic approach identifies local DNA-sequence elements and the positional and combinatorial constraints that determine their context-dependent role in transcriptional regulation. The inferred regulatory rules correctly predict expression patterns for 73% of genes in Saccharomyces cerevisiae, utilizing microarray expression data and sequences in the 800 bp upstream of genes. Application to Caenorhabditis elegans identifies predictive regulatory elements and combinatorial rules that control the phased temporal expression of transcription factors, histones, and germline specific genes. Successful prediction requires diverse and complex rules utilizing AND, OR, and NOT logic, with significant constraints on motif strength, orientation, and relative position. This system generates a large number of mechanistic hypotheses for focused experimental validation, and establishes a predictive dynamical framework for understanding cellular behavior from genomic sequence.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tavazoie, S (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tavazoie@molbio.princeton.edu	Rosa, Bruce/F-6393-2010; Beer, Michael/AFV-4282-2022	Beer, Michael A/0000-0001-9955-3809				An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Davidson GS, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P23, DOI 10.1109/INFVIS.2001.963275; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hartigan J., 1975, CLUSTERING ALGORITHM; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KLASS M, 1988, J MOL BIOL, V199, P15, DOI 10.1016/0022-2836(88)90375-0; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LHERNAULT S, 1997, SPERMATOGENESIS, P271; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; RISANNEN J, 1989, STOCHASTIC COMPLEXIT; ROBERTS SB, 1989, J MOL BIOL, V206, P567, DOI 10.1016/0022-2836(89)90566-4; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x	50	442	453	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					185	198		10.1016/S0092-8674(04)00304-6	http://dx.doi.org/10.1016/S0092-8674(04)00304-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084257	Bronze			2022-12-28	WOS:000220913400007
J	Lambert, TW; Goldacre, M; Vallance, E; Mallick, N				Lambert, TW; Goldacre, M; Vallance, E; Mallick, N			Characteristics of consultants who hold distinction awards in England and Wales: database analysis with particular reference to sex and ethnicity	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether women, ethnic minorities, and particular specialties are discriminated against in the receipt of NHS distinction awards. Design Analysis of database of consultants eligible for distinction awards. Setting England and Wales, 2002. Main outcome measures Holding of B, A, and Aplus distinction awards, analysed for all awards, irrespective of when made, and for awards made in the last five years studied. Results Women and doctors from ethnic minorities were substantially under-represented among award holders when no account was taken of potential confounding factors. Differences diminished after multivariate analysis, but some remained significant. For example, the adjusted odds ratio of women holding awards compared with men was 0.69 (95% confidence interval 0.59 to 0.82) for any award and 1.37 (0.86 to 2.20) for Aplus awards; the odds ratio for any award for non-white doctors trained abroad compared with white doctors trained in the United Kingdom was 0.45 (0.37 to 0.56). In the last five years studied, the adjusted ratio of women to men was 0.94 (0.79 to 1.10) for B awards and 1.54 (0.85 to 2.83) for Aplus awards. The adjusted ratio for non-white British trained consultants was 0.86 (0.62 to 1.17) for B awards and 1.20 (0.37 to 3.87) for Aplus awards; for non-white consultants trained abroad it was 0.68 (0.54 to 0.85) for B awards and 0.69 (0.15 to 3.10) for Aplus awards; and for white consultants trained abroad it was 0.70 (0.54 to 0.91) for B awards and 0.90 (0.38 to 2.15) for Aplus awards. Conclusion Historical under-representation in award holding by women and doctors from ethnic minorities was partly explained by time spent as a consultant. Recent awards showed no under-representation of women and no appreciable under-representation of ethnic minorities overall. However, doctors who trained abroad-both white and non-white-remained under-represented for B awards.	Univ Oxford, Dept Publ Hlth, UK Med Careers Res Grp, Oxford OX3 7LF, England; Dept Hlth, ACCEA Secretariat, London SE1 6LH, England	University of Oxford	Goldacre, M (corresponding author), Univ Oxford, Dept Publ Hlth, UK Med Careers Res Grp, Oxford OX3 7LF, England.	michael.goldacre@public-health.ox.ac.uk		Lambert, Trevor/0000-0001-9688-3036				*DEP HLTH, 2001, REW CMM EXC NHS CONS; Esmail A, 1998, BRIT MED J, V316, P193; KENDELL R, 1994, EL9499 NHS EX; *ROYAL COMM DOCT D, 1960, CMND939; *ROYAL COMM DOCT D, 1960, REP ROYAL COMM DOCT; Royal Commission on the National Health Service, 1979, CMND7615; SPENS W, 1948, CMND7420	7	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2004	328	7452					1347	1349		10.1136/bmj.38062.639190.44	http://dx.doi.org/10.1136/bmj.38062.639190.44			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828DH	15090443	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000221952700017
J	Marinkovic, SP; Gillen, LM; Stanton, SL				Marinkovic, SP; Gillen, LM; Stanton, SL			Managing nocturia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SACRAL NEUROMODULATION; URINARY SYMPTOMS; SLEEP; POPULATION; FREQUENCY; POLYURIA		So Illinois Sch Med, Div Urol, Decatur, GA USA; St Marys Hosp, Dept Urol, Decatur, GA USA; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	Southern Illinois University System; Southern Illinois University; St Georges University London	Marinkovic, SP (corresponding author), So Illinois Sch Med, Div Urol, Suite 2500,1800 E Lakeshore Rd, Decatur, GA USA.	Serge1127@yahoo.com						ASPLUND R, 1992, SCAND J UROL NEPHROL, V26, P345, DOI 10.3109/00365599209181224; BARKER JC, 1988, GERONTOLOGIST, V28, P99, DOI 10.1093/geront/28.1.99; Broman JE, 1996, NEUROPHYSIOL CLIN, V26, P30, DOI 10.1016/0987-7053(96)81532-2; Drake MJ, 2004, J UROLOGY, V171, P1199, DOI 10.1097/01.ju.0000110442.47593.ea; Fultz NH, 1996, UROL CLIN N AM, V23, P1, DOI 10.1016/S0094-0143(05)70288-3; Hassouna MM, 2000, J UROLOGY, V163, P1849, DOI 10.1016/S0022-5347(05)67558-1; HENNESSY CH, 1986, EVALUATION REV, V10, P178, DOI 10.1177/0193841X8601000202; HETTA J, 1985, ANN CLIN RES, V17, P252; Hunsballe JM, 1997, J UROLOGY, V158, P830, DOI 10.1016/S0022-5347(01)64330-1; JOLLEYS JV, 1994, BRIT J UROL, V74, P551, DOI 10.1111/j.1464-410X.1994.tb09182.x; KRIEGER J, 1993, UROL INT, V50, P93, DOI 10.1159/000282460; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Matthiesen TB, 1996, J UROLOGY, V156, P1292, DOI 10.1016/S0022-5347(01)65572-1; *MEDTR, WHAT IS INT THER; Middelkoop HAM, 1996, J GERONTOL A-BIOL, V51, pM108, DOI 10.1093/gerona/51A.3.M108; PEDERSEN PA, 1988, BRIT J UROL, V62, P145, DOI 10.1111/j.1464-410X.1988.tb04294.x; SAITO M, 1993, BRIT J UROL, V72, P38, DOI 10.1111/j.1464-410X.1993.tb06453.x; SHAH PJR, 1994, ASSESSMENT PATIENTS; Spinelli M, 2003, J UROLOGY, V170, P1905, DOI 10.1097/01.ju.0000092634.64580.9a; SULLIVAN MP, 1993, ALTERNATE METHODS TR; SWITHINBANK LV, 1998, NEUROUROL URODYNAM, V16, P432; Umlauf MG, 1996, UROL CLIN N AM, V23, P127, DOI 10.1016/S0094-0143(05)70298-6; Weiss JP, 2000, J UROLOGY, V163, P5, DOI 10.1016/S0022-5347(05)67961-X; Weiss JP, 1998, NEUROUROL URODYNAM, V17, P467, DOI 10.1002/(SICI)1520-6777(1998)17:5<467::AID-NAU2>3.3.CO;2-V	24	24	24	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1063	1066		10.1136/bmj.328.7447.1063	http://dx.doi.org/10.1136/bmj.328.7447.1063			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117794	Green Published			2022-12-28	WOS:000221174500023
J	Kumar, S; O'Brien, A				Kumar, S; O'Brien, A			Recent developments in fetal medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOWN-SYNDROME; 3-DIMENSIONAL ULTRASOUND; MATERNAL BLOOD; IN-UTERO; MANAGEMENT; EXPERIENCE; DIAGNOSIS; MYELOMENINGOCELE; IDENTIFICATION; SURGERY		Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W12 0HS, England	Imperial College London	Kumar, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, Du Cane Rd, London W12 0HS, England.	sailesh.kumar@ic.ac.uk	Kumar, Sailesh/M-3207-2014; Kumar, Sailesh/A-9203-2011	Kumar, Sailesh/0000-0003-0832-4811; 				ADZICK NS, 1993, WORLD J SURG, V17, P342, DOI 10.1007/BF01658702; Birchall JE, 2003, BRIT J HAEMATOL, V122, P275, DOI 10.1046/j.1365-2141.2003.04408.x; Bruner JP, 1999, JAMA-J AM MED ASSOC, V282, P1819, DOI 10.1001/jama.282.19.1819; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Choolani M, 2001, BLOOD, V98, P554, DOI 10.1182/blood.V98.3.554; Costa JM, 2003, CLIN CHEM, V49, P981, DOI 10.1373/49.6.981; Dyson RL, 2000, ULTRASOUND OBST GYN, V16, P321, DOI 10.1046/j.1469-0705.2000.00183.x; Egan JFX, 2000, OBSTET GYNECOL, V96, P979, DOI 10.1016/S0029-7844(00)01044-9; Evans MI, 2001, AM J OBSTET GYNECOL, V184, P97, DOI 10.1067/mob.2001.108074; FISK NM, 2000, UNBORN PATIENT ART S; HARRISON MR, 1990, NEW ENGL J MED, V322, P1582, DOI 10.1056/NEJM199005313222207; HARRISON MR, 1982, J PEDIATR SURG, V17, P728, DOI 10.1016/S0022-3468(82)80437-5; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; Haverkamp F, 2001, Eur J Paediatr Neurol, V5, P21, DOI 10.1053/ejpn.2001.0400; Hecher K, 1999, AM J OBSTET GYNECOL, V180, P717, DOI 10.1016/S0002-9378(99)70278-4; James D, 1998, BRIT MED J, V316, P1580, DOI 10.1136/bmj.316.7144.1580; Kohl T, 2000, AM J CARDIOL, V85, P1230, DOI 10.1016/S0002-9149(00)00733-5; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kumar S, 2003, CLIN PERINATOL, V30, P507, DOI 10.1016/S0095-5108(03)00060-5; Levine D, 1997, RADIOLOGY, V204, P635, DOI 10.1148/radiology.204.3.9280237; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Pettenati MJ, 2002, PRENATAL DIAG, V22, P193, DOI 10.1002/pd.282; Quintero R A, 1999, J Perinatol, V19, P550, DOI 10.1038/sj.jp.7200292; Quintero RA, 2003, AM J OBSTET GYNECOL, V188, P1333, DOI 10.1067/mob.2003.292; Quintero RA, 2001, LANCET, V357, P1947, DOI 10.1016/S0140-6736(00)05084-4; Ryall RG, 2001, PRENATAL DIAG, V21, P553; Scriven PN, 2001, HUM REPROD, V16, P2267, DOI 10.1093/humrep/16.11.2267; Smith-Bindman R, 2003, AM J OBSTET GYNECOL, V189, P980, DOI 10.1067/S0002-9378(03)00721-X; Thein ATA, 2000, PRENATAL DIAG, V20, P275, DOI 10.1002/(SICI)1097-0223(200004)20:4<275::AID-PD799>3.0.CO;2-Z; Timor-Tritsch IE, 2002, CURR OPIN OBSTET GYN, V14, P569, DOI 10.1097/00001703-200212000-00001; Tulipan N, 1999, PEDIATR NEUROSURG, V31, P137, DOI 10.1159/000028849; Tworetzky W, 2003, J AM COLL CARDIOL, V41, p496A; Welsh A, 2003, PRENATAL DIAG, V23, P1033, DOI 10.1002/pd.717; Yaron Y, 1999, AM J OBSTET GYNECOL, V180, P1268, DOI 10.1016/S0002-9378(99)70627-7; Zhong XY, 2000, PRENATAL DIAG, V20, P795	36	18	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					1002	1006		10.1136/bmj.328.7446.1002	http://dx.doi.org/10.1136/bmj.328.7446.1002			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105327	Green Published			2022-12-28	WOS:000221130100024
J	Egan, ME; Pearson, M; Weiner, SA; Rajendran, V; Rubin, D; Glockner-Pagel, J; Canny, S; Du, K; Lukacs, GL; Caplan, MJ				Egan, ME; Pearson, M; Weiner, SA; Rajendran, V; Rubin, D; Glockner-Pagel, J; Canny, S; Du, K; Lukacs, GL; Caplan, MJ			Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SARCOPLASMIC-RETICULUM; PARTIAL RESTORATION; CHLORIDE CHANNEL; CLINICAL-TRIAL; CFTR FUNCTION; MICE; CA2+; COMPARTMENTS; DEGRADATION	Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator ( CFTR). The most common mutation, DeltaF508, results in the production of a misfolded CFTR protein that is retained in the endoplasmic reticulum and targeted for degradation. Curcumin is a nontoxic Ca-adenosine triphosphatase pump inhibitor that can be administered to humans safely. Oral administration of curcumin to homozygous DeltaF508 CFTR mice in doses comparable, on a weight-per-weight basis, to those well tolerated by humans corrected these animals' characteristic nasal potential difference defect. These effects were not observed in mice homozygous for a complete knockout of the CFTR gene. Curcumin also induced the functional appearance of DeltaF508 CFTR protein in the plasma membranes of transfected baby hamster kidney cells. Thus, curcumin treatment may be able to correct defects associated with the homozygous expression of DeltaF508 CFTR.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathol,Program Cell & Lung Biol, Toronto, ON M5G 1X8, Canada	Yale University; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St,POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu		Lukacs, Gergely/0000-0003-0900-0675; Canny, Susan/0000-0002-1762-6718; Weiner, Scott/0000-0003-4339-6407; Caplan, Michael/0000-0001-5768-4405	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK053428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042136] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK053428, DK17433, DK53428] Funding Source: Medline; NIGMS NIH HHS [GM42136] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Brady KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1173, DOI 10.1152/ajplung.2001.281.5.L1173; Cheng AL, 2001, ANTICANCER RES, V21, P2895; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clarke LL, 1996, LAB ANIM SCI, V46, P612; Davis P B, 2001, Pediatr Rev, V22, P257, DOI 10.1542/pir.22-8-257; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Grubb Barbara R, 2002, Methods Mol Med, V70, P525; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Kelley TJ, 1997, P NATL ACAD SCI USA, V94, P2604, DOI 10.1073/pnas.94.6.2604; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; PIND S, 1994, J BIOL CHEM, V269, P12784; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; TABCHARANI JA, 1992, BIOPHYS J, V62, P1, DOI 10.1016/S0006-3495(92)81759-9; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	27	462	497	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					600	602		10.1126/science.1093941	http://dx.doi.org/10.1126/science.1093941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105504				2022-12-28	WOS:000220975100053
J	Himelstein, BP; Hilden, JM; Boldt, AM; Weissman, D				Himelstein, BP; Hilden, JM; Boldt, AM; Weissman, D			Medical progress - Pediatric palliative care	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							QUALITY-OF-LIFE; GENERIC CORE SCALES; POSTTRAUMATIC STRESS; AFFECTIONAL BONDS; INTENSIVE-CARE; YOUNG-CHILDREN; CANCER; DEATH; RELIABILITY; SYMPTOMS		Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol, Milwaukee, WI 53201 USA; Childrens Hosp Wisconsin, Pediat Palliat Care Program, Milwaukee, WI 53201 USA; Med Coll Wisconsin, Dept Internal Med, Div Neoplast Dis & Related Disorders, Milwaukee, WI 53201 USA; Cleveland Clin, Childrens Hosp, Dept Pediat Hematol Oncol, Cleveland, OH 44106 USA; Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Palliat Care Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin; Cleveland Clinic Foundation; Medical College of Wisconsin	Himelstein, BP (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol, 9000 W Wisconsin Ave,MS 792, Milwaukee, WI 53201 USA.	bhimelstein@chw.org						Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; ARMSTRONGDAILEY A, 1993, HOSPICE CARE CHILDRE; Balk, 1996, HDB ADOLESCENT DEATH; BERTMAN SL, 1999, GRIEF HEALING ARTS C; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P421, DOI 10.1192/bjp.130.5.421; Bradley EH, 2001, AM J MED, V111, P218, DOI 10.1016/S0002-9343(01)00798-7; Byock IR, 1998, PALLIATIVE MED, V12, P231, DOI 10.1191/026921698670234618; Carson MG, 2000, PALLIATIVE MED, V14, P25, DOI 10.1191/026921600677786382; *CHILDR HOSP INT, 1998, 1998 SURV HOSP CAR C; *CHILDR HOSP INT, 2004, STAND CAR CHI PACC P; *CHIPPS ADM POL WO, 2001, CALL CHANG REC IMPR; Christ G. H., 2003, CHILDREN DIE IMPROVI, P553; Christ GH, 2002, JAMA-J AM MED ASSOC, V288, P1269, DOI 10.1001/jama.288.10.1269; Collins JJ, 2002, J PAIN SYMPTOM MANAG, V23, P10, DOI 10.1016/S0885-3924(01)00375-X; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; CORR C, 1995, CHILDREN MOURNING MO, P8; *CTR ADV PALL CAR, 2004, PALL CAR LEAD CTR OV; *CTR MED MED SERV, 2003, MED HOSP BEN; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; Davies B, 2002, J PALLIATIVE CARE, V18, P59, DOI 10.1177/082585970201800109; Davies B., 1999, SHADOWS SUN EXPERIEN; Doka KJ, 1993, LIVING LIFE THREATEN; DOKA KJ, 1995, CHILDREN MOURNING MO; Faulkner K. W., 2001, HOSPICE CARE CHILDRE, P9; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P887, DOI 10.1542/peds.109.5.887; Field M.J., 2003, CHILDREN DIE IMPROVI; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Furth G. M., 1988, SECRET WORLD DRAWING; Ginzburg K, 2002, OMEGA-J DEATH DYING, V45, P119, DOI 10.2190/XUW5-QGQ9-KCB8-K6WW; Grimaldo DA, 2001, ANESTHESIOLOGY, V95, P43, DOI 10.1097/00000542-200107000-00012; Hilden JM, 2001, IMPROVING PALLIATIVE, P161; Hughes P, 2002, LANCET, V360, P114, DOI 10.1016/S0140-6736(02)09410-2; KANE JR, 2002, PRINCIPLES PRACTICE, P1044; Kenyon BL, 2001, OMEGA-J DEATH DYING, V43, P63, DOI 10.2190/0X2B-B1N9-A579-DVK1; KOPELMAN LM, 1988, NEW ENGL J MED, V318, P677, DOI 10.1056/NEJM198803173181105; Kornblith AB, 2001, J CLIN ONCOL, V19, P2111, DOI 10.1200/JCO.2001.19.8.2111; Kunin H, 1997, ETHICS BEHAV, V7, P43, DOI 10.1207/s15327019eb0701_4; *LAST ACTS PALL CA, PREC PALL CAR CHILDR; LEVETOWN M, 2000, COMPENDIUM PEDIAT PA; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Middleton Warwick, 1993, P44, DOI 10.1017/CBO9780511664076.004; *NAT VIT STAT SYST, 2004, MORT DAT NAT VIT STA; National Hospice and Palliative Care Organization, 2003, NHPCO FACTS FIG; Nelson JE, 2001, CRIT CARE MED, V29, P277, DOI 10.1097/00003246-200102000-00010; Nelson RM, 2000, PEDIATRICS, V106, P351; Pfefferbaum B, 2000, PSYCHIATR SERV, V51, P386, DOI 10.1176/appi.ps.51.3.386; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; *ROYAL COLL PAED C, 1997, GUID DEV CHILDR PALL; Sabatino CP, 1999, J LAW MED ETHICS, V27, P297, DOI 10.1111/j.1748-720X.1999.tb01465.x; SCHNEIDERMAN G, 1994, CAN J PSYCHIAT, V39, P215, DOI 10.1177/070674379403900404; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; SHAPIRO DL, 1984, JAMA-J AM MED ASSOC, V252, P2031, DOI 10.1001/jama.252.15.2031; Silveira MJ, 2000, JAMA-J AM MED ASSOC, V284, P2483, DOI 10.1001/jama.284.19.2483; Smith TJ, 1998, CANC TREAT, P81; Sourkes BM, 1995, ARMFULS TIME PSYCHOL; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sterkenburg CA, 1996, J PALLIATIVE CARE, V12, P18, DOI 10.1177/082585979601200104; Stevens M.M., 1998, OXFORD TXB PALLIATIV, P1045; Stoppelbein L, 2000, J AM ACAD CHILD PSY, V39, P1112, DOI 10.1097/00004583-200009000-00010; TAKETOMO CG, 2001, PEDIAT DOSAGE HDB; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Weir RF, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3527716; Wheeler I, 2001, DEATH STUD, V25, P51, DOI 10.1080/07481180126147; WHITE ML, 1991, JAMA-J AM MED ASSOC, V266, P410, DOI 10.1001/jama.1991.03470030110035; *WHO, 1998, RED MORT MAJ KILL CH; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; ZISOOK S, 1988, International Journal of Family Psychiatry, V9, P135; [No title captured]	74	327	339	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1752	1762		10.1056/NEJMra030334	http://dx.doi.org/10.1056/NEJMra030334			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814AJ	15103002				2022-12-28	WOS:000220947300010
J	Hampton, T				Hampton, T			New smallpox vaccine shows promise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1825	1825		10.1001/jama.291.15.1825	http://dx.doi.org/10.1001/jama.291.15.1825			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100185				2022-12-28	WOS:000220871200004
J	Muller, U; Exadaktylos, A; Roeder, C; Pisan, M; Eggli, S; Juni, P				Muller, U; Exadaktylos, A; Roeder, C; Pisan, M; Eggli, S; Juni, P			Effect of a flow chart on use of blood transfusions in primary total hip and knee replacement: prospective before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem A suspected high proportion of unnecessary blood transfusions occur in patients undergoing total joint replacement. Design Prospective before and after study evaluating the impact of a one page flow chart aimed at reducing the use of blood transfusions. Setting Orthopaedic tertiary care centre in Winterthur, Switzerland. 208 patients underwent primary total joint replacement of hips or knees during the control period (October 1998 to September 1999) and 217 during the intervention period (October 1999 to September 2000). Key measures for improvement Proportion of patients receiving allogencic blood transfusions. Strategies for change A simple one page flow chart, which summarised graphically the perioperative decision pathways for anaemic patients, was placed in all charts of patients undergoing total joint replacement and handed out to medical staff from 4 October 1999 onwards. The implementation of the flow chart focused on its endorsement by chief physicians and the development of a sense of "ownership" among physicians and nurses. Effects of change The proportion of patients receiving allogeneic blood decreased from 35.0% to 19.8% (absolute difference - 15.2%, 95% confidence interval - 23.3 to - 7.0%). The percentage of patients donating and receiving autologous blood also decreased. This led to overall savings of about; pound23 000 ($42 470; E34 441) (pound103.50 per patient undergoing total joint replacement). Differences became more pronounced after adjustment for confounding factors. Lessons learnt Allogeneic blood transfusions in primary hip and knee replacement surgery may be reduced cost effectively by implementing a one page flow chart. Five key elements may have contributed: simplicity; wide distribution; no requirement for major changes; endorsement by local opinion leaders; and development of a sense of ownership. These elements may be used in other contexts to achieve sustained change of clinical practice.	Univ Bristol, UK Med Res Council, Hlth Serv Res Collaborat, Dept Social Med, Bristol BS8 1TH, Avon, England; Univ Bern, Inst Evaluat Res Orthopaed Surg, CH-3001 Bern, Switzerland; Univ Bern, Dept Anaesthesiol, Inselspital, CH-3010 Bern, Switzerland; Kantonsspital Winterthur, Dept Orthopaed Surg, CH-8400 Winterthur, Switzerland; Univ Bern, Dept Orthopaed Surg, CH-3010 Bern, Switzerland	University of Bristol; University of Bern; University of Bern; University of Bern		juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670				AUDET AM, 1992, ANN INTERN MED, V116, P403, DOI 10.7326/0003-4819-116-5-403; Efron B., 1994, MONOGRAPHS STAT APPL; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HILL SR, 2002, COCHRANE DB SYST REV, V2; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; MARINO PL, 1998, BLOOD COMPONENT THER; MCCLELLAND B, 1994, TRANSFUS CLIN BIOL, V1, P425, DOI 10.1016/S1246-7820(06)80026-1; PAGE MH, 1984, AUST NZ J SURG, V54, P141, DOI 10.1111/j.1445-2197.1984.tb06705.x; Regan F, 2002, BRIT MED J, V325, P143, DOI 10.1136/bmj.325.7356.143; SIRCHIA G, 1994, TRANSFUSION MED, V4, P251; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Williamson LM, 1999, BRIT MED J, V319, P16, DOI 10.1136/bmj.319.7201.16; WOHL H, 1977, NEW ENGL J MED, V296, P1044, DOI 10.1056/NEJM197705052961806	13	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					934	938		10.1136/bmj.328.7445.934	http://dx.doi.org/10.1136/bmj.328.7445.934			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087341	Green Submitted, Green Published			2022-12-28	WOS:000220994400026
J	von Harsdorf, R; Poole-Wilson, PA; Dietz, R				von Harsdorf, R; Poole-Wilson, PA; Dietz, R			Regenerative capacity of the myocardium: implications for treatment of heart failure	LANCET			English	Review							BONE-MARROW CELLS; CYCLIN-DEPENDENT KINASES; MESENCHYMAL STEM-CELLS; LEFT-VENTRICULAR DYSFUNCTION; CARDIOMYOCYTE DNA-SYNTHESIS; TRANSPLANTED HUMAN HEARTS; SMOOTH-MUSCLE CELLS; GROWTH-FACTOR-I; CARDIAC MYOCYTES; TRANSGENIC MICE	Research into myocardial regeneration has an exciting future, shown by the results of experimental and clinical work challenging the dogma that the heart is a postmitotic non-regenerating organ. Such studies have initiated a lively debate about the feasibility of novel treatment approaches leading to the recovery of damaged myocardial tissue. The possibility of reconstituting dead myocardium by endogenous cardiomyocyte replication, transplantation, or activation of stem cells-or even cloning of an artifical heart-is being advanced, and will be a major subject of future research. Although health expenditure for heart failure in the industrial world is high, we are still a long way from being able to treat the cause of reduced myocardial contractility. Despite the hopes of some people, conventional treatment for heart failure does not achieve myocardial regeneration. We present a virtual case report of a patient with acute myocardial infarction; we discuss treatment options, including strategies aimed at organ regeneration.	Humboldt Univ, Charite, Dept Cardiol, Berlin, Germany; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	von Harsdorf, R (corresponding author), Humboldt Univ, Univ Klinikum Charite, Med Klin Schwerpunkt Kardiol, Campus Virchow Klinikum, D-13353 Berlin, Germany.	ruediger.harsdorf@charite.de						Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Borisov AB, 1999, WOUND REPAIR REGEN, V7, P26, DOI 10.1046/j.1524-475X.1999.00026.x; Braunwald E, 2000, CIRCULATION, V102, P14; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P10733, DOI 10.1073/pnas.191217898; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; FIELD LJ, 1988, SCIENCE, V239, P1029, DOI 10.1126/science.2964082; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; Flink IL, 1998, J MOL CELL CARDIOL, V30, P563, DOI 10.1006/jmcc.1997.0620; Glaser R, 2002, CIRCULATION, V106, P17, DOI 10.1161/01.CIR.0000021923.58307.8F; Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0; Hauck L, 2002, CIRC RES, V91, P782, DOI 10.1161/01.RES.0000041030.98642.41; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; HRUBAN RH, 1993, AM J PATHOL, V142, P975; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Khand A, 2000, J AM COLL CARDIOL, V36, P2284, DOI 10.1016/S0735-1097(00)00995-5; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Konstam MA, 2000, CIRCULATION, V102, P1076, DOI 10.1161/01.CIR.102.10.1076; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Li JM, 1998, AM J PHYSIOL-HEART C, V275, pH814, DOI 10.1152/ajpheart.1998.275.3.H814; Liao HS, 2001, CIRC RES, V88, P443; Limana F, 2002, P NATL ACAD SCI USA, V99, P6257, DOI 10.1073/pnas.092672899; Linzbach A J, 1975, Triangle, V14, P17; Liu Y, 1996, J CELL BIOL, V133, P325, DOI 10.1083/jcb.133.2.325; Mahon NG, 1999, HEART, V81, P478, DOI 10.1136/hrt.81.5.478; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 1996, CIRC RES, V78, P126, DOI 10.1161/01.RES.78.1.126; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Rumyantsev P P, 1977, Int Rev Cytol, V51, P186; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; Sadoshima J, 1997, CIRC RES, V80, P228, DOI 10.1161/01.RES.80.2.228; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; SEN A, 1988, J BIOL CHEM, V263, P19132; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, J CLIN INVEST, V99, P2644, DOI 10.1172/JCI119453; SOONPAA MH, 1994, CELL TISSUE RES, V275, P377, DOI 10.1007/BF00319437; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tamamori M, 1998, AM J PHYSIOL-HEART C, V275, pH2036, DOI 10.1152/ajpheart.1998.275.6.H2036; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; UENO H, 1988, J CELL BIOL, V107, P1911, DOI 10.1083/jcb.107.5.1911; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; VRACKO R, 1989, AM J PATHOL, V134, P993; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang JS, 2001, J THORAC CARDIOV SUR, V122, P699, DOI 10.1067/mtc.2001.116317; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; ZAK R, 1974, CIRC RES, V35, P17; Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67	98	47	51	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1306	1313		10.1016/S0140-6736(04)16006-6	http://dx.doi.org/10.1016/S0140-6736(04)16006-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094278				2022-12-28	WOS:000220904900023
J	Buckingham, S				Buckingham, S			Data's future shock	NATURE			English	Article									Univ Oxford, MRC, Funct Genom Unit, Oxford OX1 2JD, England	University of Oxford	Buckingham, S (corresponding author), Univ Oxford, MRC, Funct Genom Unit, Oxford OX1 2JD, England.								0	20	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					774	779		10.1038/428774a	http://dx.doi.org/10.1038/428774a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085141	Bronze			2022-12-28	WOS:000220823800045
J	Koga, T; Inui, M; Inoue, K; Kim, S; Suematsu, A; Kobayashi, E; Iwata, T; Ohnishi, H; Matozaki, T; Kodama, T; Taniguchi, T; Takayanagi, H; Takai, T				Koga, T; Inui, M; Inoue, K; Kim, S; Suematsu, A; Kobayashi, E; Iwata, T; Ohnishi, H; Matozaki, T; Kodama, T; Taniguchi, T; Takayanagi, H; Takai, T			Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis	NATURE			English	Article							NATURAL-KILLER-CELLS; OSTEOCLAST DIFFERENTIATION; MYELOID CELLS; FC-RECEPTORS; ACTIVATION; MICE; INDUCTION; SYSTEM; GAMMA; BETA	Costimulatory signals are required for activation of immune cells(1), but it is not known whether they contribute to other biological systems. The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption(2,3). Receptor activator of NF-kappaB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF)(4,5). But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis(6). Here we show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)(7)-harbouring adaptors(8-10), Fc receptor common gamma subunit (FcRgamma) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation. In osteoclast precursor cells, FcRgamma and DAP12 associate with multiple immunoreceptors(11-15) and activate calcium signalling through phospholipase Cgamma. Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis. These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.	Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, COE Program Frontier Res Mol Destruct & Reconstru, Bunkyo Ku, Tokyo 1138549, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan; Gunma Univ, Biosignal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gumma 3718512, Japan; Univ Tokyo, Dept Mol Biol & Med, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Gunma University; University of Tokyo	Takayanagi, H (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	taka.cell@tmd.ac.jp; tostakai@idac.tohoku.ac.jp		Kobayashi, Eiji/0000-0002-7303-2797				Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Olcese L, 1997, J IMMUNOL, V158, P5083; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; PEREZMONTFORT R, 1983, BIOCHEMISTRY-US, V22, P5722, DOI 10.1021/bi00294a007; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573	30	628	659	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					758	763		10.1038/nature02444	http://dx.doi.org/10.1038/nature02444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085135				2022-12-28	WOS:000220823800042
J	Lonsdorf, EV; Eberly, LE; Pusey, AE				Lonsdorf, EV; Eberly, LE; Pusey, AE			Sex differences in learning in chimpanzees	NATURE			English	Editorial Material									Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lonsdorf, EV (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	elonsdorf@lpzoo.org		Eberly, Lynn/0000-0003-4763-330X; Pusey, Anne/0000-0002-2280-8954				BLOTE AW, 1989, HUM MOV STUD, V17, P187; BLOTE AW, 1989, HUM MOV STUD, V17, P133; BOESCH C, 1991, ANIM BEHAV, V41, P530, DOI 10.1016/S0003-3472(05)80857-7; Davies Patricia L., 2000, Physical and Occupational Therapy in Pediatrics, V20, P19, DOI 10.1300/J006v20n01_03; Goodall J., 1963, S ZOOL SOC LOND, V10, P39; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; MCGREW WC, 1992, CHOMPANZEE MAT CULTU; Vederhus L, 1996, INTELLIGENCE, V23, P33, DOI 10.1016/S0160-2896(96)80004-3; WARRICK PD, 1993, J EDUC PSYCHOL, V85, P693, DOI 10.1037/0022-0663.85.4.693; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	11	183	189	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					715	716		10.1038/428715a	http://dx.doi.org/10.1038/428715a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085121				2022-12-28	WOS:000220823800026
J	Todd, JJ; Marois, R				Todd, JJ; Marois, R			Capacity limit of visual short-term memory in human posterior parietal cortex	NATURE			English	Article							WORKING-MEMORY; NEURAL SYSTEM; STORAGE; REPRESENTATION; DISSOCIATION; CONSTRAINTS; BINDING; OBJECT	At any instant, our visual system allows us to perceive a rich and detailed visual world. Yet our internal, explicit representation of this visual world is extremely sparse: we can only hold in mind a minute fraction of the visual scene(1,2). These mental representations are stored in visual short-term memory (VSTM). Even though VSTM is essential for the execution of a wide array of perceptual and cognitive functions(3-5), and is supported by an extensive network of brain regions(6-9), its storage capacity is severely limited(10-13). With the use of functional magnetic resonance imaging, we show here that this capacity limit is neurally reflected in one node of this network: activity in the posterior parietal cortex is tightly correlated with the limited amount of scene information that can be stored in VSTM. These results suggest that the posterior parietal cortex is a key neural locus of our impoverished mental representation of the visual world.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Marois, R (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 530 Wilson Hall, Nashville, TN 37203 USA.	rene.marois@vanderbilt.edu						Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dodwell, 1972, NEW HORIZONS PSYCHOL, P62; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Jolic&OELIG;ur P., 2001, LIMITS ATTENTION, P82; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rosnow RL, 1996, PSYCHOL SCI, V7, P253, DOI 10.1111/j.1467-9280.1996.tb00369.x; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	30	1049	1079	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					751	754		10.1038/nature02466	http://dx.doi.org/10.1038/nature02466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085133				2022-12-28	WOS:000220823800040
J	Britton, WJ; Lockwood, DNJ				Britton, WJ; Lockwood, DNJ			Leprosy	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; NERVE-FUNCTION IMPAIRMENT; NECROSIS-FACTOR-ALPHA; HLA-CLASS-II; PHENOLIC GLYCOLIPID-I; T-CELL RESPONSES; MOUSE FOOT PAD; MYCOBACTERIUM-LEPRAE; PAUCIBACILLARY LEPROSY; DIHYDROPTEROATE SYNTHASE	Leprosy remains an important health problem worldwide. The disease is caused by a chronic granulomatous infection of the skin and peripheral nerves with Mycobacterium leprae. The clinical range from tuberculoid to lepromatous leprosy is a result of variation in the cellular immune response to the mycobacterium. The resulting impairment of nerve function causes the disabilities associated with leprosy. This review summarises recent advances in understanding of the biology of leprosy, clinical features of the disease, the current diagnostic criteria, and the new approaches to treatment of the infection and the immune-mediated complications. Supervised multi-drug therapy (MDT) for fixed durations is highly effective for all forms of the disease. The widespread implementation of MDT has been associated with a fall in the prevalence of the leprosy but as yet no reduction in the case-detection rate globally. Thus, leprosy control activities must be maintained for decades to Interrupt transmission of infection.	Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2006, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; London Sch Hyg & Trop Med, London WC1, England; Hosp Trop Dis, London NW1 0PE, England	University of Sydney; Centenary Institute; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Britton, WJ (corresponding author), Centenary Inst Canc Med & Cell Biol, Locked Bag No 6, Newtown, NSW 2042, Australia.	wbritton@med.usyd.edu.au		Britton, Warwick/0000-0001-6721-9646				Alcais A, 2000, J INFECT DIS, V181, P302, DOI 10.1086/315174; ANDERSON AM, 2002, P 16 INT LEPR C SALV; Bakker MI, 2002, TROP MED INT HEALTH, V7, P780, DOI 10.1046/j.1365-3156.2002.00931.x; BAUMGART KW, 1993, T ROY SOC TROP MED H, V87, P412, DOI 10.1016/0035-9203(93)90016-J; BELLKROTOSKI J, 1987, J HAND SURG-AM, V12A, P155, DOI 10.1016/S0363-5023(87)80189-2; BOERRIGTER G, 1991, INT J LEPROSY, V59, P255; Brennan PJ, 2001, LEPROSY REV, V72, P415; Brennan PJ, 2000, LEPROSY REV, V71, pS50; Britton WJ, 1998, LEPROSY REV, V69, P225; Britton WJ, 2004, INFECT DIS-NOR, P1507; Cho SN, 2001, CLIN DIAGN LAB IMMUN, V8, P138, DOI 10.1128/CDLI.8.1.138-142.2001; CHO SN, 1983, INFECT IMMUN, V41, P1077, DOI 10.1128/IAI.41.3.1077-1083.1983; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; CONVIT J, 1992, LANCET, V339, P446, DOI 10.1016/0140-6736(92)91056-E; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Courtright P, 2002, LEPROSY REV, V73, P225; Croft RP, 2000, LANCET, V355, P1603, DOI 10.1016/S0140-6736(00)02216-9; Croft RP, 2000, LEPROSY REV, V71, P18; Croft RP, 1999, LEPROSY REV, V70, P140; Cross H, 2001, LEPROSY REV, V72, P276; Dasananjali K, 1997, INT J LEPROSY, V65, P28; de Oliveira MLW, 1998, WHO TECH REP SER, V874, P1; deJong R, 1997, J IMMUNOL, V159, P786; Dockrell HM, 2000, INFECT IMMUN, V68, P5846, DOI 10.1128/IAI.68.10.5846-5855.2000; Durrheim DN, 2002, LEPROSY REV, V73, P326; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Fleming CJ, 1996, BRIT J DERMATOL, V134, P784, DOI 10.1111/j.1365-2133.1996.tb06992.x; Garcia VE, 1999, J IMMUNOL, V162, P6114; Garcia VE, 1997, J IMMUNOL, V159, P1328; Gebre S, 2000, LEPROSY REV, V71, P325; Geluk A, 2002, INFECT IMMUN, V70, P2544, DOI 10.1128/IAI.70.5.2544-2548.2002; Girdhar BK, 2000, LEPROSY REV, V71, P144; GODAL T, 1973, BRIT MED J, V3, P557, DOI 10.1136/bmj.3.5880.557; GROENEN G, 1995, LEPROSY REV, V66, P134; Gupte M D, 1998, Indian J Lepr, V70, P369; HATTA M, 1995, T ROY SOC TROP MED H, V89, P381, DOI 10.1016/0035-9203(95)90018-7; HOGEWEG M, 1991, LEPROSY REV, V62, P143; Honore N, 2001, LEPROSY REV, V72, P441; HONORE N, 1993, ANTIMICROB AGENTS CH, V37, P414, DOI 10.1128/AAC.37.3.414; *INT LEPRS ASS, 2002, INT J LEPR OTHER M S, V70, pS1; Ishikawa A, 2001, LEPROSY REV, V72, P322; JAKEMAN P, 1994, LANCET, V343, P432, DOI 10.1016/S0140-6736(94)92686-7; JAMET P, 1995, INT J LEPROSY, V63, P195; JI BH, 1985, LEPROSY REV, V56, P265; Ji BH, 2001, INT J LEPROSY, V69, P54; Jullien D, 1997, J IMMUNOL, V158, P800; Kai M, 1999, FEMS MICROBIOL LETT, V177, P231, DOI 10.1111/j.1574-6968.1999.tb13737.x; Kampirapap K, 1998, INT J LEPROSY, V66, P16; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; KAWUMA HJS, 1994, INT J LEPROSY, V62, P521; Kazen RO, 1999, LEPROSY REV, V70, P63; KHANOLKARYOUNG S, 1995, CLIN EXP IMMUNOL, V99, P196, DOI 10.1111/j.1365-2249.1995.tb05532.x; Kim J, 2001, J IMMUNOL, V167, P779, DOI 10.4049/jimmunol.167.2.779; KIRAN KU, 1991, LEPROSY REV, V62, P150; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Lawn SD, 2003, CLIN INFECT DIS, V36, pE5, DOI 10.1086/344446; LEVY L, 1974, INT J LEPROSY, V42, P165; Lienhardt C, 1996, INT J LEPROSY, V64, P383; Little D, 2001, INFECT IMMUN, V69, P3413, DOI 10.1128/IAI.69.5.3413-3417.2001; Lockwood DNJ, 1996, LEPROSY REV, V67, P253; Lockwood DNJ, 1999, INT J LEPROSY, V67, P6; Lockwood DNJ, 1997, LEPROSY REV, V68, P299; Lockwood DNJ, 2002, BRIT MED J, V324, P1516, DOI 10.1136/bmj.324.7352.1516; Lockwood DNJ, 2001, QJM-INT J MED, V94, P207, DOI 10.1093/qjmed/94.4.207; LUCAS S, 1993, LEPROSY REV, V64, P97; Mahajan P M, 1996, Indian J Lepr, V68, P137; Manandhar R, 1999, INT J LEPROSY, V67, P270; Manandhar R, 2002, CLIN EXP IMMUNOL, V128, P333, DOI 10.1046/j.1365-2249.2002.01791.x; MARLOWE SNS, 2002, P 16 INT LEPR C SALV; MARLOWE SNS, IN PRESS T R SOC TRO; Marques MAM, 2001, J MED MICROBIOL, V50, P23, DOI 10.1099/0022-2615-50-1-23; Martin E, 2001, VACCINE, V19, P1391, DOI 10.1016/S0264-410X(00)00374-1; Matsuoka M, 2000, INT J LEPROSY, V68, P121; Meisner SJ, 2001, AM J TROP MED HYG, V65, P733, DOI 10.4269/ajtmh.2001.65.733; MISRA N, 1995, IMMUNOLOGY, V86, P97; Moreira AL, 1998, INT J LEPROSY, V66, P61; Morrison A, 2000, LEPROSY REV, V71, P128; MUTIS T, 1994, P NATL ACAD SCI USA, V91, P9456, DOI 10.1073/pnas.91.20.9456; MUTIS T, 1993, J IMMUNOL, V150, P4641; Nath I, 2000, IMMUNOL LETT, V75, P69, DOI 10.1016/S0165-2478(00)00271-6; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Ngamying M, 2003, INFECT IMMUN, V71, P1596, DOI 10.1128/IAI.71.3.1596-1598.2003; Nicholls PG, 2000, LEPROSY REV, V71, P422; Noordeen SK, 1994, LEPROSY, P29; Peters ES, 2002, LEPROSY REV, V73, P262; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Ramaprasad P, 1997, LEPROSY REV, V68, P301; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rea TH, 2000, INT J LEPROSY, V68, P129; RICHARDUS JH, 2002, P 16 INT LEPR C SALV; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROACH TIA, 1993, J IMMUNOL, V150, P1886; ROCHE PW, 1991, AM J TROP MED HYG, V44, P702, DOI 10.4269/ajtmh.1991.44.702; ROCHE PW, 1990, INT J LEPROSY, V58, P319; Roche PW, 2001, INT J LEPROSY, V69, P93; ROCHE PW, 1992, INT J LEPROSY, V60, P36; Roy S, 1997, J INFECT DIS, V176, P530, DOI 10.1086/517282; SAMPAIO EP, 1995, INFECT IMMUN, V63, P1848, DOI 10.1128/IAI.63.5.1848-1854.1995; Santos AR, 2002, J INFECT DIS, V186, P1687, DOI 10.1086/345366; SARNO EN, 1991, CLIN EXP IMMUNOL, V84, P103; Saunderson P, 2000, LEPROSY REV, V71, P285; Saunderson P, 2000, LEPROSY REV, V71, P34; Saunderson P, 2000, LEPROSY REV, V71, pS106; Seboka G, 1998, LEPROSY REV, V69, P182; SEKAR B, 1994, INT J LEPROSY, V62, P527; Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754; SHEPARD CC, 1960, J EXP MED, V112, P445, DOI 10.1084/jem.112.3.445; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Shin YC, 2000, J CLIN MICROBIOL, V38, P4535, DOI 10.1128/JCM.38.12.4535-4538.2000; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Sieling PA, 1999, J IMMUNOL, V162, P1851; SIELING PA, 1994, IMMUNOBIOLOGY, V191, P378, DOI 10.1016/S0171-2985(11)80443-2; SIELING PA, 1994, J IMMUNOL, V153, P3639; Smith CM, 2000, J INFECTION, V41, P137, DOI 10.1053/jinf.2000.0698; Smith WCS, 2000, LEPROSY REV, V71, pS138; SMITH WCS, 1997, LEPROSY REV, V68, P165; SOARES DJ, 1995, LEPROSY REV, V66, P210; Spierings E, 2001, J IMMUNOL, V166, P5883, DOI 10.4049/jimmunol.166.10.5883; Srinivasan H., 1994, LEPROSY, V2, P411; Suneetha S, 1998, LEPROSY REV, V69, P351; Thole JER, 1999, J IMMUNOL, V162, P6912; Thole JER, 1995, MOL MICROBIOL, V18, P791, DOI 10.1111/j.1365-2958.1995.18050791.x; Triccas JA, 1998, J CLIN MICROBIOL, V36, P2363, DOI 10.1128/JCM.36.8.2363-2365.1998; Triccas JA, 1996, INFECT IMMUN, V64, P5171, DOI 10.1128/IAI.64.12.5171-5177.1996; van Beers SM, 1999, INT J LEPROSY, V67, P119; Van Brakel WH, 2000, LEPROSY REV, V71, pS146; VANBRAKEL WH, 1992, LEPROSY REV, V63, P231; Villahermosa LG, 2004, AM J TROP MED HYG, V70, P197, DOI 10.4269/ajtmh.2004.70.197; *WHO, 1982, WHO TECH REP SER, V675, P1; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P1; *WHO, 2002, WHOCDSCPECEE200229 W; WILLIAMS DL, 1990, J INFECT DIS, V162, P193, DOI 10.1093/infdis/162.1.193; Williams DL, 2000, ANTIMICROB AGENTS CH, V44, P1530, DOI 10.1128/AAC.44.6.1530-1537.2000; Williams DL, 2001, J CLIN MICROBIOL, V39, P2083, DOI 10.1128/JCM.39.6.2083-2088.2001; *WORLD HLTH ASS, 1991, WHA449; YAMAMURA M, 1992, J IMMUNOL, V149, P1470; YAWALKAR SJ, 1982, LANCET, V1, P1199; Young D, 2003, LEPROSY REV, V74, P11	139	529	564	1	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1209	1219		10.1016/S0140-6736(04)15952-7	http://dx.doi.org/10.1016/S0140-6736(04)15952-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081655				2022-12-28	WOS:000220748100022
J	Zhang, JF; Green, HW; Bozhilov, K; Jin, ZM				Zhang, JF; Green, HW; Bozhilov, K; Jin, ZM			Faulting induced by precipitation of water at grain boundaries in hot subducting oceanic crust	NATURE			English	Article							UPPER-MANTLE; EARTHQUAKES; LITHOSPHERE; SOLUBILITY; DEHYDRATION; DEFORMATION; SERPENTINE; HYDROXYL; RHEOLOGY; MINERALS	Dehydration embrittlement has been proposed to explain both intermediate- and deep-focus earthquakes in subduction zones(1-5). Because such earthquakes primarily occur at shallow depths or within the core of the subducting plate, dehydration at relatively low temperatures has been emphasized(6-8). However, recent careful relocation of subduction-zone earthquakes(9,10) shows that at depths of 100-250 km, earthquakes continue in the uppermost part of the slab (probably the former oceanic crust that has been converted to eclogite) where temperatures are higher. Here we show that at such pressures and temperatures, eclogite lacking hydrous phases but with significant hydroxyl incorporated as defects in pyroxene and garnet develops a faulting instability associated with precipitation of water at grain boundaries and the production of very small amounts of melt. This new faulting mechanism satisfactorily explains high-temperature earthquakes in subducting oceanic crust and could potentially be involved in much deeper earthquakes in connection with similar precipitation of water in the mantle transition zone (400-700 km depth). Of potential importance for all proposed high-pressure earthquake mechanisms is the very small amount of fluid required to trigger this instability.	Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; China Univ Geosci, Dept Earth Sci, Wuhan 430074, Peoples R China	University of California System; University of California Riverside; University of California System; University of California Riverside; China University of Geosciences	Green, HW (corresponding author), Univ Calif Riverside, Inst Geophys & Planetary Phys, Riverside, CA 92521 USA.	harry.green@ucr.edu		Zhang, Junfeng/0000-0002-2834-2833				Dobson DP, 2002, SCIENCE, V298, P1407, DOI 10.1126/science.1075390; GREEN HW, 1987, ACTA METALL MATER, V35, P1301, DOI 10.1016/0001-6160(87)90011-3; Green HW, 2002, REV MINERAL GEOCHEM, V51, P181, DOI 10.2138/gsrmg.51.1.181; GREEN HW, 1995, ANNU REV EARTH PL SC, V23, P169, DOI 10.1146/annurev.ea.23.050195.001125; Hacker B.R., 2003, J GEOPHYS RES, V108; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; HOGREFE A, 1994, NATURE, V372, P351, DOI 10.1038/372351a0; Igarashi T, 2001, J GEOPHYS RES-SOL EA, V106, P2177, DOI 10.1029/2000JB900386; Ingrin J, 2000, EUR J MINERAL, V12, P543; Jin ZM, 2001, GEOLOGY, V29, P667, DOI 10.1130/0091-7613(2001)029<0667:ERIFSL>2.0.CO;2; KARATO S, 1986, NATURE, V319, P309, DOI 10.1038/319309a0; Katayama I, 2003, AM MINERAL, V88, P229; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Lu R, 1997, CONTRIB MINERAL PETR, V129, P35, DOI 10.1007/s004100050321; Omori S., 2002, B EARTHQ RES I TOKYO, V76, P455; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; Poli S, 2002, ANNU REV EARTH PL SC, V30, P207, DOI 10.1146/annurev.earth.30.091201.140550; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Rauch M, 2002, CONTRIB MINERAL PETR, V143, P525, DOI 10.1007/s00410-002-0365-6; Rossman GR, 1996, PHYS CHEM MINER, V23, P299, DOI 10.1007/BF00207777; RUSHMER T, 1996, GEOPHYS MONOGR SER, V96, P299; SCHOLZ CH, 2002, MECH EARTHQUAKES FAU, P37; SHELLY DR, 2002, EOS, V83, pF1257; SILVER PG, 1995, SCIENCE, V268, P69, DOI 10.1126/science.268.5207.69; Smyth JR, 1997, EARTH PLANET SC LETT, V146, pE9, DOI 10.1016/S0012-821X(96)00230-0; SMYTH JR, 1991, NATURE, V351, P732, DOI 10.1038/351732a0; Ulmer P., 1999, MANTLE PETROLOGY FIE, P259	28	74	109	9	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					633	636		10.1038/nature02475	http://dx.doi.org/10.1038/nature02475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071590				2022-12-28	WOS:000220697200038
J	Paez, JG; Janne, PA; Lee, JC; Tracy, S; Greulich, H; Gabriel, S; Herman, P; Kaye, FJ; Lindeman, N; Boggon, TJ; Naoki, K; Sasaki, H; Fujii, Y; Eck, MJ; Sellers, WR; Johnson, BE; Meyerson, M				Paez, JG; Janne, PA; Lee, JC; Tracy, S; Greulich, H; Gabriel, S; Herman, P; Kaye, FJ; Lindeman, N; Boggon, TJ; Naoki, K; Sasaki, H; Fujii, Y; Eck, MJ; Sellers, WR; Johnson, BE; Meyerson, M			EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; BRAF GENE; INHIBITOR; SENSITIVITY; TRIAL; AMPLIFICATION; COMBINATION; PACLITAXEL; EFFICACY	Receptor tyrosine kinase genes were sequenced in non - small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15 of 58 unselected tumors from Japan and 1 of 61 from the United States. Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan. EGFR mutations were found in additional lung cancer samples from U. S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines. These results suggest that EGFR mutations may predict sensitivity to gefitinib.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; Natl Naval Med Res Inst, Genet Branch, NCI, Bethesda, MD 20889 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Naval Medical Research Center (NMRC); Harvard University; Brigham & Women's Hospital; Nagoya City University	Sellers, WR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	William_Sellers@dfci.harvard.edu; Bruce_Johnson@dfci.harvard.edu; Matthew_Meyerson@dfci.harvard.edu	Naoki, Katsuhiko/J-5937-2019; kaye, frederic/E-2437-2011; Meyerson, Matthew L/E-7123-2012	Naoki, Katsuhiko/0000-0002-9637-1388; 	NATIONAL CANCER INSTITUTE [ZIASC007256, Z01SC007256] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey R, 2003, LUNG CANCER, V41, pS71, DOI DOI 10.1016/S0169-5002(03)91900-3; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Fujishita T, 2003, ONCOLOGY-BASEL, V64, P399, DOI 10.1159/000070299; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janne PA, 2004, LUNG CANCER-J IASLC, V44, P221, DOI 10.1016/j.lungcan.2003.12.014; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Naoki K, 2002, CANCER RES, V62, P7001; Ono M, 2004, MOL CANCER THER, V3, P465; RUSCH V, 1993, CANCER RES, V53, P2379; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816	26	7574	8154	31	934	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2004	304	5676					1497	1500		10.1126/science.1099314	http://dx.doi.org/10.1126/science.1099314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15118125				2022-12-28	WOS:000221795800043
J	Watts, G				Watts, G			Commentary: the defence of dirt	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE				Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; Rook GAW, 2004, SPRINGER SEMIN IMMUN, V25, P237, DOI 10.1007/s00281-003-0148-9; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2	5	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2004	328	7450					1226	1226		10.1136/bmj.38075.565822.55	http://dx.doi.org/10.1136/bmj.38075.565822.55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15121715	Green Published			2022-12-28	WOS:000221677200016
J	Holtzendorff, J; Hung, D; Brende, P; Reisenauer, A; Viollier, PH; McAdams, HH; Shapiro, L				Holtzendorff, J; Hung, D; Brende, P; Reisenauer, A; Viollier, PH; McAdams, HH; Shapiro, L			Oscillating global regulators control the genetic circuit driving a bacterial cell cycle	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; CAULOBACTER-CRESCENTUS; HISTIDINE KINASE; DNA-REPLICATION; LOCALIZATION; DIVISION; IDENTIFICATION; PROGRESSION; CTRA	A newly identified cell-cycle master regulator protein, GcrA, together with the CtrA master regulator, are key components of a genetic circuit that drives cell-cycle progression and asymmetric polar morphogenesis in Caulobacter crescentus. The circuit drives out-of-phase temporal and spatial oscillation of GcrA and CtrA concentrations, producing time- and space-dependent transcriptional regulation of modular functions that implement cell-cycle processes. The CtrA/GcrA regulatory circuit controls expression of polar differentiation factors and the timing of DNA replication. CtrA functions as a silencer of the replication origin and GcrA as an activator of components of the replisome and the segregation machinery.	Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Shapiro, L (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	shapiro@stanford.edu	Viollier, Patrick/AAD-9405-2021	Viollier, Patrick/0000-0002-5249-9910	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32506, GM1426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jenal U, 2002, CURR OPIN MICROBIOL, V5, P558, DOI 10.1016/S1369-5274(02)00378-8; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 2000, TRENDS CELL BIOL, V10, P483, DOI 10.1016/S0962-8924(00)01840-7; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Marques MDV, 1997, J BACTERIOL, V179, P5502, DOI 10.1128/jb.179.17.5502-5510.1997; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Reisenauer A, 2002, EMBO J, V21, P4969, DOI 10.1093/emboj/cdf490; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630	27	148	151	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2004	304	5673					983	987		10.1126/science.1095191	http://dx.doi.org/10.1126/science.1095191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820IV	15087506				2022-12-28	WOS:000221383300040
J	Tschumperlin, DJ; Dai, GH; Maly, IV; Kikuchi, T; Laiho, LH; McVittie, AK; Haley, KJ; Lilly, CM; So, PTC; Lauffenburger, DA; Kamm, RD; Drazen, JM				Tschumperlin, DJ; Dai, GH; Maly, IV; Kikuchi, T; Laiho, LH; McVittie, AK; Haley, KJ; Lilly, CM; So, PTC; Lauffenburger, DA; Kamm, RD; Drazen, JM			Mechanotransduction through growth-factor shedding into the extracellular space	NATURE			English	Article							IN-THE-LUNG; MECHANICAL-STRESS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; BRONCHIAL EPITHELIUM; AUTOCRINE LOOPS; FACTOR RECEPTOR; SHEAR-STRESS; G-PROTEINS; RELEASE	Physical forces elicit biochemical signalling in a diverse array of cells, tissues and organisms(1-3), helping to govern fundamental biological processes. Several hypotheses have been advanced that link physical forces to intracellular signalling pathways, but in many cases the molecular mechanisms of mechanotransduction remain elusive(1-9). Here we find that compressive stress shrinks the lateral intercellular space surrounding epithelial cells, and triggers cellular signalling via autocrine binding of epidermal growth factor family ligands to the epidermal growth factor receptor. Mathematical analysis predicts that constant rate shedding of autocrine ligands into a collapsing lateral intercellular space leads to increased local ligand concentrations that are sufficient to account for the observed receptor signalling; direct experimental comparison of signalling stimulated by compressive stress versus exogenous soluble ligand supports this prediction. These findings establish a mechanism by which mechanotransduction arises from an autocrine ligand - receptor circuit operating in a dynamically regulated extracellular volume, not requiring induction of force-dependent biochemical processes within the cell or cell membrane.	Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pulm & Crit Care, Boston, MA 02115 USA; MIT, Biol Engn Div, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Drazen, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Physiol Program, Boston, MA 02115 USA.	jdrazen@nejm.org	Drazen, Jeffrey M/E-5841-2012; Kamm, Roger D/I-7630-2012	/0000-0002-7232-304X; Dai, Guohao/0000-0001-7346-2685	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB015871] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Ali MH, 2002, CRIT CARE MED, V30, pS198, DOI 10.1097/00003246-200205001-00005; Blount P, 2003, NEURON, V37, P731, DOI 10.1016/S0896-6273(03)00122-3; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; DULL RO, 1992, J VASC RES, V29, P410, DOI 10.1159/000158959; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Han OH, 1998, AM J PHYSIOL-GASTR L, V275, pG534, DOI 10.1152/ajpgi.1998.275.3.G534; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; KONDO M, 1992, AM J PHYSIOL, V262, P176; Lauffenburger DA, 1998, P NATL ACAD SCI USA, V95, P15368, DOI 10.1073/pnas.95.26.15368; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; MARTINS MA, 1990, J CLIN INVEST, V85, P170, DOI 10.1172/JCI114408; OHASHI Y, 1992, AM REV RESPIR DIS, V145, P1469, DOI 10.1164/ajrccm/145.6.1469; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; SPRING KR, 1978, SCIENCE, V200, P54, DOI 10.1126/science.635571; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Torday JS, 2003, CELL BIOCHEM BIOPHYS, V37, P235; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Yamamoto K, 2003, AM J PHYSIOL-HEART C, V285, pH793, DOI 10.1152/ajpheart.01155.2002	30	249	258	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					83	86		10.1038/nature02543	http://dx.doi.org/10.1038/nature02543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15103386	Green Accepted, Bronze			2022-12-28	WOS:000221222100049
J	Jenet, FA; Ransom, SM				Jenet, FA; Ransom, SM			The geometry of the double-pulsar system J0737-3039 from systematic intensity variations	NATURE			English	Article							PRECESSION; B1913+16	Two pulsars (PSR J0737 - 3039A(1) and B-2) were recently discovered in highly relativistic orbits around one another. The system contains a rapidly rotating pulsar with a spin period of 22.7 ms and a slow companion with a spin period of 2.77 s, referred to here as 'A' and 'B', respectively. A unique property of the system is that the pulsed radio flux from B increases systematically by almost two orders of magnitude during two short portions of its orbit(2). Here we report a geometrical model of the system that simultaneously explains the intensity variations of B and provides constraints on the spin axis orientation and emission geometry of A. Our model assumes that B's pulsed radio flux increases when illuminated by emission from A. We predict that A's pulse profile will evolve considerably over the next several years owing to geodetic precession until it disappears entirely in 15 - 20 years.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; MIT, Ctr Space Res, Cambridge, MA 02139 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); McGill University; Massachusetts Institute of Technology (MIT)	Jenet, FA (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	merlyn@alum.mit.edu		Ransom, Scott/0000-0001-5799-9714				ARONS J, UNPUB ASTROPHYS J; BARKER BM, 1975, ASTROPHYS J, V199, pL25, DOI 10.1086/181840; BARKER BM, 1975, PHYS REV D, V12, P329, DOI 10.1103/PhysRevD.12.329; BURGAY M, 2004, NATURE, V426, P521; DEMOREST P, 2004, UNPUB ASTROPHYS J; KASPI VM, 2004, UNPUB ASTROPHYS J; Kramer M, 1998, ASTROPHYS J, V509, P856, DOI 10.1086/306535; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; LYNE AG, 1988, MON NOT R ASTRON SOC, V234, P477, DOI 10.1093/mnras/234.3.477; Lyne AG, 1998, MON NOT R ASTRON SOC, V295, P743, DOI 10.1046/j.1365-8711.1998.01144.x; RADHAKRISHNAN V, 1969, ASTROPHYS LETT, V3, P225; RANSOM S, 2004, UNPUB ASTROPHYS J; Vetterling W.T., 1988, NUMERICAL RECIPES C	14	28	29	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					919	921		10.1038/nature02509	http://dx.doi.org/10.1038/nature02509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118719	Green Submitted			2022-12-28	WOS:000221083000033
J	Singh, JA				Singh, JA			Health research and human rights in South Africa	LANCET			English	Editorial Material									Univ Kwazulu Natal, Ctr AIDS Programme Res S Africa, ZA-4041 Durban, South Africa	University of Kwazulu Natal		singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					*DEP HLTH S AFR, 2001, HLTH RES POL S AFR; Department of Health of South Africa, 1997, WHIT PAP TRANSF HLTH; MBEKI T, ANC HAS NO FINANCIAL	3	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1393	1393		10.1016/S0140-6736(04)16054-6	http://dx.doi.org/10.1016/S0140-6736(04)16054-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15112694	Green Submitted, Bronze			2022-12-28	WOS:000220996300027
J	Thomas, J; Harden, A; Oakley, A; Oliver, S; Sutcliffe, K; Rees, R; Brunton, G; Kavanagh, J				Thomas, J; Harden, A; Oakley, A; Oliver, S; Sutcliffe, K; Rees, R; Brunton, G; Kavanagh, J			Integrating qualitative research with trials in systematic reviews	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-EDUCATION INTERVENTIONS		Inst Educ, Evidence Policy & Practice Informat & Coordinatin, Social Sci Res Unit, London WC1H 0NR, England	University of London; University College London; UCL Institute of Education	Thomas, J (corresponding author), Inst Educ, Evidence Policy & Practice Informat & Coordinatin, Social Sci Res Unit, London WC1H 0NR, England.	j.thomas@ioc.ac.uk		Sutcliffe, Katy/0000-0002-5469-8649; Oliver, Sandy/0000-0001-9571-269X; Thomas, James/0000-0003-4805-4190; Rees, Rebecca/0000-0003-1413-1952				Boulton M, 1996, J Eval Clin Pract, V2, P171, DOI 10.1111/j.1365-2753.1996.tb00041.x; Cobb A K, 1987, J Nurs Educ, V26, P138; Dixon-Woods M, 2001, BRIT MED J, V323, P765, DOI 10.1136/bmj.323.7316.765; HARDEN A, IN PRESS J EPIDEMIOL; HARDEN A, IN PRESS INT J SOC R; Harden A, 2001, HLTH ED J, V60, P339, DOI DOI 10.1177/001789690106000406; LOEVINSOHN BP, 1990, INT J EPIDEMIOL, V19, P788, DOI 10.1093/ije/19.4.788; MCDONALD G, 1992, BR J SOC WORK, V22, P615; *MED SOC GROUP, 1996, MED SOCIOLOGY NEWS, V22, P69; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; Peersman G., 1997, EPPI CTR REV GUIDELI; *QSR INT, NVIVO VERS 2 0; Roberts KA, 2002, LANCET, V360, P1596, DOI 10.1016/S0140-6736(02)11560-1; Thomas J., 2003, CHILDREN HLTH EATING; Wilson D.B, 2001, PRACTICAL METAANALYS, V1	15	296	297	1	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 24	2004	328	7446					1010	1012		10.1136/bmj.328.7446.1010	http://dx.doi.org/10.1136/bmj.328.7446.1010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105329	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000221130100026
J	Budanov, AV; Sablina, AA; Feinstein, E; Koonin, EV; Chumakov, PM				Budanov, AV; Sablina, AA; Feinstein, E; Koonin, EV; Chumakov, PM			Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD	SCIENCE			English	Article							CYSTEINE-SULFINIC ACID; TUBERCULOSIS ALKYLHYDROPEROXIDASE AHPD; ALKYL HYDROPEROXIDE REDUCTASE; OXIDATIVE STRESS; NITROSATIVE STRESS; HYDROGEN-PEROXIDE; DEFENSE; IDENTIFICATION; OVEROXIDATION; INACTIVATION	Acting as a signal, hydrogen peroxide circumvents antioxidant defense by over-oxidizing peroxiredoxins (Prxs), the enzymes that metabolize peroxides. We show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of Prxs containing Cys-SO2H, thus reestablishing the antioxidant firewall. Sestrins contain a predicted redox-active domain homologous to AhpD, the enzyme catalyzing the reduction of a bacterial Prx, AhpC. Purified Hi95 (sestrin 2) protein supports adenosine triphosphate-dependent reduction of over-oxidized Prxl in vitro, indicating that unlike AhpD, which is a disulfide reductase, sestrins are cysteine sulfinyl reductases. As modulators of peroxide signaling and antioxidant defense, sestrins constitute potential therapeutic targets.	Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Canc Res Ctr, Moscow 1154785, Russia; Quark Biotech Inc, IL-70400 Ness Ziona, Israel; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Cleveland Clinic Foundation; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Chumakov, PM (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chumakp@ccf.org	Budanov, Andrei V/HGD-5487-2022; Sablina, Anna/P-2818-2019; Chumakov, Peter M/E-7731-2014; Sablina, Anna/B-2217-2017	Budanov, Andrei V/0000-0002-7943-1000; Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Chumakov, Peter/0000-0002-8078-2908	NATIONAL LIBRARY OF MEDICINE [ZIALM000061, Z01LM000061] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; BUDANOV AV, UNPUB; BYRK R, 2002, SCIENCE, V295, P1073, DOI DOI 10.1126/SCIENCE.1067798; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; Nunn CM, 2002, J BIOL CHEM, V277, P20033, DOI 10.1074/jbc.M200864200; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	592	622	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					596	600		10.1126/science.1095569	http://dx.doi.org/10.1126/science.1095569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105503				2022-12-28	WOS:000220975100052
J	Cordier, P; Ungar, T; Zsoldos, L; Tichy, G				Cordier, P; Ungar, T; Zsoldos, L; Tichy, G			Dislocation creep in MgSiO3 perovskite at conditions of the Earth's uppermost lower mantle	NATURE			English	Article							HIGH-TEMPERATURE CREEP; X-RAY-DIFFRACTION; PROFILE ANALYSIS; VISCOSITY; DEFORMATION; SYSTEMATICS; PRESSURE; CRYSTALS; ANALOG	Seismic anisotropy provides an important observational constraint on flow in the Earth's deep interior. The quantitative interpretation of anisotropy, however, requires knowledge of the slip geometry of the constitutive minerals that are responsible for producing rock fabrics. The Earth's lower mantle is mostly composed of (Mg, Fe) SiO3 perovskite(1), but as MgSiO3 perovskite is not stable at high temperature under ambient pressure, it has not been possible to investigate its mechanical behaviour with conventional laboratory deformation experiments. To overcome this limitation, several attempts were made to infer the mechanical properties of MgSiO3 perovskite on the basis of analogue materials(2-7). But perovskites do not constitute an analogue series for plastic deformation, and therefore the direct investigation of MgSiO3 perovskite is necessary. Here we have taken advantage of recent advances in experimental high-pressure rheology(8) to perform deformation experiments on coarse-grained MgSiO3 polycrystals under pressure and temperature conditions of the uppermost lower mantle. We show that X-ray peak broadening measurements developed in metallurgy can be adapted to low-symmetry minerals to identify the elementary deformation mechanisms activated under these conditions. We conclude that, under uppermost lower-mantle conditions, MgSiO3 perovskite deforms by dislocation creep and may therefore contribute to producing seismic anisotropy in rocks at such depths.	Univ Sci & Technol Lille, UMR CNRS 8008, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France; Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; Eotvos Lorand Univ, Dept Solid State Phys, H-1518 Budapest, Hungary; Eotvos Lorand Univ, Dept Gen Phys, H-1518 Budapest, Hungary	Universite de Lille - ISITE; Universite de Lille; University of Bayreuth; Eotvos Lorand University; Eotvos Lorand University	Cordier, P (corresponding author), Univ Sci & Technol Lille, UMR CNRS 8008, Lab Struct & Proprietes Etat Solide, F-59655 Villeneuve Dascq, France.	Patrick.Cordier@univ-lille1.fr	Cordier, Patrick/D-2357-2012	Cordier, Patrick/0000-0002-1883-2994				BEAUCHESNE S, 1989, PHYS EARTH PLANET IN, V55, P187, DOI 10.1016/0031-9201(89)90242-2; BEAUCHESNE S, 1990, PHYS EARTH PLANET IN, V61, P182, DOI 10.1016/0031-9201(90)90105-7; CAGLIOTI G, 1958, NUCL INSTRUM METHODS, V3, P223, DOI 10.1016/0369-643X(58)90029-X; Chen JH, 2002, NATURE, V419, P824, DOI 10.1038/nature01130; Cordier P, 2001, MAT SCI ENG A-STRUCT, V309, P38, DOI 10.1016/S0921-5093(00)01795-0; HORIUCHI H, 1987, AM MINERAL, V72, P357; KARATO S, 1990, GEOPHYS RES LETT, V17, P13, DOI 10.1029/GL017i001p00013; Krivoglaz M. A., 1983, XRAY NEUTRON DIFFRAC; Krivoglaz M. A., 1969, THEORY XRAY THERMAL; KUZEL R, 1989, J APPL CRYSTALLOGR, V22, P299, DOI 10.1107/S0021889889001585; Li P, 1996, PHYS EARTH PLANET IN, V95, P19, DOI 10.1016/0031-9201(95)03107-3; McNamara AK, 2002, NATURE, V416, P310, DOI 10.1038/416310a; Merkel S, 2003, EARTH PLANET SC LETT, V209, P351, DOI 10.1016/S0012-821X(03)00098-0; POIRIER JP, 1983, PHYS EARTH PLANET IN, V32, P273, DOI 10.1016/0031-9201(83)90131-0; Ribarik G, 2001, J APPL CRYSTALLOGR, V34, P669, DOI 10.1107/S0021889801011451; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Ungar T, 1996, APPL PHYS LETT, V69, P3173, DOI 10.1063/1.117951; Ungar T, 2001, J APPL CRYSTALLOGR, V34, P298, DOI 10.1107/S0021889801003715; Wang ZC, 1999, PHYS EARTH PLANET IN, V110, P51, DOI 10.1016/S0031-9201(98)00130-7; WANG ZC, 1993, PHYS EARTH PLANET IN, V79, P299, DOI 10.1016/0031-9201(93)90111-L; Wilkens M., 1970, Physica Status Solidi A, V2, P359, DOI 10.1002/pssa.19700020224	21	124	126	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					837	840		10.1038/nature02472	http://dx.doi.org/10.1038/nature02472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103372				2022-12-28	WOS:000220952300035
J	Davies, SJC; Jackson, PR; Potokar, J; Nutt, DJ				Davies, SJC; Jackson, PR; Potokar, J; Nutt, DJ			Treatment of anxiety and depressive disorders in patients with cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Review							PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; DOUBLE-BLIND; MYOCARDIAL-INFARCTION; POSTSTROKE DEPRESSION; CHEST-PAIN; PANIC DISORDER; REUPTAKE INHIBITORS; RANDOMIZED-TRIAL	What role do selective serotonin reuptake inhibitors have in treating psychiatric morbidity in patients with cardiovascular disease? This review discusses the safety and efficacy of various antidepressants in this group of patients and their potential for improving cardiovascular outcomes.	Psychopharmacol Unit, Bristol BS1 3NY, Avon, England; Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Bristol; University of Sheffield	Davies, SJC (corresponding author), Psychopharmacol Unit, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England.	simon.davies@bristol.ac.uk		Davies, Simon/0000-0003-0095-5993				ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004; AVERY D, 1976, ARCH GEN PSYCHIAT, V33, P1029; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P24; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; *BOST COLL DRUG SU, 1972, LANCET, V1, P529; Brook RD, 2000, AM J HYPERTENS, V13, p112S, DOI 10.1016/S0895-7061(00)00228-4; Dam M, 1996, STROKE, V27, P1211, DOI 10.1161/01.STR.27.7.1211; Davies SJC, 2003, ARCH INTERN MED, V163, P592, DOI 10.1001/archinte.163.5.592; Davies SJC, 1999, AM J MED, V107, P310, DOI 10.1016/S0002-9343(99)00237-5; Esler M, 2001, AM J HYPERTENS, V14, p139S, DOI 10.1016/S0895-7061(01)02081-7; Fleet RP, 1996, AM J MED, V101, P371, DOI 10.1016/S0002-9343(96)00224-0; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; Fruehwald S, 2003, J NEUROL, V250, P347, DOI 10.1007/s00415-003-1014-3; GLASSMAN AH, 1993, J CLIN PSYCHIAT, V54, P16; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; GLASSMAN AH, 1983, JAMA-J AM MED ASSOC, V250, P1997, DOI 10.1001/jama.250.15.1997; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; LEHNERT H, 1987, J CARDIOVASC PHARM, V10, P389, DOI 10.1097/00005344-198710000-00003; Mayou RA, 1997, PSYCHOL MED, V27, P1021, DOI 10.1017/S0033291797005254; McFarlane A, 2001, AM HEART J, V142, P617, DOI 10.1067/mhj.2001.116766; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; POLYAK J, 2001, J HYPERTENS S2, V19, pS64; Potokar JP, 2000, INT J CLIN PRACT, V54, P110; Preskorn SH, 1998, J PSYCHOPHARMACOL, V12, pS89, DOI 10.1177/0269881198012003051; RABKIN JG, 1983, AM J PSYCHIAT, V140, P1072; Rasmussen A, 2003, PSYCHOSOMATICS, V44, P216, DOI 10.1176/appi.psy.44.3.216; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; Robinson RG, 2000, AM J PSYCHIAT, V157, P351, DOI 10.1176/appi.ajp.157.3.351; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; Roose SP, 2003, BIOL PSYCHIAT, V54, P262, DOI 10.1016/S0006-3223(03)00320-2; ROOSE SP, 1986, JAMA-J AM MED ASSOC, V256, P3253, DOI 10.1001/jama.256.23.3253; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Strik JJMH, 1998, INT CLIN PSYCHOPHARM, V13, P263, DOI 10.1097/00004850-199811000-00004; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; Thurston RC, 2001, PAIN, V93, P95, DOI 10.1016/S0304-3959(01)00327-X; VEITH RC, 1982, NEW ENGL J MED, V306, P954, DOI 10.1056/NEJM198204223061603; Wiart L, 2000, STROKE, V31, P1829, DOI 10.1161/01.STR.31.8.1829; Wuttke H, 2002, CLIN PHARMACOL THER, V72, P429, DOI 10.1067/mcp.2002.127111; Yeragani VK, 1999, NEUROPSYCHOBIOLOGY, V40, P124, DOI 10.1159/000026608; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	48	37	37	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					939	943		10.1136/bmj.328.7445.939	http://dx.doi.org/10.1136/bmj.328.7445.939			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814SM	15087342	Green Published			2022-12-28	WOS:000220994400027
J	Secombe, J; Pierce, SB; Eisenman, RN				Secombe, J; Pierce, SB; Eisenman, RN			Myc: A weapon of mass destruction	CELL			English	Review							DROSOPHILA MYC; CELL-CYCLE; PROLIFERATION; APOPTOSIS; ONCOGENES; NETWORK; MAX	Growth and proliferation potentiated by deregulated myc oncogene expression is balanced by myc-induced apoptosis. Abrogation of this apoptotic pathway in Myc overexpressing cells leads to cancer progression. Recent work has shown that cell clones in the Drosophila wing disc with higher dMyc expression levels act as supercompetitors to potentiate the programmed death of surrounding normal cells. Yet another paper identifies dE2F1 as a critical component of pathways that normally restrict the ability of growth perturbing genes like dMyc to cause organ overgrowth.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98109 USA.	eisenman@fhcrc.org		Pierce, Sarah/0000-0001-6739-7135				Burke R, 1996, DEVELOPMENT, V122, P2261; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hueber AO, 1998, TRENDS GENET, V14, P364, DOI 10.1016/S0168-9525(98)01520-0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEVENS D, 2003, DEVELOPMENT, V131, P775; Milan M, 1998, BIOESSAYS, V20, P969, DOI 10.1002/(SICI)1521-1878(199812)20:12<969::AID-BIES1>3.0.CO;2-L; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; PIERCE SB, 2004, IN PRESS DEVELOPMENT; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235	17	101	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					153	156		10.1016/S0092-8674(04)00336-8	http://dx.doi.org/10.1016/S0092-8674(04)00336-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084254	Bronze			2022-12-28	WOS:000220913400004
J	Parker, LH; Schmidt, M; Jin, SW; Gray, AM; Beis, D; Pham, T; Frantz, G; Palmieri, S; Hillan, K; Stainier, DYR; de Sauvage, FJ; Ye, WL				Parker, LH; Schmidt, M; Jin, SW; Gray, AM; Beis, D; Pham, T; Frantz, G; Palmieri, S; Hillan, K; Stainier, DYR; de Sauvage, FJ; Ye, WL			The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation	NATURE			English	Article							ZEBRAFISH GENE; MUTANT EMBRYOS; EXPRESSION; ANGIOGENESIS; NOTOCHORD; DOMAIN; MORPHOGENESIS; PROTEIN; HOMOLOG; CLOCHE	Vascular development is a complex but orderly process that is tightly regulated. A number of secreted factors produced by surrounding cells regulate endothelial cell (EC) differentiation, proliferation, migration and coalescence into cord-like structures(1,2). Vascular cords then undergo tubulogenesis to form vessels with a central lumen(3,4). But little is known about how tubulogenesis is regulated in vivo. Here we report the identification and characterization of a new EC-derived secreted factor, EGF-like domain 7 (Egfl7). Egfl7 is expressed at high levels in the vasculature associated with tissue proliferation, and is downregulated in most of the mature vessels in normal adult tissues. Loss of Egfl7 function in zebrafish embryos specifically blocks vascular tubulogenesis. We uncover a dynamic process during which gradual separation and proper spatial arrangement of the angioblasts allow subsequent assembly of vascular tubes. This process fails to take place in Egfl7 knockdown embryos, leading to the failure of vascular tube formation. Our study defines a regulator that controls a specific and important step in vasculogenesis.	Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ye, WL (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	loni@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Ye, Weilan/0000-0002-6219-3982; Beis, Dimitris/0000-0003-2579-7848; Schmidt, Maike/0000-0001-9062-1828; Stainier, Didier/0000-0002-0382-0026; Dichgans, Martin/0000-0002-0654-387X				Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Childs S, 2002, DEVELOPMENT, V129, P973; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Folkman J, 1997, EXS, V79, P1; Fong GH, 1999, DEVELOPMENT, V126, P3015; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Liao W, 1997, DEVELOPMENT, V124, P381; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.0.CO;2-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Parker LH, 1999, METHOD CELL BIOL, V59, P313; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Sumoy L, 1997, MECH DEVELOP, V63, P15, DOI 10.1016/S0925-4773(97)00671-0; Vokes SA, 2002, DEVELOPMENT, V129, P775; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	27	290	331	4	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					754	758		10.1038/nature02416	http://dx.doi.org/10.1038/nature02416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085134				2022-12-28	WOS:000220823800041
J	Cook, DJ; Montori, VM; McMullin, JP; Finfer, SR; Rocker, GM				Cook, DJ; Montori, VM; McMullin, JP; Finfer, SR; Rocker, GM			Improving patients' safety locally: changing clinician behaviour	LANCET			English	Article							CRITICALLY ILL PATIENTS; EVIDENCE BASED POLICY; VENOUS THROMBOEMBOLISM; GASTROESOPHAGEAL-REFLUX; MYOCARDIAL-INFARCTION; PULMONARY ASPIRATION; ATRIAL-FIBRILLATION; PREVENTION; COMPLICATIONS; MEDICATIONS	Safety initiatives in hospitals should focus on common health care interventions that when used appropriately can improve important health outcomes, and when used inappropriately or not at all, result in substantial harm. We suggest that errors of omission should be a safety priority. We focus on preventive health care interventions, and describe five steps that can improve patients' safety by changing clinician behaviour. The steps are to: do an environmental scan; understand current behaviour, target behaviour for change (why, what, when, where, and who); adopt effective strategies to change behaviour; and synergise.	McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3A5, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3A5, Canada; Mayo Clin, Div Endocrinol Diabet Metab Nutr & Internal Med, Rochester, MN USA; Univ Sydney, Royal N Shore Hosp, Intens Therapy Unit, Sydney, NSW 2006, Australia; Dalhousie Univ, Dept Med, Halifax, NS, Canada	McMaster University; McMaster University; Mayo Clinic; Royal North Shore Hospital; University of Sydney; Dalhousie University	Cook, DJ (corresponding author), McMaster Univ, Med Ctr, Dept Med, 1200 Main St W, Hamilton, ON L8N 3A5, Canada.	debcook@mcmaster.ca		Montori, Victor/0000-0003-0595-2898				ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bion JF, 2004, LANCET, V363, P970, DOI 10.1016/S0140-6736(04)15793-0; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; BUIST MD, 2002, BRIT MED J, V324, P1; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campion EW, 2003, NEW ENGL J MED, V348, P1083, DOI 10.1056/NEJMp030033; Cook D, 2000, CRIT CARE MED, V28, P3547, DOI 10.1097/00003246-200010000-00034; Cook D, 2001, J CRIT CARE, V16, P161, DOI 10.1053/jcrc.2001.30665; Cook D, 2000, J CRIT CARE, V15, P127, DOI 10.1053/jcrc.2000.19224; Cook D, 2001, CRIT CARE, V5, P336, DOI 10.1186/cc1066; Cook DJ, 2002, CRIT CARE MED, V30, P1472, DOI 10.1097/00003246-200207000-00012; Curry SJ, 2000, CHEST, V118, p40S, DOI 10.1378/chest.118.2_suppl.40S; Devereaux PJ, 2001, BMJ-BRIT MED J, V323, P1218, DOI 10.1136/bmj.323.7323.1218; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; DYER C, 2002, BRIT MED J, V324, P1476; Geerts W, 2002, J CRIT CARE, V17, P95, DOI 10.1053/jcrc.2002.33941; Grap M J, 1999, Am J Crit Care, V8, P475; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; HAM C, 1995, BRIT MED J, V310, P71, DOI 10.1136/bmj.310.6972.71; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hillman K, 2001, RESUSCITATION, V48, P105, DOI 10.1016/S0300-9572(00)00334-8; Holzer M, 2002, NEW ENGL J MED, V346, P549; IBANEZ J, 1992, JPEN-PARENTER ENTER, V16, P419, DOI 10.1177/0148607192016005419; KANNEL WB, 1998, AM J CARDIOL, V0082; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MCMULLIN JP, 2002, SURVIVING INTENSIVE, P287; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Morse MA, 2001, JAMA-J AM MED ASSOC, V285, P1201, DOI 10.1001/jama.285.9.1201; OROZCOLEVI M, 1995, AM J RESP CRIT CARE, V152, P1387, DOI 10.1164/ajrccm.152.4.7551400; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; REEVE BK, 1999, CLIN INTENSIVE CARE, V10, P241; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; Wachter RM, 2002, ANN INTERN MED, V136, P850, DOI 10.7326/0003-4819-136-11-200206040-00015; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	40	70	70	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1224	1230		10.1016/S0140-6736(04)15955-2	http://dx.doi.org/10.1016/S0140-6736(04)15955-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081657				2022-12-28	WOS:000220748100025
J	Elzi, L; Decker, M; Battegay, M; Rutishauser, J; Blum, J				Elzi, L; Decker, M; Battegay, M; Rutishauser, J; Blum, J			Chest pain after travel to the tropics	LANCET			English	Article							EOSINOPHILIC MENINGITIS; THAILAND		Univ Basel Hosp, Div Infect Dis, CH-4002 Basel, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4002 Basel, Switzerland; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of Basel; University of Basel; University of Basel; Swiss Tropical & Public Health Institute	Elzi, L (corresponding author), Univ Basel Hosp, Div Infect Dis, CH-4002 Basel, Switzerland.	Elzil@uhbs.ch						Chandenier J, 2001, CLIN INFECT DIS, V32, pE154, DOI 10.1086/320520; KRAIVICHIAN P, 1992, T ROY SOC TROP MED H, V86, P418, DOI 10.1016/0035-9203(92)90248-B; Moore DAJ, 2003, EMERG INFECT DIS, V9, P647; PUNYAGUPTA S, 1990, J NEUROL SCI, V96, P241, DOI 10.1016/0022-510X(90)90136-B; SCHMUTZHARD E, 1988, J NEUROL NEUROSUR PS, V51, P80, DOI 10.1136/jnnp.51.1.80	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1198	1198		10.1016/S0140-6736(04)15950-3	http://dx.doi.org/10.1016/S0140-6736(04)15950-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081653				2022-12-28	WOS:000220748100011
J	Dyall, SD; Brown, MT; Johnson, PJ				Dyall, SD; Brown, MT; Johnson, PJ			Ancient invasions: From endosymbionts to organelles	SCIENCE			English	Review							PROTEIN IMPORT; MEMBRANE-PROTEIN; GENE-TRANSFER; CHLOROPLAST DNA; MITOCHONDRIAL; EVOLUTION; HYDROGENOSOMES; PATHWAYS; NUCLEUS; ORIGINS	The acquisitions of mitochondria and plastids were important events in the evolution of the eukaryotic cell, supplying it with compartmentalized bioenergetic and biosynthetic factories. Ancient invasions by eubacteria through symbiosis more than a billion years ago initiated these processes. Advances in geochemistry, molecular phylogeny, and cell biology have offered insight into complex molecular events that drove the evolution of endosymbionts into contemporary organelles. In losing their autonomy, endosymbionts lost the bulk of their genomes, necessitating the evolution of elaborate mechanisms for organelle biogenesis and metabolite exchange. In the process, symbionts acquired many host-derived properties, lost much of their eubacterial identity, and were transformed into extraordinarily diverse organelles that reveal complex histories that we are only beginning to decipher.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Johnson, PJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	johnsonp@ucla.edu			NIAID NIH HHS [AI27857] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027857, R29AI027857, R01AI027857] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Daley DO, 2002, P NATL ACAD SCI USA, V99, P10510, DOI 10.1073/pnas.122354399; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2003, J BIOL CHEM, V278, P30548, DOI 10.1074/jbc.M304032200; DYALL SD, UNPUB; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gabriel K, 2001, TRENDS BIOCHEM SCI, V26, P36, DOI 10.1016/S0968-0004(00)01684-4; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Glockner G, 2000, J MOL EVOL, V51, P382; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Macasev D, 2000, PLANT PHYSIOL, V123, P811, DOI 10.1104/pp.123.3.811; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin W, 1999, EUR J PHYCOL, V34, P287, DOI 10.1017/S0967026299002231; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Muller M, 1998, SYST ASSOC SPEC VOL, V56, P109; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Reumann S, 1999, TRENDS PLANT SCI, V4, P302, DOI 10.1016/S1360-1385(99)01449-1; Robinson C, 2001, TRAFFIC, V2, P245, DOI 10.1034/j.1600-0854.2001.1r010.x; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Soll J, 2002, CURR OPIN PLANT BIOL, V5, P529, DOI 10.1016/S1369-5266(02)00296-0; Stegemann S, 2003, P NATL ACAD SCI USA, V100, P8828, DOI 10.1073/pnas.1430924100; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X	52	496	540	4	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					253	257		10.1126/science.1094884	http://dx.doi.org/10.1126/science.1094884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073369				2022-12-28	WOS:000220719400036
J	Clement, BM				Clement, BM			Dependence of the duration of geomagnetic polarity reversals on site latitude	NATURE			English	Article							MATUYAMA-BRUNHES; PALEOMAGNETIC RECORDS; SOUTHERN-HEMISPHERE; LOWER JARAMILLO; UPPER OLDUVAI; TRANSITION; ATLANTIC; FIELD	An important constraint on the processes governing the geodynamo-the flow in the outer core responsible for generating Earth's magnetic field-is the duration of geomagnetic polarity reversals; that is, how long it takes for Earth's magnetic field to reverse(1). It is generally accepted that Earth's magnetic field strength drops to low levels during polarity reversals, and the field direction progresses through a 1808 change while the field is weak(1). The time it takes for this process to happen, however, remains uncertain, with estimates ranging from a few thousand up to 28,000 years. Here I present an analysis of the available sediment records of the four most recent polarity reversals. These records yield an average estimate of about 7,000 years for the time it takes for the directional change to occur. The variation about this mean duration is not random, but instead varies with site latitude, with shorter durations observed at low-latitude sites, and longer durations observed at mid- to high-latitude sites. Such variation of duration with site latitude is predicted by simple geometrical reversal models, in which non-dipole fields are allowed to persist while the axial dipole decays through zero and then builds in the opposite direction, and provides a constraint on numerical dynamo models.	Florida Int Univ, Dept Earth Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Clement, BM (corresponding author), Florida Int Univ, Dept Earth Sci, SW 8th St & 107th Ave, Miami, FL 33199 USA.	clementb@fiu.edu		Clement, Bradford/0000-0003-1122-669X				ATHANOSSOPOLOUS J, 1993, THESIS U CALIF, P225; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Channell JET, 1997, NATURE, V389, P712, DOI 10.1038/39570; Channell JET, 1997, EARTH PLANET SC LETT, V153, P103, DOI 10.1016/S0012-821X(97)00164-7; CISOWSKI SM, 1992, P ODP SCI RES, V126, P341; CLEMENT BM, 1982, PHILOS T R SOC A, V306, P113, DOI 10.1098/rsta.1982.0071; CLEMENT BM, 1984, J GEOPHYS RES, V89, P1049, DOI 10.1029/JB089iB02p01049; CLEMENT BM, 1987, INITIAL REP DEEP SEA, V94, P831; CLEMENT BM, 1984, NATURE, V310, P488, DOI 10.1038/310488a0; CLEMENT BM, 1991, GEOPHYS RES LETT, V18, P81, DOI 10.1029/90GL02714; CLEMENT BM, 1985, PHYS EARTH PLANET IN, V39, P301, DOI 10.1016/0031-9201(85)90144-X; Coe RS, 2000, PHILOS T R SOC A, V358, P1141, DOI 10.1098/rsta.2000.0578; Dormy E, 2000, GEOCHEM GEOPHY GEOSY, V1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; Gee J., 1991, P ODP SCI RES, V121, P377; HERREROBERVERA E, 1986, NATURE, V322, P159, DOI 10.1038/322159a0; HERREROBERVERA E, 1992, GEOPHYS J INT, V108, P535, DOI 10.1111/j.1365-246X.1992.tb04634.x; HOLT JW, 1995, EARTH PLANET SC LETT, V133, P475, DOI 10.1016/0012-821X(95)00100-Q; McElhinny MW, 1996, SURV GEOPHYS, V17, P575, DOI 10.1007/BF01888979; McMillan DG, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Merrill RT, 1999, REV GEOPHYS, V37, P201, DOI 10.1029/1998RG900004; Oda H, 2000, GEOPHYS J INT, V142, P319, DOI 10.1046/j.1365-246x.2000.00130.x; OKADA M, 1989, PHYS EARTH PLANET IN, V56, P133, DOI 10.1016/0031-9201(89)90043-5; Singer BS, 1996, EARTH PLANET SC LETT, V139, P47, DOI 10.1016/0012-821X(96)00003-9; THEYER F, 1985, J GEOPHYS RES-SOLID, V90, P1963, DOI 10.1029/JB090iB02p01963; VALET JP, 1989, EARTH PLANET SC LETT, V94, P371, DOI 10.1016/0012-821X(89)90154-4; VALET JP, 1988, EARTH PLANET SC LETT, V87, P463, DOI 10.1016/0012-821X(88)90009-X; Yamazaki T, 2002, SCIENCE, V295, P2435, DOI 10.1126/science.1068541; ZHU RX, 1994, EARTH PLANET SC LETT, V125, P143, DOI 10.1016/0012-821X(94)90212-7	29	135	144	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					637	640		10.1038/nature02459	http://dx.doi.org/10.1038/nature02459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071591				2022-12-28	WOS:000220697200039
J	Sudbo, J; Lippman, SM; Lee, JJ; Mao, L; Kildal, W; Sudbo, A; Sagen, S; Bryne, M; El-Naggar, A; Risberg, B; Evensen, JF; Reith, A				Sudbo, J; Lippman, SM; Lee, JJ; Mao, L; Kildal, W; Sudbo, A; Sagen, S; Bryne, M; El-Naggar, A; Risberg, B; Evensen, JF; Reith, A			RETRACTED: The influence of resection and aneuploidy on mortality in oral leukoplakia (Retracted article. See vol 355 pg 1927, 2006)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Retracted Publication							SQUAMOUS-CELL CARCINOMA; NECK-CANCER; FIELD CANCERIZATION; CLINICAL-IMPLICATIONS; GENETIC PROGRESSION; MEDICAL PROGRESS; HEAD; RISK; LESIONS; RECOMMENDATIONS	BACKGROUND: Although the standard treatment of oral leukoplakia ranges from watchful waiting to complete resection, the value of these approaches is unknown. METHODS: We studied the relations among resection, ploidy status, and death from cancer in 103 patients with diploid dysplastic oral leukoplakia, 20 patients with tetraploid lesions, and 27 patients with aneuploid lesions. Data on cancer-specific mortality and treatment were obtained from the Cancer Registry of Norway, Statistics Norway, and chart reviews. RESULTS: Primary oral carcinoma developed in 47 of the 150 patients with leukoplakia (31 percent) -- 5 with diploid, 16 with tetraploid, and 26 with aneuploid leukoplakia -- during a mean follow-up of 80 months (range, 4 to 237). The margin status of the initial leukoplakia resection had no relation to the development of oral cancer (P=0.95). Twenty-six of the 47 patients in whom cancer developed (4 with prior tetraploid and 22 with prior aneuploid lesions) had recurrences (55 percent); the recurrences were more frequently multiple and distant (within the oral cavity) among patients with aneuploid lesions than among those with tetraploid or diploid lesions. All 47 patients underwent a standard regimen of surgery and radiation, followed by chemotherapy in the 26 with recurrent cancer. Only patients with aneuploid leukoplakia died of oral cancer; the five-year rate of death from cancer was 72 percent. Aneuploidy-related first carcinomas were diagnosed at a more advanced stage than were carcinomas originating from diploid or tetraploid leukoplakia (P=0.03) and were more likely to be lethal regardless of the stage. CONCLUSIONS: Complete resection of aneuploid leukoplakia does not reduce the high risk of aggressive carcinoma and death from oral cancer.	Univ Oslo, Norwegian Radium Hosp, Dept Med Oncol & Radiotherapy, Div Digital Pathol, N-0310 Oslo, Norway; Univ Oslo, Norwegian Radium Hosp, Dept Pathol, Div Cytol, N-0310 Oslo, Norway; Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol & Head & Neck Surg, Houston, TX 77030 USA; Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; Univ Oslo, Dept Oral Biol, Oslo, Norway	University of Oslo; University of Oslo; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Norwegian University of Science & Technology (NTNU); University of Oslo	Sudbo, A (corresponding author), Univ Oslo, Norwegian Radium Hosp, Dept Med Oncol & Radiotherapy, Div Digital Pathol, Ullernchausseen 70, N-0310 Oslo, Norway.	jon.sudbo@rh.uio.no	Mao, Li/C-7570-2011; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Lee, Jack/P-7331-2019	Mao, Li/0000-0001-7263-3358; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Lee, Jack/0000-0002-4584-929X	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bedi GC, 1996, CANCER RES, V56, P2484; Bouquot J E, 1995, Pract Periodontics Aesthet Dent, V7, P59; Braakhuis BJM, 2002, HEAD NECK-J SCI SPEC, V24, P198, DOI 10.1002/hed.10042.abs; Braakhuis BJM, 2003, CANCER RES, V63, P1727; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; Califano J, 1996, CANCER RES, V56, P2488; Califano J, 2000, CLIN CANCER RES, V6, P347; CHIESA F, 1993, ORAL ONCOL, V29B, P23, DOI 10.1016/0964-1955(93)90006-Z; COTE RA, 1979, SYSTEMATIZED NOMENCL, V1, P61; DECKER J, 1982, NEW ENGL J MED, V306, P1151, DOI 10.1056/NEJM198205133061905; FLEMING ID, 1997, AJCC CANC STAGING MA, P29; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; FORASTIERE A, 2002, NEW ENGL J MED, V346, P788; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lee JJ, 2000, AM STAT, V54, P63, DOI 10.2307/2685614; Lee JJ, 2000, CLIN CANCER RES, V6, P1702; Lippman SM, 2002, CANCER RES, V62, P5119; Lippman SM, 2001, NEW ENGL J MED, V344, P1323, DOI 10.1056/NEJM200104263441710; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; MORK J, 1995, APMIS, V103, P375, DOI 10.1111/j.1699-0463.1995.tb01121.x; O'Shaughnessy JA, 2002, CLIN CANCER RES, V8, P314; Partridge M, 2000, CANCER RES, V60, P3893; Pindborg JJ, 1997, HISTOLOGICAL TYPING, P21; Reibel J, 2003, MED PRIN PRACT, V12, P22, DOI 10.1159/000069845; Scully C, 2000, BRIT MED J, V321, P225, DOI 10.1136/bmj.321.7255.225; SHAFER WG, 1975, CANCER-AM CANCER SOC, V36, P1021, DOI 10.1002/1097-0142(197509)36:3<1021::AID-CNCR2820360327>3.0.CO;2-W; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Sudbo J, 2002, J CLIN ONCOL, V20, P456, DOI 10.1200/JCO.20.2.456; Sudbo J, 2001, NEW ENGL J MED, V344, P1270, DOI 10.1056/NEJM200104263441702; Sudbo Jon, 2003, Tidsskr Nor Laegeforen, V123, P1518; Tradati N, 1997, ORAL ONCOL, V33, P317, DOI 10.1016/S1368-8375(97)00016-X; Tralongo V, 1999, ANTICANCER RES, V19, P3503; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Zhang L, 2001, ORAL ONCOL, V37, P505, DOI 10.1016/S1368-8375(00)00140-8	35	80	82	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1405	1413		10.1056/NEJMoa033374	http://dx.doi.org/10.1056/NEJMoa033374			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070790				2022-12-28	WOS:000220562500007
J	Cogle, CR; Yachnis, AT; Laywell, ED; Zander, DS; Wingard, JR; Steindler, DA; Scott, EW				Cogle, CR; Yachnis, AT; Laywell, ED; Zander, DS; Wingard, JR; Steindler, DA; Scott, EW			Bone marrow transdifferentiation in brain after transplantation: a retrospective study	LANCET			English	Article							HEMATOPOIETIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PURKINJE NEURONS; DENTATE GYRUS; ADULT MICE; NEUROGENESIS; DIFFERENTIATE; ENGRAFTMENT; HIPPOCAMPUS	Background End-organ repair by adult haemopoietic stem cells is under great scrutiny with investigators challenging the notion of these cells' plasticity. Some investigations of animals and short-term human bone marrow transplants suggest that bone marrow can repair brain. We looked for evidence of clinically relevant marrow-derived restorative neurogenesis: long-term, multilineage, neural engraftment that is not the result of cell-fusion events. Methods We examined autopsy brain specimens from three sex-mismatched female bone-marrow-transplantation patients, a female control, and a male control. We did immunohistochemistry, fluorescence in-situ hybridisation, and tissue analysis to look for multilineage, donor-derived neurogenesis. Findings Hippocampal cells containing a Y chromosome were present up to 6 years post-transplant in all three patients. Transgender neurons accounted for 1% of all neurons; there was no evidence of fusion events since only one X chromosome was present. Moreover, transgender astrocytes and microglia made up 1-2% of all glial cells. Interpretation Postnatal human neuropoiesis happens, and human haemopoietic cells can transdifferentiate into neurons, astrocytes, and microglia in a long-term setting without fusing. Transplantable human haemopoietic cells could serve as a therapeutic source for long-term regenerative neuropoiesis.	Univ Florida, Shands Canc Ctr, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Scott, EW (corresponding author), Univ Florida, Shands Canc Ctr, Program Stem Cell Biol & Regenerat Med, 1600 SW Archer Rd,ARB R4-244,POB 100232, Gainesville, FL 32610 USA.	escott@ufl.edu	Steindler, Dennis/AAJ-5811-2020; Zander, Dani/W-1692-2019; Cogle, Christopher/H-1746-2016	Zander, Dani/0000-0002-9243-8354; Cogle, Christopher/0000-0001-5422-6863; Yachnis, Anthony/0000-0002-6971-0698; Wingard, John/0000-0001-7478-5398	NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070143, R01HL070738, R21HL070813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037556] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09126-25] Funding Source: Medline; NHLBI NIH HHS [HL70813, HL70738, HL70143] Funding Source: Medline; NINDS NIH HHS [NS37556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liu JL, 1998, J NEUROSCI, V18, P7768; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Parent JM, 1997, J NEUROSCI, V17, P3727; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rajagopal J, 2003, SCIENCE, V299, P363; Reed Ann M, 2003, Curr Rheumatol Rep, V5, P458, DOI 10.1007/s11926-003-0057-x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Steindler DA, 2002, LANCET, V359, P1047, DOI 10.1016/S0140-6736(02)08096-0; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tham TN, 2001, EUR J NEUROSCI, V13, P845, DOI 10.1046/j.0953-816x.2000.01451.x; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053	39	243	270	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1432	1437		10.1016/S0140-6736(04)16102-3	http://dx.doi.org/10.1016/S0140-6736(04)16102-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121406				2022-12-28	WOS:000221130300010
J	Di Carlo, P; Brune, WH; Martinez, M; Harder, H; Lesher, R; Ren, XR; Thornberry, T; Carroll, MA; Young, V; Shepson, PB; Riemer, D; Apel, E; Campbell, C				Di Carlo, P; Brune, WH; Martinez, M; Harder, H; Lesher, R; Ren, XR; Thornberry, T; Carroll, MA; Young, V; Shepson, PB; Riemer, D; Apel, E; Campbell, C			Missing OH reactivity in a forest: Evidence for unknown reactive biogenic VOCs	SCIENCE			English	Article							ATMOSPHERIC PARTICLES; HYDROXYL RADICALS; AEROSOL FORMATION; DECIDUOUS FOREST; TROPOSPHERIC OH; CHEMISTRY; HYDROCARBONS; OZONE; OZONOLYSIS; EMISSIONS	Forest emissions of biogenic volatile organic compounds (BVOCs), such as isoprene and other terpenes, play a role in the production of tropospheric ozone and aerosols. In a northern Michigan forest, the direct measurement of total OH reactivity, which is the inverse of the OH lifetime, was significantly greater than expected. The difference between measured and expected OH reactivity, called the missing OH reactivity, increased with temperature, as did emission rates for terpenes and other BVOCs. These measurements are consistent with the hypothesis that unknown reactive BVOCs, perhaps terpenes, provide the missing OH reactivity.	Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; Univ Aquila, Dipartimento Fis, CETEMPS, I-67010 Coppito, Laquila, Italy; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Ohio Univ, Dept Chem Engn, Athens, OH 45701 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47301 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Coral Gables, FL 33124 USA; Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of L'Aquila; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Miami; National Center Atmospheric Research (NCAR) - USA	Di Carlo, P (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	piero.dicarlo@aquila.infn.it	Harder, Hartwig D/L-2511-2014; Ren, Xinrong/E-7838-2015; Thornberry, Troy D/H-7106-2013; Di Carlo, Piero/Q-4450-2016; Di Carlo, Piero/C-1657-2016; Ren, Xinrong/B-2229-2010; Harder, Hartwig/AAE-8557-2019; Shepson, Paul B/E-9955-2012; Brune, William/U-7661-2017	Harder, Hartwig D/0000-0002-6868-714X; Ren, Xinrong/0000-0001-9974-1666; Di Carlo, Piero/0000-0003-4971-4509; Di Carlo, Piero/0000-0003-4971-4509; Harder, Hartwig/0000-0002-6868-714X; Brune, William/0000-0002-1609-4051				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Aschmann SM, 2002, ATMOS ENVIRON, V36, P4347, DOI 10.1016/S1352-2310(02)00355-2; Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P215, DOI 10.1063/1.556012; Atkinson R, 2003, ATMOS ENVIRON, V37, pS197, DOI 10.1016/S1352-2310(03)00391-1; Carroll MA, 2001, J GEOPHYS RES-ATMOS, V106, P24275, DOI 10.1029/2001JD900189; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Donahue NM, 1998, GEOPHYS RES LETT, V25, P59, DOI 10.1029/97GL53560; Donahue NM, 1996, J PHYS CHEM-US, V100, P5821, DOI 10.1021/jp9525503; Faloona I, 2001, J GEOPHYS RES-ATMOS, V106, P24315, DOI 10.1029/2000JD900691; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Griffin RJ, 1999, J GEOPHYS RES-ATMOS, V104, P3555, DOI 10.1029/1998JD100049; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; KAUFMAN F, 1984, J PHYS CHEM-US, V88, P4909, DOI 10.1021/j150665a024; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; Kleinman LI, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014569; Kovacs TA, 2003, J ENVIRON MONITOR, V5, P68, DOI 10.1039/b204339d; Kovacs TA, 2001, J ATMOS CHEM, V39, P105, DOI 10.1023/A:1010614113786; Kurpius MR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016785; Lewis AC, 2000, NATURE, V405, P778, DOI 10.1038/35015540; Meng Z, 1997, SCIENCE, V277, P116, DOI 10.1126/science.277.5322.116; O'Dowd CD, 2002, NATURE, V416, P497, DOI 10.1038/416497a; Paulson SE, 1997, GEOPHYS RES LETT, V24, P3193, DOI 10.1029/97GL03163; Pfeiffer T, 1998, CHEM PHYS LETT, V298, P351, DOI 10.1016/S0009-2614(98)01208-1; Ren XR, 2003, ATMOS ENVIRON, V37, P3639, DOI 10.1016/S1352-2310(03)00459-X; Ryerson TB, 2001, SCIENCE, V292, P719, DOI 10.1126/science.1058113; Schade GW, 1999, GEOPHYS RES LETT, V26, P2187, DOI 10.1029/1999GL900444; STEVENS PS, 1994, J GEOPHYS RES-ATMOS, V99, P3543, DOI 10.1029/93JD03342; Stockwell WR, 1997, J GEOPHYS RES-ATMOS, V102, P25847, DOI 10.1029/97JD00849; Tan D, 2001, J GEOPHYS RES-ATMOS, V106, P24407, DOI 10.1029/2001JD900016; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0	30	313	315	15	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					722	725		10.1126/science.1094392	http://dx.doi.org/10.1126/science.1094392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118159				2022-12-28	WOS:000221105300041
J	Osterholm, MT; Norgan, AP				Osterholm, MT; Norgan, AP			The role of irradiation in food safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA.							Andrews L S, 1998, Rev Environ Contam Toxicol, V154, P1; [Anonymous], 1981, World Health Organ Tech Rep Ser, V659, P1; BARNA J, 1979, ACTA ALIMENT HUNG, V8, P205; BURNOUF D, 2002, 3171 INTRREG, P1; Crawford LM, 2001, IRRADIATION FOR FOOD SAFETY AND QUALITY, P9; de Bruyn IN, 2000, RADIAT PHYS CHEM, V57, P223, DOI 10.1016/S0969-806X(99)00385-0; Dickson J.S., 2001, FOOD IRRADIATION PRI, P23; Diehl J. F., 1995, SAFETY IRRADIATED FO; Diehl JF, 2002, RADIAT PHYS CHEM, V63, P211, DOI 10.1016/S0969-806X(01)00622-3; Farkas J, 1998, INT J FOOD MICROBIOL, V44, P189, DOI 10.1016/S0168-1605(98)00132-9; *FOOD AGR ORG UN, 1981, AGR SERV B, V43; Food Safety and Inspection Service, 2003, REC CAS; *FOODB OUTBR RESP, 2000, FOODB DIS OUTBR BACT; FRENZEN PD, 2000, USDA ERS AGR INF B, V757; *GEN ACC OFF, 2000, GAORCED00217; GIDDINGS G, 1996, RADIAT PHYS CHEM, V48, P364; JOSEPHSON ES, 1983, J FOOD SAFETY, V5, P161, DOI 10.1111/j.1745-4565.1983.tb00469.x; Loaharanu P., 2003, IRRADIATED FOODS; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molins RA, 2001, FOOD CONTROL, V12, P347, DOI 10.1016/S0956-7135(01)00035-4; MOLINS RA, 2001, FOOD IRRADIATION PRI, P131; NARVAIZ P, 1996, RADIAT PHYS CHEM, V48, P360; Raul F, 2002, NUTR CANCER, V44, P188, DOI 10.1207/S15327914NC4402_11; ROYBALL J, 2003, BEEF MAGAZINES  0906; SATIN M, 1996, FOOD IRRADIATON GUID; Sommers CH, 2003, J AGR FOOD CHEM, V51, P6367, DOI 10.1021/jf030348o; Tauxe RV, 2001, EMERG INFECT DIS, V7, P516, DOI 10.3201/eid0707.017706; THAYER DW, 1987, J FOOD PROTECT, V50, P278, DOI 10.4315/0362-028X-50.4.278; Wheeler TL, 1999, J ANIM SCI, V77, P3219; Wood OB, 2000, J AM DIET ASSOC, V100, P246, DOI 10.1016/S0002-8223(00)00075-4; 2003, CONSUMER REPORTS AUG, P34; 1997, FED REG, V62, P64107	32	41	43	7	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1898	1901		10.1056/NEJMsb032657	http://dx.doi.org/10.1056/NEJMsb032657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115836				2022-12-28	WOS:000221080300015
J	Benvenga, S				Benvenga, S			Uses of error - Errors based on units of measure	LANCET			English	Editorial Material									Univ Messina Policlin, Dept Med & Clin Pharmacol, Programme Mol & Clin Endocrinol, I-98125 Messina, Italy	AOU Policlinico Gaetano Martino	Benvenga, S (corresponding author), Univ Messina Policlin, Dept Med & Clin Pharmacol, Programme Mol & Clin Endocrinol, I-98125 Messina, Italy.								0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1368	1368		10.1016/S0140-6736(04)16049-2	http://dx.doi.org/10.1016/S0140-6736(04)16049-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110496	Green Published			2022-12-28	WOS:000220996300013
J	Damy, T; Ratajczak, P; Shah, AM; Camors, E; Marty, I; Hasenfuss, G; Marotte, F; Samuel, JL; Heymes, C				Damy, T; Ratajczak, P; Shah, AM; Camors, E; Marty, I; Hasenfuss, G; Marotte, F; Samuel, JL; Heymes, C			Increased neuronal nitric oxide synthase-derived NO production in the failing human heart	LANCET			English	Article								Experimental data suggest that nitric oxide (NO) generated from neuronal NO synthase (nNOS) modulates the myocardial inotropic state. To assess the contribution of NO, derived from endothelial and neuronal isoforms, to the pathophysiology of congestive heart failure in human beings, we compared expression, localisation, and specific activity of NOS isoforms in myocardium from patients with dilated cardiomyopathy with those in controls who had died from head trauma or intracranial bleeds. Diseased hearts had a significant increase in nNOS mRNA and protein expression, and activity associated with the translocation of nNOS to the sarcolemma through interactions with caveolin 3. Enhanced nNOS activity counteracted a decrease in eNOS expression and activity. Our results provide evidence of increased nNOS-derived NO in the failing human heart. Such altered regulation may be important in the pathophysiology of cardiac dysfunction in human congestive heart failure.	Hop Lariboisiere, INSERM, U572, IFR J Marrey Paris 7, F-75475 Paris 10, France; Kings Coll London, Guys Kings & St Thomass Sch Med, Dept Cardiol, London WC2R 2LS, England; CEA, INSERM, DBMS, Grenoble, France; Univ Gottingen, Dept Cardiol, D-3400 Gottingen, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Gottingen	Heymes, C (corresponding author), Hop Lariboisiere, INSERM, U572, IFR J Marrey Paris 7, 41 Blvd Chapelle, F-75475 Paris 10, France.	Christophe.Heymes@larib.inserm.fr	Marty, Isabelle/N-7114-2017; Heymes, Christophe/Y-9368-2019; Marty, Isabelle/ABF-5362-2020; Ratajczak, Philippe/H-5398-2012	Heymes, Christophe/0000-0002-6666-6193; Marty, Isabelle/0000-0003-3625-913X; Shah, Ajay/0000-0002-6547-0631; Samuel, Jane-Lise/0000-0002-7346-2404				Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Damy T, 2003, FASEB J, V17, P1934, DOI 10.1096/fj.02-1208fje; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8	7	196	224	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1365	1367		10.1016/S0140-6736(04)16048-0	http://dx.doi.org/10.1016/S0140-6736(04)16048-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110495				2022-12-28	WOS:000220996300012
J	Papadopoulos, MC; Abel, PM; Agranoff, D; Stich, A; Tarelli, E; Bell, BA; Planche, T; Loosemore, A; Saadoun, S; Wilkins, P; Krishna, S				Papadopoulos, MC; Abel, PM; Agranoff, D; Stich, A; Tarelli, E; Bell, BA; Planche, T; Loosemore, A; Saadoun, S; Wilkins, P; Krishna, S			A novel and accurate diagnostic test for human African trypanosomiasis	LANCET			English	Article							SLEEPING SICKNESS; PROSTATE-CANCER; SERUM; ANGOLA	Introduction Human African trypanosomiasis (sleeping sickness) affects up to half a million people every year in sub-Saharan Africa. Because current diagnostic tests for the disease have low accuracy, we sought to develop a novel test that can diagnose human African trypanosomiasis with high sensitivity and specificity. Methods We applied serum samples from 85 patients with African trypanosomiasis and 146 control patients who had other parasitic and non-parasitic infections to a weak cation exchange chip, and analysed with surface-enhanced laser desorption-ionisation time-of-flight mass spectrometry. Mass spectra were then assessed with three powerful data-mining tools: a tree classifier, a neural network, and a genetic algorithm. Findings. Spectra (2-100 kDa) were grouped into training (n=122) and testing (n=109) sets. The training set enabled data-mining software to identify distinct serum proteomic signatures characteristic of human African trypanosomiasis among 206 protein clusters. Sensitivity and specificity, determined with the testing set, were 100% and 98.6%, respectively, when the majority opinion of the three algorithms was considered. This novel approach is much more accurate than any other diagnostic test. Interpretation Our report of the accurate diagnosis of an infection by use of proteomic signature analysis could form the basis for diagnostic tests for the disease, monitoring of response to treatment, and for improving the accuracy of patient recruitment in large-scale epidemiological studies.	St George Hosp, Sch Med, Dept Cellular & Mol Sci, London SW17 0RE, England; St George Hosp, Sch Med, Dept Neurosurg, London, England; St George Hosp, Sch Med, Dept Neuropathol, London, England; St George Hosp, Sch Med, Biom Ctr, London, England; ANGOTRIP, Morro Da Luz, Luanda, Angola; Med Mission Inst, Dept Trop Med, Wurzburg, Germany	St Georges University London; St Georges University London; St Georges University London; St Georges University London	Krishna, S (corresponding author), St George Hosp, Sch Med, Dept Cellular & Mol Sci Infect Dis, London SW17 0RE, England.	s.krishna@sghms.ac.uk		Planche, Timothy/0000-0002-0263-0888; Papadopoulos, Marios/0000-0001-9174-4176; Krishna, Sanjeev/0000-0003-0066-0634; Saadoun, Samira/0000-0002-5480-5678				ABEL P, 2003, IN PRESS TROP MED IN; Adam BL, 2002, CANCER RES, V62, P3609; [Anonymous], [No title captured]; Chen C.H., 1996, FUZZY LOGIC NEURAL N; Clarke W, 2003, ANN SURG, V237, P660, DOI 10.1097/00000658-200305000-00008; DUMAS M, 1999, PROGR HUMAN AFRICAN, P344; Esposito F, 1997, IEEE T PATTERN ANAL, V19, P476, DOI 10.1109/34.589207; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; FUNG ET, 2002, COMPUTATIONAL PROT S, V32, pS34; Li JN, 2002, CLIN CHEM, V48, P1296; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; NOIREAU F, 1988, T ROY SOC TROP MED H, V82, P237, DOI 10.1016/0035-9203(88)90430-0; PAYS E, 1999, PROGR HUMAN AFRICAN, P31; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Poon TCW, 2003, CLIN CHEM, V49, P752, DOI 10.1373/49.5.752; Qu YS, 2002, CLIN CHEM, V48, P1835; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stich A, 2002, BRIT MED J, V325, P203, DOI 10.1136/bmj.325.7357.203; STICH AH, 2003, PARASITOL TODAY, V19, P195; *VASS COLL, CLIN CALC 1 OBS SAMP; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	24	103	109	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1358	1363		10.1016/S0140-6736(04)16046-7	http://dx.doi.org/10.1016/S0140-6736(04)16046-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110493				2022-12-28	WOS:000220996300010
J	Rauch, F; Glorieux, FH				Rauch, F; Glorieux, FH			Osteogenesis imperfecta	LANCET			English	Review							GROWTH-HORMONE TREATMENT; CYCLICAL INTRAVENOUS PAMIDRONATE; SKELETAL STRUCTURAL ADAPTATIONS; HUMAN PARATHYROID-HORMONE; MECHANICAL USAGE SATMU; COLLAGEN MESSENGER-RNA; REDEFINING WOLFF LAW; I COLLAGEN; BONE-RESORPTION; HEARING-LOSS	Osteogenesis imperfecta is a genetic disorder of increased bone fragility, low bone mass, and other connective-tissue manifestations. The most frequently used classification outlines four clinical types, which we have expanded to seven distinct types. In most patients the disorder is caused by mutations in one of the two genes encoding collagen type 1, but in some individuals no such mutations are detectable. The most important therapeutic advance is the introduction of bisphosphonate treatment for moderate to severe forms of osteogenesis imperfecta. However, at present, the best treatment regimen and the long-term outcomes of bisphosphonate therapy are unknown. Although this treatment does not constitute a cure, it is an adjunct to physiotherapy, rehabilitation, and orthopaedic care. Gene-based therapy presently remains in the early stages of preclinical research.	Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; McGill Univ, Montreal, PQ H3G 1A6, Canada	McGill University; McGill University	Glorieux, FH (corresponding author), Shriners Hosp Children, Genet Unit, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.	glorieux@shriners.mcgill.ca	Emilia, Ianes/AAJ-7497-2021; Steiner, Robert D./AAJ-5756-2020; Carriero, Alessandra/D-7893-2013; Dawson, Paul A/B-1268-2012	Steiner, Robert D./0000-0003-4177-4590; Carriero, Alessandra/0000-0001-8103-4795; Rauch, Frank/0000-0002-6261-0360				Adami S, 2003, J BONE MINER RES, V18, P126, DOI 10.1359/jbmr.2003.18.1.126; ALBRIGHT JA, 1981, CLIN ORTHOP RELAT R, P88; Antoniazzi F, 1996, J PEDIATR-US, V129, P432, DOI 10.1016/S0022-3476(96)70077-X; Astrom E, 1998, ACTA PAEDIATR, V87, P64; Astrom E, 2002, ARCH DIS CHILD, V86, P356, DOI 10.1136/adc.86.5.356; Banerjee I, 2002, ARCH DIS CHILD, V87, P562, DOI 10.1136/adc.87.6.562-a; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; BEIGHTON P, 1985, CLIN GENET, V28, P69; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; BIKLE DD, 1994, J BONE MINER RES, V9, P1777; Bishop NJ, 1999, NAT MED, V5, P466, DOI 10.1038/8528; Boyde A, 1999, CALCIFIED TISSUE INT, V64, P185, DOI 10.1007/s002239900600; BRENNER RE, 1993, MONATSSCHR KINDERH, V141, P940; Brumsen C, 1997, MEDICINE, V76, P266, DOI 10.1097/00005792-199707000-00005; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; Byers PH, 2000, CURR OPIN PEDIATR, V12, P603, DOI 10.1097/00008480-200012000-00016; Cabral WA, 2002, J BIOL CHEM, V277, P4215, DOI 10.1074/jbc.M109048200; Cabral WA, 2001, MOL GENET METAB, V72, P326, DOI 10.1006/mgme.2001.3155; Camacho NP, 1999, J BONE MINER RES, V14, P264, DOI 10.1359/jbmr.1999.14.2.264; COLE DEC, 1987, J PEDIATR-US, V110, P76; COLE DEC, 1983, AM J MED GENET, V14, P725, DOI 10.1002/ajmg.1320140414; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Dawson PA, 2000, NUCLEIC ACIDS RES, V28, P4013, DOI 10.1093/nar/28.20.4013; DEVOGELAER JP, 1987, SKELETAL RADIOL, V16, P360, DOI 10.1007/BF00350961; Dobrocky I, 1999, EUR RADIOL, V9, P665, DOI 10.1007/s003300050729; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; Engelbert RHH, 1998, ARCH PHYS MED REHAB, V79, P1590, DOI 10.1016/S0003-9993(98)90426-9; Engelbert RHH, 1999, ARCH PHYS MED REHAB, V80, P896, DOI 10.1016/S0003-9993(99)90080-1; Evans KD, 2003, BONE, V32, P268, DOI 10.1016/S8756-3282(02)00974-2; Falk MJ, 2003, PEDIATRICS, V111, P573, DOI 10.1542/peds.111.3.573; Fazzalari NL, 1997, ANAT REC, V248, P1; Fedarko NS, 1996, J BONE MINER RES, V11, P800; FEDARKO NS, 1995, J BONE MINER RES, V10, P1122; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Fratzl P, 1996, J CLIN INVEST, V97, P396, DOI 10.1172/JCI118428; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; FROST HM, 1990, ANAT RECORD, V226, P414, DOI 10.1002/ar.1092260403; Galicka A, 2002, J PATHOL, V196, P235, DOI 10.1002/path.1030; Gerber LH, 1998, ARCH PHYS MED REHAB, V79, P46, DOI 10.1016/S0003-9993(98)90207-6; Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470; Giraud F, 2002, JOINT BONE SPINE, V69, P486, DOI 10.1016/S1297-319X(02)00434-7; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grabner B, 2001, BONE, V29, P453, DOI 10.1016/S8756-3282(01)00594-4; Grissom LE, 2003, PEDIATR RADIOL, V33, P226, DOI 10.1007/s00247-003-0865-1; Grzesik WJ, 2002, J BIOL CHEM, V277, P43638, DOI 10.1074/jbc.M202124200; Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; HUAUX JP, 1988, J PEDIATR ORTHOPED, V8, P71, DOI 10.1097/01241398-198801000-00017; Jepsen KJ, 1996, J ORTHOP RES, V14, P493, DOI 10.1002/jor.1100140320; Jepsen KJ, 1997, J BIOMECH, V30, P1141, DOI 10.1016/S0021-9290(97)00088-2; Kadler KE, 1996, BIOCHEM J, V316, P1; Karbowski A, 2000, EUR J PEDIATR SURG, V10, P119, DOI 10.1055/s-2008-1072339; Khan SA, 1997, J BONE MINER RES, V12, P1700, DOI 10.1359/jbmr.1997.12.10.1700; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; KRUSE HP, 1975, HORM METAB RES, V7, P488, DOI 10.1055/s-0028-1093710; Kuijpers G, 2002, BRIT MED J, V324, P1218, DOI 10.1136/bmj.324.7347.1218; Kuurila K, 2000, EUR J PEDIATR, V159, P515, DOI 10.1007/s004310051322; Kuurila K, 2002, ANN OTO RHINOL LARYN, V111, P939, DOI 10.1177/000348940211101014; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; LandsmeerBeker EA, 1997, EUR J PEDIATR, V156, P792, DOI 10.1007/s004310050715; Lee YS, 2001, EUR J PEDIATR, V160, P641, DOI 10.1007/s004310100844; Liu P, 2001, BONE, V29, P331, DOI 10.1016/S8756-3282(01)00590-7; Lund AM, 1998, J CRAN GENET DEV BIO, V18, P30; Lygidakis NA, 1996, ORAL SURG ORAL MED O, V81, P567, DOI 10.1016/S1079-2104(96)80048-5; Maasalu K, 2003, ACTA PAEDIATR, V92, P452; Malmgren B, 2002, ACTA ODONTOL SCAND, V60, P65, DOI 10.1080/000163502753509446; Marini JC, 2003, J BONE MINER RES, V18, P237, DOI 10.1359/jbmr.2003.18.2.237; Marini JC, 1999, NAT MED, V5, P466, DOI 10.1038/8326; Marlowe A, 2002, J MED GENET, V39, P382, DOI 10.1136/jmg.39.6.382; McAllion SJ, 1996, J CLIN PATHOL, V49, P627, DOI 10.1136/jcp.49.8.627; McPherson E, 1997, AM J MED GENET, V70, P28, DOI 10.1002/(SICI)1096-8628(19970502)70:1<28::AID-AJMG6>3.3.CO;2-N; Miller ME, 1999, OSTEOPOROSIS INT, V9, P427, DOI 10.1007/s001980050167; Millington-Ward S, 2002, HUM MOL GENET, V11, P2201, DOI 10.1093/hmg/11.19.2201; Misof K, 1997, J CLIN INVEST, V100, P40, DOI 10.1172/JCI119519; Montpetit K, 2003, PEDIATRICS, V111, pE601, DOI 10.1542/peds.111.5.e601; Moore M S, 1998, Am J Orthop (Belle Mead NJ), V27, P797; Mornet E, 2000, HUM MUTAT, V15, P309, DOI 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C; Mundlos S, 1996, J BIOL CHEM, V271, P21068, DOI 10.1074/jbc.271.35.21068; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Parfitt AM, 1996, J BONE MINER RES, V11, P150; PATERSON CR, 1984, NEW ENGL J MED, V310, P1694, DOI 10.1056/NEJM198406283102602; Paterson CR, 1996, BRIT MED J, V312, P351; Paterson CR, 2001, J LARYNGOL OTOL, V115, P280; PEDERSEN U, 1984, SCAND AUDIOL, V13, P67, DOI 10.3109/01050398409043042; Petersen K, 1998, J DENT CHILD, V65, P305; Plotkin H, 2000, J CLIN ENDOCR METAB, V85, P1846, DOI 10.1210/jc.85.5.1846; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; Rauch F, 2003, J BONE MINER RES, V18, P610, DOI 10.1359/jbmr.2003.18.4.610; Rauch F, 2003, J CLIN ENDOCR METAB, V88, P986, DOI 10.1210/jc.2002-021371; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Rieker O, 1998, EUR RADIOL, V8, P1137, DOI 10.1007/s003300050521; Roldan EJA, 1999, J PEDIATR ENDOCR MET, V12, P555; Roschger P, 2001, J STRUCT BIOL, V136, P126, DOI 10.1006/jsbi.2001.4427; Rowe D.W., 1998, METABOLIC BONE DIS C, V3, P651, DOI [10.1016/B978-012068700-8/50024-4, DOI 10.1016/B978-012068700-8/50024-4]; Sarafova AP, 1998, HUM MUTAT, V11, P395, DOI 10.1002/(SICI)1098-1004(1998)11:5<395::AID-HUMU7>3.3.CO;2-W; Sarathchandra P, 2000, J PATHOL, V192, P385; SCHENK R, 1986, CALCIFIED TISSUE INT, V38, P342, DOI 10.1007/BF02555748; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shapiro JR, 2003, CALCIFIED TISSUE INT, V72, P103, DOI 10.1007/s00223-001-1055-5; SHAPIRO JR, 1992, J CLIN INVEST, V89, P567, DOI 10.1172/JCI115622; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH R, 1995, BRIT J RHEUMATOL, V34, P68; Smith R, 2001, BRIT MED J, V322, P63, DOI 10.1136/bmj.322.7278.63; Srivastava T, 1999, CLIN PEDIATR, V38, P687, DOI 10.1177/000992289903801201; Toudjarska I, 2001, ANTISENSE NUCLEIC A, V11, P341, DOI 10.1089/108729001753231722; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vieira NE, 1999, BONE, V25, P501, DOI 10.1016/S8756-3282(99)00186-6; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Wilkinson JM, 1998, J BONE JOINT SURG BR, V80B, P999, DOI 10.1302/0301-620X.80B6.8667; Willing MC, 1996, AM J HUM GENET, V59, P799; Zacharin M, 2002, J PEDIATR ENDOCR MET, V15, P163; Zeitlin L, 2003, PEDIATRICS, V111, P1030, DOI 10.1542/peds.111.5.1030; Zeitlin L, 2003, J PEDIATR ORTHOP B, V12, P77, DOI 10.1097/01.bpb.0000049567.52224.fa	128	829	892	0	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1377	1385		10.1016/S0140-6736(04)16051-0	http://dx.doi.org/10.1016/S0140-6736(04)16051-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110498				2022-12-28	WOS:000220996300024
J	Glazman, LI; Ashoori, RC				Glazman, LI; Ashoori, RC			Coupling qubits by waves on the electron sea	SCIENCE			English	Editorial Material									Univ Minnesota, Dept Phys, Minneapolis, MN 55455 USA; MIT, Dept Phys, Cambridge, MA 02139 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT)	Glazman, LI (corresponding author), Univ Minnesota, Dept Phys, Minneapolis, MN 55455 USA.	glazman@physics.spa.umn.edu; ashoori@mit.edu						Amato A, 1997, REV MOD PHYS, V69, P1119, DOI 10.1103/RevModPhys.69.1119; Craig NJ, 2004, SCIENCE, V304, P565, DOI 10.1126/science.1095452; Hanson R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.196802; JONES BA, 1987, PHYS REV LETT, V58, P843, DOI 10.1103/PhysRevLett.58.843; Kouwenhoven L, 1998, PHYS WORLD, V11, P35; Kouwenhoven L, 2001, PHYS WORLD, V14, P33; Ziman J. M., 1995, PRINCIPLES THEORY SO	7	27	27	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					524	525		10.1126/science.1097442	http://dx.doi.org/10.1126/science.1097442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105482				2022-12-28	WOS:000220975100027
J	Stein, PD; Hull, RD; Patel, KC; Olson, RE; Ghali, WA; Brant, R; Biel, RK; Bharadia, V; Kalra, NK				Stein, PD; Hull, RD; Patel, KC; Olson, RE; Ghali, WA; Brant, R; Biel, RK; Bharadia, V; Kalra, NK			D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism - A systematic review	ANNALS OF INTERNAL MEDICINE			English	Review							DEEP-VEIN THROMBOSIS; RAPID D-DIMER; PLASMA D-DIMER; ANTITHROMBIN-III COMPLEXES; LATEX D-DIMER; FIBRIN DEGRADATION-PRODUCTS; WHOLE-BLOOD ASSAY; LINKED-IMMUNOSORBENT-ASSAY; SYMPTOMATIC OUTPATIENTS; DIAGNOSTIC-VALUE	Background: Despite extensive literature, the diagnostic role of D-dimer for deep venous thrombosis (DVT) or pulmonary embolism (PE) remains unclear, reflecting multiple D-dimer assays and concerns about differing sensitivities and variability. Purpose: To systematically review trials that assessed sensitivity, specificity, likelihood ratios, and variability among D-dimer assays. Data Sources: Studies in all languages were identified by searching PubMed from 1983 to January 2003 and EMBASE from 1988 to January 2003. Study Selection: The researchers selected prospective studies that compared D-dimer with a reference standard. Studies of high methodologic quality were included in the primary analyses; sensitivity analysis included additional weaker studies. Data Extraction: Two authors collected data on study-level factors: D-dimer assay used, cutoff value, and whether patients had suspected DVT or PE. Data Synthesis: For DVT, the enzyme-linked immunosorbent assay (ELISA) and quantitative rapid ELISA dominate the rank order for these values: sensitivity, 0.96 (95% confidence limit [CL], 0.91 to 1.00), and negative likelihood ratio, 0.12 (CL, 0.04 to 0.33); and sensitivity, 0.96 (CL, 0.90 to 1.00), and negative likelihood ratio, 0.09 (CL, 0.02 to 0.41), respectively. For PE, the ELISA and quantitative rapid ELISA also dominate the rank order for these values: sensitivity, 0.95 (CL, 0.85 to 1.00), and negative likelihood ratio, 0.13 (CL, 0.03 to 0.58); and sensitivity, 0.95 (CL, 0.83 to 1.00), and negative likelihood ratio, 0.13 (CL, 0.02 to 0.84), respectively. The ELISA and quantitative rapid ELISA have negative likelihood ratios that yield a high certainty for excluding DVT or PE. The positive likelihood values, which are in the general range of 1.5 to 2.5, do not greatly increase the certainty of diagnosis. Sensitivity analyses do not affect these findings. Limitations: Although many studies evaluated multiple D-dimer assays, findings are based largely on indirect comparisons of test performance characteristics across studies. Conclusion: The ELISAs in general dominate the comparative ranking among the D-dimer assays for sensitivity and negative likelihood ratio. For excluding PE or DVT, a negative result on quantitative rapid ELISA is as diagnostically useful as a normal lung scan or negative duplex ultrasonography finding.	St Joseph Mercy Oakland, Pontiac, MI 48341 USA; Wayne State Univ, Detroit, MI USA; Univ Calgary, Calgary, AB, Canada; Oakland Univ, Rochester, MI 48063 USA	Saint Joseph Mercy Health System (SJMHS); Wayne State University; University of Calgary; Oakland University	Stein, PD (corresponding author), St Joseph Mercy Oakland, 44555 Woodward Ave,Suite 107, Pontiac, MI 48341 USA.	steinp@trinity-health.org		Brant, Rollin/0000-0002-8026-2451				Aschwanden M, 1999, J VASC SURG, V30, P929, DOI 10.1016/S0741-5214(99)70019-4; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; BONEU B, 1991, THROMB HAEMOSTASIS, V65, P28; Bonnin F, 1997, EUR J NUCL MED, V24, P444, DOI 10.1007/BF00881819; Borg JY, 1997, THROMB HAEMOSTASIS, V77, P602; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BOUMAN CSC, 1995, THROMB RES, V77, P225, DOI 10.1016/0049-3848(95)91610-W; BOUNAMEAUX H, 1989, AM J CLIN PATHOL, V91, P82, DOI 10.1093/ajcp/91.1.82; Bounameaux H, 1990, Blood Coagul Fibrinolysis, V1, P577, DOI 10.1097/00001721-199010000-00045; BOUNAMEAUX H, 1989, BIOMED PHARMACOTHER, V43, P385, DOI 10.1016/0753-3322(89)90066-8; BOUNAMEAUX H, 1992, J MAL VASCUL, V17, P91; Bova C, 2000, Ital Heart J Suppl, V1, P116; Bradley M, 2000, CLIN RADIOL, V55, P525, DOI 10.1053/crad.1999.0482; BRENNER B, 1995, BLOOD COAGUL FIBRIN, V6, P219, DOI 10.1097/00001721-199505000-00004; Brill-Edwards P, 1999, THROMB HAEMOSTASIS, V82, P688; Brown MD, 2002, ANN EMERG MED, V40, P133, DOI 10.1067/mem.2002.124755; Bucek RA, 2001, THROMB RES, V103, P17, DOI 10.1016/S0049-3848(00)00367-4; Caliezi C, 1999, THROMB HAEMOSTASIS, V81, P50; CARTER CJ, 1993, THROMB HAEMOSTASIS, V69, P8; Carter CJ, 1999, J EMERG MED, V17, P605, DOI 10.1016/S0736-4679(99)00047-5; CHANGLIEM GS, 1991, HAEMOSTASIS, V21, P106; CHAPMAN CS, 1990, CLIN LAB HAEMATOL, V12, P37; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; DALE S, 1994, THROMB HAEMOSTASIS, V71, P270; DAngelo A, 1996, THROMB HAEMOSTASIS, V75, P412; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; de Monye W, 2002, THROMB RES, V107, P283, DOI 10.1016/S0049-3848(02)00186-X; DEBOER WA, 1991, NETH J MED, V38, P65; DEMERS C, 1992, THROMB HAEMOSTASIS, V67, P408; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Duet M, 1998, THROMB RES, V91, P1, DOI 10.1016/S0049-3848(98)00048-6; Egermayer P, 1998, THORAX, V53, P830, DOI 10.1136/thx.53.10.830; Elias A, 1996, THROMB HAEMOSTASIS, V76, P518; Escoffre-Barbe M, 1998, AM J CLIN PATHOL, V109, P748; Farrell S, 2000, ANN EMERG MED, V35, P121, DOI 10.1016/S0196-0644(00)70130-2; FLORES J, 1995, RESPIRATION, V62, P258; Funfsinn N, 2001, BLOOD COAGUL FIBRIN, V12, P165, DOI 10.1097/00001721-200104000-00001; Gavaud C, 1996, J MAL VASCUL, V21, P22; Gerometta M, 2000, THROMB HAEMOSTASIS, V84, P1134; GINSBERG JS, 1995, THROMB HAEMOSTASIS, V73, P35; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; GINSBERG JS, 1993, CHEST, V104, P1679, DOI 10.1378/chest.104.6.1679; GOLDHABER SZ, 1988, AM HEART J, V116, P505, DOI 10.1016/0002-8703(88)90625-4; GOLDHABER SZ, 1993, JAMA-J AM MED ASSOC, V270, P2819, DOI 10.1001/jama.270.23.2819; Gosselin RC, 2000, BLOOD COAGUL FIBRIN, V11, P715, DOI 10.1097/00001721-200012000-00004; Guazzaloca G, 1997, Minerva Cardioangiol, V45, P259; HANSSON PO, 1994, J INTERN MED, V235, P143, DOI 10.1111/j.1365-2796.1994.tb01048.x; Harper P, 2001, NEW ZEAL MED J, V114, P61; HARRISON KA, 1993, J NUCL MED, V34, P896; HEATON DC, 1987, J LAB CLIN MED, V110, P588; HEIJBOER H, 1992, THROMB HAEMOSTASIS, V67, P510; Heit JA, 1999, ARCH PATHOL LAB MED, V123, P235; IBRAHIM KMA, 1992, MED J AUSTRALIA, V157, P574, DOI 10.5694/j.1326-5377.1992.tb137384.x; *INS CORP, 2002, S PLUS VERS 6 1 2 RE; Jacq F, 1997, PRESSE MED, V26, P1132; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Janssen MCH, 1997, THROMB HAEMOSTASIS, V77, P262; Janssen MCH, 1997, THROMB RES, V86, P423, DOI 10.1016/S0049-3848(97)00088-1; Johanning JM, 1999, AM J SURG, V178, P98, DOI 10.1016/S0002-9610(99)00136-1; Jossang Bjarne, 1992, Tidsskrift for den Norske Laegeforening, V112, P1153; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Khaira HS, 1998, EUR J VASC ENDOVASC, V15, P235, DOI 10.1016/S1078-5884(98)80182-2; Killick SB, 1997, BRIT J HAEMATOL, V96, P846, DOI 10.1046/j.1365-2141.1997.d01-2097.x; Kline JA, 2001, JAMA-J AM MED ASSOC, V285, P761, DOI 10.1001/jama.285.6.761; Knecht MF, 1997, THROMB RES, V88, P413, DOI 10.1016/S0049-3848(97)00276-4; Kozman H, 1997, SOUTHERN MED J, V90, P907, DOI 10.1097/00007611-199709000-00009; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; KRONEMAN H, 1991, HAEMOSTASIS, V21, P286; Kruip MJHA, 1999, CLIN APPL THROMB-HEM, V5, P222; Kutinsky I, 1999, ARCH INTERN MED, V159, P1569, DOI 10.1001/archinte.159.14.1569; LaCapra S, 2000, BLOOD COAGUL FIBRIN, V11, P371, DOI 10.1097/00001721-200006000-00009; Larsen TB, 2002, J INTERN MED, V252, P36, DOI 10.1046/j.1365-2796.2002.00998.x; Lee AYY, 1999, ANN INTERN MED, V131, P417, DOI 10.7326/0003-4819-131-6-199909210-00004; Legnani C, 1997, BLOOD COAGUL FIBRIN, V8, P296, DOI 10.1097/00001721-199707000-00006; Legnani C, 1999, BLOOD COAGUL FIBRIN, V10, P69, DOI 10.1097/00001721-199903000-00002; Legnani C, 1999, FIBRINOLYSIS PROTEOL, V13, P139, DOI 10.1016/S0268-9499(99)90101-7; LEITHA T, 1991, CHEST, V100, P1536, DOI 10.1378/chest.100.6.1536; Lennox AF, 1999, THORAX, V54, pS33, DOI 10.1136/thx.54.2008.S33; Lennox AF, 1999, J VASC SURG, V30, P794, DOI 10.1016/S0741-5214(99)70003-0; LENZHOFER R, 1993, WIEN KLIN WOCHENSCHR, V105, P492; Leroyer C, 1997, THROMB HAEMOSTASIS, V77, P637; LICHEY J, 1991, KLIN WOCHENSCHR, V69, P522, DOI 10.1007/BF01649289; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lindahl TL, 1999, THROMB HAEMOSTASIS, V82, P1772; Lindahl TL, 1998, SCAND J CLIN LAB INV, V58, P307, DOI 10.1080/00365519850186481; Mac Gillavry MR, 2001, THROMB HAEMOSTASIS, V85, P995; Mauron T, 1998, THROMB HAEMOSTASIS, V79, P1217, DOI 10.1055/s-0037-1615046; Mayer W, 1997, VASA-J VASCULAR DIS, V26, P97; Meyer G, 1998, BLOOD COAGUL FIBRIN, V9, P603, DOI 10.1097/00001721-199810000-00006; NAPODANO RJ, 1999, DIAGNOSTIC STRATEGIE; Oger E, 1998, AM J RESP CRIT CARE, V158, P65, DOI 10.1164/ajrccm.158.1.9710058; OTT P, 1988, ACTA MED SCAND, V224, P263; Pannocchia A, 1996, FIBRINOLYSIS, V10, P117, DOI 10.1016/S0268-9499(96)80064-6; PAPPAS AA, 1993, ARCH PATHOL LAB MED, V117, P977; Permpikul Chairat, 2000, Journal of the Medical Association of Thailand, V83, P732; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Perrier A, 2003, J GEN INTERN MED, V18, P228; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINI M, 1993, FIBRINOLYSIS, V7, P391, DOI 10.1016/0268-9499(93)90064-3; Quinn DA, 1999, AM J RESP CRIT CARE, V159, P1445, DOI 10.1164/ajrccm.159.5.9808094; QUINN RJ, 1994, RADIOLOGY, V190, P509, DOI 10.1148/radiology.190.2.8284407; REBER G, 1995, BLOOD COAGUL FIBRIN, V6, P460, DOI 10.1097/00001721-199507000-00014; ROWBOTHAM BJ, 1987, THROMB HAEMOSTASIS, V57, P59; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sadouk M, 2000, CLIN CHEM, V46, P286; Sassa H, 1996, JPN CIRC J, V60, P201, DOI 10.1253/jcj.60.201; Scarano L, 1997, THROMB RES, V86, P93, DOI 10.1016/S0049-3848(97)00053-4; Shitrit D, 2001, THROMB RES, V102, P125, DOI 10.1016/S0049-3848(01)00221-3; Siragusa S, 2001, HAEMATOLOGICA, V86, P856; SPEISER W, 1990, THROMB HAEMOSTASIS, V64, P196; Stein PD, 1998, CHEST, V113, P499, DOI 10.1378/chest.113.2.499; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tapson VF, 1999, AM J RESP CRIT CARE, V160, P1043; ten Wolde M, 2002, ARCH INTERN MED, V162, P1880, DOI 10.1001/archinte.162.16.1880; TENGBORN L, 1994, HAEMOSTASIS, V24, P344; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Trujillo-Santos AJ, 2000, MED CLIN-BARCELONA, V114, P46, DOI 10.1016/S0025-7753(00)71185-7; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; VANBERGEN PFMM, 1989, THROMB HAEMOSTASIS, V62, P1043; Veitl M, 1996, THROMB RES, V82, P399, DOI 10.1016/0049-3848(96)00089-8; Wahlander K, 1999, BLOOD COAGUL FIBRIN, V10, P121; Wallis JW, 2000, THROMB HAEMOSTASIS, V84, P925; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1999, THROMB HAEMOSTASIS, V81, P493; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297; Wijns W, 1998, ACTA CLIN BELG, V53, P270; Wildberger JE, 1997, ROFO-FORTSCHR RONTG, V167, P79, DOI 10.1055/s-2007-1015495; Wildberger JE, 1998, INVEST RADIOL, V33, P232, DOI 10.1097/00004424-199804000-00006	133	544	594	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					589	602		10.7326/0003-4819-140-8-200404200-00005	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096330				2022-12-28	WOS:000220851700001
J	Rawdon, S				Rawdon, S			Role of next of kin in accessing health records of deceased relatives - Commentary: needs of the living should come first	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rosy@gothere.uk.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					954	954		10.1136/bmj.328.7445.954	http://dx.doi.org/10.1136/bmj.328.7445.954			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087351	Green Published			2022-12-28	WOS:000220994400036
J	Robinson, GE				Robinson, GE			Beyond nature and nurture	SCIENCE			English	Editorial Material							GENE-EXPRESSION; BEHAVIOR		Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	generobi@life.uiuc.edu						Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Chakravarti A, 2003, NATURE, V421, P412, DOI 10.1038/nature01401; Ferster D, 2004, SCIENCE, V303, P1619, DOI 10.1126/science.1096224; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Schatz BR, 2002, COMPUTER, V35, P54, DOI 10.1109/2.976919; TURNER JRG, 1983, BIOL J LINN SOC, V20, P277, DOI 10.1111/j.1095-8312.1983.tb01877.x; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	10	74	76	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					397	399		10.1126/science.1095766	http://dx.doi.org/10.1126/science.1095766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087536				2022-12-28	WOS:000220845400033
J	Anderson, GL; Limacher, M; Assaf, AR; Bassford, T; Beresford, SAA; Black, H; Bonds, D; Brunner, R; Brzyski, R; Caan, B; Chlebowski, R; Curb, D; Gass, M; Hays, J; Heiss, G; Hendrix, S; Howard, BV; Hsia, J; Hubbell, A; Jackson, R; Johnson, KC; Judd, H; Kotchen, JM; Kuller, L; LaCroix, AZ; Lane, D; Langer, RD; Lasser, N; Lewis, CE; Manson, J; Margolis, K; Ockene, J; O'Sullivan, MJ; Phillips, L; Prentice, RL; Ritenbaugh, C; Robbins, J; Rossouw, JE; Sarto, G; Stefanick, ML; Van Horn, L; Wactawski-Wende, J; Wallace, R; Wassertheil-Smoller, S				Anderson, GL; Limacher, M; Assaf, AR; Bassford, T; Beresford, SAA; Black, H; Bonds, D; Brunner, R; Brzyski, R; Caan, B; Chlebowski, R; Curb, D; Gass, M; Hays, J; Heiss, G; Hendrix, S; Howard, BV; Hsia, J; Hubbell, A; Jackson, R; Johnson, KC; Judd, H; Kotchen, JM; Kuller, L; LaCroix, AZ; Lane, D; Langer, RD; Lasser, N; Lewis, CE; Manson, J; Margolis, K; Ockene, J; O'Sullivan, MJ; Phillips, L; Prentice, RL; Ritenbaugh, C; Robbins, J; Rossouw, JE; Sarto, G; Stefanick, ML; Van Horn, L; Wactawski-Wende, J; Wallace, R; Wassertheil-Smoller, S		WHI Steering Comm	Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; PLUS PROGESTIN; RISK; BREAST; METAANALYSIS; PREVENTION; FRACTURES; ATHEROSCLEROSIS; PROGRESSION	Context Despite decades of use and considerable research, the role of estrogen alone in preventing chronic diseases in postmenopausal women remains uncertain. Objective To assess the effects on major disease incidence rates of the most commonly used postmenopausal hormone therapy in the United States. Design, Setting, and Participants A randomized, double-blind, placebo-controlled disease prevention trial (the estrogen-alone component of the Women's Health Initiative [WHI]) conducted in 40 US clinical centers beginning in 1993. Enrolled were 10739 postmenopausal women, aged 50-79 years, with prior hysterectomy, including 23% of minority race/ethnicity. Intervention Women were randomly assigned to receive either 0.625 mg/d of conjugated equine estrogen (CEE) or placebo. Main Outcome Measures The primary outcome was coronary heart disease (CHID) incidence (nonfatal myocardial infarction or CHID death). Invasive breast cancer incidence was the primary safety outcome. A global index of risks and benefits, including these primary outcomes plus stroke, pulmonary embolism (PE), colorectal cancer, hip fracture, and deaths from other causes, was used for summarizing overall effects. Results In February 2004, after reviewing data through November 30, 2003, the National Institutes of Health (NIH) decided to end the intervention phase of the trial early. Estimated hazard ratios (HRs) (95% confidence intervals [CIs]) for CEE vs placebo for the major clinical outcomes available through February 29, 2004 (average follow-up 6.8 years), were: CHID, 0.91 (0.75-1.12) with 376 cases; breast cancer, 0.77 (0.59-1.01) with 218 cases; stroke, 1.39 (1.10-1.77) with 276 cases; PE, 1.34 (0.87-2.06) with 85 cases; colorectal cancer, 1.08 (0.75-1.55) with 119 cases; and hip fracture, 0.61 (0.41-0.91) with 102 cases. Corresponding results for composite outcomes were: total cardiovascular disease, 1.12 (1.01-1.24); total cancer, 0.93 (0.81-1.07); total fractures, 0.70 (0.63-0.79); total mortality, 1.04 (0.88-1.22), and the global index, 1.01 (0.91-1.12). For the outcomes significantly affected by CEE, there was an absolute excess risk of 12 additional strokes per 10000 person-years and an absolute risk reduction of 6 fewer hip fractures per 10000 person-years. The estimated excess risk for all monitored events in the global index was a nonsignificant 2 events per 10000 person-years. Conclusions The use of CEE increases the risk of stroke, decreases the risk of hip fracture, and does not affect CHID incidence in postmenopausal women with prior hysterectomy over an average of 6.8 years. A possible reduction in breast cancer risk requires further investigation. The burden of incident disease events was equivalent in the CEE and placebo groups, indicating no overall benefit. Thus, CEE should not be recommended for chronic disease prevention in postmenopausal women.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, WHI Clin Coordinating Ctr, Seattle, WA 98109 USA; Univ Florida, Hlth Sci Ctr, Div Cardiovasc Med, Gainesville, FL 32610 USA; Brown Univ, Providence, RI 02912 USA; Univ Arizona, Tucson, AZ USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Univ Nevada, Reno, NV 89557 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Kaiser Permanente, Div Res, Oakland, CA USA; Harbor UCLA Res & Educ Inst, Torrance, CA USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ Cincinnati, Cincinnati, OH USA; Baylor Coll Med, Houston, TX 77030 USA; Univ N Carolina, Chapel Hill, NC USA; Wayne State Univ, Sch Med, Hutzel Hosp, Detroit, MI USA; Howard Univ, MedStar Res Inst, Washington, DC 20059 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Univ Calif Irvine, Orange, CA 92668 USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Tennessee, Memphis, TN USA; Univ Calif Los Angeles, Los Angeles, CA USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Univ Pittsburgh, Pittsburgh, PA USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Univ Alabama Birmingham, Birmingham, AL USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Univ Minnesota, Minneapolis, MN USA; Univ Massachusetts, Fallon Clin, Worcester, MA 01605 USA; Univ Miami, Miami, FL 33152 USA; Emory Univ, Atlanta, GA 30322 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Calif Davis, Sacramento, CA 95817 USA; NHLBI, Bethesda, MD 20892 USA; Univ Wisconsin, Madison, WI USA; Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Buffalo, Buffalo, NY USA; Univ Iowa, Iowa City, IA USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	Fred Hutchinson Cancer Center; State University System of Florida; University of Florida; Brown University; University of Arizona; Rush University; Wake Forest University; Wake Forest Baptist Medical Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Texas System; University of Texas Health San Antonio; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Hawaii System; University System of Ohio; University of Cincinnati; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Wayne State University; Howard University; George Washington University; University of California System; University of California Irvine; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester; University of Miami; Emory University; Kaiser Permanente; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wisconsin System; University of Wisconsin Madison; Stanford University; Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Iowa; Yeshiva University; Albert Einstein College of Medicine	Anderson, GL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, WHI Clin Coordinating Ctr, 1100 Fairview Ave N,M3-A410,POB 19024, Seattle, WA 98109 USA.	garnet@whi.org	Wactawski-Wende, Jean/AGH-5457-2022	Wactawski-Wende, Jean/0000-0003-3096-9595; Margolis, Karen/0000-0003-1862-7402; Caan, Bette/0000-0002-5803-310X				Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cherry N, 2002, LANCET, V360, P2001; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; COX DR, 1972, J R STAT SOC B, V34, P187; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; DUPONT WD, 1991, ARCH INTERN MED, V151, P67, DOI 10.1001/archinte.151.1.67; Freedman L, 1996, CONTROL CLIN TRIALS, V17, P509, DOI 10.1016/S0197-2456(96)00016-5; Grady D, 1997, JAMA-J AM MED ASSOC, V278, P477, DOI 10.1001/jama.1997.03550060053030; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hill DA, 2000, AM J OBSTET GYNECOL, V182, P270, DOI 10.1016/S0002-9378(00)70210-9; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hsia J, 2003, AM J CARDIOL, V92, P264, DOI 10.1016/S0002-9149(03)00621-0; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002; WYSOWSKI DK, 1995, OBSTET GYNECOL, V85, P6, DOI 10.1016/0029-7844(94)00339-F	43	3340	3455	6	211	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1701	1712		10.1001/jama.291.14.1701	http://dx.doi.org/10.1001/jama.291.14.1701			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082697	Bronze			2022-12-28	WOS:000220788700027
J	Gregory, JM; Huybrechts, P; Raper, SCB				Gregory, JM; Huybrechts, P; Raper, SCB			Climatology - Threatened loss of the Greenland ice-sheet	NATURE			English	Editorial Material									Univ Reading, Dept Meteorol, Ctr Global Atmospher Modelling, Reading RG6 6BB, Berks, England; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PR, Devon, England; Free Univ Brussels, Dept Geog, B-1050 Brussels, Belgium; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	Met Office - UK; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; NERC National Centre for Earth Observation; University of Reading; Met Office - UK; Hadley Centre; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Gregory, JM (corresponding author), Univ Reading, Dept Meteorol, Ctr Global Atmospher Modelling, Reading RG6 6BB, Berks, England.	j.m.gregory@reading.ac.uk	Gregory, Jonathan/J-2939-2016; Huybrechts, Philippe/J-5278-2013	Gregory, Jonathan/0000-0003-1296-8644; Huybrechts, Philippe/0000-0003-1406-0525				Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; CROWLEY TJ, 1995, PALEOCEANOGRAPHY, V10, P357, DOI 10.1029/95PA00662; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Greve R, 2000, CLIMATIC CHANGE, V46, P289, DOI 10.1023/A:1005647226590; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; HUYBRECHTS P, 1991, GLOBAL PLANET CHANGE, V89, P399, DOI 10.1016/0921-8181(91)90119-H; Toniazzo T, 2004, J CLIMATE, V17, P21, DOI 10.1175/1520-0442(2004)017<0021:CIOAGD>2.0.CO;2; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0	8	160	164	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					616	616		10.1038/428616a	http://dx.doi.org/10.1038/428616a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071587	Green Published, Bronze			2022-12-28	WOS:000220697200031
J	Hafeez, A; Riaz, R; Shah, SU; Pervaiz, J; Southall, D				Hafeez, A; Riaz, R; Shah, SU; Pervaiz, J; Southall, D			Integrating health care for mothers and children in refugee camps and at district level	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AFGHAN REFUGEES; MORTALITY; QUALITY	Health care for mothers and children is inadequate in most refugee situations and in poorly resourced countries. The authors argue that, as well as providing primary (home based) care for basic health care, there is a need to integrate primary care with adequately functioning hospital based care for a healthcare system to succeed.	Child Advocacy Int Pakistan, Islamabad, Pakistan; Prov Dept Hlth, Commissionerate Afghan Refugees, Med Serv, Peshawar, Pakistan			davids@doctors.org.uk						Bartlett LA, 2002, LANCET, V359, P643, DOI 10.1016/S0140-6736(02)07808-X; Benatar SR, 1997, BRIT MED J, V315, P1634, DOI 10.1136/bmj.315.7123.1634; BOSS LP, 1987, INT J EPIDEMIOL, V16, P556, DOI 10.1093/ije/16.4.556; Duke T, 2003, ARCH DIS CHILD, V88, P563, DOI 10.1136/adc.88.7.563; Forrest CB, 2002, J FAM PRACTICE, V51, P215; PATTINSON RC, 1995, S AFR MED J, V85, P145; Rahman A, 2003, ACTA PSYCHIAT SCAND, V108, P392, DOI 10.1034/j.1600-0447.2003.00220.x; Salinas AM, 1997, INT J QUAL HEALTH C, V9, P93, DOI 10.1093/intqhc/9.2.93; Sogan D, 1998, PEDIATRICS, V102, P1193, DOI 10.1542/peds.102.5.1193; Starfield Barbara, 2002, J Am Board Fam Pract, V15, P473	10	11	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2004	328	7443					834	836		10.1136/bmj.328.7443.834	http://dx.doi.org/10.1136/bmj.328.7443.834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811CG	15070645	Green Published			2022-12-28	WOS:000220749400028
J	Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M				Hviid, A; Stellfeld, M; Wohlfahrt, J; Melbye, M			Childhood vaccination and type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION; RISK; INFECTIONS; VACCINES; IDDM; AUTOIMMUNE; MECHANISMS; MELLITUS; DISEASE	BACKGROUND: A link between childhood vaccinations and the development of type 1 diabetes has been proposed. METHODS: We evaluated a cohort comprising all children born in Denmark from January 1, 1990, through December 31, 2000, for whom detailed information on vaccinations and type 1 diabetes was available. Using Poisson regression models, we estimated rate ratios according to vaccination status, including the trend associated with the number of doses, among all children and in a subgroup of children who had siblings with type 1 diabetes. Given recent claims of clustering of cases of diabetes two to four years after vaccination, we also estimated rate ratios during the period after vaccination. RESULTS: Type 1 diabetes was diagnosed in 681 children during 4,720,517 person-years of follow-up. The rate ratio for type 1 diabetes among children who received at least one dose of vaccine, as compared with unvaccinated children, was 0.91 (95 percent confidence interval, 0.74 to 1.12) for Haemophilus influenzae type b vaccine; 1.02 (95 percent confidence interval, 0.75 to 1.37) for diphtheria, tetanus, and inactivated poliovirus vaccine; 0.96 (95 percent confidence interval, 0.71 to 1.30) for diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine; 1.06 (95 percent confidence interval, 0.80 to 1.40) for whole-cell pertussis vaccine; 1.14 (95 percent confidence interval, 0.90 to 1.45) for measles, mumps, and rubella vaccine; and 1.08 (95 percent confidence interval, 0.74 to 1.57) for oral poliovirus vaccine. The development of type 1 diabetes in genetically predisposed children (defined as those who had siblings with type 1 diabetes) was not significantly associated with vaccination. Furthermore, there was no evidence of any clustering of cases two to four years after vaccination with any vaccine. CONCLUSIONS: These results do not support a causal relation between childhood vaccination and type 1 diabetes.	Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Dept Med, DK-2300 Copenhagen S, Denmark	Aarhus University; Statens Serum Institut; Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	aii@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2000, Diabetologia, V43, P47; [Anonymous], 2002, IMMUNIZATION SAFETY; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BLOM L, 1991, DIABETOLOGIA, V34, P176, DOI 10.1007/BF00418272; Classen DC, 1997, INFECT DIS CLIN PRAC, V6, P449, DOI 10.1097/00019048-199706070-00007; Classen JB, 1999, AUTOIMMUNITY, V31, P43, DOI 10.3109/08916939908993858; Classen JB, 2003, J PEDIATR ENDOCR MET, V16, P495; Classen JB, 2002, AUTOIMMUNITY, V35, P247, DOI 10.1080/08916930290028175; Classen JB, 1996, AUTOIMMUNITY, V24, P137, DOI 10.3109/08916939608995359; Classen JB, 2001, MED HYPOTHESES, V57, P532, DOI 10.1054/mehy.2001.1352; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Green A, 2000, LANCET, V355, P873; Halsey NA, 1999, PEDIATR INFECT DIS J, V18, P23, DOI 10.1097/00006454-199903000-00002; Hills, 1993, STAT MODELS EPIDEMIO; Hummel M, 2000, DIABETES CARE, V23, P969, DOI 10.2337/diacare.23.7.969; Jefferson T, 1998, J EPIDEMIOL COMMUN H, V52, P674, DOI 10.1136/jech.52.10.674; Knudsen LB, 1998, DAN MED BULL, V45, P320; MALIG C, 1996, 66 IIVRS; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; 2000, LANCET, V356, P1690	24	81	85	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1398	1404		10.1056/NEJMoa032665	http://dx.doi.org/10.1056/NEJMoa032665			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070789	Bronze			2022-12-28	WOS:000220562500006
J	Fahey, T				Fahey, T			Commentary: Valuable insights from morbidity coding in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-FAILURE; PREVALENCE		Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland	University of Dundee	Fahey, T (corresponding author), Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland.	t.p.fahey@dundee.ac.uk	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783				Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; MCALISTER FA, 2004, BMJ; Porcheret M, 2004, J AM MED INFORM ASSN, V11, P78, DOI 10.1197/jamia.M1362; Richards H, 2000, J EPIDEMIOL COMMUN H, V54, P714, DOI 10.1136/jech.54.9.714; Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 8	2004	328	7448					1113	1113		10.1136/bmj.38084.560475.55	http://dx.doi.org/10.1136/bmj.38084.560475.55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15107314	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000221281000022
J	Ghosh, M; Song, XY; Mouneimne, G; Sidani, M; Lawrence, DS; Condeelis, JS				Ghosh, M; Song, XY; Mouneimne, G; Sidani, M; Lawrence, DS; Condeelis, JS			Cofilin promotes actin polymerization and defines the direction of cell motility	SCIENCE			English	Article							DEPOLYMERIZING FACTOR; ARP2/3 COMPLEX; LEADING-EDGE; LIM-KINASE; PHOSPHORYLATION; FILAMENTS; PROTEINS; OVEREXPRESSION; DICTYOSTELIUM; LOCALIZATION	A general caging method for proteins that are regulated by phosphorylation was used to study the in vivo biochemical action of cofilin and the subsequent cellular response. By acute and local activation of a chemically engineered, light-sensitive phosphocofilin mimic, we demonstrate that cofilin polymerizes actin, generates protrusions, and determines the direction of cell migration. We propose a role for cofilin that is distinct from its role as an actin-depolymerizing factor.	Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Condeelis, JS (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	condeeli@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061034, R01GM038511] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38511, GM61034] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE H, 1993, EXP CELL RES, V206, P1, DOI 10.1006/excr.1993.1113; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; CONDEELIS J, 2003, CELL MOTILITY MOL OR, P175; COX D, 1992, J CELL BIOL, V116, P943, DOI 10.1083/jcb.116.4.943; Cox D, 1996, MOL BIOL CELL, V7, P803, DOI 10.1091/mbc.7.5.803; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ghosh M, 2002, J AM CHEM SOC, V124, P2440, DOI 10.1021/ja017592l; GHOSH M, UNPUB; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; Meberg PJ, 2000, J NEUROSCI, V20, P2459; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Samstag Y, 1996, J IMMUNOL, V156, P4167; Shestakova EA, 1999, CANCER RES, V59, P1202; Soll DR, 1995, INT REV CYTOL, V163, P43; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	27	526	553	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					743	746		10.1126/science.1094561	http://dx.doi.org/10.1126/science.1094561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118165				2022-12-28	WOS:000221105300048
J	Sawin, KE				Sawin, KE			The spindle gets bigger	CELL			English	Editorial Material							ANIMAL-CELLS		Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Sawin, KE (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.			Sawin, Kenneth/0000-0002-2607-2219				BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gachet Y, 2004, EMBO J, V23, P1289, DOI 10.1038/sj.emboj.7600156; KIEFER B, 1966, J MOL BIOL, V20, P75, DOI 10.1016/0022-2836(66)90118-5; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9	8	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 30	2004	117	3					281	283		10.1016/S0092-8674(04)00404-0	http://dx.doi.org/10.1016/S0092-8674(04)00404-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109489	Bronze			2022-12-28	WOS:000221176400003
J	Gribble, FM; Reimann, F				Gribble, FM; Reimann, F			Open to control - New hope for patients with neonatal diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Cambridge, Dept Clin Biochem, Cambridge, England	University of Cambridge	Gribble, FM (corresponding author), Univ Cambridge, Dept Clin Biochem, Cambridge, England.			Reimann, Frank/0000-0001-9399-6377; Gribble, Fiona/0000-0002-4232-2898	Wellcome Trust [071187] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548	2	3	3	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1817	1818		10.1056/NEJMp048044	http://dx.doi.org/10.1056/NEJMp048044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115828				2022-12-28	WOS:000221080300004
J	Neumayer, L; Giobbie-Hurder, A; Jonasson, O; Fitzgibbons, R; Dunlop, D; Gibbs, J; Reda, D; Henderson, W				Neumayer, L; Giobbie-Hurder, A; Jonasson, O; Fitzgibbons, R; Dunlop, D; Gibbs, J; Reda, D; Henderson, W		Vet Affairs Cooperative Studies	Open mesh versus Laparoscopic mesh repair of inguinal hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAIN; HERNIORRHAPHY	BACKGROUND Repair of inguinal hernias in men is a common surgical procedure, but the most effective surgical technique is unknown. METHODS We randomly assigned men with inguinal hernias at 14 Veterans Affairs (VA) medical centers to either open mesh or laparoscopic mesh repair. The primary outcome was recurrence of hernias at two years. Secondary outcomes included complications and patient-centered outcomes. RESULTS Of the 2164 patients who were randomly assigned to one of the two procedures, 1983 underwent an operation; two-year follow-up was completed in 1696 (85.5 percent). Recurrences were more common in the laparoscopic group ( 87 of 862 patients [10.1 percent]) than in the open group ( 41 of 834 patients [4.9 percent]; odds ratio, 2.2; 95 percent confidence interval, 1.5 to 3.2). The rate of complications was higher in the laparoscopic-surgery group than in the open-surgery group (39.0 percent vs. 33.4 percent; adjusted odds ratio, 1.3; 95 percent confidence interval, 1.1 to 1.6). The laparoscopic-surgery group had less pain initially than the open-surgery group on the day of surgery ( difference in mean score on a visual-analogue scale, 10.2 mm; 95 percent confidence interval, 4.8 to 15.6) and at two weeks (6.1 mm; 95 percent confidence interval, 1.7 to 10.5) and returned to normal activities one day earlier ( adjusted hazard ratio for a shorter time to return to normal activities, 1.2; 95 percent confidence interval, 1.1 to 1.3). In prespecified analyses, there was a significant interaction between the surgical approach ( open or laparoscopic) and the type of hernia ( primary or recurrent) (P = 0.012). Recurrence was significantly more common after laparoscopic repair than after open repair of primary hernias (10.1 percent vs. 4.0 percent), but rates of recurrence after repair of recurrent hernias were similar in the two groups ( 10.0 percent and 14.1 percent, respectively). CONCLUSIONS The open technique is superior to the laparoscopic technique for mesh repair of primary hernias.	Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; Univ Utah, Dept Surg, Salt Lake City, UT USA; VA Cooperat Studies Program Coordinating Ctr, Hines, IL USA; Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA; Creighton Univ, Dept Surg, Omaha, NE 68178 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Univ Colorado, Hlth Outcomes Program, Aurora, CO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Creighton University; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus	Neumayer, L (corresponding author), VAMC, 112,500 Foothill Dr, Salt Lake City, UT 84148 USA.	leigh.neumayer@hsc.utah.edu	Giobbie-Hurder, Anita/AAU-6193-2021; , Robert/A-2904-2019	, Domenic/0000-0003-1831-4270; , Robert/0000-0002-3652-7686				*AC PAIN MAN GUID, 1992, AHCPR PUBL; Amid PK, 1996, EUR J SURG, V162, P447; AMID PK, 1997, LICHTENSTEIN OPEN TE; Bird SB, 2001, ANN EMERG MED, V38, P639, DOI 10.1067/mem.2001.118012; Condon RE, 1995, HERNIA, P269; Cunningham J, 1996, ANN SURG, V224, P598, DOI 10.1097/00000658-199611000-00003; *DAT AN PROD DIV, 2000, SPLUSS TRIAL US MAN; FITZGIBBONS RJ, 1995, ANN SURG, V221, P3, DOI 10.1097/00000658-199501000-00002; FITZGIBBONS RJ, 1997, TRANSABDOMINAL PREPE; Friis E, 1996, AM J SURG, V172, P315, DOI 10.1016/S0002-9610(96)00188-2; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Kark AE, 1998, J AM COLL SURGEONS, V186, P447, DOI 10.1016/S1072-7515(98)00057-X; Kumar S, 2002, BRIT J SURG, V89, P1476, DOI 10.1046/j.1365-2168.2002.02260.x; Liem MSL, 1996, AM J SURG, V171, P281, DOI 10.1016/S0002-9610(97)89569-4; Liem MSL, 1997, NEW ENGL J MED, V336, P1541, DOI 10.1056/NEJM199705293362201; McCormack K, 2003, Cochrane Database Syst Rev, pCD001785, DOI 10.1002/14651858.CD001785; MCKERNAN JB, 1993, SURG ENDOSC-ULTRAS, V7, P26, DOI 10.1007/BF00591232; Neumayer L, 2003, J AM COLL SURGEONS, V196, P743, DOI 10.1016/S1072-7515(03)00004-8; O'Dwyer P, 1999, LANCET, V354, P185; OBERLIN P, 1995, BRIT J SURG, V82, P65; PAYNE JH, 1994, ARCH SURG-CHICAGO, V129, P973; Rowntree LG, 1944, J AMER MED ASSOC, V125, P821, DOI 10.1001/jama.1944.02850300001001; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; SMITH CD, 1997, INGUINAL HERNIORRHAP; Sondenaa K, 2001, EUR J SURG, V167, P125; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright D, 1998, Semin Laparosc Surg, V5, P227	27	659	684	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1819	1827		10.1056/NEJMoa040093	http://dx.doi.org/10.1056/NEJMoa040093			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15107485	Bronze			2022-12-28	WOS:000221080300005
J	Plotkin, JB; Dushoff, J; Fraser, HB				Plotkin, JB; Dushoff, J; Fraser, HB			Detecting selection using a single genome sequence of M-tuberculosis and P-falciparum	NATURE			English	Article							NUCLEOTIDE SUBSTITUTION; EXPRESSION; EVOLUTION; PROTEINS; PATTERNS	Selective pressures on proteins are usually measured by comparing nucleotide sequences(1). Here we introduce a method to detect selection on the basis of a single genome sequence. We catalogue the relative strength of selection on each gene in the entire genomes of Mycobacterium tuberculosis and Plasmodium falciparum. Our analysis confirms that most antigens are under strong selection for amino-acid substitutions, particularly the PE/PPE family(2) of putative surface proteins in M. tuberculosis and the EMP1 family(3) of cytoadhering surface proteins in P. falciparum. We also identify many uncharacterized proteins that are under strong selection in each pathogen. We provide a genome-wide analysis of natural selection acting on different stages of an organism's life cycle: genes expressed in the ring stage(4) of P. falciparum are under stronger positive selection than those expressed in other stages of the parasite's life cycle. Our method of estimating selective pressures requires far fewer data than comparative sequence analysis, and it measures selection across an entire genome; the method can readily be applied to a large range of sequenced organisms.	Harvard Soc Fellows, Cambridge, MA 02138 USA; Bauer Ctr Gen Res, Cambridge, MA 02138 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Berkeley	Plotkin, JB (corresponding author), Harvard Soc Fellows, 7 Divin Ave, Cambridge, MA 02138 USA.	jplotkin@fas.harvard.edu	Plotkin, Joshua B/E-6947-2013					Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Escalante AA, 1998, GENETICS, V149, P189; FELSENSTEIN J, 1981, BIOL J LINN SOC, V16, P183, DOI 10.1111/j.1095-8312.1981.tb01847.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gould SJ, 2002, STRUCTURE EVOLUTIONA; HUDSON RR, 1987, GENETICS, V116, P153; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lobry JR, 2002, GENOME BIOL, V3; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Skeiky YAW, 2000, J IMMUNOL, V165, P7140, DOI 10.4049/jimmunol.165.12.7140; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TAJIMA F, 1989, GENETICS, V123, P585; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	30	73	76	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					942	945		10.1038/nature02458	http://dx.doi.org/10.1038/nature02458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118727	hybrid			2022-12-28	WOS:000221083000041
J	Hessler, AM; Lowe, DR; Jones, RL; Bird, DK				Hessler, AM; Lowe, DR; Jones, RL; Bird, DK			A lower limit for atmospheric carbon dioxide levels 3.2 billion years ago	NATURE			English	Article							SOUTH-AFRICA; EARLY EARTH; PRECAMBRIAN ATMOSPHERE; OXYGEN; OXIDATION; EVOLUTION; AUSTRALIA; PALEOSOL; MINERALS; SIDERITE	The quantification of greenhouse gases present in the Archaean atmosphere is critical for understanding the evolution of atmospheric oxygen, surface temperatures and the conditions for life on early Earth. For instance, it has been argued(1-4) that small changes in the balance between two potential greenhouse gases, carbon dioxide and methane, may have dictated the feedback cycle involving organic haze production and global cooling. Climate models have focused on carbon dioxide as the greenhouse gas responsible for maintaining above-freezing surface temperatures during a time of low solar luminosity(5,6). However, the analysis of 2.75-billion-year (Gyr)-old(7) palaeosols-soil samples preserved in the geologic record-have recently provided an upper constraint on atmospheric carbon dioxide levels well below that required in most climate models to prevent the Earth's surface from freezing. This finding prompted many to look towards methane as an additional greenhouse gas to satisfy climate models(1,4,8,9). Here we use model equilibrium reactions for weathering rinds on 3.2-Gyr-old river gravels to show that the presence of iron-rich carbonate relative to common clay minerals requires a minimum partial pressure of carbon dioxide several times higher than present-day values. Unless actual carbon dioxide levels were considerably greater than this, climate models(5,6,8) predict that additional greenhouse gases would still need to have a role in maintaining above-freezing surface temperatures.	Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	Stanford University	Hessler, AM (corresponding author), Grand Valley State Univ, Dept Geol, Allendale, MI 49401 USA.	hesslera@gvsu.edu						Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Brown L.L., 1999, THESIS PENN STATE U; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; Eriksson KA, 1978, CANADIAN SOC PETROLE, V5, P287; EUGSTER HP, 1973, ECON GEOL, V68, P1144, DOI 10.2113/gsecongeo.68.7.1144; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GRANDSTAFF DE, 1980, PRECAMBRIAN RES, V13, P1, DOI 10.1016/0301-9268(80)90056-X; HART MH, 1978, ICARUS, V33, P23, DOI 10.1016/0019-1035(78)90021-0; HESSLER AM, 2001, THESIS STANFORD U; HEUBECK C, 1994, PRECAMBRIAN RES, V68, P257, DOI 10.1016/0301-9268(94)90033-7; Holland HD., 1984, CHEM EVOLUTION ATMOS; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; KAMO SL, 1994, TECTONICS, V13, P167, DOI 10.1029/93TC02254; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; KRUPP R, 1994, ECON GEOL BULL SOC, V89, P1581, DOI 10.2113/gsecongeo.89.7.1581; MACFARLANE AW, 1994, PRECAMBRIAN RES, V65, P297, DOI 10.1016/0301-9268(94)90110-4; MOZLEY PS, 1989, GEOLOGY, V17, P704, DOI 10.1130/0091-7613(1989)017<0704:RBDEAT>2.3.CO;2; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; POSTMA D, 1982, AM J SCI, V282, P1151, DOI 10.2475/ajs.282.8.1151; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Rye R, 2000, GEOLOGY, V28, P483, DOI 10.1130/0091-7613(2000)28<483:LAWAGE>2.0.CO;2; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; WOLERY TJ, 1997, EQ3 6 SOFTWARE PACKA; Yang WB, 2003, AM J SCI, V303, P187, DOI 10.2475/ajs.303.3.187	30	105	106	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					736	738		10.1038/nature02471	http://dx.doi.org/10.1038/nature02471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085128				2022-12-28	WOS:000220823800035
J	Arhem, P				Arhem, P			Voltage sensing in ion channels: a 50-year-old mystery resolved?	LANCET			English	Review							DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; SODIUM-CHANNELS; CHARGE MOVEMENT; MOLECULAR-BASIS; S4; SENSOR; SEQUENCE; PORE		Karolinska Inst, Nobel Inst Neurophysiol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Arhem, P (corresponding author), Karolinska Inst, Nobel Inst Neurophysiol, SE-17177 Stockholm, Sweden.	petarhem@neuro.ki.se						Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Miller G, 2003, SCIENCE, V300, P2020, DOI 10.1126/science.300.5628.2020; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, NAT STRUCT BIOL, V5, P421, DOI 10.1038/nsb0698-421	21	6	7	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1221	1223		10.1016/S0140-6736(04)15954-0	http://dx.doi.org/10.1016/S0140-6736(04)15954-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15083826	Bronze			2022-12-28	WOS:000220748100024
J	Marcy, TP; Fahey, DW; Gao, RS; Popp, PJ; Richard, EC; Thompson, TL; Rosenlof, KH; Ray, EA; Salawitch, RJ; Atherton, CS; Bergmann, DJ; Ridley, BA; Weinheimer, AJ; Loewenstein, M; Weinstock, EM; Mahoney, MJ				Marcy, TP; Fahey, DW; Gao, RS; Popp, PJ; Richard, EC; Thompson, TL; Rosenlof, KH; Ray, EA; Salawitch, RJ; Atherton, CS; Bergmann, DJ; Ridley, BA; Weinheimer, AJ; Loewenstein, M; Weinstock, EM; Mahoney, MJ			Quantifying stratospheric ozone in the upper troposphere with in situ measurements of HCl	SCIENCE			English	Article							LOWERMOST STRATOSPHERE; TRACER CORRELATIONS; HYDROGEN-CHLORIDE; AIRCRAFT; EXCHANGE; ALTITUDE; BALLOON; ER-2; HNO3; NOY	We have developed a chemical ionization mass spectrometry technique for precise in situ measurements of hydrochloric acid (HCl) from a high-altitude aircraft. In measurements at subtropical latitudes, minimum HCl values found in the upper troposphere ( UT) were often near or below the detection limit of the measurements (0.005 parts per billion by volume), indicating that background HCl values are much lower than a global mean estimate. However, significant abundances of HCl were observed in many UT air parcels, as a result of stratosphere-to-troposphere transport events. We developed a method for diagnosing the amount of stratospheric ozone in these UT parcels using the compact linear correlation of HCl with ozone found throughout the lower stratosphere (LS). Expanded use of this method will lead to improved quanti. cation of cross-tropopause transport events and validation of global chemical transport models.	NOAA, Aeron Lab, Boulder, CO 80305 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lawrence Livermore Natl Lab, Div Atmospher Sci, Livermore, CA 94550 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Harvard Univ, Cambridge, MA 02138 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Center Atmospheric Research (NCAR) - USA; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University	Marcy, TP (corresponding author), NOAA, Aeron Lab, Boulder, CO 80305 USA.	tmarcy@al.noaa.gov	Salawitch, Ross/B-4605-2009; Fahey, David W/G-4499-2013; Gao, Ru-Shan/H-7455-2013; Rosenlof, Karen H/B-5652-2008; Ray, Eric/D-5941-2013; Bergmann, Daniel J/F-9801-2011	Salawitch, Ross/0000-0001-8597-5832; Fahey, David W/0000-0003-1720-0634; Gao, Ru-Shan/0000-0001-6985-1637; Rosenlof, Karen H/0000-0002-0903-8270; Ray, Eric/0000-0001-8727-9849; Bergmann, Daniel J/0000-0003-4357-6301				Bethan S, 1996, Q J ROY METEOR SOC, V122, P929, DOI 10.1002/qj.49712253207; DENNING RF, 1989, J GEOPHYS RES-ATMOS, V94, P16757, DOI 10.1029/JD094iD14p16757; Dibb JE, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001347; ENNIS CA, 2003, SCI ASSESSMENT OZONE; FEHSENFELD FC, 1993, GLOBAL ATMOSPHERIC C, P169; Fischer H, 2000, GEOPHYS RES LETT, V27, P97, DOI 10.1029/1999GL010879; Gauss M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002624; GRAEDEL TE, 1995, GLOBAL BIOGEOCHEM CY, V9, P47, DOI 10.1029/94GB03103; Hauglustaine DA, 2001, J GEOPHYS RES-ATMOS, V106, P32337, DOI 10.1029/2001JD900175; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Hoor P, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000289; Houghton J. T., 2001, CLIMATE CHANGE 2001; Lelieveld J, 1997, GEOPHYS RES LETT, V24, P603, DOI 10.1029/97GL00255; Logan JA, 1999, J GEOPHYS RES-ATMOS, V104, P16115, DOI 10.1029/1998JD100096; Murphy DM, 1994, J GEOPHYS RES-ATMOS, V99, P5325, DOI 10.1029/93JD03558; Neuman JA, 2000, REV SCI INSTRUM, V71, P3886, DOI 10.1063/1.1289679; Neuman JA, 2001, ATMOS ENVIRON, V35, P5789, DOI 10.1016/S1352-2310(01)00354-5; Nevison CD, 1999, GLOBAL BIOGEOCHEM CY, V13, P737, DOI 10.1029/1999GB900018; Plumb RA, 2000, J GEOPHYS RES-ATMOS, V105, P10047, DOI 10.1029/1999JD901023; PLUMB RA, 1992, J GEOPHYS RES-ATMOS, V97, P10145, DOI 10.1029/92JD00450; Prather MJ, 1997, GEOPHYS RES LETT, V24, P3189, DOI 10.1029/97GL03027; PROFFITT MH, 1983, REV SCI INSTRUM, V54, P1719, DOI 10.1063/1.1137316; Richard EC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003884; RIDLEY BA, 1994, J GEOPHYS RES-ATMOS, V99, P25519, DOI 10.1029/94JD02210; Rotman DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2002JD003155; Russell JM, 1996, J GEOPHYS RES-ATMOS, V101, P10151, DOI 10.1029/95JD01696; Stohl A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002490; Toon GC, 1999, J GEOPHYS RES-ATMOS, V104, P26779, DOI 10.1029/1999JD900379; Tuck AF, 1997, Q J ROY METEOR SOC, V123, P1; VIERKORNRUDOLPH B, 1984, J ATMOS CHEM, V2, P47, DOI 10.1007/BF00127262; Volk CM, 1997, J GEOPHYS RES-ATMOS, V102, P25543, DOI 10.1029/97JD02215; Webster CR, 2000, J GEOPHYS RES-ATMOS, V105, P11711, DOI 10.1029/1999JD901135; WEINSTOCK EM, 1994, REV SCI INSTRUM, V65, P3544, DOI 10.1063/1.1144536; Wild O, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003283; WILSON JC, 1991, J GEOPHYS RES-ATMOS, V96, P17415, DOI 10.1029/91JD01357; Zahn A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001529	36	51	53	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					261	265		10.1126/science.1093418	http://dx.doi.org/10.1126/science.1093418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073371				2022-12-28	WOS:000220719400038
J	Schrepf, R; Limmert, T; Weber, PC; Theisen, K; Sellmayer, A				Schrepf, R; Limmert, T; Weber, PC; Theisen, K; Sellmayer, A			Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia	LANCET			English	Article							SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; PREVENTION	Increased consumption of n-3 fatty acids reduces mortality from sudden cardiac death, indicating that such acids have anti-arrhythmic effects. We did electrophysiological testing in ten patients with implanted cardioverter defibrillators who were at high risk of sudden cardiac death. To assess their immediate effects on the induction of sustained ventricular tachycardia, n-3 fatty acids were infused. Such tachycardia was not induced in five of seven patients. Our findings show that infusion of n-3 polyunsaturated fatty acids does not induce arrhythmia, but did result in a reduction of sustained ventricular tachycardia in some patients.	Klinikum Univ Munchen, Kardiol Med Poliklin, Kreislaufkrankheiten, D-80336 Munich, Germany; Klinikum Univ Munchen, Inst Prophylaxe & Epidemiol, Kreislaufkrankheiten, D-80336 Munich, Germany	University of Munich; University of Munich	Sellmayer, A (corresponding author), Klinikum Univ Munchen, Kardiol Med Poliklin, Kreislaufkrankheiten, D-80336 Munich, Germany.	alois.sellmayer@medpoli.med.uni-muenchen.de						Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Weylandt KH, 1996, LIPIDS, V31, P977, DOI 10.1007/BF02522692	6	103	109	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1441	1442		10.1016/S0140-6736(04)16105-9	http://dx.doi.org/10.1016/S0140-6736(04)16105-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121409				2022-12-28	WOS:000221130300013
J	Teixeira, MT; Arneric, M; Sperisen, P; Lingner, J				Teixeira, MT; Arneric, M; Sperisen, P; Lingner, J			Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states	CELL			English	Article							REPEAT DIVERGENCE; BINDING-PROTEIN; END PROTECTION; SIZE CONTROL; IN-VIVO; DNA; ELONGATION; MECHANISM; DEGRADATION; MAINTENANCE	Telomerase counteracts telomere erosion that stems from incomplete chromosome end replication and nucleolytic processing. A precise understanding of telomere length homeostasis has been hampered by the lack of assays that delineate the nonuniform telomere extension events of single chromosome molecules. Here, we measure telomere elongation at nucleotide resolution in Saccharomyces cerevisiae. The number of nucleotides added to a telomere in a single cell cycle varies between a few to more than 100 nucleotides and is independent of telomere length. Telomerase does not act on every telomere in each cell cycle, however. Instead, it exhibits an increasing preference for telomeres as their lengths decline. Deletion of the telomeric proteins Rif1 or Rif2 gives rise to longer telomeres by increasing the frequency of elongation events. Thus, by taking a molecular snapshot of a single round of telomere replication, we demonstrate that telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Lausanne, Switzerland; Natl Ctr Competence Res Frontiers Genet, CH-1066 Epalinges, Lausanne, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Lausanne, Switzerland	Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Lingner, J (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Lausanne, Switzerland.	joachim.lingner@isrec.unil.ch	Teixeira, Maria Teresa/A-2100-2011	Teixeira, Maria Teresa/0000-0002-9466-7951; Lingner, Joachim/0000-0002-2853-5803				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bucholc M, 2001, MOL CELL BIOL, V21, P6559, DOI 10.1128/MCB.21.19.6559-6573.2001; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Evans SK, 2000, J CELL SCI, V113, P3357; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Forstemann K, 2001, MOL CELL BIOL, V21, P7277, DOI 10.1128/MCB.21.21.7277-7286.2001; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; Ray A, 1999, MOL CELL BIOL, V19, P31; Ray A, 1999, P NATL ACAD SCI USA, V96, P15044, DOI 10.1073/pnas.96.26.15044; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shore D, 1997, BIOL CHEM, V378, P591; Singh SM, 2003, P NATL ACAD SCI USA, V100, P5718, DOI 10.1073/pnas.1036868100; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teixeira MT, 2002, EMBO REP, V3, P652, DOI 10.1093/embo-reports/kvf133; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	77	403	408	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					323	335		10.1016/S0092-8674(04)00334-4	http://dx.doi.org/10.1016/S0092-8674(04)00334-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109493	Bronze			2022-12-28	WOS:000221176400007
J	Goodby, JW				Goodby, JW			Sivaramakrishna Chandrasekhar (1930-2004) - Obituary	NATURE			English	Biographical-Item									Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull	Goodby, JW (corresponding author), Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England.	j.w.goodby@chem.hull.ac.uk							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					906	906		10.1038/428906a	http://dx.doi.org/10.1038/428906a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118714	Bronze			2022-12-28	WOS:000221083000029
J	Levi, MA				Levi, MA			Dreaming of clean nukes	NATURE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Levi, MA (corresponding author), Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.							*DEP DEF, 2004, REP DEF SCI BOARD TA; GLASSTONE S, 1977, EFFECTS NUCL WEAPONS, P261; KUCIA C, 2003, ARMS CONTROL TODAY, V33, P37; LEVI MA, 2002, FIRE HOLE NUCL NONNO; MAY MM, 2003, EFFECTIVENESS NUCL W, P19; Nelson R. W., 2002, SCI GLOBAL SECURITY, V10, P1; *US DEP DEF EN, 2001, NUCL POST REV	7	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					892	892		10.1038/428892a	http://dx.doi.org/10.1038/428892a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118700	Bronze			2022-12-28	WOS:000221083000018
J	Meigs, JB; Hu, FB; Rifai, N; Manson, JE				Meigs, JB; Hu, FB; Rifai, N; Manson, JE			Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; INSULIN-RESISTANCE; DEPENDENT VASODILATION; ATHEROSCLEROSIS RISK; LIFE-STYLE; E-SELECTIN; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; BLOOD-FLOW	Context Endothelial dysfunction occurs in diagnosed type 2 diabetes mellitus but may also precede development of diabetes. Objective To determine whether elevated plasma levels of biomarkers reflecting endothelial dysfunction (E-selectin; intercellular adhesion molecule 1 [ICAM-1]; and vascular cell adhesion molecule 1 [VCAM-1]) predict development of type 2 diabetes in initially nondiabetic women. Design and Setting Prospective, nested case-control study within the Nurses' Health Study, an ongoing US study initiated in 1976. Participants Of 121700 women initially enrolled, 32826 provided blood samples in 1989-1990; of those free of diabetes, cardiovascular disease, or cancer at baseline, 737 developed incident diabetes by 2000. Controls (n = 785) were selected according to matched age, fasting status, and race. Main Outcome Measure Risk of confirmed clinically diagnosed type 2 diabetes by baseline levels of E-selectin, ICAM-1, and VCAM-1. Results Baseline median levels of the biomarkers were significantly higher among cases than among controls (E-selectin, 61.2 vs 45.4 ng/mL; ICAM-1, 264.9 vs 247.0 ng/mL; VCAM-1, 545.4 vs 526.0 ng/mL [all P values less than or equal to .004]). Elevated E-selectin and ICAM-1 levels predicted incident diabetes in logistic regression models conditioned on matching criteria and adjusted for body mass index (BMI), family history of diabetes, smoking, diet score, alcohol intake, activity index, and postmenopausal hormone use. The adjusted relative risks for incident diabetes in the top quintile vs the bottom quintiles were 5.43 for E-selectin (95% confidence interval [CI], 3.47-8.50), 3.56 for ICAM-1 (95% Cl, 2.28-5.58), and 1.12 for VCAM-1 (95% Cl, 0.76-1.66). Adjustment for waist circumference instead of BMI or further adjustment for baseline levels of C-reactive protein, fasting insulin, and hemoglobin A(1c) or exclusion of cases diagnosed during the first 4 years of follow-up did not alter these associations. Conclusion Endothelial dysfunction predicts type 2 diabetes in women independent of other known risk factors, including obesity and subclinical inflammation.	Massachusetts Gen Hosp, Gen Internal Med Unit, Div Gen Med, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Gen Internal Med Unit, Div Gen Med, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	jmeigs@partners.org	CLIHON, Residencia Medica/K-4896-2013; Meigs, James/P-3927-2019	CLIHON, Residencia Medica/0000-0001-6734-2513; Meigs, James/0000-0002-2439-2657	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046519, R01DK036798, R01DK058845] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK46519, DK58845, DK36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertini JP, 1998, DIABETES CARE, V21, P1008, DOI 10.2337/diacare.21.6.1008; Arcaro G, 2002, CIRCULATION, V105, P576, DOI 10.1161/hc0502.103333; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; BARON AD, 1994, INSULIN RESISTANCE, P961; Bonadonna RC, 1998, CIRCULATION, V98, P234, DOI 10.1161/01.CIR.98.3.234; Brevetti G, 2001, THROMB HAEMOSTASIS, V85, P63; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; Caballero AE, 2003, METABOLISM, V52, P173, DOI 10.1053/meta.2003.50023; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Cominacini L, 1998, DIABETES, V47, P130, DOI 10.2337/diabetes.47.1.130; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Ferri C, 1998, DIABETES, V47, P660, DOI 10.2337/diabetes.47.4.660; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Freeman DJ, 2001, CIRCULATION, V103, P357; Gavin JR, 1997, DIABETES CARE, V20, P1183; GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HANKINSON SE, 1989, CLIN CHEM, V35, P2313; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hogikyan RV, 1998, J CLIN ENDOCR METAB, V83, P1946, DOI 10.1210/jc.83.6.1946; Holmlund A, 2002, ATHEROSCLEROSIS, V165, P271, DOI 10.1016/S0021-9150(02)00234-4; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Hwang SJ, 1997, CIRCULATION, V96, P4219; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; MILES PDG, 1995, DIABETES, V44, P947, DOI 10.2337/diabetes.44.8.947; Nawawi H, 2003, ATHEROSCLEROSIS, V169, P283, DOI 10.1016/S0021-9150(03)00193-X; O'Driscoll G, 1999, J AM COLL CARDIOL, V33, P1506, DOI 10.1016/S0735-1097(99)00065-0; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Ruige JB, 1998, CIRCULATION, V97, P996; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Serne EH, 1999, CIRCULATION, V99, P896, DOI 10.1161/01.CIR.99.7.896; Serne EH, 2002, DIABETES, V51, P1515, DOI 10.2337/diabetes.51.5.1515; Tan KCB, 2002, J CLIN ENDOCR METAB, V87, P563, DOI 10.1210/jc.87.2.563; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vehkavaara S, 1999, DIABETES CARE, V22, P2055, DOI 10.2337/diacare.22.12.2055; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 1990, NUTR EPIDEMIOLOGY; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882	56	460	489	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1978	1986		10.1001/jama.291.16.1978	http://dx.doi.org/10.1001/jama.291.16.1978			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113816				2022-12-28	WOS:000221062000029
J	Delbanco, T; Sands, DZ				Delbanco, T; Sands, DZ			Electrons in flight - E-mail between doctors and patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Delbanco, T (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Kane B, 1998, J AM MED INFORM ASSN, V5, P104, DOI 10.1136/jamia.1998.0050104; *MANH RES, 2002, CYB HLTH V2 0; *MANH RES, 2003, TAK PULS V3 0; PEW, 2012, PEW INT AM LIF PROJ	5	53	54	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1705	1707		10.1056/NEJMp038209	http://dx.doi.org/10.1056/NEJMp038209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102994				2022-12-28	WOS:000220947300002
J	Kato, H; Ichinose, Y; Ohta, M; Hata, E; Tsubota, N; Tada, H; Watanabe, Y; Wada, H; Tsuboi, M; Hamajima, N; Ohta, M				Kato, H; Ichinose, Y; Ohta, M; Hata, E; Tsubota, N; Tada, H; Watanabe, Y; Wada, H; Tsuboi, M; Hamajima, N; Ohta, M		Japan Lung Canc Res Grp Postsurgic	A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II-TRIAL; UFT PLUS CISPLATIN; RESECTED STAGE-I; CANCER; 5-FLUOROURACIL; CARCINOMA; SURVIVAL	Background: In a previous phase 3 trial of adjuvant chemotherapy after resection of non-small-cell lung cancer, a combination of uracil and tegafur (often referred to as UFT) taken orally was shown to prolong survival. A subgroup analysis disclosed that most patients who benefited had pathological stage I adenocarcinoma. Methods: We randomly assigned patients with completely resected pathological stage I adenocarcinoma of the lung to receive either oral uracil-tegafur (250 mg of tegafur per square meter of body-surface area per day) for two years or no treatment. Randomization was performed with stratification according to the pathological tumor category (T1 vs. T2), sex, and age. The primary end point was overall survival. Results: From January 1994 through March 1997, 999 patients were enrolled. Twenty patients were found to be ineligible and were excluded from the analysis after randomization; 491 patients were assigned to receive uracil-tegafur and 488 were assigned to observation. The median duration of follow-up for surviving patients was 73 months. The difference in overall survival between the two groups was statistically significant in favor of the uracil-tegafur group (P=0.04 by a stratified log-rank test). Grade 3 toxic effects occurred in 10 of the 482 patients (2 percent) who actually received uracil-tegafur. Conclusions: Adjuvant chemotherapy with uracil-tegafur improves survival among patients with completely resected pathological stage I adenocarcinoma of the lung.	Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan; Tokyo Med Univ, Dept Surg, Tokyo, Japan; Natl Okinawa Hosp, Dept Surg, Okinawa, Japan; Mitsui Mem Hosp, Dept Surg, Resp Dis Ctr, Tokyo 101, Japan; Hyogo Med Ctr Adults, Dept Thorac Surg, Akashi, Hyogo, Japan; Osaka City Gen Hosp, Dept Pulm Surg, Osaka, Japan; Kanazawa Univ, Dept Surg 1, Kanazawa, Ishikawa 920, Japan; Kyoto Univ, Dept Thorac Surg, Kyoto, Japan; Nagoya Univ, Dept Prevent Med Biostat & Med Decis Making, Nagoya, Aichi, Japan	Tokyo Medical University; Mitsui Memorial Hospital; Osaka City General Hospital; Kanazawa University; Kyoto University; Nagoya University	Ichinose, Y (corresponding author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	yichinos@nk-cc.go.jp	Hamajima, Nobuyuki/I-7237-2014					Breathnach OS, 2001, J THORAC CARDIOV SUR, V121, P42, DOI 10.1067/mtc.2001.110190; COX DR, 1972, J R STAT SOC B, V34, P187; Endo C, 2003, LUNG CANCER-J IASLC, V40, P181, DOI 10.1016/S0169-5002(03)00032-1; FELD R, 1993, JNCI-J NATL CANCER I, V85, P299, DOI 10.1093/jnci/85.4.299; FUJII S, 1979, GANN, V70, P209; HAMADA C, 2003, PROG P EUR CANC C, V39, pS231; Hamajima Nobuyuki, 1999, International Journal of Clinical Oncology, V4, P133, DOI 10.1007/s101470050042; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Ho DH, 1998, CLIN CANCER RES, V4, P2085; ICHINOSE Y, 1995, CANCER, V75, P2677, DOI 10.1002/1097-0142(19950601)75:11<2677::AID-CNCR2820751106>3.0.CO;2-D; Ichinose Y, 1999, ONCOLOGY-NY, V13, P98; Ichinose Y, 2000, CANCER, V88, P318, DOI 10.1002/(SICI)1097-0142(20000115)88:2<318::AID-CNCR11>3.0.CO;2-6; ICHINOSE Y, 2002, PROG P AM SOC CLIN O, V21, pA321; ICHINOSE Y, 2001, P AN M AM SOC CLIN, V20, pA311; IKENAKA K, 1979, GANN, V70, P353; IMAIZUMI M, 2003, PROG P WORLD C LUNG, V41, pS54; KEICHO N, 1986, JPN J CLIN ONCOL, V16, P143, DOI 10.1093/oxfordjournals.jjco.a039130; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Myrdal G, 2003, ANN THORAC SURG, V75, P356, DOI 10.1016/S0003-4975(02)04321-7; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; OHTA M, 1993, J THORAC CARDIOV SUR, V106, P703, DOI 10.1016/S0022-5223(19)33714-6; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OKIMOTO N, 1996, JPN J LUNG CANC, V36, P863; Saito J, 2001, LUNG CANCER-J IASLC, V31, P285, DOI 10.1016/S0169-5002(00)00183-5; Scagliotti GV, 2003, JNCI-J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Shimizu E, 1986, Gan To Kagaku Ryoho, V13, P2970; Shirakusa T, 2002, JPN J LUNG CANC, V42, P555, DOI DOI 10.2482/HAIGAN.42.555; TADA H, 2002, P AN M AM SOC CLIN, V21, pA313; Tanaka F, 2001, BRIT J CANCER, V84, P263, DOI 10.1054/bjoc.2000.1579; TANAKA F, 2001, PROG P EUR CANC C, V37, pS29; The Japan Lung Cancer Society, 1987, GEN RUL CLIN PATH RE; Vokes EE, 2002, J CLIN ONCOL, V20, P4191, DOI 10.1200/JCO.2002.03.054; Wada H, 1996, J CLIN ONCOL, V14, P1048, DOI 10.1200/JCO.1996.14.4.1048; *WHO, 1979, OFFS PUBL WHO, V48, P14; Yonekura K, 1999, CLIN CANCER RES, V5, P2185	38	616	637	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1713	1721		10.1056/NEJMoa032792	http://dx.doi.org/10.1056/NEJMoa032792			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102997				2022-12-28	WOS:000220947300005
J	Webster, SM; del Camino, D; Dekker, JP; Yellen, G				Webster, SM; del Camino, D; Dekker, JP; Yellen, G			Intracellular gate opening in Shaker K+ channels defined by high-affinity metal bridges	NATURE			English	Article							POTASSIUM CHANNEL; ACTIVATION GATE; INACTIVATION GATE; CRYSTAL-STRUCTURE; S6 SEGMENT; PORE; MUTATIONS; S4; COOPERATIVITY; CONDUCTANCE	Voltage-gated potassium channels such as Shaker help to control electrical signalling in neurons by regulating the passage of K+ across cell membranes. Ion flow is controlled by a voltage-dependent gate at the intracellular side of the pore, formed by the crossing of four alpha-helices-the inner-pore helices. The prevailing model of gating is based on a comparison of the crystal structures of two bacterial channels-KcsA in a closed state and MthK in an open state-and proposes a hinge motion at a conserved glycine that splays the inner-pore helices wide open(1). We show here that two types of intersubunit metal bridge, involving cysteines placed near the bundle crossing, can occur simultaneously in the open state. These bridges provide constraints on the open Shaker channel structure, and on the degree of movement upon opening. We conclude that, unlike predictions from the structure of MthK, the inner-pore helices of Shaker probably maintain the KcsA-like bundle-crossing motif in the open state, with a bend in this region at the conserved proline motif (Pro-X-Pro) not found in the bacterial channels. A narrower opening of the bundle crossing in Shaker K+ channels may help to explain why Shaker has an approximately tenfold lower conductance than its bacterial relatives.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	gary_yellen@hms.harvard.edu		Yellen, Gary/0000-0003-4228-7866; Webster, Sarah/0000-0003-3269-2948	NINDS NIH HHS [R01 NS029693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Forman SA, 1999, BIOCHEMISTRY-US, V38, P14559, DOI 10.1021/bi9914457; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	28	168	180	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					864	868		10.1038/nature02468	http://dx.doi.org/10.1038/nature02468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103379				2022-12-28	WOS:000220952300043
J	de Kretser, DM				de Kretser, DM			Differences in the prevalence of cryptorchidism	LANCET			English	Editorial Material							YOUNGS SYNDROME; OBSTRUCTIVE AZOOSPERMIA		Monash Univ, Monash Inst Reprod & Dev, Melbourne, Vic 3168, Australia	Monash University	de Kretser, DM (corresponding author), Monash Univ, Monash Inst Reprod & Dev, Melbourne, Vic 3168, Australia.	david.de.kretser@med.monash.edu.au						ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Handelsman DJ, 2001, REPROD FERT DEVELOP, V13, P317, DOI 10.1071/RD00103; HANDELSMAN DJ, 1984, NEW ENGL J MED, V310, P3, DOI 10.1056/NEJM198401053100102; HENDRY WF, 1993, BMJ-BRIT MED J, V307, P1579, DOI 10.1136/bmj.307.6919.1579; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Toppari J, 2001, HUM REPROD UPDATE, V7, P282, DOI 10.1093/humupd/7.3.282; WILTON LJ, 1991, FERTIL STERIL, V55, P144; YOUNG D, 1970, J REPROD FERTIL, V23, P541; ANDROLOGY AUSTR	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1250	1251		10.1016/S0140-6736(04)16029-7	http://dx.doi.org/10.1016/S0140-6736(04)16029-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094266				2022-12-28	WOS:000220904900003
J	Choe, SB; Acremann, Y; Scholl, A; Bauer, A; Doran, A; Stohr, J; Padmore, HA				Choe, SB; Acremann, Y; Scholl, A; Bauer, A; Doran, A; Stohr, J; Padmore, HA			Vortex core-driven magnetization dynamics	SCIENCE			English	Article							EXCITATIONS	Time-resolved x-ray imaging shows that the magnetization dynamics of a micron-sized pattern containing a ferromagnetic vortex is determined by its handedness, or chirality. The out-of-plane magnetization in the nanometer-scale vortex core induces a three-dimensional handedness in the planar magnetic structure, leading to a precessional motion of the core parallel to a subnanosecond field pulse. The core velocity was an order of magnitude higher than expected from the static susceptibility. These results demonstrate that handedness, already well known to be important in biological systems, plays an important role in the dynamics of microscopic magnets.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Free Univ Berlin, D-14195 Berlin, Germany	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Free University of Berlin	Choe, SB (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	SBChoe@lbl.gov	Choe, Sug-Bong/AAO-4427-2020; Scholl, Andreas/K-4876-2012	Scholl, Andreas/0000-0002-1990-4769; padmore, howard/0000-0003-0172-4871; Doran, Andrew/0000-0001-5158-4569				Acremann Y, 2000, SCIENCE, V290, P492, DOI 10.1126/science.290.5491.492; ARGYLE BE, 1984, PHYS REV LETT, V53, P190, DOI 10.1103/PhysRevLett.53.190; Gerrits T, 2002, NATURE, V418, P509, DOI 10.1038/nature00905; Guslienko KY, 2002, J APPL PHYS, V91, P8037, DOI 10.1063/1.1450816; Natali M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.157203; Park JP, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020403; Scholl A, 2000, SCIENCE, V287, P1014, DOI 10.1126/science.287.5455.1014; Shinjo T, 2000, SCIENCE, V289, P930, DOI 10.1126/science.289.5481.930; STOHR J, 1993, SCIENCE, V259, P658, DOI 10.1126/science.259.5095.658; VOLKEL AR, 1994, PHYS REV B, V50, P12711, DOI 10.1103/PhysRevB.50.12711; Wachowiak A, 2002, SCIENCE, V298, P577, DOI 10.1126/science.1075302	11	510	518	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					420	422		10.1126/science.1095068	http://dx.doi.org/10.1126/science.1095068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087545				2022-12-28	WOS:000220845400042
J	Lal, R; Griffin, M; Apt, J; Lave, L; Morgan, MG				Lal, R; Griffin, M; Apt, J; Lave, L; Morgan, MG			Ecology - Managing soil carbon	SCIENCE			English	Editorial Material							ORGANIC-MATTER; SEQUESTRATION RATES; CROPPING SYSTEMS; TILLAGE; PRODUCTIVITY; EROSION; MANURE		Ohio State Univ, Sch Nat Resources, Carbon Management & Sequestrat Ctr, Columbus, OH 43210 USA; Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	University System of Ohio; Ohio State University; Carnegie Mellon University; Carnegie Mellon University	Lal, R (corresponding author), Ohio State Univ, Sch Nat Resources, Carbon Management & Sequestrat Ctr, 2021 Coffey Rd, Columbus, OH 43210 USA.	lal.1@osu.edu	Griffin, William/M-2943-2014; Lal, Rattan/D-2505-2013; Apt, Jay/AFN-6031-2022	Griffin, William/0000-0002-1709-4280; 				BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Dalal RC, 1995, AUST J EXP AGR, V35, P903, DOI 10.1071/EA9950903; DERPSCH R, 2003, 2 WORLD C CONS AGR 1; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Hobbs P, 2004, SUSTAINABLE AGR INT; JENKINSON DS, 1991, AGRON J, V83, P2, DOI 10.2134/agronj1991.00021962008300010008x; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R., 1999, Progress in Environmental Science, V1, P307; LAL R, 2000, SOIL SCI, V165; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Sa JCD, 2001, SOIL SCI SOC AM J, V65, P1486, DOI 10.2136/sssaj2001.6551486x; Smith P, 2000, SCIENCE, V287, P428; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Uhlen G., 1995, Norwegian Journal of Agricultural Sciences, V9, P143; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930	17	236	278	6	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					393	393		10.1126/science.1093079	http://dx.doi.org/10.1126/science.1093079			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087532				2022-12-28	WOS:000220845400029
J	Plane, JMC; Murray, BJ; Chu, XZ; Gardner, CS				Plane, JMC; Murray, BJ; Chu, XZ; Gardner, CS			Removal of meteoric iron on polar mesospheric clouds	SCIENCE			English	Article							ATOMIC OXYGEN; TEMPERATURE; MODEL	Polar mesospheric clouds are thin layers of nanometer-sized ice particles that occur at altitudes between 82 and 87 kilometers in the high-latitude summer mesosphere. These clouds overlap in altitude with the layer of iron ( Fe) atoms that is produced by the ablation of meteoroids entering the atmosphere. Simultaneous observations of the Fe layer and the clouds, made by lidar during midsummer at the South Pole, demonstrate that essentially complete removal of Fe atoms can occur inside the clouds. Laboratory experiments and atmospheric modeling show that this phenomenon is explained by the efficient uptake of Fe on the ice particle surface.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of East Anglia; University of Illinois System; University of Illinois Urbana-Champaign	Plane, JMC (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	j.plane@uea.ac.uk	Murray, Benjamin/C-1219-2010; Chu, Xinzhao/I-5670-2015; Plane, John M C/C-7444-2015	Murray, Benjamin/0000-0002-8198-8131; Chu, Xinzhao/0000-0001-6147-1963; Plane, John M C/0000-0003-3648-6893				Chu XZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002524; Chu XZ, 2002, APPL OPTICS, V41, P4400, DOI 10.1364/AO.41.004400; Espy PJ, 2002, J ATMOS SOL-TERR PHY, V64, P1823, DOI 10.1016/S1364-6826(02)00191-8; GARCIA RR, 1994, J GEOPHYS RES-ATMOS, V99, P12937, DOI 10.1029/94JD00725; HANSEN G, 1989, GEOPHYS RES LETT, V16, P1445, DOI 10.1029/GL016i012p01445; Helmer M, 1998, J GEOPHYS RES-ATMOS, V103, P10913, DOI 10.1029/97JD03075; HUNTEN DM, 1980, J ATMOS SCI, V37, P1342, DOI 10.1175/1520-0469(1980)037<1342:SADPOM>2.0.CO;2; Lubken FJ, 1999, J GEOPHYS RES-ATMOS, V104, P9135; McBride N, 1999, ADV SPACE RES-SERIES, V23, P73, DOI 10.1016/S0273-1177(98)00232-4; McHugh M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016859; Murray BJ, 2003, ADV SPACE RES-SERIES, V31, P2075, DOI 10.1016/S0273-1177(03)00231-X; Murray BJ, 2003, PHYS CHEM CHEM PHYS, V5, P4129, DOI 10.1039/b305555h; Pan WL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003217; Plane JMC, 2003, ADV SPACE RES-SERIES, V32, P699, DOI 10.1016/S0273-1177(03)00401-0; SANDER SP, 2003, 0225 JET PROP LAB; Self DE, 2003, PHYS CHEM CHEM PHYS, V5, P1407, DOI 10.1039/b211900e; Shimazaki T, 1985, MINOR CONSTITUENTS M; THOMAS GE, 1991, REV GEOPHYS, V29, P553, DOI 10.1029/91RG01604; Thomas GE, 2001, ADV SPACE RES, V28, P937, DOI 10.1016/S0273-1177(01)80021-1; von Zahn U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002409; von Zahn U., 2003, EOS T AM GEOPHYS UN, V84, P261, DOI [10.1029/2003eo280001, DOI 10.1029/2003EO280001]; Yrjola I, 1998, ASTRON ASTROPHYS, V330, P739	22	60	61	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					426	428		10.1126/science.1093236	http://dx.doi.org/10.1126/science.1093236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087546				2022-12-28	WOS:000220845400044
J	Weaver, AJ; Hillaire-Marcel, C				Weaver, AJ; Hillaire-Marcel, C			Global warming and the next ice age	SCIENCE			English	Editorial Material							THERMOHALINE CIRCULATION; ATLANTIC-OCEAN; COLD; WILL		Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Univ Quebec, GEOTOP, Montreal, PQ H3C 3P8, Canada	University of Victoria; University of Quebec; University of Quebec Montreal	Weaver, AJ (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada.	weaver@uvic.ca	Hillaire-Marcel, Claude/H-1441-2012; Weaver, Andrew J/E-7590-2011; Hillaire-Marcel, Claude/C-9153-2013	Weaver, Andrew J/0000-0001-8919-3598; Hillaire-Marcel, Claude/0000-0002-3733-4632				Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; ANKLIN M, 1993, NATURE, V364, P203, DOI 10.1038/364203a0; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; CALVIN WH, 1998, ATLANTIC MONTHLY, V281, P47; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; de Vernal A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000665; Gent PR, 2001, GEOPHYS RES LETT, V28, P1023, DOI 10.1029/2000GL011727; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jones EP, 2001, POLAR RES, V20, P139, DOI 10.1111/j.1751-8369.2001.tb00049.x; Kuijpers A, 2003, MAR GEOL, V195, P109, DOI 10.1016/S0025-3227(02)00684-9; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; LEMLEY B, 2002, DISCOVER, V23, P35; Rahmstorf S, 1997, NEW SCI, V153, P26; WEAVER AJ, IN PRESS GEOSCI CAN; Wood RA, 1999, NATURE, V399, P572, DOI 10.1038/21170; WU P, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.129/2003GL018584	19	36	39	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					400	402		10.1126/science.1096503	http://dx.doi.org/10.1126/science.1096503			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087538				2022-12-28	WOS:000220845400035
J	Valk, PJM; Verhaak, RGW; Beijen, MA; Erpelinck, CAJ; van Doorn-Khosrovani, SBV; Boer, JM; Beverloo, HB; Moorhouse, MJ; van der Spek, PJ; Lowenberg, B; Delwel, R				Valk, PJM; Verhaak, RGW; Beijen, MA; Erpelinck, CAJ; van Doorn-Khosrovani, SBV; Boer, JM; Beverloo, HB; Moorhouse, MJ; van der Spek, PJ; Lowenberg, B; Delwel, R			Prognostically useful gene-expression profiles in acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; MUTATIONS; CANCER; FLT3; AML; CLASSIFICATION; REARRANGEMENTS; ABNORMALITIES; SURVIVAL; DISTINCT	Background: In patients with acute myeloid leukemia (AML) a combination of methods must be used to classify the disease, make therapeutic decisions, and determine the prognosis. However, this combined approach provides correct therapeutic and prognostic information in only 50 percent of cases. Methods: We determined the gene-expression profiles in samples of peripheral blood or bone marrow from 285 patients with AML using Affymetrix U133A GeneChips containing approximately 13,000 unique genes or expression-signature tags. Data analyses were carried out with Omniviz, significance analysis of microarrays, and prediction analysis of microarrays software. Statistical analyses were performed to determine the prognostic significance of cases of AML with specific molecular signatures. Results: Unsupervised cluster analyses identified 16 groups of patients with AML on the basis of molecular signatures. We identified the genes that defined these clusters and determined the minimal numbers of genes needed to identify prognostically important clusters with a high degree of accuracy. The clustering was driven by the presence of chromosomal lesions (e.g., t(8;21), t(15;17), and inv(16)), particular genetic mutations (CEBPA), and abnormal oncogene expression (EVI1). We identified several novel clusters, some consisting of specimens with normal karyotypes. A unique cluster with a distinctive gene-expression signature included cases of AML with a poor treatment outcome. Conclusions: Gene-expression profiling allows a comprehensive classification of AML that includes previously identified genetically defined subgroups and a novel cluster with an adverse prognosis.	Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam ZH, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GE Rotterdam ZH, Netherlands; Erasmus Univ, Med Ctr, Dept Bioinformat, NL-3015 GE Rotterdam ZH, Netherlands; Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Valk, PJM (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Ee13,Dr Molewaterpl 50, NL-3015 GE Rotterdam ZH, Netherlands.	p.valk@erasmusmc.nl	Valk, Peter/AAX-2823-2020; Boer, Judith/A-7546-2010; Verhaak, Roel/ABE-7058-2020	Boer, Judith/0000-0003-4848-7789; Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar/0000-0003-1239-9867				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, HEMATOL J, V4, P31; Boeckx N, 2002, LEUKEMIA, V16, P368, DOI 10.1038/sj.leu.2402387; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kiyoi H, 1999, BLOOD, V93, P3074; LILLY M, 1992, ONCOGENE, V7, P727; LOCOCO F, 1989, BRIT J HAEMATOL, V73, P480; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 1997, J CLIN ONCOL, V15, P3496; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; OSSENKOPPELE GJ, IN PRESS BLOOD; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; TOUW I, 1991, LEUKEMIA, V5, P687; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, HAEMATOLOGICA, V89, P106; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459	28	1061	1136	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1617	1628		10.1056/NEJMoa040465	http://dx.doi.org/10.1056/NEJMoa040465			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084694	Green Published			2022-12-28	WOS:000220819800006
J	Shelton, JD; Halperin, DT; Nantulya, V; Potts, M; Gayle, HD; Holmes, KK				Shelton, JD; Halperin, DT; Nantulya, V; Potts, M; Gayle, HD; Holmes, KK			Partner reduction is crucial for balanced "ABC" approach to FRV prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIV; PREVALENCE; BEHAVIORS; POPULATION; ZAMBIA		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA; Global Fund AIDS TB & Malaria, Geneva, Switzerland; Univ Calif Berkeley, Berkeley, CA 94720 USA; Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; Univ Washington, Ctr AIDS & Sexually Transmitted Dis, Seattle, WA 98104 USA	United States Agency for International Development (USAID); University of California System; University of California Berkeley; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle	Halperin, DT (corresponding author), US Agcy Int Dev, Bur Global Hlth, 1300 Pennsylvania Ave, Washington, DC 20523 USA.	dhalp@worldwidedialup.net	, Holmes/K-6215-2019					Agha S, 2002, AIDS, V16, P291, DOI 10.1097/00002030-200201250-00021; Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Anderson RM, 1999, SEXUALLY TRANSMITTED; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bernstein RS, 1998, INTERFACES, V28, P101, DOI 10.1287/inte.28.3.101; Bessinger R., 2003, SEXUAL BEHAV HIV FER; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Garnett GP, 1998, AIDS PATIENT CARE ST, V12, P435, DOI 10.1089/apc.1998.12.435; GREEN E, 2003, NY TIMES        0301; Green EC, 2000, SEX TRANSM INFECT, V76, P145, DOI 10.1136/sti.76.2.145-a; HALPERIN DT, 2002, INT AIDS C BARC JUL; Hearst N, 2003, CONDOMS AIDS PREVENT; HOGLE JA, 2002, WHAT HAPPENED UGANDA; KRISTOF N, 2003, NY TIMES        0110; Low-Beer D, 2002, LANCET, V360, P1788, DOI 10.1016/S0140-6736(02)11701-6; Low-Beer Daniel, 2003, Afr J AIDS Res, V2, P9, DOI 10.2989/16085906.2003.9626555; Mekonnen Y, 2003, AIDS, V17, P223, DOI 10.1097/00002030-200301240-00013; Miller DG, 1997, J VOICE, V11, P1, DOI 10.1016/S0892-1997(97)80018-5; *NAT CTR HIV AIDS, 2003, BEH SENT SURV BSS, V5; PILCHER CD, IN PRESS AIDS; ROBINSON NJ, 1995, AIDS, V9, P1263, DOI 10.1097/00002030-199511000-00008; Rotello Gabriel, 1997, SEXUAL ECOLOGY AIDS; Stammers T, 2002, LANCET, V360, P1792, DOI 10.1016/S0140-6736(02)11709-0; *UN EC SOC AFF, 2002, HIV AIDS AW BEH; *UNAIDS, 2002, REP GLOB HIV AIDS EP; UNAIDS, 2003, AIDS EP UPD 2003; USAID/AIDSMark, 2003, MAL CIRC CURR EP FIE; VanLandingham B, 2002, INT FAM PLAN PERSPEC, V28, P6	30	146	149	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					891	893		10.1136/bmj.328.7444.891	http://dx.doi.org/10.1136/bmj.328.7444.891			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073076	Green Published			2022-12-28	WOS:000220871400026
J	Van Camp, G; Flamez, A; Cosyns, B; Weytjens, C; Muyldermans, L; Van Zandijcke, M; De Sutter, J; Santens, P; Decoodt, P; Moerman, C; Schoors, D				Van Camp, G; Flamez, A; Cosyns, B; Weytjens, C; Muyldermans, L; Van Zandijcke, M; De Sutter, J; Santens, P; Decoodt, P; Moerman, C; Schoors, D			Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease	LANCET			English	Article							PRIMARY PULMONARY-HYPERTENSION; RETROPERITONEAL FIBROSIS; 5-HT2B RECEPTORS; FENFLURAMINE; DETERMINANTS; VALVULOPATHY; PATIENT	Background Restrictive valvular heart disease has been reported in patients with Parkinson's disease treated with pergolide. However, few data are available on frequency, severity, dose dependency, and reversibility of pergolide-induced disease, nor on the pulmonary pressures of these patients. We aimed to clarify these characteristics in a large group of patients. Methods 78 patients with Parkinson's disease treated with pergolide and 18 never treated with an ergot-derived dopamine agonist (controls) were evaluated by echocardiography. A valvular scoring system was used, ranging from I (proven ergot-like restrictive valvular heart disease) to 4 (no disease). For the mitral valve, tenting areas and tenting distances were measured. Systolic pulmonary artery pressures were derived from the tricuspid regurgitant jet. Findings Restrictive valvular heart disease of any type was present in 26 (33%) patients in the pergolide group and none in controls (p=0.0025). Important disease (score 1 or 2) was present in 15 (19%) patients in the pergolide group and none in controls (p=0.066). Mean tenting distances and tenting areas of the mitral valve were 1.08 cm (range 0.55-2.66) and 2.39 cm(2) (0.88-4.59) in the restrictive mitral valve group versus 0.63 cm (0.22-1.20) and 1.39 cm(2) (0.39-3.23) in the non-restrictive group (p=0.003 and p<0.0001, respectively). Significant correlation was noted between cumulative doses of pergolide and tenting areas of the mitral valves (r=0.412, p=0.017). Mean systolic pulmonary artery pressures were 39.3 mm Hg (range 25-71) in the high-dose group versus 38.5 mm Hg (20-65) in the low-dose group (p=0.76) and 31 mm Hg (25-40) in controls (p=0.02 vs all patients given pergolide). In six patients, pergolide treatment was stopped because of restrictive valvular heart disease, in two of whom regression of disease was shown. Interpretation Restrictive valvular heart disease is not a rare finding in patients treated with pergolide. Clinicians should consider changing to a non-ergot drug if this disease is diagnosed.	Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, B-1090 Brussels, Belgium; Free Univ Brussels, Akad Ziekenhuis, Dept Neurol, B-1090 Brussels, Belgium; AZ St Jan Brugge, Dept Cardiol, Brugge, Belgium; AZ St Jan Brugge, Dept Neurol, Brugge, Belgium; UZ Gent, Dept Cardiol, Ghent, Belgium; UZ Gent, Dept Neurol, Ghent, Belgium; CHU Brugmann, Dept Neurol, Brussels, Belgium; CHU Brugmann, Dept Cardiol, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Van Camp, G (corresponding author), Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, Laarbeeklaan 101, B-1090 Brussels, Belgium.	guy.vancamp@az.vub.ac.be	santens, patrick/O-2505-2013; Flamez, Anja/AAJ-5530-2020	Santens, Patrick/0000-0002-8886-9776				Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; Danoff SK, 2001, CHEST, V120, P313, DOI 10.1378/chest.120.1.313; Delcroix M, 1998, EUR RESPIR J, V12, P271, DOI 10.1183/09031936.98.12020271; *FDA, 2003 SAF AL PERM PER; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; JIMENEZJIMENEZ FJ, 1995, CLIN NEUROPHARMACOL, V18, P277, DOI 10.1097/00002826-199506000-00009; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Mondal BK, 2000, INT J CLIN PRACT, V54, P403; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Rahimtoola SH, 2002, MAYO CLIN PROC, V77, P1275, DOI 10.4065/77.12.1275; Rothman RB, 2000, CIRCULATION, V102, P2836; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Shaunak S, 1999, J NEUROL NEUROSUR PS, V66, P79, DOI 10.1136/jnnp.66.1.79; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; *US FDA, 1997, MMWR-MORBID MORTAL W, V46, P1061; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2	18	251	258	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1179	1183		10.1016/S0140-6736(04)15945-X	http://dx.doi.org/10.1016/S0140-6736(04)15945-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081648				2022-12-28	WOS:000220748100006
J	Brousseau, ME; Schaefer, EJ; Wolfe, ML; Bloedon, LT; Digenio, AG; Clark, RW; Mancuso, JP; Rader, DJ				Brousseau, ME; Schaefer, EJ; Wolfe, ML; Bloedon, LT; Digenio, AG; Clark, RW; Mancuso, JP; Rader, DJ			Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; MEN; PLASMA; RISK; ATHEROSCLEROSIS; DEFICIENCY; EVENTS; ASSOCIATION; PRAVASTATIN	BACKGROUND: Decreased high-density lipoprotein (HDL) cholesterol levels constitute a major risk factor for coronary heart disease; however, there are no therapies that substantially raise HDL cholesterol levels. Inhibition of cholesteryl ester transfer protein (CETP) has been proposed as a strategy to raise HDL cholesterol levels. METHODS: We conducted a single-blind, placebo-controlled study to examine the effects of torcetrapib, a potent inhibitor of CETP, on plasma lipoprotein levels in 19 subjects with low levels of HDL cholesterol (<40 mg per deciliter [1.0 mmol per liter]), 9 of whom were also treated with 20 mg of atorvastatin daily. All the subjects received placebo for four weeks and then received 120 mg of torcetrapib daily for the following four weeks. Six of the subjects who did not receive atorvastatin also participated in a third phase, in which they received 120 mg of torcetrapib twice daily for four weeks. RESULTS: Treatment with 120 mg of torcetrapib daily increased plasma concentrations of HDL cholesterol by 61 percent (P<0.001) and 46 percent (P=0.001) in the atorvastatin and non-atorvastatin cohorts, respectively, and treatment with 120 mg twice daily increased HDL cholesterol by 106 percent (P<0.001). Torcetrapib also reduced low-density lipoprotein (LDL) cholesterol levels by 17 percent in the atorvastatin cohort (P=0.02). Finally, torcetrapib significantly altered the distribution of cholesterol among HDL and LDL subclasses, resulting in increases in the mean particle size of HDL and LDL in each cohort. CONCLUSIONS: In subjects with low HDL cholesterol levels, CETP inhibition with torcetrapib markedly increased HDL cholesterol levels and also decreased LDL cholesterol levels, both when administered as monotherapy and when administered in combination with a statin.	Tufts Univ New England Med Ctr, Div Endocrinol Metab Diabet & Mol Med, Lipid Res Lab, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Pfizer Inc, Dept Cardiovasc & Metab Dis, Groton, CT 06340 USA; Pfizer Inc, Dept Clin Biostat, Groton, CT 06340 USA	Tufts Medical Center; Tufts University; University of Pennsylvania; University of Pennsylvania; Pfizer; Pfizer	Brousseau, ME (corresponding author), Tufts Univ New England Med Ctr, Div Endocrinol Metab Diabet & Mol Med, Lipid Res Lab, 750 Washington St,Box 216, Boston, MA 02111 USA.	brousseau@tufts.edu; rader@mail.med.upenn.edu			NCRR NIH HHS [M01-RR00040, M01-RR00054] Funding Source: Medline; NHLBI NIH HHS [R01-HL60935] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040, M01RR000054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060935] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Brousseau ME, 2002, ARTERIOSCL THROM VAS, V22, P1148, DOI 10.1161/01.ATV.0000024566.57589.2E; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GAYNOR BJ, 1994, ATHEROSCLEROSIS, V110, P101, DOI 10.1016/0021-9150(94)90073-6; GENEST JJ, 1991, AM J CARDIOL, V67, P1185, DOI 10.1016/0002-9149(91)90924-A; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; IKEWAKI K, 1995, J CLIN INVEST, V96, P1573, DOI 10.1172/JCI118196; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Kothari HV, 1997, ATHEROSCLEROSIS, V128, P59, DOI 10.1016/S0021-9150(96)05981-3; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; MCNAMARA JR, 1995, CLIN CHEM, V41, P232; NGUYEN T, 1989, CLIN CHEM, V35, P1086; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; OTVOS JD, 1992, CLIN CHEM, V38, P1632; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2003, JAMA-J AM MED ASSOC, V290, P2322, DOI 10.1001/jama.290.17.2322; Rittershaus CW, 2000, ARTERIOSCL THROM VAS, V20, P2106, DOI 10.1161/01.ATV.20.9.2106; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schaefer EJ, 2002, AM J CARDIOL, V90, P689, DOI 10.1016/S0002-9149(02)02591-2; SCHAEFER EJ, 1994, J LIPID RES, V35, P871; Schank RC, 2000, CYBERPSYCHOL BEHAV, V3, P9, DOI 10.1089/109493100316184; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; Sugano M, 1996, J BIOL CHEM, V271, P19080, DOI 10.1074/jbc.271.32.19080; TALL AR, 1993, J LIPID RES, V34, P1255; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WHITLOCK ME, 1989, J CLIN INVEST, V84, P129, DOI 10.1172/JCI114132; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	40	575	613	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1505	1515		10.1056/NEJMoa031766	http://dx.doi.org/10.1056/NEJMoa031766			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071125				2022-12-28	WOS:000220682000006
J	Rodrigues, ASL; Andelman, SJ; Bakarr, MI; Boitani, L; Brooks, TM; Cowling, RM; Fishpool, LDC; da Fonseca, GAB; Gaston, KJ; Hoffmann, M; Long, JS; Marquet, PA; Pilgrim, JD; Pressey, RL; Schipper, J; Sechrest, W; Stuart, SN; Underhill, LG; Waller, RW; Watts, MEJ; Yan, X				Rodrigues, ASL; Andelman, SJ; Bakarr, MI; Boitani, L; Brooks, TM; Cowling, RM; Fishpool, LDC; da Fonseca, GAB; Gaston, KJ; Hoffmann, M; Long, JS; Marquet, PA; Pilgrim, JD; Pressey, RL; Schipper, J; Sechrest, W; Stuart, SN; Underhill, LG; Waller, RW; Watts, MEJ; Yan, X			Effectiveness of the global protected area network in representing species diversity	NATURE			English	Article							CONSERVATION TARGETS; BIODIVERSITY; EXTINCTION; PATTERNS; ECOLOGY; PARKS	The Fifth World Parks Congress in Durban, South Africa, announced in September 2003 that the global network of protected areas now covers 11.5% of the planet's land surface(1). This surpasses the 10% target proposed a decade earlier, at the Caracas Congress(2), for 9 out of 14 major terrestrial biomes(1). Such uniform targets based on percentage of area have become deeply embedded into national and international conservation planning(3). Although politically expedient, the scientific basis and conservation value of these targets have been questioned(4,5). In practice, however, little is known of how to set appropriate targets, or of the extent to which the current global protected area network fulfils its goal of protecting biodiversity. Here, we combine five global data sets on the distribution of species and protected areas to provide the first global gap analysis assessing the effectiveness of protected areas in representing species diversity. We show that the global network is far from complete, and demonstrate the inadequacy of uniform-that is, 'one size fits all'-conservation targets.	Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Conservat Int, IUCN SSCCI CABS Biodivers Assessement Unit, Washington, DC 20036 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; World Agroforestry Ctr ICRAF, Gigiri Nairobi, Kenya; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, I-00185 Rome, Italy; Univ Port Elizabeth, Dept Bot, Terr Ecol Res Unit, ZA-6000 Port Elizabeth, South Africa; BirdLife Int, Cambridge CB3 0NA, England; Univ Fed Minas Gerais, Dept Zool, BR-31270 Belo Horizonte, MG, Brazil; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; New S Wales Dept Environm & Conservat, Armidale, NSW 2350, Australia; Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83844 USA; Univ Cape Town, Dept Stat Sci, Avian Demog Unit, ZA-7701 Rondebosch, South Africa; Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China	Conservation International; Conservation International; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; CGIAR; World Agroforestry (ICRAF); Sapienza University Rome; Nelson Mandela University; BirdLife International; Universidade Federal de Minas Gerais; University of Sheffield; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Office of Environment & Heritage - New South Wales; Idaho; University of Idaho; University of Cape Town; Chinese Academy of Sciences; Institute of Zoology, CAS	Rodrigues, ASL (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA.	a.rodrigues@conservation.org	Rodrigues, Ana/GYQ-6273-2022; Marquet, Pablo A/B-7732-2009; Rodrigues, Ana S.L./A-5914-2009; Pressey, Bob/C-8370-2013; Hoffmann, Michael/E-6419-2010; Cowling, Richard/AFU-6261-2022	Marquet, Pablo A/0000-0001-6369-9339; Rodrigues, Ana S.L./0000-0003-4775-0127; Pressey, Bob/0000-0003-2740-0330; Hoffmann, Michael/0000-0003-4785-2254; Watts, Matthew/0000-0002-9094-1335; Underhill, Les/0000-0002-8758-1527; Brooks, Thomas/0000-0001-8159-3116				Andelman SJ, 2003, ECOL LETT, V6, P818, DOI 10.1046/j.1461-0248.2003.00503.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Birdlife International, 2000, THREAT BIRDS WORLD; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; CHAPE S, 2003, UN LIST PROTECTED AR; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Green M., 1997, STATE WORLDS PROTECT; IUCN (The World Conservation Union), 1994, GUID PROT AR MAN CAT; IUCN (World Conservation Union), 2003, IUCN RED LIST THREAT; Iverson JB, 2003, EMYSYSTEM WORLD TURT; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Lacher Thomas E. Jr, 1998, P199; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Rodrigues ASL, 2001, ECOL LETT, V4, P602, DOI 10.1046/j.1461-0248.2001.00275.x; Sattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; *WORLD CONS UN, 1993, 4 WORLD C NAT PARK P; *WORLD DAT PROT AR, 2003, WORLD DAT PROT AR	30	955	1051	21	732	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					640	643		10.1038/nature02422	http://dx.doi.org/10.1038/nature02422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071592	Green Accepted			2022-12-28	WOS:000220697200040
J	Dixon, T; Shaw, M; Frankel, S; Ebrahim, S				Dixon, T; Shaw, M; Frankel, S; Ebrahim, S			Hospital admissions, age, and death: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; POPULATION; LIFE; INCREASE; SPENT	Objectives Ageing of the population brings the possibility of increased burdens for acute hospital services because of the marked increase in many common diseases with age. We aimed to examine the relation between age and use of acute services in hospitals in the period before death in a national sample of deaths in hospital. Design Retrospective cohort analysis of English hospital episode statistics database. Setting All NHS hospitals in England. Data set All post-neonatal deaths occurring in English NHS hospitals during financial year 1999-2000, with episodes of care in the previous three years determined through matching on sex, date of birth, and postcode. Main outcome measures Total bed days, mean and median length of stay. Results 253 799 in-hospital deaths were identified, representing about 45% of all deaths occurring in 1999-2000. Patients who died in hospital spent a median of 23 days in hospital in the three years before death; the median rose with age up to 45 years, but was fairly stable for ages 45 and above. The number of admissions to NHS hospitals in die three years before death averaged 3.6; this peaked at 10.4 in patients aged 5-9 years and decreased with age to in those aged 85 and over. Conclusions The average number of bed days spent in hospital in the period before death does not increase with increasing age.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Shaw, M (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	mary.shaw@bristol.ac.uk						Brameld KJ, 1998, J EPIDEMIOL COMMUN H, V52, P740, DOI 10.1136/jech.52.11.740; Brockmann H, 2002, SOC SCI MED, V55, P593, DOI 10.1016/S0277-9536(01)00190-3; Busse R, 2002, J EPIDEMIOL COMMUN H, V56, P289, DOI 10.1136/jech.56.4.289; COHEN GD, 1994, ANN INTERN MED, V121, P146, DOI 10.7326/0003-4819-121-2-199407150-00014; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; HENDERSON J, 1990, BRIT MED J, V301, P17, DOI 10.1136/bmj.301.6742.17; Himsworth RL, 1999, BRIT MED J, V319, P1338, DOI 10.1136/bmj.319.7221.1338; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Maynard A, 2001, BRIT MED J, V322, P734, DOI 10.1136/bmj.322.7288.734; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; *OFF NAT STAT, 2000, MORT STAT GEN DH1, V33; Wanless D, 2001, SECURING OUR FUTURE; WANLESS D, 2001, SECURING FUTURE HLTH; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	15	42	42	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2004	328	7451					1288	1290		10.1136/bmj.38072.481933.EE	http://dx.doi.org/10.1136/bmj.38072.481933.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826PN	15090442	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000221841100018
J	Hoeper, MM; Krowka, MJ; Strassburg, CP				Hoeper, MM; Krowka, MJ; Strassburg, CP			Portopulmonary hypertension and hepatopulmonary syndrome	LANCET			English	Review							PRIMARY PULMONARY-HYPERTENSION; NITRIC-OXIDE SYNTHASE; INTRAHEPATIC PORTOSYSTEMIC SHUNT; LIVER-TRANSPLANTATION; ARTERIAL-HYPERTENSION; PORTAL-HYPERTENSION; DOPPLER-ECHOCARDIOGRAPHY; POTENTIAL MECHANISM; PROSTACYCLIN ANALOG; ANTAGONIST BOSENTAN	The clinically and pathophysiologically distinct entities of portopulmonary hypertension and hepatopulmonary syndrome occur in a substantial proportion of patients who have advanced liver disease of different causes. These disorders are notoriously underdiagnosed, but they have a substantial impact on survival and require focused treatment. Abnormal intrapulmonary vascular dilatation, the hallmark of hepatopulmonary syndrome, can cause profound hypoxaemia that can be very difficult to treat. By contrast, portopulmonary hypertension results from excessive pulmonary vasoconstriction and vascular remodelling that eventually leads to right-heart failure. Insights into the pathogeneses of these syndromes have led to novel therapeutic approaches. However, in severely affected patients, effective treatment remains a difficult task. In selected patients, liver transplantation represents the only treatment option, but the decision to do isolated liver transplantation is particularly challenging in patients who have severe pulmonary disease involvement. Data from several centres have contributed to provide criteria that allow improved prediction of which patients may, or may not, benefit from liver transplantation alone.	Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany; Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30623 Hannover, Germany; Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Hannover Medical School; Hannover Medical School; Mayo Clinic	Hoeper, MM (corresponding author), Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany.	hoeper.marius@mh-hannover.de	Hoeper, Marius C/Z-1546-2019	Hoeper, Marius C/0000-0001-9086-2293				Abrams GA, 1999, TRANSPLANTATION, V68, P1809, DOI 10.1097/00007890-199912150-00028; AGUSTI AGN, 1990, J HEPATOL, V10, P251, DOI 10.1016/0168-8278(90)90061-U; ALBERTS WM, 1991, ARCH INTERN MED, V151, P2383, DOI 10.1001/archinte.151.12.2383; ALLGAIER HP, 1995, J HEPATOL, V23, P102, DOI 10.1016/0168-8278(95)80318-1; Arguedas MR, 2003, HEPATOLOGY, V37, P192, DOI 10.1053/jhep.2003.50023; Arroliga AC, 2000, CHEST, V118, P1224, DOI 10.1378/chest.118.4.1224; Auletta M, 2000, ANGIOLOGY, V51, P1013, DOI 10.1177/000331970005101206; Avendano CE, 2001, LIVER TRANSPLANT, V7, P1081, DOI 10.1053/jlts.2001.29416; Barst RJ, 2002, CHEST, V121, P1860, DOI 10.1378/chest.121.6.1860; Benjaminov FS, 2003, GUT, V52, P1355, DOI 10.1136/gut.52.9.1355; Brussino L, 2003, LANCET, V362, P43, DOI 10.1016/S0140-6736(03)13807-X; Budhiraja R, 2003, CHEST, V123, P562, DOI 10.1378/chest.123.2.562; Carter EP, 2002, AM J PHYSIOL-LUNG C, V283, pL346, DOI 10.1152/ajplung.00385.2001; Castro M, 1996, MAYO CLIN PROC, V71, P543, DOI 10.4065/71.6.543; Castro M, 1996, CLIN CHEST MED, V17, P35, DOI 10.1016/S0272-5231(05)70297-5; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Colle IO, 2003, HEPATOLOGY, V37, P401, DOI 10.1053/jhep.2003.50060; Collisson EA, 2002, LIVER TRANSPLANT, V8, P925, DOI 10.1053/jlts.2002.35544; Corley DA, 1997, GASTROENTEROLOGY, V113, P728, DOI 10.1053/gast.1997.v113.agast971130728; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; De BK, 2002, GASTROENTEROLOGY, V122, P897, DOI 10.1053/gast.2002.32419; De BK, 2000, GASTROENTEROLOGY, V118, P192, DOI 10.1016/S0016-5085(00)70428-8; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dennis CM, 1996, J HEART LUNG TRANSPL, V15, P536; DEWOLF AM, 1993, ANESTHESIOLOGY, V78, P213, DOI 10.1097/00000542-199301000-00037; EDELL ES, 1989, AM REV RESPIR DIS, V140, P1631, DOI 10.1164/ajrccm/140.6.1631; EDWARDS BS, 1987, J AM COLL CARDIOL, V10, P1233, DOI 10.1016/S0735-1097(87)80123-7; Fallon MB, 2000, ANN INTERN MED, V133, P738, DOI 10.7326/0003-4819-133-9-200011070-00016; Fallon MB, 1997, GASTROENTEROLOGY, V113, P606, DOI 10.1053/gast.1997.v113.pm9247483; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580; Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2; Ghofrani HA, 2003, J AM COLL CARDIOL, V42, P158, DOI 10.1016/S0735-1097(03)00555-2; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gupta D, 2001, AM J GASTROENTEROL, V96, P3395; HADENGUE A, 1991, GASTROENTEROLOGY, V100, P520, DOI 10.1016/0016-5085(91)90225-A; HANSON CA, 1990, AM REV RESPIR DIS, V142, P39, DOI 10.1164/ajrccm/142.1.39; Herve P, 1998, EUR RESPIR J, V11, P1153, DOI 10.1183/09031936.98.11051153; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; JAMISON BM, 1995, HUM PATHOL, V26, P987, DOI 10.1016/0046-8177(95)90088-8; Kim WR, 2000, LIVER TRANSPLANT, V6, P453, DOI 10.1053/jlts.2000.7573; KONERU B, 1994, TRANSPLANTATION, V58, P1133; Krowka MJ, 2000, CHEST, V118, P615, DOI 10.1378/chest.118.3.615; Krowka MJ, 1999, HEPATOLOGY, V30, P641, DOI 10.1002/hep.510300307; KROWKA MJ, 1990, CHEST, V97, P1165, DOI 10.1378/chest.97.5.1165; KROWKA MJ, 1993, CHEST, V104, P515, DOI 10.1378/chest.104.2.515; Krowka MJ, 1997, MAYO CLIN PROC, V72, P44, DOI 10.4065/72.1.44; Krowka MJ, 2000, LIVER TRANSPLANT, V6, P443, DOI 10.1053/jlts.2000.6356; Kuo PC, 1999, TRANSPLANTATION, V67, P1087, DOI 10.1097/00007890-199904270-00001; Kuo PC, 1997, TRANSPLANTATION, V63, P604, DOI 10.1097/00007890-199702270-00020; LANGE PA, 1995, ANN INTERN MED, V122, P521, DOI 10.7326/0003-4819-122-7-199504010-00008; Lasch HM, 2001, LIVER TRANSPLANT, V7, P147, DOI 10.1053/jlts.2001.21287; Levy MT, 1996, J GASTROEN HEPATOL, V11, P734, DOI 10.1111/j.1440-1746.1996.tb00323.x; Liu LC, 2001, HEPATOLOGY, V33, P722, DOI 10.1053/jhep.2001.22701; Lodato RF, 2001, AM J RESP CRIT CARE, V163, P312, DOI 10.1164/ajrccm.163.2.ed2000e; Luo B, 1998, J HEPATOL, V29, P571, DOI 10.1016/S0168-8278(98)80152-9; Luo B, 2003, J HEPATOL, V38, P556, DOI 10.1016/S0168-8278(03)00012-6; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mal H, 1999, J HEPATOL, V31, P360, DOI 10.1016/S0168-8278(99)80236-0; Martinez GP, 2001, J HEPATOL, V34, P651, DOI 10.1016/S0168-8278(00)00108-2; MCDONNELL PJ, 1983, AM REV RESPIR DIS, V127, P437, DOI 10.1164/arrd.1983.127.4.437; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Naeije R, 2003, SWISS MED WKLY, V133, P163; Nunes H, 2001, AM J RESP CRIT CARE, V164, P879, DOI 10.1164/ajrccm.164.5.2009008; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Ooi H, 2002, CIRCULATION, V106, P1618, DOI 10.1161/01.CIR.0000034444.31846.F4; Paramesh AS, 2003, PEDIATR TRANSPLANT, V7, P157, DOI 10.1034/j.1399-3046.2003.00033.x; Philit F, 1997, RESPIRATION, V64, P173; PLEVAK D, 1993, TRANSPLANT P, V25, P1840; Plotkin JS, 1998, TRANSPLANTATION, V65, P457, DOI 10.1097/00007890-199802270-00001; Rabiller A, 2002, AM J RESP CRIT CARE, V166, P514, DOI 10.1164/rccm.200201-027OC; Raffy O, 1996, AM J RESP CRIT CARE, V153, P1169, DOI 10.1164/ajrccm.153.3.8630562; Ramsay M A, 1997, Liver Transpl Surg, V3, P494, DOI 10.1002/lt.500030503; Regev A, 2001, J VIRAL HEPATITIS, V8, P83, DOI 10.1046/j.1365-2893.2001.00270.x; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rich S, 1998, WORLD S PRIM PULM HY; RIEGLER JL, 1995, GASTROENTEROLOGY, V109, P978, DOI 10.1016/0016-5085(95)90409-3; ROBALINO BD, 1991, J AM COLL CARDIOL, V17, P492, DOI 10.1016/S0735-1097(10)80121-4; RODRIGUEZROISIN R, 1987, AM REV RESPIR DIS, V135, P1085; ROLANDO N, 1990, HEPATOLOGY, V11, P49, DOI 10.1002/hep.1840110110; Rolla G, 1998, ANN INTERN MED, V129, P375, DOI 10.7326/0003-4819-129-5-199809010-00005; Rolla G, 1997, HEPATOLOGY, V26, P842, DOI 10.1002/hep.510260406; Rubin LJ, 2002, EXPERT OPIN INV DRUG, V11, P991; Schenk P, 2000, ANN INTERN MED, V133, P701, DOI 10.7326/0003-4819-133-9-200011070-00012; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; Schott R, 1999, CHEST, V115, P1748, DOI 10.1378/chest.115.6.1748; Schraufnagel DE, 1996, CLIN CHEST MED, V17, P1, DOI 10.1016/S0272-5231(05)70295-1; Schroeder RA, 2000, DIGEST DIS SCI, V45, P2405, DOI 10.1023/A:1005651327654; SCOTT V, 1993, TRANSPLANT P, V25, P1789; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Strassburg CP, 2003, BEST PRACT RES CL GA, V17, P369, DOI 10.1016/S1521-6918(03)00025-8; SWANSON KL, 2003, AM J RESP CRIT CARE, V167, pA693; Taille C, 2003, TRANSPLANTATION, V75, P1482, DOI 10.1097/01.TP.0000061612.78954.6C; Taura P, 1996, ANESTH ANALG, V83, P675, DOI 10.1097/00000539-199610000-00003; Teuber Gerlinde, 2002, Eur J Intern Med, V13, P311, DOI 10.1016/S0953-6205(02)00066-3; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Torregrosa M, 2001, TRANSPLANTATION, V71, P572, DOI 10.1097/00007890-200102270-00015; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Vachiery F, 1997, J HEPATOL, V27, P492, DOI 10.1016/S0168-8278(97)80353-4; VALLANCE P, 1991, LANCET, V337, P776, DOI 10.1016/0140-6736(91)91384-7; WALLWORK J, 1987, LANCET, V2, P182; Whyte MKB, 1998, J HEPATOL, V29, P85, DOI 10.1016/S0168-8278(98)80182-7; Zhang M, 1999, AM J PHYSIOL-GASTR L, V277, pG944, DOI 10.1152/ajpgi.1999.277.5.G944	104	315	334	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1461	1468		10.1016/S0140-6736(04)16107-2	http://dx.doi.org/10.1016/S0140-6736(04)16107-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121411				2022-12-28	WOS:000221130300021
J	Uibu, T; Oksa, P; Auvinen, A; Honkanen, E; Metsarinne, K; Saha, H; Uitti, J; Roto, P				Uibu, T; Oksa, P; Auvinen, A; Honkanen, E; Metsarinne, K; Saha, H; Uitti, J; Roto, P			Asbestos exposure as a risk factor for retroperitoneal fibrosis	LANCET			English	Article							CHRONIC PERIAORTITIS; MESENTERY; RETENTION; OMENTUM; FIBERS; CANCER	Background Retroperitoneal fibrosis (RPF) is an uncommon disease with unknown causation in most cases. The pathognomonic finding is a fibrous mass covering the abdominal aorta and the ureters. Our aim was to clarify the possible role of asbestos exposure in the development of RPF. The hypothesis was based on the ability of asbestos to cause fibrosis in pulmonary and pleural tissue. Methods We undertook a case-control study of 43 patients with the disease (86% of eligible cases) treated in three university hospital districts of Finland in 1990-2001. For every patient, five population-based controls were selected, matched by age, sex, and central hospital district. We assessed asbestos exposure and medical history using a postal questionnaire and a personal interview. Of the 215 eligible controls, 179 (83%) participated in the study. Findings The age-standardised incidence of RPF was 0.10 (95% Cl 0.07-0.14) per 100 000 person-years. The disease was strongly associated with asbestos exposure. The odds ratio (OR) was 5.54 (1.64-18.65) for less than 10 fibre-years of asbestos exposure and 8.84 (2.03-38.50) for 10 or more fibre-years, the attributable fraction being 82% and 89%, respectively. Other risk factors were previous use of ergot derivates (OR 9.92 [1.63-60.26]), abdominal aortic aneurysm (OR 6.73 [0.81-56.08]), and smoking for more than 20 pack-years (OR 4.73 [1.28-17.41]). Interpretation Our results show that occupational asbestos exposure is an important causal factor for RPF. For patients with work-related asbestos exposure, RPF should be considered an occupational disease.	Tampere Univ Hosp, Dept Resp Med, Tampere, Finland; Tampere Univ Hosp, Tampere Reg Inst Occupat Hlth, Tampere, Finland; Tampere Univ Hosp, Clin Occupat Med, Tampere, Finland; Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; Turku Univ Hosp, Dept Internal Med, FIN-20520 Turku, Finland; Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FIN-00014 Helsinki, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Turku; University of Helsinki; Helsinki University Central Hospital	Uibu, T (corresponding author), Tampere Reg Inst Occupat Hlth, POB 486, FIN-33101 Tampere, Finland.	toomas.uibu@saunalahti.fi	Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020	Auvinen, Anssi/0000-0003-1125-4818				Albarran J., 1905, ASS FR UROL, V9, P511; ARMITAGE P, 2002, STAT METHODS MED RES, P683; Begin R, 1996, OCCUPATIONAL ENV RES, P293; Blatter BM, 1997, OCCUP ENVIRON MED, V54, P54, DOI 10.1136/oem.54.1.54; BOULARD JC, 1995, LANCET, V345, P1379, DOI 10.1016/S0140-6736(95)92584-8; CHURG A, 1995, AM J RESP CRIT CARE, V151, P1409, DOI 10.1164/ajrccm.151.5.7735593; De Luca S, 1998, ANN UROL, V32, P153; Dodson RF, 2000, CHEST, V117, P486, DOI 10.1378/chest.117.2.486; Dodson RF, 2001, TOXICOL IND HEALTH, V17, P138, DOI 10.1191/0748233701th101oa; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; DONALDSON K, 1989, BRIT J IND MED, V46, P271; Gilkeson GS, 1996, RHEUM DIS CLIN N AM, V22, P23, DOI 10.1016/S0889-857X(05)70260-X; GRAHAM JR, 1966, NEW ENGL J MED, V274, P359, DOI 10.1056/NEJM196602172740701; Henderson DW, 1997, SCAND J WORK ENV HEA, V23, P311; HILLERDAL G, 1980, EUR J RESPIR DIS, V61, P129; HUUSKONEN MS, 1995, AM J IND MED, V28, P123, DOI 10.1002/ajim.4700280111; Kamp DW, 1999, THORAX, V54, P638, DOI 10.1136/thx.54.7.638; KING DS, 1947, NEW ENGL J MED, V236, P407, DOI 10.1056/NEJM194703132361105; KOEP L, 1977, SURGERY, V81, P2507; MAGUIRE GP, 1991, NEW YORK STATE J MED, V91, P357; MITCHINSON MJ, 1984, HISTOPATHOLOGY, V8, P589, DOI 10.1111/j.1365-2559.1984.tb02371.x; ORMOND JK, 1948, J UROLOGY, V59, P1072, DOI 10.1016/S0022-5347(17)69482-5; PARUMS DV, 1990, ARCH PATHOL LAB MED, V114, P383; PETO J, 1995, LANCET, V345, P535, DOI 10.1016/S0140-6736(95)90462-X; Sauni R, 1998, AM J IND MED, V33, P418, DOI 10.1002/(SICI)1097-0274(199804)33:4<418::AID-AJIM13>3.0.CO;2-1; Souilamas R, 2001, SURG RADIOL ANAT, V23, P159, DOI 10.1007/s00276-001-0159-y; TOSSAVAINEN A, 1994, ENVIRON HEALTH PERSP, V102, P253, DOI 10.2307/3432098; Vaglio A, 2003, AM J MED, V114, P454, DOI 10.1016/S0002-9343(03)00056-1; WAGENKNECHT LV, 1978, RETROPERITONEALE FIB	29	128	143	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1422	1426		10.1016/S0140-6736(04)16100-X	http://dx.doi.org/10.1016/S0140-6736(04)16100-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121404				2022-12-28	WOS:000221130300008
J	Linder, P				Linder, P			The life of RNA with proteins	SCIENCE			English	Editorial Material							DEAD-BOX PROTEINS; SACCHAROMYCES-CEREVISIAE; REQUIREMENT; DISRUPTION; HELICASE; MOTORS		CMU, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland	University of Geneva	Linder, P (corresponding author), CMU, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	patrick.linder@medecine.unige.ch						Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x	12	18	19	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					694	695		10.1126/science.1097850	http://dx.doi.org/10.1126/science.1097850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118153				2022-12-28	WOS:000221105300033
J	Tarsounas, M; Munoz, P; Claas, A; Smiraldo, PG; Pittman, DL; Blasco, MA; West, SC				Tarsounas, M; Munoz, P; Claas, A; Smiraldo, PG; Pittman, DL; Blasco, MA; West, SC			Telomere maintenance requires the RAD51D recombination/repair protein	CELL			English	Article							BLOOM-SYNDROME; SYNDROME HELICASE; BINDING PROTEIN; LENGTH; REPAIR; CELLS; TRF2; POT1; ASSOCIATION; FUSIONS	The five RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) are required in mammalian cells for normal levels of genetic recombination and resistance to DNA-damaging agents. We report here that RAD51D is also involved in telomere maintenance. Using immunofluorescence labeling, electron microscopy, and chromatin immunoprecipitation assays, RAD51D was shown to localize to the telomeres of both meiotic and somatic cells. Telomerase-positive Rad51d(-/-) Trp53(-/-) primary mouse embryonic fibroblasts (MEFs) exhibited telomeric DNA repeat shortening compared to Trp53(-/-) or wild-type MEFs. Moreover, elevated levels of chromosomal aberrations were detected, including telomeric end-to-end fusions, a signature of telomere dysfunction. Inhibition of RAD51D synthesis in telomerase-negative immortalized human cells by siRNA also resulted in telomere erosion and chromosome fusion. We conclude that RAD51D plays a dual cellular role in both the repair of DNA double-strand breaks and telomere protection against attrition and fusion.	London Res Inst, Canc Res UK, S Mimms EN6 3LD, Herts, England; Spanish Natl Canc Ctr, Mol Oncol Program, Madrid 28029, Spain; Med Coll Ohio, Dept Physiol & Mol Med, Toledo, OH 43614 USA	Cancer Research UK; Centro Nacional de Investigaciones Oncologicas (CNIO)	West, SC (corresponding author), London Res Inst, Canc Res UK, Clare Hall Labs,Blanche Lane, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; West, Stephen/0000-0001-8848-9418	Breast Cancer Now [2002:445] Funding Source: Medline	Breast Cancer Now		Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Braybrooke JP, 2003, J BIOL CHEM, V278, P48357, DOI 10.1074/jbc.M308838200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jaco I, 2003, MOL CELL BIOL, V23, P5572, DOI 10.1128/MCB.23.16.5572-5580.2003; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Le S, 1999, GENETICS, V152, P143; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Pittman DL, 2000, GENESIS, V26, P167, DOI 10.1002/(SICI)1526-968X(200003)26:3<167::AID-GENE1>3.0.CO;2-M; Ramirez R, 2003, J BIOL CHEM, V278, P836, DOI 10.1074/jbc.M206818200; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Stansel RM, 2001, EMBO J, V20, P5532; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tarsounas M, 1999, J CELL SCI, V112, P423; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	64	178	190	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					337	347		10.1016/S0092-8674(04)00337-X	http://dx.doi.org/10.1016/S0092-8674(04)00337-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109494	Bronze			2022-12-28	WOS:000221176400008
J	Yin, YD; Rioux, RM; Erdonmez, CK; Hughes, S; Somorjai, GA; Alivisatos, AP				Yin, YD; Rioux, RM; Erdonmez, CK; Hughes, S; Somorjai, GA; Alivisatos, AP			Formation of hollow nanocrystals through the nanoscale Kirkendall Effect	SCIENCE			English	Article							SHAPE; OXIDATION; BEHAVIOR; COBALT; SIZE	Hollow nanocrystals can be synthesized through a mechanism analogous to the Kirkendall Effect, in which pores form because of the difference in diffusion rates between two components in a diffusion couple. Starting with cobalt nanocrystals, we show that their reaction in solution with oxygen and either sulfur or selenium leads to the formation of hollow nanocrystals of the resulting oxide and chalcogenides. This process provides a general route to the synthesis of hollow nanostructures of a large number of compounds. A simple extension of the process yielded platinum-cobalt oxide yolk-shell nanostructures, which may serve as nanoscale reactors in catalytic applications.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	alivis@uclink4.berkeley.edu	Yin, Yadong/D-5987-2011; Alivisatos, Paul/N-8863-2015	Yin, Yadong/0000-0003-0218-3042; Alivisatos, Paul/0000-0001-6895-9048				ALDINGER F, 1974, ACTA METALL MATER, V22, P923, DOI 10.1016/0001-6160(74)90059-5; BIRCHENALL CE, 1956, J ELECTROCHEM SOC, V103, P619, DOI 10.1149/1.2430174; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Colson J. C., 1972, P 7 INT S REACT SOL, P283; CORTRIGHT RD, 1991, J CATAL, V127, P342, DOI 10.1016/0021-9517(91)90230-2; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DEVIN A, 1966, COBALT, V30, P19; Ghoniem NM, 2001, J COMPUT-AIDED MATER, V8, P1, DOI 10.1023/A:1015062218246; GIBBS GB, 1981, OXID MET, V16, P147, DOI 10.1007/BF00603749; Gu WQ, 1999, J AM CHEM SOC, V121, P9467, DOI 10.1021/ja990818o; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Johnson SA, 1999, SCIENCE, V283, P963, DOI 10.1126/science.283.5404.963; Li AP, 1999, ADV MATER, V11, P483, DOI 10.1002/(SICI)1521-4095(199904)11:6<483::AID-ADMA483>3.0.CO;2-I; Mrowec S, 1998, J MATER SCI, V33, P2617, DOI 10.1023/A:1004313504810; MROWEC S, 1977, OXID MET, V11, P365, DOI 10.1007/BF00608018; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; On DT, 2001, APPL CATAL A-GEN, V222, P299; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Puntes VF, 2001, APPL PHYS LETT, V78, P2187, DOI 10.1063/1.1362333; Puntes VF, 2002, J AM CHEM SOC, V124, P12874, DOI 10.1021/ja027262g; Sanders WS, 2003, MAT SCI ENG A-STRUCT, V352, P150, DOI 10.1016/S0921-5093(02)00890-0; Schwarz US, 2000, PHYS REV E, V62, P6957, DOI 10.1103/PhysRevE.62.6957; SMIGELSKAS AD, 1947, T AM I MIN MET ENG, V171, P130; Sobal NS, 2003, J PHYS CHEM B, V107, P7351, DOI 10.1021/jp034200j; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Turro NJ, 2000, ACCOUNTS CHEM RES, V33, P637, DOI 10.1021/ar980103a; Zhao DY, 1998, CURR OPIN SOLID ST M, V3, P111, DOI 10.1016/S1359-0286(98)80073-9	29	3015	3071	68	2088	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					711	714		10.1126/science.1096566	http://dx.doi.org/10.1126/science.1096566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118156	Green Submitted			2022-12-28	WOS:000221105300038
J	Abeles, M				Abeles, M			Time is precious	SCIENCE			English	Editorial Material							PROPAGATION; SYNCHRONY; NETWORKS		Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, Jerusalem, Israel	Bar Ilan University; Hebrew University of Jerusalem	Abeles, M (corresponding author), Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel.	moshe.abeles@mail.biu.ac.il						Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M., 1982, LOCAL CORTICAL CIRCU; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Bienenstock E, 1996, BRAIN THEORY, P269, DOI 10.1016/B978-044482046-4/50057-2; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; SHASTRI L, 1993, BEHAV BRAIN SCI, V16, P417, DOI 10.1017/S0140525X00030910; von der Malsburg C, 1981, 812 M PLANCK I BIOPH	11	30	31	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					523	524		10.1126/science.1097725	http://dx.doi.org/10.1126/science.1097725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105481				2022-12-28	WOS:000220975100026
J	Chadderton, P; Margrie, TW; Hausser, M				Chadderton, P; Margrie, TW; Hausser, M			Integration of quanta in cerebellar granule cells during sensory processing	NATURE			English	Article							NEURONAL EXCITABILITY; SYNAPTIC CURRENTS; GABA(A) RECEPTORS; DENDRITIC SPINES; CALCIUM-RELEASE; RAT CEREBELLUM; PURKINJE-CELLS; MOSSY FIBERS; CORTEX; INHIBITION	To understand the computations performed by the input layers of cortical structures, it is essential to determine the relationship between sensory-evoked synaptic input and the resulting pattern of output spikes. In the cerebellum, granule cells constitute the input layer, translating mossy fibre signals into parallel fibre input to Purkinje cells(1). Until now, their small size and dense packing(1,2) have precluded recordings from individual granule cells in vivo. Here we use whole-cell patch-clamp recordings to show the relationship between mossy fibre synaptic currents evoked by somatosensory stimulation and the resulting granule cell output patterns. Granule cells exhibited a low ongoing firing rate, due in part to dampening of excitability by a tonic inhibitory conductance mediated by GABA(A) (gamma-aminobutyric acid type A) receptors. Sensory stimulation produced bursts of mossy fibre excitatory postsynaptic currents (EPSCs) that summate to trigger bursts of spikes. Notably, these spike bursts were evoked by only a few quantal EPSCs, and yet spontaneous mossy fibre inputs triggered spikes only when inhibition was reduced. Our results reveal that the input layer of the cerebellum balances exquisite sensitivity with a high signal-to-noise ratio. Granule cell bursts are optimally suited to trigger glutamate receptor activation(3-5) and plasticity(6-8) at parallel fibre synapses, providing a link between input representation and memory storage in the cerebellum.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Chadderton, Paul/0000-0002-6276-1011				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLIMAS R, 1982, CEREBELLUM NEW VISTA, P189; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Morissette J, 1996, EXP BRAIN RES, V109, P240; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	30	515	519	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					856	860		10.1038/nature02442	http://dx.doi.org/10.1038/nature02442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103377	Green Published			2022-12-28	WOS:000220952300041
J	Korf, HW; Wicht, H				Korf, HW; Wicht, H			The public cadaver	NATURE			English	Editorial Material									Univ Frankfurt, Fac Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Korf, HW (corresponding author), Univ Frankfurt, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.		Korf, Horst/ACX-9860-2022	Korf, Horst/0000-0002-5051-0303				HAESER H, 1853, LEHRBUCH GESCH MED, V1; Korf HW, 2002, CELL TISSUE RES, V309, P1, DOI 10.1007/s00441-002-0586-z; Stukenbrock Karin, 2001, SOZIALGESCHICHTE ANA; Yamaguchi S, 2001, NATURE, V409, P684, DOI 10.1038/35055628; 2004, NATURE, V428, P243	5	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					805	805		10.1038/428805a	http://dx.doi.org/10.1038/428805a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103356				2022-12-28	WOS:000220952300021
J	Cho, EY; Smith-Warner, SA; Ritz, J; van den Brandt, PA; Colditz, GA; Folsom, AR; Freudenheim, JL; Giovannucci, E; Goldbohm, RA; Graham, S; Holmberg, L; Kim, DH; Malila, N; Miller, AB; Pietinen, P; Rohan, TE; Sellers, TA; Speizer, FE; Willett, WC; Wolk, A; Hunter, DJ				Cho, EY; Smith-Warner, SA; Ritz, J; van den Brandt, PA; Colditz, GA; Folsom, AR; Freudenheim, JL; Giovannucci, E; Goldbohm, RA; Graham, S; Holmberg, L; Kim, DH; Malila, N; Miller, AB; Pietinen, P; Rohan, TE; Sellers, TA; Speizer, FE; Willett, WC; Wolk, A; Hunter, DJ			Alcohol intake and colorectal cancer: A pooled analysis of 8 cohort studies	ANNALS OF INTERNAL MEDICINE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; YORK-STATE COHORT; RECTAL-CANCER; COLON-CANCER; DIETARY ASSESSMENT; DIGESTIVE-TRACT; BREAST-CANCER; RISK-FACTORS; VITAMIN-D; BEVERAGE CONSUMPTION	Background: Epidemiologic studies have generally reported positive associations between alcohol consumption and risk for colorectal cancer. However, findings related to specific alcoholic beverages or different anatomic sites in the large bowel have been inconsistent. Objective: To examine the relationship of total alcohol intake and intake from specific beverages to the incidence of colorectal cancer and to evaluate whether other potential risk factors modify the association. Design: Pooled analysis of primary data from 8 cohort studies in 5 countries. Setting: North America and Europe. Participants: 489 979 women and men with no history of cancer other than nonmelanoma skin cancer at baseline. Measurements: Alcohol intake was assessed in each study at baseline by using a validated food-frequency questionnaire. Results: During a maximum of 6 to 16 years of follow-up across the studies, 4687 cases of colorectal cancer were documented. In categorical analyses, increased risk for colorectal cancer was limited to persons with an alcohol intake of 30 g/d or greater (approximately greater than or equal to2 drinks/d), a consumption level reported by 4% of women and 13% of men. Compared with nondrinkers, the pooled multivariate relative risks were 1.16 (95% Cl, 0.99 to 1.36) for persons who consumed 30 to less than 45 g/d and 1.41 (Cl, 1.16 to 1.72) for those who consumed 45 g/d or greater. No significant heterogeneity by study or sex was observed. The association was evident for cancer of the proximal colon, distal colon, and rectum. No clear difference in relative risks was found among specific alcoholic beverages. Limitations: The study included only one measure of alcohol consumption at baseline and could not investigate lifetime alcohol consumption, alcohol consumption at younger ages, or changes in alcohol consumption during follow-up. It also could not examine drinking patterns or duration of alcohol use. Conclusions: A single determination of alcohol intake correlated with a modest relative elevation in colorectal cancer rate, mainly at the highest levels of alcohol intake.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Ctr Canc Prevent, Boston, MA 02115 USA; Maastricht Univ, Maastricht, Netherlands; TNO, Nutr & Food Res Inst, NL-3700 AJ Zeist, Netherlands; Univ Minnesota, Minneapolis, MN USA; SUNY Buffalo, Buffalo, NY 14260 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Reg Oncol Ctr, Uppsala, Sweden; Natl Inst Environm Med, Stockholm, Sweden; Hallym Univ, Coll Med, Chunchon, South Korea; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Natl Publ Hlth Inst, Helsinki, Finland; Univ Toronto, Fac Med, Toronto, ON, Canada; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Maastricht University; Netherlands Organization Applied Science Research; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yeshiva University; Albert Einstein College of Medicine; Hallym University; Finnish Cancer Registry; Finland National Institute for Health & Welfare; University of Toronto; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cho, EY (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	eunyoung.cho@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; van den Brandt, Piet/0000-0001-8781-8099; Freudenheim, Jo/0000-0002-9301-0499	NATIONAL CANCER INSTITUTE [K07CA078548] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075, CA78548] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON TW, 1988, INTRO MULTIVARIATE S; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; Bandera EV, 2002, NUTR CANCER, V42, P41, DOI 10.1207/S15327914NC421_6; BIDOLI E, 1992, INT J CANCER, V50, P223, DOI 10.1002/ijc.2910500211; BOSTICK RM, 1993, AM J EPIDEMIOL, V137, P1302, DOI 10.1093/oxfordjournals.aje.a116640; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Choi SW, 1999, J NUTR, V129, P1945, DOI 10.1093/jn/129.11.1945; CHOI SY, 1991, INT J CANCER, V49, P381, DOI 10.1002/ijc.2910490312; Chyou PH, 1996, ANN EPIDEMIOL, V6, P276, DOI 10.1016/S1047-2797(96)00047-6; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fenech M, 2001, MUTAT RES-FUND MOL M, V475, P57, DOI 10.1016/S0027-5107(01)00079-3; FERRARONI M, 1989, INT J EPIDEMIOL, V18, P556, DOI 10.1093/ije/18.3.556; Feskanich Diane, 1994, Annals of Epidemiology, V4, P181, DOI 10.1016/1047-2797(94)90095-7; FREUDENHEIM JL, 1990, NUTR CANCER, V13, P101, DOI 10.1080/01635589009514050; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; GAPSTUR SM, 1994, INT J EPIDEMIOL, V23, P50, DOI 10.1093/ije/23.1.50; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Glynn SA, 1996, CANCER CAUSE CONTROL, V7, P214, DOI 10.1007/BF00051297; GOLDBOHM RA, 1994, CANCER CAUSE CONTROL, V5, P95, DOI 10.1007/BF01830255; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; GRAHAM S, 1992, AM J EPIDEMIOL, V136, P1327, DOI 10.1093/oxfordjournals.aje.a116445; Gregory JF, 1997, EUR J CLIN NUTR, V51, pS54; HERBERT V, 1987, AM J CLIN NUTR, V45, P661, DOI 10.1093/ajcn/45.4.661; HIRAYAMA T, 1989, LANCET, V2, P725, DOI 10.1016/S0140-6736(89)90782-4; Homann N, 2000, INT J CANCER, V86, P169, DOI 10.1002/(SICI)1097-0215(20000415)86:2&lt;169::AID-IJC4&gt;3.0.CO;2-3; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; HU JF, 1991, INT J EPIDEMIOL, V20, P362, DOI 10.1093/ije/20.2.362; Hunter DJ, 1996, NEW ENGL J MED, V334, P356, DOI 10.1056/NEJM199602083340603; Jain M, 1996, AM J EPIDEMIOL, V143, P953, DOI 10.1093/oxfordjournals.aje.a008839; KABAT GC, 1986, INT J EPIDEMIOL, V15, P494, DOI 10.1093/ije/15.4.494; KAMPMAN E, 1994, CANCER RES, V54, P3186; KLATSKY AL, 1988, AM J EPIDEMIOL, V128, P1007; KUNE GA, 1992, NUTR CANCER, V18, P97, DOI 10.1080/01635589209514210; KUNE S, 1987, Nutrition and Cancer, V9, P43; La Vecchia C, 1997, CANCER EPIDEM BIOMAR, V6, P1007; LeMarchand L, 1997, CANCER RES, V57, P4787; LONGNECKER MP, 1990, CANCER CAUSE CONTROL, V1, P59, DOI 10.1007/BF00053184; LONGNECKER MP, 1990, CANCER CAUSE CONTROL, V1, P5, DOI 10.1007/BF00053178; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; MEYER F, 1993, AM J EPIDEMIOL, V138, P225, DOI 10.1093/oxfordjournals.aje.a116851; *MICR, 1993, EPICURE US GUID PEAN; MILLER AB, 1983, INT J CANCER, V32, P155, DOI 10.1002/ijc.2910320204; MUNGER RG, 1992, AM J EPIDEMIOL, V136, P192, DOI 10.1093/oxfordjournals.aje.a116485; Murata M, 1999, JPN J CANCER RES, V90, P711, DOI 10.1111/j.1349-7006.1999.tb00805.x; NEWCOMB PA, 1993, CANCER CAUSE CONTROL, V4, P405, DOI 10.1007/BF00050858; PETERS RK, 1989, CANCER RES, V49, P5459; PETERS RK, 1992, CANCER CAUSE CONTROL, V3, P457, DOI 10.1007/BF00051359; PICKLE LW, 1984, CANCER RES, V44, P363; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P667, DOI 10.1093/oxfordjournals.aje.a115014; POLLACK ES, 1984, NEW ENGL J MED, V310, P617, DOI 10.1056/NEJM198403083101003; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman K., 1998, MODERN EPIDEMIOLOGY; Salaspuro M, 1996, ANN MED, V28, P195, DOI 10.3109/07853899609033120; SEITZ HK, 1990, GASTROENTEROLOGY, V98, P406, DOI 10.1016/0016-5085(90)90832-L; Slattery M L, 1990, Epidemiology, V1, P141, DOI 10.1097/00001648-199003000-00010; Slattery ML, 1997, NUTR CANCER, V28, P52, DOI 10.1080/01635589709514553; STEMMERMANN GN, 1990, DIGEST DIS SCI, V35, P1414, DOI 10.1007/BF01536750; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Terry P, 2002, INT J CANCER, V97, P864, DOI 10.1002/ijc.10138; Terry P, 2002, NUTR CANCER, V43, P39, DOI 10.1207/S15327914NC431_4; Terry P, 2001, NUTR CANCER, V39, P176, DOI 10.1207/S15327914nc392_3; TUYNS AJ, 1982, INT J CANCER, V30, P9, DOI 10.1002/ijc.2910300103; *USDA, 1998, USDA NUTR DAT STAND; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525; [World Cancer Research Fund American Institute for Cancer Research], 1997, FOOD NUTR PREV CANC	75	324	335	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					603	613		10.7326/0003-4819-140-8-200404200-00007	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096331	Green Published			2022-12-28	WOS:000220851700003
J	Vijan, S; Hayward, RA				Vijan, S; Hayward, RA			Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; PRIMARY-PREVENTION; CHOLESTEROL LEVELS; SUBGROUP ANALYSIS; VASCULAR-DISEASE; MORTALITY; STATINS; INSULIN	Background: Cardiovascular disease is the primary complication and cause of death in patients with type 2 diabetes mellitus. Modification of cardiovascular risk factors may improve patient outcomes. Purpose: To evaluate the effectiveness of pharmacologic lipid-lowering therapy on outcomes in type 2 diabetes mellitus. Data Sources: Review of the literature. Study Selection: Randomized trials evaluating clinical outcomes of lipid-lowering treatment in patients with diabetes. Data Extraction: Studies were identified by searching the Cochrane Library, MEDLINE, meta-analyses, review articles, and inquiries to experts. The Cochrane Library and MEDLINE searches were done in September 2002. Data were abstracted onto standardized forms by a single reviewer and were confirmed by a second reviewer. Data Synthesis: Meta-analysis of 6 primary prevention studies showed that lipid-lowering medications reduced risks for cardiovascular outcomes (relative risk, 0.78 [95% Cl, 0.67 to 0.89]; absolute risk reduction, 0.03 [Cl, 0.01 to 0.04] in 4.3 years of treatment); 1 major cardiovascular event was prevented by treating 34 to 35 patients. Meta-analysis of 8 studies of secondary prevention showed a similar relative risk (0.76 [Cl, 0.59 to 0.93]) but more than twice the absolute risk reduction (0.07 [Cl, 0.03 to 0.12] in 4.9 years of treatment) and a number needed to treat for benefit of 13 to 14. Most studies compared a lipid-lowering drug with placebo but did not evaluate the effect of reaching specific cholesterol levels. The benefit of lipid lowering with a fixed dose of a statin appeared to be similar regardless of starting cholesterol levels. Limitations: Target cholesterol levels and the effectiveness of dose titration (or the use of multiple agents) have not been rigorously examined. Conclusions: in patients with type 2 diabetes, treatment with lipid-lowering agents reduces cardiovascular risk. Most patients, including those whose baseline low-density lipoprotein cholesterol levels are below 2.97 mmol/L (<115 mg/dL), and possibly below 2.59 mmol/L (<100 mg/dL), benefit from statins. Moderate doses of these drugs suffice in most patients with diabetes.	Univ Michigan, Ctr Practice Management & Outcomes Res, Vet Affairs Hlth Serv Res & Dev, Ann Arbor, MI 48105 USA; Michigan Diabet Res & Training Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Vijan, S (corresponding author), Univ Michigan, Ctr Practice Management & Outcomes Res, Vet Affairs Hlth Serv Res & Dev, 2215 Fuller Rd,Mailstop 11H, Ann Arbor, MI 48105 USA.	svijan@umich.edu						*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; [Anonymous], 1995, DIAB AM; BARRETTCONNOR E, 1982, AM J EPIDEMIOL, V115, P657, DOI 10.1093/oxfordjournals.aje.a113348; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DEGRAUW WJC, 1995, DIABETIC MED, V12, P117; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FEINGOLD KR, 1992, ARTERIOSCLER THROMB, V12, P1496, DOI 10.1161/01.ATV.12.12.1496; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Grover SA, 2000, CIRCULATION, V102, P722, DOI 10.1161/01.CIR.102.7.722; Harris M I, 1990, Clin Geriatr Med, V6, P703; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hoogwerf BJ, 1999, DIABETES, V48, P1289, DOI 10.2337/diabetes.48.6.1289; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kinlay S, 2003, AM J CARDIOL, V91, p9B, DOI 10.1016/S0002-9149(02)03268-X; KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979; Kmietowicz Z, 2001, BRIT MED J, V323, P1145, DOI 10.1136/bmj.323.7322.1145; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; KROLEWSKI AS, 1977, DIABETOLOGIA, V13, P345, DOI 10.1007/BF01223277; Liao JK, 2002, INT J CARDIOL, V86, P5, DOI 10.1016/S0167-5273(02)00195-X; Meigs JB, 1997, AM J MED, V102, P38, DOI 10.1016/S0002-9343(96)00383-X; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; MORRISH NJ, 1991, DIABETOLOGIA, V34, P584, DOI 10.1007/BF00400278; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ray NF, 1998, DIABETES CARE, V21, P296; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rosenson R S, 1999, Curr Cardiol Rep, V1, P225, DOI 10.1007/s11886-999-0027-7; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Smith CC, 2003, ARCH INTERN MED, V163, P688, DOI 10.1001/archinte.163.6.688; Snow V, 2003, ANN INTERN MED, V138, P587, DOI 10.7326/0003-4819-138-7-200304010-00017; Sotiriou CG, 2000, ANN PHARMACOTHER, V34, P1432; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US DEP HHS, 2002, NAT DIAB FACT SHEET; Vijan S, 2000, DIABETOLOGIA, V43, P125, DOI 10.1007/s001250050017; Vijan S, 2003, ANN INTERN MED, V138, P593, DOI 10.7326/0003-4819-138-7-200304010-00018; WINGARD DL, 1993, DIABETES CARE, V16, P1022, DOI 10.2337/diacare.16.7.1022; Xydakis AM, 2002, AM J CARDIOL, V90, p21K	51	144	150	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					650	658		10.7326/0003-4819-140-8-200404200-00013	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096337				2022-12-28	WOS:000220851700009
J	Shibata, N; Pennycook, SJ; Gosnell, TR; Painter, GS; Shelton, WA; Becher, PF				Shibata, N; Pennycook, SJ; Gosnell, TR; Painter, GS; Shelton, WA; Becher, PF			Observation of rare-earth segregation in silicon nitride ceramics at subnanometre dimensions	NATURE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; IMPROVED FRACTURE-TOUGHNESS; MICROSTRUCTURAL DESIGN; SI3N4	Silicon nitride (Si3N4) ceramics are used in numerous applications because of their superior mechanical properties(1,2). Their intrinsically brittle nature is a critical issue, but can be overcome by introducing whisker-like microstructural features(3,4). However, the formation of such anisotropic grains is very sensitive to the type of cations used as the sintering additives(1,2,5). Understanding the origin of dopant effects, central to the design of high-performance Si3N4 ceramics, has been sought for many years. Here we show direct images of dopant atoms (La) within the nanometre-scale intergranular amorphous films typically found at grain boundaries, using aberration corrected Z-contrast scanning transmission electron microscopy. It is clearly shown that the La atoms preferentially segregate to the amorphous/crystal interfaces. First-principles calculations confirm the strong preference of La for the crystalline surfaces, which is essential for forming elongated grains and a toughened microstructure. Whereas principles of micrometre-scale structural design are currently used to improve the mechanical properties of ceramics, this work represents a step towards the atomic-level structural engineering required for the next generation of ceramics.	Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37831 USA; Pixon LLC, Setauket, NY 11733 USA; Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Shibata, N (corresponding author), Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37831 USA.	shibatan@ornl.gov	Shibata, Naoya/E-5327-2013; Pennycook, Stephen/AAA-1112-2019	Pennycook, Stephen/0000-0002-3210-6323				AVERILL FW, 1994, PHYS REV B, V50, P7262, DOI 10.1103/PhysRevB.50.7262; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Becher PF, 1998, J AM CERAM SOC, V81, P2821, DOI 10.1111/j.1151-2916.1998.tb02702.x; CHEN IW, 1993, MRS P MAT RES SOC, V287; Gu H, 1998, J AM CERAM SOC, V81, P3125, DOI 10.1111/j.1151-2916.1998.tb02747.x; Hoffmann MJ, 2000, MATER RES SOC SYMP P, V586, P65; Kleebe HJ, 1997, J CERAM SOC JPN, V105, P453, DOI 10.2109/jcersj.105.453; KRAMER M, 1993, J AM CERAM SOC, V76, P2778, DOI 10.1111/j.1151-2916.1993.tb04015.x; Krivanek OL, 2003, ULTRAMICROSCOPY, V96, P229, DOI 10.1016/S0304-3991(03)00090-1; LANGE FF, 1973, J AM CERAM SOC, V56, P518, DOI 10.1111/j.1151-2916.1973.tb12401.x; PAINTER GS, UNPUB PHYS REV LETT; Pennycook SJ, 2002, ADV IMAG ELECT PHYS, V123, P173; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; Sun EY, 1998, J AM CERAM SOC, V81, P2831, DOI 10.1111/j.1151-2916.1998.tb02703.x; Sun EY, 1999, ACTA MATER, V47, P2777, DOI 10.1016/S1359-6454(99)00122-6; TANI E, 1986, AM CERAM SOC BULL, V65, P1311; Ziegler A, 2003, J AM CERAM SOC, V86, P1777, DOI 10.1111/j.1151-2916.2003.tb03554.x; [No title captured]	18	257	260	10	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					730	733		10.1038/nature02410	http://dx.doi.org/10.1038/nature02410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085126				2022-12-28	WOS:000220823800033
J	Orosz, GM; Magaziner, J; Hannan, EL; Morrison, RS; Koval, K; Gilbert, M; McLaughlin, M; Halm, EA; Wang, JJ; Litke, A; Silberzweig, SB; Siu, AL				Orosz, GM; Magaziner, J; Hannan, EL; Morrison, RS; Koval, K; Gilbert, M; McLaughlin, M; Halm, EA; Wang, JJ; Litke, A; Silberzweig, SB; Siu, AL			Association of timing of surgery for hip fracture and patient outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEMORAL FRACTURE; ELDERLY PATIENTS; OPERATIVE DELAY; MORTALITY; TIME; COMPLICATIONS; MORBIDITY; ADMISSION; RECOVERY; IMPACT	Context. Previous studies of surgical timing in patients with hip fracture have yielded conflicting findings on mortality and have not focused on functional outcomes. Objective To examine the association of timing of surgical repair of hip fracture with function and other outcomes, Design Prospective cohort study including analyses matching cases of early (:524 hours) and late (>24 hours) surgery with propensity scores and excluding patients who might not. be candidates for early surgery. Setting Four hospitals in the New York City metropolitan area. Participants A total of 1206 patients aged 50 years or older admitted with hip fracture over 29 months, ending December 1999. Main Outcome Measures Function (using the Functional Independence Measure), survival, pain, and length of stay (LOS). Results Of the patients treated with surgery (n=1178), 33.8% had surgery within 24 hours. Earlier surgery was not associated with improved mortality (hazard ratio, 0.75; 95% confidence interval [CI], 0.52-1.08) or improved locomotion (difference of -0.04 points; 95% Cl, -0.49 to 0.39). Earlier surgery was associated with fewer days of severe and very severe pain (difference of -0.22 days; 95% Cl, -0.41 to -0.03) and shorter LOS by 1.94 days (P<.001), but postoperative pain and LOS after surgery did not differ: Analyses with propensity scores yielded similar results. When the cohort included only patients who were medically stable at admission and therefore eligible for early surgery, the results were unchanged except that early surgery was associated with fewer major complications (odds ratio, 0.26; 95% Cl, 0.07-0.95). Conclusions Early surgery was not associated with improved function or mortality, but it was associated with reduced pain and LOS and probably major complications among patients medically stable at admission. Additional research is needed on whether functional outcomes may be improved. In the meantime, patients with hip fracture who are medically stable should receive early surgery when possible.	Mt Sinai Sch Med, Dept Geriatr, New York, NY USA; Mt Sinai Sch Med, Dept Orthoped, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA; Mt Sinai Sch Med, Dept Hlth Policy, New York, NY USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; SUNY Albany, Sch Publ Hlth, Dept Hlth Policy & Management, Albany, NY 12222 USA; Hosp Joint Dis & Med Ctr, Dept Orthoped, New York, NY USA; Bronx Vet Adm Med Ctr, GRECC, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System; State University of New York (SUNY) Albany; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Siu, AL (corresponding author), Mt Sinai Med Ctr, Box 1070,1 Gustave L Levy Pl, New York, NY 10029 USA.	albert.siu@mssm.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009459, R01HS009973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG000833, R01AG021992, K24AG000918] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS009973, U18HS09459-0, U18 HS009459, R01HS09973] Funding Source: Medline; NIA NIH HHS [K24 AG000918, K08AG00833-01, R01 AG021992] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BREDAHL C, 1992, INJURY, V23, P83, DOI 10.1016/0020-1383(92)90037-S; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAVIS FM, 1987, BRIT J ANAESTH, V59, P1080, DOI 10.1093/bja/59.9.1080; DIEHR P, 1995, MED CARE, V33, pAS164; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; DOLK T, 1990, INJURY, V21, P369, DOI 10.1016/0020-1383(90)90121-A; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Hedstrom M, 1999, INJURY, V30, P341, DOI 10.1016/S0020-1383(99)00094-7; Hefley WF, 1996, J BONE JOINT SURG AM, V78A, P581, DOI 10.2106/00004623-199604000-00012; Hoenig H, 1997, ARCH INTERN MED, V157, P513, DOI 10.1001/archinte.157.5.513; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P42; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; PENROD JD, IN PRESS J AM GERIAT; PEREZ JV, 1995, INJURY, V26, P237, DOI 10.1016/0020-1383(95)90008-L; ROGERS FB, 1995, J TRAUMA, V39, P261, DOI 10.1097/00005373-199508000-00012; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; *US DEP HHS, 1999, MMWR-MORBID MORTAL W, V48, P33; VERSLUYSEN M, 1986, BRIT MED J, V292, P1311, DOI 10.1136/bmj.292.6531.1311; VILLAR RN, 1986, BRIT MED J, V293, P1203, DOI 10.1136/bmj.293.6556.1203; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010	28	393	414	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1738	1743		10.1001/jama.291.14.1738	http://dx.doi.org/10.1001/jama.291.14.1738			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082701	Green Accepted, Bronze			2022-12-28	WOS:000220788700031
J	Moon, SY; Chang, GY				Moon, SY; Chang, GY			A complication of cosmetic surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US Army Gen Hosp 121st, Seoul, South Korea	United States Department of Defense; United States Army	Moon, SY (corresponding author), US Army Gen Hosp 121st, Seoul, South Korea.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1549	1549		10.1056/NEJMicm010941	http://dx.doi.org/10.1056/NEJMicm010941			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071129				2022-12-28	WOS:000220682000010
J	Yanega, GM; Rubega, MA				Yanega, GM; Rubega, MA			Feeding mechanisms: Hummingbird jaw bends to aid insect capture - This tiny bird has a neat trick to trap flies in mid-air with its long nectar-seeking beak.	NATURE			English	Editorial Material									Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Yanega, GM (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	gregar.yanega@uconn.edu	Yanega, Gregor/P-5776-2017	Yanega, Gregor/0000-0001-7896-7738				Altshuler DL, 2003, SCIENCE, V300, P588, DOI 10.1126/science.1084477; Baker HG., 1982, BIOCH ASPECTS EVOLUT, P131; BRICE AT, 1991, PHYSIOL ZOOL, V64, P611, DOI 10.1086/physzool.64.2.30158193; Buhler P., 1981, P439; BUHLER PZ, 1970, MORPHOL TIERE, V66, P337; FITZPATRICK JW, 1983, ORNITHOLOGICAL MONOG, P447; STORER RW, 1971, AVIAN BIOL, P150; Zusi Richard L., 1993, P391	8	30	30	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					615	615		10.1038/428615a	http://dx.doi.org/10.1038/428615a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071586	Bronze			2022-12-28	WOS:000220697200030
J	Bland, JM; Altman, DG				Bland, JM; Altman, DG			The logrank test	BRITISH MEDICAL JOURNAL			English	Article							STATISTICS NOTES		Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Canc Res UK NHS Ctr Stat Med, Inst Hlth Sci, Oxford OX3 7LF, England	University of York - UK; Cancer Research UK; University of Oxford	Bland, JM (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.							Altman DG, 1998, BRIT MED J, V317, P468; ALTMAN DG, 1991, PRACTICAL STAT MED R, P371; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; ROSTOMILY RC, 1994, NEUROSURGERY, V35, P378, DOI 10.1227/00006123-199409000-00004	4	459	477	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 1	2004	328	7447					1073	1073		10.1136/bmj.328.7447.1073	http://dx.doi.org/10.1136/bmj.328.7447.1073			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117797	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000221174500032
J	Dushoff, J				Dushoff, J			Comment on "Metapopulation persistence with age-dependent disturbance or succession"	SCIENCE			English	Editorial Material									Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA	Princeton University	Dushoff, J (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA.	dushoff@eno.princeton.edu						DIEKMANN O, 1990, J MATH BIOL, V28, P365; Feller W., 1971, INTRO PROBABILITY TH, V2; Hastings A, 2003, SCIENCE, V301, P1525, DOI 10.1126/science.1087570; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012	4	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118146				2022-12-28	WOS:000221105300024
J	Hentze, MW; Muckenthaler, MU; Andrews, NC				Hentze, MW; Muckenthaler, MU; Andrews, NC			Balancing acts: Molecular control of mammalian iron metabolism	CELL			English	Review							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE HEPCIDIN; FERRITIN MESSENGER-RNA; METAL-ION TRANSPORTER; TRANSFERRIN RECEPTOR; HEREDITARY HEMOCHROMATOSIS; REGULATORY PROTEIN-2; FRIEDREICH ATAXIA; HYPOTRANSFERRINEMIC MICE; JUVENILE HEMOCHROMATOSIS	Iron is ubiquitous in the environment and in biology. The study of iron biology focuses on physiology and homeostasis-understanding how cells and organisms regulate their iron content, how diverse tissues orchestrate iron allocation, and how dysregulated iron homeostasis leads to common hematological, metabolic, and neurodegenerative diseases. This has provided novel insights into gene regulation and unveiled remarkable links to the immune system.	Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Heidelberg Univ, D-69120 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	hentze@embl.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876; Muckenthaler, Martina/0000-0002-3778-510X; Andrews, Nancy/0000-0003-0243-4462				Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; BRITTENHAM GM, 1994, IRON METABOLISM HLTH, P31; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; BUYS SS, 1991, BLOOD, V78, P3288; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DESOUSA M, 1988, ANN NY ACAD SCI, V526, P310; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Eisenstein RS, 2003, J NUTR, V133, p1510S, DOI 10.1093/jn/133.5.1510S; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; FINCH C, 1994, BLOOD, V84, P1697; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gerber J, 2002, MITOCHONDRION, V2, P71, DOI 10.1016/S1567-7249(02)00041-7; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; HARRISON PM, 1977, SEMIN HEMATOL, V14, P55; HENTZE MW, 1988, GENE, V72, P201, DOI 10.1016/0378-1119(88)90145-X; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kang DK, 2003, J BIOL CHEM, V278, P14857, DOI 10.1074/jbc.M300616200; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LAFTAH AH, 2004, BLOOD           0129, DOI DOI 10.1182/BOOD-2003-03-0953; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; Liu XB, 2002, BLOOD CELL MOL DIS, V29, P315, DOI 10.1006/bcmd.2002.0572; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Meyron-Holtz EG, 1999, BLOOD, V94, P3205, DOI 10.1182/blood.V94.9.3205.421k25_3205_3211; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Miyajima H, 2002, BLOOD CELL MOL DIS, V29, P433, DOI 10.1006/bcmd.2002.0561; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Mwanjewe J, 2004, BIOCHEM J, V378, P975, DOI 10.1042/BJ20031187; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; NEMETH E, 2004, IN PRESS J CLIN INVE; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Pandolfo M, 2002, BLOOD CELL MOL DIS, V29, P536, DOI 10.1006/bcmd.2002.0591; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Paraskeva E, 1999, MOL CELL BIOL, V19, P807; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Perry G, 2002, CNS DRUGS, V16, P339, DOI 10.2165/00023210-200216050-00006; Phillips JD, 2001, P NATL ACAD SCI USA, V98, P259, DOI 10.1073/pnas.011481398; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Ponka P, 1997, BLOOD, V89, P1; RAJA KB, 1986, BRIT J HAEMATOL, V64, P587, DOI 10.1111/j.1365-2141.1986.tb02214.x; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Tomatsu S, 2003, P NATL ACAD SCI USA, V100, P15788, DOI 10.1073/pnas.2237037100; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Waheed A, 2002, P NATL ACAD SCI USA, V99, P3117, DOI 10.1073/pnas.042701499; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	103	1315	1394	14	203	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					285	297		10.1016/S0092-8674(04)00343-5	http://dx.doi.org/10.1016/S0092-8674(04)00343-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109490	hybrid			2022-12-28	WOS:000221176400004
J	Zeng, QY				Zeng, QY			Drinking alcohol and gout	LANCET			English	Editorial Material							TAIWAN; URATE		Shantou Univ Med Coll, Dept Rheumatol, Shantou 515041, Guangdong, Peoples R China		Zeng, QY (corresponding author), Shantou Univ Med Coll, Dept Rheumatol, Shantou 515041, Guangdong, Peoples R China.	qyzeng@stu.edu.cn						CASSIM B, 1994, ANN RHEUM DIS, V53, P759, DOI 10.1136/ard.53.11.759; Chou CT, 1998, BRIT J RHEUMATOL, V37, P258; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; EASTMOND CJ, 1995, BRIT J RHEUMATOL, V34, P756; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Kamienski Mary, 2003, Orthop Nurs, V22, P16, DOI 10.1097/00006416-200301000-00006; Lyu LC, 2003, AM J CLIN NUTR, V78, P690, DOI 10.1093/ajcn/78.4.690; Zeng QY, 2003, CHINESE MED J-PEKING, V116, P66	8	2	3	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1251	1252		10.1016/S0140-6736(04)16030-3	http://dx.doi.org/10.1016/S0140-6736(04)16030-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094267				2022-12-28	WOS:000220904900004
J	Roodman, GD				Roodman, GD			Mechanisms of disease: Mechanisms of bone metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HORMONE-RELATED PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; OSTEOCLASTOGENESIS-INHIBITORY FACTOR; PARATHYROID-HORMONE; MULTIPLE-MYELOMA; PROSTATE-CANCER; BREAST-CANCER; TUMOR-CELLS; DIFFERENTIATION FACTOR; MOLECULAR-MECHANISMS		Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; Dept Vet Affairs Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roodman, GD (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol, Kaufmann Med Bldg,Suite 601,3471 5th Ave, Pittsburgh, PA 15213 USA.	roodmangd@msx.upmc.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013625] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHBAROU A, 1994, CANCER RES, V54, P2372; Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73; BALLESTER OF, 1994, BLOOD, V83, P1903; BARILLE S, 1995, BLOOD, V86, P3151; BATAILLE R, 1992, HEMATOL ONCOL CLIN N, V6, P285, DOI 10.1016/S0889-8588(18)30345-9; BATAILLE R, 1995, BRIT J HAEMATOL, V90, P721, DOI 10.1111/j.1365-2141.1995.tb05609.x; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; BOYDE A, 1986, Scanning Electron Microscopy, P1537; Buchs N, 2000, EUR J ENDOCRINOL, V142, P500, DOI 10.1530/eje.0.1420500; CHARHON SA, 1983, CANCER, V51, P918, DOI 10.1002/1097-0142(19830301)51:5<918::AID-CNCR2820510526>3.0.CO;2-J; Cheung WC, 2002, LEUKEMIA, V16, P1182, DOI 10.1038/sj.leu.2402481; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Choi SJ, 2001, J CLIN INVEST, V108, P1833, DOI 10.1172/JCI13116; Choi Sun Jin, 2000, Blood, V96, P671; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coleman RE, 2001, SEMIN ONCOL, V28, P11, DOI 10.1053/sonc.2001.24155; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Costa L, 2002, J CLIN ONCOL, V20, P850, DOI 10.1200/JCO.20.3.850; Cramer SD, 1996, J UROLOGY, V156, P526, DOI 10.1016/S0022-5347(01)65919-6; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Gordon S, 2002, BRIT J HAEMATOL, V119, P475, DOI 10.1046/j.1365-2141.2002.03824.x; Grano M, 2000, BIOCHEM BIOPH RES CO, V270, P1097, DOI 10.1006/bbrc.2000.2569; Guise TA, 2003, CANCER-AM CANCER SOC, V97, P779, DOI 10.1002/cncr.11129; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hofbauer LC, 1998, EUR J ENDOCRINOL, V139, P152, DOI 10.1530/eje.0.1390152; HORTON MA, 1993, J BONE MINER RES, V8, P239; Iwasaki T, 1999, INT J HEMATOL, V70, P163; KAHN, 1994, BLOOD, V84, P3602; KAHN D, 1994, BLOOD, V83, P958; Karaplis A C, 2000, Rev Endocr Metab Disord, V1, P331, DOI 10.1023/A:1026526703898; Kasperk CH, 1997, CALCIFIED TISSUE INT, V60, P368, DOI 10.1007/s002239900245; KODAMA H, 1991, J EXP MED, V173, P1291, DOI 10.1084/jem.173.5.1291; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; KURIHARA N, 1990, J IMMUNOL, V144, P4226; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee YP, 2002, CANCER RES, V62, P5564; LEONARD RCF, 1981, CLIN RADIOL, V32, P291, DOI 10.1016/S0009-9260(81)80043-8; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Maeda H, 1997, J UROLOGY, V157, P539, DOI 10.1016/S0022-5347(01)65196-6; Magrangeas F, 2003, BLOOD, V101, P4998, DOI 10.1182/blood-2002-11-3385; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Mundy G R, 2001, Rev Endocr Metab Disord, V2, P105, DOI 10.1023/A:1010015309973; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Oades GM, 2002, PROSTATE CANCER P D, V5, P264, DOI 10.1038/sj.pcan.4500607; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Oyajobi BO, 2003, BLOOD, V102, P311, DOI 10.1182/blood-2002-12-3905; Oyajobi BO, 2003, CANCER-AM CANCER SOC, V97, P813, DOI 10.1002/cncr.11133; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; POWELL GJ, 1991, CANCER RES, V51, P3059; Powles T, 2002, J CLIN ONCOL, V20, P3219, DOI 10.1200/JCO.2002.11.080; RABBANI SA, 1990, BIOCHEM BIOPH RES CO, V173, P1058, DOI 10.1016/S0006-291X(05)80893-9; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Roudier MP, 2003, CLIN EXP METASTAS, V20, P171, DOI 10.1023/A:1022627421000; Sati HIA, 1999, BRIT J HAEMATOL, V104, P350, DOI 10.1046/j.1365-2141.1999.01193.x; Sezer O, 2002, BLOOD, V99, P4646, DOI 10.1182/blood-2002-01-0148; Sezer O, 2002, J CLIN ONCOL, V20, P353, DOI 10.1200/JCO.2002.20.1.353; Shen XL, 2003, MOL CELL ENDOCRINOL, V199, P165, DOI 10.1016/S0303-7207(02)00287-3; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Soutar RL, 1996, LEUKEMIA LYMPHOMA, V24, P111, DOI 10.3109/10428199609045719; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Tamada T, 2001, J BONE MINER METAB, V19, P45, DOI 10.1007/s007740170059; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Teoh G, 1997, HEMATOL ONCOL CLIN N, V11, P27, DOI 10.1016/S0889-8588(05)70413-5; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tsukii K, 1998, BIOCHEM BIOPH RES CO, V246, P337, DOI 10.1006/bbrc.1998.8610; Uneda S, 2003, BRIT J HAEMATOL, V120, P53, DOI 10.1046/j.1365-2141.2003.04040.x; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Wada N, 2001, Breast Cancer, V8, P131, DOI 10.1007/BF02967492; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/00007632-200208151-00002; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yi B, 2002, CANCER RES, V62, P917; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	87	1585	1673	4	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1655	1664		10.1056/NEJMra030831	http://dx.doi.org/10.1056/NEJMra030831			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084698				2022-12-28	WOS:000220819800010
J	Sutkin, G; Mamlok, V				Sutkin, G; Mamlok, V			Fetus papyraceus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Sutkin, G (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA.			Sutkin, Gary/0000-0002-6336-5109					0	1	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1665	1665		10.1056/NEJMicm020196	http://dx.doi.org/10.1056/NEJMicm020196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084699				2022-12-28	WOS:000220819800011
J	Leung, KL; Kwok, SPY; Lam, SCW; Lee, JFY; Yiu, RYC; Ng, SSM; Lai, PBS; Lau, WY				Leung, KL; Kwok, SPY; Lam, SCW; Lee, JFY; Yiu, RYC; Ng, SSM; Lai, PBS; Lau, WY			Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial	LANCET			English	Article							ASSISTED RESECTION; OPEN COLECTOMY; COLON-CANCER; SURGERY	Background Although laparoscopic resection of colorectal carcinoma improves post-operative recovery, long-term survival and disease control are the determining factors for its application. We aimed to test the null hypothesis that there was no difference in survival after laparoscopic and open resection for rectosigmoid cancer. Methods From Sept 21, 1993, to Oct 21, 2002, 403 patients with rectosigmoid carcinoma were randomised to receive either laparoscopic assisted (n=203) or conventional open (n=200) resection of the tumour. Survival and disease-free interval were the main endpoints. Patients were last followed-up in March, 2003. Perioperative data were recorded and direct cost of operation estimated. Data were analysed by intention to treat. Findings The demographic data of the two groups were similar. After curative resection, the probabilities of survival at 5 years of the laparoscopic and open resection groups were 76.1% (SE 3.7%) and 72.9% (4.0%) respectively. The probabilities of being disease free at 5 years were 75.3% (3.7%) and 78.3% (3.7%),, respectively. The operative time of the laparoscopic group was significantly longer, whereas postoperative recovery was significantly better than for the open resection group, but these benefits were at the expense of higher direct cost. The distal margin, the number of lymph nodes found in the resected specimen, overall morbidity and operative mortality did not differ between groups. Interpretation Laparoscopic resection of rectosigmoid carcinoma does not jeopardise survival and disease control of patients. The justification for adoption of laparoscopic technique would depend on the perceived value of its effectiveness in improving short-term post-operative outcomes.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Leung, KL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	leungkl@msn.com	Lai, Paul BS/K-8556-2015; Ng, Simon S. M./M-1219-2018	Lai, Paul BS/0000-0002-9469-6728; Ng, Simon S. M./0000-0002-5389-9297				[Anonymous], 1997, AJCC CANC STAGING MA; Braga M, 2002, ANN SURG, V236, P759, DOI 10.1097/00000658-200212000-00008; Chapman AE, 2001, ANN SURG, V234, P590, DOI 10.1097/00000658-200111000-00003; CUSCHIERI A, 1992, WORLD J SURG, V16, P1089, DOI 10.1007/BF02067066; Jacobs M, 1991, Surg Laparosc Endosc, V1, P144; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Leung KL, 1997, ARCH SURG-CHICAGO, V132, P761; Leung KL, 2000, ANN SURG, V231, P506, DOI 10.1097/00000658-200004000-00008; Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9; NAT'L RESEARCH COUNCIL, 2000, TECHN APPR GUID, P17; ROBINSON R, 1993, BMJ-BRIT MED J, V307, P670, DOI 10.1136/bmj.307.6905.670; Stage JG, 1997, BRIT J SURG, V84, P391, DOI 10.1046/j.1365-2168.1997.02516.x; Stead ML, 2000, CRIT REV ONCOL HEMAT, V33, P99, DOI 10.1016/S1040-8428(99)00057-8; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; Weiss E. G., 1996, Annals Academy of Medicine Singapore, V25, P694	15	680	732	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1187	1192		10.1016/S0140-6736(04)15947-3	http://dx.doi.org/10.1016/S0140-6736(04)15947-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081650				2022-12-28	WOS:000220748100008
J	Oransky, I				Oransky, I			Gertie Florentine Marx - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1241	1241		10.1016/S0140-6736(04)15972-2	http://dx.doi.org/10.1016/S0140-6736(04)15972-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15124607				2022-12-28	WOS:000220748100042
J	Proctor, RN				Proctor, RN			Should medical historians be working for the tobacco industry?	LANCET			English	Editorial Material									Penn State Univ, Dept Hist, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Proctor, RN (corresponding author), Penn State Univ, Dept Hist, University Pk, PA 16802 USA.	mp5@psu.edu						Burnham John C., 1993, BAD HABITS DRINKING; GLANTZ SA, 1996, CIGARETTE PAPERS, P171; HARLEY D, 1993, B HIST MED, V67, P28; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; MAGGI L, AM PROSPECT, V11; Proctor R., 1999, NAZI WAR CANC; Roffo A. H., 1940, MONATSSCHRIFT KREBSB, V8, P97; Rothman DJ, 2003, B HIST MED, V77, P25, DOI 10.1353/bhm.2003.0035; SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1	9	21	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1174	1175		10.1016/S0140-6736(04)15981-3	http://dx.doi.org/10.1016/S0140-6736(04)15981-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081644				2022-12-28	WOS:000220748100002
J	Bloche, MG				Bloche, MG			Health care disparities - Science, politics, and race	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Ctr Law, Washington, DC 20057 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Ctr Law, Washington, DC 20057 USA.							Agency for Healthcare Research and Quality, 2003, NAT HEALTHC DISP REP; BLOCHE MG, 2004, LOS ANGELES TIM 0215, pM1; Breyer S.G., 1993, BREAKING VICIOUS CIR, V1st ed.; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; PEAR R, 2004, NY TIMES        0222, P16; *UN SCI, 2004, SCI INT POL INV BUSH; *US HOUS REPR, 2004, CAS STUD POL SCI CHA; VEDANTAM S, 2004, WASHINGTON POST 0114, pA17	8	43	43	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1568	1570		10.1056/NEJMsb045005	http://dx.doi.org/10.1056/NEJMsb045005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810CI	15071133				2022-12-28	WOS:000220682000016
J	Wynne, CDL				Wynne, CDL			The perils of anthropomorphism - Consciousness should be ascribed to animals only with extreme caution.	NATURE			English	Editorial Material									Univ Florida, Dept Psychol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wynne, CDL (corresponding author), Univ Florida, Dept Psychol, Gainesville, FL 32611 USA.			Wynne, Clive/0000-0001-8408-1466				BLUMBERG MS, 1995, AM PSYCHOL, V50, P133; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; Mitchell RW, 1997, ANTHROPOMORPHISM ANE; Wynne CDL., 2004, ANIMALS THINK	4	79	84	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					606	606		10.1038/428606a	http://dx.doi.org/10.1038/428606a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810IE	15071579	Bronze			2022-12-28	WOS:000220697200023
J	Le Blanc, K; Rasmusson, I; Sundberg, B; Gotherstrom, C; Hassan, M; Uzunel, M; Ringden, O				Le Blanc, K; Rasmusson, I; Sundberg, B; Gotherstrom, C; Hassan, M; Uzunel, M; Ringden, O			Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells	LANCET			English	Article								Adult bone-marrow-derived mesenchymal stem cells are immunosuppressive and prolong the rejection of mismatched skin grafts in animals. We transplanted haploidentical mesenchymal stem cells in a patient with severe treatment-resistant grade IV acute graft-versus-host disease of the gut and liver. Clinical response was striking. The patient is now well after 1 year. We postulate that mesenchymal stem cells have a potent immunosuppressive effect in vivo.	Huddinge Univ Hosp, Div Clin Immunol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Ctr Allogen Stem Cell Transplantat, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Haematol, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Le Blanc, K (corresponding author), Huddinge Univ Hosp, Div Clin Immunol, F79, SE-14186 Stockholm, Sweden.	Katarina.Leblanc@medhs.ki.se	Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859; Gotherstrom, Cecilia/0000-0003-3782-0048				DENNE SM, 2003, BLOOD, V101, P2999; Frassoni F, 2002, BONE MARROW TRANSPL, V29, pS2; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Uzunel M, 2001, BLOOD, V98, P1982, DOI 10.1182/blood.V98.6.1982	5	2067	2198	2	122	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1439	1441		10.1016/S0140-6736(04)16104-7	http://dx.doi.org/10.1016/S0140-6736(04)16104-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121408				2022-12-28	WOS:000221130300012
J	Boris, AV; Kovaleva, NN; Dolgov, OV; Holden, T; Lin, CT; Keimer, B; Bernhard, C				Boris, AV; Kovaleva, NN; Dolgov, OV; Holden, T; Lin, CT; Keimer, B; Bernhard, C			In-plane spectral weight shift of charge carriers in YBa2Cu3O6.9	SCIENCE			English	Article							OPTICAL SUM-RULE; ENERGY; SUPERCONDUCTIVITY	The temperature-dependent redistribution of the spectral weight of the CuO2 plane-derived conduction band of the YBa2 Cu-3 O-6.9 high-temperature superconductor (superconducting transition temperature = 92.7 kelvin) was studied with wide-band (0.01- to 5.6-electron volt) spectroscopic ellipsometry. A superconductivity-induced transfer of the spectral weight involving a high-energy scale in excess of 1 electron volt was observed. Correspondingly, the charge carrier spectral weight was shown to decrease in the superconducting state. The ellipsometric data also provide detailed information about the evolution of the optical self-energy in the normal and superconducting states.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Moscow District, Russia; CUNY Brooklyn Coll, Dept Phys, Brooklyn, NY 11210 USA	Max Planck Society; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; City University of New York (CUNY) System; Brooklyn College (CUNY)	Boris, AV (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.	A.Boris@fkf.mpg.de	Boris, Alexander/AAG-5662-2019; Kovaleva, Natalia/H-2520-2014; Dolgov, Oleg V./M-8120-2015	Kovaleva, Natalia/0000-0002-4970-7782; Dolgov, Oleg V./0000-0001-8997-2671; Keimer, Bernhard/0000-0001-5220-9023				Anderson P. W., 1997, THEORY SUPERCONDUCTI; Basov DN, 1999, SCIENCE, V283, P49, DOI 10.1126/science.283.5398.49; BORIS AV, 2002, PHYS REV LETT, V89, P4907; Chakravarty S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.100504; Chakravarty S, 1999, PHYS REV LETT, V82, P2366, DOI 10.1103/PhysRevLett.82.2366; COOPER SL, 1993, PHYS REV B, V47, P8233, DOI 10.1103/PhysRevB.47.8233; Feng DL, 2001, PHYS REV LETT, V86, P5550, DOI 10.1103/PhysRevLett.86.5550; Hirsch JE, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035103; Hirsch JE, 2000, PHYS REV B, V62, P15131, DOI 10.1103/PhysRevB.62.15131; HOLCOMB MJ, 2001, PHYS REV B, V63, DOI UNSP 224514; Karakozov AE, 2002, SOLID STATE COMMUN, V124, P119, DOI 10.1016/S0038-1098(02)00486-6; KIRCHER J, 1992, PHYSICA C, V192, P473, DOI 10.1016/0921-4534(92)90856-8; MALDAGUE PF, 1977, PHYS REV B, V16, P15131; Molegraaf HJA, 2002, SCIENCE, V295, P2239, DOI 10.1126/science.1069947; Norman MR, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.100506; Pasler V, 1998, PHYS REV LETT, V81, P1094, DOI 10.1103/PhysRevLett.81.1094; Rubhausen M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224514; Santander-Syro AF, 2003, EUROPHYS LETT, V62, P568, DOI 10.1209/epl/i2003-00388-9; Tanner D.B., 1992, PHYSICAL PROPERTIES, P363; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Tsvetkov AA, 1998, NATURE, V395, P360, DOI 10.1038/26439	21	85	85	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					708	710		10.1126/science.1095532	http://dx.doi.org/10.1126/science.1095532			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118155	Green Submitted			2022-12-28	WOS:000221105300037
J	Forrest, SR				Forrest, SR			The path to ubiquitous and low-cost organic electronic appliances on plastic	NATURE			English	Review							LIGHT-EMITTING DEVICES; ELECTROLUMINESCENT DEVICES; HIGH-RESOLUTION; THIN-FILMS; DEGRADATION PROCESSES; EFFICIENT; DIODES; TRANSISTORS; TRANSPORT; POLYMERS	Organic electronics are beginning to make significant inroads into the commercial world, and if the field continues to progress at its current rapid pace, electronics based on organic thin-film materials will soon become a mainstay of our technological existence. Already products based on active thin-film organic devices are in the market place, most notably the displays of several mobile electronic appliances. Yet the future holds even greater promise for this technology, with an entirely new generation of ultralow-cost, lightweight and even flexible electronic devices in the offing, which will perform functions traditionally accomplished using much more expensive components based on conventional semiconductor materials such as silicon.	Princeton Univ, Dept Elect Engn, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA	Princeton University	Forrest, SR (corresponding author), Princeton Univ, Dept Elect Engn, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA.	forrest@princeton.edu						Anthopoulos TD, 2003, APPL PHYS LETT, V82, P4824, DOI 10.1063/1.1586999; Aziz H, 1998, APPL PHYS LETT, V72, P2642, DOI 10.1063/1.121442; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Blanchet GB, 2003, APPL PHYS LETT, V82, P463, DOI 10.1063/1.1533110; Blom PWM, 1997, PHYS REV B, V55, pR656, DOI 10.1103/PhysRevB.55.R656; BRAUN D, 1991, APPL PHYS LETT, V58, P1982, DOI 10.1063/1.105039; BULOVIC V, 2000, ELECTROLUMINESCENCE, V1, P262; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; BURROWS PE, 1995, J CRYST GROWTH, V156, P91, DOI 10.1016/0022-0248(95)00310-X; BURROWS PE, 1994, APPL PHYS LETT, V65, P2922, DOI 10.1063/1.112532; BURROWS PE, 1994, APPL PHYS LETT, V64, P2285, DOI 10.1063/1.111645; Campbell AJ, 2001, APPL PHYS LETT, V79, P2133, DOI 10.1063/1.1406143; Chou SY, 1999, APPL PHYS LETT, V75, P1004, DOI 10.1063/1.124579; DO LM, 1994, J APPL PHYS, V76, P5118, DOI 10.1063/1.357224; Drury CJ, 1998, APPL PHYS LETT, V73, P108, DOI 10.1063/1.121783; Endo J, 2002, JPN J APPL PHYS 2, V41, pL358, DOI 10.1143/JJAP.41.L358; FORREST SR, 1984, J APPL PHYS, V56, P543, DOI 10.1063/1.333944; Forrest SR, 1997, CHEM REV, V97, P1793, DOI 10.1021/cr941014o; Fukase A, 2002, JPN J APPL PHYS 2, V41, pL334, DOI 10.1143/JJAP.4l.L334; Gao WY, 2001, APPL PHYS LETT, V79, P4040, DOI 10.1063/1.1424067; Gelinck GH, 2000, APPL PHYS LETT, V77, P1487, DOI 10.1063/1.1290728; Granstrom M, 1998, NATURE, V395, P257, DOI 10.1038/26183; Greenbaum E, 2001, J PHYS CHEM B, V105, P3605, DOI 10.1021/jp0042821; Greenbaum E, 2002, BIOPHYS J, V82, p42A; Gu G, 1997, OPT LETT, V22, P172, DOI 10.1364/OL.22.000172; Gu G, 1998, IEEE J SEL TOP QUANT, V4, P83, DOI 10.1109/2944.669473; Gundlach DJ, 1997, IEEE ELECTR DEVICE L, V18, P87, DOI 10.1109/55.556089; GUSTAFSSON G, 1992, NATURE, V357, P477, DOI 10.1038/357477a0; GUTMANN F, 1981, ORGANIC SEMICONDUC A; Hebner TR, 1998, APPL PHYS LETT, V73, P1775, DOI 10.1063/1.122278; Hebner TR, 1998, APPL PHYS LETT, V72, P519, DOI 10.1063/1.120807; Jiang XZ, 2002, J APPL PHYS, V91, P6717, DOI 10.1063/1.1469692; KARL N, 1989, MOL CRYST LIQ CRYST, V171, P31, DOI 10.1080/00268948908065785; Karnakis DM, 1998, APPL SURF SCI, V127, P781, DOI 10.1016/S0169-4332(97)00742-3; Kido J, 1998, APPL PHYS LETT, V73, P2866, DOI 10.1063/1.122612; Kim C, 2003, ADV MATER, V15, P541, DOI 10.1002/adma.200390127; Kim C, 2000, SCIENCE, V288, P831, DOI 10.1126/science.288.5467.831; Kitaigorodsky A., 1973, MOL CRYSTALS MOL; Kwong RC, 2002, APPL PHYS LETT, V81, P162, DOI 10.1063/1.1489503; Lee CL, 2000, APPL PHYS LETT, V77, P2280, DOI 10.1063/1.1315629; Lin YY, 1997, 55TH ANNUAL DEVICE RESEARCH CONFERENCE, DIGEST - 1997, P60, DOI 10.1109/DRC.1997.612475; Ma DG, 2003, SYNTHETIC MET, V137, P1125, DOI 10.1016/S0379-6779(02)00954-2; PARKER ID, 1994, J APPL PHYS, V75, P1656, DOI 10.1063/1.356350; Peumans P, 2001, APPL PHYS LETT, V79, P126, DOI 10.1063/1.1384001; Peumans P, 2000, APPL PHYS LETT, V76, P3855, DOI 10.1063/1.126800; Peumans P, 2003, NATURE, V425, P158, DOI 10.1038/nature01949; Pfeiffer M, 2002, ADV MATER, V14, P1633, DOI 10.1002/1521-4095(20021118)14:22<1633::AID-ADMA1633>3.0.CO;2-#; Pope, 1982, ELECT PROCESSES ORGA; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; Shimoda T, 2003, MRS BULL, V28, P821, DOI 10.1557/mrs2003.231; Shtein M, 2003, J APPL PHYS, V93, P4005, DOI 10.1063/1.1557783; Shtein M, 2002, APPL PHYS LETT, V81, P268, DOI 10.1063/1.1491009; Shtein M, 2001, J APPL PHYS, V89, P1470, DOI 10.1063/1.1332419; SHTEIN M, IN PRESS ADV MAT; SILINSH EA, 1980, ORGANIC MOL CRYSTALS, pCH1; Sirringhaus H, 2000, APPL PHYS LETT, V77, P406, DOI 10.1063/1.126991; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Stutzmann N, 2003, SCIENCE, V299, P1881, DOI 10.1126/science.1081279; Stutzmann N, 2000, NATURE, V407, P613, DOI 10.1038/35036545; Suh MC, 2003, ADV MATER, V15, P1254, DOI 10.1002/adma.200304721; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Vaeth K. M., 2003, Information Display, V19, P12; van de Craats AM, 2003, ADV MATER, V15, P495, DOI 10.1002/adma.200390114; Wang J, 1999, APPL PHYS LETT, V75, P2767, DOI 10.1063/1.125143; WARTA W, 1985, APPL PHYS A-MATER, V36, P163, DOI 10.1007/BF00624938; Werner AG, 2003, APPL PHYS LETT, V82, P4495, DOI 10.1063/1.1583872; Wu CC, 1996, APPL PHYS LETT, V69, P3117, DOI 10.1063/1.116800; Xu G., 2003, Information Display, V19, P18; Zaumseil J, 2003, APPL PHYS LETT, V82, P793, DOI 10.1063/1.1541941	69	4412	4594	25	1874	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					911	918		10.1038/nature02498	http://dx.doi.org/10.1038/nature02498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118718				2022-12-28	WOS:000221083000032
J	Gulick, RM; Ribaudo, HJ; Shikuma, CM; Lustgarten, S; Squires, KE; Meyer, WA; Acosta, EP; Schackman, BR; Pilcher, CD; Murphy, RL; Maher, WE; Witt, MD; Reichman, RC; Snyder, S; Klingman, KL; Kuritzkes, DR				Gulick, RM; Ribaudo, HJ; Shikuma, CM; Lustgarten, S; Squires, KE; Meyer, WA; Acosta, EP; Schackman, BR; Pilcher, CD; Murphy, RL; Maher, WE; Witt, MD; Reichman, RC; Snyder, S; Klingman, KL; Kuritzkes, DR		AIDS Clin Trials Grp Study A5095	Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; CLINICAL-TRIALS; LAMIVUDINE-ZIDOVUDINE; COMBINATION THERAPY; INSULIN-RESISTANCE; DRUG-RESISTANCE; HIV-1-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE	BACKGROUND Regimes containing three nucleoside reverse-transcriptase inhibitors offer an alternative to regimes containing nonnucleoside reverse-transcriptase inhibitors or protease inhibitors for the initial treatment of human immunodeficiency virus type 1 (HIV-1) infection, but data from direct comparisons are limited. METHODS This randomized, double-blind study involved three antiretroviral regimens for the initial treatment of subjects infected with HIV-1: zidovudine - lamivudine - abacavir, zidovudine - lamivudine plus efavirenz, and zidovudine - lamivudine - abacavir plus efavirenz. RESULTS We enrolled a total of 1147 subjects with a mean baseline HIV-1 RNA level of 4.85 log(10) (71,434) copies per milliliter and a mean CD4 cell count of 238 per cubic millimeter were enrolled. A scheduled review by the data and safety monitoring board with the use of prespecified stopping boundaries led to a recommendation to stop the triple-nucleoside group and to present the results in the triple-nucleoside group in comparison with pooled data from the efavirenz groups. After a median follow-up of 32 weeks, 82 of 382 subjects in the triple-nucleoside group (21 percent) and 85 of 765 of those in the combined efavirenz groups (11 percent) had virologic failure; the time to virologic failure was significantly shorter in the triple-nucleoside group (P < 0.001). This difference was observed regardless of the pretreatment HIV-1 RNA stratum (at least 100,000 copies per milliliter or below this level; P &LE; 0.001 for both comparisons). Changes in the CD4 cell count and the incidence of grade 3 or grade 4 adverse events did not differ significantly between the groups. CONCLUSIONS In this trial of the initial treatment of HIV-1 infection, the triple-nucleoside combination of abacavir, zidovudine, and lamivudine was virologically inferior to a regimen containing efavirenz and two or three nucleosides.	Cornell Univ, Weill Med Coll, New York, NY USA; Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; Univ Hawaii, Honolulu, HI 96822 USA; Univ So Calif, Med Ctr, Los Angeles, CA USA; Quest Diagnost, Baltimore, MD USA; Univ Alabama, Birmingham, AL USA; Univ N Carolina, Chapel Hill, NC USA; Northwestern Univ, Chicago, IL 60611 USA; Ohio State Univ, Columbus, OH 43210 USA; Harbor UCLA Med Ctr, Los Angeles, CA USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Social & Sci Syst, Silver Spring, MD USA; NIAID, Div Aids, Bethesda, MD 20892 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; University of Hawaii System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Rochester; Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gulick, RM (corresponding author), Cornell Clin Trials Unit, Box 566,525 E 68th St, New York, NY 10021 USA.	rgulick@med.cornell.edu	Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Murphy, Robert/0000-0003-3936-2052	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635, M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034832, U01AI038858, U01AI046386, U01AI025859, U01AI025868, U01AI027673, U01AI027661, U01AI025915, U01AI027668, P30AI028697, U01AI046376, U01AI039156, P30AI042851, P30AI042848, P30AI050410, U01AI046339, K24AI051966, U01AI046370, U01AI025897, U01AI027664, U01AI027658, U01AI027660, U01AI032782, U01AI025879, U01AI038855, U01AI025924, U01AI025903, U01AI046381, U01AI027659, U01AI027675, U01AI032775, U01AI027670, K23AI001781, P30AI027767] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00052, RR00047, RR00046, RR00044, RR 02635, RR00096, RR00865] Funding Source: Medline; NIAID NIH HHS [AI 27659, AI 27668, AI 32775, AI 32782, AI 27673, AI 34832, AI 27670, AI 27664, AI 27661, AI 25915, AI 38855, AI 25924, AI 27658, AI 42851, AI 28697, AI 27767, AI 25879, AI 25897, AI 27660, AI 46339, AI 46370, AI 46376, AI 46381, AI 25903, AI 46386, AI 50410, AI 51966, AI 27675, AI 25868, AI 25859, AI 01781, AI 38858, AI 39156, AI 42848] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ait-Khaled M, 2002, ANTIVIR THER, V7, P43; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Henry K, 2001, J INFECT DIS, V183, P571, DOI 10.1086/318527; JENNISON C, 2000, GROUP SEQUNTIAL METH; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kirkland LR, 2002, CLIN INFECT DIS, V34, P511, DOI 10.1086/338400; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matheron S, 2003, ANTIVIR THER, V8, P163; MOUTON Y, 1997, AIDS, V11, pF1071; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN CLIN PRACT TR, 2003, GUID US ANT AG HIV I; Paterson DL, 2002, ANN INTERN MED, V136, P253, DOI 10.7326/0003-4819-136-3-200202050-00020; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Podzamczer D, 2002, ANTIVIR THER, V7, P81; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; STASZEWSKI S, 2001, JAMA-J AM MED ASSOC, V285, P2858; Trotta MP, 2002, JAIDS, V31, pS128, DOI 10.1097/00126334-200212153-00008; Trotta MP, 2003, AIDS, V17, P1099, DOI 10.1097/00002030-200305020-00026; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; VIBHAGOOL A, 2001, 1 IAS C HIV PATH TRE, P102; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; WEI LJ, 1985, BIOMETRIKA, V72, P359; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; YENI PG, 2003, JAMA-J AM MED ASSOC, V289, P32	37	411	424	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1850	1861		10.1056/NEJMoa031772	http://dx.doi.org/10.1056/NEJMoa031772			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115831	Green Published			2022-12-28	WOS:000221080300008
J	Fan, HY; Yang, K; Boye, DM; Sigmon, T; Malloy, KJ; Xu, HF; Lopez, GP; Brinker, CJ				Fan, HY; Yang, K; Boye, DM; Sigmon, T; Malloy, KJ; Xu, HF; Lopez, GP; Brinker, CJ			Self-assembly of ordered, robust, three-dimensional gold nanocrystal/silica arrays	SCIENCE			English	Article							QUANTUM DOTS; OPTICAL GAIN; NANOPARTICLES; SUPERLATTICES; ORGANIZATION; MESOPHASES; TRANSPORT; FILMS; DNA	We report the synthesis of a new nanocrystal (NC) mesophase through self-assembly of water-soluble NC micelles with soluble silica. The mesophase comprises gold nanocrystals arranged within a silica matrix in a face-centered cubic lattice with cell dimensions that are adjustable through control of the nanocrystal diameter and/or the alkane chain lengths of the primary alkanethiol stabilizing ligands or the surrounding secondary surfactants. Under kinetically controlled silica polymerization conditions, evaporation drives self-assembly of NC micelles into ordered NC/silica thin-film mesophases during spin coating. The intermediate NC micelles are water soluble and of interest for biolabeling. Initial experiments on a metal-insulator-metal capacitor fabricated with an ordered three-dimensional gold nanocrystal/silica array as the "insulator" demonstrated collective Coulomb blockade behavior below 100 kelvin and established the current-voltage scaling relationship for a well-defined three-dimensional array of Coulomb islands.	Sandia Natl Labs, Cham Synth & Nanomat Dept, Adv Mat Lab, Albuquerque, NM 87106 USA; Univ New Mexico, NSF, Ctr Microengn Mat, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; Univ New Mexico, Ctr High Technol Mat, Albuquerque, NM 87131 USA; Davidson Coll, Dept Phys, Davidson, NC 28035 USA	United States Department of Energy (DOE); Sandia National Laboratories; National Science Foundation (NSF); University of New Mexico; University of New Mexico; Davidson College	Fan, HY (corresponding author), Sandia Natl Labs, Cham Synth & Nanomat Dept, Adv Mat Lab, 1001 Univ Blvd SE, Albuquerque, NM 87106 USA.	hfan@sandia.gov; cjbrink@sandia.gov	Malloy, Kevin/E-5994-2010					Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Black CT, 2000, SCIENCE, V290, P1131, DOI 10.1126/science.290.5494.1131; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978; Doshi DA, 2000, SCIENCE, V290, P107, DOI 10.1126/science.290.5489.107; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; GRABERT H, 1992, SINGLE CHARGE TUNNEL; KIRCZENOW G, 1992, PHYS REV B, V46, P1439, DOI 10.1103/PhysRevB.46.1439; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Lu YF, 2000, J AM CHEM SOC, V122, P5258, DOI 10.1021/ja9935862; MIDDLETON AA, 1993, PHYS REV LETT, V71, P3198, DOI 10.1103/PhysRevLett.71.3198; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; NEUGEBAUER CA, 1962, J APPL PHYS, V33, P74, DOI 10.1063/1.1728531; Parthasarathy R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076801; Peng DL, 1999, APPL PHYS LETT, V74, P76, DOI 10.1063/1.122956; Petruska MA, 2003, ADV MATER, V15, P610, DOI 10.1002/adma.200304450; Pileni MP, 2001, J PHYS CHEM B, V105, P3358, DOI 10.1021/jp0039520; PRESS WH, 1986, NUMERICAL RECIPES AR, pCH14; RIMBERG AJ, 1995, PHYS REV LETT, V74, P4714, DOI 10.1103/PhysRevLett.74.4714; STAFFORD CA, 1994, PHYS REV LETT, V72, P3590, DOI 10.1103/PhysRevLett.72.3590; Sundar VC, 2002, ADV MATER, V14, P739, DOI 10.1002/1521-4095(20020517)14:10<739::AID-ADMA739>3.0.CO;2-Y	27	465	502	5	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					567	571		10.1126/science.1095140	http://dx.doi.org/10.1126/science.1095140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105495				2022-12-28	WOS:000220975100043
J	Jung, GY; Stephanopoulos, G				Jung, GY; Stephanopoulos, G			A functional protein chip for pathway optimization and in vitro metabolic engineering	SCIENCE			English	Article							TREHALOSE; YEAST; GLYCOLYSIS	Pathway optimization is difficult to achieve owing to complex, nonlinear, and largely unknown interactions of enzymes, regulators, and metabolites. We report a pathway reconstruction using RNA display - derived messenger RNA - enzyme fusion molecules. These chimeras are immobilized by hybridization of their messenger RNA end with homologous capture DNA spotted on a substrate surface. Enzymes thus immobilized retain activity proportional to the amount of capture DNA, allowing modulation of the relative activity of pathway enzymes. Entire pathways can thus be reconstructed and optimized in vitro from genomic information. We provide concept validation with the sequential reactions catalyzed by luciferase and nucleoside diphosphate kinase and further illustrate this method with the optimization of the five-step pathway for trehalose synthesis.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Room 56-469, Cambridge, MA 02139 USA.	gregstep@mit.edu	Jung, Gyoo Yeol/R-7194-2019					BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Chi ZM, 2003, J BIOTECHNOL, V102, P135, DOI 10.1016/S0168-1656(03)00021-X; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Hugenholtz J, 2002, ANTON LEEUW INT J G, V82, P217, DOI 10.1023/A:1020608304886; Jorgensen H, 2002, APPL MICROBIOL BIOT, V59, P310, DOI 10.1007/s00253-002-1017-5; KACSER H, 1993, EUR J BIOCHEM, V216, P361, DOI 10.1111/j.1432-1033.1993.tb18153.x; Karamohamed S, 1999, BIOTECHNIQUES, V26, P728, DOI 10.2144/99264rr02; KIENLE I, 1993, YEAST, V9, P907; Klapa MI, 2003, EUR J BIOCHEM, V270, P3525, DOI 10.1046/j.1432-1033.2003.03732.x; Koffas MAG, 2003, METAB ENG, V5, P32, DOI 10.1016/S1096-7176(03)00002-8; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; Pitts WJ, 2000, J MED CHEM, V43, P27, DOI 10.1021/jm9900321; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Stafford DE, 2002, P NATL ACAD SCI USA, V99, P1801, DOI 10.1073/pnas.032681699; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Stephanopoulos G. N., 1998, METAB ENG, P115, DOI [10.1016/b978-012666260-3/50005-4, DOI 10.1016/B978-012666260-3/50005-4]; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Weng S, 2002, PROTEOMICS, V2, P48, DOI 10.1002/1615-9861(200201)2:1<48::AID-PROT48>3.0.CO;2-I	20	50	60	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					428	431		10.1126/science.1096920	http://dx.doi.org/10.1126/science.1096920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087547				2022-12-28	WOS:000220845400045
J	Bullinger, L; Dohner, K; Bair, E; Frohling, S; Schlenk, RF; Tibshirani, R; Dohner, H; Pollack, JR				Bullinger, L; Dohner, K; Bair, E; Frohling, S; Schlenk, RF; Tibshirani, R; Dohner, H; Pollack, JR			Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; STUDY-GROUP ULM; NORMAL CYTOGENETICS; NORMAL HEMATOPOIESIS; PREDICT SURVIVAL; IN-VIVO; AML 10; MLL; TUMORS; CANCER	Background: In patients with acute myeloid leukemia (AML), the presence or absence of recurrent cytogenetic aberrations is used to identify the appropriate therapy. However, the current classification system does not fully reflect the molecular heterogeneity of the disease, and treatment stratification is difficult, especially for patients with intermediate-risk AML with a normal karyotype. Methods: We used complementary-DNA microarrays to determine the levels of gene expression in peripheral-blood samples or bone marrow samples from 116 adults with AML (including 45 with a normal karyotype). We used unsupervised hierarchical clustering analysis to identify molecular subgroups with distinct gene-expression signatures. Using a training set of samples from 59 patients, we applied a novel supervised learning algorithm to devise a gene-expression-based clinical-outcome predictor, which we then tested using an independent validation group comprising the 57 remaining patients. Results: Unsupervised analysis identified new molecular subtypes of AML, including two prognostically relevant subgroups in AML with a normal karyotype. Using the supervised learning algorithm, we constructed an optimal 133-gene clinical-outcome predictor, which accurately predicted overall survival among patients in the independent validation group (P=0.006), including the subgroup of patients with AML with a normal karyotype (P=0.046). In multivariate analysis, the gene-expression predictor was a strong independent prognostic factor (odds ratio, 8.8; 95 percent confidence interval, 2.6 to 29.3; P<0.001). Conclusions: The use of gene-expression profiling improves the molecular classification of adult AML.	Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany	Stanford University; Stanford University; Stanford University; Ulm University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, 269 Campus Dr,CCSR 3245A, Stanford, CA 94305 USA.	pollack1@stanford.edu	Schlenk, Richard/AAG-3218-2019; Döhner, Hartmut/C-8933-2016; Bullinger, Lars/AAL-7965-2020	Döhner, Hartmut/0000-0003-2116-5536; Bair, Eric/0000-0001-8733-7869; Bullinger, Lars/0000-0002-5890-5510				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bloomfield CD, 1998, CANCER RES, V58, P4173; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Caligiuri MA, 1998, CANCER RES, V58, P55; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Frohling S, 2002, J CLIN ONCOL, V20, P2480, DOI 10.1200/JCO.2002.08.155; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GILES FJ, 2002, ACUTE MYELOID LEUKEM, P73; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Lowenberg B, 2001, BEST PRACT RES CL HA, V14, P65, DOI 10.1053/beha.2000.0116; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Mrozek K, 2001, BEST PRACT RES CL HA, V14, P19, DOI 10.1053/beha.2000.0114; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tanabe S, 1996, GENE CHROMOSOME CANC, V15, P206, DOI 10.1002/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	45	766	826	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1605	1616		10.1056/NEJMoa031046	http://dx.doi.org/10.1056/NEJMoa031046			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084693				2022-12-28	WOS:000220819800005
J	Shapiro, MD; Marks, ME; Peichel, CL; Blackman, BK; Nereng, KS; Jonsson, B; Schluter, D; Kingsley, DM				Shapiro, MD; Marks, ME; Peichel, CL; Blackman, BK; Nereng, KS; Jonsson, B; Schluter, D; Kingsley, DM			Genetic and developmental basis of evolutionary pelvic reduction in threespine sticklebacks	NATURE			English	Article							GASTEROSTEUS-ACULEATUS; T-BOX; PUNGITIUS-PUNGITIUS; BROOK STICKLEBACK; CULAEA-INCONSTANS; HINDLIMB; LIMB; POPULATIONS; DROSOPHILA; IDENTITY	Hindlimb loss has evolved repeatedly in many different animals by means of molecular mechanisms that are still unknown. To determine the number and type of genetic changes underlying pelvic reduction in natural populations, we carried out genetic crosses between threespine stickleback fish with complete or missing pelvic structures. Genome-wide linkage mapping shows that pelvic reduction is controlled by one major and four minor chromosome regions. Pitx1 maps to the major chromosome region controlling most of the variation in pelvic size. Pelvic-reduced fish show the same left-right asymmetry seen in Pitx1 knockout mice, but do not show changes in Pitx1 protein sequence. Instead, pelvic-reduced sticklebacks show site-specific regulatory changes in Pitx1 expression, with reduced or absent expression in pelvic and caudal fin precursors. Regulatory mutations in major developmental control genes may provide a mechanism for generating rapid skeletal changes in natural populations, while preserving the essential roles of these genes in other processes.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Holar Agr Coll, Inst Freshwater Fisheries, IS-551 Saudarkrokur, Iceland; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; Fred Hutchinson Cancer Center; University of British Columbia	Kingsley, DM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu	Marks, Melissa/V-6587-2019	Marks, Melissa/0000-0003-2625-6322; Schluter, Dolph/0000-0003-1683-7836; Peichel, Catherine/0000-0002-7731-8944; Blackman, Benjamin/0000-0003-4936-6153				Bejder L, 2002, EVOL DEV, V4, P445, DOI 10.1046/j.1525-142X.2002.02033.x; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; BELL MA, 1987, BIOL J LINN SOC, V31, P347, DOI 10.1111/j.1095-8312.1987.tb01998.x; BELL MA, 1985, COPEIA, P437; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; BELL MA, 1985, PALEOBIOLOGY, V11, P258, DOI 10.1017/S0094837300011581; Bell MA, 1974, NAT HIST MUS ANGEL C, V257, P1; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; CAMPBELL RN, 1979, P ROY SOC EDINB B, V77, P377, DOI 10.1017/S026972700001280X; Campione M, 1999, DEVELOPMENT, V126, P1225; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Darwin C.R., 1859, ORIGIN SPECIES MEANS, P450; EDGE TA, 1983, CAN FIELD NAT, V97, P334; Garrity DM, 2002, DEVELOPMENT, V129, P4635; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; GILES N, 1983, J ZOOL, V199, P535; Hoogland R., 1957, Behaviour, V10, P205; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lanctot C, 1999, DEVELOPMENT, V126, P1805; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, DEVELOPMENT, V125, P2825; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; MOODIE GEE, 1976, SYST ZOOL, V25, P49, DOI 10.2307/2412778; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; NELSON JS, 1971, COPEIA, P707; NELSON JS, 1977, J FISH RES BOARD CAN, V34, P1314, DOI 10.1139/f77-193; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; REIST JD, 1980, CAN J ZOOL, V58, P1253, DOI 10.1139/z80-175; Ross M.T., 1999, CURRENT PROTOCOLS HU; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shang J, 1997, DEV DYNAM, V209, P242, DOI 10.1002/(SICI)1097-0177(199706)209:2<242::AID-AJA10>3.0.CO;2-0; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Struthers J., 1881, J ANATOMY PHYSL, V15, P141; STRUTHERS J, 1881, J ANAT PHYSL, V15, P302; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Wilkinson D.G., 1993, ESSENTIAL DEV BIOL P, P257; Ziuganov VV, 1995, BEHAVIOUR, V132, P1095, DOI 10.1163/156853995X00478; [No title captured]	51	637	655	9	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					717	723		10.1038/nature02415	http://dx.doi.org/10.1038/nature02415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085123				2022-12-28	WOS:000220823800030
J	Field, J; Brace, S				Field, J; Brace, S			Pre-social benefits of extended parental care	NATURE			English	Article							SUBSOCIAL INTERTIDAL BEETLE; BLEDIUS-SPECTABILIS; SOLITARY WASP; PARASITISM; EVOLUTION; EUSOCIALITY; HYMENOPTERA; ADVANTAGE; BEES	The evolution of helping, in which some individuals forfeit their own reproduction and help others to reproduce, is a central problem in evolutionary biology. Recently proposed insurance-based mechanisms rely on a pre-existing life history with a long period of offspring dependency relative to the short life expectancies of adult carers(1-4): a lone mother's offspring are doomed if she dies young, whereas after a helper dies, other group members can finish rearing the offspring(5,6). A critical question, however, is how this life history could evolve in ancestral non-social populations, as offspring survival would then depend on a single, short-lived carer. Here, we resolve this paradox by focusing on the extended parental care inherent in prolonged dependency. We show experimentally that in non-social wasps, extended care can significantly reduce the impact of interspecific parasites. Under extended care, offspring are less vulnerable by the time they are exposed to parasites, and costs of parasitism are reduced because mothers have the option to terminate investment in failing offspring. By experimentally simulating aspects of extended care in a species where it is lacking, we demonstrate that neither benefit requires specialized behaviour. Such benefits could therefore offset the disadvantage of prolonged dependency in non-social species, thereby facilitating the evolution of helping.	UCL, Dept Biol, London NW1 2HE, England	University of London; University College London	Field, J (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	jeremy.field@ucl.ac.uk						[Anonymous], 1976, SPHECID WASPS WORLD; Baerends G. P., 1941, Tijdschrift voor Entomologie Amsterdam, V84, P68; Beekman M, 2003, TRENDS ECOL EVOL, V18, P277, DOI 10.1016/S0169-5347(03)00068-5; Carpenter J.M., 1991, P7; Cowan D.P., 1991, P33; Evans H.E., 1966, COMP ETHOLOGY EVOLUT; EVANS HOWARD E., 1959, AMER MIDLAND NAT, V62, P449, DOI 10.2307/2422538; Fabre J.-H., 1916, HUNTING WASPS; FIELD J, 1989, BEHAVIOUR, V110, P219, DOI 10.1163/156853989X00475; FIELD J, 1989, BEHAVIOUR, V110, P23, DOI 10.1163/156853989X00367; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; GODFRAY HCJ, 1994, PARASITOIDS; HAGER BJ, 1985, PSYCHE-STUTTGART, V92, P7451; Hunt James H., 1994, P211; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; O'Neill K. M., 2001, SOLITARY WASPS; Queller David C., 1996, P218; QUELLER DC, 1994, P ROY SOC B-BIOL SCI, V256, P105, DOI 10.1098/rspb.1994.0056; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve H.K., 1991, P99; ROSENHEIM JA, 1987, ANN ENTOMOL SOC AM, V80, P739, DOI 10.1093/aesa/80.6.739; SAMUEL CT, 1987, FACTORS AFFECTING CO; Schwarz MP, 2003, SYST BIOL, V52, P1, DOI 10.1080/10635150390132632; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; Wcislo WT, 1996, J INSECT BEHAV, V9, P643, DOI 10.1007/BF02213885; WYATT TD, 1989, ANIM BEHAV, V38, P778, DOI 10.1016/S0003-3472(89)80110-1; WYATT TD, 1989, BEHAVIOUR, V110, P76, DOI 10.1163/156853989X00394; [No title captured]	30	48	49	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					650	652		10.1038/nature02427	http://dx.doi.org/10.1038/nature02427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071594				2022-12-28	WOS:000220697200043
J	Miyazaki, M; Fujii, A; Ebata, T; Mikami, N				Miyazaki, M; Fujii, A; Ebata, T; Mikami, N			Infrared spectroscopic evidence for protonated water clusters forming nanoscale cages	SCIENCE			English	Article							AMORPHOUS ICE; SPECTRA; ION; HYDRATION; SURFACES; CATIONS; MODE; H2O	Size-dependent development of the hydrogen bond network structure in large-sized clusters of protonated water, H+(H2O)(n) ( n = 4 to 27), was probed by infrared spectroscopy of OH stretches. Spectral changes with cluster size demonstrate that the chain structures at small sizes ( n less than or similar to 10) develop into two-dimensional net structures ( similar to 10 < n < 21), and then into nanometer-scaled cages ( n greater than or equal to 21).	Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Tohoku University	Fujii, A (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	asuka@qclhp.chem.tohoku.ac.jp; nmikami@qclhp.chem.tohoku.ac.jp	Ebata, Takayuki/AAX-8561-2020; Fujii, Asuka/J-9793-2016; Miyazaki, Mitsuhiko/C-1328-2015; Ebata, TAKAYUKI/I-2382-2018	Fujii, Asuka/0000-0002-6854-9636; Miyazaki, Mitsuhiko/0000-0003-1965-4779; Ebata, TAKAYUKI/0000-0002-6236-9116				BUCH V, 1991, J CHEM PHYS, V94, P4091, DOI 10.1063/1.460638; Buck U, 1998, PHYS REV LETT, V80, P2578, DOI 10.1103/PhysRevLett.80.2578; DALLESKA NF, 1993, J AM CHEM SOC, V115, P12125, DOI 10.1021/ja00078a059; Devlin JP, 2001, J PHYS CHEM A, V105, P974, DOI 10.1021/jp003455j; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hodges MP, 2000, CHEM PHYS LETT, V324, P279, DOI 10.1016/S0009-2614(00)00584-4; Huisken F, 1996, J CHEM PHYS, V104, P17, DOI 10.1063/1.470871; Jiang JC, 1998, CHEM PHYS LETT, V289, P373, DOI 10.1016/S0009-2614(98)00437-0; Jiang JC, 2000, J AM CHEM SOC, V122, P1398, DOI 10.1021/ja990033i; Khan A, 2000, CHEM PHYS LETT, V319, P440, DOI 10.1016/S0009-2614(00)00175-5; Liu K, 1996, NATURE, V381, P501, DOI 10.1038/381501a0; MAGNERA TF, 1991, CHEM PHYS LETT, V182, P363, DOI 10.1016/0009-2614(91)80230-U; Miyazaki M, 2003, PHYS CHEM CHEM PHYS, V5, P1137, DOI 10.1039/b210293e; NAGASHIMA U, 1986, J CHEM PHYS, V84, P209, DOI 10.1063/1.450172; OKUMURA M, 1990, J PHYS CHEM-US, V94, P3416, DOI 10.1021/j100372a014; PRIBBLE RN, 1994, SCIENCE, V265, P75, DOI 10.1126/science.265.5168.75; ROWLAND B, 1991, J CHEM PHYS, V95, P1378, DOI 10.1063/1.461119; SATO S, 1994, SPECTROCHIM ACTA A, V50, P1413, DOI 10.1016/0584-8539(94)E0051-B; Singer SJ, 2000, J CHEM PHYS, V112, P710, DOI 10.1063/1.480603; WEI S, 1991, J CHEM PHYS, V94, P3268, DOI 10.1063/1.459796; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305	21	436	458	13	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1134	1137		10.1126/science.1096037	http://dx.doi.org/10.1126/science.1096037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15118121				2022-12-28	WOS:000221524500036
J	Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG; Haluska, FG; Louis, DN; Christiani, DC; Settleman, J; Haber, DA				Lynch, TJ; Bell, DW; Sordella, R; Gurubhagavatula, S; Okimoto, RA; Brannigan, BW; Harris, PL; Haserlat, SM; Supko, JG; Haluska, FG; Louis, DN; Christiani, DC; Settleman, J; Haber, DA			Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; PHASE-II TRIAL; EGF RECEPTOR; ZD1839; COMBINATION; EFFICACY; IRESSA; SAFETY; GENE; SKIN	BACKGROUND: Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR). However, about 10 percent of patients have a rapid and often dramatic clinical response. The molecular mechanisms underlying sensitivity to gefitinib are unknown. METHODS: We searched for mutations in the EGFR gene in primary tumors from patients with non-small-cell lung cancer who had a response to gefitinib, those who did not have a response, and those who had not been exposed to gefitinib. The functional consequences of identified mutations were evaluated after the mutant proteins were expressed in cultured cells. RESULTS: Somatic mutations were identified in the tyrosine kinase domain of the EGFR gene in eight of nine patients with gefitinib-responsive lung cancer, as compared with none of the seven patients with no response (P<0.001). Mutations were either small, in-frame deletions or amino acid substitutions clustered around the ATP-binding pocket of the tyrosine kinase domain. Similar mutations were detected in tumors from 2 of 25 patients with primary non-small-cell lung cancer who had not been exposed to gefitinib (8 percent). All mutations were heterozygous, and identical mutations were observed in multiple patients, suggesting an additive specific gain of function. In vitro, EGFR mutants demonstrated enhanced tyrosine kinase activity in response to epidermal growth factor and increased sensitivity to inhibition by gefitinib. CONCLUSIONS: A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib. These mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor. Screening for such mutations in lung cancers may identify patients who will have a response to gefitinib.	Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Lynch, TJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.				NATIONAL CANCER INSTITUTE [P50CA090578, R01CA092824] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA 090578, P30 CA0516, R01 CA 092824] Funding Source: Medline; PHS HHS [P01 95281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Frederick L, 2000, CANCER RES, V60, P1383; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Li B, 2003, CANCER RES, V63, P7443; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pegram M D, 2000, Cancer Treat Res, V103, P57; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wakeling AE, 2002, CANCER RES, V62, P5749	28	8884	9470	27	1258	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2004	350	21					2129	2139		10.1056/NEJMoa040938	http://dx.doi.org/10.1056/NEJMoa040938			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	821XM	15118073	Green Accepted			2022-12-28	WOS:000221496700005
J	Dunkle, KL; Jewkes, RK; Brown, HC; Gray, GE; McIntryre, JA; Harlow, SD				Dunkle, KL; Jewkes, RK; Brown, HC; Gray, GE; McIntryre, JA; Harlow, SD			Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; PARTNER VIOLENCE; AMERICAN WOMEN; REPRODUCTIVE HEALTH; DOMESTIC VIOLENCE; SEXUAL ABUSE; INEQUALITIES; BEHAVIORS; SURVIVORS	Background Gender-based violence and gender inequality are increasingly cited as important determinants of women's HIV risk: yet empirical research on possible connections remains limited. No study on women has yet assessed gender-based violence as a risk factor for HIV after adjustment for women's own high-risk behaviours, although these are known to be associated with experience of violence. Methods We did a cross-sectional study of 1366 women presenting for antenatal care at four health centres in Soweto. South Africa, who accepted routine antenatal HIV testing. Private face-to-face interviews were done in local languages and included assessement of sociodemographic characteristics, experience of gender-based violence, the South African adaptation of the Sexual Relationship Power Scale (SRPS). and risk behaviours including multiple, concurrent. and casual male partners, and transactional sex. Findings After adjustment for age and current relationship status and women's risk behaviour, intimate partner violence (odds ratio 1.48. 95% Cl 1.15-1-89) and high levels of male control in a woman's current relationship as measured by the SRPS (1.52, 1.13-2.04) were associated with HIV seropositivity. Child sexual assault, forced first intercourse, and adult sexual assault by non-partners were not associated with HIV serostatus. Interpretation Women with violent or controlling male partners are at increased risk of HIV infection. We postulate that abusive men are more likely to have HIV and impose risky sexual practices on partners. Research on connections between social constructions of masculinity, intimate partner violence, male dominance in relationships, and HIV risk behaviours in men. as well as effective interventions, are urgently needed.	MRC, Gender & Hlth Grp, ZA-0001 Pretoria, South Africa; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Reprod Hlth Res Unit, ZA-2050 Wits, South Africa; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, ZA-2050 Wits, South Africa; Univ Witwatersrand, Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, ZA-2050 Wits, South Africa	University of Michigan System; University of Michigan; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Dunkle, KL (corresponding author), MRC, Gender & Hlth Grp, Private Bag X385, ZA-0001 Pretoria, South Africa.	kdunkle@umich.edu	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Jewkes, Rachel/0000-0002-4330-6267				ABRAHAMS N, 2002, THESIS U CAPE TOWN C; Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; CHOI KH, 1998, AIDS BEHAV, V2, P33, DOI DOI 10.1023/A:1022355206905; El-Bassel N, 2000, J FAM VIOLENCE, V15, P209, DOI 10.1023/A:1007532917759; El-Bassel N, 1998, Violence Vict, V13, P377; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Garcia-Moreno C, 2000, AIDS, V14, pS253; HALL W, 1993, ADDICTION, V88, P1627, DOI 10.1111/j.1360-0443.1993.tb02037.x; He H, 1998, WOMEN HEALTH, V27, P161, DOI 10.1300/J013v27n01_10; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; PIOT P, 1999, HIV AIDS VIOLENCE WO; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; RAOGUPTA G, 13 INT AIDS C 2000 D; *S AFR DEP HLTH, 1999, S AFR DEM HLTH SURV; *UNAIDS WHO, 2002, AIDS EP UPD; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wingood GM, 2000, AM J PREV MED, V19, P270, DOI 10.1016/S0749-3797(00)00228-2; Wingood GM, 1997, AM J PREV MED, V13, P380, DOI 10.1016/S0749-3797(18)30158-2; Wingood GM, 1998, J WOMENS HEALTH, V7, P77, DOI 10.1089/jwh.1998.7.77; World Health Organization, 2002, WORLD REPORT VIOLENC; ZIERLER S, 1991, AM J PUBLIC HEALTH, V81, P572, DOI 10.2105/AJPH.81.5.572; Zierler S, 1996, AM J PREV MED, V12, P304, DOI 10.1016/S0749-3797(18)30283-6; Zierler S, 1997, ANNU REV PUBL HEALTH, V18, P401, DOI 10.1146/annurev.publhealth.18.1.401	29	881	893	0	129	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1415	1421		10.1016/S0140-6736(04)16098-4	http://dx.doi.org/10.1016/S0140-6736(04)16098-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816ST	15121402				2022-12-28	WOS:000221130300006
J	Martin, SL; Curtis, S				Martin, SL; Curtis, S			Gender-based violence and HIV/AIDS: recognising links and acting on evidence	LANCET			English	Editorial Material									Univ N Carolina, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Martin, SL (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Campus Box 7445, Chapel Hill, NC 27599 USA.	sandra_martin@unc.edu						Amnesty International, 2004, ITS OUR HANDS STOP V; HEISE L, 1999, POPULATION REPORTS L, V11; *UNAIDS, WOM FRONTL AIDS RESP; *US DEP STAT, PRES EM PLAN AIDS RE	4	25	25	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1410	1411		10.1016/S0140-6736(04)16133-3	http://dx.doi.org/10.1016/S0140-6736(04)16133-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816ST	15121398				2022-12-28	WOS:000221130300002
J	Horn, M; Collingro, A; Schmitz-Esser, S; Beier, CL; Purkhold, U; Fartmann, B; Brandt, P; Nyakatura, GJ; Droege, M; Frishman, D; Rattei, T; Mewes, HW; Wagner, M				Horn, M; Collingro, A; Schmitz-Esser, S; Beier, CL; Purkhold, U; Fartmann, B; Brandt, P; Nyakatura, GJ; Droege, M; Frishman, D; Rattei, T; Mewes, HW; Wagner, M			Illuminating the evolutionary history of chlamydiae	SCIENCE			English	Article							ORDER CHLAMYDIALES; GENOME SEQUENCES; TRACHOMATIS; PNEUMONIAE; GENES; PARACHLAMYDIACEAE; IDENTIFICATION; ACANTHAMOEBA; SECRETION; DIVERSITY	Chlamydiae are the major cause of preventable blindness and sexually transmitted disease. Genome analysis of a chlamydia-related symbiont of free-living amoebae revealed that it is twice as large as any of the pathogenic chlamydiae and had few signs of recent lateral gene acquisition. We showed that about 700 million years ago the last common ancestor of pathogenic and symbiotic chlamydiae was already adapted to intracellular survival in early eukaryotes and contained many virulence factors found in modern pathogenic chlamydiae, including a type III secretion system. Ancient chlamydiae appear to be the originators of mechanisms for the exploitation of eukaryotic cells.	Univ Vienna, Inst Ecol & Conservat Biol, Dept Microbial Ecol, A-1090 Vienna, Austria; MWG Biotech AG, D-85560 Ebersberg, Germany; Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany	University of Vienna; Technical University of Munich	Horn, M (corresponding author), Univ Vienna, Inst Ecol & Conservat Biol, Dept Microbial Ecol, Althanstr 14, A-1090 Vienna, Austria.	horn@microbial-ecology.net	Wagner, Michael/A-7801-2011; Schmitz-Esser, Stephan/AAA-7287-2019; Frishman, Dmitrij/AAT-7815-2020; Horn, Matthias/G-1136-2011; Collingro, Astrid/ABA-2082-2021; Rattei, Thomas/F-1366-2011; Mewes, Hans-Werner/A-8204-2019	Wagner, Michael/0000-0002-9778-7684; Schmitz-Esser, Stephan/0000-0002-1907-0709; Horn, Matthias/0000-0002-8309-5855; Collingro, Astrid/0000-0002-4100-832X; Rattei, Thomas/0000-0002-0592-7791; Mewes, Hans-Werner/0000-0002-9713-6398				Amann R, 1997, APPL ENVIRON MICROB, V63, P115, DOI 10.1128/AEM.63.1.115-121.1997; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fritsche TR, 2000, APPL ENVIRON MICROB, V66, P2613, DOI 10.1128/AEM.66.6.2613-2619.2000; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Hatch TP, 1999, CHLAMYDIA, P29; Horn M, 2000, MICROBIOL-SGM, V146, P1231, DOI 10.1099/00221287-146-5-1231; Horn M, 2001, FEMS MICROBIOL LETT, V204, P71, DOI 10.1111/j.1574-6968.2001.tb10865.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; McClarty G, 1999, CHLAMYDIA, P69; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Schachter J, 1999, CHLAMYDIA, P139; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311; Stephens RS, 1999, CHLAMYDIA, P9; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; WEISBURG WG, 1986, J BACTERIOL, V167, P570, DOI 10.1128/jb.167.2.570-574.1986; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	26	324	576	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					728	730		10.1126/science.1096330	http://dx.doi.org/10.1126/science.1096330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15073324				2022-12-28	WOS:000221105300043
J	Jamrozik, K				Jamrozik, K			ABC of smoking cessation - Policy priorities for tobacco control	BRITISH MEDICAL JOURNAL			English	Review									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Jamrozik, K (corresponding author), Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia.							Glantz S.A., 1996, CIGARETTE PAPERS; Jha P., 1999, CURBING EPIDEMIC GOV; RICHMOND R, 1996, ED MED STUDENTS TOBA	3	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 24	2004	328	7446					1007	1009		10.1136/bmj.328.7446.1007	http://dx.doi.org/10.1136/bmj.328.7446.1007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105328	Green Submitted, Green Published			2022-12-28	WOS:000221130100025
J	Lattimer, JM; Prakash, M				Lattimer, JM; Prakash, M			The physics of neutron stars	SCIENCE			English	Review							X-RAY-SPECTRUM; GENERAL-RELATIVITY; DENSE MATTER; MASS; EQUATION; CONSTRAINTS; EMISSION; BURST; OSCILLATIONS; ATMOSPHERES	Neutron stars are some of the densest manifestations of massive objects in the universe. They are ideal astrophysical laboratories for testing theories of dense matter physics and provide connections among nuclear physics, particle physics, and astrophysics. Neutron stars may exhibit conditions and phenomena not observed elsewhere, such as hyperon-dominated matter, deconfined quark matter, superfluidity and superconductivity with critical temperatures near 10(10) kelvin, opaqueness to neutrinos, and magnetic fields in excess of 10(13) Gauss. Here, we describe the formation, structure, internal composition, and evolution of neutron stars. Observations that include studies of pulsars in binary systems, thermal emission from isolated neutron stars, glitches from pulsars, and quasi-periodic oscillations from accreting neutron stars provide information about neutron star masses, radii, temperatures, ages, and internal compositions.	SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lattimer, JM (corresponding author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.	lattimer@mail.astro.sunysb.edu; prakash@snare.physics.sunysb.edu	Lattimer, James M/L-6242-2017; Prakash, Madappa/D-9820-2016	Lattimer, James M/0000-0002-5907-4552; 				ALCOCK C, 1988, ANNU REV NUCL PART S, V38, P161, DOI 10.1146/annurev.ns.38.120188.001113; Alford M, 2001, ANNU REV NUCL PART S, V51, P131, DOI 10.1146/annurev.nucl.51.101701.132449; ANDERSON PW, 1975, NATURE, V256, P25, DOI 10.1038/256025a0; ASHWORTH M, 1983, NATURE, V301, P313, DOI 10.1038/301313a0; Bailes M, 2003, ASTROPHYS J, V595, pL49, DOI 10.1086/378939; Barziv O, 2001, ASTRON ASTROPHYS, V377, P925, DOI 10.1051/0004-6361:20011122; BAYM G, 1975, ANNU REV NUCL PART S, V25, P27, DOI 10.1146/annurev.ns.25.120175.000331; BAYM G, 1979, ANNU REV ASTRON ASTR, V17, P415, DOI 10.1146/annurev.aa.17.090179.002215; Bedaque PF, 2002, NUCL PHYS A, V697, P802, DOI 10.1016/S0375-9474(01)01272-6; Bethe HA, 1998, ASTROPHYS J, V506, P780, DOI 10.1086/306265; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; Brisken WF, 2003, ASTROPHYS J, V593, pL89, DOI 10.1086/378184; Brown EF, 1998, ASTROPHYS J, V504, pL95, DOI 10.1086/311578; BURROWS A, 1988, ASTROPHYS J, V334, P891, DOI 10.1086/166885; BURROWS A, 1992, PHYS REV D, V45, P3361, DOI 10.1103/PhysRevD.45.3361; Burrows A, 2000, NATURE, V403, P727, DOI 10.1038/35001501; BURROWS A, 1986, ASTROPHYS J, V307, P178, DOI 10.1086/164405; Burwitz V, 2001, ASTRON ASTROPHYS, V379, pL35, DOI 10.1051/0004-6361:20011304; Caraveo PA, 1996, ASTROPHYS J, V461, pL91, DOI 10.1086/310012; Chabrier G, 1997, ASTROPHYS J, V477, pL99, DOI 10.1086/310535; Clark JS, 2002, ASTRON ASTROPHYS, V392, P909, DOI 10.1051/0004-6361:20021184; COLLINS JC, 1975, PHYS REV LETT, V34, P1353, DOI 10.1103/PhysRevLett.34.1353; Cottam J, 2002, NATURE, V420, P51, DOI 10.1038/nature01159; Delgaty MSR, 1998, COMPUT PHYS COMMUN, V115, P395, DOI 10.1016/S0010-4655(98)00130-1; Drake JJ, 2002, ASTROPHYS J, V572, P996, DOI 10.1086/340368; FLOWERS E, 1976, ASTROPHYS J, V205, P541, DOI 10.1086/154308; Fransson C, 2002, NEW ASTRON REV, V46, P487, DOI 10.1016/S1387-6473(02)00188-4; FRIEDMAN JL, 1986, ASTROPHYS J, V304, P115, DOI 10.1086/164149; Glendenning N.K., 1997, COMPACT STARS NUCL P; GLENDENNING NK, 1992, PHYS REV D, V46, P1274, DOI 10.1103/PhysRevD.46.1274; GLENDENNING NK, 1985, ASTROPHYS J, V293, P470, DOI 10.1086/163253; Haensel P, 2002, ASTRON ASTROPHYS, V385, P301, DOI 10.1051/0004-6361:20020131; HAENSEL P, 1995, ASTRON ASTROPHYS, V296, P745; Hailey CJ, 2002, ASTROPHYS J, V578, pL133, DOI 10.1086/344716; Heinke CO, 2003, ASTROPHYS J, V588, P452, DOI 10.1086/374039; Heiselberg H, 2000, ANNU REV NUCL PART S, V50, P481, DOI 10.1146/annurev.nucl.50.1.481; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; Jonker PG, 2003, MON NOT R ASTRON SOC, V339, P663, DOI 10.1046/j.1365-8711.2003.06193.x; Jung CK, 2000, AIP CONF PROC, V533, P29, DOI 10.1063/1.1361721; Kalogera V, 2004, ASTROPHYS J, V601, pL179, DOI 10.1086/382155; KAPLAN DB, 1986, PHYS LETT B, V179, P409; KAPLAN DB, 1986, PHYS LETT B, V175, P57, DOI 10.1016/0370-2693(86)90331-X; Kaplan DL, 2002, ASTROPHYS J, V571, P447, DOI 10.1086/339879; Lange C, 2001, MON NOT R ASTRON SOC, V326, P274, DOI 10.1046/j.1365-8711.2001.04606.x; LATTIMER JM, 1990, ASTROPHYS J, V355, P241, DOI 10.1086/168758; LATTIMER JM, 1991, PHYS REV LETT, V66, P2701, DOI 10.1103/PhysRevLett.66.2701; Lattimer JM, 2001, ASTROPHYS J, V550, P426, DOI 10.1086/319702; LATTIMER JM, 1974, ASTROPHYS J, V192, pL145, DOI 10.1086/181612; Link B, 1999, PHYS REV LETT, V83, P3362, DOI 10.1103/PhysRevLett.83.3362; Link B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.101101; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; MANCHESTER N, 1997, PULSARS; Michaels R., 2000, PR00003 JEFF LAB; Mori K, 2002, ASTROPHYS J, V564, P914, DOI 10.1086/323985; Nice DJ, 2001, ASTROPHYS J, V549, P516, DOI 10.1086/319079; NICE DJ, IAU S, V218; NICE DJ, 2003, ASTRON SOC PAC C SER, V302; NICE DJ, 2004, COMMUNICATION; Oppenheimer JR, 1939, PHYS REV, V55, P0374, DOI 10.1103/PhysRev.55.374; Orosz JA, 1999, MON NOT R ASTRON SOC, V305, P132, DOI 10.1046/j.1365-8711.1999.t01-1-02420.x; Page D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.131101; Pavlov GG, 1996, ASTROPHYS J, V472, pL33, DOI 10.1086/310355; PETHICK CJ, 1992, REV MOD PHYS, V64, P1133, DOI 10.1103/RevModPhys.64.1133; PETHICK CJ, 1995, ANNU REV NUCL PART S, V45, P429; Prakash M, 2004, J PHYS G NUCL PARTIC, V30, pS451, DOI [10.1088/0954-3899/30/1/053, 10.1088/0954-3899/30/l/053]; Prakash M, 2001, ANNU REV NUCL PART S, V51, P295, DOI 10.1146/annurev.nucl.51.101701.132514; Psaltis D, 1998, ASTROPHYS J, V501, pL95, DOI 10.1086/311455; Quaintrell H, 2003, ASTRON ASTROPHYS, V401, P313, DOI 10.1051/0004-6361:20030120; RHO M, 1979, MESONS NUCL, V3; RHOADES CE, 1974, PHYS REV LETT, V32, P324, DOI 10.1103/PhysRevLett.32.324; ROMANI RW, 1987, ASTROPHYS J, V313, P718, DOI 10.1086/165010; Rutledge RE, 2002, ASTROPHYS J, V578, P405, DOI 10.1086/342306; Sanwal D, 2002, ASTROPHYS J, V574, pL61, DOI 10.1086/342368; SHAPIRO II, 1964, PHYS REV LETT, V13, P789, DOI 10.1103/PhysRevLett.13.789; Slane PO, 2002, ASTROPHYS J, V571, pL45, DOI 10.1086/341179; Splaver EM, 2002, ASTROPHYS J, V581, P509, DOI 10.1086/344202; Tauris TM, 1999, ASTRON ASTROPHYS, V350, P928; Thorsett SE, 1999, ASTROPHYS J, V512, P288, DOI 10.1086/306742; Tolman RC, 1934, P NATL ACAD SCI USA, V20, P379, DOI 10.1073/pnas.20.6.379; Tomsick JA, 2002, ASTROPHYS J, V581, P570, DOI 10.1086/344130; TOMSICK JA, COMMUNICATION; Tsuruta S, 1998, PHYS REP, V292, P2; van der Klis M, 2000, ANNU REV ASTRON ASTR, V38, P717, DOI 10.1146/annurev.astro.38.1.717; van Straten W, 2001, NATURE, V412, P158, DOI 10.1038/35084015; VANKERKWIJK MH, 1995, ASTRON ASTROPHYS, V303, P497; Walter FM, 2002, ASTROPHYS J, V576, pL145, DOI 10.1086/343850; WEISBERG JM, 2003, ASTRON SOC PAC C SER, V302; Yakovlev DG, 1999, ASTRON ASTROPHYS, V343, P650	89	928	958	9	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					536	542		10.1126/science.1090720	http://dx.doi.org/10.1126/science.1090720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105490	Green Submitted			2022-12-28	WOS:000220975100035
J	Langer, P; Hogendoorn, K; Keller, L				Langer, P; Hogendoorn, K; Keller, L			Tug-of-war over reproduction in a social bee	NATURE			English	Article							EXONEURA-BICOLOR HYMENOPTERA; ALLODAPINE BEE; SKEW MODELS; ANIMAL SOCIETIES; EVOLUTION; ASSOCIATIONS; RELATEDNESS; BEHAVIOR; TESTS	One of the main transitions in evolution is the shift from solitary organisms to societies with reproductive division of labour(1,2). Understanding social evolution requires us to determine how ecological, social and genetic factors jointly influence group stability and partitioning of reproduction between group members(3-8). Here we test the role of the three key factors predicted to influence social evolution by experimentally manipulating them in a social allodapine bee. We show that increased relatedness between nestmates results in more even reproduction among group members and a greater productivity per individual. By contrast, the degree of reproductive skew is not influenced by the opportunity for solitary breeding or by the potential benefits of cooperation. Relatedness also has a positive effect on group stability and overall productivity. These findings are in line with predictions of the tug-of-war models, in which the degree of reproductive division of labour is determined primarily by selfish competition between group members. The alternative view, where the degree of reproductive skew is the outcome of a social contract between potential breeders, was not supported by the data.	Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	University of Lausanne; Flinders University South Australia	Langer, P (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biol Bldg, CH-1015 Lausanne, Switzerland.	Philipp.Langer@ie-zea.unil.ch; Laurent.Keller@ie-zea.unil.ch	keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953				Bull NJ, 1996, BEHAV ECOL SOCIOBIOL, V39, P267, DOI 10.1007/s002650050289; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; Fournier D, 2001, ANIM BEHAV, V62, P1039, DOI 10.1006/anbe.2001.1848; GADAGKAR R, 1993, EXPERIENTIA, V49, P714, DOI 10.1007/BF01923958; Haydock J, 2002, P NATL ACAD SCI USA, V99, P7178, DOI 10.1073/pnas.102624199; Hogendoorn K, 2001, INSECT SOC, V48, P392, DOI 10.1007/PL00001796; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Keller L, 1999, LEVELS SELECTION EVO; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P265, DOI 10.1098/rspb.2002.2238; LANGER P, IN PRESS MOL ECOL NO; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Reeve H.K., 1991, P99; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; REEVE HK, 1995, AM NAT, V145, P119, DOI 10.1086/285731; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve Hudson K., 1993, P45; Schwarz MP, 1998, INSECT SOC, V45, P349, DOI 10.1007/s000400050095; SCHWARZ MP, 1994, EVOLUTION, V48, P1684, DOI 10.1111/j.1558-5646.1994.tb02205.x; SCHWARZ MP, 1986, INSECT SOC, V33, P258, DOI 10.1007/BF02224245; Silberbauer L. X., 1992, Australian Zoologist, V28, P67; SILBERBAUER LX, 1995, INSECT SOC, V42, P201, DOI 10.1007/BF01242455; STEVENS MI, 1997, THESIS FLINDERS U S; Szathmary E, 1995, MAJOR TRANSITIONS EV; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X	30	85	87	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					844	847		10.1038/nature02431	http://dx.doi.org/10.1038/nature02431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103374	Green Published			2022-12-28	WOS:000220952300037
J	Patek, SN; Korff, WL; Caldwell, RL				Patek, SN; Korff, WL; Caldwell, RL			Biomechanics: Deadly strike mechanism of a mantis shrimp - This shrimp packs a punch powerful enough to smash its prey's shell underwater	NATURE			English	Editorial Material							SNAPPING SHRIMP; HEMISQUILLA; BUBBLES; MUSCLE		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Patek, SN (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	patek@socrates.berkeley.edu		Korff, Wyatt/0000-0001-8396-1533; Patek, S. N./0000-0001-9738-882X				Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Bennet-Clark H.C., 1976, pUnpaginated; Brennen C.E., 1995, CAVITATION BUBBLE DY; BURROWS M, 1972, J EXP ZOOL, V179, P379, DOI 10.1002/jez.1401790309; BURROWS M, 1969, Z VERGL PHYSIOL, V62, P361, DOI 10.1007/BF00299261; CURREY JD, 1982, J MATER SCI, V37, P1939; Gronenberg W, 1996, J COMP PHYSIOL A, V178, P727, DOI 10.1007/BF00225821; Lohse D, 2001, NATURE, V413, P477, DOI 10.1038/35097152; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114	10	204	214	23	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					819	820		10.1038/428819a	http://dx.doi.org/10.1038/428819a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103366				2022-12-28	WOS:000220952300029
J	Vogel, EK; Machizawa, MG				Vogel, EK; Machizawa, MG			Neural activity predicts individual differences in visual working memory capacity	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; BRAIN-REGIONS; ATTENTION; TASK; STORAGE; CONJUNCTIONS; PATTERNS; FEATURES; ROLES	Contrary to our rich phenomenological visual experience, our visual short-term memory system can maintain representations of only three to four objects at any given moment(1,2). For over a century, the capacity of visual memory has been shown to vary substantially across individuals, ranging from 1.5 to about 5 objects(3-7). Although numerous studies have recently begun to characterize the neural substrates of visual memory processes(8-12), a neurophysiological index of storage capacity limitations has not yet been established. Here, we provide electrophysiological evidence for lateralized activity in humans that reflects the encoding and maintenance of items in visual memory. The amplitude of this activity is strongly modulated by the number of objects being held in the memory at the time, but approaches a limit asymptotically for arrays that meet or exceed storage capacity. Indeed, the precise limit is determined by each individual's memory capacity, such that the activity from low-capacity individuals reaches this plateau much sooner than that from high-capacity individuals. Consequently, this measure provides a strong neurophysiological predictor of an individual's capacity, allowing the demonstration of a direct relationship between neural activity and memory capacity.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Vogel, EK (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 530 Wilson Hall, Nashville, TN 37203 USA.	vogel@darkwing.uoregon.edu	Machizawa, Maro G/B-5918-2008; Vogel, Edward K/AAW-9466-2021	Machizawa, Maro G/0000-0002-5727-1421; 				Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; FUSTER JM, 1982, J NEUROSCI, V2, P361; Gratton G, 1998, PSYCHOPHYSIOLOGY, V35, P638, DOI 10.1111/1469-8986.3560638; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; KYLLONEN PC, 1990, INTELLIGENCE, V14, P398; Logie R. H., 1995, VISUOSPATIAL WORKING; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Ruchkin DS, 1997, NEUROPSYCHOLOGIA, V35, P195, DOI 10.1016/S0028-3932(96)00068-1; RUCHKIN DS, 1995, PSYCHOPHYSIOLOGY, V32, P399, DOI 10.1111/j.1469-8986.1995.tb01223.x; RUCHKIN DS, 1990, ELECTROEN CLIN NEURO, V76, P419, DOI 10.1016/0013-4694(90)90096-3; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Sperling G., 1960, PSYCHOL MONOGRAPHS, V74, DOI [10.1037/h0093759, DOI 10.1037/H0093759]; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698	30	1202	1226	14	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					748	751		10.1038/nature02447	http://dx.doi.org/10.1038/nature02447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085132				2022-12-28	WOS:000220823800039
J	Sudlow, CLM				Sudlow, CLM			Epilepsy and stroke	LANCET			English	Editorial Material							GENERAL-PRACTICE; SEIZURES; MANAGEMENT; POPULATION; DATABASE; AGE		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sudlow, CLM (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	csudlow@skull.dcn.ed.ac.uk	Sudlow, Cathie LM/F-3420-2010	Sudlow, Cathie/0000-0002-7725-7520	Wellcome Trust [063668] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Gibbs RGJ, 2001, STROKE, V32, P1085, DOI 10.1161/01.STR.32.5.1085; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; RICCI S, 1993, NEUROEPIDEMIOLOGY, V13, P290; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; SHINTON RA, 1987, LANCET, V1, P11; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; TALLIS R, 1991, AGE AGEING, V20, P442, DOI 10.1093/ageing/20.6.442; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; WARLOW CP, 2001, STROKE PRACTICAL GUI, P73	12	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1175	1176		10.1016/S0140-6736(04)15982-5	http://dx.doi.org/10.1016/S0140-6736(04)15982-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081645				2022-12-28	WOS:000220748100003
J	Okamoto, S; Millis, AJ				Okamoto, S; Millis, AJ			Electronic reconstruction at an interface between a Mott insulator and a band insulator	NATURE			English	Article							TRANSITION-METAL OXIDES; SURFACE; SUPERLATTICES; LATTICE; PHYSICS; SRTIO3	Surface science is an important and well-established branch of materials science involving the study of changes in material properties near a surface or interface. A fundamental issue has been atomic reconstruction: how the surface lattice symmetry differs from the bulk. 'Correlated-electron compounds' are materials in which strong electron-electron and electron-lattice interactions produce new electronic phases, including interaction-induced (Mott) insulators, many forms of spin, charge and orbital ordering, and (presumably) high-transition-temperature superconductivity(1,2). Here we propose that the fundamental issue for the new field of correlated-electron surface/interface science is 'electronic reconstruction': how does the surface/interface electronic phase differ from that in the bulk? As a step towards a general understanding of such phenomena, we present a theoretical study of an interface between a strongly correlated Mott insulator and a band insulator. We find dramatic interface-induced electronic reconstructions: in wide parameter ranges, the near-interface region is metallic and ferromagnetic, whereas the bulk phase on either side is insulating and anti-ferromagnetic. Extending the analysis to a wider range of interfaces and surfaces is a fundamental scientific challenge and may lead to new applications for correlated electron materials.	Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University	Millis, AJ (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	millis@phys.columbia.edu	Okamoto, Satoshi/G-5390-2011	Okamoto, Satoshi/0000-0002-0493-7568				Altieri S, 2001, THIN SOLID FILMS, V400, P9, DOI 10.1016/S0040-6090(01)01484-5; Altieri S, 2000, PHYS REV B, V61, P16948, DOI 10.1103/PhysRevB.61.16948; DUFFY DM, 1983, J PHYS C SOLID STATE, V16, P4087, DOI 10.1088/0022-3719/16/21/009; Fang Z, 2000, PHYS REV LETT, V84, P3169, DOI 10.1103/PhysRevLett.84.3169; FUJITANI H, 1995, PHYS REV B, V51, P2098, DOI 10.1103/PhysRevB.51.2098; Hesper R, 2000, PHYS REV B, V62, P16046, DOI 10.1103/PhysRevB.62.16046; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Izumi M, 2001, MAT SCI ENG B-SOLID, V84, P53, DOI 10.1016/S0921-5107(01)00569-4; Kiyama T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167202; Maiti K, 2001, EUROPHYS LETT, V55, P246, DOI 10.1209/epl/i2001-00406-6; Maiti K, 1998, PHYS REV LETT, V80, P2885, DOI 10.1103/PhysRevLett.80.2885; Matzdorf R, 2000, SCIENCE, V289, P746, DOI 10.1126/science.289.5480.746; MIZOKAWA T, 1995, PHYS REV B, V51, P12880, DOI 10.1103/PhysRevB.51.12880; Mochizuki M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167203; MOORE RG, IN PRESS PHYS STATUS; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; OKIMOTO Y, 1995, PHYS REV B, V51, P9581, DOI 10.1103/PhysRevB.51.9581; Potthoff M, 1999, PHYS REV B, V60, P7834, DOI 10.1103/PhysRevB.60.7834; SAKUDO T, 1971, PHYS REV LETT, V26, P851, DOI 10.1103/PhysRevLett.26.851; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462	21	450	452	4	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					630	633		10.1038/nature02450	http://dx.doi.org/10.1038/nature02450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071589				2022-12-28	WOS:000220697200037
J	Pui, C; Relling, MV; Downing, JR				Pui, C; Relling, MV; Downing, JR			Mechanisms of disease: Acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; THYMIDYLATE SYNTHASE GENE; CHROMOSOME TRANSLOCATIONS; MOLECULAR MECHANISMS; HOX11L2 EXPRESSION; MLL TRANSLOCATIONS; MYELOID-LEUKEMIA; FOLLOW-UP; CHILDHOOD; FUSION		St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, C (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org			NATIONAL CANCER INSTITUTE [R01CA060419, R01CA051001, U01CA060419, R29CA051001, P30CA021765, R37CA036401, R01CA078224, R01CA036401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [CA-78224, CA-21765, CA-71970, CA-60419, CA-51001, CA-36401] Funding Source: Medline; NIGMS NIH HHS [GM-61393, GM-61374] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander FE, 2001, CANCER RES, V61, P2542; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; ARMSTRONG SA, IN PRESS BLOOD; Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Ballerini P, 2002, BLOOD, V100, P991, DOI 10.1182/blood-2001-11-0093; Batova A, 2002, BLOOD, V100, P3319, DOI 10.1182/blood-2002-02-0567; Belkov VM, 1999, BLOOD, V93, P1643, DOI 10.1182/blood.V93.5.1643.405k06_1643_1650; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Buske C, 2000, INT J HEMATOL, V71, P301; Campana D, 2003, BRIT J HAEMATOL, V121, P823, DOI 10.1046/j.1365-2141.2003.04393.x; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Cave H, 2004, BLOOD, V103, P442, DOI 10.1182/blood-2003-05-1495; Chen CL, 1997, BLOOD, V89, P1701, DOI 10.1182/blood.V89.5.1701.1701_1701_1707; Cheng KK, 2000, BRIT J CANCER, V83, P1573, DOI 10.1054/bjoc.2000.1550; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Cheok MH, 2003, NAT GENET, V34, P231, DOI 10.1038/ng0603-231b; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Davies SM, 2002, BLOOD, V100, P67, DOI 10.1182/blood.V100.1.67; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Downing JR, 2003, CURR OPIN GENET DEV, V13, P48, DOI 10.1016/S0959-437X(02)00018-7; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Ernst P, 2002, CURR OPIN HEMATOL, V9, P282, DOI 10.1097/00062752-200207000-00004; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Ferrando AA, 2003, SEMIN HEMATOL, V40, P274, DOI 10.1016/S0037-1963(03)00195-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Franco RF, 2001, BRIT J HAEMATOL, V115, P616, DOI 10.1046/j.1365-2141.2001.03140.x; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Gokbuget Nicola, 2002, Rev Clin Exp Hematol, V6, P114, DOI 10.1046/j.1468-0734.2002.00068.x; Greaves M, 2002, BRIT MED J, V324, P283, DOI 10.1136/bmj.324.7332.283; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harms DO, 2000, LEUKEMIA, V14, P2234, DOI 10.1038/sj.leu.2401974; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hiebert SW, 2001, CURR OPIN HEMATOL, V8, P197, DOI 10.1097/00062752-200107000-00003; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Kantarjian HM, 2000, J CLIN ONCOL, V18, P547, DOI 10.1200/JCO.2000.18.3.547; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Lauten M, 2003, HAEMATOLOGICA, V88, P353; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Loh ML, 2002, CURR OPIN HEMATOL, V9, P345, DOI 10.1097/00062752-200207000-00013; Lorsbach RB, 2001, INT J HEMATOL, V74, P258, DOI 10.1007/BF02982058; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Moreno TMC, 2002, LEUKEMIA, V16, P2037, DOI 10.1038/sj.leu.2402697; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Omura-Minamisawa M, 2000, CLIN CANCER RES, V6, P1219; Pane F, 2002, ONCOGENE, V21, P8652, DOI 10.1038/sj.onc.1206094; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2003, LEUKEMIA, V17, P700, DOI 10.1038/sj.leu.2402883; Pui CH, 2003, NEW ENGL J MED, V349, P1299; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 2002, BEST PRACT RES CL HA, V15, P741, DOI 10.1053/beha.2002.0225; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2001, LEUKEMIA, V15, P707, DOI 10.1038/sj.leu.2402111; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Relling MV, 2000, LANCET, V356, P285, DOI 10.1016/S0140-6736(00)02503-4; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Relling MV, 1999, BLOOD, V93, P2817; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Schrappe M, 2000, BLOOD, V95, P3310; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; Stock W, 2000, BLOOD, V95, P2364; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; TARTAGLIA M, IN PRESS BLOOD; Taub JW, 2002, LEUKEMIA, V16, P764, DOI 10.1038/sj.leu.2402428; Taub JW, 2002, BLOOD, V99, P2992, DOI 10.1182/blood.V99.8.2992; Thompson JR, 2001, LANCET, V358, P1935, DOI 10.1016/S0140-6736(01)06959-8; Thomsen JB, 1999, CANCER-AM CANCER SOC, V86, P1080, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Ulrich CM, 2001, BLOOD, V98, P231, DOI 10.1182/blood.V98.1.231; Urano W, 2002, PHARMACOGENETICS, V12, P183, DOI 10.1097/00008571-200204000-00002; Venkatakrishnan K, 2000, CLIN PHARMACOKINET, V38, P111, DOI 10.2165/00003088-200038020-00002; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	111	916	993	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1535	1548		10.1056/NEJMra023001	http://dx.doi.org/10.1056/NEJMra023001			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071128				2022-12-28	WOS:000220682000009
J	Murakami, M; Hirose, K; Kawamura, K; Sata, N; Ohishi, Y				Murakami, M; Hirose, K; Kawamura, K; Sata, N; Ohishi, Y			Post-perovskite phase transition in MgSiO3	SCIENCE			English	Article							EQUATION-OF-STATE; (MG,FE)SIO3 PEROVSKITE; CRYSTAL-STRUCTURE; HIGH-PRESSURE; MANTLE; STABILITY; TEMPERATURE; BASE; DYNAMICS; GPA	In situ x-ray diffraction measurements of MgSiO3 were performed at high pressure and temperature similar to the conditions at Earth's core-mantle boundary. Results demonstrate that MgSiO3 perovskite transforms to a new high-pressure form with stacked SiO6-octahedral sheet structure above 125 gigapascals and 2500 kelvin (2700-kilometer depth near the base of the mantle) with an increase in density of 1.0 to 1.2%. The origin of the D" seismic discontinuity may be attributed to this post-perovskite phase transition. The new phase may have large elastic anisotropy and develop preferred orientation with platy crystal shape in the shear flow that can cause strong seismic anisotropy below the D" discontinuity.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Japan Agcy Marine Earth Sci & Technol, Inst Frontier Res Earth Evolut, Kanagawa 2370061, Japan; Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Synchrotron Radiation Research Institute	Murakami, M (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	mmurakam@geo.titech.ac.jp; kei@geo.titech.ac.jp	Hirose, Kei/C-2165-2009; Murakami, Motohiko/G-2806-2010	Hirose, Kei/0000-0003-4366-7721; Murakami, Motohiko/0000-0002-2165-2994				Fei YW, 1999, AM MINERAL, V84, P272; Fiquet G, 2000, GEOPHYS RES LETT, V27, P21, DOI 10.1029/1999GL008397; Fiquet G, 1998, PHYS EARTH PLANET IN, V105, P21, DOI 10.1016/S0031-9201(97)00077-0; Jamieson J.C., 1982, HIGH PRESSURE RES GE; KNITTLE E, 1987, SCIENCE, V235, P668, DOI 10.1126/science.235.4789.668; LAY T, 1983, GEOPHYS J ROY ASTR S, V75, P799, DOI 10.1111/j.1365-246X.1983.tb05010.x; Mao HK, 1997, SCIENCE, V278, P2098, DOI 10.1126/science.278.5346.2098; Masters G, 2003, PHYS EARTH PLANET IN, V140, P159, DOI 10.1016/j.pepi.2003.07.008; MEADE C, 1995, SCIENCE, V268, P1743, DOI 10.1126/science.268.5218.1743; MITCHELL BJ, 1973, J GEOPHYS RES, V78, P6009, DOI 10.1029/JB078i026p06009; Murakami M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016722; NOEL H, 1976, ACTA CRYSTALLOGR B, V32, P1593, DOI 10.1107/S0567740876005931; Ono S, 2002, PHYS CHEM MINER, V29, P527, DOI 10.1007/s00269-002-0263-5; Saxena SK, 1996, SCIENCE, V274, P1357, DOI 10.1126/science.274.5291.1357; Serghiou G, 1998, SCIENCE, V280, P2093, DOI 10.1126/science.280.5372.2093; Shen G., 1996, P 3 NIRIM INT S ADV, P149; Shim SH, 2000, PHYS EARTH PLANET IN, V120, P327, DOI 10.1016/S0031-9201(00)00154-0; Shim SH, 2001, SCIENCE, V293, P2437, DOI 10.1126/science.1061235; Sidorin I, 1999, J GEOPHYS RES-SOL EA, V104, P15005, DOI 10.1029/1999JB900065; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; STIXRUDE L, 1993, NATURE, V364, P613, DOI 10.1038/364613a0; UCHIDA T, 1996, REV HIGH PRESS SCI T, V5, P261; Warren MC, 1998, MINERAL MAG, V62, P585, DOI 10.1180/002646198547981; Watanuki T, 2001, REV SCI INSTRUM, V72, P1289, DOI 10.1063/1.1343869; WENTZCOVITCH RM, 1993, PHYS REV LETT, V70, P3947, DOI 10.1103/PhysRevLett.70.3947; Wysession ME, 1998, GEODYNAMICS, V28, P273; XIONG DH, 1986, PHYS EARTH PLANET IN, V43, P244, DOI 10.1016/0031-9201(86)90051-8	27	990	1029	10	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					855	858		10.1126/science.1095932	http://dx.doi.org/10.1126/science.1095932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15073323	Green Submitted			2022-12-28	WOS:000221243000039
J	Albert, C				Albert, C			Fish oil - an appetising alternative to anti-arrhythmic drugs?	LANCET			English	Editorial Material							POLYUNSATURATED FATTY-ACIDS; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; CONSUMPTION; PREVENTION; RISK; DISEASE; TRIAL		Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Albert, C (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA.	calbert@partners.org						Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; BURR ML, 1989, LANCET, V2, P757; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Christensen JH, 1997, AM J CARDIOL, V79, P1670, DOI 10.1016/S0002-9149(97)00220-8; GUALLAR E, 1995, J AM COLL CARDIOL, V25, P387, DOI 10.1016/0735-1097(94)00370-6; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; ROSENBAUM MS, 1991, J AM COLL CARDIOL, V17, P133, DOI 10.1016/0735-1097(91)90716-M; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5	14	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 1	2004	363	9419					1412	1413		10.1016/S0140-6736(04)16135-7	http://dx.doi.org/10.1016/S0140-6736(04)16135-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121400				2022-12-28	WOS:000221130300004
J	Radom, L				Radom, L			John A. Pople (1925-2004) - Obituary	NATURE			English	Biographical-Item									Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of Sydney	Radom, L (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	radom@chem.usyd.edu.au		Radom, Leo/0000-0001-8249-1314					0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					816	816		10.1038/428816a	http://dx.doi.org/10.1038/428816a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103364	Bronze			2022-12-28	WOS:000220952300028
J	Vinogradov, AE				Vinogradov, AE			Testing genome complexity	SCIENCE			English	Letter									Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Vinogradov, AE (corresponding author), Russian Acad Sci, Inst Cytol, Tikhoretsky Ave 4, St Petersburg 194064, Russia.	aevin@mail.cytspb.rssi.ru	Vinogradov, Alexander E/GZA-4008-2022; Vinogradov, Alexander E/R-3923-2016	Vinogradov, Alexander E/0000-0001-5540-8896; 				Ohno S., 1970, EVOLUTION GENE DUPLI	1	23	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					389	390						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087529				2022-12-28	WOS:000220845400021
J	O'Gara, PT; Greenfield, AJ; Afridi, NA; Houser, SL; Harris, NL; Januzzi, JL; Evans-Molina, C				O'Gara, PT; Greenfield, AJ; Afridi, NA; Houser, SL; Harris, NL; Januzzi, JL; Evans-Molina, C			A 38-year-old woman with acute onset of pain in the chest - Proximal aortic dissection, associated with pregnancy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTRAMURAL HEMATOMA; COMPUTED-TOMOGRAPHY; INTERNATIONAL REGISTRY; THORACIC AORTA; ULCER; PROGRESSION; MANAGEMENT; DIAGNOSIS; CRITERIA; ANEURYSM		Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.		Januzzi, James/Y-2436-2019					AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Cambria RP, 2002, J VASC SURG, V35, P1295, DOI 10.1067/mva.2002.123982; Chavan A, 1997, CIRCULATION, V96, P2124; COOKE JP, 1988, MAYO CLIN PROC, V63, P718, DOI 10.1016/S0025-6196(12)65534-7; Ganaha F, 2002, CIRCULATION, V106, P342, DOI 10.1161/01.CIR.0000022164.26075.5A; Guo DC, 2001, CIRCULATION, V103, P2461; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HIRST AE, 1958, MEDICINE, V37, P217, DOI 10.1097/00005792-195809000-00003; ISHIKAWA K, 1988, J AM COLL CARDIOL, V12, P964, DOI 10.1016/0735-1097(88)90462-7; Isselbacher EM, 2002, AM J MED, V113, P244, DOI 10.1016/S0002-9343(02)01232-9; Kaji S, 1999, CIRCULATION, V100, P281; KAZEROONI EA, 1992, RADIOLOGY, V183, P759, DOI 10.1148/radiology.183.3.1584933; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; MANALOESTRELLA P, 1967, ARCH PATHOL, V83, P336; MANDEL W, 1954, NEW ENGL J MED, V251, P1059, DOI 10.1056/NEJM195412232512607; Maraj R, 2000, AM J CARDIOL, V86, P664, DOI 10.1016/S0002-9149(00)01049-3; Mohiaddin RH, 2001, CIRCULATION, V103, pE18; Mohr-Kahaly S, 2001, J AM COLL CARDIOL, V37, P1611, DOI 10.1016/S0735-1097(01)01189-5; Moore AG, 2002, AM J CARDIOL, V89, P1235, DOI 10.1016/S0002-9149(02)02316-0; Nienaber CA, 2002, CIRCULATION, V106, P284, DOI 10.1161/01.CIR.0000023453.90533.82; NIENABER CA, 1995, CIRCULATION, V92, P1465, DOI 10.1161/01.CIR.92.6.1465; OSKOUI R, 1994, AM J CARDIOL, V73, P821, DOI 10.1016/0002-9149(94)90888-5; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; Qin XJ, 1997, BIOL REPROD, V56, P812, DOI 10.1095/biolreprod56.4.812; Rutherford R B, 1995, Semin Vasc Surg, V8, P299; Sawhney NS, 2001, CHEST, V120, P1340, DOI 10.1378/chest.120.4.1340; Schnitker MA, 1944, ANN INTERN MED, V20, P486, DOI 10.7326/0003-4819-20-3-486; Song JK, 2002, AM J MED, V113, P181, DOI 10.1016/S0002-9343(02)01171-3; Suzuki T, 2000, ANN INTERN MED, V133, P537, DOI 10.7326/0003-4819-133-7-200010030-00013; Vaughan CJ, 2001, CIRCULATION, V103, P2469; Williams EJ, 2001, GUT, V49, P577, DOI 10.1136/gut.49.4.577; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Zeebregts CJ, 1997, ANN THORAC SURG, V64, P1345, DOI 10.1016/S0003-4975(97)00916-8	35	7	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1666	1674		10.1056/NEJMcpc049004	http://dx.doi.org/10.1056/NEJMcpc049004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084700				2022-12-28	WOS:000220819800013
J	de Jong, JJD; Lucas, LN; Kellogg, RM; van Esch, JH; Feringa, BL				de Jong, JJD; Lucas, LN; Kellogg, RM; van Esch, JH; Feringa, BL			Reversible optical transcription of supramolecular chirality into molecular chirality	SCIENCE			English	Article							SELF-ORGANIZATION	In nature, key molecular processes such as communication, replication, and enzyme catalysis all rely on a delicate balance between molecular and supramolecular chirality. Here we report the design, synthesis, and operation of a reversible, photoresponsive, self-assembling molecular system in which molecular and supramolecular chirality communicate. It shows exceptional stereoselectivity upon aggregation of the molecules during gel formation with the solvent. This chirality is locked by photochemical switching, a process that is subsequently used to induce an inverted chiral supramolecular assembly as revealed by circular dichroism spectroscopy. The optical switching between different chiral aggregated states and the interplay of molecular and supramolecular chirality offer attractive new prospects for the development of molecular memory systems and smart functional materials.	Univ Groningen, Stratingh Inst, Organ Chem Lab, NL-9747 AG Groningen, Netherlands; Syncom, NL-9747 AT Groningen, Netherlands	University of Groningen	van Esch, JH (corresponding author), Univ Groningen, Stratingh Inst, Organ Chem Lab, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	esch@chem.rug.nl; feringa@chem.rug.nl	van Esch, Jan H/E-5543-2011; Feringa, Ben L./C-1665-2013	van Esch, Jan H/0000-0001-6116-4808; 				Cornelissen JJLM, 2001, CHEM REV, V101, P4039, DOI 10.1021/cr990126i; Feringa B. L., 2001, MOL SWITCHES; Harada N., 1983, CIRCULAR DICHROIC SP; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Irie M, 2000, CHEM REV, V100, P1683, DOI 10.1021/cr980068l; Kodani T, 2000, J AM CHEM SOC, V122, P9631, DOI 10.1021/ja001350o; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Lucas LN, 2001, CHEM COMMUN, P759, DOI 10.1039/b101231m; MURATA K, 1994, J AM CHEM SOC, V116, P6664, DOI 10.1021/ja00094a023; Orr GW, 1999, SCIENCE, V285, P1049, DOI 10.1126/science.285.5430.1049; Pieroni O, 2001, ACCOUNTS CHEM RES, V34, P9, DOI 10.1021/ar990141+; ROSENGAUS J, 1995, J PHYS ORG CHEM, V8, P54, DOI 10.1002/poc.610080111; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; van Esch JH, 2000, ANGEW CHEM INT EDIT, V39, P2263; Vollmer MS, 1999, ANGEW CHEM INT EDIT, V38, P1598, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1598::AID-ANIE1598>3.0.CO;2-J; WURTHNER F, 1995, J CHEM SOC PERK T 2, P1727, DOI 10.1039/p29950001727; WURTHNER F, 1995, ANGEW CHEM INT EDIT, V34, P446, DOI 10.1002/anie.199504461; Yamamoto S, 2003, ORG LETT, V5, P1769, DOI 10.1021/ol034440h	20	587	587	6	335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					278	281		10.1126/science.1095353	http://dx.doi.org/10.1126/science.1095353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073374	Green Submitted			2022-12-28	WOS:000220719400043
J	Heavens, A; Panter, B; Jimenez, R; Dunlop, J				Heavens, A; Panter, B; Jimenez, R; Dunlop, J			The star-formation history of the Universe from the stellar populations of nearby galaxies	NATURE			English	Article							LUMINOSITY FUNCTION; REDSHIFT SURVEY; ULTRAVIOLET; EVOLUTION	The determination of the star-formation history of the Universe is a key goal of modern cosmology, as it is crucial to our understanding of how galactic structures form and evolve. Observations(1-12) of young stars in distant galaxies at different times in the past have indicated that the stellar birthrate peaked some eight billion years ago before declining by a factor of around ten to its present value. Here we report an analysis of the 'fossil record' of the current stellar populations of 96,545 nearby galaxies, from which we obtained a complete star-formation history. Our results broadly support those derived from high-redshift galaxies. We find, however, that the peak of star formation was more recent-around five billion years ago. We also show that the bigger the stellar mass of the galaxy, the earlier the stars were formed, which indicates that high- and low-mass galaxies have very different histories.	Univ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Edinburgh; University of Pennsylvania	Heavens, A (corresponding author), Univ Edinburgh, Inst Astron, Blackford Hill, Edinburgh EH9 3HJ, Midlothian, Scotland.	afh@roe.ac.uk		Jimenez, Raul/0000-0002-3370-3103; Heavens, Alan/0000-0003-1586-2773				Baldry IK, 2002, ASTROPHYS J, V569, P582, DOI 10.1086/339477; Barger AJ, 1999, ASTRON J, V117, P2656, DOI 10.1086/300890; BRUZUAL G, 1993, ASTROPHYS J, V405, P538, DOI 10.1086/172385; Calzetti D, 1997, ASTRON J, V113, P162, DOI 10.1086/118242; Chapman SC, 2003, NATURE, V422, P695, DOI 10.1038/nature01540; Connolly AJ, 1997, ASTROPHYS J, V486, pL11, DOI 10.1086/310829; Dickinson M, 2003, ASTROPHYS J, V587, P25, DOI 10.1086/368111; Dunlop J. S., 2001, DEEP MILLIMETRE SURV, P11; Fujita SS, 2003, ASTROPHYS J, V586, pL115, DOI 10.1086/374859; GALLEGO J, 1995, APJ, V455, P1; Glazebrook K, 2003, ASTROPHYS J, V587, P55, DOI 10.1086/368161; Glazebrook K, 1999, MON NOT R ASTRON SOC, V306, P843, DOI 10.1046/j.1365-8711.1999.02576.x; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; HASINGER G, IN PRESS NUCL PH B S; Heavens AF, 2000, MON NOT R ASTRON SOC, V317, P965, DOI 10.1046/j.1365-8711.2000.03692.x; Jimenez R, 2004, MON NOT R ASTRON SOC, V349, P240, DOI 10.1111/j.1365-2966.2004.07492.x; Lilly SJ, 1996, ASTROPHYS J, V460, pL1, DOI 10.1086/309975; OUCHI M, 2003, CENSUS LYMAN BREAK G; Panter B, 2003, MON NOT R ASTRON SOC, V343, P1145, DOI 10.1046/j.1365-8711.2003.06722.x; Perez-Gonzalez PG, 2003, MON NOT R ASTRON SOC, V338, P525, DOI 10.1046/j.1365-8711.2003.06078.x; Reichardt C, 2001, MON NOT R ASTRON SOC, V327, P849, DOI 10.1046/j.1365-8711.2001.04768.x; Scott SE, 2002, MON NOT R ASTRON SOC, V331, P817, DOI 10.1046/j.1365-8711.2002.05193.x; Shen SY, 2003, MON NOT R ASTRON SOC, V343, P978, DOI 10.1046/j.1365-8711.2003.06740.x; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Stanway ER, 2003, MON NOT R ASTRON SOC, V342, P439, DOI 10.1046/j.1365-8711.2003.06546.x; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; Sullivan M, 2000, MON NOT R ASTRON SOC, V312, P442, DOI 10.1046/j.1365-8711.2000.03140.x; Tresse L, 1998, ASTROPHYS J, V495, P691, DOI 10.1086/305331; Waddington I, 2001, MON NOT R ASTRON SOC, V328, P882, DOI 10.1046/j.1365-8711.2001.04934.x	29	380	381	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					625	627		10.1038/nature02474	http://dx.doi.org/10.1038/nature02474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071588	Green Submitted			2022-12-28	WOS:000220697200035
J	Hanson, RE; Crowley, JL; Bowring, SA; Ramezani, J; Gose, WA; Dalziel, IWD; Pancake, JA; Seidel, EK; Blenkinsop, TG; Mukwakwami, J				Hanson, RE; Crowley, JL; Bowring, SA; Ramezani, J; Gose, WA; Dalziel, IWD; Pancake, JA; Seidel, EK; Blenkinsop, TG; Mukwakwami, J			Coeval large-scale magmatism in the Kalahari and Laurentian cratons during Rodinia assembly	SCIENCE			English	Article							LARGE IGNEOUS PROVINCE; UMKONDO DOLERITES; MIDCONTINENT RIFT; EASTERN ZIMBABWE; MAFIC INTRUSIONS; ZIRCON AGES; PALEOMAGNETISM; GEOCHRONOLOGY; ROCKS; BADDELEYITE	We show that intraplate magmatism occurred 1106 to 1112 million years ago over an area of two million square kilometers within the Kalahari craton of southern Africa, during the same magnetic polarity chron as voluminous magmatism within the cratonic core of North America. These contemporaneous magmatic events occurred while the Rodinia supercontinent was being assembled and are inferred to be parts of a single large igneous province emplaced across the two cratons. Widespread intraplate magmatism during Rodinia assembly shows that mantle upwellings required to generate such provinces may occur independently of the supercontinent cycle.	Texas Christian Univ, Dept Geol, Ft Worth, TX 76129 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Texas, Inst Geophys, Austin, TX 78759 USA; Univ Texas, Dept Geol Sci, Austin, TX 78759 USA; Univ Western Australia, Sch Earth & Geog Sci, Tecton Special Res Ctr, Crawley, WA 6009, Australia; EG&G Tech Serv Inc, Morgantown, WV 26505 USA; James Cook Univ N Queensland, Dept Earth Sci, Townsville, Qld 4811, Australia; Univ Zimbabwe, Dept Geol, Harare, Zimbabwe	Texas Christian University; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Western Australia; James Cook University; University of Zimbabwe	Hanson, RE (corresponding author), Texas Christian Univ, Dept Geol, Ft Worth, TX 76129 USA.	r.hanson@tcu.edu	Blenkinsop, Tom/I-9204-2019; Dalziel, Ian/G-5926-2010; Blenkinsop, Thomas G/B-4619-2011	Blenkinsop, Tom/0000-0001-9684-0749; Blenkinsop, Thomas G/0000-0001-9684-0749; Crowley, James/0000-0001-5069-0773				ALLEN DJ, 1997, GEOL SOC AM SPEC PAP, V312, P47; ALLSOPP HL, 1989, S AFR J GEOL, V92, P11; ANDERSON DL, 1994, GEOLOGY, V22, P39, DOI 10.1130/0091-7613(1994)022<0039:SOS>2.3.CO;2; Anderson DL, 2001, SCIENCE, V293, P2016, DOI 10.1126/science.1065448; BAUER W, 2003, GEOLOGICAL SOC SPECI, V206, P247, DOI DOI 10.1144/GSL.SP.2003.206.01.13; BOWRING SA, UNPUB; Buchan KL, 2001, PRECAMBRIAN RES, V110, P9, DOI 10.1016/S0301-9268(01)00178-4; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Dalziel IWD, 2000, EARTH PLANET SC LETT, V178, P1, DOI 10.1016/S0012-821X(00)00061-3; Dalziel IWD, 2000, J GEOL, V108, P499, DOI 10.1086/314418; Davis DW, 1997, CAN J EARTH SCI, V34, P476, DOI 10.1139/e17-039; Ernst RE, 2001, GEOL SOC AM SPEC PAP, P483; French JE, 2002, CHEM GEOL, V188, P85, DOI 10.1016/S0009-2541(02)00074-8; Groenewald PB, 1995, PRECAMBRIAN RES, V75, P231, DOI 10.1016/0301-9268(95)00032-1; Guillou L, 1995, J GEOPHYS RES-SOL EA, V100, P24217, DOI 10.1029/95JB02518; GURNIS M, 1988, NATURE, V332, P695, DOI 10.1038/332695a0; HALLS HC, 1982, GEOL SOC AM MEM, V156, P173; Hanson R.E., 2003, GEOLOGICAL SOC LONDO, V206, P427; Hanson RE, 1998, GEOLOGY, V26, P1143, DOI 10.1130/0091-7613(1998)026<1143:UPZAFT>2.3.CO;2; HARGRAVES RB, 1994, S AFR J GEOL, V97, P114; HARLAN SS, 1993, CAN J EARTH SCI, V30, P1415, DOI 10.1139/e93-122; HEAMAN LM, 1992, CONTRIB MINERAL PETR, V110, P289, DOI 10.1007/BF00310744; HEAMAN LM, 1992, GEOLOGY, V20, P637, DOI 10.1130/0091-7613(1992)020<0637:GDSITP>2.3.CO;2; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; Jones DL, 2003, TECTONOPHYSICS, V375, P247, DOI 10.1016/S0040-1951(03)00341-X; JONES DL, 1966, J GEOPHYS RES, V71, P543, DOI 10.1029/JZ071i002p00543; Kampunzu AB, 1998, GEOL MAG, V135, P669, DOI 10.1017/S001675689800123X; Kampunzu AB, 2000, J AFR EARTH SCI, V30, P579, DOI 10.1016/S0899-5362(00)00040-3; KELLER GR, 1989, GEOLOGY, V17, P1049, DOI 10.1130/0091-7613(1989)017<1049:GAGCOT>2.3.CO;2; King SD, 1998, EARTH PLANET SC LETT, V160, P289, DOI 10.1016/S0012-821X(98)00089-2; MCELHINNY MW, 1964, J GEOPHYS RES, V69, P2465, DOI 10.1029/JZ069i012p02465; MCELHINNY MW, 1966, GEOPHYS J ROY ASTRON, V10, P375; Meert JG, 2003, TECTONOPHYSICS, V375, P261, DOI 10.1016/S0040-1951(03)00342-1; Munyanyiwa H, 1999, J AFR EARTH SCI, V28, P349, DOI 10.1016/S0899-5362(99)00009-3; Peters M., 1989, BERICHTE POLARFORSCH, V61, P1; PFURR N, 1991, COMMUNICATIONS GEOLO, V7, P35; PISAREVSKY SA, 2003, GEOL SOC SPEC PUBL, P35, DOI DOI 10.1144/GSL.SP.2003.206.01.04; Reeves CV, 2002, J AFR EARTH SCI, V34, P101, DOI 10.1016/S0899-5362(02)00011-8; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Schwartz MO, 1996, S AFR J GEOL, V99, P245; SHASTRI LL, 1991, GEOL SOC AM ABSTR, V232, P93; Singletary SJ, 2003, PRECAMBRIAN RES, V121, P47, DOI 10.1016/S0301-9268(02)00201-2; van Schmus W. R., 1990, GEOL SOC AM ABSTR, V22, pA174; Ward SE, 2000, J AFR EARTH SCI, V30, P689, DOI 10.1016/S0899-5362(00)00046-4; Weil AB, 2003, TECTONOPHYSICS, V375, P199, DOI 10.1016/S0040-1951(03)00339-1; WILSON JF, 1987, GEOL ASSOC CAN SPEC, V34, P433; Wingate MTD, 2004, GEOLOGY, V32, P105, DOI 10.1130/G20171.1; Wingate MTD, 2001, S AFR J GEOL, V104, P13, DOI 10.2113/104.1.13; Zartman RE, 1997, CAN J EARTH SCI, V34, P549, DOI 10.1139/e17-044	49	155	159	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1126	1129		10.1126/science.1096329	http://dx.doi.org/10.1126/science.1096329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15105458				2022-12-28	WOS:000221524500033
J	Pearce, N; Foliaki, S; Sporle, A; Cunningham, C				Pearce, N; Foliaki, S; Sporle, A; Cunningham, C			Genetics, race, ethnicity, and health	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENES; EPIDEMIOLOGY; INDIVIDUALS; MAORI		Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; Massey Univ, Sch Maori Studies, Wellington, New Zealand; Univ Auckland, Dept Stat, Auckland 1, New Zealand	Massey University; Massey University; University of Auckland	Pearce, N (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington Campus,Private Box 756, Wellington, New Zealand.	n.e.pearce@massey.ac.nz	Health, Hauora/HCH-4744-2022	Pearce, Neil/0000-0002-9938-7852; , Sunia/0000-0002-3238-5940				Ajwani S., 2003, DECADES DISPARITY ET; Cooper RS, 2003, INT J EPIDEMIOL, V32, P23, DOI 10.1093/ije/dyg036; Cruickshank JK, 2001, INT J EPIDEMIOL, V30, P111, DOI 10.1093/ije/30.1.111; Durie MH, 1995, J POLYNESIAN SOC, V104, P461; Ellison-Loschmann L, 2000, Pac Health Dialog, V7, P82; Ellison-Loschmann L, 2002, NEW ZEAL MED J, V115, P6; FITZGERALD M, 2001, TIME            0820, V33, P46; Foliaki S, 2003, BMJ-BRIT MED J, V327, P437, DOI 10.1136/bmj.327.7412.437; Foliaki S, 2003, BMJ-BRIT MED J, V327, P406, DOI 10.1136/bmj.327.7412.406; Ibrahim SA, 2003, AM J PUBLIC HEALTH, V93, P1619, DOI 10.2105/AJPH.93.10.1619; LEWONTIN RC, 1991, DOCTRINE DNA; Lewontin Richard, 1982, HUMAN DIVERSITY; MARSHALL SJ, 1994, NEW ZEAL MED J, V107, P106; McMichael AJ, 2001, HUMAN FRONTIERS ENV, DOI [10.1017/CBO9781139106924, DOI 10.1017/CBO9781139106924]; NEEL JV, 1962, AM J HUM GENET, V14, P353; POTTER JD, 1992, JAMA-J AM MED ASSOC, V268, P1573; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632	20	99	107	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1070	1072		10.1136/bmj.328.7447.1070	http://dx.doi.org/10.1136/bmj.328.7447.1070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117796	Green Published, Green Accepted			2022-12-28	WOS:000221174500028
J	ffrench-Constant, C; Colognato, H; Franklin, RJM				ffrench-Constant, C; Colognato, H; Franklin, RJM			The mysteries of Myelin unwrapped	SCIENCE			English	Editorial Material							SCHWANN-CELL; CNS; AXON		Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England; Univ Cambridge, Dept Med Genet, Cambridge CB2 1TN, England; Univ Cambridge, Dept Vet Med, Cambridge CB2 1TN, England; Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	ffrench-Constant, C (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England.	cfc@mole.bio.cam.ac.uk		Franklin, Robin/0000-0001-6522-2104				BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; CARR CE, 1990, J NEUROSCI, V10, P3227; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fanarraga ML, 1998, J COMP NEUROL, V399, P94; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hara Y, 2003, EXP NEUROL, V184, P428, DOI 10.1016/S0014-4886(03)00259-0; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862	11	20	23	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					688	689		10.1126/science.1097851	http://dx.doi.org/10.1126/science.1097851			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118149				2022-12-28	WOS:000221105300029
J	Olsen, EM; Heino, M; Lilly, GR; Morgan, MJ; Brattey, J; Ernande, B; Dieckmann, U				Olsen, EM; Heino, M; Lilly, GR; Morgan, MJ; Brattey, J; Ernande, B; Dieckmann, U			Maturation trends indicative of rapid evolution preceded the collapse of northern cod	NATURE			English	Article							LIFE-HISTORY EVOLUTION; GADUS-MORHUA; REACTION NORMS; SIZE; AGE; REPRODUCTION; POPULATIONS; PLASTICITY; FISHERIES; PATTERN	Northern cod, comprising populations of Atlantic cod ( Gadus morhua) off southern Labrador and eastern Newfoundland, supported major fisheries for hundreds of years(1). But in the late 1980s and early 1990s, northern cod underwent one of the worst collapses in the history of fisheries(2-4). The Canadian government closed the directed fishing for northern cod in July 1992, but even after a decade-long offshore moratorium, population sizes remain historically low(4). Here we show that, up until the moratorium, the life history of northern cod continually shifted towards maturation at earlier ages and smaller sizes. Because confounding effects of mortality changes and growth-mediated phenotypic plasticity are accounted for in our analyses, this finding strongly suggests fisheries-induced evolution of maturation patterns in the direction predicted by theory(5,6). We propose that fisheries managers could use the method described here as a tool to provide warning signals about changes in life history before more overt evidence of population decline becomes manifest.	Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria; Inst Marine Res, N-5817 Bergen, Norway; Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF A1C 5X1, Canada	International Institute for Applied Systems Analysis (IIASA); Institute of Marine Research - Norway; Fisheries & Oceans Canada	Olsen, EM (corresponding author), Univ Oslo, Dept Biol, Div Marine Biol & Limnol, POB 1064, N-0316 Oslo, Norway.	espeom@bio.uio.no	Heino, Mikko P/C-7241-2009; Dieckmann, Ulf/E-1424-2011; Ernande, Bruno/C-1182-2008; Olsen, Esben Moland/B-1894-2012	Heino, Mikko P/0000-0003-2928-3940; Dieckmann, Ulf/0000-0001-7089-0393; Ernande, Bruno/0000-0002-0727-5774; Olsen, Esben Moland/0000-0003-3807-7524				ALM GUNNAR, 1959, REPT INST FRESHWATER RES DROTTNINGHOLM, V40, P5; BAROT S, 2003, IR03043 IIASA; Bishop C.A., 1994, Northwest Atlantic Fisheries Organization Scientific Council Studies, V21, P105; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Haugen TO, 2001, GENETICA, V112, P475, DOI 10.1023/A:1013315116795; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P1612, DOI 10.1139/f99-088; HUTCHINGS JA, 1995, N ATLANTIC FISHERIES, P39; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; LEAR W H, 1984, Journal of Northwest Atlantic Fishery Science, V5, P143; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; MANLY FJ, 1997, RANDOMIZATION BOOTST; Morgan M. Joanne, 1997, Journal of Northwest Atlantic Fishery Science, V21, P51; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Ruzzante DE, 2001, CONSERV GENET, V2, P257, DOI 10.1023/A:1012247213644; SOHN JJ, 1977, SCIENCE, V195, P199, DOI 10.1126/science.831271; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; STOKES TK, 1993, EXPLOITATION EVOLVIN; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628	29	616	641	5	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					932	935		10.1038/nature02430	http://dx.doi.org/10.1038/nature02430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118724				2022-12-28	WOS:000221083000038
J	Shand, D				Shand, D			Pilates to pit	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Shand, D (corresponding author), The Lancet, London NW1 7BY, England.								0	8	8	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1340	1340		10.1016/S0140-6736(04)16085-6	http://dx.doi.org/10.1016/S0140-6736(04)16085-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110489				2022-12-28	WOS:000220996300006
J	Manchester, RN				Manchester, RN			Observational properties of pulsars	SCIENCE			English	Review							X-RAY PULSAR; MILLISECOND PULSARS; DISCOVERY; RADIO; PULSATIONS; EVOLUTION; SYSTEMS; BINARY; KICKS	Pulsars are remarkable clocklike celestial sources that are believed to be rotating neutron stars formed in supernova explosions. They are valuable tools for investigations into topics such as neutron star interiors, globular cluster dynamics, the structure of the interstellar medium, and gravitational physics. Searches at radio and x-ray wavelengths over the past 5 years have resulted in a large increase in the number of known pulsars and the discovery of new populations of pulsars, posing challenges to theories of binary and stellar evolution. Recent images at radio, optical, and x-ray wavelengths have revealed structures resulting from the interaction of pulsar winds with the surrounding interstellar medium, giving new insights into the physics of pulsars.	CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Manchester, RN (corresponding author), CSIRO, Australia Telescope Natl Facil, POB 76, Epping, NSW 1710, Australia.	dick.manchester@csiro.au						*ATNF, 2004, ATNF PULS CAT VERS 1; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Camilo F, 2002, ASTROPHYS J, V574, pL71, DOI 10.1086/342351; Camilo F, 2002, ASTROPHYS J, V571, pL41, DOI 10.1086/341178; Camilo F, 2002, ASTROPHYS J, V567, pL71, DOI 10.1086/339799; Camilo F, 2000, ASTROPHYS J, V541, P367, DOI 10.1086/309435; Caraveo PA, 1999, ASTRON ASTROPHYS, V344, P367; Crawford F, 2001, ASTROPHYS J, V554, P152, DOI 10.1086/321328; D'Amico N, 2002, ASTROPHYS J, V570, pL89, DOI 10.1086/341030; Dodson R, 2003, ASTROPHYS J, V596, P1137, DOI 10.1086/378089; Edwards RT, 2001, MON NOT R ASTRON SOC, V326, P358, DOI 10.1046/j.1365-8711.2001.04637.x; FOSTER RS, 1990, ASTROPHYS J, V361, P300, DOI 10.1086/169195; Freire PC, 2001, ASTROPHYS J, V557, pL105, DOI 10.1086/323248; Gavriil FP, 2002, NATURE, V419, P142, DOI 10.1038/nature01011; Gotthelf EV, 2000, ASTROPHYS J, V542, pL37, DOI 10.1086/312923; Han JL, 2002, ASTROPHYS J, V570, pL17, DOI 10.1086/340931; Helfand DJ, 2001, ASTROPHYS J, V556, P380, DOI 10.1086/321533; Hester JJ, 2002, ASTROPHYS J, V577, pL49, DOI 10.1086/344132; HOBBS G, UNPUB; Hughes JP, 2001, ASTROPHYS J, V559, pL153, DOI 10.1086/323974; Jaffe AH, 2003, ASTROPHYS J, V583, P616, DOI 10.1086/345443; JENET FA, IN PRESS ASTROPHYS J; KASPI VM, 1994, ASTROPHYS J, V428, P713, DOI 10.1086/174280; Kaspi VM, 2003, ASTROPHYS J, V596, pL71, DOI 10.1086/379093; Kramer M, 2003, MON NOT R ASTRON SOC, V342, P1299, DOI 10.1046/j.1365-8711.2003.06637.x; Lai D, 2001, ASTROPHYS J, V549, P1111, DOI 10.1086/319455; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; LORIMER DR, IN PRESS IAU S, V218; Manchester RN, 2001, MON NOT R ASTRON SOC, V328, P17, DOI 10.1046/j.1365-8711.2001.04751.x; Marshall FE, 1998, ASTROPHYS J, V499, pL179, DOI 10.1086/311381; McHugh MP, 1996, PHYS REV D, V54, P5993, DOI 10.1103/PhysRevD.54.5993; MCLAUGHLIN MA, IN PRESS IAU S, V218; Morris DJ, 2002, MON NOT R ASTRON SOC, V335, P275, DOI 10.1046/j.1365-8711.2002.05551.x; Murray SS, 2002, ASTROPHYS J, V568, P226, DOI 10.1086/338766; Ng CY, 2004, ASTROPHYS J, V601, P479, DOI 10.1086/380486; RADHAKRISHNAN V, 1969, ASTROPHYS LETT, V3, P225; SPITKOVSKY A, IN PRESS IAU S, V218; Spruit H, 1998, NATURE, V393, P139, DOI 10.1038/30168; Stairs IH, 2004, SCIENCE, V304, P547, DOI 10.1126/science.1096986; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; Torii K, 1997, ASTROPHYS J, V489, pL145, DOI 10.1086/316798; Torii K, 1999, ASTROPHYS J, V523, pL69, DOI 10.1086/312251; VRANESEVIC N, UNPUB; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733	45	36	39	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					542	546		10.1126/science.1097649	http://dx.doi.org/10.1126/science.1097649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105491				2022-12-28	WOS:000220975100036
J	Lim, PL; Kurup, A; Gopalakrishna, G; Chan, KP; Wong, CW; Ng, LC; Se-Thoe, SY; Oon, L; Bai, XL; Stanton, LW; Ruan, Y; Miller, LD; Vega, VB; James, L; Ooi, PL; Kai, CS; Olsen, SJ; Ang, B; Leo, YS				Lim, PL; Kurup, A; Gopalakrishna, G; Chan, KP; Wong, CW; Ng, LC; Se-Thoe, SY; Oon, L; Bai, XL; Stanton, LW; Ruan, Y; Miller, LD; Vega, VB; James, L; Ooi, PL; Kai, CS; Olsen, SJ; Ang, B; Leo, YS			Brief report - Laboratory-acquired severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEST-NILE-VIRUS; CLINICAL-FEATURES; HIGH-THROUGHPUT; CORONAVIRUS; SARS		Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore; Singapore Gen Hosp, Dept Med, Singapore 0316, Singapore; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Minist Hlth, Singapore, Singapore; Genome Inst Singapore, Singapore, Singapore; DSO Natl Labs, Singapore, Singapore; Ctr Dis Control & Prevent, Int Emerging Infect Program, Nonthaburi, Thailand	Tan Tock Seng Hospital; Singapore General Hospital; Singapore General Hospital; Ministry of Health-Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Lim, PL (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	pllim@post.harvard.edu	Wong, Christopher/C-5830-2008; Miller, Lance/A-5633-2009	Miller, Lance/0000-0003-3799-2528				*BERNH NOCHT I TRO, 2000, RES THER TRAIN TROP; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; *CDCP, UPD INT US CAS DEF S; *CDCP, TRAV AL REM SING; *CDCP, 2004, SARS INF TRAV; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; *MIN HLTH, 2003, BIOS SARS INC SING S; Ng LFP, 2004, J CLIN MICROBIOL, V42, P347, DOI 10.1128/JCM.42.1.347-350.2004; Ruan YJ, 2003, LANCET, V361, P1779, DOI 10.1016/S0140-6736(03)13414-9; Ruan YJ, 2003, LANCET, V361, P1832; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Shi PY, 2001, J CLIN MICROBIOL, V39, P1264, DOI 10.1128/JCM.39.4.1264-1271.2001; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; *WHO, CAS DEF SURV SEV AC; Wong CW, 2004, GENOME RES, V14, P398, DOI 10.1101/gr.2141004	20	92	97	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1740	1745		10.1056/NEJMoa032565	http://dx.doi.org/10.1056/NEJMoa032565			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15103000	Bronze			2022-12-28	WOS:000220947300008
J	Carr, A				Carr, A			Antiretroviral therapy for previously untreated HIV-1-infected adults: 2NN, or just one?	LANCET			English	Editorial Material							LAMIVUDINE; ZIDOVUDINE; INDINAVIR; TRIAL		St Vincents Hosp, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney	Carr, A (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.	acarr@stvincents.com.au						BARTLETT JA, 2002, 14 INT AIDS C BARC J; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; DELFRAISSY JF, 2002, 6 INT C DRUG THER HI; *DHHS HJ KAIS FAM, GUID US ANT AG HIV 1; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; GALLANT JE, 2003, 43 INT C ANT AG CHEM; HALL D, 2004, 11 C RETR OPP INF SA, P694; MONTANER JSG, 2001, 41 INT C ANT AG CHEM; *NAT I HLTH NAT I, IMP INT RES PHAS 3 R; National Cholesterol Education Program (U.S.), RISK ASS TOOL EST YO; Nunez Marina, 2002, HIV Clin Trials, V3, P186; Podzamczer D, 2002, ANTIVIR THER, V7, P81; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007	16	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1248	1250		10.1016/S0140-6736(04)16028-5	http://dx.doi.org/10.1016/S0140-6736(04)16028-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094265				2022-12-28	WOS:000220904900002
J	Lucassen, AM; Parker, M; Wheeler, R				Lucassen, AM; Parker, M; Wheeler, R			Role of next of kin in accessing health records of deceased relatives	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Family history is an important tool used by clinical geneticists to assess risk. Patients' recollection of family illnesses can sometimes be inaccurate or lack detail. Information obtained through medical records of the patient's relatives is therefore important. When relatives are alive, the person seeking genetic advice usually asks them for access to their medical records. However, access is more difficult if the relatives are dead. This difficulty is the result of a combination of a lack of clarity in the law and a wariness among hospital departments about releasing information in the light of recent public inquiries and means that hospital departments are often unwilling to allow access to the medical records of deceased patients without consent From their next of kin. We use a fictional case based on real experiences to illustrate the difficulties that this practice can cause in obtaining relevant information for diagnostic and surveillance management of relatives.	Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; Southampton Univ NHS Trust, Southampton SO16 5YB, Hants, England	University of Oxford; University of Southampton	Lucassen, AM (corresponding author), Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England.	annekel@soton.ac.uk	Lucassen, Anneke/D-7764-2017	Lucassen, Anneke/0000-0003-3324-4338				*COMM ETH GEN THER, 1992, CM1788 COMM ETH GEN; *GEN MED COUNC, CONF PROT PROV INF; *HUM GEN COMM, 2002, INF BAL INT US PERS; Savulescu J., 2000, J LAW MED, V8, P81	4	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					952	953		10.1136/bmj.328.7445.952	http://dx.doi.org/10.1136/bmj.328.7445.952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087350	Green Submitted, Green Published			2022-12-28	WOS:000220994400035
J	Hu, MCT; Lee, DF; Xia, WY; Golfman, LS; Fu, OY; Yang, JY; Zou, YY; Bao, SL; Hanada, N; Saso, H; Kobayashi, R; Hung, MC				Hu, MCT; Lee, DF; Xia, WY; Golfman, LS; Fu, OY; Yang, JY; Zou, YY; Bao, SL; Hanada, N; Saso, H; Kobayashi, R; Hung, MC			I kappa B kinase promotes tumorigenesis through inhibition of forkhead FOXO3a	CELL			English	Article							CELL-CYCLE REGULATION; TRANSCRIPTION FACTORS; PROTEIN; DOWNSTREAM; RECEPTOR; PATHWAY; DEATH	Nuclear exclusion of the forkhead transcription factor FOXO3a by protein kinase Akt contributes to cell survival. We investigated the pathological relationship between phosphoylated-Akt (Akt-p) and FOXO3a in primary tumors. Surprisingly, FOXO3a was found to be excluded from the nuclei of some tumors lacking Akt-p, suggesting an Akt-independent mechanism of regulating FOXO3a localization. We provide evidence for such a mechanism by showing that IkappaB kinase (IKK) physically interacts with, phosphorylates, and inhibits FOXO3a independent of Akt and causes proteolysis of FOXO3a via the Ub-dependent proteasome pathway, Cytoplasmic FOXO3a correlates with expression of IKKbeta or Akt-p in many tumors and associates with poor survival in breast cancer. Further, constitutive expression of IKKbeta promotes cell proliferation and tumorigenesis that can be overridden by FOXO3a. These results suggest the negative regulation of FOXO factors by IKK as a key mechanism for promoting cell growth and tumorigenesis.	Univ Texas, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System	Hu, MCT (corresponding author), Univ Texas, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	michu@mdanderson.org; rnhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Lee, Dung-Fang/0000-0003-2387-597X	NATIONAL CANCER INSTITUTE [P01CA099031, R01CA058880] Funding Source: NIH RePORTER; NCI NIH HHS [CA16772, R01 CA58880, P01 CA99031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	21	741	774	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					225	237		10.1016/S0092-8674(04)00302-2	http://dx.doi.org/10.1016/S0092-8674(04)00302-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084260	Bronze			2022-12-28	WOS:000220913400010
J	King, C; Ilic, A; Koelsch, K; Sarvetnick, N				King, C; Ilic, A; Koelsch, K; Sarvetnick, N			Homeostatic expansion of T cells during immune insufficiency generates autoimmunity	CELL			English	Article							NONOBESE DIABETIC MICE; COMMON GAMMA-CHAIN; NOD MICE; SYSTEMIC AUTOIMMUNITY; IL-21 RECEPTOR; CUTTING EDGE; EXPRESSION; BCL-2; APOPTOSIS; INFECTION	During illness and stress, the immune system can suffer a considerable loss of T cells (lymphopenia). The remaining T cells undergo vigorous compensatory expansion, known as homeostatic proliferation, to reconstitute the immune system. Interestingly, human diseases of autoimmune etiology often present with immune deficiencies such as lymphopenia. In this study, we show that reduced T cell numbers and the resulting exaggerated homeostatic-type proliferation of T cells generate autoimmunity. The cycling T cell population is short lived, and the depleted memory compartment fuels the generation of new effector T cells. A catalyst for these phenomena is the increased responses to the cytokine IL-21, a mediator that regulates T cell turnover. We conclude that poor T cell survival and lymphopenia precipitate autoimmune disease.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Sarvetnick, N (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noras@scripps.edu	Koelsch, Kersten/B-6745-2008; King, Cecile/Q-9794-2019	Koelsch, Kersten/0000-0002-6411-4248; King, Cecile/0000-0003-2193-2563	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054063] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54063] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; ARMITAGE RJ, 1990, INT IMMUNOL, V2, P1039, DOI 10.1093/intimm/2.11.1039; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bateman HE, 1999, J RHEUMATOL, V26, P2482; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; DARDENNE M, 1989, EUR J IMMUNOL, V19, P889, DOI 10.1002/eji.1830190516; Denny P, 1997, DIABETES, V46, P695, DOI 10.2337/diabetes.46.4.695; Di Sabatino A, 2001, IMMUNOLOGY, V103, P435, DOI 10.1046/j.1365-2567.2001.01245.x; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FOWELL D, 1991, IMMUNOL REV, V123, P37, DOI 10.1111/j.1600-065X.1991.tb00605.x; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Greenhill J P, 1966, Int Surg, V45, P28; Hernan MA, 2001, EPIDEMIOLOGY, V12, P301, DOI 10.1097/00001648-200105000-00009; Holt PG, 1998, ENVIRON HEALTH PERSP, V106, P795, DOI 10.2307/3434191; Isaacs JD, 2001, ARTHRITIS RHEUM, V44, P1998, DOI 10.1002/1529-0131(200109)44:9<1998::AID-ART348>3.0.CO;2-T; KAABA SA, 1995, IMMUNOL LETT, V47, P209, DOI 10.1016/0165-2478(95)00088-5; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kukreja A, 1999, J CLIN ENDOCR METAB, V84, P4371, DOI 10.1210/jc.84.12.4371; KWOH C K, 1992, Current Opinion in Rheumatology, V4, P138; La Gruta NL, 2000, EUR J IMMUNOL, V30, P3380; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Marrack P, 1998, IMMUNOL REV, V165, P279, DOI 10.1111/j.1600-065X.1998.tb01245.x; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Mendelsohn JA, 2002, HIST PHIL LIFE SCI, V24, P3, DOI 10.1080/03919710210001714293; Morgan DJ, 1996, J IMMUNOL, V157, P978; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Permar SR, 2003, J VIROL, V77, P7872, DOI 10.1128/JVI.77.14.7872-7879.2003; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; RABINOVITCH A, 1994, DIABETES, V43, P613, DOI 10.2337/diabetes.43.5.613; Rietz C, 2003, SCAND J IMMUNOL, V57, P342, DOI 10.1046/j.1365-3083.2003.01244.x; ROCHA B, 1983, J IMMUNOL, V131, P2158; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; SAI P, 1994, CLIN EXP IMMUNOL, V97, P138; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; SATOH J, 1988, TOHOKU J EXP MED, V155, P151, DOI 10.1620/tjem.155.151; Schaller J G, 1975, Birth Defects Orig Artic Ser, V11, P173; Serreze DV, 2001, DIABETES, V50, P1992, DOI 10.2337/diabetes.50.9.1992; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Sitnicka E, 1996, BLOOD, V88, P82; Sleasman J W, 1996, Adv Dent Res, V10, P57; Snow JW, 2003, EXP HEMATOL, V31, P1253, DOI 10.1016/j.exphem.2003.09.014; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI12173; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TWAROG FJ, 1970, J IMMUNOL, V104, P1467; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	66	530	558	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					265	277		10.1016/S0092-8674(04)00335-6	http://dx.doi.org/10.1016/S0092-8674(04)00335-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084263	Bronze			2022-12-28	WOS:000220913400013
J	Levitan, IB				Levitan, IB			A well-stocked pool	SCIENCE			English	Editorial Material							CALCIUM-CHANNELS; CALMODULIN; INACTIVATION; SUPPORTS		Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Levitan, IB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	levitani@mail.med.upenn.edu						BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	12	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					394	395		10.1126/science.1097507	http://dx.doi.org/10.1126/science.1097507			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087533				2022-12-28	WOS:000220845400030
J	Sabatier, C; Plump, AS; Ma, L; Brose, K; Tamada, A; Murakami, F; Lee, EYHP; Tessier-Lavigne, M				Sabatier, C; Plump, AS; Ma, L; Brose, K; Tamada, A; Murakami, F; Lee, EYHP; Tessier-Lavigne, M			The divergent Robo family protein Rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons	CELL			English	Article							RAT SPINAL-CORD; NERVOUS-SYSTEM; CNS MIDLINE; GUIDANCE RECEPTORS; DROSOPHILA; ROUNDABOUT; REPELLENT; ENCODES; CLONING; NEURONS	Commissural axons in vertebrates and insects are initially attracted to the nervous system midline, but once they reach this intermediate target they undergo a dramatic switch, becoming responsive to repellent Slit proteins at the midline, which expel them onto the next leg of their trajectory. We have unexpectedly implicated a divergent member of the Robo family, Rig-1 (or Robo3), in preventing premature Slit sensitivity in mammals. Expression of Rig-1 protein by commissural axons is inversely correlated with Slit sensitivity. Removal of Rig-1 results in a total failure of commissural axons to cross. Genetic and in vitro analyses indicate that Rig-1 functions to repress Slit responsiveness similarly to Commissureless (Comm) in Drosophila. Unlike Comm, however, Rig-1 does not produce its effect by downregulating Robo receptors on precrossing commissural axon membranes. These results identify a mechanism for regulating Slit repulsion that helps choreograph the precise switch from attraction to repulsion at a key intermediate axonal target.	Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, Stanford, CA 94305 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Natl Inst Basic Biol, Div Behav & Neurobiol, Okazaki, Aichi 4448585, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Genentech Inc, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Irvine; University of California System; University of California Irvine; Roche Holding; Genentech	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, Stanford, CA 94305 USA.	marctl@gene.com	Ma, Le/A-3733-2013	Ma, Le/0000-0003-2769-9416; Tamada, Atsushi/0000-0003-3677-6102				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LONG H, 2004, IN PRESS NEURON, V42; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	30	318	322	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					157	169		10.1016/S0092-8674(04)00303-4	http://dx.doi.org/10.1016/S0092-8674(04)00303-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084255	Bronze			2022-12-28	WOS:000220913400005
J	Fromhold, TM; Patane, A; Bujkiewicz, S; Wilkinson, PB; Fowler, D; Sherwood, D; Stapleton, SP; Krokhin, AA; Eaves, L; Henini, M; Sankeshwar, NS; Sheard, FW				Fromhold, TM; Patane, A; Bujkiewicz, S; Wilkinson, PB; Fowler, D; Sherwood, D; Stapleton, SP; Krokhin, AA; Eaves, L; Henini, M; Sankeshwar, NS; Sheard, FW			Chaotic electron diffusion through stochastic webs enhances current flow in superlattices	NATURE			English	Article							QUANTUM CHAOS; DYNAMICS; SYSTEM; WAVE	Understanding how complex systems respond to change is of fundamental importance in the natural sciences. There is particular interest in systems whose classical newtonian motion becomes chaotic(1-22) as an applied perturbation grows. The transition to chaos usually occurs by the gradual destruction of stable orbits in parameter space, in accordance with the Kolmo-gorov-Arnold-Moser (KAM) theorem(1-3,6-9)-a cornerstone of nonlinear dynamics that explains, for example, gaps in the asteroid belt(2). By contrast, 'non-KAM' chaos switches on and off abruptly at critical values of the perturbation frequency(6-9). This type of dynamics has wide-ranging implications in the theory of plasma physics(10), tokamak fusion(11), turbulence(6,7,12), ion traps(13), and quasicrystals(6,8). Here we realize non-KAM chaos experimentally by exploiting the quantum properties of electrons in the periodic potential of a semiconductor superlattice(22-27) with an applied voltage and magnetic field. The onset of chaos at discrete voltages is observed as a large increase in the current flow due to the creation of unbound electron orbits, which propagate through intricate web patterns(6-10,12-16) in phase space. Non-KAM chaos therefore provides a mechanism for controlling the electrical conductivity of a condensed matter device: its extreme sensitivity could find applications in quantum electronics and photonics.	Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Nottingham	Fromhold, TM (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.	mark.fromhold@nottingham.ac.uk	Sankeshwar, Nandkumar/AAD-9471-2020; Henini, Mohamed/O-3341-2019; Sankeshwar, Nandkumar S./G-7031-2012; Krokhin, Arkadii/L-7771-2014	Sankeshwar, Nandkumar/0000-0002-1326-2080; Henini, Mohamed/0000-0001-9414-8492; Eaves, Laurence/0000-0002-5334-0987; patane, amalia/0000-0003-3015-9496; Fromhold, Timothy/0000-0001-7451-2525; Bujkiewicz, Sylwia/0000-0002-3003-9403				Amann A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.193313; BELOSHAPKIN VV, 1989, NATURE, V337, P133, DOI 10.1038/337133a0; BERRY MV, 1987, PROC R SOC LON SER-A, V413, P183, DOI 10.1098/rspa.1987.0109; Canali L, 1996, PHYS REV LETT, V76, P3618, DOI 10.1103/PhysRevLett.76.3618; CHERNIKOV AA, 1987, NATURE, V326, P559, DOI 10.1038/326559a0; Chia PK, 1996, PHYS PLASMAS, V3, P1545, DOI 10.1063/1.872014; Demikhovskii VY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.154101; Demikhovskii VY, 1999, PHYS REV E, V59, P294, DOI 10.1103/PhysRevE.59.294; ESAKI L, 1970, IBM J RES DEV, V14, P61, DOI 10.1147/rd.141.0061; Fromhold TM, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155312; Fromhold TM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.046803; Gardiner SA, 1997, PHYS REV LETT, V79, P4790, DOI 10.1103/PhysRevLett.79.4790; Gutzwiller M.C., 1990, CHAOS CLASSICAL QUAN; HELLER EJ, 1984, PHYS REV LETT, V53, P1515, DOI 10.1103/PhysRevLett.53.1515; Hensinger WK, 2001, NATURE, V412, P52, DOI 10.1038/35083510; JENSEN RV, 1992, NATURE, V355, P311, DOI 10.1038/355311a0; Kamenev D. I., 2000, QUANTUM CHAOS HARMON; KARNEY CFF, 1977, PHYS REV LETT, V39, P550, DOI 10.1103/PhysRevLett.39.550; Lichtenberg A. J., 1992, REGUL CHAOTIC DYN; Patane A, 2002, APPL PHYS LETT, V81, P661, DOI 10.1063/1.1496140; Penrose R., 1974, B I MATH APPL, V10, P266; Scott RG, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.023407; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Steck DA, 2001, SCIENCE, V293, P274, DOI 10.1126/science.1061569; Stockmann H. J., 1999, QUANTUM CHAOS INTRO; TSU R, 1975, PHYS REV B, V12, P680, DOI 10.1103/PhysRevB.12.680; Wacker A, 2002, PHYS REP, V357, P1, DOI 10.1016/S0370-1573(01)00029-1; Wilkinson P, 2003, OPT LETT, V28, P1034, DOI 10.1364/OL.28.001034; Wilkinson PB, 1996, NATURE, V380, P608, DOI 10.1038/380608a0; Zaslavsky G.M., 1991, WEAK CHAOS QUASIREGU	30	104	110	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2004	428	6984					726	730		10.1038/nature02445	http://dx.doi.org/10.1038/nature02445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085125				2022-12-28	WOS:000220823800032
J	Patel, JD; Bach, PB; Kris, MG				Patel, JD; Bach, PB; Kris, MG			Lung cancer in US women - A contemporary epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-RECEPTOR-BETA; DNA ADDUCT LEVELS; SEX-DIFFERENCES; CIGARETTE-SMOKING; GENE STRUCTURE; LIVE LONGER; RISK; EXPRESSION; STAGE; SUSCEPTIBILITY	Lung cancer is the leading cause of cancer death in US women and is responsible for as many deaths as breast cancer and all gynecological cancers combined. Most lung cancer is caused by cigarette smoke. Despite all that is known about the devastating effects of cigarettes, one quarter of women in the United States continue to smoke. Women are targeted in tobacco advertising, and teenage girls are often drawn to cigarette smoking under a variety of social pressures. Following the increase in smoking, the death rate from lung cancer in US women rose 600% from 1930 to 1997. Women may be more susceptible than men to the carcinogenic properties of cigarette smoke. In addition, differences in the biology of lung cancer exist between the 2 sexes with higher levels of DNA adduct formation, increased CYP1A1 expression, decreased DNA repair capacity, and increased incidence of K-ras gene mutations in women. The novel estrogen receptor p has also been detected in lung tumors and suggests that estrogen signaling may have a biological role in tumorigenesis. Given these differences and given the enormous toll this disease has on US women, undertaking sex-specific research in lung cancer is crucial. Finally, disseminating information about this epidemic may prevent a similar epidemic in other parts of the world where women are just now becoming addicted to tobacco.	Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Patel, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, 676 N St Clair,Suite 850, Chicago, IL 60611 USA.	jd-patel@northwestern.edu		Kris, Mark/0000-0002-7317-5341				ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; Alexiou C, 2002, EUR J CARDIO-THORAC, V21, P319, DOI 10.1016/S1010-7940(01)01114-9; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Balsara BR, 1997, CANCER RES, V57, P2116; BEATTIE CW, 1985, CANCER RES, V45, P4206; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545; CAGLE PT, 1990, CANCER RES, V50, P6632; CANVER CC, 1994, J THORAC CARDIOV SUR, V108, P153; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P303; CHALOUPKA FJ, 1996, WEA INT 1996 PAC RIM; CHANG YH, 2003, P INT ASS STUD LU S2, V41, pS119; Cheng YW, 2001, ENVIRON MOL MUTAGEN, V37, P304, DOI 10.1002/em.1037; Cheng YW, 2001, CANCER RES, V61, P2799; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; Dresler CM, 2000, LUNG CANCER-J IASLC, V30, P153, DOI 10.1016/S0169-5002(00)00163-X; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Ferguson MK, 2000, J THORAC CARDIOV SUR, V119, P440, DOI 10.1016/S0022-5223(00)70121-8; FRENCH SA, 1994, AM J PUBLIC HEALTH, V84, P1818, DOI 10.2105/AJPH.84.11.1818; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; HALPERN MT, 1993, JNCI-J NATL CANCER I, V85, P457, DOI 10.1093/jnci/85.6.457; Haugen A, 2002, CARCINOGENESIS, V23, P227, DOI 10.1093/carcin/23.2.227; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; JOHNSON BE, 1988, AM J MED, V85, P194; JOHNSTON LD, 2001, MONITORING FUTURE QU; KHOSIA SS, 1983, BIOCHIM BIOPHYS ACTA, V250, P112; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kure EH, 1996, CARCINOGENESIS, V17, P2201, DOI 10.1093/carcin/17.10.2201; MCLEMORE TL, 1990, J NATL CANCER I, V82, P1333, DOI 10.1093/jnci/82.16.1333; Mollerup S, 1999, CANCER RES, V59, P3317; MUSCAT JE, 1995, CANCER LETT, V88, P1, DOI 10.1016/0304-3835(94)03608-L; Nelson HH, 1999, J NATL CANCER I, V91, P2032, DOI 10.1093/jnci/91.23.2032; OCONNELL JP, 1986, J CLIN ONCOL, V4, P1604, DOI 10.1200/JCO.1986.4.11.1604; OLLAYOS CW, 1994, ARCH PATHOL LAB MED, V118, P630; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; OSANN KE, 1993, INT J CANCER, V54, P44, DOI 10.1002/ijc.2910540108; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PATEL JD, 2003, P INT ASS STUDY L S2, V41, pS61; Perneger TV, 2001, J NATL CANCER I, V93, P1600, DOI 10.1093/jnci/93.21.1600; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; RISCH HA, 1993, AM J EPIDEMIOL, V138, P281, DOI 10.1093/oxfordjournals.aje.a116857; RYBERG D, 1994, CANCER RES, V54, P5801; SCHOENBERG JB, 1990, CANCER RES, V50, P6520; Shriver SP, 2000, JNCI-J NATL CANCER I, V92, P24, DOI 10.1093/jnci/92.1.24; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Stabile LP, 2002, CANCER RES, V62, P2141; TAIOLI E, 1994, J NATL CANCER I, V86, P869, DOI 10.1093/jnci/86.11.869; Tang DL, 1998, CARCINOGENESIS, V19, P1949, DOI 10.1093/carcin/19.11.1949; Tanoue LT, 2000, CLIN CHEST MED, V21, P47, DOI 10.1016/S0272-5231(05)70007-1; THOMSEN JS, 1994, CARCINOGENESIS, V15, P933, DOI 10.1093/carcin/15.5.933; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tomlinson R, 1997, BRIT MED J, V315, P565; Toyooka S, 2003, HUM MUTAT, V21, P229, DOI 10.1002/humu.10177; *US DEP HHS PHS OF, 2001, WOM SMOK REP SURG GE; Wei QY, 2000, J NATL CANCER I, V92, P1764; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	62	191	198	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1763	1768		10.1001/jama.291.14.1763	http://dx.doi.org/10.1001/jama.291.14.1763			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082704				2022-12-28	WOS:000220788700034
J	McNeill, A				McNeill, A			ABC of smoking cessation - Harm reduction	BRITISH MEDICAL JOURNAL			English	Review									Univ London St Georges Hosp, Sch Med, Dept Psychol, London, England	St Georges University London	McNeill, A (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Psychol, London, England.			McNeill, Ann/0000-0002-6223-4000				Bondurant, 2001, CLEARING SMOKE ASSES; Kalant H., 2000, NICOTINE PUBLIC HLTH, V117, P119; *NCI, 2001, NIH PUBL; *NCI, 2001, SMOK TOB CONTR MON N, V13; *ROYAL COLL PHYS, 2000, NIC ADD BRIT REP TOB, pCH6; *ROYAL COLL PHYS T, 2002, PROT SMOK SAV LIV CA	6	43	44	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					885	887		10.1136/bmj.328.7444.885	http://dx.doi.org/10.1136/bmj.328.7444.885			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073074	Green Published			2022-12-28	WOS:000220871400024
J	Wehrens, XHT; Lehnart, SE; Reiken, SR; Deng, SX; Vest, JA; Cervantes, D; Coromilas, J; Landry, DW; Marks, AR				Wehrens, XHT; Lehnart, SE; Reiken, SR; Deng, SX; Vest, JA; Cervantes, D; Coromilas, J; Landry, DW; Marks, AR			Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2	SCIENCE			English	Article							PHOSPHORYLATION; CHANNELS; FKBP12.6; LEAK; DRUG; CA2+; MG2+	Ventricular arrhythmias can cause sudden cardiac death (SCD) in patients with normal hearts and in those with underlying disease such as heart failure. In animals with heart failure and in patients with inherited forms of exercise-induced SCD, depletion of the channel-stabilizing protein calstabin2 (FKBP12.6) from the ryanodine receptor - calcium release channel (RyR2) complex causes an intracellular Ca2+ leak that can trigger fatal cardiac arrhythmias. A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias. Thus, enhancing the binding of calstabin2 to RyR2 may be a therapeutic strategy for common ventricular arrhythmias.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Mol Cardiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X				Gilmour RF, 2003, DRUG DISCOV TODAY, V8, P162, DOI 10.1016/S1359-6446(02)02567-9; GINSBURG KS, 2004, J PHYSL LONDON  0114; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kaneko N., 1995, U.S. Patent, Patent No. 5416066; Kimura J, 1999, JPN J PHARMACOL, V79, P275, DOI 10.1254/jjp.79.275; Kohno M, 2003, AM J PHYSIOL-HEART C, V284, pH1035, DOI 10.1152/ajpheart.00722.2002; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Marks AR, 2002, CIRCULATION, V106, P8, DOI 10.1161/01.CIR.0000021746.82888.83; Marks AR, 2001, J MOL CELL CARDIOL, V33, P615, DOI 10.1006/jmcc.2000.1343; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Most P, 2003, NAT MED, V9, P993, DOI 10.1038/nm0803-993; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; WEHRENS XH, UNPUB; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xu L, 1996, CIRC RES, V79, P1100, DOI 10.1161/01.RES.79.6.1100; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	20	342	375	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					292	296		10.1126/science.1094301	http://dx.doi.org/10.1126/science.1094301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073377				2022-12-28	WOS:000220719400048
J	Chambers, RG				Chambers, RG			David Shoenberg (1911-2004) - Obituary	NATURE			English	Biographical-Item									Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	University of Bristol	Chambers, RG (corresponding author), Univ Bristol, HH Wills Phys Lab, Tyndall Ave, Bristol BS8 1TL, Avon, England.	r.g.chambers@btinternet.com							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2004	428	6983					613	613		10.1038/428613a	http://dx.doi.org/10.1038/428613a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071584	Bronze			2022-12-28	WOS:000220697200029
J	Fremeau, RT; Kam, K; Qureshi, T; Johnson, J; Copenhagen, DR; Storm-Mathisen, J; Chaudhry, FA; Nicoll, RA; Edwards, RH				Fremeau, RT; Kam, K; Qureshi, T; Johnson, J; Copenhagen, DR; Storm-Mathisen, J; Chaudhry, FA; Nicoll, RA; Edwards, RH			Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites	SCIENCE			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; MOLECULAR-CLONING; SYNAPSIN-I; BRAIN; IDENTIFICATION; VESICLES; NEURONS; EXPRESSION; TRANSMISSION; PROBABILITY	Vesicular glutamate transporters (VGLUTs) 1 and 2 show a mutually exclusive distribution in the adult brain that suggests specialization for synapses with different properties of release. Consistent with this distribution, inactivation of the VGLUT1 gene silenced a subset of excitatory neurons in the adult. However, the same cell populations exhibited VGLUT1-independent transmission early in life. Developing hippocampal neurons transiently coexpressed VGLUT2 and VGLUT1 at distinct synaptic sites with different short-term plasticity. The loss of VGLUT1 also reduced the reserve pool of synaptic vesicles. Thus, VGLUT1 plays an unanticipated role in membrane trafficking at the nerve terminal.	Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Oslo, Inst Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oslo; University of Oslo	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu; edwards@itsa.ucsf.edu		Storm-Mathisen, Jon/0000-0002-2930-3262	NATIONAL EYE INSTITUTE [R01EY001869] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY001869] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gras C, 2002, J NEUROSCI, V22, P5442; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	27	365	376	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2004	304	5678					1815	1819		10.1126/science.1097468	http://dx.doi.org/10.1126/science.1097468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829YU	15118123				2022-12-28	WOS:000222089500049
J	Pashmforoush, M; Lu, JT; Chen, HY; St Amand, T; Kondo, R; Pradervand, S; Evans, SM; Clark, B; Feramisco, JR; Giles, W; Ho, SY; Benson, DW; Silberbach, M; Shou, WN; Chien, KR				Pashmforoush, M; Lu, JT; Chen, HY; St Amand, T; Kondo, R; Pradervand, S; Evans, SM; Clark, B; Feramisco, JR; Giles, W; Ho, SY; Benson, DW; Silberbach, M; Shou, WN; Chien, KR			Nkx2-5 pathways and congenital heart disease: Loss of ventricular myocyte lineage progressive cardiomyopathy and complete heart block	CELL			English	Article							CARDIAC CONDUCTION SYSTEM; HOMEOBOX GENE; AUTONOMIC INNERVATION; NEUREGULIN RECEPTOR; HCN CHANNELS; MOUSE HEART; EXPRESSION; MUTATIONS; DEFECTS; MUSCLE	Human mutations in Nkx2-5 lead to progressive cardiomyopathy and conduction defects via unknown mechanisms. To define these pathways, we generated mice with a ventricular-restricted knockout of Nkx2-5, which display no structural defects but have progressive complete heart block, and massive trabecular muscle overgrowth found in some patients with Nkx2-5 mutations. At birth, mutant mice display a hypoplastic atrioventricular (AV) node and then develop selective dropout of these conduction cells. Transcriptional profiling uncovered the aberrant expression of a unique panel of atrial and conduction system-restricted target genes, as well as the ectopic, high level BMP-10 expression in the adult ventricular myocardium. Further, BMP-10 is shown to be necessary and sufficient for a major component of the ventricular muscle defects. Accordingly, loss of ventricular muscle cell lineage specification into trabecular and conduction system myocytes is a new mechanistic pathway for progressive cardiomyopathy and conduction defects in congenital heart disease.	Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calgary, Sch Med, Calgary, AB T2N 4N1, Canada; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ Cincinnati, Cincinnati, OH 45221 USA; Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; University of Calgary; Imperial College London; University System of Ohio; University of Cincinnati; Oregon Health & Science University; Indiana University System; Indiana University-Purdue University Indianapolis	Chien, KR (corresponding author), Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA.	kchien@ucsd.edu	Evans, Sylvia/G-1980-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070259] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070259-03, R01 HL070259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGARD DA, 1989, METHOD CELL BIOL, V30, P353; ANDERSON RH, 1974, CIRC RES, V35, P909, DOI 10.1161/01.RES.35.6.909; Anderson RH, 2001, J CARDIOVASC ELECTR, V12, P1265, DOI 10.1046/j.1540-8167.2001.01265.x; Azene EM, 2003, J PHYSIOL-LONDON, V547, P349, DOI 10.1113/jphysiol.2003.039768; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen J, 1998, DEVELOPMENT, V125, P1943; Crick SJ, 1999, J ANAT, V195, P341, DOI 10.1046/j.1469-7580.1999.19530341.x; Crick SJ, 1999, J ANAT, V195, P359, DOI 10.1046/j.1469-7580.1999.19530359.x; ELBADAWI A, 1967, J HISTOCHEM CYTOCHEM, V15, P580, DOI 10.1177/15.10.580; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Epstein J A, 2001, Trends Genet, V17, pS13, DOI 10.1016/S0168-9525(01)02450-7; Franco D, 2001, CARDIOVASC RES, V49, P417, DOI 10.1016/S0008-6363(00)00252-2; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; GOURDIE RG, 1993, J CELL SCI, V105, P985; Gutierrez-Roelens Ilse, 2002, Hum Mutat, V20, P75, DOI 10.1002/humu.9041; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Harvey RP, 2002, COLD SPRING HARB SYM, V67, P107, DOI 10.1101/sqb.2002.67.107; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Ho SY, 2000, J CARDIOVASC ELECTR, V11, P83; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Kondo RP, 2003, J CARDIOVASC ELECTR, V14, P383, DOI 10.1046/j.1540-8167.2003.02467.x; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; NAGY A, 1990, DEVELOPMENT, V110, P815; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Ruiz-Lozano P, 2003, NAT GENET, V33, P8, DOI 10.1038/ng0103-8; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Thomas PS, 2001, ANAT RECORD, V263, P307, DOI 10.1002/ar.1106; Williams DA, 2000, BLOOD, V96, P1646	46	327	340	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					373	386		10.1016/S0092-8674(04)00405-2	http://dx.doi.org/10.1016/S0092-8674(04)00405-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109497	Bronze			2022-12-28	WOS:000221176400011
J	Lossos, IS; Czerwinski, DK; Alizadeh, AA; Wechser, MA; Tibshirani, R; Botstein, D; Levy, R				Lossos, IS; Czerwinski, DK; Alizadeh, AA; Wechser, MA; Tibshirani, R; Botstein, D; Levy, R			Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BCL-2 PROTEIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; P53; DIFFERENTIATION; OLIGONUCLEOTIDE; TRANSLOCATIONS; REARRANGEMENT; MICROARRAYS; REVEALS; DISEASE	BACKGROUND Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.	Stanford Univ, Sch Med, Div Oncol,Dept Med, Med Ctr, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Stat, Stanford, CA 94305 USA; Univ Miami, Dept Med, Div Hematol Oncol, Miami, FL USA; Appl Biosyst Inc, Foster City, CA 94404 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Miami; Thermo Fisher Scientific; Applied Biosystems	Levy, R (corresponding author), Stanford Univ, Sch Med, Div Oncol,Dept Med, Med Ctr, Rm 1105, Stanford, CA 94305 USA.	levy@stanford.edu	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Levy, Ronald/0000-0003-2061-0650	NATIONAL CANCER INSTITUTE [P01CA034233, R01CA033399, R37CA033399] Funding Source: NIH RePORTER; NCI NIH HHS [CA33399, CA34233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adida C, 2000, BLOOD, V96, P1921; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clark EA, 2001, NATURE, V411, P974, DOI 10.1038/35082119; Colomo L, 2003, BLOOD, V101, P78, DOI 10.1182/blood-2002-04-1286; COX DR, 1972, J R STAT SOC B, V34, P187; DELMER A, 1995, BLOOD, V85, P2870, DOI 10.1182/blood.V85.10.2870.bloodjournal85102870; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Drillenburg P, 1999, LEUKEMIA, V13, P1448, DOI 10.1038/sj.leu.2401490; Gascoyne RD, 1997, BLOOD, V90, P244; HARRIS NL, 1994, BLOOD, V84, P1361; Hermine O, 1996, BLOOD, V87, P265, DOI 10.1182/blood.V87.1.265.bloodjournal871265; Ichikawa A, 1997, NEW ENGL J MED, V337, P529, DOI 10.1056/NEJM199708213370804; JAFFE ES, 1998, LYMPHOMAS, P77; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Koduru PRK, 1997, BLOOD, V90, P4078, DOI 10.1182/blood.V90.10.4078; Kramer MHH, 1996, J CLIN ONCOL, V14, P2131, DOI 10.1200/JCO.1996.14.7.2131; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Krenacs L, 1998, BLOOD, V92, P1308, DOI 10.1182/blood.V92.4.1308.416k32_1308_1316; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Lossos IS, 2003, BLOOD, V101, P433, DOI 10.1182/blood-2002-06-1931; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; Moller MB, 2000, LEUKEMIA, V14, P898, DOI 10.1038/sj.leu.2401761; Mosher DF, 2001, NAT MED, V7, P290, DOI 10.1038/85426; Proost P, 1996, INT J CLIN LAB RES, V26, P211, DOI 10.1007/BF02602952; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Thorstenson YR, 2001, AM J HUM GENET, V69, P396, DOI 10.1086/321296; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vose UM, 1998, SEMIN ONCOL, V25, P483; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang AM, 1999, PATHOL INT, V49, P1043, DOI 10.1046/j.1440-1827.1999.00980.x	51	701	738	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1828	1837		10.1056/NEJMoa032520	http://dx.doi.org/10.1056/NEJMoa032520			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115829	Bronze			2022-12-28	WOS:000221080300006
J	Meyer, A				Meyer, A			Learning from the Altmeister	NATURE			English	Editorial Material									Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.		Meyer, Axel/C-9826-2009	Meyer, Axel/0000-0002-0888-8193					0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					897	897		10.1038/428897a	http://dx.doi.org/10.1038/428897a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118706				2022-12-28	WOS:000221083000022
J	Stebbing, J; Gazzard, B; Douek, DC				Stebbing, J; Gazzard, B; Douek, DC			Mechanisms of disease - Where does HIV live?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; T-CELL DEPLETION; FOLLICULAR DENDRITIC CELLS; CEREBROSPINAL-FLUID; TYPE-1 INFECTION; LYMPHOID-TISSUE; DC-SIGN; IN-VIVO; THYMOCYTE DEPLETION		NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Fac Med,Dept Immunol, Div Invest Sci, London, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London	Douek, DC (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.	ddouek@nih.gov		Stebbing, Justin/0000-0002-1117-6947				ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; BAGBY GC, 1993, MOL BASIS BLOOD DISE, P71; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Brander C, 2003, NAT MED, V9, P1359, DOI 10.1038/nm941; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Byrn RA, 1997, LANCET, V350, P1141, DOI 10.1016/S0140-6736(97)24042-0; Chene L, 1999, J VIROL, V73, P7533; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EILBOTT DJ, 1989, P NATL ACAD SCI USA, V86, P3337, DOI 10.1073/pnas.86.9.3337; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Foudraine NA, 1998, LANCET, V351, P1547, DOI 10.1016/S0140-6736(98)07333-4; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; GELMANN EP, 1983, SCIENCE, V220, P862, DOI 10.1126/science.6601822; Glass JD, 1996, ANNU REV NEUROSCI, V19, P1; GOUDSMIT J, 1986, LANCET, V2, P177; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Ho DD, 2002, CELL, V110, P135, DOI 10.1016/S0092-8674(02)00832-2; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kim TA, 2003, J IMMUNOL, V170, P2629, DOI 10.4049/jimmunol.170.5.2629; Kitchen SG, 1998, J VIROL, V72, P9054, DOI 10.1128/JVI.72.11.9054-9060.1998; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lenardo MJ, 2002, J VIROL, V76, P5082, DOI 10.1128/JVI.76.10.5082-5093.2002; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Livingstone WJ, 1996, LANCET, V348, P649, DOI 10.1016/S0140-6736(96)02091-0; Marcondes MCG, 2003, AIDS, V17, P1605, DOI 10.1097/00002030-200307250-00004; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; PEETERS MF, 1995, J MED VIROL, V47, P92, DOI 10.1002/jmv.1890470117; Piguet V, 2002, J INVEST DERMATOL, V119, P365, DOI 10.1046/j.1523-1747.2002.01840.x; POMERANTZ RJ, 1988, ANN INTERN MED, V108, P321, DOI 10.7326/0003-4819-108-3-321; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; RESNICK L, 1985, NEW ENGL J MED, V313, P1498, DOI 10.1056/NEJM198512123132402; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Schacker T, 2000, J INFECT DIS, V181, P354, DOI 10.1086/315178; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P7727, DOI 10.1073/pnas.87.19.7727; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Si-Mohamed A, 2000, J INFECT DIS, V182, P112, DOI 10.1086/315679; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; SPIEGEL H, 1992, AM J PATHOL, V140, P15; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; SU L, 1995, IMMUNITY, V2, P25, DOI 10.1016/1074-7613(95)90076-4; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Ullrich R, 1998, PATHOBIOLOGY, V66, P145, DOI 10.1159/000028012; Valentin A, 2002, P NATL ACAD SCI USA, V99, P7015, DOI 10.1073/pnas.102672999; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venturi G, 2000, J INFECT DIS, V181, P740, DOI 10.1086/315249; VERNAZZA PL, 1994, AIDS, V8, P1325, DOI 10.1097/00002030-199409000-00017; Weiss RA, 1999, NATURE, V397, P385, DOI 10.1038/17008; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wykrzykowska JJ, 1998, J EXP MED, V187, P1767, DOI 10.1084/jem.187.11.1767; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	103	115	124	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1872	1880		10.1056/NEJMra032395	http://dx.doi.org/10.1056/NEJMra032395			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115833				2022-12-28	WOS:000221080300010
J	Mastrandrea, MD; Schneider, SH				Mastrandrea, MD; Schneider, SH			Probabilistic integrated assessment of "dangerous" climate change	SCIENCE			English	Article							QUANTIFYING UNCERTAINTIES; STRATEGIES; POLICY	Climate policy decisions are being made despite layers of uncertainty. Such decisions directly influence the potential for "dangerous anthropogenic interference with the climate system." We mapped a metric for this concept, based on Intergovernmental Panel on Climate Change assessment of climate impacts, onto probability distributions of future climate change produced from uncertainty in key parameters of the coupled social-natural system-climate sensitivity, climate damages, and discount rate. Analyses with a simple integrated assessment model found that, under midrange assumptions, endogenously calculated, optimal climate policy controls can reduce the probability of dangerous anthropogenic interference from similar to45% under minimal controls to near zero.	Stanford Univ, Interdisciplinary Grad Program Environm & Resourc, Stanford, CA 94305 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Mastrandrea, MD (corresponding author), Stanford Univ, Interdisciplinary Grad Program Environm & Resourc, Stanford, CA 94305 USA.	mikemas@stanford.edu						Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Azar C, 1997, SCIENCE, V276, P1818, DOI 10.1126/science.276.5320.1818; Cubasch U, 2001, CLIMATE CHANGE 2001; DESSAI S, 2003, 34 TYND CTR; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Grubler A, 2001, NATURE, V412, P15, DOI 10.1038/35083752; HAMMITT JK, 1992, NATURE, V357, P315, DOI 10.1038/357315a0; Lempert RJ, 2000, CLIMATIC CHANGE, V45, P387, DOI 10.1023/A:1005698407365; Manne A, 1995, ENERGY J, V16, P1; Mastrandrea MD, 2001, CLIM POLICY, V1, P433, DOI 10.3763/cpol.2001.0146; Morgan M.G., 1990, UNCERTAINTY GUIDE DE; Moss R. H., 2000, GUIDANCE PAPERS CROS, P33; Moss R. H., 1997, ELEMENTS CHANGE 1996, P90; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; PATWARDHAN A, ASSESSING SCI ADDRES; Pittock AB, 2001, NATURE, V413, P249, DOI 10.1038/35095194; Roughgarden T, 1999, ENERG POLICY, V27, P415, DOI 10.1016/S0301-4215(99)00030-0; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Schneider SH., 1997, ENVIRON MODEL ASSESS, V2, P229, DOI [10.1023/A:1019090117643, DOI 10.1023/A:1019090117643]; SCHNEIDER SH, 1998, J RISK RES, V1, P165, DOI DOI 10.1080/136698798377240); Smith J.B., 2001, CLIMATE CHANGE 2001; United Nations, 2021, CLIM CHANG REC THREA; Webster M, 2002, ENERG J, V23, P97; WIGLEY T, IN PRESS CLIM CHANGE	25	178	180	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					571	575		10.1126/science.1094147	http://dx.doi.org/10.1126/science.1094147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105496				2022-12-28	WOS:000220975100044
J	Yu, ITS; Li, YG; Wong, TW; Tam, W; Chan, AT; Lee, JHW; Leung, DYC; Ho, T				Yu, ITS; Li, YG; Wong, TW; Tam, W; Chan, AT; Lee, JHW; Leung, DYC; Ho, T			Evidence of airborne transmission of the severe acute respiratory syndrome virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HONG-KONG; SARS; OUTBREAK; AGENT	Background: There is uncertainty about the mode of transmission of the severe acute respiratory syndrome (SARS) virus. We analyzed the temporal and spatial distributions of cases in a large community outbreak of SARS in Hong Kong and examined the correlation of these data with the three-dimensional spread of a virus-laden aerosol plume that was modeled using studies of airflow dynamics. Methods: We determined the distribution of the initial 187 cases of SARS in the Amoy Gardens housing complex in 2003 according to the date of onset and location of residence. We then studied the association between the location (building, floor, and direction the apartment unit faced) and the probability of infection using logistic regression. The spread of the airborne, virus-laden aerosols generated by the index patient was modeled with the use of airflow-dynamics studies, including studies performed with the use of computational fluid-dynamics and multizone modeling. Results: The curves of the epidemic suggested a common source of the outbreak. All but 5 patients lived in seven buildings (A to G), and the index patient and more than half the other patients with SARS (99 patients) lived in building E. Residents of the floors at the middle and upper levels in building E were at a significantly higher risk than residents on lower floors; this finding is consistent with a rising plume of contaminated warm air in the air shaft generated from a middle-level apartment unit. The risks for the different units matched the virus concentrations predicted with the use of multizone modeling. The distribution of risk in buildings B, C, and D corresponded well with the three-dimensional spread of virus-laden aerosols predicted with the use of computational fluid-dynamics modeling. Conclusions: Airborne spread of the virus appears to explain this large community outbreak of SARS, and future efforts at prevention and control must take into consideration the potential for airborne spread of this virus.	Chinese Univ Hong Kong, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong	Yu, ITS (corresponding author), Prince Wales Hosp, Sch Publ Hlth, Dept Community & Family Med, 4th Fl, Shatin, Hong Kong, Peoples R China.	iyu@cuhk.edu.hk	Chan, Andy/D-3361-2013; Lee, Joseph/C-1806-2009; Wong, Tze Wai/K-5344-2013; Tam, Wilson/K-1664-2019; TAM, Wilson W.S./H-5890-2019; Yu, Ignatius Tak Sun/A-9936-2008; Leung, Dennis Y.C./C-1892-2009; Li, Yuguo/A-9469-2010	TAM, Wilson W.S./0000-0003-0641-3060; Leung, Dennis Y.C./0000-0002-8917-0916; Li, Yuguo/0000-0002-2281-4529; Chan, Andy/0000-0003-2267-4949				Ash A, 1999, STAT MED, V18, P375, DOI 10.1002/(SICI)1097-0258(19990228)18:4<375::AID-SIM20>3.0.CO;2-J; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Collett D., 1991, MODELLING BINARY DAT; Donnelly CA, 2003, LANCET, V361, P1832; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferziger J. H., 2001, COMPUTATIONAL METHOD; *HONG KONG SPEC AD, 2003, OUTBR SEV AC RESP SY; *HONG KONG SPEC AD, 2004, LAT FIG 2003 SEV AC; LEBANON NH, 2004, FLUENT; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li Y., 2003, INT J VENT, V1, P3, DOI [10.1080/14733315.2003.11683640, DOI 10.1080/14733315.2003.11683640]; Li YG, 2000, BUILD ENVIRON, V35, P191, DOI 10.1016/S0360-1323(99)00011-6; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ng SKC, 2003, LANCET, V362, P570, DOI 10.1016/S0140-6736(03)14121-9; Orme M, 1998, 44 AIVC INT EN AG; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SAS Institute, 1999, SAS STAT US GUID; Sorensen JH, 2001, PHYS CHEM EARTH PT B, V26, P93, DOI 10.1016/S1464-1909(00)00223-9; Tomlinson B, 2003, LANCET, V361, P1486, DOI 10.1016/S0140-6736(03)13218-7; Varia M, 2003, CAN MED ASSOC J, V169, P285; *WHO REG OFF W PAC, 2003, ENV HLTH TEAM REP AM; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, MMWR MORB MORTAL WKL, V52, P241	26	777	811	22	182	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1731	1739		10.1056/NEJMoa032867	http://dx.doi.org/10.1056/NEJMoa032867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102999	Bronze, Green Published			2022-12-28	WOS:000220947300007
J	Sasso, FC; Carbonara, O; Nasti, R; Campana, B; Marfella, R; Torella, M; Nappi, G; Torella, R; Cozzolino, D				Sasso, FC; Carbonara, O; Nasti, R; Campana, B; Marfella, R; Torella, M; Nappi, G; Torella, R; Cozzolino, D			Glucose metabolism and coronary heart disease in patients with normal glucose tolerance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCATION END-PRODUCTS; CARDIOVASCULAR MORTALITY; OXIDATIVE STRESS; PLASMA-GLUCOSE; RISK-FACTOR; FOLLOW-UP; MEN; INSULIN; HYPERGLYCEMIA; ENDPRODUCTS	Context Several investigations as well as prospective studies have shown a significant correlation between glucose metabolism and atherosclerosis in patients without diabetes, but differences in parameters of glucose metabolism among the various degrees of coronary disease in such patients have not been specifically evaluated. Objective To investigate glucose metabolism in patients with normal glucose tolerance (NGT) and coronary heart disease (CHD). Design, Setting, and Participants Cross-sectional study of 234 men (mean [SDI age, 56.2 [6.1] years) with NGT and suspected CHD who were admitted from January 1 through June 30, 2001, to an academic medical center in Italy for coronary angiography. Main Outcome Measures Correlation of glucose metabolic factors and extent of atherosclerosis determined by coronary angiography. Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA(1c)), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR). Results Patients were divided into 4 groups based on coronary angiography: no significant stenosis (n=42), 1-vessel disease (n=72), 2-vessel disease (n=64), and 3-vessel disease (n =56). Simple correlation analysis showed that the factors correlated with the extent of atherosclerosis were levels of postload glucose (r=0.667), HbA(1c) (r=0.561), postload insulin (r=0.221), and fasting insulin (r=0.297), as well as HOMA-IR (r=0.278) (P<.001 for all). Multiple stepwise regression analysis suggested that the factors independently associated with the number of stenosed coronary arteries were levels of postload plasma glucose (r=0.572), HbA(1c) (r=0.413), postload insulin (r=0.267), and fasting insulin (r=0.174), as well as HOMA-IR (r=0.250) (P<.001 for all). Similar results were obtained after grouping patients by Duke Myocardial Jeopardy Score. Conclusions For patients with NGT and different extents of atherosclerotic disease, postload glycemia and HbA(1c) level are not equally distributed but are significantly higher in those with more severe disease. This suggests that the glycemic milieu correlates with the cardiovascular risk according to a linear model.	Univ Naples 2, Inst Internal Med, Fac Med, Via F Petrarca 64, I-80122 Naples, Italy; Univ Naples 2, Fac Med, Inst Cardiovasc Surg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Sasso, FC (corresponding author), Univ Naples 2, Inst Internal Med, Fac Med, Via F Petrarca 64, I-80122 Naples, Italy.	ferdinando.sasso@unina2.it	Sasso, Ferdinando Carlo/AAE-5665-2019; Marfella, Raffaele/C-6899-2012; Sasso, Ferdinando Carlo/AAA-8423-2020	Sasso, Ferdinando Carlo/0000-0002-9142-7848; Marfella, Raffaele/0000-0003-3960-9270; torella, michele/0000-0003-3853-3171				*AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS74, DOI DOI 10.2337/DIACARE.25.2007.S74; Austen WG, 1975, CIRCULATION S4, V51, P5; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Borch-Johnsen K, 1999, LANCET, V354, P617; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055, DOI 10.1016/S0735-1097(85)80005-X; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; FARRER M, 1995, METABOLISM, V44, P1016, DOI 10.1016/0026-0495(95)90099-3; FUJIWARA R, 1995, AM J CARDIOL, V75, P122, DOI 10.1016/S0002-9149(00)80059-4; Gavin JR, 1999, DIABETES CARE, V22, pS5; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Graham MM, 2001, AM HEART J, V142, P254, DOI 10.1067/mhj.2001.116481; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Kanauchi M, 2001, DIABETES CARE, V24, P1620, DOI 10.2337/diacare.24.9.1620; KANNEL WB, 1978, JAMA-J AM MED ASSOC, V38, P46; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543; Kowalska I, 2001, DIABETES CARE, V24, P897, DOI 10.2337/diacare.24.5.897; KUME S, 1995, AM J PATHOL, V147, P654; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; NAKAMURA Y, 1993, AM J PATHOL, V143, P1649; PAN WH, 1986, AM J EPIDEMIOL, V123, P504, DOI 10.1093/oxfordjournals.aje.a114266; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727	34	80	82	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1857	1863		10.1001/jama.291.15.1857	http://dx.doi.org/10.1001/jama.291.15.1857			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100204	Bronze			2022-12-28	WOS:000220871200026
J	Rainer, TH; Chan, PKS; Ip, M; Lee, N; Hui, DS; Smit, D; Wu, A; Ahuja, AT; Tam, JS; Sung, JJY; Cameron, P				Rainer, TH; Chan, PKS; Ip, M; Lee, N; Hui, DS; Smit, D; Wu, A; Ahuja, AT; Tam, JS; Sung, JJY; Cameron, P			The spectrum of severe acute respiratory syndrome-associated coronavirus infection	ANNALS OF INTERNAL MEDICINE			English	Article							HONG-KONG; OUTBREAK; SARS; IDENTIFICATION	Background: Whether subclinical or atypical presentations of severe acute respiratory syndrome (SARS) occur and whether clinical judgment is accurate in detecting SARS are unknown. Objectives: To describe the spectrum of SARS coronavirus infection in a large outbreak and to compare diagnoses based on clinical judgment with the SARS coronavirus test. Design: Secondary analysis of prospectively collected clinical data and archived serum. Setting: A SARS screening clinic of a university hospital in the New Territories of Hong Kong. Patients: 1221 patients attending the clinic between 12 March 2003 and 12 May 2003. Measurements: SARS coronavirus serology. Results: 145 of 553 (26%) patients had serologic evidence of SARS coronavirus infection. Of 910 patients who were managed without hospitalization, only 6 had serologic evidence of SARS. Five of the six patients had normal chest radiographs, and four had symptoms such as myalgia, chills, coughing, and feeling feverish. With the SARS coronavirus serologic test as the gold standard, the clinical diagnosis of probable SARS at hospitalization had a sensitivity of 0.96 (95% Cl, 0.91 to 0.98) and a specificity of 0.96 (Cl, 0.92 to 0.97). Limitations: Follow-up serologic samples were not obtained from almost half of the patients because they declined further testing. Some people living in the community who were infected but who had minor or no symptoms might not have visited the clinic. Conclusions: There is little evidence of widespread subclinical or mild forms of SARS coronavirus infection. Clinical diagnoses during the outbreak were reasonable and resulted in appropriate triaging.	Chinese Univ Hong Kong, Prince Wales Hosp, Trauma & Emergency Ctr, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Trauma & Emergency Ctr, Accid & Emergency Med Acad Unit, Rooms 107-113,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	rainer1091@cuhk.edu.hk	Ahuja, Anil T/H-4031-2017; Sung, Joseph J. Y./R-3203-2018; Lee, Nelson/B-6418-2008; Ip, Margaret/K-1096-2013; Chan, Paul KS/J-9360-2013; Rainer, Timothy/I-2591-2013; Hui, David Shu-Cheong/O-2754-2015	Ahuja, Anil T/0000-0002-0726-5402; Sung, Joseph J. Y./0000-0003-3125-5199; Lee, Nelson/0000-0002-0783-6607; Ip, Margaret/0000-0003-1291-6537; Chan, Paul KS/0000-0002-6360-4608; Rainer, Timothy/0000-0003-3355-3237; Hui, David Shu-Cheong/0000-0003-4382-2445; Cameron, Peter/0000-0002-1443-557X				[Anonymous], 2003, Wkly Epidemiol Rec, V78, P97; [Anonymous], 2003, UPD INT US CAS DEF S; CHAN PK, 2004, EMERG INFECT DIS, P10; Chan PKS, 2003, EMERG INFECT DIS, V9, P1453, DOI 10.3201/eid0911.030421; Chan-Yeung M, 2003, BRIT MED J, V326, P850, DOI 10.1136/bmj.326.7394.850; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ho W, 2003, LANCET, V361, P1313, DOI 10.1016/S0140-6736(03)13085-1; Hui DSC, 2003, CHEST, V124, P12, DOI 10.1378/chest.124.1.12; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, US LAB METH SARS DIA; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2003, CUM NUMB REP PROB CA	21	26	26	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					614	619		10.7326/0003-4819-140-8-200404200-00008	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096332				2022-12-28	WOS:000220851700004
J	Coale, KH; Johnson, KS; Chavez, FP; Buesseler, KO; Barber, RT; Brzezinski, MA; Cochlan, WP; Millero, FJ; Falkowski, PG; Bauer, JE; Wanninkhof, RH; Kudela, RM; Altabet, MA; Hales, BE; Takahashi, T; Landry, MR; Bidigare, RR; Wang, XJ; Chase, Z; Strutton, PG; Friederich, GE; Gorbunov, MY; Lance, VP; Hilting, AK; Hiscock, MR; Demarest, M; Hiscock, WT; Sullivan, KF; Tanner, SJ; Gordon, RM; Hunter, CN; Elrod, VA; Fitzwater, SE; Jones, JL; Tozzi, S; Koblizek, M; Roberts, AE; Herndon, J; Brewster, J; Ladizinsky, N; Smith, G; Cooper, D; Timothy, D; Brown, SL; Selph, KE; Sheridan, CC; Twining, BS; Johnson, ZI				Coale, KH; Johnson, KS; Chavez, FP; Buesseler, KO; Barber, RT; Brzezinski, MA; Cochlan, WP; Millero, FJ; Falkowski, PG; Bauer, JE; Wanninkhof, RH; Kudela, RM; Altabet, MA; Hales, BE; Takahashi, T; Landry, MR; Bidigare, RR; Wang, XJ; Chase, Z; Strutton, PG; Friederich, GE; Gorbunov, MY; Lance, VP; Hilting, AK; Hiscock, MR; Demarest, M; Hiscock, WT; Sullivan, KF; Tanner, SJ; Gordon, RM; Hunter, CN; Elrod, VA; Fitzwater, SE; Jones, JL; Tozzi, S; Koblizek, M; Roberts, AE; Herndon, J; Brewster, J; Ladizinsky, N; Smith, G; Cooper, D; Timothy, D; Brown, SL; Selph, KE; Sheridan, CC; Twining, BS; Johnson, ZI			Southern ocean iron enrichment experiment: Carbon cycling in high- and low-Si waters	SCIENCE			English	Article							EQUATORIAL PACIFIC-OCEAN; LAST GLACIAL MAXIMUM; POLAR FRONTAL ZONE; ROSS SEA; PHYTOPLANKTON GROWTH; PRIMARY PRODUCTIVITY; BIOLOGICAL RESPONSE; SILICA PRODUCTION; FERTILIZATION; BLOOM	The availability of iron is known to exert a controlling influence on biological productivity in surface waters over large areas of the ocean and may have been an important factor in the variation of the concentration of atmospheric carbon dioxide over glacial cycles. The effect of iron in the Southern Ocean is particularly important because of its large area and abundant nitrate, yet iron-enhanced growth of phytoplankton may be differentially expressed between waters with high silicic acid in the south and low silicic acid in the north, where diatom growth may be limited by both silicic acid and iron. Twomesoscaleexperiments, designed to investigate the effects of iron enrichment in regions with high and low concentrations of silicic acid, were performed in the Southern Ocean. These experiments demonstrate iron's pivotal role in controlling carbon uptake and regulating atmospheric partial pressure of carbon dioxide.	Moss Landing Marine Labs, Moss Landing, CA 95039 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Duke Univ, Nicholas Sch Environm & Earth Sci, Beaufort, NC 28516 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA 94920 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol, New Brunswick, NJ 08901 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Massachusetts, Sch Marine Sci & Technol, New Bedford, MA 02744 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; MIT, Cambridge, MA 02139 USA	Moss Landing Marine Laboratories; Monterey Bay Aquarium Research Institute; Woods Hole Oceanographic Institution; Duke University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; California State University System; San Francisco State University; University of Miami; Rutgers State University New Brunswick; Rutgers State University New Brunswick; William & Mary; Virginia Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of California System; University of California Santa Cruz; University of Massachusetts System; Oregon State University; Columbia University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Massachusetts Institute of Technology (MIT)	Coale, KH (corresponding author), Moss Landing Marine Labs, 8272 Moss Landing Rd, Moss Landing, CA 95039 USA.	coale@mlml.calstate.edu	Tozzi, Sasha/B-2111-2009; Chase, Zanna/E-9232-2013; Landry, Michael/HGF-1043-2022; Johnson, Zackary I/E-4601-2011; Koblizek, Michal/H-2851-2014; Strutton, Peter G/C-4466-2011; Johnson, Kenneth S/F-9742-2011; Wang, Xiujun/F-2641-2010	Chase, Zanna/0000-0001-5060-779X; Johnson, Zackary I/0000-0003-0793-8512; Strutton, Peter G/0000-0002-2395-9471; Johnson, Kenneth S/0000-0001-5513-5584; Wang, Xiujun/0000-0002-2859-8011; Twining, Benjamin/0000-0002-1365-9192; Selph, Karen/0000-0001-7281-4706				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARMSTRONG RA, 2002, DEEP SEA RES 2, V49, P2265; BEHRENFELD M, 1996, NATURE, V371, P508; BIDIGARE RR, 2002, EOS S, V83, pF798; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; Boyd PW, 2002, DEEP-SEA RES PT II, V49, P1803, DOI 10.1016/S0967-0645(02)00013-9; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; Brzezinski MA, 1997, LIMNOL OCEANOGR, V42, P856, DOI 10.4319/lo.1997.42.5.0856; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2003, DEEP-SEA RES PT II, V50, P635, DOI 10.1016/S0967-0645(02)00588-X; Coale KH, 1998, DEEP-SEA RES PT II, V45, P919, DOI 10.1016/S0967-0645(98)00019-8; Cochlan WP, 2002, DEEP-SEA RES PT II, V49, P3365, DOI 10.1016/S0967-0645(02)00088-7; Daly KL, 2001, J GEOPHYS RES-OCEANS, V106, P7107, DOI 10.1029/1999JC000090; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Fitzwater SE, 2000, DEEP-SEA RES PT II, V47, P3159, DOI 10.1016/S0967-0645(00)00063-1; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2571, DOI 10.1016/S0967-0645(01)00009-1; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Hales B, 2002, J ATMOS OCEAN TECH, V19, P1096, DOI 10.1175/1520-0426(2002)019<1096:TPSAHR>2.0.CO;2; Hiscock MR, 2003, DEEP-SEA RES PT II, V50, P533, DOI 10.1016/S0967-0645(02)00583-0; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JOHNSON K, 2002, EOS S, V83, pF799; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; LEVITUS S, 1998, US WORLD OCEAN ATLAS; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Moore JK, 2000, GLOBAL BIOGEOCHEM CY, V14, P455, DOI 10.1029/1999GB900051; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schlitzer R., 2000, EOS T AGU, V81, P45, DOI DOI 10.1029/00E000028; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith WO, 2000, DEEP-SEA RES PT II, V47, P3073, DOI 10.1016/S0967-0645(00)00059-X; Sweeney C, 2000, DEEP-SEA RES PT II, V47, P3395, DOI 10.1016/S0967-0645(00)00073-4; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Timmermans KR, 1998, MAR ECOL PROG SER, V166, P27, DOI 10.3354/meps166027; Trull T, 2001, DEEP-SEA RES PT II, V48, P2439, DOI 10.1016/S0967-0645(01)00003-0; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	48	471	483	4	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					408	414		10.1126/science.1089778	http://dx.doi.org/10.1126/science.1089778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087542				2022-12-28	WOS:000220845400039
J	Cochran, WW; Mouritsen, H; Wikelski, M				Cochran, WW; Mouritsen, H; Wikelski, M			Migrating songbirds recalibrate their magnetic compass daily from twilight cues	SCIENCE			English	Article							CELESTIAL CUES; ORIENTATION; BIRD; INFORMATION; CALIBRATION; PATTERNS; SUNSET; THRUSH; LIGHT; DUSK	Night migratory songbirds can use stars, sun, geomagnetic field, and polarized light for orientation when tested in captivity. We studied the interaction of magnetic, stellar, and twilight orientation cues in free-flying songbirds. We exposed Catharus thrushes to eastward-turned magnetic fields during the twilight period before takeoff and then followed them for up to 1100 kilometers. Instead of heading north, experimental birds flew westward. On subsequent nights, the same individuals migrated northward again. We suggest that birds orient with a magnetic compass calibrated daily from twilight cues. This could explain how birds cross the magnetic equator and deal with declination.	Illinois Nat Hist Survey, Champaign, IL 61820 USA; Carl von Ossietzky Univ Oldenburg, Inst Biol, Volkswagen Nachwuchsgrp Anim Nav, D-26111 Oldenburg, Germany; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Illinois Natural History Survey; Carl von Ossietzky Universitat Oldenburg; Volkswagen; Princeton University	Cochran, WW (corresponding author), 1204 W Union St, Champaign, IL 61821 USA.	Sparrow@springnet1.com; Henrik.mouritsen@uni-oldenburg.de; Wikelski@princeton.edu	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839				ABLE KP, 1993, NATURE, V364, P523, DOI 10.1038/364523a0; ABLE KP, 1982, NATURE, V299, P550, DOI 10.1038/299550a0; ABLE KP, 1995, J COMP PHYSIOL A, V177, P351; AKESSON S, 1994, ANIM BEHAV, V48, P1379, DOI 10.1006/anbe.1994.1374; ALERSTAM T, 1987, J EXP BIOL, V130, P63; Batschelet E., 1981, CIRCULAR STAT BIOL; BEASON RC, 1992, ETHOLOGY, V91, P75; BINGMAN VP, 1988, ETHOLOGY, V77, P1; COCHRAN W. W., 1967, LIVING BIRD, V6, P213; Cochran W.W., 1985, Illinois Natural History Survey Bulletin, V33, P297; COCHRAN WW, 1987, ANIM BEHAV, V35, P927, DOI 10.1016/S0003-3472(87)80132-X; COCHRAN WW, 2004, IN PRESS BIRDS 2 WOR; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; EMLEN ST, 1970, ANIM BEHAV, V18, P215, DOI 10.1016/S0003-3472(70)80031-8; EMLEN ST, 1967, AUK, V84, P309, DOI 10.2307/4083084; ENGELS WL, 1962, BIOL BULL, V123, P94, DOI 10.2307/1539506; HELBIG AJ, 1990, EXPERIENTIA, V46, P755, DOI 10.1007/BF01939958; HELBIG JA, 1991, ORIENTATION BIRDS, P270; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; MOORE FR, 1987, BIOL REV, V62, P65, DOI 10.1111/j.1469-185X.1987.tb00626.x; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Outlaw DC, 2003, AUK, V120, P299, DOI 10.1093/auk/120.2.299; PHILLIPS JB, 1992, BEHAV ECOL SOCIOBIOL, V31, P189; Pulido F, 2003, AVIAN MIGRATION, P53; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Sandberg R, 2000, ANIM BEHAV, V60, P453, DOI 10.1006/anbe.2000.1582; Sandberg R, 2002, AUK, V119, P201, DOI 10.1642/0004-8038(2002)119[0201:OONMSS]2.0.CO;2; Sauer F., 1957, Zeitschrift fuer Tierpsychologie, V14, P29; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W., 1975, Zeitschrift Tierpsychol, V39, P265; WILTSCHKO W, 1975, Zeitschrift fuer Tierpsychologie, V37, P337; Wiltschko W, 1996, J EXP BIOL, V199, P29; Wiltschko W, 1998, J COMP PHYSIOL A, V182, P521, DOI 10.1007/s003590050199; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363	41	272	283	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					405	408		10.1126/science.1095844	http://dx.doi.org/10.1126/science.1095844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087541				2022-12-28	WOS:000220845400038
J	Conselice, CJ				Conselice, CJ			Unveiling the formation of massive galaxies	SCIENCE			English	Editorial Material							LYMAN-BREAK GALAXIES; POPULATION; REDSHIFT; EVOLUTION; RED		CALTECH, Dept Astron, Pasadena, CA 91125 USA	California Institute of Technology	Conselice, CJ (corresponding author), CALTECH, Dept Astron, Pasadena, CA 91125 USA.	cc@astro.caltech.edu	Conselice, Christopher J/B-4348-2013	Conselice, Christopher/0000-0003-1949-7638				CESARE C, 2002, MON NOT R ASTRON SOC, V335, P335; Chapman SC, 2003, NATURE, V422, P695, DOI 10.1038/nature01540; Cole S, 2000, MON NOT R ASTRON SOC, V319, P168, DOI 10.1046/j.1365-8711.2000.03879.x; Conselice CJ, 2003, ASTRON J, V126, P1183, DOI 10.1086/377318; Daddi E, 2003, ASTROPHYS J, V588, P50, DOI 10.1086/374044; Dickinson M, 2003, ASTROPHYS J, V587, P25, DOI 10.1086/368111; Franx M, 2003, ASTROPHYS J, V587, pL79, DOI 10.1086/375155; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Genzel R, 2003, ASTROPHYS J, V584, P633, DOI 10.1086/345718; Giavalisco M, 1998, ASTROPHYS J, V503, P543, DOI 10.1086/306027; Madau P, 1998, ASTROPHYS J, V498, P106, DOI 10.1086/305523; Papovich C, 2001, ASTROPHYS J, V559, P620, DOI 10.1086/322412; Shapley AE, 2001, ASTROPHYS J, V562, P95, DOI 10.1086/323432; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; WORTHEY G, 1994, ASTROPHYS J SUPPL S, V95, P107, DOI 10.1086/192096	15	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					399	400		10.1126/science.1096542	http://dx.doi.org/10.1126/science.1096542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087537				2022-12-28	WOS:000220845400034
J	Lustbader, JW; Cirilli, M; Lin, C; Xu, HW; Takuma, K; Wang, N; Caspersen, C; Chen, X; Pollak, S; Chaney, M; Trinchese, F; Liu, SM; Gunn-Moore, F; Lue, LF; Walker, DG; Kuppusamy, P; Zewier, ZL; Arancio, O; Stern, D; Yan, SSD; Wu, H				Lustbader, JW; Cirilli, M; Lin, C; Xu, HW; Takuma, K; Wang, N; Caspersen, C; Chen, X; Pollak, S; Chaney, M; Trinchese, F; Liu, SM; Gunn-Moore, F; Lue, LF; Walker, DG; Kuppusamy, P; Zewier, ZL; Arancio, O; Stern, D; Yan, SSD; Wu, H			ABAD directly links A beta to mitochondrial toxicity in Alzheimer's disease	SCIENCE			English	Article							BINDING ALCOHOL-DEHYDROGENASE; AMYLOID-BETA; TRANSGENIC MICE; PEPTIDE; PROTEIN; PATHOGENESIS; DYSFUNCTION; APOPTOSIS; MODEL	Mitochondrial dysfunction is a hallmark of beta-amyloid (Abeta) -induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Abeta-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Abeta to mitochondrial toxicity. Abeta interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Abeta-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Abeta interaction and suppresses Abeta-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Abeta-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Abeta interaction may be a therapeutic target in AD.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Harbin Med Univ, Dept Immunol, Harbin 150086, Peoples R China; NYU, Dept Neurol, New York, NY 10003 USA; NYU, Nathan Kline Inst, Dementia Res Ctr, New York, NY 10016 USA; NYU, Dept Psychiat Physiol & Neurosci, New York, NY 10016 USA; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; Sun Hlth Res Inst, Sun City, AZ 85351 USA; Ohio State Univ, David Heart & Lung Res Inst, Columbus, OH 43210 USA; Med Coll Georgia, Deans Off, Augusta, GA 30912 USA	Columbia University; Columbia University; Columbia University; Columbia University; Cornell University; Harbin Medical University; New York University; Nathan Kline Institute for Psychiatric Research; New York University; New York University; University of St Andrews; Banner Research; Banner Health; Banner Sun Health Research Institute; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Yan, SSD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	sdy1@columbia.edu; haowu@med.cornell.edu	Pollak, Seth D/G-2345-2011; arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X; Gunn-Moore, Francis James/0000-0003-3422-3387; Xu, Hongwei/0000-0001-5763-3894	NIA NIH HHS [P50AG08702, 1K07AG00959, AG17490, AG16736] Funding Source: Medline; NINDS NIH HHS [NS42855] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017490, K07AG000959, R01AG016736, P50AG008702] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; ABREO MA, 2002, Patent No. 931186; Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Beyreuther K, 1997, NATURE, V389, P677, DOI 10.1038/39479; Blass JP, 2003, NEUROL RES, V25, P556, DOI 10.1179/016164103101201995; Blass JP, 2002, INT REV NEUROBIOL, V51, P325, DOI 10.1016/S0074-7742(02)51010-2; Cash AD, 2002, NEUROSCIENTIST, V8, P489, DOI 10.1177/107385802236968; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Di Rosa G, 2002, J MOL NEUROSCI, V19, P135, DOI 10.1007/s12031-002-0024-4; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; GRILL HP, 1992, J AM COLL CARDIOL, V20, P1604, DOI 10.1016/0735-1097(92)90457-X; Mattson MP, 2002, INT REV NEUROBIOL, V53, P387; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341; Torroja L, 1998, J CELL BIOL, V141, P1009, DOI 10.1083/jcb.141.4.1009; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100	22	1023	1088	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					448	452		10.1126/science.1091230	http://dx.doi.org/10.1126/science.1091230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087549				2022-12-28	WOS:000220845400051
J	Fehr, E				Fehr, E			The productivity of failures	NATURE			English	Editorial Material									Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland	University of Zurich	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.							Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; 2003, NATURE, V425, P785	2	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					701	701		10.1038/428701a	http://dx.doi.org/10.1038/428701a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085112	Bronze			2022-12-28	WOS:000220823800019
J	Rebar, RW; DeCherney, AH				Rebar, RW; DeCherney, AH			Assisted reproductive technology in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Soc Reprod Med, Birmingham, AL 35216 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rebar, RW (corresponding author), Amer Soc Reprod Med, Birmingham, AL 35216 USA.		DeCherney, Alan H/AAS-2944-2020					ABMA JC, 1997, VITAL HLTH STAT 23, V19; *CDC AM SOC REPR M, 2003, 2001 ASS REPR TECHN; Chang Wendy Y, 2003, Hum Fertil (Camb), V6, P64, DOI 10.1080/1464770312331369063	3	27	27	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1603	1604		10.1056/NEJMp048046	http://dx.doi.org/10.1056/NEJMp048046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084692				2022-12-28	WOS:000220819800004
J	Mathew, JP; Fontes, ML; Tudor, IC; Ramsay, J; Duke, P; Mazer, CD; Barash, PG; Hsu, PH; Mangano, DT				Mathew, JP; Fontes, ML; Tudor, IC; Ramsay, J; Duke, P; Mazer, CD; Barash, PG; Hsu, PH; Mangano, DT			A multicenter risk index for atrial fibrillation after cardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYPASS GRAFT-SURGERY; ASSOCIATION TASK-FORCE; C-REACTIVE PROTEIN; PRACTICE GUIDELINES; AMERICAN-COLLEGE; PREDICTORS; IMPACT; ARRHYTHMIA; ACTIVATION; COMMITTEE	Context Atrial fibrillation is a common, but potentially preventable, complication following coronary artery bypass graft (CABG) surgery. Objectives To assess the nature and consequences of atria[ fibrillation after CABG surgery and to develop a comprehensive risk index that can better identify patients at risk for atrial fibrillation. Design, Setting, and Participants Prospective observational study of 4657 patients undergoing CABG surgery between November 1996 and June 2000 at 70 centers located within 17 countries, selected using a systematic sampling technique. From a derivation cohort of 3093 patients, associations between predictor variables and postoperative atrial fibrillation were identified to develop a risk model, which was assessed in a validation cohort of 1564 patients. Main Outcome Measure New-onset atrial fibrillation after CABG surgery. Results A total of 1503 patients (32.3%) developed atrial fibrillation after CABG surgery. Postoperative atrial fibrillation was associated with subsequent greater resource use as well as with cognitive changes, renal dysfunction, and infection. Among patients in the derivation cohort, risk factors associated with atrial fibrillation were advanced age (odds ratio [OR] for 10-year increase, 1.75; 95% confidence interval [CI], 1.59-1.93); history of atrial fibrillation (OR, 2.11; 95% Cl, 1.57-2.85) or chronic obstructive pulmonary disease (OR, 1.43; 95% Cl, 1.09-1.87); valve surgery (OR, 1.74; 95% Cl, 1.31-2.32); and postoperative withdrawal of a P-blocker (OR, 1.91; 95% Cl, 1.52-2.40) or an angiotensin-converting enzyme (ACE) inhibitor (OR 1.69; 95% Cl, 1.38-2.08). Conversely, reduced risk was associated with postoperative administration of beta-blockers (OR, 0.32; 95% Cl, 0.22-0.46), ACE inhibitors (OR, 0.62; 95% Cl, 0.48-0.79), potassium supplementation (OR, 0.53; 95% Cl, 0.42-0.68), and nonsteroidal anti-inflammatory drugs (OR, 0.49; 95% Cl, 0.40-0.60). The resulting multivariable risk index had adequate discriminative power with an area under the receiver operating characteristic (ROC) curve of 0.77 in the validation sample. Forty-three percent (640/1503) of patients who had atrial fibrillation after CABG surgery experienced more than 1 episode of atrial fibrillation. Predictors of recurrent atrial fibrillation included older age, history of congestive heart failure, left ventricular hypertrophy, aortic atherosclerosis, bicaval venous cannulation, withdrawal of ACE inhibitor or p-blocker therapy, and use of amiodarone or digoxin (area under the ROC curve of 0.66). Patients with recurrent atrial fibrillation had longer hospital stays and experienced greater infectious, renal, and neurological complications than those with a single episode. Conclusions We have developed and validated models predicting the occurrence of atrial fibrillation after CABG surgery based on an analysis of a large multicenter international cohort. Our findings suggest that treatment with beta-blockers, ACE inhibitors, and/or nonsteroidal anti-inflammatory drugs may offer protection. Atrial fibrillation after CABG surgery is associated with important complications.	Duke Univ, Med Ctr, Multictr Study Perioperat Ischemia Res Grp, Durham, NC USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Cornell Univ, Weill Med Coll, Dept Anesthesiol, New York, NY USA; Ischemia Res & Educ Fdn, Editorial Off, Duke Univ Med Ctr, San Francisco, CA 94134 USA; Emory Univ Hosp, Dept Anesthesiol, Atlanta, GA 30322 USA; Univ Manitoba, Dept Anesthesiol, Winnipeg, MB, Canada; Univ Toronto, Dept Anesthesiol, Toronto, ON, Canada; Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA	Duke University; Duke University; Cornell University; Duke University; Emory University; University of Manitoba; University of Toronto; Yale University	Mathew, JP (corresponding author), Ischemia Res & Educ Fdn, Editorial Off, Duke Univ Med Ctr, 250 Execut Pk Blvd,Suite 3400, San Francisco, CA 94134 USA.	mathe014@mc.duke.edu		Mazer, Cyril David/0000-0003-2566-4308; Mathew, Joseph/0000-0002-3815-4131				Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Asher CR, 1998, AM J CARDIOL, V82, P892, DOI 10.1016/S0002-9149(98)00498-6; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Borzak S, 1998, CHEST, V113, P1489, DOI 10.1378/chest.113.6.1489; Bruins P, 1997, CIRCULATION, V96, P3542; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Cioffi G, 2000, Ital Heart J, V1, P691; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Ellenbogen K A, 1997, Adv Card Surg, V9, P109; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hravnak M, 2002, CRIT CARE MED, V30, P330, DOI 10.1097/00003246-200202000-00011; Ivanov J, 1998, CIRCULATION, V97, P673, DOI 10.1161/01.CIR.97.7.673; Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Lahey SJ, 1998, CIRCULATION, V98, pII35; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEITCH JW, 1990, J THORAC CARDIOV SUR, V100, P338; Li-Saw-Hee FL, 2001, EUR HEART J, V22, P1741, DOI 10.1053/euhj.2000.2531; Mahoney EM, 2002, J AM COLL CARDIOL, V40, P737, DOI 10.1016/S0735-1097(02)02003-X; Mathew JP, 1996, JAMA-J AM MED ASSOC, V276, P300, DOI 10.1001/jama.276.4.300; Nickerson NJ, 1999, AM J MANAG CARE, V5, P29; Pedersen OD, 1999, CIRCULATION, V100, P376, DOI 10.1161/01.CIR.100.4.376; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Stanley TO, 2002, ANESTH ANALG, V94, P290, DOI 10.1097/00000539-200202000-00011; STEINBERG J, 2000, ATRIAL FIBRILLATION; Tukek T, 2002, ANN NONINVAS ELECTRO, V7, P222, DOI 10.1111/j.1542-474X.2002.tb00167.x; Van Den Berg M P, 1995, J Card Fail, V1, P355, DOI 10.1016/S1071-9164(05)80004-1; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	33	834	892	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1720	1729		10.1001/jama.291.14.1720	http://dx.doi.org/10.1001/jama.291.14.1720			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082699	Bronze			2022-12-28	WOS:000220788700029
J	Borges, Z				Borges, Z			It is within ourselves that we start to overcome prejudice	LANCET			English	Article											Borges, Z (corresponding author), Ave Rio Branco,613 Vila Mamona, BR-79304020 Corumba, MS, Brazil.	zildaidea@terra.com.br							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1220	1220		10.1016/S0140-6736(04)15953-9	http://dx.doi.org/10.1016/S0140-6736(04)15953-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081656				2022-12-28	WOS:000220748100023
J	Kamena, F; Spang, A				Kamena, F; Spang, A			Tip20p prohibits back-fusion of COPII vesicles with the endoplasmic reticulum	SCIENCE			English	Article							RETROGRADE TRANSPORT; NUCLEOTIDE EXCHANGE; MEMBRANE-FUSION; SNARE PROTEINS; ER; GOLGI; YEAST; INTERACTS; RETRIEVAL; COATOMER	Directionality in intracellular trafficking is essential to ensure the correct localization of proteins along the secretory pathway. Here, we found evidence for an active mechanism that prohibited back-fusion of de novo - generated vesicles with their donor compartment. Tip20p is a peripheral membrane protein implicated in consumption of COPI vesicles at the endoplasmic reticulum. However, a specific mutant of TIP20 did not interfere with COPII vesicle generation but allowed these vesicles to fuse back to the endoplasmic reticulum, a process that does not occur normally in the cell.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Spang, A (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 39, D-72076 Tubingen, Germany.	anne.spang@tuebingen.mpg.de	Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203				Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cosson P, 1997, EUR J CELL BIOL, V73, P93; Frigerio G, 1998, YEAST, V14, P633, DOI 10.1002/(SICI)1097-0061(199805)14:7<633::AID-YEA267>3.0.CO;2-3; LATTERICH M, 1994, CELL, V78, P87, DOI 10.1016/0092-8674(94)90575-4; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x	18	26	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					286	289		10.1126/science.1095049	http://dx.doi.org/10.1126/science.1095049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073376				2022-12-28	WOS:000220719400046
J	Cornia, PB; Lipsky, BA; Dhaliwal, G; Saint, S				Cornia, PB; Lipsky, BA; Dhaliwal, G; Saint, S			Red snapper or crab?	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICAL-EXAMINATION; HISTORY; MESOTHELIOMA		Vet Affairs Puget Sound Hlth Care Syst, Primary & Specialty Med Care Serv, Seattle, WA 98108 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Calif San Francisco, Sch Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cornia, PB (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Primary & Specialty Med Care Serv, 1660 S Columbian Way,S-111-GIMC, Seattle, WA 98108 USA.	paul.cornia@med.va.gov	Saint, Sanjay/AAF-5126-2019; Lipsky, Benjamin A/B-4645-2013	Cornia, Paul/0000-0002-4949-9637; Lipsky, Benjamin A./0000-0001-9886-5114	AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ANTMAN KH, 1993, CHEST, V103, pS373, DOI 10.1378/chest.103.4_Supplement.373S; ASENSIO JA, 1990, ARCH SURG-CHICAGO, V125, P1477; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Light R, 1995, PLEURAL DIS; Mohamed Faheez, 2002, Curr Treat Options Oncol, V3, P375, DOI 10.1007/s11864-002-0003-6; PETERSON MC, 1992, WESTERN J MED, V156, P163; PLATT R, 1947, MANCH U MED SCH GAZ, V26, P139; Price B, 1997, AM J EPIDEMIOL, V145, P211, DOI 10.1093/oxfordjournals.aje.a009093; RUCKLE HC, 1994, MAYO CLIN PROC, V69, P69, DOI 10.1016/S0025-6196(12)61615-2; SANDLER G, 1980, AM HEART J, V100, P928, DOI 10.1016/0002-8703(80)90076-9; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; WAGNER J C, 1960, Br J Ind Med, V17, P260	12	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1443	1448		10.1056/NEJMcps032443	http://dx.doi.org/10.1056/NEJMcps032443			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070795				2022-12-28	WOS:000220562500012
J	Botchan, M				Botchan, M			Hitchhiking without covalent integration	CELL			English	Editorial Material							BROMODOMAIN PROTEIN; BRD4		Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Botchan, M (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.							CAMPBELL AM, 1962, ADV GENET, V11, P101; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; LWOFF A, 1950, ANN I PASTEUR PARIS, V78, P711; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Muzyczka N., 2001, FIELDS VIROLOGY, P2327; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	8	16	16	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 30	2004	117	3					280	281		10.1016/S0092-8674(04)00410-6	http://dx.doi.org/10.1016/S0092-8674(04)00410-6			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109488	Bronze			2022-12-28	WOS:000221176400002
J	Buriak, JM				Buriak, JM			Chemistry with nanoscale perfection	SCIENCE			English	Editorial Material									Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; Natl Inst Nanotechnol, Edmonton, AB T6G 2G2, Canada	University of Alberta; National Research Council Canada	Buriak, JM (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	jburiak@ualberta.ca		Buriak, Jillian Mary/0000-0002-9567-4328				ALDINGER F, 1974, ACTA METALL MATER, V22, P923, DOI 10.1016/0001-6160(74)90059-5; BIRCHENALL CE, 1956, J ELECTROCHEM SOC, V103, P619, DOI 10.1149/1.2430174; Colson J. C., 1972, P 7 INT S REACT SOL, P283; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Manna L, 2002, J CLUST SCI, V13, P521, DOI 10.1023/A:1021175612112; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; SMIGELSKAS AD, 1947, T AM I MIN MET ENG, V171, P130; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566	9	23	23	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					692	693		10.1126/science.1097604	http://dx.doi.org/10.1126/science.1097604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118151				2022-12-28	WOS:000221105300031
J	Davis, S; Begon, M; De Bruyn, L; Ageyev, VS; Klassovskiy, NL; Pole, SB; Viljugrein, H; Stenseth, NC; Leirs, H				Davis, S; Begon, M; De Bruyn, L; Ageyev, VS; Klassovskiy, NL; Pole, SB; Viljugrein, H; Stenseth, NC; Leirs, H			Predictive thresholds for plague in Kazakhstan	SCIENCE			English	Article							POPULATION-DYNAMICS; INFECTION; ECOLOGY; VIRUS	In Kazakhstan and elsewhere in central Asia, the bacterium Yersinia pestis circulates in natural populations of gerbils, which are the source of human cases of bubonic plague. Our analysis of field data collected between 1955 and 1996 shows that plague invades, fades out, and reinvades in response to fluctuations in the abundance of its main reservoir host, the great gerbil (Rhombomys opimus). This is a rare empirical example of the two types of abundance thresholds for infectious disease-invasion and persistence-operating in a single wildlife population. We parameterized predictive models that should reduce the costs of plague surveillance in central Asia and thereby encourage its continuance.	Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; Danish Pest Infestat Lab, DK-2800 Kongens Lyngby, Denmark; Univ Liverpool, Sch Biol Sci, Populat & Evolutionary Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Ctr Comparat Infect Dis, Liverpool L69 3BX, Merseyside, England; Inst Nat Conservat, B-1070 Brussels, Belgium; M Aikimbaevs Kazakh Sci Ctr Quarantine & Zoonot D, Alma Ata 480074, Kazakhstan; Univ Oslo, Dept Biol, CEES, N-0316 Oslo, Norway	University of Antwerp; Aarhus University; University of Liverpool; University of Liverpool; Aikimbayev's Kazakh Scientific Centre for Quarantine & Zoonotic Diseases; University of Oslo	Leirs, H (corresponding author), Univ Antwerp, Dept Biol, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	herwig.leirs@ua.ac.be	De Bruyn, Luc/C-7030-2008; Stenseth, Nils Chr./G-5212-2016; Leirs, Herwig/B-8197-2008; Viljugrein, Hildegunn/N-6657-2015	De Bruyn, Luc/0000-0002-8968-8862; Stenseth, Nils Chr./0000-0002-1591-5399; Leirs, Herwig/0000-0002-7612-5024; Viljugrein, Hildegunn/0000-0002-3798-5267; Begon, Mike/0000-0003-1715-5327				ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Biggins DE, 2001, J MAMMAL, V82, P906, DOI 10.1644/1545-1542(2001)082&lt;0906:IOIPON&gt;2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; Hess G.R., 2002, P102; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Tikhomirov E., 1999, PLAGUE MANUAL EPIDEM, P11; [No title captured]; [No title captured]; [No title captured]; [No title captured]	16	148	156	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					736	738		10.1126/science.1095854	http://dx.doi.org/10.1126/science.1095854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118163				2022-12-28	WOS:000221105300046
J	Fridlind, AM; Ackerman, AS; Jensen, EJ; Heymsfield, AJ; Poellot, MR; Stevens, DE; Wang, DH; Miloshevich, LM; Baumgardner, D; Lawson, RP; Wilson, JC; Flagan, RC; Seinfeld, JH; Jonsson, HH; VanReken, TM; Varutbangkul, V; Rissman, TA				Fridlind, AM; Ackerman, AS; Jensen, EJ; Heymsfield, AJ; Poellot, MR; Stevens, DE; Wang, DH; Miloshevich, LM; Baumgardner, D; Lawson, RP; Wilson, JC; Flagan, RC; Seinfeld, JH; Jonsson, HH; VanReken, TM; Varutbangkul, V; Rissman, TA			Evidence for the predominance of mid-tropospheric aerosols as subtropical anvil cloud nuclei	SCIENCE			English	Article							CIRRUS CLOUDS; MICROPHYSICS; EVOLUTION; POLLUTION; CLIMATE; MODEL; SIZE; AIR	NASA's recent Cirrus Regional Study of Tropical Anvils and Cirrus Layers-Florida Area Cirrus Experiment focused on anvil cirrus clouds, an important but poorly understood element of our climate system. The data obtained included the first comprehensive measurements of aerosols and cloud particles throughout the atmospheric column during the evolution of multiple deep convective storm systems. Coupling these new measurements with detailed cloud simulations that resolve the size distributions of aerosols and cloud particles, we found several lines of evidence indicating that most anvil crystals form on mid-tropospheric rather than boundary-layer aerosols. This result defies conventional wisdom and suggests that distant pollution sources may have a greater effect on anvil clouds than do local sources.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ N Dakota, Dept Atmospher Sci, Grand Forks, ND 58202 USA; Lawrence Livermore Natl Lab, Livermore, CA 94552 USA; Hampton Univ, Ctr Atmospher Sci, Hampton, VA 23681 USA; NASA, Langley Res Ctr, Hampton, VA 23681 USA; Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City 04510, DF, Mexico; Stratton Pk Engn Co Inc, Boulder, CO 80301 USA; Univ Denver, Dept Engn, Denver, CO 80208 USA; CALTECH, Dept Chem & Chem Engn, Pasadena, CA 91125 USA; Ctr Interdisciplinary Remotely Piloted Aircraft S, Marina, CA 93933 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Center Atmospheric Research (NCAR) - USA; University of North Dakota Grand Forks; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Hampton University; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Universidad Nacional Autonoma de Mexico; University of Denver; California Institute of Technology	Fridlind, AM (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	ann.fridlind@nasa.gov	Fridlind, Ann M/E-1495-2012; Ackerman, Andrew S/D-4433-2012; Heymsfield, Andrew J/E-7340-2011	Fridlind, Ann M/0000-0002-9020-0852; Ackerman, Andrew S/0000-0003-0254-6253; Heymsfield, Andrew J/0000-0003-4107-7533; Wilson, James/0000-0003-4699-5827				Ackerman AS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016634; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Clarke AD, 2002, J ATMOS SCI, V59, P363, DOI 10.1175/1520-0469(2002)059<0363:APASPI>2.0.CO;2; Del Genio AD, 2002, J CLIMATE, V15, P2597, DOI 10.1175/1520-0442(2002)015<2597:CPOTPC>2.0.CO;2; Garrett TJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018153; Graf HF, 2004, SCIENCE, V303, P1309, DOI 10.1126/science.1094411; HALL WD, 1980, J ATMOS SCI, V37, P2486, DOI 10.1175/1520-0469(1980)037<2486:ADMMWA>2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; HOUZE RA, 1977, CLOUD DYNAMICS; JACOBSON MZ, 1994, ATMOS ENVIRON, V28, P1327, DOI 10.1016/1352-2310(94)90280-1; Jensen EJ, 2001, J GEOPHYS RES-ATMOS, V106, P17237, DOI 10.1029/2000JD900649; Khain AP, 2001, GEOPHYS RES LETT, V28, P3887, DOI 10.1029/2000GL012662; KNOLLENBERG RG, 1993, J GEOPHYS RES-ATMOS, V98, P8639, DOI 10.1029/92JD02525; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; Lindzen RS, 2001, B AM METEOROL SOC, V82, P417, DOI 10.1175/1520-0477(2001)082<0417:DTEHAA>2.3.CO;2; LIST R, 1987, J ATMOS SCI, V44, P362, DOI 10.1175/1520-0469(1987)044<0362:TEODST>2.0.CO;2; LOHMANN U, 1995, J GEOPHYS RES-ATMOS, V100, P16305, DOI 10.1029/95JD01383; MEYERS MP, 1992, J APPL METEOROL, V31, P708, DOI 10.1175/1520-0450(1992)031<0708:NPINPI>2.0.CO;2; MUSIL DJ, 1986, J CLIM APPL METEOROL, V25, P1037, DOI 10.1175/1520-0450(1986)025<1037:MCOAWD>2.0.CO;2; Phillips VTJ, 2002, Q J ROY METEOR SOC, V128, P951, DOI 10.1256/0035900021643601; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; SCORER RS, 1977, ENV AERODYNAMICS; Sherwood S, 2002, SCIENCE, V295, P1272, DOI 10.1126/science.1065080; Sherwood SC, 2002, J CLIMATE, V15, P1051, DOI 10.1175/1520-0442(2002)015<1051:AAIPSI>2.0.CO;2; Singh HB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000486; STEPHENS GL, 1990, J ATMOS SCI, V47, P1742, DOI 10.1175/1520-0469(1990)047<1742:TROTMA>2.0.CO;2; TWOMEY S, 1974, ATMOS ENVIRON, V8, P1251, DOI 10.1016/0004-6981(74)90004-3; Wang PK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002581; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Xue M, 2003, METEOROL ATMOS PHYS, V82, P139, DOI 10.1007/s00703-001-0595-6; ZIPSER EJ, 2003, CLOUD SYSTEMS HURRIC, V29, pCH5	34	83	88	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					718	722		10.1126/science.1094947	http://dx.doi.org/10.1126/science.1094947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118158				2022-12-28	WOS:000221105300040
J	Regan, BC; Aloni, S; Ritchie, RO; Dahmen, U; Zettl, A				Regan, BC; Aloni, S; Ritchie, RO; Dahmen, U; Zettl, A			Carbon nanotubes as nanoscale mass conveyors	NATURE			English	Article							SCANNING TUNNELING MICROSCOPE; SINGLE ATOMS; ELECTROMIGRATION; NANOCAPILLARITY; CAPILLARITY; CHEMISTRY; SURFACES; PROBES	The development of manipulation tools that are not too 'fat' or too 'sticky' for atomic scale assembly is an important challenge facing nanotechnology(1). Impressive nanofabrication capabilities have been demonstrated with scanning probe manipulation of atoms(2-5) and molecules(4,6) on clean surfaces. However, as fabrication tools, both scanning tunnelling and atomic force microscopes suffer from a loading deficiency: although they can manipulate atoms already present, they cannot efficiently deliver atoms to the work area. Carbon nanotubes, with their hollow cores and large aspect ratios, have been suggested(7,8) as possible conduits for nanoscale amounts of material. Already much effort has been devoted to the filling of nanotubes(8-11) and the application of such techniques(12,13). Furthermore, carbon nanotubes have been used as probes in scanning probe microscopy(14-16). If the atomic placement and manipulation capability already demonstrated by scanning probe microscopy could be combined with a nanotube delivery system, a formidable nanoassembly tool would result. Here we report the achievement of controllable, reversible atomic scale mass transport along carbon nanotubes, using indium metal as the prototype transport species. This transport process has similarities to conventional electromigration, a phenomenon of critical importance to the semiconductor industry(17,18).	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@socrates.berkeley.edu	Zettl, Alex K/O-4925-2016; Ritchie, Robert O/A-8066-2008	Zettl, Alex K/0000-0001-6330-136X; Ritchie, Robert O/0000-0002-0501-6998; Regan, B. C./0000-0003-3923-2688				Adamson A. W., 1967, PHYS CHEM SURFACES; AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Collins PG, 2001, PHYS REV LETT, V86, P3128, DOI 10.1103/PhysRevLett.86.3128; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; CUMINGS JP, 2002, THESIS U CALIFORNIA; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; Duclaux L, 2002, CARBON, V40, P1751, DOI 10.1016/S0008-6223(02)00043-X; DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Gao YH, 2002, NATURE, V415, P599, DOI 10.1038/415599a; Ghosh S, 2003, SCIENCE, V299, P1042, DOI 10.1126/science.1079080; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; HUMMEL RE, 1994, INT MATER REV, V39, P97, DOI 10.1179/095066094790326194; Kono S, 1999, SURF SCI, V420, P200, DOI 10.1016/S0039-6028(98)00825-5; Kral P, 1999, PHYS REV LETT, V82, P5373, DOI 10.1103/PhysRevLett.82.5373; Kral P, 2001, PHYS REV LETT, V86, P131, DOI 10.1103/PhysRevLett.86.131; Mingo N, 2001, J PHYS CHEM B, V105, P11142, DOI 10.1021/jp011491s; Oyabu N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.176102; PEDERSON MR, 1992, PHYS REV LETT, V69, P2689, DOI 10.1103/PhysRevLett.69.2689; Pierce DG, 1997, MICROELECTRON RELIAB, V37, P1053, DOI 10.1016/S0026-2714(96)00268-5; Service RF, 2000, SCIENCE, V290, P1526, DOI 10.1126/science.290.5496.1526; Supple S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214501; Ugarte D, 1996, SCIENCE, V274, P1897, DOI 10.1126/science.274.5294.1897; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735; YASUNAGA H, 1992, SURF SCI REP, V15, P205, DOI 10.1016/0167-5729(92)90007-X; Zinke-Allmang M, 1999, THIN SOLID FILMS, V346, P1, DOI 10.1016/S0040-6090(98)01479-5	28	252	263	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					924	927		10.1038/nature02496	http://dx.doi.org/10.1038/nature02496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118721				2022-12-28	WOS:000221083000035
J	Marcus, PS				Marcus, PS			Prediction of a global climate change on Jupiter	NATURE			English	Article							GREAT RED SPOT; JOVIAN WHITE OVALS; DYNAMICS; FLOW; ATMOSPHERE; MERGER; JETS	Jupiter's atmosphere, as observed in the 1979 Voyager space craft images, is characterized by 12 zonal jet streams and about 80 vortices, the largest of which are the Great Red Spot and three White Ovals that had formed(1) in the 1930s. The Great Red Spot has been observed(2) continuously since 1665 and, given the dynamical similarities between the Great Red Spot and the White Ovals, the disappearance(3,4) of two White Ovals in 1997-2000 was unexpected. Their longevity and sudden demise has been explained(5) however, by the trapping of anticyclonic vortices in the troughs of Rossby waves, forcing them to merge. Here I propose that the disappearance of the White Ovals was not an isolated event, but part of a recurring climate cycle which will cause most of Jupiter's vortices to disappear within the next decade. In my numerical simulations, the loss of the vortices results in a global temperature change of about 10 K, which destabilizes the atmosphere and thereby leads to the formation of new vortices. After formation, the large vortices are eroded by turbulence over a time of similar to60 years-consistent with observations of the White Ovals-until they disappear and the cycle begins again.	Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Marcus, PS (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	pmarcus@me.berkeley.edu						Chandrasekhar S, 2013, HYDRODYNAMIC HYDROMA; DOWLING TE, 1989, J ATMOS SCI, V46, P3256, DOI 10.1175/1520-0469(1989)046<3256:JGRSAA>2.0.CO;2; Drazin P.G., 1982, HYDRODYNAMIC STABILI; FLASAR FM, 1986, ICARUS, V65, P280, DOI 10.1016/0019-1035(86)90140-5; Gierasch PJ, 1999, ICARUS, V142, P148, DOI 10.1006/icar.1999.6193; Hooke R., 1665, PHILOS T R SOC, V1, P3, DOI [10.1098/rstl.1665.0005, DOI 10.1098/RSTL.1665.0005]; HUMPHREYS TD, 2000, THESIS U CALIFORNIA; LOW MMM, 1986, ICARUS, V65, P353, DOI 10.1016/0019-1035(86)90143-0; MARCUS PS, 1988, NATURE, V331, P693, DOI 10.1038/331693a0; MARCUS PS, 1993, ANNU REV ASTRON ASTR, V31, P523, DOI 10.1146/annurev.aa.31.090193.002515; Marcus PS, 1998, PHYS FLUIDS, V10, P1474, DOI 10.1063/1.869668; MARCUS PS, 1990, J FLUID MECH, V215, P393, DOI 10.1017/S0022112090002695; Nezlin MV, 1994, CHAOS, V4, P187, DOI 10.1063/1.166003; Ottino JM., 1989, KINEMATICS MIXING ST; PANETTA RL, 1993, J ATMOS SCI, V50, P2073, DOI 10.1175/1520-0469(1993)050<2073:ZJIWBU>2.0.CO;2; Pedlosky J., 1987, GEOPHYS FLUID DYN; Rogers J. H., 1995, GIANT PLANET JUPITER; Sanchez-Lavega A, 1999, ICARUS, V142, P116, DOI 10.1006/icar.1999.6197; Sanchez-Lavega A, 2001, ICARUS, V149, P491, DOI 10.1006/icar.2000.6548; SOLOMON TH, 1994, PHYSICA D, V76, P70, DOI 10.1016/0167-2789(94)90251-8; SOLOMON TH, 1993, PHYS FLUIDS A-FLUID, V5, P1971, DOI 10.1063/1.858824; Sutyrin GG, 1994, CHAOS, V4, P203, DOI 10.1063/1.166004; Youssef A, 2003, ICARUS, V162, P74, DOI 10.1016/S0019-1035(02)00060-X	23	32	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					828	831		10.1038/nature02470	http://dx.doi.org/10.1038/nature02470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103369				2022-12-28	WOS:000220952300032
J	Navarro, V				Navarro, V			The world situation and WHO	LANCET			English	Editorial Material							HEALTH; MACROECONOMICS; NEOLIBERALISM; COMMISSION; CRITIQUE; BANK		Johns Hopkins Univ, Pompeu Fabra Univ, Publ & Hlth Policy Program, Baltimore, MD 21205 USA	Johns Hopkins University	Navarro, V (corresponding author), Johns Hopkins Univ, Pompeu Fabra Univ, Publ & Hlth Policy Program, 624 N Broadway, Baltimore, MD 21205 USA.	vnavarro@jhsph.edu	Navarro, Vicente/E-8174-2014	Navarro, Vicente/0000-0002-3310-3984				Banerji D, 1999, INT J HEALTH SERV, V29, P227, DOI 10.2190/RAB4-D873-99AM-ACJR; Banerji D, 2002, INT J HEALTH SERV, V32, P733, DOI 10.2190/CECN-VWK4-H8AC-BCRH; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Fee E, 2001, AM J PUBLIC HEALTH, V91, P721, DOI 10.2105/AJPH.91.5.721; Kiely R, 1998, INT J HEALTH SERV, V28, P683, DOI 10.2190/RPMG-JYB5-8DN6-AC30; Kim J. Y., 2000, DYING GROWTH GLOBAL; Ku LT, 2003, INT J HEALTH SERV, V33, P359, DOI 10.2190/PJBY-ET6G-BMQK-4EXV; Navarro V, 1998, INT J HEALTH SERV, V28, P607, DOI 10.2190/Y3X7-RG7E-6626-FVPT; NAVARRO V, 2003, POLITICAL EC SOCIAL; THOMPSON T, 2003, THESIS J HOPKINS U; TOWNSEND P, 2002, WORLD POVERTY; *UN DEV PROGR, 2000, REP INC IN WORLD TOD; *UN DEV PROGR, 2002, HUM DEV REP 2002; Waitzkin H, 2003, LANCET, V361, P523, DOI 10.1016/S0140-6736(03)12491-9; WHO, 2001, REP COMM MACR HLTH M; World Health Organization, 2000, WORLD HLTH REP 2000	16	24	29	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1321	1323		10.1016/S0140-6736(04)16008-X	http://dx.doi.org/10.1016/S0140-6736(04)16008-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813KB	15094280				2022-12-28	WOS:000220904900025
J	Zimmern, RL; Hall, A				Zimmern, RL; Hall, A			Role of next of kin in accessing health records of deceased relatives - Commentary: The arguments could be extended	BRITISH MEDICAL JOURNAL			English	Editorial Material									Strangeways Res Lab, Publ Hlth Genet Unit, Cambridge CB1 8RN, England		Zimmern, RL (corresponding author), Strangeways Res Lab, Publ Hlth Genet Unit, Cambridge Genet Knowledge Pk, Cambridge CB1 8RN, England.	ron.zimmern@srl.cam.ac.uk						*GEN MED COUNC, CONF PROT PROV INF	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					954	954		10.1136/bmj.328.7445.954-a	http://dx.doi.org/10.1136/bmj.328.7445.954-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087352	Green Published			2022-12-28	WOS:000220994400037
J	Loriaux, L				Loriaux, L			Glucocorticoid therapy in the intensive care unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA	Oregon Health & Science University	Loriaux, L (corresponding author), Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA.							CHROUSOS GP, 1993, ANN INTERN MED, V119, P1113, DOI 10.7326/0003-4819-119-11-199312010-00009; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; KEHLET H, 1975, ACTA ANAESTH SCAND, V19, P260, DOI 10.1111/j.1399-6576.1975.tb05182.x	3	24	24	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1601	1602		10.1056/NEJMp048052	http://dx.doi.org/10.1056/NEJMp048052			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084691				2022-12-28	WOS:000220819800003
J	Pischon, T; Girman, CJ; Hotamisligil, GS; Rifai, N; Hu, FB; Rimm, EB				Pischon, T; Girman, CJ; Hotamisligil, GS; Rifai, N; Hu, FB; Rimm, EB			Plasma adiponectin levels and risk of myocardial infarction in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLEMENT-RELATED PROTEIN; FATTY-ACID OXIDATION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; BINDING PROTEIN; ADIPOSE; ASSOCIATION; EXPRESSION	Context Adiponectin, a recently discovered adipocyte-derived peptide, is involved in the regulation of insulin sensitivity and lipid oxidation and, purportedly, in the development of atherosclerosis and coronary heart disease in humans. Objective To assess prospectively whether plasma adiponectin concentrations are associated with risk of myocardial infarction (MI). Design, Setting, and Participants Nested case-control study among 18225 male participants of the Health Professionals Follow-up Study aged 40 to 75 years who were free of diagnosed cardiovascular disease at the time of blood draw (199371995). During 6 years of follow-up through January 31, 2000, 266 men subsequently developed nonfatal MI or fatal coronary heart disease. Using risk set sampling, controls were selected in a 2:1 ratio matched for age, date of blood draw, and smoking status (n=532). Main Outcome Measure Incidence of nonfatal MI and fatal coronary heart disease by adiponectin level. Results After adjustment for matched variables, participants in the highest compared with the lowest quintile of adiponectin levels had a significantly decreased risk of MI (relative risk [RR], 0.39; 95% confidence interval [CI], 0.23-0.64; P for trend <.001). Additional adjustment for family history of MI, body mass index, alcohol consumption, physical activity, and history of diabetes and hypertension did not substantively affect this relationship (RR, 0.41; 95% Cl, 0.24-0.70; P for trend <.001). Further adjustment for hemoglobin A(1c) or C-reactive protein levels also had little impact, but additional adjustment for low- and high-density lipoprotein cholesterol levels modestly attenuated this association (RR, 0.56; 95% Cl, 0.32-0.99; P for trend=.02). Conclusions High plasma adiponectin concentrations are associated with lower risk of MI in men. This relationship can be only partly explained by differences in blood lipids and is independent of inflammation and glycemic status.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Humboldt Univ, Charite, Franz Volhard Clin, Berlin, Germany; Merck Res Labs, Dept Epidemiol, West Point, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Merck & Company	Pischon, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	tpischon@hsph.harvard.edu	Pischon, Tobias/HGE-8577-2022; Adiels, Martin/C-9278-2011; Hu, Frank/C-1919-2013	Pischon, Tobias/0000-0003-1568-767X; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; *DEP AGR, 1992, COMP FOODS RAW PROC; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Halleux CM, 2001, BIOCHEM BIOPH RES CO, V288, P1102, DOI 10.1006/bbrc.2001.5904; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Kazumi T, 2002, DIABETES CARE, V25, P971, DOI 10.2337/diacare.25.6.971; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kojima S, 2003, HEART, V89, P667, DOI 10.1136/heart.89.6.667; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lindsay R, 2003, DIABETES, V52, pA161; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsubara M, 2003, EUR J ENDOCRINOL, V148, P657, DOI 10.1530/eje.0.1480657; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Rifai N, 1998, CLIN CHEM, V44, P1242; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P93; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; STINSHOFF K, 1977, CLIN CHEM, V23, P1029; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	58	1377	1445	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1730	1737		10.1001/jama.291.14.1730	http://dx.doi.org/10.1001/jama.291.14.1730			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082700	Bronze			2022-12-28	WOS:000220788700030
J	Jureidini, JN; Doecke, CJ; Mansfield, PR; Haby, MM; Menkes, DB; Tonkin, AL				Jureidini, JN; Doecke, CJ; Mansfield, PR; Haby, MM; Menkes, DB; Tonkin, AL			Efficacy and safety of antidepressants for children and adolescents	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; PLACEBO; MEDICATION; FLUOXETINE; PAROXETINE; CLINICIAN		Womens & Childrens Hosp, Dept Psychol Med, Adelaide, SA 5006, Australia; Univ S Australia, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5000, Australia; Univ S Australia, Dept Gen Practice, Adelaide, SA 5005, Australia; Univ Adelaide, Dept Clin & Expt Pharmacol, Adelaide, SA 5005, Australia; Dept Human Serv, Hlth Surveillance & Evaluat Sect, Melbourne, Vic 3000, Australia; Univ Wales, Acad Unit, Wrexham LL13 7YP, Wales	Womens & Childrens Hospital Australia; University of South Australia; University of South Australia; University of Adelaide; Glyndwr University	Jureidini, JN (corresponding author), Womens & Childrens Hosp, Dept Psychol Med, Adelaide, SA 5006, Australia.	jureidinij@wch.sa.gov.au	Mansfield, Peter/Q-8707-2019; Jureidini, Jon/AFS-5457-2022; Haby, Michelle/AGL-3386-2022	Haby, Michelle/0000-0001-6203-9195; Jureidini, Jon/0000-0001-7585-2660				Braconnier A, 2003, J AM ACAD CHILD PSY, V42, P22, DOI 10.1097/00004583-200301000-00007; Chan RTW, 2002, MED J AUSTRALIA, V177, P448; Committee on Safety of Medicines. Selective Serotonin Reuptake Inhibitors (SSRIs), SEL SER REUPT INH SS; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Ernst H, 2002, INT J MANAG REV, V4, P1, DOI 10.1111/1468-2370.00075; *FDA CTR DRUG EV R, BACKGR SUIC ASS ANT; *FDA CTR DRUG EV R, STAT REV PROZ PED OC; Harrington R, 1998, BRIT MED J, V316, P1559, DOI 10.1136/bmj.316.7144.1559; Herxheimer A, 2004, CAN MED ASSOC J, V170, P487; Hughes CW, 2000, NEUROPSYCHOPHARMACOL, V23, P591, DOI 10.1016/S0893-133X(00)00098-1; Jureidini J, 2003, J AM ACAD CHILD PSY, V42, P514, DOI 10.1097/01.CHI.0000046825.95464.DA; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Keller MB, 2003, J AM ACAD CHILD PSY, V42, P514, DOI 10.1097/S0890-8567(09)60933-3; KING RA, 1991, J AM ACAD CHILD PSY, V30, P179, DOI 10.1097/00004583-199103000-00003; Kirsch I, 2003, COMPLEMENT THER MED, V11, P193, DOI 10.1016/S0965-2299(03)00109-2; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Mandoki MW, 1997, PSYCHOPHARMACOL BULL, V33, P149; Moncrieff J., 2004, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD003012.PUB2; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; Safer DJ, 2003, AM J PSYCHIAT, V160, P438, DOI 10.1176/appi.ajp.160.3.438; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; Swartzman LC, 1998, CLIN PHARMACOL THER, V64, P1, DOI 10.1016/S0009-9236(98)90016-9; Varley CK, 2003, JAMA-J AM MED ASSOC, V290, P1091, DOI 10.1001/jama.290.8.1091; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033	24	197	203	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					879	883		10.1136/bmj.328.7444.879	http://dx.doi.org/10.1136/bmj.328.7444.879			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812XE	15073072	Green Submitted, Green Published			2022-12-28	WOS:000220871400020
J	Cossart, P; Sansonetti, PJ				Cossart, P; Sansonetti, PJ			Bacterial invasion: The paradigms of enteroinvasive pathogens	SCIENCE			English	Review							TYPHIMURIUM-CONTAINING VACUOLES; LISTERIA-MONOCYTOGENES; III SECRETION; N-WASP; SHIGELLA-FLEXNERI; ARP2/3 COMPLEX; CALCIUM INFLUX; RHO GTPASES; PROTEIN; SALMONELLA	Invasive bacteria actively induce their own uptake by phagocytosis in normally nonphagocytic cells and then either establish a protected niche within which they survive and replicate, or disseminate from cell to cell by means of an actin-based motility process. The mechanisms underlying bacterial entry, phagosome maturation, and dissemination reveal common strategies as well as unique tactics evolved by individual species to establish infection.	Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, F-75015 Paris, France; Inst Pasteur, Dept Biol Cellulaire & Infect, CNRS, U389,Unite Pathogenie Microbienne Mol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, 28 Rue Dr Roux, F-75015 Paris, France.	pcossart@pasteur.fr; psan.son@pasteur.fr						Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Bierne H, 2002, J CELL SCI, V115, P3357; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; BIERNE H, UNPUB; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; BOUGNERES L, UNPUB; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Decatur AL, 2000, SCIENCE, V290, P992, DOI 10.1126/science.290.5493.992; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; DUSSURGET O, IN PRESS ANN REV MIC; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Isberg RR, 2001, J CELL SCI, V114, P21; Kagnoff MF, 2003, MICROBIAL PATHOGENESIS AND THE INTESTINAL EPITHELIAL CELL, P155; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lecuit M, 2000, P NATL ACAD SCI USA, V97, P10008, DOI 10.1073/pnas.97.18.10008; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; McGee K, 2003, FEBS LETT, V533, P35, DOI 10.1016/S0014-5793(02)03745-6; McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; MOUNIER J, UNPUB; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; SEVEAU S, UNPUB; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SOUSA S, UNPUB; SOUSA S, IN PRESS J CELL SCI; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	69	740	795	1	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					242	248		10.1126/science.1090124	http://dx.doi.org/10.1126/science.1090124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073367				2022-12-28	WOS:000220719400034
J	Block, GA; Martin, KJ; de Francisco, ALM; Turner, SA; Avram, MM; Suranyi, MG; Hercz, G; Cunningham, J; Abu-Alfa, AK; Messa, P; Coyne, DW; Locatelli, F; Cohen, RM; Evenepoel, P; Moe, SM; Fournier, A; Braun, J; McCary, LC; Zani, VJ; Olson, KA; Drueke, TB; Goodman, WG				Block, GA; Martin, KJ; de Francisco, ALM; Turner, SA; Avram, MM; Suranyi, MG; Hercz, G; Cunningham, J; Abu-Alfa, AK; Messa, P; Coyne, DW; Locatelli, F; Cohen, RM; Evenepoel, P; Moe, SM; Fournier, A; Braun, J; McCary, LC; Zani, VJ; Olson, KA; Drueke, TB; Goodman, WG			Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARATHYROID-HORMONE LEVELS; STAGE RENAL-DISEASE; DIALYSIS PATIENTS; CALCIMIMETIC AMG-073; PHOSPHATE-METABOLISM; MORTALITY RISK; CALCIUM; CALCIFICATION; RECEPTOR; ASSOCIATION	BACKGROUND: Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular disease and adverse clinical outcomes. Calcimimetics target the calcium-sensing receptor and lower parathyroid hormone levels without increasing calcium and phosphorus levels. We report the results of two identical randomized, double-blind, placebo-controlled trials evaluating the safety and effectiveness of the calcimimetic agent cinacalcet hydrochloride. METHODS: Patients who were receiving hemodialysis and who had inadequately controlled secondary hyperparathyroidism despite standard treatment were randomly assigned to receive cinacalcet (371 patients) or placebo (370 patients) for 26 weeks. Once-daily doses were increased from 30 mg to 180 mg to achieve intact parathyroid hormone levels of 250 pg per milliliter or less. The primary end point was the percentage of patients with values in this range during a 14-week efficacy-assessment phase. RESULTS: Forty-three percent of the cinacalcet group reached the primary end point, as compared with 5 percent of the placebo group (P<0.001). Overall, mean parathyroid hormone values decreased 43 percent in those receiving cinacalcet but increased 9 percent in the placebo group (P<0.001). The serum calcium-phosphorus product declined by 15 percent in the cinacalcet group and remained unchanged in the placebo group (P<0.001). Cinacalcet effectively reduced parathyroid hormone levels independently of disease severity or changes in vitamin D sterol dose. CONCLUSIONS: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.	Denver Nephrologists, Denver, CO 80218 USA; St Louis Univ, St Louis, MO 63103 USA; Hosp Marques Valdecilla, Santander, Spain; Amgen Inc, Thousand Oaks, CA USA; Long Isl Coll Hosp, Brooklyn, NY 11201 USA; Liverpool Hosp, Liverpool, NSW, Australia; Humber River Reg Hosp, Toronto, ON, Canada; UCL Hosp, London, England; Yale Univ, Sch Med, New Haven, CT USA; Osped Civile S Andrea, La Spezia, Italy; Washington Univ, Sch Med, St Louis, MO 63130 USA; Osped Manzoni, Lecce, Italy; Presbyterian Med Ctr, Philadelphia, PA USA; Univ Ziekenhuis Gasthuisberg, Louvain, Belgium; Indiana Univ, Sch Med, Indianapolis, IN USA; Ctr Hosp Univ Amiens, Amiens, France; Kuratorium Dialyse, Nurnberg, Germany; Hop Necker Enfants Malad, Paris, France; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Saint Louis University; Hospital Universitario Marques de Valdecilla (HUMV); Amgen; Long Island College Hospital; Liverpool Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London; Yale University; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Presbyterian Medical Center; KU Leuven; University Hospital Leuven; Indiana University System; Indiana University-Purdue University Indianapolis; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Block, GA (corresponding author), Denver Nephrologists, 1601 E 19th Ave 4300, Denver, CO 80218 USA.	gablock@denverneph.net	Centeno, Patricia Pacios/O-8368-2016; Block, Geoffrey/AAV-8070-2021; P, Evenepoel/D-9597-2018	Block, Geoffrey/0000-0002-4646-7074; P, Evenepoel/0000-0002-2846-2026				Block GA, 2000, AM J KIDNEY DIS, V35, P1226, DOI 10.1016/S0272-6386(00)70064-3; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Brown E M, 1993, Curr Opin Nephrol Hypertens, V2, P541, DOI 10.1097/00041552-199307000-00004; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fox J, 1999, ENDOCRINE, V10, P97, DOI 10.1385/ENDO:10:2:97; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Goodman WG, 2000, KIDNEY INT, V58, P436, DOI 10.1046/j.1523-1755.2000.00183.x; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Goodman WG, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341017; Goodman WG, 2001, KIDNEY INT, V59, P1187, DOI 10.1046/j.1523-1755.2001.00605.x; Hammerland LG, 1998, MOL PHARMACOL, V53, P1083; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; Hsu CH, 1997, AM J KIDNEY DIS, V29, P641, DOI 10.1016/S0272-6386(97)90352-8; Indridason OS, 2000, KIDNEY INT, V57, P282, DOI 10.1046/j.1523-1755.2000.00819.x; Johnson CA, 2002, AM J KIDNEY DIS, V39, P1270, DOI 10.1053/ajkd.2002.33401; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; LARSSON L, 1978, CLIN CHEM, V24, P1962; Lindberg JS, 2003, KIDNEY INT, V63, P248, DOI 10.1046/j.1523-1755.2003.00720.x; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P723, DOI 10.1093/ndt/17.5.723; Maung HM, 2001, AM J KIDNEY DIS, V37, P532; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; Owda A, 2003, RENAL FAILURE, V25, P595, DOI 10.1081/JDI-120022551; Quarles LD, 2003, J AM SOC NEPHROL, V14, P575, DOI 10.1097/01.ASN.0000050224.03126.AD; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ribeiro S, 1998, NEPHROL DIAL TRANSPL, V13, P2037, DOI 10.1093/ndt/13.8.2037; Salem MM, 1997, AM J KIDNEY DIS, V29, P862, DOI 10.1016/S0272-6386(97)90459-5; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Slatopolsky E, 1999, KIDNEY INT, V56, pS14, DOI 10.1046/j.1523-1755.1999.07304.x; WANG M, 1995, AM J KIDNEY DIS, V26, P836, DOI 10.1016/0272-6386(95)90453-0	31	804	840	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1516	1525		10.1056/NEJMoa031633	http://dx.doi.org/10.1056/NEJMoa031633			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071126				2022-12-28	WOS:000220682000007
J	Somers, MJ; Daouk, GH; McCluskey, RT				Somers, MJ; Daouk, GH; McCluskey, RT			Case 11-2004: A boy with rash, edema, and hypertension - Severe lupus nephritis with mixed proliferative and membranous features (World Health Organization class IV or V), with high activity and moderate chronicity indexes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYCOPHENOLATE-MOFETIL; RENAL-DISEASE; ERYTHEMATOSUS; CHILDHOOD; GLOMERULONEPHRITIS; ONSET; METAANALYSIS; PROGRESSION; CHILDREN		Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pediat Nephrol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Somers, MJ (corresponding author), Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.							AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Bansal VK, 1997, AM J KIDNEY DIS, V29, P193, DOI 10.1016/S0272-6386(97)90029-9; BARRON KS, 1993, ARTHRITIS RHEUM, V36, P348, DOI 10.1002/art.1780360310; Buratti S, 2001, J RHEUMATOL, V28, P2103; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; DAHA MR, 1978, J IMMUNOL, V120, P1389; Denton MD, 2001, AM J TRANSPLANT, V1, P288, DOI 10.1034/j.1600-6143.2001.001003288.x; Dharnidharka VR, 1998, PEDIATR NEPHROL, V12, P576, DOI 10.1007/s004670050508; Falk RJ, 2000, NEW ENGL J MED, V343, P1182, DOI 10.1056/NEJM200010193431610; FRIES JF, 1978, ARCH INTERN MED, V138, P1386, DOI 10.1001/archinte.138.9.1386; GEWURZ A, 1978, ARTHRITIS RHEUM, V21, P28, DOI 10.1002/art.1780210106; Gloor JM, 1998, LUPUS, V7, P639, DOI 10.1191/096120398678920785; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; IITAKA K, 1995, PEDIATR NEPHROL, V9, P272, DOI 10.1007/BF02254182; Jafar TH, 2002, ANN INTERN MED, V137, P299; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; KASHGARIAN M, 1994, KIDNEY INT, V45, P928, DOI 10.1038/ki.1994.123; Klein-Gitelman M, 2002, RHEUM DIS CLIN N AM, V28, P561, DOI 10.1016/S0889-857X(02)00015-7; Lehman TJA, 2000, J PEDIATR-US, V136, P243, DOI 10.1016/S0022-3476(00)70109-0; McCluskey RT, 1975, KIDNEY PATHOLOGY DEC, P435; NEUGARTEN J, 1984, AM J KIDNEY DIS, V3, P371, DOI 10.1016/S0272-6386(84)80086-4; SCHALLER J, 1982, CLIN RHEUM DIS, V8, P219; Schwartz MM, 2000, KIDNEY INT, V58, P1354, DOI 10.1046/j.1523-1755.2000.00293.x; Stiller M, 2000, Clin Oral Investig, V4, P176, DOI 10.1007/s007840000070; TUCKER LB, 1995, BRIT J RHEUMATOL, V34, P866; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	34	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1550	1559		10.1056/NEJMcpc030041	http://dx.doi.org/10.1056/NEJMcpc030041			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071130				2022-12-28	WOS:000220682000012
J	Benn, CS; Melbye, M; Wohlfahrt, J; Bjorksten, B; Aaby, P				Benn, CS; Melbye, M; Wohlfahrt, J; Bjorksten, B; Aaby, P			Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life	BRITISH MEDICAL JOURNAL			English	Article							FAMILY-SIZE; HAY-FEVER; RESPIRATORY-INFECTIONS; BIRTH COHORT; CHILDREN; ASTHMA; PREVALENCE; ALLERGY; DETERMINANTS; ANTIBODIES	Objectives To determine whether early infectious diseases could explain the association between number of siblings and other markers of microbial exposure and the development of atopic dermatitis before the age of 18 months. Design Cohort study. Information on atopic dermatitis, infectious diseases occurring before 6 months of age, number of siblings, early day care, pet keeping, farm residence, and background factors was collected in telephone interviews. Setting Danish national birth cohort. Participants 24341 mother-child pairs. Main outcome measures Incidence rate ratios of atopic dermatitis. Results 13070 children (54%) had at least one clinically apparent infectious disease before 6 months of age. At age 18 months, 2638 (10.8%) of the children had had atopic dermatitis. The risk of atopic dermatitis increased with each infectious disease before 6 months of age (incidence rate ratio 1.08,95% confidence interval 1.04 to 1.13). The risk of atopic dermatitis decreased with each additional exposure to three or more siblings, day care, pet ownership, and farm residence (0.86, 0.81 to 0.93). Conclusions Early infections do not seem to protect against allergic diseases. The protective effect of number of siblings, day care, pet ownership, and farm residence remained after adjustment for clinically apparent infectious diseases, suggesting that the effect is established independently early in life.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; Projecto Saude Bandim, Bissau, Guinea Bissau; Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Stockholm, Sweden	Aarhus University; Statens Serum Institut; Karolinska Institutet; Karolinska Institutet	Benn, CS (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark.	C.Benn.cb@ssi.dk		Aaby, Peter/0000-0001-8331-1389; melbye, mads/0000-0001-8264-6785				Benn CS, 2003, ACTA DERM-VENEREOL, V83, P347; Bjorksten B, 1999, J ALLERGY CLIN IMMUN, V104, P1119; Bodner C, 1998, THORAX, V53, P28, DOI 10.1136/thx.53.1.28; Bohme M, 2002, ACTA DERM-VENEREOL, V82, P98, DOI 10.1080/00015550252948112; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Linneberg A, 2003, J ALLERGY CLIN IMMUN, V111, P847, DOI 10.1067/mai.2003.1335; Matricardi PM, 2001, CURR OPIN ALLERGY CL, V1, P413, DOI 10.1097/00130832-200110000-00006; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McKeever TM, 2002, J ALLERGY CLIN IMMUN, V109, P43, DOI 10.1067/mai.2002.121016; Nafstad P, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e38; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ponsonby AL, 1999, THORAX, V54, P664, DOI 10.1136/thx.54.8.664; RYSTEDT I, 1986, BRIT J DERMATOL, V114, P575, DOI 10.1111/j.1365-2133.1986.tb04064.x; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Strannegard O, 2001, ALLERGY, V56, P91, DOI 10.1034/j.1398-9995.2001.056002091.x; Wickens KL, 1999, EPIDEMIOLOGY, V10, P699, DOI 10.1097/00001648-199911000-00009	23	134	135	2	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2004	328	7450					1223	1226		10.1136/bmj.38069.512245.FE	http://dx.doi.org/10.1136/bmj.38069.512245.FE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15121716	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000221677200015
J	Shin, JW; Hammer, NI; Diken, EG; Johnson, MA; Walters, RS; Jaeger, TD; Duncan, MA; Christie, RA; Jordan, KD				Shin, JW; Hammer, NI; Diken, EG; Johnson, MA; Walters, RS; Jaeger, TD; Duncan, MA; Christie, RA; Jordan, KD			Infrared signature of structures associated with the H+(H2O)(n) (n=6 to 27) clusters	SCIENCE			English	Article							FREE JET EXPANSION; DODECAHEDRAL CLUSTERS; HYDRATED PROTONS; WATER CLUSTERS; IONS; SPECTROSCOPY; (H2O)(20); SPECTRUM; DYNAMICS; ENERGY	We report the OH stretching vibrational spectra of size-selected H+(H2O)(n) clusters through the region of the pronounced "magic number" at n = 21 in the cluster distribution. Sharp features are observed in the spectra and assigned to excitation of the dangling OH groups throughout the size range 6 less than or equal to n less than or equal to 27. A multiplet of such bands appears at small cluster sizes. This pattern simplifies to a doublet at n = 11, with the doublet persisting up to n = 20, but then collapsing to a single line in the n = 21 and n = 22 clusters and reemerging at n = 23. This spectral simplification provides direct evidence that, for the magic number cluster, all the dangling OH groups arise from water molecules in similar binding sites.	Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA; Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Yale University; University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, MA (corresponding author), Yale Univ, Sterling Chem Lab, POB 208107, New Haven, CT 06520 USA.	mark.johnson@yale.edu; maduncan@uga.edu; jordan@imap.pitt.edu	Shin, Joong-Won/D-5213-2009; Christie, Richard/E-5144-2015	Christie, Richard/0000-0001-8603-5834; Hammer, Nathan/0000-0002-6221-2709				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; BEGEMANN MH, 1983, PHYS REV LETT, V51, P554, DOI 10.1103/PhysRevLett.51.554; CAMPAGNOLA PJ, 1991, J CHEM PHYS, V95, P7998, DOI 10.1063/1.461330; Castleman AW, 1996, J PHYS CHEM-US, V100, P12911, DOI 10.1021/jp961030k; Davidson D.W, 1973, WATER CRYSTALLINE HY, P115; Duncan MA, 2003, INT REV PHYS CHEM, V22, P407, DOI 10.1080/0144235031000095201; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Hodges MP, 2000, CHEM PHYS LETT, V324, P279, DOI 10.1016/S0009-2614(00)00584-4; Jiang JC, 2000, J AM CHEM SOC, V122, P1398, DOI 10.1021/ja990033i; JOHNSON MA, 1988, TECHNIQUES CHEM, V20, P591; Johnson MS, 1996, CHEM PHYS LETT, V260, P551, DOI 10.1016/0009-2614(96)00911-6; KASSNER JL, 1976, J CHEM PHYS, V64, P1860, DOI 10.1063/1.432330; Kelterbaum R, 1996, THEOCHEM-J MOL STRUC, V371, P205, DOI 10.1016/S0166-1280(96)04736-7; Khan A, 2000, CHEM PHYS LETT, V319, P440, DOI 10.1016/S0009-2614(00)00175-5; KLOTS CE, 1985, J CHEM PHYS, V83, P5854, DOI 10.1063/1.449615; KOZACK RE, 1993, J CHEM PHYS, V99, P2978, DOI 10.1063/1.465204; LAASONEN K, 1994, J PHYS CHEM-US, V98, P10079, DOI 10.1021/j100091a022; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; McDonald S, 1998, J PHYS CHEM A, V102, P2824, DOI 10.1021/jp9803539; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; Schmitt UW, 1999, J CHEM PHYS, V111, P9361, DOI 10.1063/1.480032; SEARCY JQ, 1974, J CHEM PHYS, V61, P5282, DOI 10.1063/1.1681876; SHI Z, 1993, J CHEM PHYS, V99, P8009, DOI 10.1063/1.465678; SHIN JW, 2004, 227 AM CHEM SOC NAT; Svanberg M, 1998, J PHYS CHEM A, V102, P1865, DOI 10.1021/jp980052z; WEI S, 1991, J CHEM PHYS, V94, P3268, DOI 10.1063/1.459796; Zundel G., 1976, Hydrogen bond. Recent developments in theory and experiments. II. Structure and spectroscopy, P683	29	516	537	9	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1137	1140		10.1126/science.1096466	http://dx.doi.org/10.1126/science.1096466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15118122				2022-12-28	WOS:000221524500037
J	Lee, JLC; Everitt, BJ; Thomas, KL				Lee, JLC; Everitt, BJ; Thomas, KL			Independent cellular processes for hippocampal memory consolidation and reconsolidation	SCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; RETROGRADE-AMNESIA; REACTIVATED MEMORY; PROTEIN-SYNTHESIS; RAT HIPPOCAMPUS; RECOGNITION MEMORY; REGULATED KINASE; MESSENGER-RNA; FEAR MEMORIES	The idea that new memories undergo a time-dependent consolidation process after acquisition has received considerable experimental support. More controversial has been the demonstration that established memories, once recalled, become labile and sensitive to disruption, requiring "reconsolidation" to become permanent. By infusing antisense oligodeoxynucleotides into the hippocampus of rats, we show that consolidation and reconsolidation are doubly dissociable component processes of memory. Consolidation involves brain-derived neurotrophic factor ( BDNF) but not the transcription factor Zif268, whereas reconsolidation recruits Zif268 but not BDNF. These findings confirm a requirement for BDNF specifically in memory consolidation and also resolve the role of Zif268 in brain plasticity, learning, and memory.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Thomas, KL (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales.	thomaskl5@cf.ac.uk	Thomas, Kerrie L/A-6509-2010; Lee, Jonathan LC/A-9629-2008	Thomas, Kerrie L/0000-0003-3355-9583; Lee, Jonathan LC/0000-0002-2284-2482; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GORDON WC, 1977, PHYSIOL BEHAV, V18, P95, DOI 10.1016/0031-9384(77)90099-3; GORDON WC, 1977, AM J PSYCHOL, V90, P231, DOI 10.2307/1422045; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hebb Donald O., 1949, ORG BEHAV; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelly A, 2003, J NEUROSCI, V23, P5354; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Miller RR, 2000, NAT REV NEUROSCI, V1, P214, DOI 10.1038/35044578; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; OVERTON DA, 1964, J COMP PHYSIOL PSYCH, V57, P3, DOI 10.1037/h0048023; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; RICHARDSON CL, 1992, BRAIN RES, V580, P147, DOI 10.1016/0006-8993(92)90938-6; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	45	600	622	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					839	843		10.1126/science.1095760	http://dx.doi.org/10.1126/science.1095760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15073322				2022-12-28	WOS:000221243000034
J	Dornan, D; Wertz, I; Shimizu, H; Arnott, D; Frantz, GD; Dowd, P; O' Rourke, K; Koeppen, H; Dixit, VM				Dornan, D; Wertz, I; Shimizu, H; Arnott, D; Frantz, GD; Dowd, P; O' Rourke, K; Koeppen, H; Dixit, VM			The ubiquitin ligase COP1 is a critical negative regulator of p53	NATURE			English	Article							LIGHT CONTROL; TRANSCRIPTION; MDM2; EXPRESSION; REPRESSION; PROMOTES; SWITCH; JUN	COP1 ( constitutively photomorphogenic 1) is a RING-finger-containing protein that functions to repress plant photomorphogenesis, the light-mediated programme of plant development. Mutants of COP1 are constitutively photomorphogenic, and this has been attributed to their inability to negatively regulate the proteins LAF1 (ref. 1) and HY5 ( ref. 2). The role of COP1 in mammalian cells is less well characterized(3). Here we identify the tumour-suppressor protein p53 as a COP1-interacting protein. COP1 increases p53 turnover by targeting it for degradation by the proteasome in a ubiquitin-dependent fashion, independently of MDM2 or Pirh2, which are known to interact with and negatively regulate p53. Moreover, COP1 serves as an E3 ubiquitin ligase for p53 in vitro and in vivo, and inhibits p53-dependent transcription and apoptosis. Depletion of COP1 by short interfering RNA ( siRNA) stabilizes p53 and arrests cells in the G1 phase of the cell cycle. Furthermore, we identify COP1 as a p53-inducible gene, and show that the depletion of COP1 and MDM2 by siRNA cooperatively sensitizes U2-OS cells to ionizing-radiation-induced cell death. Overall, these results indicate that COP1 is a critical negative regulator of p53 and represents a new pathway for maintaining p53 at low levels in unstressed cells.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ Calif Davis, Dept Human Physiol, Davis, CA 95616 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Davis	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Doonan J, 1996, NATURE, V380, P481, DOI 10.1038/380481a0; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Hardtke CS, 2000, PLANT PHYSIOL, V124, P1548, DOI 10.1104/pp.124.4.1548; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jin SK, 2001, J CELL SCI, V114, P4139; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Ma LG, 2002, PLANT CELL, V14, P2383, DOI 10.1105/tpc.004416; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Neff MM, 2000, GENE DEV, V14, P257; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shimizu H, 2003, TRENDS BIOCHEM SCI, V28, P346, DOI 10.1016/S0968-0004(03)00140-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-30	24	497	521	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2004	429	6987					86	92		10.1038/nature02514	http://dx.doi.org/10.1038/nature02514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818CB	15103385				2022-12-28	WOS:000221222100050
J	Gaudioso, J; Salerno, RM				Gaudioso, J; Salerno, RM			Biosecurity and research: Minimizing adverse impacts	SCIENCE			English	Editorial Material									Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Gaudioso, J (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.							BLOOM BR, 2003, HARVARD MAG, V106, P48; *CDC, 2004, CDCS 8 NAT S BIOS BI; *GAO, 2003, GAO03847; GAUDIOSO J, 2004, BTR 2004 UN SCI TECH; SILBERMAN DH, 2004, COMMUNICATION   0206; *US GAO, 2001, GAO02208T	6	23	25	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					687	687		10.1126/science.1096911	http://dx.doi.org/10.1126/science.1096911			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118148				2022-12-28	WOS:000221105300028
J	Xie, SY; Gao, F; Lu, X; Huang, RB; Wang, CR; Zhang, X; Liu, ML; Deng, SL; Zheng, LS				Xie, SY; Gao, F; Lu, X; Huang, RB; Wang, CR; Zhang, X; Liu, ML; Deng, SL; Zheng, LS			Capturing the labile fullerene[50] as C50Cl10	SCIENCE			English	Article							C-36; FULLERENES		Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China; Xiamen Univ, Dept Chem, Xiamen 361005, Peoples R China; Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China; Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Mol Phys, Wuhan 430071, Peoples R China	Xiamen University; Xiamen University; Chinese Academy of Sciences; Institute of Chemistry, CAS; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Xie, SY (corresponding author), Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.	syxie@jingxian.xmu.edu.cn	Xie, SY/G-3439-2010; Zheng, LS/G-3433-2010; Hung, RB/G-4591-2010; Zhang, Xu/B-4753-2015; Lu, Xin/G-4639-2010; Deng, Shunliu/G-3983-2010; Liu, Maili/A-8543-2011	Lu, Xin/0000-0003-4968-9462; Liu, Maili/0000-0002-9359-915X				BAKOWIES D, 1991, J AM CHEM SOC, V113, P3704, DOI 10.1021/ja00010a012; Fowler PW, 2001, J CHEM SOC PERK T 2, P487, DOI 10.1039/b009370j; Gao F, 2003, CHEM COMMUN, P2676, DOI 10.1039/b306921b; GUO T, 1992, SCIENCE, V257, P1661, DOI 10.1126/science.257.5077.1661; Heath JR, 1998, NATURE, V393, P730, DOI 10.1038/31579; KADISH KM, 2002, FULLERENE CHEM PHYS; Koshio A, 2000, J AM CHEM SOC, V122, P398, DOI 10.1021/ja9934347; Koshio A, 2000, J PHYS CHEM B, V104, P7908, DOI 10.1021/jp001263i; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; Piskoti C, 1998, NATURE, V393, P771, DOI 10.1038/31668	10	300	319	7	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					699	699		10.1126/science.1095567	http://dx.doi.org/10.1126/science.1095567			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	816JD	15118154				2022-12-28	WOS:000221105300034
J	Correge, T; Gagan, MK; Beck, JW; Burr, GS; Cabioch, G; Le Cornec, F				Correge, T; Gagan, MK; Beck, JW; Burr, GS; Cabioch, G; Le Cornec, F			Interdecadal variation in the extent of South Pacific tropical waters during the Younger Dryas event	NATURE			English	Article							SEA-SURFACE TEMPERATURE; THERMAL STRUCTURE; CLIMATE-CHANGE; OCEAN; CORAL; ENSO; DEGLACIATION; CIRCULATION; RECORD	During the Younger Dryas event, about 12,000 years ago, the Northern Hemisphere cooled by between 2 and 10 degreesC (refs 1, 2) whereas East Antarctica experienced warming(3). But the spatial signature of the event in the southern mid-latitudes and tropics is less well known, as records are sparse and inconclusive(4-16). Here we present high-resolution analyses of skeletal Sr/Ca and O-18/O-16 ratios for a giant fossil Diploastrea heliopora coral that was preserved in growth position on the raised reef terraces of Espiritu Santo Island, Vanuatu, in the southwestern tropical Pacific Ocean(17). Our data indicate that sea surface temperatures in Vanuatu were on average 4.5 +/- 1.3 degreesC cooler during the Younger Dryas event than today, with a significant interdecadal modulation. The amplified annual cycle of sea surface temperatures, relative to today, indicates that cooling was caused by the compression of tropical waters towards the Equator. The positive correlation in our record between the oxygen isotope ratios of sea water and sea surface temperatures suggests that the South Pacific convergence zone, which brings O-18-depleted precipitation to the area today, was not active during the Younger Dryas period.	Inst Rech Dev, Noumea, New Caledonia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Arizona, NSF, Arizona AMS Facil, Tucson, AZ 85721 USA; Inst Rech Dev, F-93143 Bondy, France	Institut de Recherche pour le Developpement (IRD); Australian National University; National Science Foundation (NSF); University of Arizona; Institut de Recherche pour le Developpement (IRD)	Correge, T (corresponding author), Inst Rech Dev, UR 055 Paleotrop,BPA5, Noumea, New Caledonia.	thierry.correge@noumea.ird.nc	Gagan, Michael/L-5014-2018	Gagan, Michael/0000-0002-8279-323X; Burr, George/0000-0003-0068-7589				An SI, 2000, J CLIMATE, V13, P2044, DOI 10.1175/1520-0442(2000)013<2044:ICOTSO>2.0.CO;2; Anderson DE, 1997, PROG PHYS GEOG, V21, P230, DOI 10.1177/030913339702100203; Andres MS, 2003, EARTH PLANET SC LETT, V216, P515, DOI 10.1016/S0012-821X(03)00556-9; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Bennett KD, 2000, SCIENCE, V290, P325, DOI 10.1126/science.290.5490.325; Burr GS, 1998, RADIOCARBON, V40, P1093, DOI 10.1017/S0033822200019147; CABIOCH G, 1998, IAS SPECIAL PUBLICAT, V25, P261; Correge T, 2000, PALEOCEANOGRAPHY, V15, P465, DOI 10.1029/1999PA000409; DELCROIX T, 1989, J MAR RES, V47, P777, DOI 10.1357/002224089785076046; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GAGAN MK, 1994, EARTH PLANET SC LETT, V121, P549, DOI 10.1016/0012-821X(94)90090-6; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Guilderson TP, 2001, MAR GEOL, V172, P75, DOI 10.1016/S0025-3227(00)00115-8; Karspeck AR, 2002, J PHYS OCEANOGR, V32, P2350, DOI 10.1175/1520-0485(2002)032<2350:TPCSIA>2.0.CO;2; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; Patrick A, 1997, PALEOCEANOGRAPHY, V12, P649, DOI 10.1029/97PA01553; PETEET D, 1995, QUATERN INT, V28, P93, DOI 10.1016/1040-6182(95)00049-O; Ren L, 2003, GEOCHIM COSMOCHIM AC, V67, P1609, DOI 10.1016/S0016-7037(02)00917-1; Rodbell DT, 2000, QUATERNARY RES, V54, P328, DOI 10.1006/qres.2000.2177; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; Stoll HM, 1998, GEOCHIM COSMOCHIM AC, V62, P1107, DOI 10.1016/S0016-7037(98)00042-8; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Thunell RC, 1996, QUATERNARY RES, V46, P72, DOI 10.1006/qres.1996.0045; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; Watanabe T, 2003, GEOCHIM COSMOCHIM AC, V67, P1349, DOI 10.1016/S0016-7037(02)01221-8	30	89	93	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2004	428	6986					927	929		10.1038/nature02506	http://dx.doi.org/10.1038/nature02506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118722				2022-12-28	WOS:000221083000036
J	Rozzi, FVR; de Castro, JMB				Rozzi, FVR; de Castro, JMB			Surprisingly rapid growth in Neanderthals	NATURE			English	Article							DENTAL DEVELOPMENT; PLEISTOCENE HOMINIDS; ENAMEL; TOOTH; MICROSTRUCTURE; DIMORPHISM; ATAPUERCA; ONTOGENY; PATTERN; TEETH	Life-history traits correlate closely with dental growth(1), so differences in dental growth within Homo can enable us to determine how somatic development has evolved and to identify developmental shifts that warrant species-level distinctions(2-4). Dental growth can be determined from the speed of enamel formation (or extension rate)(5,6). We analysed the enamel extension rate in Homo antecessor (8 teeth analysed), Homo heidelbergensis (106), Homo neanderthalensis ('Neanderthals'; 146) and Upper Palaeolithic-Mesolithic Homo sapiens (100). Here we report that Upper Palaeolithic-Mesolithic H. sapiens shared an identical dental development pattern with modern humans, but that H. antecessor and H. heidelbergensis had shorter periods of dental growth. Surprisingly, Neanderthals were characterized by having the shortest period of dental growth. Because dental growth is an excellent indicator of somatic development(1), our results suggest that Neanderthals developed faster even than their immediate ancestor, H. heidelbergensis. Dental growth became longer and brain size increased from the Plio-Pleistocene in hominid evolution. Neanderthals, despite having a large brain, were characterized by a short period of development. This autapomorphy in growth is an evolutionary reversal, and points strongly to a specific distinction between H. sapiens and H. neanderthalensis.	CNRS, UPR 2147, F-75014 Paris, France; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Rozzi, FVR (corresponding author), CNRS, UPR 2147, 44 Rue Amiral, F-75014 Paris, France.	ramrozzi@ivry.cnrs.fr						Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; BEYNON AD, 1987, SCANNING MICROSCOPY, V1, P663; BOUGHNER J, IN PRESS J HUM EVOL; Charnov Eric L., 1993, P1; de Castro JMB, 2001, AM J PHYS ANTHROPOL, V114, P325, DOI 10.1002/ajpa.1044; de Castro JMB, 1999, P NATL ACAD SCI USA, V96, P4210, DOI 10.1073/pnas.96.7.4210; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean M.C., 1988, P107; DEAN MC, 1987, J HUM EVOL, V16, P197, DOI 10.1016/0047-2484(87)90076-5; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DEAN MC, 1985, AM J PHYS ANTHROPOL, V68, P233, DOI 10.1002/ajpa.1330680210; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; RAMIREZROZZI FV, 1993, CR ACAD SCI II, V316, P1635; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Rozzi FR, 1996, AM J PHYS ANTHROPOL, V99, P625, DOI 10.1002/ajpa.1330990403; Rozzi FR, 2002, HUMAN EVOLUTION THROUGH DEVELOPMENTAL CHANGE, P319; Rozzi FVR, 1997, CR ACAD SCI II A, V325, P293, DOI 10.1016/S1251-8050(97)88303-6; Schwartz GT, 2001, INT J PRIMATOL, V22, P837, DOI 10.1023/A:1012073601808; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; Shellis RP, 1998, J HUM EVOL, V35, P387, DOI 10.1006/jhev.1998.0260; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; Stearns S.C., 1992, pi; Tompkins RL, 1996, AM J PHYS ANTHROPOL, V99, P103; WOLPOFF MH, 1979, AM J PHYS ANTHROPOL, V50, P67, DOI 10.1002/ajpa.1330500110; ZILBERMAN U, 1992, J ANAT, V180, P387	30	183	189	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					936	939		10.1038/nature02428	http://dx.doi.org/10.1038/nature02428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816AO	15118725				2022-12-28	WOS:000221083000039
J	Balthrop, J; Forrest, S; Newman, MEJ; Williamson, MM				Balthrop, J; Forrest, S; Newman, MEJ; Williamson, MM			Technological networks and the spread of computer viruses	SCIENCE			English	Editorial Material							INTERNET		Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; Santa Fe Inst, Santa Fe, NM 87505 USA; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; HP Labs Bristol, Bristol BS34 8QZ, Avon, England	University of New Mexico; The Santa Fe Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Balthrop, J (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	forrest@cs.unm.edu						Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Kephart J. O., 1991, Proceedings. 1991 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.91CH2986-8), P343, DOI 10.1109/RISP.1991.130801; Kleinberg J.M., 1999, COMPUTING COMBINATOR, DOI DOI 10.1007/3-540-48686-0_1; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Moore D, 2003, IEEE INFOCOM SER, P1901; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Somayaji A, 2000, USENIX ASSOCIATION PROCEEDINGS OF THE NINTH USENIX SECURITY SYMPOSIUM, P185; Staniford S, 2002, USENIX ASSOCIATION PROCEEDINGS OF THE 11TH USENIX SECURITY SYMPOSIUM, P149; Tyler JR, 2003, COMMUNITIES AND TECHNOLOGIES, P81; Williamson MM, 2003, 19TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P76, DOI 10.1109/CSAC.2003.1254312; Williamson MM, 2003, COMPLEXITY, V9, P34, DOI 10.1002/cplx.20005; Williamson MM, 2002, 18TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P61, DOI 10.1109/CSAC.2002.1176279	17	192	206	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					527	529		10.1126/science.1095845	http://dx.doi.org/10.1126/science.1095845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105484				2022-12-28	WOS:000220975100029
J	Kim, SV; Flavell, RA				Kim, SV; Flavell, RA			CD8 alpha alpha and T cell memory	SCIENCE			English	Editorial Material							EXPRESSION		Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Kim, SV (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Kim, Sangwon V./S-1166-2016	Kim, Sangwon V./0000-0001-8453-7080				Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SCHIEFERDECKER HL, 1990, J IMMUNOL, V144, P2541; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416	10	7	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					529	530		10.1126/science.1097678	http://dx.doi.org/10.1126/science.1097678			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105485				2022-12-28	WOS:000220975100030
J	Puskas, JD; Williams, WH; Mahoney, EM; Huber, PR; Block, PC; Duke, PG; Staples, JR; Glas, KE; Marshall, JJ; Leimbach, ME; McCall, SA; Petersen, RJ; Bailey, DE; Weintraub, WS; Guyton, RA				Puskas, JD; Williams, WH; Mahoney, EM; Huber, PR; Block, PC; Duke, PG; Staples, JR; Glas, KE; Marshall, JJ; Leimbach, ME; McCall, SA; Petersen, RJ; Bailey, DE; Weintraub, WS; Guyton, RA			Off-pump vs conventional coronary artery bypass grafting: Early and 1-year graft patency, cost, and quality-of-life outcomes a randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ON-PUMP; CARDIOPULMONARY BYPASS; COMPLETE REVASCULARIZATION; BEATING-HEART; SURGERY; OPERATION	Context Previous trials of off-pump coronary artery bypass (OPCAB) have enrolled selected patients and have not rigorously evaluated long-term graft patency. A preliminary report showed OPCAB achieved improved inhospital outcomes, similar completeness of revascularization, and shorter lengths of stay compared with conventional coronary artery bypass grafting (CABG). Objective To assess graft patency, clinical and quality-of-life outcomes, and cost among patients While in the hospital and at 1-year follow-up. Design, Setting, and Patients Randomized controlled trial of patients unselected for coronary anatomy, ventricular function, or comorbidities between March 10, 2000, and August 20, 2001, at a US academic center. A total of 200 patients were enrolled; 3 patients were withdrawn after randomization for mitral valve repair or replacement. Follow-up was complete for 197 patients at 30 days; 185 at 1 year. Interventions One surgical session consisting of elective OPCAB or CABG with cardiopulmonary bypass. The surgeon had extensive experience performing off-pump surgery; patients were subsequently managed by blinded protocols. Main Outcome Measures Coronary angiography documented graft patency prior to hospital discharge and at 1 year; health-related quality of life; and cost of the index and subsequent hospitalization(s). Results Graft patency was similar for OPCAB and conventional CABG with cardiopulmonary bypass at 30 days (absolute difference, 1.3%; 95% confidence interval [CI], -0.66% to 3.31 %; P=.1 9) and at 1 year (absolute difference, -2.2% 95% Cl, -6.1% to 1.7%; P=.27). Rates of death, stroke, myocardial infarction, angina, and reintervention were similar at 30 days and 1 year. There were no significant differences in health-related quality of life. Mean total hospitalization cost per patient at hospital discharge was $2272 (95% Cl, $755-$3732) less for OPCAB (P=.002) and $1955 (95% Cl, -$766 to $4727) less at 1 year (P=.08). Conclusions In this randomized single-surgeon trial among unselected patients with angiographic follow-up, OPCAB achieved similar graft patency in the hospital and at 1 year. Cardiac outcomes and health-related quality of life at 30 days and 1 year were similar and patients incurred a lower cost. OPCAB may provide complete revascularization that is durable and cost-effective.	Emory Univ, Sch Med, Div Cardiothorac Surg, Atlanta, GA USA; Emory Univ, Sch Med, Div Cardiol, Atlanta, GA USA; Emory Univ, Sch Med, Dept Cardiav Anesthesiol, Atlanta, GA USA; Emory Ctr Outcomes Res, Atlanta, GA USA; New England Res Inst, Watertown, MA 02172 USA	Emory University; Emory University; Emory University; HealthCore, Inc	Puskas, JD (corresponding author), Crawford W Long Mem Hosp, 6th Floor,Med Off Tower,550 Peachtree St NE, Atlanta, GA 30308 USA.	john_puskas@emoryhealthcare.org						Angelini GD, 2002, LANCET, V359, P1194, DOI 10.1016/S0140-6736(02)08216-8; Ascione R, 1999, ANN THORAC SURG, V68, P2237, DOI 10.1016/S0003-4975(99)01123-6; Becker Edwin, 1996, ENCY NUCL MAGNETIC R, V1, P1; Bonchek LI, 1998, CIRCULATION, V98, P495, DOI 10.1161/01.CIR.98.6.495; Cartier R, 2000, J THORAC CARDIOV SUR, V119, P221, DOI 10.1016/S0022-5223(00)70176-0; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; Cooley DA, 2000, ANN THORAC SURG, V70, P1779, DOI 10.1016/S0003-4975(00)02052-X; Czerny M, 2001, ANN THORAC SURG, V71, P165, DOI 10.1016/S0003-4975(00)02230-X; Diegeler A, 2000, ANN THORAC SURG, V69, P1162, DOI 10.1016/S0003-4975(99)01574-X; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9; Efron B., 1994, MONOGRAPHS STAT APPL; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; FITZGIBBON GM, 1986, J THORAC CARDIOV SUR, V91, P773; GANZ W, 1985, NEW ENGL J MED, V313, P1018; Immer FF, 2003, ANN THORAC SURG, V76, P27, DOI 10.1016/S0003-4975(03)00187-5; Jones EL, 1996, J THORAC CARDIOV SUR, V112, P227, DOI 10.1016/S0022-5223(96)70243-X; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kim KB, 2001, ANN THORAC SURG, V72, pS1033, DOI 10.1016/S0003-4975(01)02946-0; Kurlansky PA, 2003, J THORAC CARDIOV SUR, V126, P7, DOI 10.1016/S0022-5223(02)73472-7; Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MacGillivray TE, 2002, NEW ENGL J MED, V347, P551, DOI 10.1056/NEJMp020078; Mack MJ, 1998, ANN THORAC SURG, V66, P1055, DOI 10.1016/S0003-4975(98)00815-7; Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9; Mitchell J, 1995, PER CASE PROSPECTIVE; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; *NAT SOC THOR SURG, AD CARD DAT FALL 200; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Omeroglu SN, 2000, ANN THORAC SURG, V70, P844, DOI 10.1016/S0003-4975(00)01567-8; Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4; Puskas J D, 2001, Semin Thorac Cardiovasc Surg, V13, P82; Puskas JD, 2001, ANN THORAC SURG, V71, P1477, DOI 10.1016/S0003-4975(01)02473-0; Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324; Quigley RL, 2003, HEART SURG FORUM, V6, P94; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Song HK, 2003, EUR J CARDIO-THORAC, V24, P947, DOI 10.1016/S1010-7940(03)00616-X; Stump DA, 2000, ANN THORAC SURG, V70, P1782, DOI 10.1016/S0003-4975(00)02202-5; van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zamvar V, 2002, BRIT MED J, V325, P1268, DOI 10.1136/bmj.325.7375.1268; SOCIAL SECURITY DEAT	44	424	452	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1841	1849		10.1001/jama.291.15.1841	http://dx.doi.org/10.1001/jama.291.15.1841			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100202	Bronze			2022-12-28	WOS:000220871200024
J	Larson, EB				Larson, EB		SGIM Task Force Domain Gen Int Med	Health care system chaos should spur innovation: Summary of a report of the Society of General Internal Medicine Task Force on the domain of general internal medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPROVING PRIMARY-CARE; REGIONAL-VARIATIONS; CHRONIC ILLNESS; CLINICAL-RESEARCH; SATISFACTION; PHYSICIAN; SPECIALTY; MEDICARE; FUTURE; MANAGEMENT	The Society of General Internal Medicine asked a task force to redefine the domain of general internal medicine. The Society believes that the chaos and dysfunction that characterize today's medical care and the challenges facing general internal medicine should spur innovation. The task force proposed the following recommendations. Remaining true to its core values and competencies, general internal medicine should stay both broad and deep, ranging from uncomplicated primary care to continuous care of patients with multiple, complex, chronic diseases. Postgraduate and continuing education should develop mastery. Wherever they practice, general internists should be able to lead teams and be responsible for the care given by their teams, embrace changes in information systems, and aim to provide most of the care required by their patients. Current financing of physician services, especially fee-for-service, must be changed to recognize the value of services performed outside the traditional face-to-face visit and give practitioners incentives to improve quality and efficiency and provide comprehensive, ongoing care. General internal medicine residency training should provide both broad and deep medical knowledge as well as mastery of informatics, management, and team leadership. General internal medicine residents should have options to tailor their final 1 to 2 years to fit their practice goals, often earning a certificate of added qualification in generalist fields. Research should expand to include practice and operations management, developing more effective shared decision making and transparent medical records and promoting the close personal connection that both doctors and patients want. The task force believes that these changes will benefit patients and the public and reenergize general internal medicine.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Larson, EB (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	Larson.e@ghc.org	Tao, Youyou/D-2367-2014					Anderson GF, 2003, ARCH INTERN MED, V163, P437, DOI 10.1001/archinte.163.4.437; [Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; DAVIDOFF F, 1981, CONN MED, V45, P167; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Ginsburg PB, 2003, ANN INTERN MED, V138, P233, DOI 10.7326/0003-4819-138-3-200302040-00020; Grumbach K, 1999, NEW ENGL J MED, V341, P2008, DOI 10.1056/NEJM199912233412611; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; KOHN LT, 1999, TO ERR IS HUMAN BUIL; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Larson EB, 2004, J GEN INTERN MED, V19, P69, DOI 10.1111/j.1525-1497.2004.31337.x; Larson EB, 2001, ANN INTERN MED, V134, P997, DOI 10.7326/0003-4819-134-10-200105150-00013; Leigh JP, 2002, ARCH INTERN MED, V162, P1577, DOI 10.1001/archinte.162.14.1577; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; LESSER CS, 2003, FINDINGS HSC, V63, P1; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; Moore G, 2003, ANN INTERN MED, V138, P244, DOI 10.7326/0003-4819-138-3-200302040-00032; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Phelps CE, 2003, ANN INTERN MED, V138, P348, DOI 10.7326/0003-4819-138-4-200302180-00016; Rosenberg RN, 2003, JAMA-J AM MED ASSOC, V289, P1305, DOI 10.1001/jama.289.10.1305; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Safran DG, 2003, ANN INTERN MED, V138, P248, DOI 10.7326/0003-4819-138-3-200302040-00033; Sandy LG, 2002, NEW ENGL J MED, V347, P1971, DOI 10.1056/NEJMsb021260; Schroeder SA, 2002, ACAD MED, V77, P767, DOI 10.1097/00001888-200208000-00003; SCHROEDER SA, 1986, ANN INTERN MED, V104, P554, DOI 10.7326/0003-4819-104-4-554; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Showstack J, 2003, ANN INTERN MED, V138, P268, DOI 10.7326/0003-4819-138-3-200302040-00036; SOX HC, 1994, ANN INTERN MED, V121, P616, DOI 10.7326/0003-4819-121-8-199410150-00011; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; THUROW LC, 1999, ATLANTIC MONTHLY, V283, P57; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Weingarten SR, 2002, ARCH INTERN MED, V162, P527, DOI 10.1001/archinte.162.5.527; Wilensky GR, 2003, ANN INTERN MED, V138, P350, DOI 10.7326/0003-4819-138-4-200302180-00017; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	41	43	44	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					639	643		10.7326/0003-4819-140-8-200404200-00011	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096335				2022-12-28	WOS:000220851700007
J	Goldhaber, SZ				Goldhaber, SZ			Pulmonary embolism	LANCET			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; RECURRENT VENOUS THROMBOEMBOLISM; FACTOR-V-LEIDEN; BRAIN NATRIURETIC PEPTIDE; INTENSITY WARFARIN THERAPY; ELECTIVE HIP-ARTHROPLASTY; SIMPLE CLINICAL-MODEL; VENA-CAVA FILTER; A-DOUBLE-BLIND	Pulmonary embolism (PE) is a common illness that can cause death and disability. It is difficult to detect because patients present with a wide array of symptoms and signs. The clinical setting can raise suspicion, and certain inherited and acquired risk factors predispose susceptible individuals. D-dimer concentration in blood is the best laboratory screening test, and chest CT has become the most widespread imaging test. Treatment requires rapid and accurate risk stratification before haemodynamic decomperisation and the development of cardiogenic shock. Anticoagulation is the foundation of therapy. Right-ventricular dysfunction on echocardiography and higher than normal concentrations of troponin identify high-risk patients who might need escalation of therapy with thrombolysis or embolectomy even if the blood pressure is normal on presentation. When patients are admitted to medical wards or when patients undergo surgery, their physicians should prescribe prophylactic measures to prevent PE. After hospital discharge, prophylaxis should continue for about a month for patients at high risk of thromboembolism.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Goldhaber, SZ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	sgoldhaber@partners.org						Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; AGNELLI G, 1995, CIRCULATION, V92, P2819, DOI 10.1161/01.CIR.92.10.2819; Aklog L, 2002, CIRCULATION, V105, P1416, DOI 10.1161/01.CIR.0000012526.21603.25; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Ariens RAS, 2002, LANCET, V359, P667, DOI 10.1016/S0140-6736(02)07813-3; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bauer KA, 2001, NEW ENGL J MED, V345, P1305, DOI 10.1056/NEJMoa011099; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; BERGQVIST D, 1985, BRIT J SURG, V72, P105, DOI 10.1002/bjs.1800720211; Bernardi E, 2000, THROMB HAEMOSTASIS, V84, P22, DOI 10.1055/s-0037-1613961; Bounameaux H, 2002, LANCET, V359, P1710, DOI 10.1016/S0140-6736(02)08660-9; Breddin HK, 2001, NEW ENGL J MED, V344, P626, DOI 10.1056/NEJM200103013440902; Brummel KE, 2001, CIRCULATION, V104, P2311, DOI 10.1161/hc4401.098492; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Cohen AT, 2001, THROMB HAEMOSTASIS, V85, P940; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Colwell CW, 1999, J BONE JOINT SURG AM, V81A, P932, DOI 10.2106/00004623-199907000-00005; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; Cromheecke ME, 2000, LANCET, V356, P97, DOI 10.1016/S0140-6736(00)02470-3; Crowther MA, 1999, ARCH INTERN MED, V159, P46, DOI 10.1001/archinte.159.1.46; Crowther MA, 2002, ANN INTERN MED, V137, P251, DOI 10.7326/0003-4819-137-4-200208200-00009; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cuzick J, 2002, LANCET, V360, P817; Dalen JE, 2003, J THROMB HAEMOST, V1, P1130, DOI 10.1046/j.1538-7836.2003.00343.x; Daniel LR, 2001, CHEST, V120, P474, DOI 10.1378/chest.120.2.474; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Douketis JD, 2002, ARCH INTERN MED, V162, P1465, DOI 10.1001/archinte.162.13.1465; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-1; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Goldacre MJ, 2000, LANCET, V355, P1968, DOI 10.1016/S0140-6736(00)02331-X; Goldhaber SZ, 2002, ANN INTERN MED, V136, P691, DOI 10.7326/0003-4819-136-9-200205070-00012; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 2002, CHEST, V122, P1933, DOI 10.1378/chest.122.6.1933; Goldhaber SZ, 2002, NEW ENGL J MED, V347, P1131, DOI 10.1056/NEJMp020107; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Gottschalk A, 2002, SEMIN NUCL MED, V32, P173, DOI 10.1053/snuc.2002.124177; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; Greinacher A, 1999, CIRCULATION, V99, P73, DOI 10.1161/01.CIR.99.1.73; Grifoni S, 2000, CIRCULATION, V101, P2817, DOI 10.1161/01.CIR.101.24.2817; Hamel E, 2001, CHEST, V120, P120, DOI 10.1378/chest.120.1.120; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; HIRSCH DR, 1995, JAMA-J AM MED ASSOC, V274, P335, DOI 10.1001/jama.274.4.335; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Hull RD, 2000, ARCH INTERN MED, V160, P2199, DOI 10.1001/archinte.160.14.2199; Hull RD, 2001, ARCH INTERN MED, V161, P1952, DOI 10.1001/archinte.161.16.1952; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Hull RD, 2000, ARCH INTERN MED, V160, P2208, DOI 10.1001/archinte.160.14.2208; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Joffe HV, 2002, CIRCULATION, V106, P1874, DOI 10.1161/01.CIR.0000031705.57473.1C; KAKKAR VV, 1975, LANCET, V2, P674; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kelly J, 2002, LANCET, V359, P456, DOI 10.1016/S0140-6736(02)07669-9; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; Kucher N, 2003, CIRCULATION, V107, P1576, DOI 10.1161/01.CIR.0000064898.51892.09; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Lassen MR, 2002, NEW ENGL J MED, V347, P726, DOI 10.1056/NEJMoa011327; Lassen MR, 2002, LANCET, V359, P1715, DOI 10.1016/S0140-6736(02)08652-X; Leclerc JR, 1998, ARCH INTERN MED, V158, P873, DOI 10.1001/archinte.158.8.873; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Lewis BE, 2001, CIRCULATION, V103, P1838; Martinelli I, 2002, THROMB HAEMOSTASIS, V87, P791; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; Meyer G, 2001, Semin Vasc Med, V1, P247, DOI 10.1055/s-2001-18494; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Millward SF, 2001, J VASC INTERV RADIOL, V12, P1053, DOI 10.1016/S1051-0443(07)61590-5; Miniati M, 2001, AM J MED, V110, P528, DOI 10.1016/S0002-9343(01)00693-3; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Nakamura M, 2001, CLIN CARDIOL, V24, P132, DOI 10.1002/clc.4960240207; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nicolaides AN, 2001, INT ANGIOL, V20, P1; O'Brien J, 2000, LANCET, V355, P1295; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; Pengo V, 2001, THROMB HAEMOSTASIS, V85, P418; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Pistolesi M, 2002, EUR RESPIR J, V19, p28S, DOI 10.1183/09031936.02.00270602; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 2002, ARCH INTERN MED, V162, P1966, DOI 10.1001/archinte.162.17.1966; Price DT, 1997, ANN INTERN MED, V127, P895, DOI 10.7326/0003-4819-127-10-199711150-00007; Qanadli SD, 2000, RADIOLOGY, V217, P447, DOI 10.1148/radiology.217.2.r00nv01447; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Rice L, 2002, ANN INTERN MED, V136, P210, DOI 10.7326/0003-4819-136-3-200202050-00009; Ridker PM, 1999, CIRCULATION, V99, P999, DOI 10.1161/01.CIR.99.8.999; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Sarasin FP, 2002, THROMB HAEMOSTASIS, V87, P586; Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stein PD, 1996, CHEST, V109, P78, DOI 10.1378/chest.109.1.78; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; STEIN PD, 1995, CHEST, V107, P139, DOI 10.1378/chest.107.1.139; ten Wolde M, 2003, CIRCULATION, V107, P2082, DOI 10.1161/01.CIR.0000070020.79932.DB; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Thabut G, 2002, J AM COLL CARDIOL, V40, P1660, DOI 10.1016/S0735-1097(02)02381-1; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; Turpie AGG, 2002, LANCET, V359, P1721, DOI 10.1016/S0140-6736(02)08648-8; Turpie AGG, 2001, NEW ENGL J MED, V344, P619, DOI 10.1056/NEJM200103013440901; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; vanBeek EJR, 1997, ARCH INTERN MED, V157, P2593, DOI 10.1001/archinte.157.22.2593; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 2001, THROMB HAEMOSTASIS, V85, P947; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; White RH, 2000, ARCH INTERN MED, V160, P2033, DOI 10.1001/archinte.160.13.2033; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403; Wicki J, 2000, THROMB HAEMOSTASIS, V84, P548, DOI 10.1055/s-0037-1614065; Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.877	143	296	330	2	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1295	1305		10.1016/S0140-6736(04)16004-2	http://dx.doi.org/10.1016/S0140-6736(04)16004-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094276				2022-12-28	WOS:000220904900021
J	Slowther, A; Johnston, C; Goodall, J; Hope, T				Slowther, A; Johnston, C; Goodall, J; Hope, T			Development of clinical ethics committees	BRITISH MEDICAL JOURNAL			English	Article								Clinical practice raises a wide variety of ethical issues that can be difficult for individual doctors to resolve. Some NHS trusts have established clinical ethics committees to provide ethical support. These commit. tees had largely worked alone until a meeting of committee representatives in January 2001 led to the development of the UK Clinical Ethics Network. The principal aims of the network are to promote the development of clinical ethics support in the United Kingdom, to encourage a high level of ethical debate in clinical practice, and to facilitate sharing of best practice between clinical ethics committees (box 1).(1) We consider the emergence of clinical ethics support in the context of similar development in other countries.	Inst Hlth Sci, Ethox Ctr, Oxford OX3 7LF, England	University of Oxford	Slowther, A (corresponding author), Inst Hlth Sci, Ethox Ctr, Oxford OX3 7LF, England.	anne-marie.slowther@ethox.ox.ac.uk		Johnston, Carolyn/0000-0002-7910-5117				Ehleben C M, 1998, HEC Forum, V10, P71, DOI 10.1023/A:1008814919396; Fox E, 1996, J CLIN ETHIC, V7, P127; *JOINT COMM ACCR H, 1996, COMPR ACCR MAN HOSP, pR1; LAPUMA J, 1989, ARCH INTERN MED, V149, P1109, DOI 10.1001/archinte.149.5.1109; Larcher VF, 1997, J MED ETHICS, V23, P245, DOI 10.1136/jme.23.4.245; MEIJBURG HV, 1994, HEC FORUM, V6, P139; RUYTER KW, 2000, ETHICAL FUNCTION HOS, P91; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Slowther A, 1998, J MED ETHICS, V24, P207, DOI 10.1136/jme.24.3.207; Slowther A, 2001, CLIN ETHICS SUPPORT; *UK CLIN ETH NETW, NETW; *UK CLIN ETH NETW, WHAT AR CLIN ETH COM	12	49	49	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					950	952		10.1136/bmj.328.7445.950	http://dx.doi.org/10.1136/bmj.328.7445.950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814SM	15087349	Green Published			2022-12-28	WOS:000220994400034
J	Henshilwood, C; d'Errico, F; Vanhaeren, M; van Niekerk, K; Jacobs, Z				Henshilwood, C; d'Errico, F; Vanhaeren, M; van Niekerk, K; Jacobs, Z			Middle stone age shell beads from South Africa	SCIENCE			English	Article							BLOMBOS CAVE		Univ Bergen, Ctr Dev Studies, N-5020 Bergen, Norway; SUNY Stony Brook, Stony Brook, NY 11794 USA; Inst Prehist & Geol Quaternaire, UMR 5808, F-33405 Talence, France; UMR 7041, F-92023 Nanterre, France; CSIR, ZA-0001 Pretoria, South Africa; Univ Wales, Aberystwyth, Dyfed, Wales	University of Bergen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Council for Scientific & Industrial Research (CSIR) - South Africa; Aberystwyth University	Henshilwood, C (corresponding author), Univ Bergen, Ctr Dev Studies, N-5020 Bergen, Norway.	chris@blomboscave.co.za	Jacobs, Zenobia/B-2721-2012; Henshilwood, Christopher S/K-3806-2014; van Niekerk, Karen/J-3511-2015	Jacobs, Zenobia/0000-0001-5424-5837; Henshilwood, Christopher S/0000-0002-2818-293X; van Niekerk, Karen/0000-0003-2261-6861				Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; Dubin Lois Shen, 1987, HIST BEADS; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Jacobs Z, 2003, J HUM EVOL, V44, P613, DOI 10.1016/S0047-2484(03)00049-6; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798	7	372	382	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					404	404		10.1126/science.1095905	http://dx.doi.org/10.1126/science.1095905			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087540				2022-12-28	WOS:000220845400037
J	Lee, GS; Neiditch, MB; Salus, SS; Roth, DB				Lee, GS; Neiditch, MB; Salus, SS; Roth, DB			RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination	CELL			English	Article							FREE V(D)J RECOMBINATION; MAMMALIAN-CELLS; SIGNAL SEQUENCES; IN-VIVO; NONHOMOLOGOUS RECOMBINATION; CHROMOSOMAL TRANSLOCATION; STRUCTURE REQUIREMENTS; XRCC4-DEFICIENT CELLS; MUTATIONAL ANALYSIS; DIRECTED REPAIR	The two major pathways for repairing double-strand breaks (DSBs), homologous recombination and nonhomologous end joining (NHEJ), have traditionally been thought to operate in different stages of the cell cycle. This division of labor is not absolute, however, and precisely what governs the choice of pathway to repair a given DSB has remained enigmatic. We pursued this question by studying the site-specific DSBs created during V(D)J recombination, which relies on classical NHEJ to repair the broken ends. We show that mutations that form unstable RAG post-cleavage complexes allow DNA ends to participate in both homologous recombination and the error-prone alternative NHEJ pathway. By abrogating a key function of the complex, these mutations reveal it to be a molecular shepherd that guides DSBs to the proper pathway. We also find that RAG-mediated nicks efficiently stimulate homologous recombination and discuss the implications of these findings for oncogenic chromosomal rearrangements, evolution, and gene targeting.	NYU, Sch Med, Skirball Inst Biomol Med, Lab 2 10, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University	Roth, DB (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Lab 2 10, New York, NY 10016 USA.	roth@saturn.med.nyu.edu		Neiditch, Matthew/0000-0002-7039-4469	NIAID NIH HHS [AI36420] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036420] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; Arcangioli B, 2000, EMBO J, V19, P1389, DOI 10.1093/emboj/19.6.1389; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Brandt VL, 2002, CURR OPIN IMMUNOL, V14, P224, DOI 10.1016/S0952-7915(02)00325-4; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; FABRE F, 1978, NATURE, V272, P795, DOI 10.1038/272795a0; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Grawunder U, 1997, NUCLEIC ACIDS RES, V25, P1375, DOI 10.1093/nar/25.7.1375; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Han JO, 1998, NUCLEIC ACIDS RES, V26, P3769, DOI 10.1093/nar/26.16.3769; Han JO, 1997, MOL CELL BIOL, V17, P2226, DOI 10.1128/MCB.17.4.2226; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Huye LE, 2002, MOL CELL BIOL, V22, P3460, DOI 10.1128/MCB.22.10.3460-3473.2002; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Leu TMJ, 1997, IMMUNITY, V7, P303, DOI 10.1016/S1074-7613(00)80532-4; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lewis SM, 2000, J EXP MED, V191, P1631, DOI 10.1084/jem.191.10.1631; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; ROTH DB, 1985, P NATL ACAD SCI USA, V82, P3355, DOI 10.1073/pnas.82.10.3355; Roth DB, 2002, MOL CELL, V10, P1, DOI 10.1016/S1097-2765(02)00573-7; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; ROTH DB, 2000, GENOME BIOL, V1, P1011; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P550, DOI 10.1093/nar/22.3.550; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Schultz HY, 2001, MOL CELL, V7, P65, DOI 10.1016/S1097-2765(01)00155-1; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Steen SB, 1996, GENES CELLS, V1, P543; Steen SB, 1997, EMBO J, V16, P2656, DOI 10.1093/emboj/16.10.2656; STRATHERN JN, 1991, GENETICS, V127, P61; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; Tsai CL, 2002, GENE DEV, V16, P1934, DOI 10.1101/gad.984502; TYCKO B, 1990, CANCER CELL-MON REV, V2, P1; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Vanasse GJ, 1999, BLOOD, V94, P3997, DOI 10.1182/blood.V94.12.3997.424k44_3997_4010; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; WAKE CT, 1984, MOL CELL BIOL, V4, P387, DOI 10.1128/MCB.4.3.387; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	71	192	198	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					171	184		10.1016/S0092-8674(04)00301-0	http://dx.doi.org/10.1016/S0092-8674(04)00301-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084256	Bronze			2022-12-28	WOS:000220913400006
J	Toroczkai, Z; Bassler, KE				Toroczkai, Z; Bassler, KE			Jamming is limited in scale-free systems	NATURE			English	Editorial Material							NETWORKS		Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Complex Syst Grp, Los Alamos, NM 87545 USA; Univ Houston, Dept Phys, Houston, TX 77204 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Houston System; University of Houston	Toroczkai, Z (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies, POB 1663, Los Alamos, NM 87545 USA.	toro@lanl.gov	Toroczkai, Zoltan/A-3421-2008; Toroczkai, Zoltan/AAC-8446-2019	Toroczkai, Zoltan/0000-0002-6602-2849; Toroczkai, Zoltan/0000-0002-6602-2849				Anghel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.058701; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B., 2001, RANDOM GRAPHS; LAKHINA A, 2003, P IEEE INF 03; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rabani Y, 1998, ANN IEEE SYMP FOUND, P694, DOI 10.1109/SFCS.1998.743520	6	184	190	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					716	716		10.1038/428716a	http://dx.doi.org/10.1038/428716a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085122				2022-12-28	WOS:000220823800027
J	Armbrecht, I; Perfecto, I; Vandermeer, J				Armbrecht, I; Perfecto, I; Vandermeer, J			Enigmatic biodiversity correlations: Ant diversity responds to diverse resources	SCIENCE			English	Article							SPECIES-DIVERSITY; COMMUNITIES	A pattern noted in ecology is that diversity at one level begets diversity at other levels. In the case of consumers competing for similar resources, the diversity of those resources is thought to provide some degree of niche diversification in which a diverse set of consumer species can coexist. If, however, the diverse resources are not sufficiently distinct from one another, from the standpoint of the consumer species, such niche diversification will not exist. We experimentally show that a diverse array of twigs attracted 80% more species of twig-nesting ants than a monospecific collection of twigs. The specific tree species from which the twigs were derived did not explain the pattern. It appears that diversity per se at one level ( twigs) creates conditions that promote diversity at another level ( nesting ants).	Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Valle, Dept Biol, Cali 25360, Colombia; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidad del Valle; University of Michigan System; University of Michigan	Armbrecht, I (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 430 E Univ, Ann Arbor, MI 48109 USA.	inge@univalle.edu.co						ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; BYRNE MM, 1994, BIOTROPICA, V26, P61, DOI 10.2307/2389111; Cameron T, 2002, TRENDS ECOL EVOL, V17, P495, DOI 10.1016/S0169-5347(02)02618-6; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; DELAVEAU P, 1988, B SOC BOT FR-ACTUAL, V135, P25, DOI 10.1080/01811789.1988.10826899; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Gause G. F., 1934, STRUGGLE EXISTENCE; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hubbell Stephen P., 2001, V32, pi; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Kaspari M, 1996, OIKOS, V76, P443, DOI 10.2307/3546338; LEVINGS S C, 1981, Psyche (Cambridge), V88, P265, DOI 10.1155/1981/20795; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Perez-Morales J.V., 1977, SCI FUNGORUM, V11, P99, DOI [10.33885/sf.1977.2.466, DOI 10.33885/SF.1977.2.466]; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SOULE ME, 1991, SCIENCE, V253, P744, DOI 10.1126/science.253.5021.744; Vandermeer J, 2002, P NATL ACAD SCI USA, V99, P8731, DOI 10.1073/pnas.142073599; WILSON EO, 1959, ECOLOGY, V40, P437, DOI 10.2307/1929761	23	139	147	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					284	286		10.1126/science.1094981	http://dx.doi.org/10.1126/science.1094981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073375				2022-12-28	WOS:000220719400045
J	Roesch, MR; Olson, CR				Roesch, MR; Olson, CR			Neuronal activity related to reward value and motivation in primate frontal cortex	SCIENCE			English	Article							SUPPLEMENTARY EYE FIELD; ORBITOFRONTAL CORTEX; PREFRONTAL NEURONS; PARIETAL CORTEX; EXPECTED REWARD; LIMBIC SYSTEM; MONKEY; STRIATUM; PREMOTOR; SIGNALS	In several areas of the macaque brain, neurons. re during delayed-response tasks at a rate determined by the value of the reward expected at the end of the trial. The activity of these neurons might be related to the value of the expected reward or to the degree of motivation induced by expectation of the reward. We describe results indicating that the nature of reward-dependent activity varies across areas. Neuronal activity in orbitofrontal cortex represents the value of the expected reward, whereas neuronal activity in premotor cortex reflects the degree of motivation.	Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roesch, MR (corresponding author), Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	roesch@cnbc.cmu.edu			NCRR NIH HHS [P41RR03631] Funding Source: Medline; NEI NIH HHS [EY08098, EY11831] Funding Source: Medline; NIMH NIH HHS [MH45156] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011831, P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Glimcher PW, 2002, NEURON, V36, P323, DOI 10.1016/S0896-6273(02)00962-5; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Martin-Soelch C, 2001, BRAIN RES REV, V36, P139, DOI 10.1016/S0165-0173(01)00089-3; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ono T, 2000, J NEUROL, V247, P23, DOI 10.1007/PL00007780; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla Robert A, 2003, Span J Psychol, V6, P185; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Stellar E., 1982, PHYSL MECH MOTIVATIO, P377; Stellar J. R., 1985, NEUROBIOLOGY MOTIVAT; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 1998, REV NEUROSCIENCE, V9, P225; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	29	390	396	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					307	310		10.1126/science.1093223	http://dx.doi.org/10.1126/science.1093223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073380				2022-12-28	WOS:000220719400052
J	Blackburn, E				Blackburn, E			Bioethics and the political distortion of biomedical science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA USA	University of California System; University of California San Francisco	Blackburn, E (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA USA.								0	37	38	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1379	1380		10.1056/NEJMp048072	http://dx.doi.org/10.1056/NEJMp048072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808IJ	15070784				2022-12-28	WOS:000220562500001
J	Loayza, D; de Lange, T				Loayza, D; de Lange, T			Telomerase regulation at the telomere: A binary switch	CELL			English	Editorial Material							LENGTH		Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	Loayza, D (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748	7	10	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					279	280		10.1016/S0092-8674(04)00409-X	http://dx.doi.org/10.1016/S0092-8674(04)00409-X			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109487	Bronze			2022-12-28	WOS:000221176400001
J	Stoneburner, RL; Low-Beer, D				Stoneburner, RL; Low-Beer, D			Population-level HIV declines and behavioral risk avoidance in Uganda	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SEXUAL-BEHAVIOR; PREGNANT-WOMEN; PREVALENCE; AIDS; TRANSMISSION; DYNAMICS; HIV/AIDS; COHORT; TRENDS	Uganda provides the clearest example that human immunodeficiency virus (HIV) is preventable if populations are mobilized to avoid risk. Despite limited resources, Uganda has shown a 70% decline in HIV prevalence since the early 1990s, linked to a 60% reduction in casual sex. The response in Uganda appears to be distinctively associated with communication about acquired immunodeficiency syndrome (AIDS) through social networks. Despite substantial condom use and promotion of biomedical approaches, other African countries have shown neither similar behavioral responses nor HIV prevalence declines of the same scale. The Ugandan success is equivalent to a vaccine of 80% effectiveness. Its replication will require changes in global HIV/AIDS intervention policies and their evaluation.	Univ Cambridge, Populat Hlth Evaluat Unit, Cambridge, England	University of Cambridge	Stoneburner, RL (corresponding author), Univ Cambridge, Populat Hlth Evaluat Unit, Cambridge, England.	randstoneburner@netzero.net						AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; ASIIMWEOKIROR G, 1996, 11 INT C AIDS VANC B; BESSINGER R, 2003, TRENDS SEXUAL FERTIL; *CENTR BOARD HLTH, 2004, ANC SENT SURV HIV SY; Fennema JSA, 1998, AIDS, V12, P931, DOI 10.1097/00002030-199808000-00016; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; HESSOL NA, 1989, AM J EPIDEMIOL, V130, P1167, DOI 10.1093/oxfordjournals.aje.a115445; HOGLE JA, 2002, WHAT HAPPENED UGANDA; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Konde-Lule J K, 1995, Health Transit Rev, V5 Suppl, P27; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; Low-Beer D, 2002, LANCET, V360, P1788, DOI 10.1016/S0140-6736(02)11701-6; MARTIN JL, 1987, AM J PUBLIC HEALTH, V77, P578, DOI 10.2105/AJPH.77.5.578; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; MCKUSICK L, 1985, AM J PUBLIC HEALTH, V75, P493, DOI 10.2105/AJPH.75.5.493; MERTENS T, 1994, AIDS, V8, P1359, DOI 10.1097/00002030-199410000-00002; MOODI R, 1991, EVALUATION STUDY UGA; MUGYENYI P, COMMUNICATION; MUSINGUZI J, 1996, REPORT RESULTS POPUL; *N MAND CHILDR FUN, 2002, S AFR NAT HIV PREV B; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; Rose G., 1992, STRATEGY PREVENTIVE; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stoneburner R, 1998, AIDS, V12, P226; STONEBURNER R, 2000, 13 INT C AIDS DURB S; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; STONEBURNER RL, 1993, AM J EPIDEMIOL, V138, P1093, DOI 10.1093/oxfordjournals.aje.a116827; STONEBURNER RL, 1997, ASSESSMENT EMERGING; STONEBURNER RL, IN PRESS INT J EPIDE; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Susser M, 1996, AM J PUBLIC HEALTH, V86, P1713, DOI 10.2105/AJPH.86.12.1713; Tarantola D, 1997, AIDS, V11 Suppl B, pS5; *UNAIDS, 1998, MEAS SUCC UG; UNAIDS, 1999, TRENDS HIV INC PREV; UNAIDS, 2003, AIDS EP UPD; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; Weidle PJ, 2002, LANCET, V359, P2261, DOI 10.1016/S0140-6736(02)09297-8; *WHO, 1991, STESASERA119 WHO; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	44	327	330	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					714	718		10.1126/science.1093166	http://dx.doi.org/10.1126/science.1093166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816JD	15118157				2022-12-28	WOS:000221105300039
J	Hachet, O; Ephrussi, A				Hachet, O; Ephrussi, A			Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization	NATURE			English	Article							BICOID MESSENGER-RNA; EXON-EXON JUNCTIONS; MAGO NASHI; RIBONUCLEOPROTEIN-PARTICLES; DROSOPHILA OOCYTE; BINDING PROTEIN; GERM PLASM; POSTERIOR; POLE; COMPLEX	oskar messenger RNA localization at the posterior pole of the Drosophila oocyte is essential for germline and abdomen formation in the future embryo(1,2). The nuclear shuttling proteins Y14/Tsunagi and Mago nashi are required for oskar mRNA localization, and they co-localize with oskar mRNA at the posterior pole of the oocyte(3-5). Their human homologues, Y14/ RBM8 and Magoh, are core components of the exon - exon junction complex (EJC)(6-9). The EJC is deposited on mRNAs in a splicing-dependent manner, 20 - 24 nucleotides upstream of exon - exon junctions, independently of the RNA sequence(6-8). This indicates a possible role of splicing in oskar mRNA localization, challenging the established notion that the oskar 3 0 untranslated region (3' UTR) is sufficient for this process. Here we show that splicing at the first exon - exon junction of oskar RNA is essential for oskar mRNA localization at the posterior pole. We revisit the issue of sufficiency of the oskar 3' UTR for posterior localization and show that the localization of unrelated transcripts bearing the oskar 3' UTR is mediated by endogenous oskar mRNA. Our results reveal an important new function for splicing: regulation of messenger ribonucleoprotein complex assembly and organization for mRNA cytoplasmic localization.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1,Postfach 10-2209, D-69117 Heidelberg, Germany.	ephrussi@embl-heidelberg.de	Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620				AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V1; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; HORTON RM, 1991, BIOTECHNIQUES, V5, P528; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Macchi P, 2003, J NEUROSCI, V23, P5778; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Mohr SE, 2001, GENE DEV, V15, P2886; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; RONGO C, 1995, DEVELOPMENT, V121, P2737; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; Wagner C, 2001, J MOL BIOL, V313, P511, DOI 10.1006/jmbi.2001.5057; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0	30	252	257	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					959	963		10.1038/nature02521	http://dx.doi.org/10.1038/nature02521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118729				2022-12-28	WOS:000221083000045
J	Bischoff-Ferrari, HA; Dawson-Hughes, B; Willett, WC; Staehelin, HB; Bazemore, MG; Zee, RY; Wong, JB				Bischoff-Ferrari, HA; Dawson-Hughes, B; Willett, WC; Staehelin, HB; Bazemore, MG; Zee, RY; Wong, JB			Effect of vitamin D on falls - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							D SUPPLEMENTATION; SECONDARY HYPERPARATHYROIDISM; CALCIUM SUPPLEMENTATION; ELDERLY PERSONS; HIP FRACTURE; RISK-FACTORS; HEALTH-CARE; WOMEN; COMMUNITY; BONE	Context Falls among elderly individuals occur frequently, increase with age, and lead to substantial morbidity and mortality. The role of vitamin D in preventing falls among elderly people has not been well established. Objective To assess the effectiveness of vitamin D in preventing an older person from failing. Data Sources MEDLINE and the Cochrane Controlled Trials Register from January 1960 to February 2004, EMBASE from January 1991 to February 2004, clinical experts, bibliographies, and abstracts, Search terms included trial terms: randomized-controlled trial or controlled-clinical trial or random-allocation or double-blind method, or single-blind method or uncontrolled-trials with vitamin D terms: cholecalciferol or hydroxycholecalciferols or calcifediol or dihydroxycholecalciferols or calcitriol or vitamin D/aa[analogs & derivates] or ergocalciferol or vitamin D/bl[blood]; and with accidental falls or falls, and humans. Study Selection We included only double-blind randomized, controlled trials (RCTs) of vitamin D in elderly populations (mean age, 60 years) that examined falls resulting from low trauma for which the method of fall ascertainment and definition of falls were defined explicitly. Studies including patients in unstable health states were excluded. Five of 38 identified studies were included in the primary analysis and 5 other studies were included in a sensitivity analysis. Data Extraction Independent extraction by 3 authors using predefined data fields including study quality indicators. Data Synthesis Based on 5 RCTs involving 1237 participants, vitamin D reduced the corrected odds ratio (OR) of falling by 22% (corrected OR, 0.78; 95% confidence interval [CI], 0.64-0.92) compared with patients receiving calcium or placebo. From the pooled risk difference, the number needed to treat (NNT) was 15 (95% Cl, 8-53), or equivalently 15 patients would need to be treated with vitamin D to prevent 1 person from failing. The inclusion of 5 additional studies, involving 10001 participants, in a sensitivity analysis resulted in a smaller but still significant effect size (corrected RR, 0.87; 95% Cl, 0.80-0.96). Subgroup analyses suggested that the effect size was independent of calcium supplementation, type of vitamin D, duration of therapy, and sex, but reduced sample sizes made the results statistically nonsignificant for calcium supplementation, cholecalciferol, and among men. Conclusions Vitamin D supplementation appears to reduce the risk of falls among ambulatory or institutionalized older individuals with stable health by more than 20%. Further studies examining the effect of alternative types of vitamin D and their doses, the role of calcium supplementation, and effects in men should be considered.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Aging, Boston, MA 02120 USA; Harvard Univ, Brigham & Womens Hosp,Sch Med, Robert B Brigham Arthrit & Musculoskeletal Dis Cl, Div Rheumatol Immunol & Allergy, Boston, MA 02120 USA; Harvard Univ, Brigham & Womens Hosp,Sch Med, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02120 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02138 USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Div Clin Decis Making, Dept Med, Boston, MA USA; Univ Basel Hosp, Dept Geriatr, CH-4031 Basel, Switzerland; Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; University of Basel; Cincinnati Children's Hospital Medical Center	Bischoff-Ferrari, HA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Aging, 1620 Tremont St, Boston, MA 02120 USA.	hbischof@hsph.harvard.edu		Bischoff-Ferrari, Heike/0000-0002-4554-658X; Wong, John/0000-0003-4203-9010				BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; BOLAND R, 1986, ENDOCR REV, V7, P434, DOI 10.1210/edrv-7-4-434; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; CAMPBELL AJ, 1981, AGE AGEING, V10, P47, DOI 10.1093/ageing/10.1.47; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; Englander F, 1996, J FORENSIC SCI, V41, P733; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P3618, DOI 10.1210/jc.86.8.3618; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Larsen ER, 2002, J BONE MINER RES, V17, pS157; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Rizzo JA, 1998, MED CARE, V36, P1174, DOI 10.1097/00005650-199808000-00006; SATTIN RW, 1990, AM J EPIDEMIOL, V131, P1028, DOI 10.1093/oxfordjournals.aje.a115594; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; SORENSEN OH, 1979, CLIN SCI, V56, P157, DOI 10.1042/cs0560157; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	918	978	1	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1999	2006		10.1001/jama.291.16.1999	http://dx.doi.org/10.1001/jama.291.16.1999			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815SM	15113819				2022-12-28	WOS:000221062000032
J	Wilson, JF				Wilson, JF			Cheaper drugs in foreign markets increase the focus on domestic drug prices	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				CALFEE JE, 2003, HLTH POLICY OUTL NOV; DANZON PM, HLTH AFFAIRS; WAGNER JL, ANN REV PUBLIC HLTH	3	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					677	680		10.7326/0003-4819-140-8-200404200-00044	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00044			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096358				2022-12-28	WOS:000220851700034
J	Lowdon, D				Lowdon, D			Interactive case report - A 66 year old woman with breathlessness: case outcome - Commentary: Patient's view	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Victoria Hosp, Dundee DD2 1SP, Scotland			douglas.lowdon@tpct.scot.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					944	945		10.1136/bmj.328.7445.944	http://dx.doi.org/10.1136/bmj.328.7445.944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087344	Green Published			2022-12-28	WOS:000220994400029
J	Matzel, KE; Kamm, MA; Stosser, M; Baeten, CGMI; Christiansen, J; Madoff, R; Mellgren, A; Nicholls, RJ; Rius, J; Rosen, H				Matzel, KE; Kamm, MA; Stosser, M; Baeten, CGMI; Christiansen, J; Madoff, R; Mellgren, A; Nicholls, RJ; Rius, J; Rosen, H		MDT 301 Study Grp	Sacral spinal nerve stimulation for faecal incontinence: multicentre study	LANCET			English	Article							QUALITY-OF-LIFE; DYNAMIC GRACILOPLASTY; URINARY-INCONTINENCE; VOIDING DYSFUNCTION; ANAL INCONTINENCE; PREVALENCE; NEUROMODULATION; MANAGEMENT; SPHINCTER; EFFICACY	Background In patients with faecal incontinence in whom conservative treatment fails, options are limited for those with a functionally deficient but morphologically intact sphincter. We investigated the effect of sacral nerve stimulation on continence and quality of life. Methods In this multicentre prospective trial, 37 patients underwent a test stimulation period, followed by implantation of a neurostimulator for chronic stimulation in 34. Effect on continence was assessed by daily bowel-habit diaries over a 3-week period and on quality of life by the disease-specific American Society of Colon and Rectal Surgeons (ASCRS) questionnaire and the standard short form health survey questionnaire (SF-36). Every patient served as his or her own control. Findings Frequency of incontinent episodes per week fell (mean 16.4 vs 3.1 and 2.0 at 12 and 24 months; p<0.0001) for both urge and passive incontinence during median follow-up of 23.9 months. Mean number of days per week with incontinent episodes also declined (4.5 vs 1.4 and 1.2 at 12 and 24 months, p<0.0001), as did staining (5.6 vs 2.4 at 12 months; p<0.0001) and pad use (5.9 vs 3.7 at 12 months; p<0.0001). Ability to postpone defecation was enhanced (at 12 months, p<0.0001), and ability to completely empty the bowel was slightly raised during follow-up (at 12 months, p=0.4122). Quality of life improved in all four ASCRS scales (p<0.0001) and in seven of eight SF-36 scales, though only social functioning was significantly improved (p=0.0002). Interpretation Sacral nerve stimulation greatly improves continence and quality of life in selected patients with morphologically intact or repaired sphincter complex offering a treatment for patients in whom treatment options are limited.	Univ Hosp Erlangen, Dept Gen Surg, Erlangen, Germany; St Marks Hosp, London EC1V 2PS, England; Medtron Europe Sarl, Tolochenaz, Switzerland; Maastricht Univ Hosp, Dept Gen Surg, Maastricht, Netherlands; Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark; Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; Danderyd Hosp, Dept Surg, Stockholm, Sweden; Hosp Mutua Terrassa, Dept Gen Surg, Terrassa, Spain; Danube Hosp SMZ Ost, Dept Gen Surg, Vienna, Austria	University of Erlangen Nuremberg; Imperial College London; Maastricht University; Maastricht University Medical Centre (MUMC); University of Copenhagen; Herlev & Gentofte Hospital; University of Minnesota System; University of Minnesota Twin Cities; Danderyds Hospital; Hospital Universitario Mutua Terrassa; Donauspital	Matzel, KE (corresponding author), Univ Erlangen Nurnberg, Chirurg Klin Poliklin, Maximilianspl, D-91054 Erlangen, Germany.	Klaus.Matzel@chir.imed.uni-erlangen.de						Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; CAMPBELL AJ, 1985, AGE AGEING, V14, P65, DOI 10.1093/ageing/14.2.65; Janknegt RA, 1997, UROLOGY, V49, P358, DOI 10.1016/S0090-4295(96)00506-7; Kamm MA, 1998, BRIT MED J, V316, P528, DOI 10.1136/bmj.316.7130.528; Kenefick NJ, 2002, BRIT J SURG, V89, P896, DOI 10.1046/j.1365-2168.2002.02119.x; Leroi AM, 2001, DIS COLON RECTUM, V44, P779, DOI 10.1007/BF02234695; MADOFF RD, 1992, NEW ENGL J MED, V326, P1002; Malouf AJ, 2000, ANN SURG, V232, P143, DOI 10.1097/00000658-200007000-00020; MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3; MATZEL KE, 1995, LANGENBECK ARCH CHIR, V380, P184; Matzel KE, 2001, DIS COLON RECTUM, V44, P59, DOI 10.1007/BF02234822; Matzel KE, 2001, DIS COLON RECTUM, V44, P1427, DOI 10.1007/BF02234593; MILLER R, 1989, BRIT J SURG, V76, P1058, DOI 10.1002/bjs.1800761024; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Roberts RO, 1999, J AM GERIATR SOC, V47, P837, DOI 10.1111/j.1532-5415.1999.tb03841.x; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120; Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823; SCHMIDT RA, 1990, UROLOGY, V35, P388, DOI 10.1016/0090-4295(90)80078-2; SCHMIDT RA, 1988, NEUROUROL URODYNAM, V7, P585, DOI 10.1002/nau.1930070607; SIEGEL SW, 1992, UROL CLIN N AM, V19, P163; Siegel SW, 2000, UROLOGY, V56, P87, DOI 10.1016/S0090-4295(00)00597-5; SPINELLI M, 2002, EUR UROL, V208, P1; THON WF, 1991, WORLD J UROL, V9, P138; Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292; Vaizey CJ, 1999, GUT, V44, P407, DOI 10.1136/gut.44.3.407; Ware J. E., 1993, SF36 HLTH SURVEY MAN; WEXNER SD, 1991, DIS COLON RECTUM, V34, P22, DOI 10.1007/BF02050202; Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3	30	217	222	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1270	1276		10.1016/S0140-6736(04)15999-0	http://dx.doi.org/10.1016/S0140-6736(04)15999-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094271				2022-12-28	WOS:000220904900008
J	Mori, MX; Erickson, MG; Yue, DT				Mori, MX; Erickson, MG; Yue, DT			Functional stoichiometry and local enrichment of calmodulin interacting with Ca2+ channels	SCIENCE			English	Article							CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; NUCLEUS; CA2+/CALMODULIN; PREASSOCIATION; FACILITATION; SUPPORTS; MEDIATE	Calmodulin (CaM) interactions with Ca2+ channels mediate both Ca2+ regulation of channels and local Ca2+ triggering of transcription factors implicated in neuronal memory. Crucial to these functions are the number of CaM molecules (CaMs) regulating each channel, and the number of CaMs privy to the local Ca2+ signal from each channel. To resolve these parameters, we fused L-type Ca2+ channels to single CaM molecules. These chimeric molecules revealed that a single CaM directs L-type channel regulation. Similar fusion molecules were used to estimate the local CaM concentration near Ca2+ channels. This estimate indicates marked enrichment of local CaM, as if a "school" of nearby CaMs were poised to enhance the transduction of local Ca2+ entry into diverse signaling pathways.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca2 Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Ca2 Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca2 Signals Lab, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu						Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Ikeda SR, 2001, SCIENCE, V294, P318, DOI 10.1126/science.1066160; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Maier LS, 2000, J MOL CELL CARDIOL, V32, P2249, DOI 10.1006/jmcc.2000.1252; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Soong TW, 2002, J NEUROSCI, V22, P10142; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	30	156	159	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					432	435		10.1126/science.1093490	http://dx.doi.org/10.1126/science.1093490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087548				2022-12-28	WOS:000220845400046
J	Chen, D; Cane, MA; Kaplan, A; Zebiak, SE; Huang, DJ				Chen, D; Cane, MA; Kaplan, A; Zebiak, SE; Huang, DJ			Predictability of El Nino over the past 148 years	NATURE			English	Article							SOUTHERN-OSCILLATION; OPTIMAL-GROWTH; COUPLED MODEL; LA-NINA; ENSO; PREDICTION; FORECASTS; PACIFIC; ONSET; SKILL	Forecasts of El Nino climate events are routinely provided and distributed, but the limits of El Nino predictability are still the subject of debate. Some recent studies suggest that the predictability is largely limited by the effects of high-frequency atmospheric 'noise'(1-7), whereas others emphasize limitations arising from the growth of initial errors in model simulations(8-10). Here we present retrospective forecasts of the interannual climate fluctuations in the tropical Pacific Ocean for the period 1857 to 2003, using a coupled ocean-atmosphere model. The model successfully predicts all prominent El Nino events within this period at lead times of up to two years. Our analysis suggests that the evolution of El Nino is controlled to a larger degree by self-sustaining internal dynamics than by stochastic forcing. Model-based prediction of El Nino therefore depends more on the initial conditions than on unpredictable atmospheric noise. We conclude that throughout the past century, El Nino has been more predictable than previously envisaged.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; State Ocean Adm, Lab Ocean Dynam Proc & Satellite Oceanog, Hangzhou, Peoples R China	Columbia University; State Oceanic Administration	Chen, D (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	dchen@ldeo.columbia.edu	Cane, Mark/I-8086-2012; Chen, Dake/E-7082-2011	Cane, Mark/0000-0001-5408-2388				BALMASEDA MA, 1995, J CLIMATE, V8, P2705, DOI 10.1175/1520-0442(1995)008<2705:DASDOE>2.0.CO;2; Barnston AG, 1999, B AM METEOROL SOC, V80, P217, DOI 10.1175/1520-0477(1999)080<0217:PSOSAD>2.0.CO;2; Boulanger JP, 2001, GEOPHYS RES LETT, V28, P1603, DOI 10.1029/2000GL012364; CANE MA, 1986, NATURE, V321, P827, DOI 10.1038/321827a0; Chang P, 1996, PHYSICA D, V98, P301, DOI 10.1016/0167-2789(96)00116-9; Chen D, 2000, GEOPHYS RES LETT, V27, P2585, DOI 10.1029/1999GL011078; CHEN D, 1995, SCIENCE, V269, P1699, DOI 10.1126/science.269.5231.1699; Davis Mike, 2002, LATE VICTORIAN HOLOC; Fedorov AV, 2003, B AM METEOROL SOC, V84, P911, DOI 10.1175/BAMS-84-7-911; Goddard L, 2001, INT J CLIMATOL, V21, P1111, DOI 10.1002/joc.636; GOSWAMI BN, 1991, J CLIMATE, V4, P3, DOI 10.1175/1520-0442(1991)004<0003:POACOA>2.0.CO;2; JIN FF, 1994, SCIENCE, V264, P70, DOI 10.1126/science.264.5155.70; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kessler WS, 2001, J CLIMATE, V14, P3055, DOI 10.1175/1520-0442(2001)014<3055:EROTMJ>2.0.CO;2; Kirtman BP, 1998, J CLIMATE, V11, P2804, DOI 10.1175/1520-0442(1998)011<2804:DVIEPA>2.0.CO;2; Latif M, 1998, J GEOPHYS RES-OCEANS, V103, P14375, DOI 10.1029/97JC03413; McPhaden MJ, 1999, GEOPHYS RES LETT, V26, P2961, DOI 10.1029/1999GL004901; McPhaden MJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016872; Meinen CS, 2000, J CLIMATE, V13, P3551, DOI 10.1175/1520-0442(2000)013<3551:OOWWVC>2.0.CO;2; Moore AM, 1999, J CLIMATE, V12, P1199, DOI 10.1175/1520-0442(1999)012<1199:SFOEBT>2.0.CO;2; PENLAND C, 1995, J CLIMATE, V8, P1999, DOI 10.1175/1520-0442(1995)008<1999:TOGOTS>2.0.CO;2; Perigaud CM, 2000, GEOPHYS RES LETT, V27, P389, DOI 10.1029/1999GL010781; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Smith TM, 2003, J CLIMATE, V16, P1495, DOI 10.1175/1520-0442-16.10.1495; Thompson CJ, 2000, J CLIMATE, V13, P2818, DOI 10.1175/1520-0442(2000)013<2818:ALSDMO>2.0.CO;2; TZIPERMAN E, 1994, SCIENCE, V264, P72, DOI 10.1126/science.264.5155.72; Xue Y, 1997, MON WEATHER REV, V125, P2043, DOI 10.1175/1520-0493(1997)125<2043:POACMO>2.0.CO;2; ZEBIAK SE, 1989, J CLIMATE, V2, P1381, DOI 10.1175/1520-0442(1989)002<1381:OTDOAT>2.0.CO;2; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2	30	367	402	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					733	736		10.1038/nature02439	http://dx.doi.org/10.1038/nature02439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085127				2022-12-28	WOS:000220823800034
J	Liu, ET; Karuturi, KR				Liu, ET; Karuturi, KR			Microarrays and clinical investigations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREDICTION		Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Genome Institute of Singapore (GIS)	Liu, ET (corresponding author), Genome Inst Singapore, Singapore, Singapore.		Liu, Edison/C-4141-2008					Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	3	46	48	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1595	1597		10.1056/NEJMp048050	http://dx.doi.org/10.1056/NEJMp048050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084689				2022-12-28	WOS:000220819800001
J	Khatami, R; Maret, S; Werth, E; Retey, J; Schmid, D; Maly, F; Tafti, M; Bassetti, CL				Khatami, R; Maret, S; Werth, E; Retey, J; Schmid, D; Maly, F; Tafti, M; Bassetti, CL			Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway	LANCET			English	Article							MUTATION	Narcolepsy with cataplexy is thought to be a hypocretin ligand or hypocretin receptor deficiency syndrome caused by genetic and environmental factors. We looked for an abnormality of the hypocretin pathway in HLA-DQBI*0602-positive monozygotic twins who were concordant for narcolepsy-cataplexy. They had normal cerebrospinal fluid concentrations of hypocretin-1, and we found no mutation in the prepro-hypocretin gene or either hypocretin receptor gene. Our finding points to the existence of presumably genetic forms of narcolepsy with cataplexy without any demonstrable defect in the hypocretin pathway.	Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Pharmacol & Toxicol, Sect Psychopharmacol & Sleep Res, CH-8006 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich	Bassetti, CL (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	claudio.bassetti@usz.ch	Werth, E/AAN-7955-2021; Tafti, Mehdi/A-8887-2017	Tafti, Mehdi/0000-0002-6997-3914; Werth, Esther/0000-0002-5099-3122; van der Meer, Julia/0000-0002-1913-5146; Bassetti, Claudio/0000-0002-4535-0245				Honda M, 2001, BIOL PSYCHIAT, V49, P943, DOI 10.1016/S0006-3223(01)01090-3; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Olafsdottir BR, 2001, NEUROLOGY, V57, P1896, DOI 10.1212/WNL.57.10.1896; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690	5	41	41	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1199	1200		10.1016/S0140-6736(04)15951-5	http://dx.doi.org/10.1016/S0140-6736(04)15951-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081654				2022-12-28	WOS:000220748100012
J	Chung, KKK; Thomas, B; Li, XJ; Pletnikova, O; Troncoso, JC; Marsh, L; Dawson, VL; Dawson, TM				Chung, KKK; Thomas, B; Li, XJ; Pletnikova, O; Troncoso, JC; Marsh, L; Dawson, VL; Dawson, TM			S-nitrosylation of Parkin regulates ubiquitination and compromises Parkin's protective function	SCIENCE			English	Article							NEURONAL NITRIC-OXIDE; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; PROTEIN LIGASE; DISEASE; NEURODEGENERATION; MUTATIONS; COMPLEX; PATHOGENESIS; ASSOCIATION	Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD). We show that parkin is S-nitrosylated in vitro, as well as in vivo in a mouse model of PD and in brains of patients with PD and diffuse Lewy body disease. Moreover, S-nitrosylation inhibits parkin's ubiquitin E3 ligase activity and its protective function. The inhibition of parkin's ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in these disorders by impairing the ubiquitination of parkin substrates.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	NINDS NIH HHS [NS38377] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Feany MB, 2003, NEURON, V38, P13, DOI 10.1016/S0896-6273(03)00201-0; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hattori N, 2003, J NEUROL, V250, P2, DOI 10.1007/s00415-003-1302-y; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Liberatore GT, 1999, NAT MED, V5, P1403; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Przedborski T, 2003, ADV NEUROL, V91, P83; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	33	608	626	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2004	304	5675					1328	1331		10.1126/science.1093891	http://dx.doi.org/10.1126/science.1093891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	824EV	15105460				2022-12-28	WOS:000221669600056
J	Zwier, TS				Zwier, TS			The structure of protonated water clusters	SCIENCE			English	Editorial Material									Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	zwier@purdue.edu						EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; SEARCY JQ, 1974, J CHEM PHYS, V61, P5282, DOI 10.1063/1.1681876; Shin JW, 2004, SCIENCE, V304, P1137, DOI 10.1126/science.1096466; WEI S, 1991, J CHEM PHYS, V94, P3268, DOI 10.1063/1.459796; ZUNDEL G, 1968, Z PHYS CHEM NEUE FOL, V58, P225	6	111	134	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1119	1120		10.1126/science.1098129	http://dx.doi.org/10.1126/science.1098129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15118124				2022-12-28	WOS:000221524500028
J	Tinel, A; Tschopp, J				Tinel, A; Tschopp, J			The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress	SCIENCE			English	Article							DOMAIN-CONTAINING PROTEIN; CELL-DEATH; INDUCED APOPTOSIS; ADAPTER MOLECULE; MITOCHONDRIA; INDUCTION; ENCODES; BETA; GENE	Apoptosis is triggered by activation of initiator caspases upon complex-mediated clustering of the inactive zymogen, as occurs in the caspase-9 activating apoptosome complex. Likewise, caspase-2, which is involved in stress-induced apoptosis, is recruited into a large protein complex, the molecular composition of which remains elusive. We show that activation of caspase-2 occurs in a complex that contains the death domain - containing protein PIDD, whose expression is induced by p53, and the adaptor protein RAIDD. Increased PIDD expression resulted in spontaneous activation of caspase-2 and sensitization to apoptosis by genotoxic stimuli. Because PIDD functions in p53-mediated apoptosis, the complex assembled by PIDD and caspase-2 is likely to regulate apoptosis induced by genotoxins.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@ib.unil.ch						Ahmad M, 1997, CANCER RES, V57, P615; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; TINEL A, UNPUB; Troy CM, 2000, J NEUROSCI, V20, P1386; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976	21	484	507	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2004	304	5672					843	846		10.1126/science.1095432	http://dx.doi.org/10.1126/science.1095432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	818KC	15073321				2022-12-28	WOS:000221243000035
J	Lohmann, KJ; Lohmann, CMF; Ehrhart, LM; Bagley, DA; Swing, T				Lohmann, KJ; Lohmann, CMF; Ehrhart, LM; Bagley, DA; Swing, T			Animal behaviour - Geomagnetic map used in sea-turtle navigation	NATURE			English	Editorial Material									Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Central Florida	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	klohmann@email.unc.edu						Able KP, 2001, J AVIAN BIOL, V32, P174, DOI 10.1034/j.1600-048X.2001.320211.x; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; AVENS L, IN PRESS J EXP BIOL; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Lohmann KJ., 2003, LOGGERHEAD SEA TURTL, P44; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054	10	197	217	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					909	910		10.1038/428909a	http://dx.doi.org/10.1038/428909a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118716				2022-12-28	WOS:000221083000030
J	Snook, RR; Hosken, DJ				Snook, RR; Hosken, DJ			Sperm death and dumping in Drosophila	NATURE			English	Article							FEMALE; DISPLACEMENT; COMPETITION; STORAGE; MELANOGASTER; MALES; BEHAVIOR	Mating with more than one male is the norm for females of many species. In addition to generating competition between the ejaculates of different males(1,2), multiple mating may allow females to bias sperm use(3,4). In Drosophila melanogaster, the last male to inseminate a female sires approximately 80% of subsequent progeny(5). Both sperm displacement, where resident spermare removed from storage by the incoming ejaculate of the copulating male(6), and sperm incapacitation, where incoming seminal fluids supposedly interfere with resident sperm(7), have been implicated in this pattern of sperm use(5-12). But the idea of incapacitation is problematic because there are no known mechanisms by which an individual could damage rival sperm and not their own. Females also influence the process of sperm use(13,14), but exactly how is unclear. Here we show that seminal fluids do not kill rival sperm and that any 'incapacitation' is probably due to spermageing during spermstorage. We also show that females release stored sperm from the reproductive tract ( sperm dumping) after copulation with a second male and that this requires neither incoming sperm nor seminal fluids. Instead, males may cause stored sperm to be dumped or females may differentially eject sperm from the previous mating.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Zurich, Zool Museum, CH-8703 Zurich, Switzerland	University of Sheffield; University of Zurich	Snook, RR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	r.snook@sheffield.ac.uk	Snook, Rhonda/D-7291-2016	Snook, Rhonda/0000-0003-1852-1448				ALONSOPIMENTEL H, 1994, CELL TISSUE RES, V275, P467, DOI 10.1007/BF00318816; Arthur BI, 1998, P ROY SOC B-BIOL SCI, V265, P1749, DOI 10.1098/rspb.1998.0498; Birkhead TR, 1998, SPERM COMPETITION SE; Civetta A, 2000, GENET RES, V75, P143, DOI 10.1017/S0016672399004292; Civetta A, 1999, CURR BIOL, V9, P841, DOI 10.1016/S0960-9822(99)80370-4; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; Cordoba-Aguilar A, 1999, P ROY SOC B-BIOL SCI, V266, P779, DOI 10.1098/rspb.1999.0705; DEVRIES JK, 1964, EVOLUTION, V18, P271, DOI 10.2307/2406401; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; GILCHRIST AS, 1995, J INSECT PHYSIOL, V41, P1087, DOI 10.1016/0022-1910(95)00068-6; Gilchrist AS, 2000, EVOLUTION, V54, P534, DOI 10.1111/j.0014-3820.2000.tb00056.x; Gromko M.H., 1984, P371; GROMKO MH, 1984, EVOLUTION, V38, P1273, DOI 10.1111/j.1558-5646.1984.tb05649.x; HARSHMAN LG, 1994, EVOLUTION, V48, P758, DOI [10.2307/2410484, 10.1111/j.1558-5646.1994.tb01359.x]; HEED WB, 1990, GENETICS SPECIATION, P253; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; LEFEVRE G, 1962, GENETICS, V42, P1719; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Moore HDM, 1999, P ROY SOC B-BIOL SCI, V266, P2343, DOI 10.1098/rspb.1999.0929; OTRONEN M, 1991, BEHAV ECOL SOCIOBIOL, V29, P33, DOI 10.1007/BF00164292; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pitnick S, 2000, EVOLUTION, V54, P1052, DOI 10.1111/j.0014-3820.2000.tb00107.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; SCOTT D, 1990, J INSECT PHYSIOL, V36, P451, DOI 10.1016/0022-1910(90)90063-L; Simmons L.W., 1998, P341, DOI 10.1016/B978-012100543-6/50035-0; Simmons L. W., 2001, MG BEH ECOL; Wheeler M. R., 1947, University of Texas Publications no, V4720, P78; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897	30	147	148	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					939	941		10.1038/nature02455	http://dx.doi.org/10.1038/nature02455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118726	Green Accepted			2022-12-28	WOS:000221083000040
J	Ruskin, R				Ruskin, R			The scar	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ronaldruskinmd@aol.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1941	1942		10.1001/jama.291.16.1941	http://dx.doi.org/10.1001/jama.291.16.1941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113791				2022-12-28	WOS:000221062000001
J	Norman, GR; Shannon, SI; Marrin, ML				Norman, GR; Shannon, SI; Marrin, ML			The need for needs assessment in continuing medical education	BRITISH MEDICAL JOURNAL			English	Article							PHYSICIANS; PERFORMANCE; VALIDITY; TRIAL; TOOL		McMaster Univ, Program Educ Res & Dev, Hamilton, ON L8S 4K1, Canada	McMaster University	Norman, GR (corresponding author), McMaster Univ, Program Educ Res & Dev, Bldg T-13,1280 Main St W, Hamilton, ON L8S 4K1, Canada.	norman@mcmaster.ca						Bergus GR, 2000, ARCH FAM MED, V9, P541, DOI 10.1001/archfami.9.6.541; Cohen R, 2002, ACAD MED, V77, P1247, DOI 10.1097/00001888-200212000-00022; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Fox RD, 1998, BRIT MED J, V316, P466, DOI 10.1136/bmj.316.7129.466; GORDON MJ, 1991, ACAD MED, V66, P762, DOI 10.1097/00001888-199112000-00012; Grant J, 2002, BRIT MED J, V324, P156, DOI 10.1136/bmj.324.7330.156; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; MASON R, 2001, BRIT MED J, V322, P1600; Norcini JJ, 1999, BRIT MED J, V319, P1183, DOI 10.1136/bmj.319.7218.1183; Norman GR, 1998, CAN MED ASSOC J, V158, P177; Page GG, 1995, CAN MED ASSOC J, V153, P1723; Parboosingh JT, 1993, ANN R COLL PHYS SURG, V26, P512; Perol D, 2002, ACAD MED, V77, P407, DOI 10.1097/00001888-200205000-00011; SHIN JH, 1993, CAN MED ASSOC J, V148, P969; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Slotnick HB, 1999, ACAD MED, V74, P1106, DOI 10.1097/00001888-199910000-00014	16	92	94	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 24	2004	328	7446					999	1001		10.1136/bmj.328.7446.999	http://dx.doi.org/10.1136/bmj.328.7446.999			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105326	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000221130100023
J	Renehan, AG; Zwahlen, M; Minder, C; O'Dwyer, ST; Shalet, SM; Egger, M				Renehan, AG; Zwahlen, M; Minder, C; O'Dwyer, ST; Shalet, SM; Egger, M			Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis	LANCET			English	Article							PROSTATE-SPECIFIC ANTIGEN; FACTOR-I; BREAST-CANCER; COLORECTAL-CANCER; LUNG-CANCER; COLON-CANCER; FACTOR BINDING-PROTEIN-3; PLASMA-LEVELS; LIFE-STYLE; SERUM	Background Insulin-like growth factor (IGF)-1 and its main binding protein, IGFBP-3, modulate cell growth and survival, and are thought to be important in tumour development. Circulating concentrations of IGF-1 might be associated with an increased risk of cancer, whereas IGFBP-3 concentrations could be associated with a decreased cancer risk. Methods We did a systematic review and meta-regression analysis of case-control studies, including studies nested in cohorts, of the association between concentrations of IGF-1 and IGFBP-3 and prostate, colorectal, premenopausal and postmenopausal breast, and lung cancer. Study-specific dose-response slopes were obtained by relating the natural log of odds ratios for different exposure levels to blood concentrations normalised to a percentile scale. Findings We identified 21 eligible studies (26 datasets), which included 3609 cases and 7137 controls. High concentrations of IGF-1 were associated with an increased risk of prostate cancer (odds ratio comparing 75th with 25th percentile 1.49, 95% Cl 1.14-1.95) and premenopausal breast cancer (1.65, 1.26-2.08) and high concentrations of IGFBP-3 were associated with increased risk of premenopausal breast cancer (1.51, 1.01-2.27). Associations were larger in assessments of plasma samples than in serum samples, and in standard case-control studies compared with nested studies. Interpretation Circulating concentrations of IGF-1 and IGFBP-3 are associated with an increased risk of common cancers, but associations are modest and vary between sites. Although laboratory methods need to be standardised, these epidemiological observations could have major implications for assessment of risk and prevention of cancer.	Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England; Christie Hosp NHS Trust, Dept Endocrinol, Manchester M20 4BX, Lancs, England; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital; University of Bern; University of Bristol	Renehan, AG (corresponding author), Christie Hosp NHS Trust, Dept Surg, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	arenehan@picr.man.ac.uk	; Renehan, Andrew/K-5992-2015	Egger, Matthias/0000-0001-7462-5132; Renehan, Andrew/0000-0003-4309-4396				Allen NE, 2002, CANCER EPIDEM BIOMAR, V11, P1441; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chang S, 2002, CANCER EPIDEM BIOMAR, V11, P758; Chokkalingam AP, 2001, CANCER EPIDEM BIOMAR, V10, P421; Del Giudice ME, 1998, BREAST CANCER RES TR, V47, P111, DOI 10.1023/A:1005831013718; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamandi A, 2000, J CLIN ENDOCR METAB, V85, P2327, DOI 10.1210/jc.85.6.2327; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2008, SYSTEMATIC REV HLTH, V2nd, DOI DOI 10.1002/9780470693926.CH12; Finne P, 2000, J CLIN ENDOCR METAB, V85, P2744, DOI 10.1210/jc.85.8.2744; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; FRYSTYK J, 1994, FEBS LETT, V348, P185, DOI 10.1016/0014-5793(94)00602-4; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Harman SM, 2000, J CLIN ENDOCR METAB, V85, P4258, DOI 10.1210/jc.85.11.4258; Harvie M, 2002, REC RES DEV NUTRIT, V5, P91; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V6; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Kaklamani VG, 1999, J CLIN ONCOL, V17, P813, DOI 10.1200/JCO.1999.17.3.813; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; London SJ, 2002, JNCI-J NATL CANCER I, V94, P749, DOI 10.1093/jnci/94.10.749; Lukanova A, 2001, INT J CANCER, V92, P888, DOI 10.1002/ijc.1265; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; McTiernan A, 2003, MED SCI SPORT EXER, V35, P1841, DOI 10.1249/01.MSS.0000093749.90499.63; Muti P, 2002, CANCER EPIDEM BIOMAR, V11, P1361; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Platz EA, 1999, CANCER EPIDEM BIOMAR, V8, P1107; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Pollak M, 2000, EUR J CANCER, V36, P1224, DOI 10.1016/S0959-8049(00)00102-7; Probst-Hensch NM, 2001, BRIT J CANCER, V85, P1695, DOI 10.1054/bjoc.2001.2172; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Renehan AG, 2003, GROWTH HORM IGF RES, V13, P341, DOI 10.1016/S1096-6374(03)00112-6; Renehan AG, 2001, BRIT J SURG, V88, P107, DOI 10.1046/j.1365-2168.2001.01645.x; Rosendal L, 2002, J APPL PHYSIOL, V93, P1669, DOI 10.1152/japplphysiol.00145.2002; RUAN WF, 1995, ENDOCRINOLOGY, V136, P1296, DOI 10.1210/en.136.3.1296; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961; Spitz MR, 2002, CANCER EPIDEM BIOMAR, V11, P1413; Stattin P, 2000, J NATL CANCER I, V92, P1910, DOI 10.1093/jnci/92.23.1910; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; STEWART BW, 2003, WORLD CANC REP; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Wu YP, 2002, CANCER RES, V62, P1030; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 2002, CANCER EPIDEM BIOMAR, V11, P705; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	60	1286	1361	0	113	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1346	1353		10.1016/S0140-6736(04)16044-3	http://dx.doi.org/10.1016/S0140-6736(04)16044-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110491				2022-12-28	WOS:000220996300008
J	Tramer, MR				Tramer, MR			Commentary: It's not just about rubbing - topical capsaicin and topical salicylates may be useful as adjuvants to conventional pain treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland	University of Geneva	Tramer, MR (corresponding author), Univ Hosp Geneva, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland.	martin.tramer@hcuge.ch						Mason L, 2004, BMJ-BRIT MED J, V328, P995, DOI 10.1136/bmj.38040.607141.EE; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; Moore RA, 1998, BRIT MED J, V316, P333, DOI 10.1136/bmj.316.7128.333	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					998	998		10.1136/bmj.328.7446.998	http://dx.doi.org/10.1136/bmj.328.7446.998			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105325	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000221130100022
J	Cresswell, P				Cresswell, P			Cutting and pasting antigenic peptides	SCIENCE			English	Editorial Material							CLASS-I MOLECULES; DISPLAY		Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu						Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522	6	17	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					525	527		10.1126/science.1097508	http://dx.doi.org/10.1126/science.1097508			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105483				2022-12-28	WOS:000220975100028
J	Furnes, H; Banerjee, NR; Muehlenbachs, K; Staudigel, H; de Wit, M				Furnes, H; Banerjee, NR; Muehlenbachs, K; Staudigel, H; de Wit, M			Early life recorded in archean pillow lavas	SCIENCE			English	Article							BARBERTON GREENSTONE-BELT; BIOLOGICALLY MEDIATED DISSOLUTION; SOUTH-AFRICA; BASALTIC GLASS; VOLCANIC GLASS; MOUNTAIN LAND; ONVERWACHT; HISTORY; OCEAN; CRUST	Pillow lava rims from the Mesoarchean Barberton Greenstone Belt in South Africa contain micrometer-scale mineralized tubes that provide evidence of submarine microbial activity during the early history of Earth. The tubes formed during microbial etching of glass along fractures, as seen in pillow lavas from recent oceanic crust. The margins of the tubes contain organic carbon, and many of the pillow rims exhibit isotopically light bulk-rock carbonate delta(13)C values, supporting their biogenic origin. Overlapping metamorphic and magmatic dates from the pillow lavas suggest that microbial life colonized these subaqueous volcanic rocks soon after their eruption almost 3.5 billion years ago.	Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Cape Town, Ctr Interact Graph Comp Earth Syst, ZA-7701 Rondebosch, South Africa	University of Bergen; University of Alberta; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Cape Town	Furnes, H (corresponding author), Univ Bergen, Dept Earth Sci, Allegaten 41, N-5007 Bergen, Norway.	Harald.Furnes@geo.uib.no	Banerjee, Neil/G-5358-2015	Banerjee, Neil/0000-0001-7471-766X				Banerjee NR, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000470; Dann JC, 2000, S AFR J GEOL, V103, P47, DOI 10.2113/103.1.47; DERONDE CEJ, 1994, TECTONICS, V13, P983, DOI 10.1029/94TC00353; DEWIT MJ, 1987, J AFR EARTH SCI, V6, P681, DOI 10.1016/0899-5362(87)90007-8; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Furnes H, 2003, GEOL SOC SPEC PUBL, V218, P415, DOI 10.1144/GSL.SP.2003.218.01.21; Furnes H, 1999, EARTH PLANET SC LETT, V166, P97, DOI 10.1016/S0012-821X(99)00005-9; Furnes H, 2001, GEOCHEM GEOPHY GEOSY, V2; Furnes H, 2001, CHEM GEOL, V173, P313, DOI 10.1016/S0009-2541(00)00285-0; HOFFMAN SE, 1986, NATURE, V321, P55, DOI 10.1038/321055a0; KAMO SL, 1994, TECTONICS, V13, P167, DOI 10.1029/93TC02254; KRUMBEIN WE, 1991, GEOMICROBIOL J, V9, P139, DOI 10.1080/01490459109385995; LOPEZMARTINEZ M, 1992, PRECAMBRIAN RES, V57, P91, DOI 10.1016/0301-9268(92)90095-6; Nakamura K, 2003, GEOCHIM COSMOCHIM AC, V67, pA326; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Rogers JR, 2004, CHEM GEOL, V203, P91, DOI 10.1016/j.chemgeo.2003.09.001; ROSS KA, 1986, GEOLOGY, V14, P571, DOI 10.1130/0091-7613(1986)14<571:BGOGS>2.0.CO;2; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Staudigel H, 1998, EARTH PLANET SC LETT, V164, P233, DOI 10.1016/S0012-821X(98)00207-6; Staudigel H, 1995, CHEM GEOL, V126, P147, DOI 10.1016/0009-2541(95)00115-X; THORSETH IH, 1995, CHEM GEOL, V119, P139, DOI 10.1016/0009-2541(94)00098-S; THORSETH IH, 1992, GEOCHIM COSMOCHIM AC, V56, P845, DOI 10.1016/0016-7037(92)90104-Q; Thorseth IH, 1995, CHEM GEOL, V126, P137, DOI 10.1016/0009-2541(95)00114-8; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Torsvik T, 1998, EARTH PLANET SC LETT, V162, P165, DOI 10.1016/S0012-821X(98)00164-2	25	240	261	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					578	581		10.1126/science.1095858	http://dx.doi.org/10.1126/science.1095858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105498				2022-12-28	WOS:000220975100046
J	Eagleman, DM; Jacobson, JE; Sejnowski, TJ				Eagleman, DM; Jacobson, JE; Sejnowski, TJ			Perceived luminance depends on temporal context	NATURE			English	Article							PRIMARY VISUAL-CORTEX; BRIGHTNESS; SURFACE; REPRESENTATION; CONTRAST	Brightness-the perception of an object's luminance-arises from complex and poorly understood interactions at several levels of processing(1). It is well known that the brightness of an object depends on its spatial context(2), which can include perceptual organization(3), scene interpretation(4), three-dimensional interpretation(5), shadows(6), and other high-level percepts. Here we present a new class of illusion in which temporal relations with spatially neighbouring objects can modulate a target object's brightness. When compared with a nearby patch of constant luminance, a brief flash appears brighter with increasing onset asynchrony. Simultaneous contrast, retinal effects, masking, apparent motion and attentional effects cannot account for this illusory enhancement of brightness. This temporal context effect indicates that two parallel streams-one adapting and one non-adapting-encode brightness in the visual cortex.	Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Philosophy, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Eagleman, DM (corresponding author), Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, 6431 Fannin St,Suite 7-046, Houston, TX 77030 USA.	david.eagleman@uth.tmc.edu	Sejnowski, Terrence/AAV-5558-2021		Howard Hughes Medical Institute Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; COWEY A, 1974, EXP BRAIN RES, V21, P447; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GILCHRIST AL, 1994, LIGHTNESS BRIGHTNESS; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Koffka K, 1935, PRINCIPLES GESTALT P; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sulzer, 1902, J PHYSIOL PATHOL GEN, P632; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124	16	31	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					854	856		10.1038/nature02467	http://dx.doi.org/10.1038/nature02467			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15085147	Green Accepted			2022-12-28	WOS:000220952300040
J	Lello, J; Boag, B; Fenton, A; Stevenson, IR; Hudson, PJ				Lello, J; Boag, B; Fenton, A; Stevenson, IR; Hudson, PJ			Competition and mutualism among the gut helminths of a mammalian host	NATURE			English	Article							VOLE CLETHRIONOMYS-GLAREOLUS; ANOPLOCEPHALINE CESTODES; TRICHINELLA-SPIRALIS; HAEMONCHUS-CONTORTUS; INFECTIONS; PATTERNS; COEXISTENCE; POPULATION; CONCURRENT; PARASITES	Most animal species are infected with multiple parasite species; however, the role of interspecific parasite interactions in influencing parasite dynamics and shaping parasite communities has been unclear. Although laboratory studies have found evidence of cross-immunity, immunosuppression and competition(1-6), analyses of hosts in the field have generally concluded that parasite communities are little more than random assemblages(7-14). Here we present evidence of consistent interspecific interactions in a natural mammalian system, revealed through the analysis of parasite intensity data collected from a free-ranging rabbit (Oryctolagus cuniculus) population, sampled monthly for a period of 23 yr. The wild rabbit plays host to a diverse gut helminth community(15-17) that reflects the communities seen in other economically important domestic herbivores(18,19). These findings suggest that parasite interactions could have profound implications for the dynamics of parasite communities. The efficacy of parasite control programmes could be jeopardized if such interactions are not taken into account. In contrast, a clear understanding of such interactions may provide the basis for the development of more environmentally acceptable methods of parasite control.	CSIRO, Livestock Ind, FD McMaster Labs, Armidale, NSW 2350, Australia; Univ Stirling, Dept Biol Sci, Stirling FK9 4LA, Scotland; Penn State Univ, Dept Biol, Mueller Lab 513, University Pk, PA 16802 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Stirling; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lello, J (corresponding author), CSIRO, Livestock Ind, FD McMaster Labs, Locked Bag 1,PO Armidale, Armidale, NSW 2350, Australia.	Joanne.Lello@csiro.au	Fenton, Andy/B-5972-2009; Lello, Joanne/AAG-7838-2021; Lello, Joanne/A-5261-2010; Hudson, Peter/AAB-8080-2020	Fenton, Andy/0000-0002-7676-917X; Lello, Joanne/0000-0002-2640-1027; Hudson, Peter/0000-0003-0468-3403				ADAMS DB, 1989, INT J PARASITOL, V19, P717, DOI 10.1016/0020-7519(89)90056-8; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; Behnke JM, 2001, PARASITOLOGY, V123, P401, DOI 10.1017/S0031182001008605; BEHNKE JM, 1978, EXP PARASITOL, V46, P121, DOI 10.1016/0014-4894(78)90162-5; Boag B., 1999, Aspects of Applied Biology, V53, P119; BOAG B, 1989, P HELM SOC WASH, V56, P116; Boag B, 2001, INT J PARASITOL, V31, P1421, DOI 10.1016/S0020-7519(01)00270-3; BUSH AO, 1986, CAN J ZOOL, V64, P142, DOI 10.1139/z86-023; Christensen CM, 1997, PARASITOLOGY, V114, P273, DOI 10.1017/S003118209600844X; CHRISTENSEN NO, 1987, PARASITOL RES, V73, P387, DOI 10.1007/BF00538196; Cornell SJ, 2003, P NATL ACAD SCI USA, V100, P7401, DOI 10.1073/pnas.0832206100; COWAN DP, 1983, THESIS U LONDON; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; CROFTON HD, 1954, PARASITOLOGY, V44, P313, DOI 10.1017/S0031182000018953; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; DOBSON A, 1994, PARASITOLOGY, V109, pS97, DOI 10.1017/S0031182000085115; DOBSON RJ, 1995, INT J PARASITOL, V25, P495, DOI 10.1016/0020-7519(94)00157-J; FORBES M, 1994, OECOLOGIA, V97, P520, DOI 10.1007/BF00325891; Forbes MR, 1999, OECOLOGIA, V120, P613, DOI 10.1007/s004420050897; FORD GE, 1971, IMMUNOLOGY, V21, P1073; HAUKISALMI V, 1993, J ANIM ECOL, V62, P221, DOI 10.2307/5353; HAUKISALMI V, 1993, J ANIM ECOL, V62, P230, DOI 10.2307/5354; MEADBRIGGS AR, 1973, PARASITOLOGY, V67, P351, DOI 10.1017/S0031182000046576; MEADBRIGGS AR, 1975, J HELMINTHOL, V49, P49; MICHEL JF, 1953, NATURE, V172, P312, DOI 10.1038/172312a0; Nilssen AC, 1998, PARASITOLOGY, V117, P273, DOI 10.1017/S0031182098003060; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Poulin R, 1996, OECOLOGIA, V105, P545, DOI 10.1007/BF00330018; Poulin R, 2001, PARASITOLOGY, V122, pS3, DOI 10.1017/S0031182000016991; SILVER BB, 1980, J PARASITOL, V66, P786, DOI 10.2307/3280669	30	234	240	1	112	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					840	844		10.1038/nature02490	http://dx.doi.org/10.1038/nature02490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103373	Bronze			2022-12-28	WOS:000220952300036
J	Berns, A				Berns, A			Good news for gene therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.							Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207	5	27	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1679	1680		10.1056/NEJMcibr040341	http://dx.doi.org/10.1056/NEJMcibr040341			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084702				2022-12-28	WOS:000220819800015
J	Andrews, LB; Buenger, N; Bridge, J; Rosenow, L; Stoney, D; Gaensslen, RE; Karamanski, T; Lewis, R; Paradise, J; Inlander, A; Gonen, D				Andrews, LB; Buenger, N; Bridge, J; Rosenow, L; Stoney, D; Gaensslen, RE; Karamanski, T; Lewis, R; Paradise, J; Inlander, A; Gonen, D			Constructing ethical guidelines for biohistory	SCIENCE			English	Editorial Material							EINSTEIN,ALBERT		IIT, Inst Sci Law & Technol, Chicago, IL 60661 USA; Chicago Hist Soc, Chicago, IL 60614 USA; Chicago Kent Coll Law, Chicago, IL 60661 USA; Loyola Univ, Chicago, IL 60626 USA; McCrone Inst, Chicago, IL 60616 USA; Univ Illinois, Coll Pharm, Chicago, IL 60680 USA	Illinois Institute of Technology; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Andrews, LB (corresponding author), IIT, Inst Sci Law & Technol, Chicago, IL 60661 USA.	landrews@kent-law.edu	Lewis, Russell E/A-4616-2015	Lewis, Russell E/0000-0002-2002-4339; Stoney, David/0000-0002-3916-696X				Anderson B, 1996, NEUROSCI LETT, V210, P161, DOI 10.1016/0304-3940(96)12693-8; Andrews L.B., 2001, BODY BAZAAR MARKET H; BOYD C, 1994, PRIVATE LIVES A EINS; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; MARTIN R, 2000, BEETHOVENS HAIR, P232; McCartney Scott, 1994, WALL STREET J   1128, pA1; MICOZZI M, 1991, CADUCEUS MUSEUM J HL, V38, P7; Stone R, 2004, SCIENCE, V303, P753, DOI 10.1126/science.303.5659.753; Witelson SF, 1999, LANCET, V353, P2149, DOI 10.1016/S0140-6736(98)10327-6	9	13	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					215	216		10.1126/science.1094372	http://dx.doi.org/10.1126/science.1094372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073360				2022-12-28	WOS:000220719400026
J	Sil, AK; Maeda, S; Sano, Y; Roop, DR; Karin, M				Sil, AK; Maeda, S; Sano, Y; Roop, DR; Karin, M			IkB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis	NATURE			English	Article							NF-KAPPA-B; VERTEBRATE LIMB; MICE LACKING; PHOSPHORYLATION; EXPRESSION; ACTIVATION; GENE; REQUIREMENT; ANTAGONISM; RECEPTOR	IkappaB kinase-alpha (IKK-alpha)(1) exhibits protein-kinase-dependent and -independent functions. Its kinase activity is required for lymphoid organogenesis(2) and mammary gland development(3), whereas a kinase-independent activity is required for epidermal keratinocyte differentiation(4). In addition to failed epidermal differentiation, IKK-alpha-deficient mice exhibit abnormal skeletal and craniofacial morphogenesis(4-6). As similar defects are not exhibited by mice that experience systemic inhibition of NF-kappaB(7), we postulated that the morphogenetic defects in IKK-alpha-deficient mice are not caused by reduced NF-kappaB activity but instead are due to failed epidermal differentiation that disrupts proper epidermal-mesodermal interactions. We tested this hypothesis by introducing an epidermal-specific Ikka (also known as Chuk) transgene into IKK-alpha-deficient mice. Mice lacking IKK-alpha in all cell types including bone and cartilage, but not in basal epidermal keratinocytes, exhibit normal epidermal differentiation and skeletal morphology. Thus, epidermal differentiation is required for proper morphogenesis of mesodermally derived skeletal elements. One way by which IKK-alpha controls skeletal and craniofacial morphogenesis is by repressing expression of fibroblast growth factor (FGF) family members, such as FGF8, whose expression is specifically elevated in the limb bud ectoderm of IKK-alpha-deficient mice.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu						Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dudley AT, 2000, CURR OPIN GENET DEV, V10, P387, DOI 10.1016/S0959-437X(00)00101-5; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; TAKAHASHI H, 1995, HISTOPATHOLOGY, V26, P45, DOI 10.1111/j.1365-2559.1995.tb00619.x; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TORREY TW, 1970, MORPHOGENESIS VERTEB, P275; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; WESSELLS NK, 1997, TISSUE INTERACTIONS; WILKINSON DG, 1993, IN SITU HYBRIDIZATIO; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yi SE, 2000, DEVELOPMENT, V127, P621; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	173	182	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					660	664		10.1038/nature02421	http://dx.doi.org/10.1038/nature02421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071597				2022-12-28	WOS:000220697200046
J	Kietselaer, BLJH; Reutelingsperger, CPM; Heidendal, GAK; Daemen, MJAP; Mess, WH; Hofstra, L; Narula, J				Kietselaer, BLJH; Reutelingsperger, CPM; Heidendal, GAK; Daemen, MJAP; Mess, WH; Hofstra, L; Narula, J			Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							APOPTOTIC MACROPHAGES; DEATH		Univ Hosp Maastricht, NL-6202 AZ Maastricht, Netherlands; Univ Calif Irvine, Med Ctr, Orange, CA 92868 USA	Maastricht University; Maastricht University Medical Centre (MUMC); University of California System; University of California Irvine	Kietselaer, BLJH (corresponding author), Univ Hosp Maastricht, NL-6202 AZ Maastricht, Netherlands.	l.hofstra@cardio.azm.nl	Mess, Werner/AAB-9527-2020	Daemen, Mat/0000-0003-1076-199X; Kietselaer, Bas/0000-0002-0096-8594				Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; Kolodgie FD, 2000, AM J PATHOL, V157, P1259, DOI 10.1016/S0002-9440(10)64641-X; Kolodgie FD, 2003, CIRCULATION, V108, P3134, DOI 10.1161/01.CIR.0000105761.00573.50; Narula J, 2001, NAT MED, V7, P1347, DOI 10.1038/nm1201-1347	5	226	242	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1472	1473		10.1056/NEJM200404013501425	http://dx.doi.org/10.1056/NEJM200404013501425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070807				2022-12-28	WOS:000220562500036
J	Levitsky, LL				Levitsky, LL			Childhood immunizations and chronic illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THIMEROSAL; AUTISM		Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Levitsky, LL (corresponding author), Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA.							Atkinson MA, 2001, LANCET, V358, P766; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Madsen KM, 2003, PEDIATRICS, V112, P604, DOI 10.1542/peds.112.3.604; Nelson KB, 2003, PEDIATRICS, V111, P674, DOI 10.1542/peds.111.3.674; Offit PA, 2003, PEDIATRICS, V111, P653, DOI 10.1542/peds.111.3.653; PICKERING LK, 2003, RED BOOK 2003 REPORT	6	7	10	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1380	1382		10.1056/NEJMp048034	http://dx.doi.org/10.1056/NEJMp048034			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070785				2022-12-28	WOS:000220562500002
J	Rudolf, PM; Bernstein, IBG				Rudolf, PM; Bernstein, IBG			Counterfeit drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Rudolf, PM (corresponding author), US FDA, Rockville, MD 20857 USA.							*FOOD DRUG ADM, 2004, COMB COUNT DRUGS REP	1	47	47	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1384	1386		10.1056/NEJMp038231	http://dx.doi.org/10.1056/NEJMp038231			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070787				2022-12-28	WOS:000220562500004
J	Steinbrook, R				Steinbrook, R			Science, politics, and federal advisory committees	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GOVERNMENT; ADVICE; PANEL											Anderson FR, 2003, ISSUES SCI TECHNOL, V19, P34; Begley S, 2002, WALL STR J, pB1; Blackburn E, 2004, NEW ENGL J MED, V350, P1379, DOI 10.1056/NEJMp048072; CAPLAN A, 2004, COMMUNICATION   0303; *COMM ORG STRUCT N, 2003, ENH VIT NIH ORG CH; Drazen JM, 2003, NEW ENGL J MED, V349, P2259, DOI 10.1056/NEJMe038192; Federman D.D., 2003, RESPONSIBLE RES; Ferber D, 2002, SCIENCE, V297, P1456; Ferber D, 2002, SCIENCE, V298, P1323, DOI 10.1126/science.298.5597.1323; Ferber D, 2002, SCIENCE, V298, P732, DOI 10.1126/science.298.5594.732; *GEN ACC OFF, 2001, GAO01536; HILTS PJ, 1989, NY TIMES        0819, pA1; HILTS PJ, 1989, NY TIMES        0901, pA19; Jasanoff Sheila., 2003, SCI PUBL POLICY, V30, P157, DOI [10.3152/147154303781780542, DOI 10.3152/147154303781780542]; Jasanoff Sheila, 1990, 5 BRANCH SCI ADVISER; Kass Leon, 2004, Washington Post, pA27; Kennedy D, 2003, SCIENCE, V302, P17, DOI 10.1126/science.302.5642.17; Kennedy D, 2003, SCIENCE, V299, P625, DOI 10.1126/science.299.5607.625; LEARY WE, 1995, NY TIMES        0924, pA26; Loomis D, 2002, SCIENCE, V298, P1335, DOI 10.1126/science.298.5597.1335; MARSHALL E, 1983, SCIENCE, V219, P1303, DOI 10.1126/science.219.4590.1303; Michaels D, 2002, SCIENCE, V298, P703, DOI 10.1126/science.298.5594.703; MILBANK D, 2004, WASH POST       0902, pA1; *OFF FED ADV COMM, OV FED AD COMM NIH; Steinbrook R, 2004, NEW ENGL J MED, V350, P103, DOI 10.1056/NEJMp038230; TUMULTY K, 2002, TIME            1014, P21; *US HOUS REPR, 2003, POL SCI BUSH ADM; WEISS R, 2004, WASH POST       0228, pA6; Weiss Rick, 2002, Washington Post, pA10; Weiss Rick, 2004, WASH POST, pA19; ZITNR A, 2003, LOS ANGELES TIM 1223, pA1	31	35	35	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1454	1460		10.1056/NEJMhpr033416	http://dx.doi.org/10.1056/NEJMhpr033416			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808IJ	15070798				2022-12-28	WOS:000220562500015
J	Tu, JV; Willison, DJ; Silver, FL; Fang, J; Richards, JA; Laupacis, A; Kapral, MK				Tu, JV; Willison, DJ; Silver, FL; Fang, J; Richards, JA; Laupacis, A; Kapral, MK		Investigators Registry Canadian St	Impracticability of informed consent in the Registry of the Canadian Stroke Network	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; MEDICAL-RECORDS; HEALTH; PRIVACY; THREAT	BACKGROUND: Government legislators and research ethics boards in some jurisdictions require all patients to give written informed consent before enrollment in clinical registries. However, the effect of such a requirement on the use of clinical registries and the extent to which registry data can be generalized remain uncertain. METHODS: We examined the effectiveness of a comprehensive attempt to obtain informed consent between June 2001 and December 2002 on the overall participation rate and the characteristics of participating patients in the Registry of the Canadian Stroke Network, a prospective registry based at 20 major stroke centers across Canada. RESULTS: The overall participation rate (i.e., the consent rate among all potential participants) was 39.3 percent of 4285 eligible patients during phase 1 of the project (June 2001 through February 2002) and 50.6 percent of 2823 eligible patients during phase 2 (June 2002 through December 2002), despite the presence of neurologic research nurse coordinators at each site. Many patients died or left the hospital before they could be approached for consent. Major selection biases were found; the in-hospital mortality rate was much lower among patients who were enrolled (6.9 percent) than among those who were not enrolled (21.7 percent) (relative risk of in-hospital death, 3.13; 95 percent confidence interval, 2.65 to 3.70; P<0.001). We estimate that approximately $500,000 (Canadian dollars) was spent on consent-related issues during the first two years of the registry. CONCLUSIONS: Obtaining written informed consent for participation in a stroke registry led to important selection biases, such that registry patients were not representative of the typical patient with stroke at each center. These findings highlight the need for legislation on privacy and policies permitting waivers of informed consent for minimal-risk observational research.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Hlth Network, Div Neurol, Toronto, ON, Canada; Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Tu, JV (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	tu@ices.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Tu, Jack/0000-0003-0111-722X				Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Brown P, 2000, BRIT MED J, V321, P849, DOI 10.1136/bmj.321.7265.849; *CAN I HLTH RES, 2001, REC INT APPL PERS IN; Hill MD, 2001, CAN J NEUROL SCI, V28, P232, DOI 10.1017/S0317167100001384; HILL MD, 2002, CAN J NEUROL SCI, V29, P103; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Kulynych J, 2002, NEW ENGL J MED, V346, P201, DOI 10.1056/NEJM200201173460312; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCarthy DB, 1999, HEALTH SERV RES, V34, P417; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Tu JV, 2003, ARCH INTERN MED, V163, P293, DOI 10.1001/archinte.163.3.293; Upshur REG, 2001, CAN MED ASSOC J, V165, P888; Vandenbroucke JP, 1998, BRIT MED J, V316, P1331, DOI 10.1136/bmj.316.7141.1331; Verity C, 2002, BRIT MED J, V324, P1210, DOI 10.1136/bmj.324.7347.1210; Woolf SH, 2000, ARCH FAM MED, V9, P1111, DOI 10.1001/archfami.9.10.1111	19	305	307	0	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1414	1421		10.1056/NEJMsa031697	http://dx.doi.org/10.1056/NEJMsa031697			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070791	Bronze			2022-12-28	WOS:000220562500008
J	Benenson, Y; Gil, B; Ben-Dor, U; Adar, R; Shapiro, E				Benenson, Y; Gil, B; Ben-Dor, U; Adar, R; Shapiro, E			An autonomous molecular computer for logical control of gene expression	NATURE			English	Article							CELL LUNG-CANCER; DNA SOLUTION; COMPUTATION; ANTISENSE; MACHINE; APOPTOSIS; DESIGN	Early biomolecular computer research focused on laboratory-scale, human-operated computers for complex computational problems(1-7). Recently, simple molecular-scale autonomous programmable computers were demonstrated(8-15) allowing both input and output information to be in molecular form. Such computers, using biological molecules as input data and biologically active molecules as outputs, could produce a system for 'logical' control of biological processes. Here we describe an autonomous biomolecular computer that, at least in vitro, logically analyses the levels of messenger RNA species, and in response produces a molecule capable of affecting levels of gene expression. The computer operates at a concentration of close to a trillion computers per microlitre and consists of three programmable modules: a computation module, that is, a stochastic molecular automaton(12-17); an input module, by which specific mRNA levels or point mutations regulate software molecule concentrations, and hence automaton transition probabilities; and an output module, capable of controlled release of a short single-stranded DNA molecule. This approach might be applied in vivo to biochemical sensing, genetic engineering and even medical diagnosis and treatment. As a proof of principle we programmed the computer to identify and analyse mRNA of disease-related genes(18-22) associated with models of small-cell lung cancer and prostate cancer, and to produce a single-stranded DNA molecule modelled after an anticancer drug.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shapiro, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il	Benenson, Yaakov/B-1433-2009		European Research Council [233047] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		ADAR R, UNPUB P NATL ACAD SC; ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Balzani V, 2003, CHEMPHYSCHEM, V4, P49, DOI 10.1002/cphc.200390007; Bar-Ziv R, 2002, P NATL ACAD SCI USA, V99, P11589, DOI 10.1073/pnas.162369099; Benenson Y, 2003, P NATL ACAD SCI USA, V100, P2191, DOI 10.1073/pnas.0535624100; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; BENENSON Y, 2004, DEKKER ENCY NANOSCIE, P2043; Capoulade C, 2001, BLOOD, V97, P1043, DOI 10.1182/blood.V97.4.1043; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Holmlund JT, 2003, ANN NY ACAD SCI, V1002, P244, DOI 10.1196/annals.1281.027; Holzer S, 2000, J AM MED INFORM ASSN, P364; Khodor J, 1999, BIOSYSTEMS, V52, P93, DOI 10.1016/S0303-2647(99)00036-2; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Pedersen N, 2003, CANCER RES, V63, P1943; RABIN MO, 1963, INFORM CONTROL, V6, P230, DOI 10.1016/S0019-9958(63)90290-0; Ruben AJ, 2000, NAT REV MOL CELL BIO, V1, P69, DOI 10.1038/35036086; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; TAKAHASHI T, 1991, ONCOGENE, V6, P1775; Thorns C, 2002, PATHOL INT, V52, P578, DOI 10.1046/j.1320-5463.2002.01400.x; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	580	638	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2004	429	6990					423	429		10.1038/nature02551	http://dx.doi.org/10.1038/nature02551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823WN	15116117	Green Accepted			2022-12-28	WOS:000221644600041
J	Riordan, DC				Riordan, DC			Interaction strategies of lesbian, gay, and bisexual healthcare practitioners in the clinical examination of patients: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-STUDENTS; DOCTORS; NEED; SEX; PHYSICIANS; CHAPERONES; WOMEN	Objective To explore how lesbian, gay, and bisexual healthcare practitioners manage their identity in the clinical examination of patients. Design Qualitative study using grounded theory. Setting Hospital and primary health care. Participants 16 healthcare professionals who identified themselves as lesbian, gay, or bisexual, and who are involved in the clinical examination of patients. Results Healthcare professionals engage in a complex interplay of identity management strategies to avoid homophobic abuse; as a signal of safety from homophobia and understanding for their lesbian, gay, and bisexual patients and as a desexualisation strategy principally for gay men and their women patients. Their training has not helped them deal with ethical and medicolegal anxieties. Conclusion In the light of new legislation, published guidelines will help training and governing bodies understand and help ameliorate the added pressures on their lesbian, gay, and bisexual students and medical staff.	St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	St Georges University London	Riordan, DC (corresponding author), St George Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England.	driordan@sghms.ac.uk						Acker J, 1990, GENDER SOC, V4, P139, DOI 10.1177/089124390004002002; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bignell CJ, 1999, BMJ-BRIT MED J, V319, P137, DOI 10.1136/bmj.319.7203.137; *BRIT MED ASS, 1997, TRUST DOCT PAT REL G; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Brogan DJ, 1999, JAMA-J AM MED ASSOC, V282, P1290, DOI 10.1001/jama.282.13.1290; Burke BP, 2001, BRIT MED J, V322, P422, DOI 10.1136/bmj.322.7283.422; CHALLACOMBE CB, 1983, PRACTITIONER, V227, P848; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; DOYAL L, 2003, BRIT MED J, V327, P939; *GAY LESB ASS DOCT, 2002, IMPR WORK LIV; *GEN MED COUNC, 2001, INT EX; Giuffre PA, 2000, GENDER SOC, V14, P457, DOI 10.1177/089124300014003006; Goffman E., 1990, STIGMA NOTES MANAGEM; HAERN J, 1990, SEXUALITY ORG; Hughes C, 2003, BMJ-BRIT MED J, V327, P939, DOI 10.1136/bmj.327.7421.939; Jackson S., 2003, SEXUALITIES SOC READ, P69; KNOWLES R, 1999, BRIT MED J, V319, P137; Lewis RJ, 2001, J HOMOSEXUAL, V42, P63, DOI 10.1300/J082v42n01_04; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Moynihan C, 1998, BRIT MED J, V317, P1072; O'Flynn N, 2002, BRIT MED J, V325, P683, DOI 10.1136/bmj.325.7366.683; Plummer K., 1975, SEXUAL STIGMA INTERA; Risdon C, 2000, CAN MED ASSOC J, V162, P331; Selby M, 1999, BRIT MED J, V318, P1129; Strauss A., 1990, BASICS QUALITATIVE R; Torrance CJ, 1999, BRIT MED J, V319, P159, DOI 10.1136/bmj.319.7203.159	28	15	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2004	328	7450					1227	1229		10.1136/bmj.38071.774525.EB	http://dx.doi.org/10.1136/bmj.38071.774525.EB			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	824HL	15113753	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000221677200017
J	Davenport, M; de Goyet, JD; Stringer, MD; Mieli-Yergani, G; Kelly, DA; McClean, P; Spitz, L				Davenport, M; de Goyet, JD; Stringer, MD; Mieli-Yergani, G; Kelly, DA; McClean, P; Spitz, L			Seamless management of biliary atresia in England and Wales (1999-2002)	LANCET			English	Article							SPLENIC MALFORMATION SYNDROME; KASAI PORTOENTEROSTOMY; CHILDREN; REGISTRY	Background Before 1999, infants born in the UK with suspected biliary atresia were investigated in regional centres, and, if confirmed, a Kasai operation was done there. Since 1999, all infants with suspected biliary atresia in England and Wales, UK, have been referred to one of three designated centres where both the Kasai operation and liver transplantation (if necessary) could be done. Methods We assessed clearance of jaundice (bilirubin <20 mu mol/L) as an early outcome in all cases of biliary atresia referred from one of the three centres. We then estimated survival using the Kaplan-Meier method with endpoints of liver transplantation or death. Findings 148 infants with biliary atresia were treated between January, 1999, and June, 2002. A primary portoenterostomy was done in 142 (96%) infants and a primary liver transplant in five (3%). One child died before any intervention. Early clearance of jaundice after portoenterostomy was achieved in 81 of 142 (57%) infants. Liver transplantation was done in 52 (37%) of those undergoing portoenterostomy. 13 (9%) infants died. Of the 135 children who survived, 84 (62%) still have their native liver and 51 (38%) had transplantation. The median follow-up of survivors was 2.13 (range 0.5-4.1) years. The overall 4-year estimated actuarial survival was 89% (95% Cl 82-94). The 4-year estimated actuarial survival with native liver was 51% (42-59%). Interpretation Our early results suggest that surgical outcome can be improved by centralisation of care to supraregional centres.	Kings Coll Hosp London, Dept Paediat Surg, London SE5 9RS, England; Birmingham Childrens Hosp, Birmingham, W Midlands, England; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; Inst Child Hlth, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of Birmingham; Saint James's University Hospital; University of London; University College London	Davenport, M (corresponding author), Kings Coll Hosp London, Dept Paediat Surg, Denmark Hill, London SE5 9RS, England.	Mark.Davenport@kingsch.nhs.uk	Goyet, Jean de Ville de/A-1708-2014; Goyet, Jean de Ville de/I-6913-2019; Davenport, Mark/AAZ-5775-2020; Mieli-Vergani, Giorgina/G-5616-2011	Goyet, Jean de Ville de/0000-0001-7681-6178; Goyet, Jean de Ville de/0000-0001-7681-6178; Mieli-Vergani, Giorgina/0000-0002-8215-4489				BARBE T, 1995, J PEDIATR-US, V126, P571, DOI 10.1016/S0022-3476(95)70351-9; Chardot C, 2001, J PEDIATR-US, V138, P224, DOI 10.1067/mpd.2001.111276; Chardot C, 1999, HEPATOLOGY, V30, P606, DOI 10.1002/hep.510300330; DAVENPORT M, 1993, SURGERY, V113, P662; Davenport M, 1997, J PEDIATR SURG, V32, P479, DOI 10.1016/S0022-3468(97)90611-4; DAVENPORT M, IN PRESS J PEDIAT SU; Davison S, 1999, BRIT MED J, V318, P1013, DOI 10.1136/bmj.318.7189.1013; DICK MC, 1985, ARCH DIS CHILD, V60, P512, DOI 10.1136/adc.60.6.512; Ibrahim M, 1997, TOHOKU J EXP MED, V181, P85, DOI 10.1620/tjem.181.85; KARRER FM, 1990, J PEDIATR SURG, V25, P1076, DOI 10.1016/0022-3468(90)90222-U; Lloyd D, 2000, LANCET, V355, P1099, DOI 10.1016/S0140-6736(05)72221-2; MCCLEMENT JW, 1985, BRIT MED J, V290, P345, DOI 10.1136/bmj.290.6465.345; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; OTTE JB, 1994, HEPATOLOGY, V20, P41; Sasaki T, 2000, J PEDIATR SURG, V35, P1647, DOI 10.1053/jpsu.2000.18343; Schoen BT, 2001, J PEDIATR SURG, V36, P97, DOI 10.1053/jpsu.2001.20020; Taylor RM, 2003, EUR J PEDIATR, V162, P539, DOI 10.1007/s00431-003-1238-3	17	176	192	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1354	1357		10.1016/S0140-6736(04)16045-5	http://dx.doi.org/10.1016/S0140-6736(04)16045-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110492				2022-12-28	WOS:000220996300009
J	Karim, QA				Karim, QA			HIV treatment in South Africa: overcoming impediments to get started	LANCET			English	Editorial Material									Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, QA (corresponding author), Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa.	abdoolq2@nu.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X				*DEP HLTH RSA, 2002, 12 NAT HIV SURV WOM; KARIM SSA, 2001, AIDS CLIN CARE, V70, P63; Kasper Toby, 2003, ESSENT DRUGS MONIT, V32, P20	3	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1394	1394		10.1016/S0140-6736(04)16055-8	http://dx.doi.org/10.1016/S0140-6736(04)16055-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15112695	Green Submitted			2022-12-28	WOS:000220996300028
J	Karim, SSA				Karim, SSA			Medical education after the first decade of democracy in South Africa	LANCET			English	Editorial Material									Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ Kwazulu Natal, CAPRISA, Nelson R Mandela Sch Med, ZA-4013 Durban, South Africa.		Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019; Karim, Salim Abdool/AAE-7118-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; 				de Villiers PJT, 1999, MED EDUC, V33, P716, DOI 10.1046/j.1365-2923.1999.00545.x; NAIDU E, 2004, SUNDAY TRIBUNE  0321, P1; *PARL MON GROUP HL, 2001, ADM MED STUD STAT SU; Reid SJ, 2001, S AFR MED J, V91, P329; Weiner R, 1998, S AFR J SCI, V94, P59	5	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1395	1395		10.1016/S0140-6736(04)16056-X	http://dx.doi.org/10.1016/S0140-6736(04)16056-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15112696	Green Submitted			2022-12-28	WOS:000220996300029
J	Pechacek, TF; Babb, S				Pechacek, TF; Babb, S			Commentary: How acute and reversible are the cardiovascular risks of secondhand smoke?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ENVIRONMENTAL TOBACCO-SMOKE; CORONARY-HEART-DISEASE; PASSIVE SMOKING; FREE WORKPLACES; EXPOSURE; METAANALYSIS; BEHAVIOR		Ctr Dis Control & Prevent, Off Smoking & Hlth K50, Secondhand Smoke Work Grp, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Pechacek, TF (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth K50, Secondhand Smoke Work Grp, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	TPechacek@cdc.gov						*AM COUNC SCI HLTH, 1999, ENV TOB SMOK HLTH RI; [Anonymous], PUBL HLTH ACT PLAN P; Bailar JC, 1999, NEW ENGL J MED, V340, P958, DOI 10.1056/NEJM199903253401211; Barnoya J, 2004, AM J MED, V116, P201, DOI 10.1016/j.amjmed.2003.11.005; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Brownson RC, 2002, ANNU REV PUBL HEALTH, V23, P333, DOI 10.1146/annurev.publhealth.23.100901.140551; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; California Department of Health Services, 2002, CAL TOB CONTR UPD; *CDC, 2002, MMWR-MORBID MORTAL W, V51, P300; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; Enstrom JE, 2003, BMJ-BRIT MED J, V326, P1057, DOI 10.1136/bmj.326.7398.1057; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; Howard G, 1999, ENVIRON HEALTH PERSP, V107, P837, DOI 10.2307/3434562; Howard G, 1999, ENVIRON HEALTH PERSP, V107, P853, DOI 10.2307/3434565; *INT AG RES CANC, IN PRESS MON EV CARC, V83; LABARTHE DR, 1998, EPIDEMIOLOGY PREVENT; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; Repace J., 2003, AIR QUALITY SURVEY R; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; SARGENT RP, 2003, 52 ANN SCI SESS AM C; TRAVERS MJ, 2004, SOC RES NIC TOB ANN; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; *US DEP HHS, 2003, 2 CDCP US DEP HHS NA; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R	34	73	74	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 24	2004	328	7446					980	983		10.1136/bmj.328.7446.980	http://dx.doi.org/10.1136/bmj.328.7446.980			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105323	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000221130100012
J	Bilezikian, JP; Silverberg, SJ				Bilezikian, JP; Silverberg, SJ			Clinical practice - Asymptomatic primary hyperparathyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; IMMUNORADIOMETRIC ASSAY; LONGITUDINAL CHANGES; SERUM-CALCIUM; FOLLOW-UP; SURGERY; OSTEOPOROSIS; DISEASE		Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University	Bilezikian, JP (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032333] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK032333] Funding Source: Medline; PHS HHS [32333] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albright F., 1948, PARATHYROID GLANDS M; Alexander HR, 2002, J BONE MINER RES, V17, pN133; Allendorf J, 2003, J CLIN ENDOCR METAB, V88, P3015, DOI 10.1210/jc.2002-021095; Bilezikian J. P., 1996, KIDNEY STONES MED SU, P783; Bilezikian JP, 2002, J BONE MINER RES, V17, pN2; CHAN AK, 1995, ANN SURG, V222, P402, DOI 10.1097/00000658-199509000-00017; Chow CC, 2003, J CLIN ENDOCR METAB, V88, P581, DOI 10.1210/jc.2002-020890; Clark OH, 2003, J CLIN ENDOCR METAB, V88, P3011, DOI 10.1210/jc.2003-030588; COPE O, 1966, NEW ENGL J MED, V274, P1174, DOI 10.1056/NEJM196605262742105; El-Hajj Fuleihan G, 1999, J CLIN DENSITOM, V2, P153, DOI 10.1385/JCD:2:2:153; FULEIHAN GE, 2001, PRINCIPLES BONE BIOL, P1031; Gao P, 2001, J BONE MINER RES, V16, P605, DOI 10.1359/jbmr.2001.16.4.605; Genc H, 2003, J AM COLL SURGEONS, V196, P535, DOI 10.1016/S1072-7515(03)00108-X; Grey AB, 1996, ANN INTERN MED, V125, P360, DOI 10.7326/0003-4819-125-5-199609010-00002; Guo CY, 1996, J CLIN ENDOCR METAB, V81, P3487, DOI 10.1210/jc.81.10.3487; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; Hedback G, 1998, EUR J CLIN INVEST, V28, P271; Juppner H, 2002, J BONE MINER RES, V17, pN81; Khosla S, 1999, J BONE MINER RES, V14, P1700, DOI 10.1359/jbmr.1999.14.10.1700; Lee NC, 2002, ARCH SURG-CHICAGO, V137, P896, DOI 10.1001/archsurg.137.8.896; Marcus R, 2002, J BONE MINER RES, V17, pN146; Mithal A., 2001, PARATHYROIDS, P375; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nilsson IL, 2002, J BONE MINER RES, V17, pN68; PALMER M, 1987, SURGERY, V102, P1; Parker CR, 2002, J CLIN ENDOCR METAB, V87, P4482, DOI 10.1210/jc.2001-010385; Peacock M, 2003, J BONE MINER RES, V18, pS17; Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x; POTTS JT, 1991, J BONE MINER RES S2, V6; ROUSSOW JE, 2002, JAMA-J AM MED ASSOC, V228, P321; Rubin MR, 2003, J CLIN ENDOCR METAB, V88, P1174, DOI 10.1210/jc.2002-020667; Shoback DM, 2003, J CLIN ENDOCR METAB, V88, P5644, DOI 10.1210/jc.2002-021597; Silverberg SJ, 2003, J CLIN ENDOCR METAB, V88, P5348, DOI 10.1210/jc.2003-031014; Silverberg SJ, 2003, J CLIN ENDOCR METAB, V88, P4725, DOI 10.1210/jc.2002-021266; Silverberg SJ, 2002, AM J MED, V113, P681, DOI 10.1016/S0002-9343(02)01306-2; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P4007, DOI 10.1210/jc.81.11.4007; Silverberg SJ, 2002, J BONE MINER RES, V17, pN117; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Silverberg SJ, 1999, AM J MED, V107, P561, DOI 10.1016/S0002-9343(99)00294-6; SOLOMON BL, 1994, AM J MED, V96, P101, DOI 10.1016/0002-9343(94)90128-7; Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106; TURKEN SA, 1989, AM J MED, V87, P553; Udelsman R, 2000, ANN SURG, V232, P331, DOI 10.1097/00000658-200009000-00005; Wermers RA, 1998, AM J MED, V104, P115, DOI 10.1016/S0002-9343(97)00270-2; Zanchetta JR, 2003, J BONE MINER RES, V18, P539, DOI 10.1359/jbmr.2003.18.3.539	46	197	219	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1746	1751		10.1056/NEJMcp032200	http://dx.doi.org/10.1056/NEJMcp032200			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15103001				2022-12-28	WOS:000220947300009
J	Koch, GW; Sillett, SC; Jennings, GM; Davis, SD				Koch, GW; Sillett, SC; Jennings, GM; Davis, SD			The limits to tree height	NATURE			English	Article							SHADE TOLERANCE; CONDUCTANCE; CALIFORNIA; PHYSIOLOGY; DROUGHT; XYLEM; CO2	Trees grow tall where resources are abundant, stresses are minor, and competition for light places a premium on height growth(1,2). The height to which trees can grow and the biophysical determinants of maximum height are poorly understood. Some models predict heights of up to 120 m in the absence of mechanical damage(3,4), but there are historical accounts of taller trees(5). Current hypotheses of height limitation focus on increasing water transport constraints in taller trees and the resulting reductions in leaf photosynthesis(6). We studied redwoods (Sequoia sempervirens), including the tallest known tree on Earth (112.7 m), in wet temperate forests of northern California. Our regression analyses of height gradients in leaf functional characteristics estimate a maximum tree height of 122-130 m barring mechanical damage, similar to the tallest recorded trees of the past. As trees grow taller, increasing leaf water stress due to gravity and path length resistance may ultimately limit leaf expansion and photosynthesis for further height growth, even with ample soil moisture.	No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Env Res, Flagstaff, AZ 86011 USA; Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; Pepperdine Univ, Div Nat Sci, Malibu, CA 90263 USA	Northern Arizona University; Northern Arizona University; California State University System; California State Polytechnic University, Humboldt; Pepperdine University	Koch, GW (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	george.koch@nau.edu						Bond BJ, 1999, OECOLOGIA, V120, P183, DOI 10.1007/s004420050847; Boyer JS., 1995, MEASURING WATER STAT; Carder AC, 1995, FOREST GIANTS WORLD; Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Friend A. D., 1993, P101; Hacke UG, 2003, PLANT CELL ENVIRON, V26, P303, DOI 10.1046/j.1365-3040.2003.00962.x; Jennings G. M., 2003, THESIS HUMBOLDT STAT; KING DA, 1990, AM NAT, V135, P809, DOI 10.1086/285075; Kramer P.J., 1995, WATER RELATIONS PLAN; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 1998, TREE PHYSIOL, V18, P681; PARKHURST DF, 1994, NEW PHYTOL, V126, P449, DOI 10.1111/j.1469-8137.1994.tb04244.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sawyer JO, 2000, REDWOOD FOREST HIST, P81; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Taiz L., 2002, PLANT PHYSIOL; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Van de Water PK, 2002, OECOLOGIA, V132, P332, DOI 10.1007/s00442-002-0973-x; Vogel J. C., 1993, Stable isotopes and plant carbon-water relations., P29; Waring R. H., 1985, FOREST ECOSYSTEMS; Warren CR, 2003, PLANT CELL ENVIRON, V26, P1215, DOI 10.1046/j.1365-3040.2003.01044.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; YODER BJ, 1994, FOREST SCI, V40, P513; Zimmermann M.H., 1984, XYLEM STRUCTURE ASCE, V26, P165	29	751	821	24	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					851	854		10.1038/nature02417	http://dx.doi.org/10.1038/nature02417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103376				2022-12-28	WOS:000220952300039
J	Vermillion, JM; Harris, FS				Vermillion, JM; Harris, FS			Hemispheric arteriovenous malformation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Texas A&M Hlth Sci Ctr, Temple, TX 76508 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Vermillion, JM (corresponding author), Texas A&M Hlth Sci Ctr, Temple, TX 76508 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					E15	E15		10.1056/ENEJMicm020733	http://dx.doi.org/10.1056/ENEJMicm020733			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15103014				2022-12-28	WOS:000220947300012
J	Muller, HM; Oberwalder, M; Fiegl, H; Morandell, M; Goebel, G; Zitt, M; Muhlthaler, M; Ofner, D; Margreiter, R; Widschwendter, M				Muller, HM; Oberwalder, M; Fiegl, H; Morandell, M; Goebel, G; Zitt, M; Muhlthaler, M; Ofner, D; Margreiter, R; Widschwendter, M			Methylation changes in faecal DNA: a marker for colorectal cancer screening?	LANCET			English	Article								DNA methylation is a common molecular alteration in colorectal cancer cells. We report an assessment of faecal DNA from patients with colorectal cancer and controls to determine the feasibility, sensitivity, and specificity of this approach. By use of MethyLight analysis of faecal DNA from three independent sets of patients, we identified SFRP2 methylation as a sensitive single DNA-based marker for identification of colorectal cancer in stool samples (sensitivity 90% [CI 56-100] and specificity 77% [46-95] in the training set [n=23]; sensitivity 77% [46-95] and specificity 77% [46-95] in an independent test set [n=26]). Whether a combination of genetic and epigenetic markers will identify colorectal cancer at an early stage remains to be shown.	Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria; Med Univ Innsbruck, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria; Med Univ Innsbruck, Dept Biostat & Documentat, A-6020 Innsbruck, Austria; St Vinzenz Hosp, Dept Gen Surg, Zams, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Widschwendter, M (corresponding author), Med Univ Innsbruck, Dept Obstet & Gynecol, Anichstr 35, A-6020 Innsbruck, Austria.	martin.widschwendter@uibk.ac.at	Goebel, Georg/P-6909-2015; Fiegl, Heidi/K-4445-2017	Fiegl, Heidi/0000-0002-1236-6806; Widschwendter, Martin/0000-0002-7778-8380				Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Muller HM, 2003, CANCER RES, V63, P7641; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294	6	217	266	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1283	1285		10.1016/S0140-6736(04)16002-9	http://dx.doi.org/10.1016/S0140-6736(04)16002-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094274				2022-12-28	WOS:000220904900011
J	Unger, RH				Unger, RH			The hyperleptinemia of obesity - Regulator of caloric surpluses	CELL			English	Editorial Material							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; FOOD-INTAKE; WEIGHT; LEPTIN		UT SW Med Ctr, Dept Internal Med, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Unger, RH (corresponding author), UT SW Med Ctr, Dept Internal Med, Touchstone Ctr Diabet Res, 5323 Harry Hines Blvd,Y8-212, Dallas, TX 75390 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK002700, R01DK002700] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-02700] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057	12	62	69	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					145	146		10.1016/S0092-8674(04)00339-3	http://dx.doi.org/10.1016/S0092-8674(04)00339-3			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084251	Bronze			2022-12-28	WOS:000220913400001
J	Gines, P; Cardenas, A; Arroyo, V; Rodes, J				Gines, P; Cardenas, A; Arroyo, V; Rodes, J			Current concepts - Management of cirrhosis and ascites	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SPONTANEOUS BACTERIAL PERITONITIS; INTRAHEPATIC PORTOSYSTEMIC SHUNT; TYPE-1 HEPATORENAL-SYNDROME; ORTHOTOPIC LIVER-TRANSPLANTATION; PRETRANSPLANT RENAL-FUNCTION; REFRACTORY ASCITES; TOTAL PARACENTESIS; ALBUMIN INFUSION; TENSE ASCITES; INTRAVENOUS ALBUMIN		Hosp Clin Barcelona, Liver Unit, E-08036 Barcelona, Spain; Univ Barcelona, Inst Invest Biomed August Pi Sunyer, Barcelona, Spain; Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Gines, P (corresponding author), Hosp Clin Barcelona, Liver Unit, Villarroel 170, E-08036 Barcelona, Spain.	gines@medicina.ub.es	Ginès, Pere/C-7730-2014; Arroyo, Vicente/F-9189-2015	Ginès, Pere/0000-0003-4657-4504; Arroyo, Vicente/0000-0002-2728-1848; cardenas, andres/0000-0002-0764-7873				ANDERSON RN, 2002, NATL VITAL STAT REPO, V50; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; BERNARDI M, 1993, LIVER, V13, P156; Bosch J, 2003, J HEPATOL, V38, pS54, DOI 10.1016/S0168-8278(02)00430-0; Brensing KA, 2000, GUT, V47, P288, DOI 10.1136/gut.47.2.288; Casado M, 1998, GASTROENTEROLOGY, V114, P1296, DOI 10.1016/S0016-5085(98)70436-6; Clavien PA, 1998, ANN SURG, V227, P440, DOI 10.1097/00000658-199803000-00017; COSBY RL, 1989, MINER ELECTROL METAB, V15, P261; DAMICO G, 1986, DIGEST DIS SCI, V31, P468, DOI 10.1007/BF01320309; Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343; EPSTEIN M, 1970, AM J MED, V49, P175, DOI 10.1016/S0002-9343(70)80073-0; FASSIO E, 1992, J HEPATOL, V14, P310, DOI 10.1016/0168-8278(92)90176-P; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez-Esparrach G, 2001, J HEPATOL, V34, P46, DOI 10.1016/S0168-8278(00)00011-8; FernandezEsparrach G, 1997, J HEPATOL, V26, P614, DOI 10.1016/S0168-8278(97)80427-8; FernandezEsparrach G, 1997, J HEPATOL, V26, P1430; FOLLO A, 1994, HEPATOLOGY, V20, P1495, DOI 10.1002/hep.1840200619; GATTA A, 1991, HEPATOLOGY, V14, P231, DOI 10.1002/hep.1840140205; GINES A, 1993, J HEPATOL, V17, P220, DOI 10.1016/S0168-8278(05)80042-X; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9; Gines P, 1998, HEPATOLOGY, V28, P851, DOI 10.1002/hep.510280337; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; GINES P, 1987, GASTROENTEROLOGY, V93, P234, DOI 10.1016/0016-5085(87)91007-9; Gines P, 2002, GASTROENTEROLOGY, V123, P1839, DOI 10.1053/gast.2002.37073; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; GINES P, 1991, NEW ENGL J MED, V325, P829, DOI 10.1056/NEJM199109193251201; Gines P, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P431; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; Grange JD, 1998, J HEPATOL, V29, P430, DOI 10.1016/S0168-8278(98)80061-5; Guevara M, 1998, HEPATOLOGY, V28, P416, DOI 10.1002/hep.510280219; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; LUCA A, 1995, HEPATOLOGY, V22, P753, DOI 10.1016/0270-9139(95)90293-7; Martin PY, 1998, NEW ENGL J MED, V339, P533, DOI 10.1056/NEJM199808203390807; Moreau R, 2002, GASTROENTEROLOGY, V122, P923, DOI 10.1053/gast.2002.32364; Mulkay JP, 2001, ACTA GASTRO-ENT BELG, V64, P15; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; OCHS A, 1995, NEW ENGL J MED, V332, P1587; Ortega R, 2002, HEPATOLOGY, V36, P941, DOI 10.1053/jhep.2002.35819; PANOS MZ, 1990, HEPATOLOGY, V11, P662, DOI 10.1002/hep.1840110420; PANOS MZ, 1990, HEPATOLOGY, V12, P186; Pomier-Layrargues G, 2003, HEPATOLOGY, V38, P238, DOI 10.1053/jhep.2003.50276; POZZI M, 1994, GASTROENTEROLOGY, V106, P709, DOI 10.1016/0016-5085(94)90706-4; Restuccia T, 2003, J HEPATOL, V38, P69, DOI 10.1016/S0168-8278(03)80292-1; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Rossle M, 2000, NEW ENGL J MED, V342, P1701, DOI 10.1056/NEJM200006083422303; Rouillard SS, 1998, ANN INTERN MED, V128, P374, DOI 10.7326/0003-4819-128-5-199803010-00006; RuizdelArbol L, 1997, GASTROENTEROLOGY, V113, P579, DOI 10.1053/gast.1997.v113.pm9247479; Runyon BA, 1998, HEPATOLOGY, V27, P264, DOI 10.1002/hep.510270139; RUNYON BA, 1992, ANN INTERN MED, V117, P215, DOI 10.7326/0003-4819-117-3-215; SALERNO F, 1991, HEPATOLOGY, V13, P707, DOI 10.1002/hep.1840130416; SALERNO F, 1987, J HEPATOL, V5, P102, DOI 10.1016/S0168-8278(87)80067-3; Salo J, 1996, J HEPATOL, V25, P916, DOI 10.1016/S0168-8278(96)80297-2; Sanyal AJ, 2003, GASTROENTEROLOGY, V124, P634, DOI 10.1053/gast.2003.50088; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; SHEAR L, 1970, NEW ENGL J MED, V282, P1391, DOI 10.1056/NEJM197006182822502; SHERLOCK S, 2002, DIS LIVER BILIARY SY, P127; SHIFFMAN ML, 1995, HEPATOLOGY, V22, P1591, DOI 10.1002/hep.1840220536; SINGH N, 1995, ANN INTERN MED, V122, P595, DOI 10.7326/0003-4819-122-8-199504150-00007; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; TITO L, 1988, HEPATOLOGY, V8, P27, DOI 10.1002/hep.1840080107; Tripathi D, 2002, EUR J GASTROEN HEPAT, V14, P827, DOI 10.1097/00042737-200208000-00003; Uriz J, 2000, J HEPATOL, V33, P43, DOI 10.1016/S0168-8278(00)80158-0	66	493	536	0	24	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1646	1654		10.1056/NEJMra035021	http://dx.doi.org/10.1056/NEJMra035021			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084697				2022-12-28	WOS:000220819800009
J	Barsky, SH; McGonigle, K				Barsky, SH; McGonigle, K			Pseudomyxoma peritonei	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Barsky, SH (corresponding author), Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA.								0	1	1	1	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					E13	E13		10.1056/ENEJMicm020137	http://dx.doi.org/10.1056/ENEJMicm020137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071141				2022-12-28	WOS:000220682000011
J	Tseng, CH; Gobell, JL; Sperling, G				Tseng, CH; Gobell, JL; Sperling, G			Long-lasting sensitization to a given colour after visual search	NATURE			English	Article							MOTION PERCEPTION; SPATIAL-FREQUENCY; ORIENTATION; DISCRIMINATION; AMPLIFICATION; PERSISTENCE; IMPROVEMENT; HYPERACUITY; ADAPTATION; ACUITY	Visual attention enables an observer to select specific visual information for processing. In an ambiguous motion task in which a coloured grating can be perceived as moving in either of two opposite directions depending on the relative salience of two colours in the display, attending to one of the colours influences the direction in which the grating appears to move(1). Here, we use this secondary effect of attention in a motion task to measure the effect of attending to a specific colour in a search task. Observers performed a search task in which they searched for a target letter in a 4x4 coloured matrix. Each of the 16 squares within a matrix was assigned one of four colours, and observers knew that the target letter would appear on only one of these colours throughout the experiment. Observers performed the ambiguous motion task before and after the search task. Attending to a particular colour for a brief period in the search task profoundly influenced the perceived direction of motion. This effect lasted for up to one month and in some cases had to be reversed by practising searches for the complementary colour, indicating a much longer-persisting effect of attention than has been observed previously.	Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tseng, CH (corresponding author), Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08854 USA.	CH_Tseng@alumni.uci.edu; Sperling@uci.edu						Anstis S. M., 1983, COLOUR VISION PHYSL, P155; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V1, P11; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FAVREAU OE, 1979, PERCEPT PSYCHOPHYS, V26, P187, DOI 10.3758/BF03199868; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; GILINSKY AS, 1968, J OPT SOC AM, V58, P13, DOI 10.1364/JOSA.58.000013; HEGGELUND P, 1976, VISION RES, V16, P1015, DOI 10.1016/0042-6989(76)90235-2; HOLLAND H. C., 1965, SPIRAL AFTER EFFECT; JONES PD, 1975, J EXP PSYCHOL HUMAN, V1, P323, DOI 10.1037/0096-1523.1.4.323; KALFIN K, 1972, VISION RES, V12, P359, DOI 10.1016/0042-6989(72)90128-9; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Lu ZL, 2001, VISION RES, V41, P2355, DOI 10.1016/S0042-6989(01)00106-7; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MASLAND RH, 1969, SCIENCE, V165, P819, DOI 10.1126/science.165.3895.819; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538	25	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					657	660		10.1038/nature02443	http://dx.doi.org/10.1038/nature02443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15071596				2022-12-28	WOS:000220697200045
J	Burstein, HJ; Polyak, K; Wong, JS; Lester, SC; Kaelin, CM				Burstein, HJ; Polyak, K; Wong, JS; Lester, SC; Kaelin, CM			Medical progress - Ductal carcinoma in situ of the breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; LYMPH-NODE BIOPSY; RANDOMIZED CONTROLLED-TRIAL; TERM FOLLOW-UP; LOCAL RECURRENCE; INTRADUCTAL-CARCINOMA; RADIATION-THERAPY; CONSERVING THERAPY; GENE-EXPRESSION; RISK-FACTORS		Brigham & Womens Hosp, Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Burstein, HJ (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	hburstein@partners.org			NATIONAL CANCER INSTITUTE [P50CA089393, R01CA094074] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA089393-040004, P50 CA089393, P50 CA089393-020004, R01 CA094074-02, P50 CA089393-030004, R01 CA094074-03, CA89393, R01 CA94074, R01 CA094074, P50 CA089393-050004, P50 CA089393-010004, R01 CA094074-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adeyinka A, 2002, CLIN CANCER RES, V8, P3788; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; Allred DC, 2002, BREAST CANCER RES TR, V76, pS81; Allred DC, 2002, BREAST CANCER RES TR, V76, pS36; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; ALLRED DC, 2002, DUCTAL CARCINOMA IN, P37; Aubele MM, 2000, DIAGN MOL PATHOL, V9, P14, DOI 10.1097/00019606-200003000-00003; Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874; Bassett L, 1997, CA-CANCER J CLIN, V47, P171, DOI 10.3322/canjclin.47.3.171; BAXTER NN, 2003, PROG P AM SOC CLIN O, V22, P27; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; Bijker N, 2001, BRIT J CANCER, V84, P539, DOI 10.1054/bjoc.2000.1618; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Bluman LG, 2001, J WOMEN HEALTH GEN-B, V10, P589, DOI 10.1089/15246090152543175; Bonnett M, 2002, MODERN PATHOL, V15, P95, DOI 10.1038/modpathol.3880497; Boyages J, 1999, CANCER, V85, P616, DOI 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7; Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B; CHEN W, 2003, PROG P AM SOC CLIN O, V22, P845; Claus EB, 2003, BREAST CANCER RES TR, V78, P7, DOI 10.1023/A:1022147920262; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Cutuli B, 2002, BREAST CANCER RES TR, V76, pS36; Cutuli B, 2002, INT J RADIAT ONCOL, V53, P868, DOI 10.1016/S0360-3016(02)02834-1; Cutuli B, 2001, EUR J CANCER, V37, P2365, DOI 10.1016/S0959-8049(01)00303-3; Cuzick J, 2002, LANCET, V360, P817; Damiani S, 1999, VIRCHOWS ARCH, V434, P227, DOI 10.1007/s004280050332; Darling MLR, 2000, AM J ROENTGENOL, V175, P1341, DOI 10.2214/ajr.175.5.1751341; de Mascarel I, 2002, CANCER, V94, P2134, DOI 10.1002/cncr.10451; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Farabegoli F, 2002, J PATHOL, V196, P280, DOI 10.1002/path.1048; FAVERLY DRG, 1994, SEMIN DIAGN PATHOL, V11, P193; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 2001, SEMIN ONCOL, V28, P400, DOI 10.1053/sonc.2001.26151; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; Fisher B, 1998, J CLIN ONCOL, V16, P441, DOI 10.1200/JCO.1998.16.2.441; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; FISHER ER, 1991, J SURG ONCOL, V47, P139, DOI 10.1002/jso.2930470302; FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P197, DOI 10.1002/1097-0142(19860115)57:2<197::AID-CNCR2820570203>3.0.CO;2-N; FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G; Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y; Gapstur SM, 1999, JAMA-J AM MED ASSOC, V281, P2091, DOI 10.1001/jama.281.22.2091; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; GUIDI AJ, 1994, J NATL CANCER I, V86, P614, DOI 10.1093/jnci/86.8.614; Gupta SK, 1997, CANCER, V80, P1740; Habel LA, 1997, ANN SURG, V225, P69, DOI 10.1097/00000658-199701000-00008; Hetelekidis S, 1999, CANCER-AM CANCER SOC, V85, P427, DOI 10.1002/(SICI)1097-0142(19990115)85:2<427::AID-CNCR21>3.0.CO;2-8; Hittmair AP, 1998, CANCER-AM CANCER SOC, V83, P2139, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2139::AID-CNCR12>3.0.CO;2-F; HOLLAND R, 1990, LANCET, V335, P519, DOI 10.1016/0140-6736(90)90747-S; HOLLAND R, 1990, J CLIN ONCOL, V8, P113, DOI 10.1200/JCO.1990.8.1.113; Intra M, 2003, ARCH SURG-CHICAGO, V138, P309, DOI 10.1001/archsurg.138.3.309; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 1997, JNCI-J NATL CANCER I, V89, P76, DOI 10.1093/jnci/89.1.76; Klauber-DeMore N, 2000, ANN SURG ONCOL, V7, P636, DOI 10.1007/s10434-000-0636-2; LAGIOS MD, 1982, CANCER-AM CANCER SOC, V50, P1309, DOI 10.1002/1097-0142(19821001)50:7<1309::AID-CNCR2820500716>3.0.CO;2-#; LAGIOS MD, 1989, CANCER, V63, P618, DOI 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J; LAMPEJO OT, 1994, SEMIN DIAGN PATHOL, V11, P215; Liberman L, 1997, AM J ROENTGENOL, V168, P489, DOI 10.2214/ajr.168.2.9016233; Luzzi V, 2001, AM J PATHOL, V158, P2005, DOI 10.1016/S0002-9440(10)64672-X; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McMasters KM, 2002, CANCER-AM CANCER SOC, V95, P15, DOI 10.1002/cncr.10641; Neuschatz AC, 2001, INT J CANCER, V96, P97, DOI 10.1002/ijc.10357; Neuschatz AC, 2002, CANCER, V94, P1917, DOI 10.1002/cncr.10460; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; Olivotto IA, 2001, CAN MED ASSOC J, V165, P277; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; PATCHEFSKY AS, 1989, CANCER, V63, P731, DOI 10.1002/1097-0142(19890215)63:4<731::AID-CNCR2820630422>3.0.CO;2-#; Pendas S, 2000, ANN SURG ONCOL, V7, P15, DOI 10.1007/s10434-000-0015-z; Porter D, 2003, MOL CANCER RES, V1, P362; Porter DA, 2001, CANCER RES, V61, P5697; RADFORD DM, 1995, CANCER RES, V55, P5180; RADFORD DM, 1996, CANCER RES, V56, P935; Rakovitch E, 2003, BREAST CANCER RES TR, V77, P285, DOI 10.1023/A:1021853302033; RECHT A, 1985, J CLIN ONCOL, V3, P1339, DOI 10.1200/JCO.1985.3.10.1339; Rudas M, 1997, EUR J CANCER, V33, P39, DOI 10.1016/S0959-8049(96)00368-1; SCHNITT SJ, 1994, CANCER, V74, P1746, DOI 10.1002/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO;2-Y; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Seth A, 2003, ANTICANCER RES, V23, P2043; Silver SA, 1998, CANCER, V82, P2382, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2382::AID-CNCR12>3.0.CO;2-L; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Silverstein MJ, 1998, J CLIN ONCOL, V16, P1367, DOI 10.1200/JCO.1998.16.4.1367; SILVERSTEIN MJ, 1995, EUR J CANCER, V31A, P1425, DOI 10.1016/0959-8049(95)00283-O; Silverstein MJ, 1996, CANCER-AM CANCER SOC, V77, P2267, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V; SILVERSTEIN MJ, 1987, CANCER, V59, P1819, DOI 10.1002/1097-0142(19870515)59:10<1819::AID-CNCR2820591023>3.0.CO;2-V; Silverstein MJ, 1999, NEW ENGL J MED, V340, P1455, DOI 10.1056/NEJM199905133401902; SILVERSTEIN MJ, 1994, CANCER, V73, P2985, DOI 10.1002/1097-0142(19940615)73:12<2985::AID-CNCR2820731216>3.0.CO;2-A; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Solin LJ, 2001, INT J RADIAT ONCOL, V50, P991, DOI 10.1016/S0360-3016(01)01517-6; Solin LJ, 1996, J CLIN ONCOL, V14, P754, DOI 10.1200/JCO.1996.14.3.754; Solin LJ, 2001, CANCER-AM CANCER SOC, V91, P1090, DOI 10.1002/1097-0142(20010315)91:6<1090::AID-CNCR1104>3.3.CO;2-4; STOMPER PC, 1992, AM J ROENTGENOL, V159, P483, DOI 10.2214/ajr.159.3.1323923; STOMPER PC, 1989, RADIOLOGY, V172, P235, DOI 10.1148/radiology.172.1.2544922; STRATTON MR, 1995, J PATHOL, V175, P195, DOI 10.1002/path.1711750207; Trentham-Dietz A, 2000, CANCER EPIDEM BIOMAR, V9, P697; Tunon-de-Lara C, 2001, AM J CLIN ONCOL-CANC, V24, P531, DOI 10.1097/00000421-200112000-00001; Vicini FA, 2002, J CLIN ONCOL, V20, P2736, DOI 10.1200/JCO.2002.07.137; Vicini FA, 2000, J CLIN ONCOL, V18, P296, DOI 10.1200/JCO.2000.18.2.296; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Warnberg F, 2001, BRIT J CANCER, V85, P869, DOI 10.1054/bjoc.2001.1995; Winchester DJ, 1997, ARCH SURG-CHICAGO, V132, P660; Wong JS, 2003, BREAST CANCER RES TR, V82, pS10; Wulfkuhle JD, 2002, CANCER RES, V62, P6740; Zavotsky J, 1999, CANCER, V85, P2439, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2439::AID-CNCR19>3.0.CO;2-J	108	388	424	0	15	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1430	1441		10.1056/NEJMra031301	http://dx.doi.org/10.1056/NEJMra031301			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070793				2022-12-28	WOS:000220562500010
J	Oransky, I				Oransky, I			Margaret Thaler Singer - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						SINGER MJ, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 31	2004	363	9406					403	403		10.1016/S0140-6736(04)15460-3	http://dx.doi.org/10.1016/S0140-6736(04)15460-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768TQ	15124608				2022-12-28	WOS:000188590900044
J	Hovind, P; Tarnow, L; Rossing, P; Jensen, BR; Graae, M; Torp, I; Binder, C; Parving, HH				Hovind, P; Tarnow, L; Rossing, P; Jensen, BR; Graae, M; Torp, I; Binder, C; Parving, HH			Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study	BRITISH MEDICAL JOURNAL			English	Article							INSULIN-DEPENDENT DIABETICS; URINARY ALBUMIN EXCRETION; BLOOD-GLUCOSE CONTROL; INTENSIVE TREATMENT; RISK-FACTORS; NEPHROPATHY; MELLITUS; PROGRESSION; HYPERTENSION; PRESSURE	Objective To evaluate baseline predictors for the development of persistent microalbuminuria and macroalbuminuria prospectively in patients with type 1 diabetes. Design Prospective observational study of an inception cohort. Setting Outpatient diabetic clinic in a tertiary referral centre, Gentofte, Denmark. Participants 286 patients (216 adults) newly diagnosed with type 1 diabetes consecutively admitted to the clinic between 1 September 1979 and 31 August 1984. Main outcome measures Persistent microalbuminuria and persistent macroalbuminuria. Results During the median follow up of 18.0 years (range 1.0-21.5 years), total of 4706 patient years of follow up, 79 of 277 patients developed persistent microalbuminuria. 27 progressed further to persistent macroalbuminuria. The cumulative incidence of persistent microalbuminuria and persistent macroalbuminuria was 33.6% (95% confidence interval 27.2% to 40.0%) and 14.6% (8.9% to 20.3%), respectively. Significant predictors (95% confidence intervals) for the development of persistent microalbuminuria were a 10-fold increase in urinary albumin excretion rate (relative risk 3.78, 1.57 to 9.13), being male (2.41, 1.43 to 4.06), a 10 mm Hg increase in mean arterial blood pressure (1.38, 1.20 to 1.57), a 1% increase in haemoglobin A(1c) (1.18, 1.04 to 1.32), and a 1 cm increase in height (0.96, 0.95 to 0.98). 28 patients with microalbuminuria (35%) regressed to normoalbuminuria either transiently (n=15) or permanently (n=13). Conclusions Around one third of patients newly diagnosed with type 1 diabetes develop persistent microalbuminuria. within the first 20 years of diabetes. Several potentially modifiable risk factors predict the development of persistent microalbuminuria and persistent macroalbuminuria.	Steno Diabet Ctr, DK-2820 Gentofte, Denmark	Steno Diabetes Center	Hovind, P (corresponding author), Steno Diabet Ctr, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.	phovind@dadlnet.dk	rossing, peter/AAH-7879-2021; rossing, peter/AAZ-3415-2021	rossing, peter/0000-0002-1531-4294; Tarnow, Lise/0000-0002-8735-966X				BANGSTAD HJ, 1993, DIABETOLOGIA, V36, P523, DOI 10.1007/BF02743268; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Close CF, 1999, DIABETIC MED, V16, P918; COONROD BA, 1993, DIABETES CARE, V16, P1376, DOI 10.2337/diacare.16.10.1376; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; FABER OK, 1977, DIABETOLOGIA, V13, P263, DOI 10.1007/BF01219710; Fagerudd JA, 1998, DIABETES, V47, P439, DOI 10.2337/diabetes.47.3.439; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; HOSTETTER TH, 1982, AM J MED, V72, P375, DOI 10.1016/0002-9343(82)90490-9; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MATHIESEN ER, 1990, DIABETES, V39, P245, DOI 10.2337/diabetes.39.2.245; MOGENSEN CE, 1995, LANCET, V346, P1080, DOI 10.1016/S0140-6736(95)91747-0; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Parving HH., 2000, KIDNEY, V6, P1731; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Rossing P, 2002, DIABETES CARE, V25, P859, DOI 10.2337/diacare.25.5.859; ROSSING P, 1995, BRIT MED J, V310, P296, DOI 10.1136/bmj.310.6975.296; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; VIBERTI GC, 1982, LANCET, V1, P1430; VIBERTI GC, 1987, BRIT MED J, V295, P515, DOI 10.1136/bmj.295.6597.515; WANG PH, 1993, LANCET, V341, P1306, DOI 10.1016/0140-6736(93)90816-Y; WILLIAMSON JR, 1986, DIABETES, V35, P20, DOI 10.2337/diabetes.35.1.20	30	266	275	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 8	2004	328	7448					1105	1108		10.1136/bmj.38070.450891.FE	http://dx.doi.org/10.1136/bmj.38070.450891.FE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15096438	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000221281000019
J	McAlister, FA; Murphy, NF; Simpson, CR; Stewart, S; MacIntyre, K; Kirkpatrick, M; Chalmers, J; Redpath, A; Capewell, S; McMurray, JJV				McAlister, FA; Murphy, NF; Simpson, CR; Stewart, S; MacIntyre, K; Kirkpatrick, M; Chalmers, J; Redpath, A; Capewell, S; McMurray, JJV			Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FUNCTIONAL STATUS; RISK-FACTORS; DISEASE; HEALTH; TRENDS; PREDICTORS; MANAGEMENT	Objectives To examine whether there are socioeconomic gradients in die incidence, prevalence, treatment, and follow up of patients with heart failure in primary care. Design Population based study. Setting 53 general practices (307741 patients) participating in the Scottish continuous morbidity recording project between 1 April 1999 and 31 March 2000. Participants 2186 adults with heart failure. Main outcome measures Comorbid diagnoses, frequency of visits to general practitioner, and prescribed drugs. Results 2186 patients with heart failure were seen (prevalence 7.1 per 1000 population, incidence 2.0 per 1000 population). The age and sex standardised incidence of heart failure increased with greater socioeconomic deprivation, from 1.8 per 1000 population in the most affluent stratum to 2.6 per 1000 population in the most deprived stratum (odds ratio 1.44, P=0.0003). On average, patients were seen 2.4 times yearly, but follow up rates were less frequent with increasing socioeconomic deprivation (from 2.6 yearly in the most affluent subgroup to 2.0 yearly in the most deprived subgroup, P=0.00009). Overall, 812 (80.6%) patients were prescribed diuretics, 396 (39.3%) angiotensin converting enzyme inhibitors, 216 (21.4%) beta blockers, 208 (20.7%) digoxin, and 86 (8.5%) spironolactone. The wide discrepancies in prescribing between different general practices disappeared after adjustment for patient age and sex. Prescribing patterns did not vary by deprivation categories on univariate or multivariate analyses. Conclusions Compared with affluent patients, socioeconomically deprived patients were 44% more likely to develop heart failure but 23% less likely to see their general practitioner on an ongoing basis. Prescribed treatment did not differ across socioeconomic gradients.	Western Infirm & Associated Hosp, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England; Univ Alberta, Dept Med, Edmonton, AB T6G 2R7, Canada; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB25 2AY, Scotland; Univ S Australia, Div Hlth Sci, Adelaide, SA 5000, Australia; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland	University of Liverpool; University of Alberta; University of Aberdeen; University of South Australia; University of Glasgow	McMurray, JJV (corresponding author), Western Infirm & Associated Hosp, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	Simpson, Colin/I-3974-2019; Macintyre, Kate/J-7174-2014; McAlister, Finlay/C-4151-2013; mcmurray, John/B-2467-2013; Simpson, Colin R/L-7180-2014; Stewart, Simon/M-3316-2016	Simpson, Colin/0000-0002-5194-8083; Macintyre, Kate/0000-0003-2741-0467; McAlister, Finlay/0000-0001-7435-3341; mcmurray, John/0000-0002-6317-3975; Simpson, Colin R/0000-0002-5194-8083; Stewart, Simon/0000-0001-9032-8998				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Blair AS, 2002, J FAM PRACTICE, V51, P169; Blatchford O, 1999, BRIT J GEN PRACT, V49, P551; Carstairs V., 1991, DEPRIVATION HLTH SCO; CICCINE G, 1999, EPIDEMIOLOGIA PREVAN, V223, P188; Clarke SP, 2000, RES NURS HEALTH, V23, P290, DOI 10.1002/1098-240X(200008)23:4<290::AID-NUR5>3.3.CO;2-S; Coughlin SS, 1998, J NATL MED ASSOC, V90, P342; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Milne RM, 1998, J EPIDEMIOL COMMUN H, V52, p20S; ONEIL M, 1995, METHOD INFORM MED, V34, P187; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Sin DD, 2002, AM J MED, V112, P120, DOI 10.1016/S0002-9343(01)01079-8; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2001, EUR HEART J, V22, P209, DOI 10.1053/euhj.2000.2291; Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12; TUDORHART J, 1971, LANCET, V1, P405; Woodward M, 1996, J EPIDEMIOL COMMUN H, V50, P570, DOI 10.1136/jech.50.5.570; Woolf SH, 1998, J FAM PRACTICE, V47, P312	24	62	63	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2004	328	7448					1110	1112A		10.1136/bmj.38043.414074.EE	http://dx.doi.org/10.1136/bmj.38043.414074.EE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	818YS	15107312	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000221281000021
J	Hamer, AJ				Hamer, AJ			ABC of rheumatology - Pain in the hip and knee	BRITISH MEDICAL JOURNAL			English	Review									No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Hamer, AJ (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.							McRae R, 1997, CLIN ORTHOPAEDIC EXA; MILLER MD, 2000, REV ORTHOPAEDICS; SOLOMON I, 2001, APLEYS SYSTEM ORTHOP	3	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 1	2004	328	7447					1067	1069		10.1136/bmj.328.7447.1067	http://dx.doi.org/10.1136/bmj.328.7447.1067			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117795	Green Published			2022-12-28	WOS:000221174500027
J	Coleman, CN; Stone, HB; Moulder, JE; Pellmar, TC				Coleman, CN; Stone, HB; Moulder, JE; Pellmar, TC			Modulation of radiation injury	SCIENCE			English	Editorial Material							PULMONARY FIBROSIS; NORMAL TISSUE		NCI, Radiat Res Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical College of Wisconsin; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Coleman, CN (corresponding author), NCI, Radiat Res Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA.	pellmar@afrri.usuhs.mil	Moulder, John E/E-6799-2012					Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Coleman C. Norman, 2003, Radiation Research, V160, P729, DOI 10.1667/RR3096; Delanian S, 2003, J CLIN ONCOL, V21, P2545, DOI 10.1200/JCO.2003.06.064; Haston CK, 2002, CANCER RES, V62, P3782; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Landauer MR, 2003, J APPL TOXICOL, V23, P379, DOI 10.1002/jat.904; Moulder JE, 2004, INT J RADIAT BIOL, V80, P3, DOI 10.1080/09553000310001642920; National Council on Radiation Protection and Measurements (NCRP), 2001, 138 NCRP; Ricks RC, 2002, MED BASIS RAD ACCIDE; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; STICKNEY DR, 2001, BLOOD, V102; Stone HB, 2002, RADIAT RES, V157, P204, DOI 10.1667/0033-7587(2002)157[0204:MNTDP]2.0.CO;2; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Trotti A, 2002, SEMIN RADIAT ONCOL, V12, P1, DOI 10.1053/srao.2002.31353	14	103	111	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					693	694		10.1126/science.1095956	http://dx.doi.org/10.1126/science.1095956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118152				2022-12-28	WOS:000221105300032
J	Black, GJ; Campbell, DB; Carter, LM; Ostro, SJ				Black, GJ; Campbell, DB; Carter, LM; Ostro, SJ			Radar detection of Iapetus	SCIENCE			English	Article							DARK SIDE; SPECTROPHOTOMETRY; SATELLITES		Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; Cornell Univ, Natl Astron & Ionosphere Ctr, Ithaca, NY 14853 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Virginia; Cornell University; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Black, GJ (corresponding author), Univ Virginia, Dept Astron, POB 3818, Charlottesville, VA 22903 USA.	gblack@virginia.edu	Carter, Lynn/D-2937-2012	Carter, Lynn/0000-0002-6245-4142; Black, Gregory/0000-0001-7237-8270				BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; CLARK RN, 1984, ICARUS, V58, P265, DOI 10.1016/0019-1035(84)90043-5; DENK T, 2000, B AM ASTRON SOC, V32, P1079; EVANS JV, 1968, RADAR ASTRONOMY, P219; LANZEROTTI LJ, 1984, NATURE, V312, P139, DOI 10.1038/312139a0; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P215, DOI 10.1029/2000GL012199; OSTRO SJ, 1992, J GEOPHYS RES-PLANET, V97, P18227, DOI 10.1029/92JE01992; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; SQUYRES SW, 1984, ICARUS, V59, P426, DOI 10.1016/0019-1035(84)90111-8; TYLER GL, 1982, SCIENCE, V215, P553, DOI 10.1126/science.215.4532.553; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111	13	19	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					553	553		10.1126/science.1096470	http://dx.doi.org/10.1126/science.1096470			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105493				2022-12-28	WOS:000220975100038
J	Trotter, JF; Osgood, MJ				Trotter, JF; Osgood, MJ			MELD scores of liver transplant recipients according to size of waiting list - Impact of organ allocation and patient outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE; MODEL	Context The Model for Endstage Liver Disease (MELD) score serves as the basis for the distribution of deceased-donor (DD) livers and was developed in response to "the final rule" mandate, whose stated principle is to allocate livers according to a patient's medical need, with less emphasis on keeping organs in the local procurement area. However, in selected areas of the United States, organs are kept in organ procurement organizations (OPOs) with small waiting lists and transplanted into less-sick patients instead of being allocated to sicker patients in nearby transplant centers in OPOs with large waiting lists. Objective To determine whether there is a difference in MELD scores for liver transplant recipients receiving transplants in small vs large OPOs. Design and Setting Retrospective review of the US Scientific Registry of Transplant Recipients between February 28, 2002, and March 31, 2003. Transplant recipients (N =4798) had end-stage liver disease and received DD livers. Main Outcome Measures MELD score distribution (range, 6-40), graft survival, and patient survival for liver transplant recipients in small (<100) and large (&GE;100 on the waiting list) OPOs. Results The distribution of MELD scores was the same in large and small OPOs; 92% had a MELD score of 18 or less, 7% had a MELD score between 19 and 24, and only 2% of listed patients had a MELD score higher than 24 (P=.85). The proportion of patients receiving transplants in small OPOs and with a MELD score higher than 24 was significantly lower than that in large OPOs (19% vs 49%; P<.001). Patient survival rates at 1 year after transplantation for small OPOs (86.4%) and large OPOs (86.6%) were not statistically different (P=.59), and neither were graft survival-rates in small OPOs (80.1 %) and large OPOs (81.3%) (P=.80). Conclusions There is a significant disparity in MELD scores in liver transplant recipients in small vs large OPOs; fewer transplant recipients in small OPOs have severe liver disease (MELD score >24). This disparity does not reflect the stated goals of the current allocation policy, which is to distribute livers according to a patient's medical need, with less emphasis on keeping organs in the local procurement area.	Univ Colorado, Hlth Sci Ctr, Div Gastroenterol Hepatol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Trotter, JF (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Gastroenterol Hepatol, 4200 E 9th Ave,B-154, Denver, CO 80262 USA.	James.Trotter@uchsc.edu						[Anonymous], ORGAN PROCUREMENT TR; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; FREEMAN RB, 2003, AM J TRANSPLANT S, V3, pA521; Institute of Medicine Committee on Organ Procurement and Transplantation Policy, 1999, ORG PROC TRANSPL ASS, P1; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; *SCI REG TRANSPL R, TRANSPL STAT CTR SPE; *SCI REG TRANSPL R, TRANSPL STAT OPO REP; US Census Bureau. State and County QuickFacts: Santa Clara County California, STAT COUNTR QUICKFAC; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	9	91	98	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1871	1874		10.1001/jama.291.15.1871	http://dx.doi.org/10.1001/jama.291.15.1871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100206	Bronze			2022-12-28	WOS:000220871200028
J	Seoane, J; Le, HV; Shen, LJ; Anderson, SA; Massague, J				Seoane, J; Le, HV; Shen, LJ; Anderson, SA; Massague, J			Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation	CELL			English	Article							GROWTH-FACTOR-BETA; C-ELEGANS DAF-16; TGF-BETA; TRANSCRIPTIONAL REPRESSION; NEOCORTICAL NEURONS; CRYSTAL-STRUCTURE; RADIAL GLIA; DNA-BINDING; LIFE-SPAN; MYC	FoxO Forkhead transcription factors are shown here to act as signal transducers at the confluence of Smad, PI3K, and FoxG1 pathways. Smad proteins activated by TGF-beta form a complex with FoxO proteins to turn on the growth inhibitory gene p21Cip1. This process is negatively controlled by the PI3K pathway, a known inhibitor of FoxO localization in the nucleus, and by the telencephalic development factor FoxG1, which we show binds to FoxO-Smad complexes and blocks p21Cip1 expression. We suggest that the activity of this network confers resistance to TGF-beta-mediated cytostasis during the development of the telencephalic neuroepithelium and in glioblastoma brain tumor cells.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Seoane, Joan/AAG-9173-2019	Seoane, Joan/0000-0002-6541-5974; Massague, Joan/0000-0001-9324-8408	NCI NIH HHS [CA34610] Funding Source: Medline; NINDS NIH HHS [NS44819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA034610, R01CA034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044819] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Jennings MT, 1997, J NEURO-ONCOL, V31, P233, DOI 10.1023/A:1005767616500; Kaestner KH, 2000, GENE DEV, V14, P142; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lopes SMCD, 2003, GENE EXPR PATTERNS, V3, P355, DOI 10.1016/S1567-133X(03)00029-2; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miller MW, 2003, J COMP NEUROL, V460, P410, DOI 10.1002/cne.10658; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Rich JN, 2003, FRONT BIOSCI-LANDMRK, V8, pE245, DOI 10.2741/992; Rodriguez C, 2001, J BIOL CHEM, V276, P30224, DOI 10.1074/jbc.M102759200; Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, J BIOL CHEM, V278, P35444, DOI 10.1074/jbc.M301413200; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Takahashi T, 1996, J NEUROSCI, V16, P5762; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	83	774	817	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					211	223		10.1016/S0092-8674(04)00298-3	http://dx.doi.org/10.1016/S0092-8674(04)00298-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084259	Bronze			2022-12-28	WOS:000220913400009
J	Smith, GR				Smith, GR			How homologous recombination is initiated: Unexpected evidence for single-strand nicks from V(D)J site-specific recombination	CELL			English	Editorial Material							GENETIC-RECOMBINATION; MODEL; DNA; BREAKS; REPAIR; YEAST		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Smith, Gerald/0000-0002-8747-1352				Arcangioli B, 1998, EMBO J, V17, P4503, DOI 10.1093/emboj/17.15.4503; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; STRATHERN JN, 1991, GENETICS, V127, P61; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8	9	22	22	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 16	2004	117	2					146	148		10.1016/S0092-8674(04)00338-1	http://dx.doi.org/10.1016/S0092-8674(04)00338-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084252	Bronze			2022-12-28	WOS:000220913400002
J	Ried, T				Ried, T			Cytogenetics - In color and digitized	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ried, T (corresponding author), NCI, Bethesda, MD 20892 USA.								0	6	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1597	1600		10.1056/NEJMp038242	http://dx.doi.org/10.1056/NEJMp038242			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084690				2022-12-28	WOS:000220819800002
J	Cleary, P; Shorvon, S; Tallis, R				Cleary, P; Shorvon, S; Tallis, R			Late-onset seizures as a predictor of subsequent stroke	LANCET			English	Article							SILENT STROKE; EPILEPTIC SEIZURES; ISCHEMIC STROKE; INFARCTION; PREVALENCE; FREQUENCY; RISK	Background Cerebrovascular disease is thought to be a major cause of epilepsy in late life. We investigated the hypothesis that the onset of seizures after the age of 60 years in people with no history of overt stroke might be associated with an increased risk of subsequent stroke. Methods Data were obtained from the UK General Practice Research Database on 4709 individuals who had seizures beginning at or after the age of 60 years, and on 4709 randomly selected controls with no history of seizures, matched for age, sex, and general practice. Individuals with a history of cerebrovascular disease, other acquired brain injury, brain tumour, drug or alcohol misuse, or dementia were not eligible for inclusion. Computerised patients' records were searched for subsequent diagnoses of stroke. Findings Log-rank testing, adjusted for matching, showed a highly significant difference in stroke-free survival between the two groups (p<0.0001). With a Cox's model, we estimated that the relative hazard of stroke at any point for people with seizures compared with the control group was 2.89 (95% Cl 2.45-3.41). Interpretation Our findings show that the onset of seizures in late life is associated with a striking increase in the risk of stroke. Further research is warranted to assess the benefit of specific interventions to prevent stroke in patients with seizures.	Gartnavel Royal Hosp, Brownlee Ctr, Glasgow, Lanark, Scotland; UCL Natl Hosp Neurol & Neurosurg, London, England; Univ Manchester, Div Geriatr Med, Manchester M13 9PL, Lancs, England	Gartnavel Royal Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Manchester	Tallis, R (corresponding author), Hope Hosp, Div Geriatr Med, Clin Sci Bldg, Salford M6 8HD, Lancs, England.	rtallis@fs1.ho.man.ac.uk	Shorvon, Simon D/A-2019-2009	Cleary, Paul/0000-0001-9335-5422				Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; CHODOSH EH, 1988, NEUROLOGY, V38, P1674, DOI 10.1212/WNL.38.11.1674; COCITO L, 1989, J NEUROL NEUROSUR PS, V52, P292, DOI 10.1136/jnnp.52.2.292; EBRAHIM S, 2003, BROCKLEHURSTS TXB GE; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; HERDERSCHEE D, 1992, STROKE, V23, P1220, DOI 10.1161/01.STR.23.9.1220; HERDERSCHEE D, 1994, CLIN NEUROL NEUROSUR, V96, P219, DOI 10.1016/0303-8467(94)90071-X; HOLLOWELL J, 1994, GEN PRACTICE RES DAT; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; KASE CS, 1989, STROKE, V20, P850, DOI 10.1161/01.STR.20.7.850; McCarron P, 2001, PUBLIC HEALTH, V115, P12, DOI 10.1038/sj.ph.1900724; RICCI S, 1994, STROKE, V25, P2293, DOI 10.1161/01.STR.25.11.2293; ROBERTS RC, 1988, EPILEPSIA, V29, P190, DOI 10.1111/j.1528-1157.1988.tb04418.x; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; SHINTON RA, 1987, LANCET, V1, P11; SHORVON SD, 1984, J NEUROL NEUROSUR PS, V47, P225, DOI 10.1136/jnnp.47.3.225; vanLatum JC, 1996, NEUROLOGY, V46, P159; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882	19	161	163	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1184	1186		10.1016/S0140-6736(04)15946-1	http://dx.doi.org/10.1016/S0140-6736(04)15946-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081649				2022-12-28	WOS:000220748100007
J	Ferriman, A				Ferriman, A			Novartis breached code after doctors say it "invented" a disease	BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1379	1379		10.1136/bmj.325.7377.1379	http://dx.doi.org/10.1136/bmj.325.7377.1379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	15083812	Green Published			2022-12-28	WOS:000179975000010
J	Weingarten, MA; Paul, M; Leibovici, L				Weingarten, MA; Paul, M; Leibovici, L			Assessing ethics of trials in systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIMICROBIAL AGENTS; NEUTROPENIC PATIENTS; UNEXPLAINED FEVER; GUIDELINES		Tel Aviv Univ, Dept Family Med, IL-69978 Tel Aviv, Israel; Beilinson Med Ctr, Internal Med & Infect Dis Unit, Rabin Med Ctr, Petah Tiqwa, Israel	Tel Aviv University; Rabin Medical Center	Weingarten, MA (corresponding author), Tel Aviv Univ, Dept Family Med, IL-69978 Tel Aviv, Israel.	weingml@post.tau.ac.il						Bauchner H, 2001, BRIT MED J, V323, P318, DOI 10.1136/bmj.323.7308.318; DOYAL L, 2000, INFORMED CONSENT MED; Foster C, 2001, ETHICS MED RES HUMAN; FREEDMAN B, 1993, HASTINGS CENT REP, V23, P13, DOI 10.2307/3562813; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; HUGHES WT, 1990, J INFECT DIS, V161, P381, DOI 10.1093/infdis/161.3.381; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; PAPPWORTH M, 1967, HUM GUINEA PIGS EXPT; Paul M, 2003, BRIT MED J, V326, P1111, DOI 10.1136/bmj.326.7399.1111; Ruiz-Canela M, 2001, J MED ETHICS, V27, P172, DOI 10.1136/jme.27.3.172; SEIDELMAN WE, 1988, MILBANK Q, V66, P221, DOI 10.2307/3350031; WADE JC, 1987, 27 INT C ANT AG CHEM; Weitzman M, 1990, 2 OPIN, V14, P27	14	31	31	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					1013	1014		10.1136/bmj.328.7446.1013	http://dx.doi.org/10.1136/bmj.328.7446.1013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816SR	15105330	Green Published			2022-12-28	WOS:000221130100027
J	Madakamutil, LT; Christen, U; Lena, CJ; Wang-Zhu, YR; Attinger, A; Sundarrajan, M; Ellmeier, W; von Herrath, MG; Jensen, P; Littman, DR; Cheroutre, H				Madakamutil, LT; Christen, U; Lena, CJ; Wang-Zhu, YR; Attinger, A; Sundarrajan, M; Ellmeier, W; von Herrath, MG; Jensen, P; Littman, DR; Cheroutre, H			CD8 alpha alpha-mediated survival and differentiation of CD8 memory T cell precursors	SCIENCE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; DEVELOPING THYMOCYTES; CORECEPTOR FUNCTION; EXPRESSION; SELECTION; RECEPTOR; THYMUS; EFFECTOR; MODULATION; ACTIVATION	Memory T cells are long-lived antigen-experienced T cells that are generally accepted to be direct descendants of proliferating primary effector cells. However, the factors that permit selective survival of these T cells are not well established. We show that homodimeric alpha chains of the CD8 molecule (CD8alphaalpha) are transiently induced on a selected subset of CD8alphabeta(+) T cells upon antigenic stimulation. These CD8alphaalpha molecules promote the survival and differentiation of activated lymphocytes into memory CD8 T cells. Thus, memory precursors can be identified among primary effector cells and are selected for survival and differentiation by CD8alphaalpha.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomed Sci, New York, NY 10016 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	La Jolla Institute for Immunology; Howard Hughes Medical Institute; New York University; New York University; Emory University	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	hilde@liai.org	Christen, Urs/A-7338-2009	Christen, Urs/0000-0003-4165-7976; Ellmeier, Wilfried/0000-0001-8192-8481	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051973, R01AI033614, R37AI033614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK054451, R01DK054451] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33614, AI51973, AI50263] Funding Source: Medline; NIDDK NIH HHS [DK54451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aranda R, 1997, J IMMUNOL, V158, P3464; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; VANOERS NSC, 1993, J IMMUNOL, V151, P777	25	160	167	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					590	593		10.1126/science.1092316	http://dx.doi.org/10.1126/science.1092316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105501				2022-12-28	WOS:000220975100050
J	Yuan, DX; Cheng, H; Edwards, RL; Dykoski, CA; Kelly, MJ; Zhang, ML; Qing, JM; Lin, YS; Wang, YJ; Wu, JY; Dorale, JA; An, ZS; Cai, YJ				Yuan, DX; Cheng, H; Edwards, RL; Dykoski, CA; Kelly, MJ; Zhang, ML; Qing, JM; Lin, YS; Wang, YJ; Wu, JY; Dorale, JA; An, ZS; Cai, YJ			Timing, duration, and transitions of the Last Interglacial Asian Monsoon	SCIENCE			English	Article							ICE-CORE RECORD; STABLE ISOTOPES; TERMINATION II; CLIMATE; PERIOD; PRECIPITATION; SPELEOTHEMS; HOLOCENE; EVENT	Thorium-230 ages and oxygen isotope ratios of stalagmites from Dongge Cave, China, characterize the Asian Monsoon and low-latitude precipitation over the past 160,000 years. Numerous abrupt changes in O-18/O-16 values result from changes in tropical and subtropical precipitation driven by insolation and millennial-scale circulation shifts. The Last Interglacial Monsoon lasted 9.7+/-1.1 thousand years, beginning with an abrupt (less than 200 years) drop in O-18/O-16 values 129.3+/-0.9 thousand years ago and ending with an abrupt (less than 300 years) rise in O-18/O-16 values 119.6+/-0.6 thousand years ago. The start coincides with insolation rise and measures of full interglacial conditions, indicating that insolation triggered the final rise to full interglacial conditions.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; Minist Land & Resources, Karst Dynam Lab, Guilin 541004, Peoples R China; Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China; Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Ministry of Natural Resources of the People's Republic of China; Nanjing Normal University; University of Iowa; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Edwards, RL (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	edwar001@umn.edu	CHENG, HAI/H-3413-2017; Cai, Yanjun/A-9462-2010; Yuan, D/G-3424-2010; Edwards, R. Lawrence/I-3124-2014; AN, Zhisheng/F-8834-2012	CHENG, HAI/0000-0002-5305-9458; Cai, Yanjun/0000-0001-7063-5050; Edwards, R. Lawrence/0000-0002-7027-5881; an, zhi sheng/0000-0002-9538-9826				An ZS, 1997, GEOLOGY, V25, P603; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHARLES CD, 1994, SCIENCE, V263, P508, DOI 10.1126/science.263.5146.508; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; CRISS RE, 1999, PRINCIPLES STABLE IS, P108; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DANSGAARD W, 1964, TELLUS, V16, P436; DORALE JA, 2000, THESIS U MINNESOTA T; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; EDWARDS RL, 2004, TREATISE GEOCHEMISTR, V6, P343; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Friedman I., 1977, DATA GEOCHEMISTRY; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; GOMEZ R, 2003, GEOL SOC AM ABSTR, V35, P587; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Jouzel J, 2000, QUATERNARY SCI REV, V19, P363, DOI 10.1016/S0277-3791(99)00069-4; KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59; Maslin MA, 2000, SCIENCE, V290, P2285; Muhs DR, 2002, QUATERNARY SCI REV, V21, P1355, DOI 10.1016/S0277-3791(01)00114-7; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Shen CC, 2002, CHEM GEOL, V185, P165, DOI 10.1016/S0009-2541(01)00404-1; Slowey NC, 1996, NATURE, V383, P242, DOI 10.1038/383242a0; Spotl C, 2002, GEOLOGY, V30, P815, DOI 10.1130/0091-7613(2002)030<0815:SOTLIP>2.0.CO;2; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918	33	886	1193	20	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					575	578		10.1126/science.1091220	http://dx.doi.org/10.1126/science.1091220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105497				2022-12-28	WOS:000220975100045
J	Angus, DC; Black, N				Angus, DC; Black, N			Improving care of the critically ill: institutional and health-care system approaches	LANCET			English	Article							PEDIATRIC INTENSIVE-CARE; MEDICAL-MALPRACTICE; ADVERSE EVENTS; UNITED-STATES; HOSPITAL MORTALITY; TRAUMA SYSTEM; SEPTIC SHOCK; OUTCOMES; QUALITY; IMPACT	Institutional and health-care system approaches complement bedside strategies to improve care of the critically ill. Focusing on the USA and the UK, we discuss seven approaches: education (especially of non-clinical managers, policy-makers, and the public), organisational guidelines, performance reporting, financial and sociobehavioural incentives to health-care professionals and institutions, regulation, legal requirements, and health-care system reorganisation. No single action is likely to have sustained effect and we recommend a combination of approaches. Several recent initiatives that hold promise tie performance reporting to financial incentives. Though performance reporting has been hampered by concerns over cost and accuracy, it remains an essential component and we recommend continued effort in this area. We also recommend more public education and use of organisational guidelines, such as admission criteria and staffing levels in intensive care units. Even if these endeavours are successful, with rising demand for services and continuing pressure to control costs, optimum care of the critically ill will not be realised without a fundamental reorganisation of services. In both the USA and UK, we recommend exploration of regionalised care, akin to US state trauma systems, and greater use of physician-extenders, such as nurse practitioners, to provide enhanced access to specialist care for critical illness.	Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; London School of Hygiene & Tropical Medicine	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, 604 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@ccm.upmc.edu	Angus, Derek C/E-9671-2012					Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Angus DC, 2001, AM J RESP CRIT CARE, V164, P1154, DOI 10.1164/ajrccm.164.7.2012126; ARROW KJ, 1963, AM ECON REV, V53, P941; *ASS PRESS, FLESH EAT BACT FORC; Audit Commission, 1999, CRIT SUCC PLAC EFF E; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Bion JF, 2004, LANCET, V363, P970, DOI 10.1016/S0140-6736(04)15793-0; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; BLACK N, 1990, LANCET, V335, P35, DOI 10.1016/0140-6736(90)90151-T; Black N, 2003, QUAL SAF HEALTH CARE, V12, P348, DOI 10.1136/qhc.12.5.348; Black Nick, 2004, J Health Serv Res Policy, V9 Suppl 1, P62, DOI 10.1258/135581904322724158; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2003, ANN INTERN MED, V139, P267, DOI 10.7326/0003-4819-139-4-200308190-00009; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carcillo JA, 2003, CRIT CARE CLIN, V19, P413, DOI 10.1016/S0749-0704(03)00013-7; Cawley James F, 2003, J Health Serv Res Policy, V8, P65, DOI 10.1258/135581903321466012; Committee on Quality of Health Care in America, 1999, ERR IS HUM BUILD SAF, P164; Cook DJ, 2004, LANCET, V363, P1224, DOI 10.1016/S0140-6736(04)15955-2; Coulter A, 1997, J Health Serv Res Policy, V2, P112; *DEP HLTH, 2002, NHS PERF RAT; DOMENIGHETTI G, 1988, LANCET, V2, P1470; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Egol A, 1999, CRIT CARE MED, V27, P633; ENTMAN SS, 1994, JAMA-J AM MED ASSOC, V272, P1588, DOI 10.1001/jama.272.20.1588; Evans R G, 1978, Hosp Trustee, V2, P6; Evans R.G., 1974, EC HLTH MED CARE, P162; Galvin R, 2002, NEW ENGL J MED, V347, P939, DOI 10.1056/NEJMsb012850; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Hannan E L, 1998, J Health Serv Res Policy, V3, P67; Herxheimer A, 2003, J ROY SOC MED, V96, P209, DOI 10.1258/jrsm.96.5.209; *JCAHO, JCAHO 2004 NAT PAT S; KELLEY MA, IN PRESS CHEST; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; *LEAPFR GROUP, FACTSH LEAPFR REG RO; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; McMullin J, 2003, UPD INT CAR, V39, P287; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; Nicholl J, 1998, BRIT MED J, V317, P1320; Pearson G, 2001, INTENS CARE MED, V27, P1670, DOI 10.1007/s001340101072; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Pronovost PJ, 2004, LANCET, V363, P1061, DOI 10.1016/S0140-6736(04)15843-1; Ratcliffe J, 1998, BMJ, V316, P1547; Reinhardt UE, 1999, JAMA-J AM MED ASSOC, V281, P462, DOI 10.1001/jama.281.5.462; Rosenbaum S, 2003, JAMA-J AM MED ASSOC, V289, P1546, DOI 10.1001/jama.289.12.1546; Rosenfeld BA, 2000, CRIT CARE MED, V28, P3925, DOI 10.1097/00003246-200012000-00034; ROWAN K, 2000, HLTH CARE UK     SPR, P42; ROWAN KR, 2004, BMJ             0223, DOI DOI 10.1136/BMJ.38007.694745.F7; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; Sanderson CFB, 1997, MED CARE, V35, P669, DOI 10.1097/00005650-199707000-00002; SCHROEDER SA, 1994, INQUIRY-J HEALTH CAR, V31, P266; SCHWARTZ GT, 1994, UCLA LAW REV, V42, P377; Sibbald Bonnie, 2004, J Health Serv Res Policy, V9 Suppl 1, P28, DOI 10.1258/135581904322724112; Sirio C A, 1994, New Horiz, V2, P321; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; SLOAN FA, 1995, MED CARE, V33, P700, DOI 10.1097/00005650-199507000-00006; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; Snyder J V, 1994, New Horiz, V2, P296; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; The Leapfrog Group, FACTSH ICU PHYS STAF; TOWSE A, 2003, REDUCING HARM PATIEN; Tse MM, 2003, GERIATR NURS, V24, P266, DOI 10.1016/S0197-4572(03)00251-9; *UK DEP HLTH, COMPR CRIT CAR REV A; *UK DEP HLTH, 2002, LEARN BRIST DEP HLTH; YOUNG C, 2002, CRITICAL CARE S1, V6, P117; NATL SERVICE FRAMEWO	84	57	57	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1314	1320		10.1016/S0140-6736(04)16007-8	http://dx.doi.org/10.1016/S0140-6736(04)16007-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	813KB	15094279	Bronze, Green Published			2022-12-28	WOS:000220904900024
J	Boyd, P				Boyd, P			Ironing out algal issues in the southern ocean	SCIENCE			English	Editorial Material							POLAR FRONTAL ZONE; PHYTOPLANKTON BLOOM; FERTILIZATION; ENRICHMENT		Univ Otago, Dept Chem, Natl Inst Water & Atmosphere, Dunedin, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago	Boyd, P (corresponding author), Univ Otago, Dept Chem, Natl Inst Water & Atmosphere, POB 56, Dunedin, New Zealand.	p.boyd@niwa.co.nz	Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911				Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; FROST BW, 1991, LIMNOL OCEANOGR, V36, P1616, DOI 10.4319/lo.1991.36.8.1616; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000	15	39	43	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					396	397		10.1126/science.1092677	http://dx.doi.org/10.1126/science.1092677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087535				2022-12-28	WOS:000220845400032
J	Jain, T; Missmer, SA; Hornstein, MD				Jain, T; Missmer, SA; Hornstein, MD			Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; MULTIPLE PREGNANCIES; INSURANCE-COVERAGE; RATES; RISK; BLASTOCYSTS; GESTATION; CULTURE; BIRTHS	Background: During the past decade in the United States, increasing attention has been paid to lowering the incidence of multiple gestations resulting from the use of assisted reproductive technology. To determine whether such efforts have been successful, we assessed national trends in embryo-transfer practice patterns and in outcomes after the use of assisted reproductive technology. Methods: We analyzed data on outcomes of assisted reproductive technology procedures as reported to the Centers for Disease Control and Prevention from 1995 to 2001 by fertility clinics in the United States. We also analyzed data from the National Center for Health Statistics on the rates of twin births and triplet or higher-order multiple births. Results: From 1995 to 2001 in the United States, the number of infertility clinics, the number of fresh-embryo cycles initiated, and the number of fresh-embryo transfers increased steadily. The average number of embryos transferred per cycle began decreasing in 1997, with the steepest decline (an 11.1 percent decrease) between 1998 and 1999. In contrast, the number of pregnancies and live births per cycle during the period from 1995 to 2001 steadily increased. Even though the percentage of pregnancies with twins did not change significantly between 1997 and 2001, the percentage of pregnancies with three or more fetuses significantly decreased every year, with the steepest decline (a 20.8 percent decrease) between 1998 and 1999, after the publication in 1998 of the American Society for Reproductive Medicine guidelines for embryo transfer. Conclusions: Since 1997 in the United States, there have been consistent decreases in both the number of embryos transferred per cycle and the percentage of pregnancies with three or more fetuses, as well as a consistent increase in the percentage of live births per cycle.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hornstein, MD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.	mhornstein@partners.org	Jain, Tarun/ABF-7304-2020	Jain, Tarun/0000-0002-8889-084X				*AM SOC REPR MED, 2000, MULT PREGN ASS INF T; American Society for Reproductive Medicine, 1999, GUID NUMB EMBR TRANS; American Society for Reproductive Medicine. Practice Committee Opinion, 1998, GUID NUMB EMBR TRANS; Andrews L, 1998, SCIENCE, V281, P651; Annas GJ, 1998, NEW ENGL J MED, V339, P935, DOI 10.1056/NEJM199809243391325; ASCHENGRAU A, 2003, ESSENTIALS EPIDEMIOL, P323; BALDWIN V, 2004, 2 GLOB C SOM MASS; BALEN AH, 1993, HUM REPROD, V8, P1324, DOI 10.1093/oxfordjournals.humrep.a138250; BERKOWITZ RL, 1988, NEW ENGL J MED, V318, P1043, DOI 10.1056/NEJM198804213181607; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; *CDCP, 2004, REPR HLTH INF SOURC; Coetsier T, 2001, HUM REPROD, V16, P790; Faber K, 1997, HUM REPROD, V12, P1614; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Gerris J, 2000, HUM REPROD, V15, P1884, DOI 10.1093/humrep/15.9.1884; Jain T, 2003, FERTIL STERIL, V80, P27, DOI 10.1016/S0015-0282(03)00576-4; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Jones HW, 2003, FERTIL STERIL, V79, P17, DOI 10.1016/S0015-0282(02)04565-X; Jones HW, 2001, FERTIL STERIL, V76, pS5; Jones HW, 2001, FERTIL STERIL, V75, P11, DOI 10.1016/S0015-0282(00)01612-5; MARTIN JA, 2002, NATL VITAL STAT REPO, V51; Martin JA, 1999, NATL VITAL STAT REPO, V47; Nygren KG, 2002, HUM REPROD, V17, P3260; Reynolds MA, 2003, FERTIL STERIL, V80, P16, DOI 10.1016/S0015-0282(03)00572-7; Roest J, 1997, FERTIL STERIL, V67, P290, DOI 10.1016/S0015-0282(97)81913-9; Schieve LA, 1999, JAMA-J AM MED ASSOC, V282, P1832, DOI 10.1001/jama.282.19.1832; Soules MR, 2001, FERTIL STERIL, V75, P15, DOI 10.1016/S0015-0282(00)01726-X; STAESSEN C, 1993, HUM REPROD, V8, P1650, DOI 10.1093/oxfordjournals.humrep.a137907; TASDEMIR M, 1995, HUM REPROD, V10, P2155; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; 2000, JAMA, V284, P299; 2002, JAMA, V278, P1521	33	108	109	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1639	1645		10.1056/NEJMsa032073	http://dx.doi.org/10.1056/NEJMsa032073			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084696				2022-12-28	WOS:000220819800008
J	McNamara, JM; Barta, Z; Houston, AI				McNamara, JM; Barta, Z; Houston, AI			Variation in behaviour promotes cooperation in the Prisoner's Dilemma game	NATURE			English	Article							TIT-FOR-TAT; EVOLUTION; STRATEGIES; CHAOS	The Prisoner's Dilemma game(1-4) is widely used to investigate how cooperation between unrelated individuals can evolve by natural selection. In this game, each player can either 'cooperate' (invest in a common good) or 'defect' (exploit the other's investment). If the opponent cooperates, you get R if you cooperate and T if you defect. If the opponent defects, you get S if you cooperate and P if you defect. Here T > R > 0 and P > S, so that 'defect' is the best response to any action by the opponent. Thus in a single play of the game, each player should defect. In our game, a fixed maximum number of rounds of the Prisoner's Dilemma game is played against the same opponent. A standard argument based on working backwards from the last round(1,5) shows that defection on all rounds is the only stable outcome. In contrast, we show that if extrinsic factors maintain variation in behaviour, high levels of co-operation are stable. Our results highlight the importance of extrinsic variability in determining the outcome of evolutionary games.	Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	McNamara, JM (corresponding author), Univ Bristol, Dept Math, Univ Walk, Bristol BS8 1TW, Avon, England.	john.mcnamara@bristol.ac.uk		Barta, Zoltan/0000-0002-7121-9865				AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P379, DOI 10.1177/002200278002400301; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; BOYD R, 1989, J THEOR BIOL, V136, P47, DOI 10.1016/S0022-5193(89)80188-2; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; Brembs B, 1996, OIKOS, V76, P14, DOI 10.2307/3545744; Brockmann HJ, 2001, ADV STUD BEHAV, V30, P1, DOI 10.1016/S0065-3454(01)80004-8; Camerer C, 2003, BEHAV GAME THEORY; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Crowley PH, 1996, EVOL ECOL, V10, P499, DOI 10.1007/BF01237881; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fishman MA, 2001, J THEOR BIOL, V209, P87, DOI 10.1006/jtbi.2000.2248; FUDENBERG D, 1990, AM ECON REV, V80, P274; Giraldeau L.A., 2000, MG BEH ECOL; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Henson SA, 1997, ANNU REV ECOL SYST, V28, P571, DOI 10.1146/annurev.ecolsys.28.1.571; Lorberbaum JP, 2002, J THEOR BIOL, V214, P155, DOI 10.1006/jtbi.2001.2455; Luce RD., 1957, GAMES DECISIONS INTR; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1995, J MATH BIOL, V33, P703; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; Sober E, 1998, UNTO OTHERS; Wahl LM, 1999, J THEOR BIOL, V200, P323, DOI 10.1006/jtbi.1999.0997; WU JZ, 1995, J CONFLICT RESOLUT, V39, P183, DOI 10.1177/0022002795039001008	30	134	135	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					745	748		10.1038/nature02432	http://dx.doi.org/10.1038/nature02432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812EW	15085131				2022-12-28	WOS:000220823800038
J	Jarman, B; Aylin, P; Bottle, A				Jarman, B; Aylin, P; Bottle, A			Dr Foster's case notes - Trends in admissions and deaths in English NHS hospitals	BRITISH MEDICAL JOURNAL			English	Article									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011					0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					855	855		10.1136/bmj.328.7444.855	http://dx.doi.org/10.1136/bmj.328.7444.855			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073069	Green Published			2022-12-28	WOS:000220871400012
J	Vigne, JD; Guilaine, J; Debue, K; Haye, L; Gerard, P				Vigne, JD; Guilaine, J; Debue, K; Haye, L; Gerard, P			Early taming of the cat in Cyprus	SCIENCE			English	Article							MUS-MUSCULUS-DOMESTICUS; NEOLITHIC LATE 9TH; MILLENNIA CAL. BC; LEVANT		Museum Natl Hist Nat, Dept Ecol & Biodivers Management, CNRS, UMR 5197, F-75231 Paris 5, France; CNRS, EHESS, Ctr Anthropol, F-31000 Toulouse, France; Coll France, Chaire Civilisat Europe Neolith & Age Bronze, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Vigne, JD (corresponding author), Museum Natl Hist Nat, Dept Ecol & Biodivers Management, CNRS, UMR 5197, CP 56, F-75231 Paris 5, France.	vigne@mnhn.fr	Gérard, Patrice/A-1564-2011	Gerard, Patrice/0000-0002-6018-6092				AUFFRAY JC, 1988, CR ACAD SCI III-VIE, V307, P517; BOEKSCHOTEN GJ, 1972, PROC K NED AKAD B-PH, V75, P306; Clutton-Brock J, 1981, DOMESTICATED ANIMALS; CROFT P, 1998, CYPRUS, P5; CRUBEZY E, IN PRESS NEOLITHIQUE; Cucchi T, 2002, C R PALEVOL, V1, P235, DOI 10.1016/S1631-0683(02)00033-7; Davis S.J.M., 1987, ARCHAEOLOGY ANIMALS; Guilaine J, 2000, CR ACAD SCI II A, V330, P75, DOI 10.1016/S1251-8050(00)00105-1; Guilaine J., 2001, PALEORIENT, V26, P137; Malek J., 1993, CAT ANCIENT EGYPT; Peltenburg E, 2000, ANTIQUITY, V74, P844, DOI 10.1017/S0003598X0006049X; ROBINSON R, 1984, EVOLUTION DOMESTICAT, P217; Serjeantson D., 1990, ANTHROPOZOOLOGICA, V13, P7; Simmons AH., 2000, FAUNAL EXTINCTION IS; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; VIGNE JD, 2000, ARCHAEOZOOLOGY NEAR, V4, P52; VIGNE JD, IN PRESS ANTROPOZOOL; Vigne Jean-Denis, 1999, P295; Woodman P, 1997, QUATERNARY SCI REV, V16, P129, DOI 10.1016/S0277-3791(96)00037-6	19	151	158	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					259	259		10.1126/science.1095335	http://dx.doi.org/10.1126/science.1095335			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	810QS	15073370				2022-12-28	WOS:000220719400037
J	Greenspan, D; Jordan, RCK				Greenspan, D; Jordan, RCK			The white lesion that kills - aneuploid dysplastic oral leukoplakia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greenspan, D (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.							Sudbo J, 2003, ORAL ONCOL, V39, P497, DOI 10.1016/S1368-8375(03)00012-5	1	14	17	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1382	1384		10.1056/NEJMp048028	http://dx.doi.org/10.1056/NEJMp048028			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070786				2022-12-28	WOS:000220562500003
J	Rosenberg, SA				Rosenberg, SA			Shedding light on immunotherapy for cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							T-CELLS; AUTOIMMUNITY; REGRESSION		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Bethesda, MD 20892 USA.				Intramural NIH HHS [Z01 SC003811-32] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC003811, Z01SC003800] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029	5	123	135	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1461	1463		10.1056/NEJMcibr045001	http://dx.doi.org/10.1056/NEJMcibr045001			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070799	Green Accepted			2022-12-28	WOS:000220562500016
J	Mitchell, P; Hope, T; Gregson, BA; Mendelow, AD				Mitchell, P; Hope, T; Gregson, BA; Mendelow, AD			Regional differences in outcome from subarachnoid haemorrhage: comparative audit	BRITISH MEDICAL JOURNAL			English	Article							SCALE		Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England	Newcastle General Hospital; Newcastle University - UK; University of Nottingham	Mitchell, P (corresponding author), Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	Patrick.Mitchell@ncl.ac.uk	Mendelow, Alexander/AAW-2878-2021	Gregson, Barbara/0000-0003-4868-9137				DRAKE CG, 1988, J NEUROSURG, V68, P985; JENNETT B, 1975, LANCET, V1, P480; NELSON MJ, 1999, SAFE NEUROSURGERY 20; SAHS AL, 1981, ANEURYSMAL SUBARACHN	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 22	2004	328	7450					1234	1235		10.1136/bmj.38084.592639.AE	http://dx.doi.org/10.1136/bmj.38084.592639.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15105285	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000221677200020
J	Demonet, JF; Taylor, MJ; Chaix, Y				Demonet, JF; Taylor, MJ; Chaix, Y			Developmental dyslexia	LANCET			English	Review							QUANTITATIVE-TRAIT LOCUS; BRAIN ACTIVATION PROFILES; CHROMOSOME 6P INFLUENCES; EVENT-RELATED POTENTIALS; READING-DISABILITY; CONTRAST SENSITIVITY; MAGNOCELLULAR DEFICIT; VISUAL-MOTION; SPELLING DISABILITY; CONVERGING EVIDENCE	Developmental dyslexia, or specific reading disability, is a disorder in which children with normal intelligence and sensory abilities show learning deficits for reading. Substantial evidence has established its biological origin and the preponderance of phonological disorders even though important phenotypic variability and comorbidity have been recorded. Diverse theories have been proposed to account for the cognitive and neurological aspects of dyslexia. Findings of genetic studies show that different loci affect specific reading disability although a direct relation has not been established between symptoms and a given genomic locus. In both children and adults with dyslexia, results of neuroimaging studies suggest defective activity and abnormal connectivity between regions crucial for language functions-eg, the left fusiform gyrus for reading-and changes in brain activity associated with performance improvement after various remedial interventions.	Hop Purpan, INSERM, U455, Toulouse, France; Fac Med Toulouse, CNRS, UMR 5549, Toulouse, France; Hop Enfants, Unite Neuropediat, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Demonet, JF (corresponding author), Hop Purpan, INSERM, U455, IFR 96, Toulouse, France.	demonet@toulouse.inserm.fr		Demonet, Jean-Francois/0000-0003-0100-6175				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Amitay S, 2002, BRAIN, V125, P2272, DOI 10.1093/brain/awf231; BAKWIN H, 1973, DEV MED CHILD NEUROL, V15, P184; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; Bednarek DB, 2002, NEUROREPORT, V13, P2521, DOI 10.1097/00001756-200212200-00028; Ben-Yehudah G, 2001, BRAIN, V124, P1381, DOI 10.1093/brain/124.7.1381; Biscaldi M, 2000, PERCEPTION, V29, P509, DOI 10.1068/p2666a; BODER E, 1973, DEV MED CHILD NEUROL, V15, P663; Breznitz Z, 2000, J GENET PSYCHOL, V161, P359, DOI 10.1080/00221320009596718; Brown WE, 2001, NEUROLOGY, V56, P781, DOI 10.1212/WNL.56.6.781; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Corina DP, 2001, NEUROREPORT, V12, P1195, DOI 10.1097/00001756-200105080-00029; Defries J.C., 2015, DEV DISABIL RES REV, V2, P39, DOI [DOI 10.1002/(SICI)1098-2779(1996)2:1<39::AID-MRDD7>3.0.CO;2-S, 10.1002/(sici)1098-2779(1996)2:13.0.co;2-s, DOI 10.1002/(SICI)1098-2779(1996)2:13.0.CO;2-S]; DEFRIES JC, 1978, BRIT J PSYCHIAT, V132, P361, DOI 10.1192/bjp.132.4.361; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DeFries JC, 1997, DYSLEXIA: BIOLOGY, COGNITION AND INTERVENTION, P20; Demonet JF, 1996, BRAIN LANG, V55, P352, DOI 10.1006/brln.1996.0109; Demonet JF, 2001, J CLIN EXP NEUROPSYC, V23, P49, DOI 10.1076/jcen.23.1.49.1218; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Eden GF, 1996, NEUROIMAGE, V4, pS108, DOI 10.1006/nimg.1996.0061; Fagerheim T, 1999, J MED GENET, V36, P664; Fawcett AJ, 2000, LANCET, V356, P89, DOI 10.1016/S0140-6736(00)02464-8; Fawcett AJ, 1999, J MOTOR BEHAV, V31, P68, DOI 10.1080/00222899909601892; FAWCETT AJ, 2003, PRESCHOOL SCREENING; FINUCCI JM, 1976, ANN HUM GENET, V40, P1, DOI 10.1111/j.1469-1809.1976.tb00161.x; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Francks C, 2002, LANCET NEUROL, V1, P483, DOI 10.1016/S1474-4422(02)00221-1; Frith U., 1999, DYSLEXIA, V5, P192, DOI [10.1002/(SICI)1099-0909(199912)5:43.0.CO;2-N, DOI 10.1002/(SICI)1099-0909(199912)5:43.0.CO;2-N, DOI 10.1002/(SICI)1099-0909(199912)5:4<192::AID-DYS144>3.0.CO;2-N]; FROSTER U, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91385-Y; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gallagher A, 2000, J CHILD PSYCHOL PSYC, V41, P203, DOI 10.1111/1469-7610.00601; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Georgiewa P, 2002, NEUROSCI LETT, V318, P5, DOI 10.1016/S0304-3940(01)02236-4; Georgiewa P, 1999, NEUROREPORT, V10, P3459, DOI 10.1097/00001756-199911080-00036; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Grant AC, 1999, NEUROPSYCHOLOGIA, V37, P1201, DOI 10.1016/S0028-3932(99)00013-5; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Grigorenko EL, 2001, AM J MED GENET, V105, P120, DOI 10.1002/1096-8628(20010108)105:1<120::AID-AJMG1075>3.3.CO;2-K; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Habib M, 2002, INT J LANG COMM DIS, V37, P289, DOI 10.1080/13682820210136278; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hatcher PJ, 1999, J EXP CHILD PSYCHOL, V72, P130, DOI 10.1006/jecp.1998.2480; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jenner AR, 2000, CEREB CORTEX, V10, P1005, DOI 10.1093/cercor/10.10.1005; Johannes S, 1996, NEUROPSYCHOLOGIA, V34, P1123, DOI 10.1016/0028-3932(96)00026-7; Khan SC, 1999, PSYCHOPHYSIOLOGY, V36, P76, DOI 10.1017/S0048577299960079; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Knopik VS, 2002, BEHAV GENET, V32, P181, DOI 10.1023/A:1016069012111; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; Kujala T, 2001, NEUROSCI BIOBEHAV R, V25, P535, DOI 10.1016/S0149-7634(01)00032-X; Labatut V, 2004, ARTIF INTELL MED, V30, P119, DOI 10.1016/S0933-3657(03)00042-3; Leonard CM, 2001, CEREB CORTEX, V11, P148, DOI 10.1093/cercor/11.2.148; Leppanen PHT, 1999, NEUROREPORT, V10, P969, DOI 10.1097/00001756-199904060-00014; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lyon G. R., 1996, MENTAL RETARDATION D, V2, P2, DOI [10.1002/(SICI)1098-2779(1996)2:1&lt2::AID-MRDD2&gt3.0.CO;2-X, DOI 10.1002/(SICI)1098-2779(1996)2:1<2::AID-MRDD2>3.0.CO;2-X]; Manis FR, 1996, COGNITION, V58, P157, DOI 10.1016/0010-0277(95)00679-6; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; McPhillips M, 2000, LANCET, V355, P537, DOI 10.1016/S0140-6736(99)02179-0; Morris DW, 2000, HUM MOL GENET, V9, P843, DOI 10.1093/hmg/9.5.843; Nagarajan S, 1999, P NATL ACAD SCI USA, V96, P6483, DOI 10.1073/pnas.96.11.6483; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Nothen MM, 1999, EUR CHILD ADOLES PSY, V8, P56; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; *ORT SOC, 1995, PERSPECTIVES, V21, P16; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Pennington BF, 2001, CHILD DEV, V72, P816, DOI 10.1111/1467-8624.00317; Petryshen TL, 2002, J MED GENET, V39, P125, DOI 10.1136/jmg.39.2.125; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Rae C, 2002, NEUROPSYCHOLOGIA, V40, P1285, DOI 10.1016/S0028-3932(01)00216-0; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Richards TL, 1999, AM J NEURORADIOL, V20, P1393; Richards TL, 2000, AM J NEURORADIOL, V21, P916; Ruff S, 2002, NEUROREPORT, V13, P1285, DOI 10.1097/00001756-200207190-00014; Rumsey JM, 1999, BRAIN LANG, V70, P187, DOI 10.1006/brln.1999.2158; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P1481, DOI 10.1001/archneur.1997.00550240035010; RUMSEY JM, 1992, ARCH NEUROL-CHICAGO, V49, P527, DOI 10.1001/archneur.1992.00530290115020; Schulte-Korne G, 1998, AM J HUM GENET, V63, P279, DOI 10.1086/301919; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); SHAN L, 1995, ENDOCR PATHOL, V6, P145, DOI 10.1007/BF02739877; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shaywitz SE, 1999, PEDIATRICS, V104, P1351, DOI 10.1542/peds.104.6.1351; Simos PG, 2002, J CHILD NEUROL, V17, P159, DOI 10.1177/088307380201700301; Simos PG, 2002, NEUROLOGY, V58, P1203, DOI 10.1212/WNL.58.8.1203; Simos PG, 2000, CEREB CORTEX, V10, P809, DOI 10.1093/cercor/10.8.809; Simos PG, 2000, NEUROSCI LETT, V290, P61, DOI 10.1016/S0304-3940(00)01322-7; Simos PG, 2000, NEUROREPORT, V11, P2443, DOI 10.1097/00001756-200008030-00021; Skottun BC, 2000, VISION RES, V40, P111, DOI 10.1016/S0042-6989(99)00170-4; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Snowling M.J., 1995, J RES READ, V18, P132, DOI DOI 10.1111/J.1467-9817.1995.TB00079.X; Sprenger-Charolles L, 2000, CAN J EXP PSYCHOL, V54, P87, DOI 10.1037/h0087332; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P114, DOI 10.1037/0022-0663.89.1.114; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein JF, 2000, BRAIN, V123, P164, DOI 10.1093/brain/123.1.164; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Talcott JB, 1998, NEURO-OPHTHALMOLOGY, V20, P187, DOI 10.1076/noph.20.4.187.3931; Talcott JB, 2000, NEUROPSYCHOLOGIA, V38, P935, DOI 10.1016/S0028-3932(00)00020-8; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Tallal P, 1998, EXP BRAIN RES, V123, P210, DOI 10.1007/s002210050563; TAYLOR MJ, 1990, PSYCHOPHYSIOLOGY, V27, P318, DOI 10.1111/j.1469-8986.1990.tb00389.x; Taylor MJ, 1999, DEV NEUROPSYCHOL, V15, P307, DOI 10.1080/87565649909540751; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2000, P NATL ACAD SCI USA, V97, P13907, DOI 10.1073/pnas.240461697; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Thomson M., 1999, DYSLEXIA, V5, P127; Torgesen JK, 1999, J EDUC PSYCHOL, V91, P579, DOI 10.1037/0022-0663.91.4.579; Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Vanni S, 1997, NEUROREPORT, V8, P1939, DOI 10.1097/00001756-199705260-00029; *WHO, 1993, INT CLASS DIS, V10; Wise BW, 2000, J EXP CHILD PSYCHOL, V77, P197, DOI 10.1006/jecp.1999.2559; Wolf M, 1999, J EDUC PSYCHOL, V91, P415, DOI 10.1037/0022-0663.91.3.415; Zerbin-Rudin E., 1967, B ORTON SOC, V17, P47	145	319	331	1	104	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1451	1460		10.1016/S0140-6736(04)16106-0	http://dx.doi.org/10.1016/S0140-6736(04)16106-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816ST	15121410				2022-12-28	WOS:000221130300020
J	Hay, AD; Schroeder, K; Fahey, T				Hay, AD; Schroeder, K; Fahey, T			10-minute consultation - Acute cough in children	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Dundee, Tayside Ctr Gen Practic, Dundee DD2 4AD, Scotland	University of Bristol; University of Dundee	Hay, AD (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.	alastair.hay@bristol.ac.uk	Fahey, Tom/C-9367-2012; Hay, Alastair/L-1818-2019	Fahey, Tom/0000-0002-5896-5783; Hay, Alastair/0000-0003-3012-375X					0	8	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 1	2004	328	7447					1062	1062		10.1136/bmj.328.7447.1062	http://dx.doi.org/10.1136/bmj.328.7447.1062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117793	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000221174500022
J	Yang, XG; Matsuda, K; Bialek, P; Jacquot, S; Masuoka, HC; Schinke, T; Li, LZ; Brancorsini, S; Sassone-Corsi, P; Townes, TM; Hanauer, A; Karsenty, G				Yang, XG; Matsuda, K; Bialek, P; Jacquot, S; Masuoka, HC; Schinke, T; Li, LZ; Brancorsini, S; Sassone-Corsi, P; Townes, TM; Hanauer, A; Karsenty, G			ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome	CELL			English	Article							MENTAL-RETARDATION SYNDROME; UNFOLDED PROTEIN RESPONSE; C-FOS GENE; TRANSCRIPTION FACTOR; CLEIDOCRANIAL DYSPLASIA; TRANSLATIONAL CONTROL; TARGETED DISRUPTION; BONE-FORMATION; CELL-SURVIVAL; MAPK PATHWAY	Coffin-Lowry Syndrome (CLS) is an X-linked mental retardation condition associated with skeletal abnormalities. The gene mutated in CLS, RSK2, encodes a growth factor-regulated kinase. However, the cellular and molecular bases of the skeletal abnormalities associated with CLS remain unknown. Here, we show that RSK2 is required for osteoblast differentiation and function. We identify the transcription factor ATF4 as a critical substrate of RSK2 that is required for the timely onset of osteoblast differentiation, for terminal differentiation of osteoblasts, and for osteoblast-specific gene expression. Additionally, RSK2 and ATF4 posttranscriptionally regulate the synthesis of Type I collagen, the main constituent of the bone matrix. Accordingly, Atf4-deficiency results in delayed bone formation during embryonic development and low bone mass throughout postnatal life. These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program, Houston, TX 77030 USA; CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Baylor College of Medicine; Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Alabama System; University of Alabama Birmingham	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu	Brancorsini, Stefano/L-8770-2015; Sassone-Corsi, Paolo/H-6182-2011; Matsuda, Koichi/D-4597-2011	Brancorsini, Stefano/0000-0002-8410-7248; Matsuda, Koichi/0000-0001-7292-2686				AUBIN JE, 2002, MESSENCHYMAL STEM CE, V1; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; COFFIN R, 1966, J PEDIATR-US, V69, P198, DOI 10.1016/S0022-3476(66)80320-7; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LOWRY B, 1971, AM J DIS CHILD, V121, P496, DOI 10.1001/archpedi.1971.02100170078009; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MCKNIGHT SL, 1992, CCAAT ENHANCER BINDI, V2; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Merienne K, 2000, ONCOGENE, V19, P4221, DOI 10.1038/sj.onc.1203712; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; PARFITT AM, 1987, J BONE MINER RES, V2, P427; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	43	601	637	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					387	398		10.1016/S0092-8674(04)00344-7	http://dx.doi.org/10.1016/S0092-8674(04)00344-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109498	Bronze			2022-12-28	WOS:000221176400012
J	Delmonico, FL				Delmonico, FL			Exchanging kidneys - Advances in living-donor transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; New England Organ Bank Inc, Boston, MA USA	Harvard University; Harvard Medical School	Delmonico, FL (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.							OJO A, SCI REGISTRY TRANSPL; Park K, 1999, TRANSPLANTATION, V67, P336, DOI 10.1097/00007890-199901270-00027; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0	3	77	80	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1812	1814		10.1056/NEJMp038228	http://dx.doi.org/10.1056/NEJMp038228			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115826				2022-12-28	WOS:000221080300002
J	Rosen, JB; Breman, JG				Rosen, JB; Breman, JG			Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations	LANCET			English	Review							PLACEBO-CONTROLLED TRIAL; IMMUNE-RESPONSE; MEASLES VACCINATION; ANTIBODY-RESPONSE; CHILDREN; CHLOROQUINE; ANEMIA; AREA	Context Malaria accounts for 1-3 million deaths yearly worldwide, mostly in children under 5 years of age in sub-Saharan Africa. Laboratory and clinical studies show an association between acute malaria and a decreased response to diphtheria and tetanus toxoids and to meningococcal, salmonella, and Haemophilus influenzae, type b vaccinations. Malaria treatment, chemoprophylaxis, or other forms of parasite suppression might improve the immune response to childhood vaccinations. However, the antimalarial 4-aminoquinolones are immunodepressive, such that antimalarial drugs might depress the vaccine response. Starting point Last year, Julius Massage and colleagues reported a randomised double-blinded placebo-controlled study in 291 infants aged 12-16 weeks in Tanzia (lancet 2003; 361: 1853-60). At enrolment, children received their third dose of combined diphtheria-tetanus-pertussis and poliomyelitis expanded vaccines with the first of three daily doses of amodiaquine intermittent preventive treatment (IPTi) or placebo. After 60 days, children receiving amodiaquine had significantly fewer malaria fevers than controls. Where next The increasing concordance of malaria control and vaccination, movement toward co-administration of IPTi with immunisation, and the increase in travellers to malarious areas who receive concurrent vaccinations and chemoprophylaxis warrant further study.	NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; NIH, Howard Hughes Med Inst, Natl Inst Hlth Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Rosen, JB (corresponding author), NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	jennifer.rosen@uhmc.sunysb.edu						BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CENAC A, 1988, T ROY SOC TROP MED H, V82, P405, DOI 10.1016/0035-9203(88)90135-6; Faucher JF, 2002, CLIN INFECT DIS, V35, P1147, DOI 10.1086/342908; GREENWOOD AM, 1981, ANN TROP MED PARASIT, V75, P261, DOI 10.1080/00034983.1981.11687439; GREENWOOD BM, 1972, LANCET, V1, P169; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; McGREGOR IAN A., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P364, DOI 10.1016/0035-9203(62)90005-6; MONJOUR L, 1982, B WORLD HEALTH ORGAN, V60, P589; MONJOUR L, 1985, PATHOL BIOL, V33, P232; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Usen S, 2000, PEDIATR INFECT DIS J, V19, P444, DOI 10.1097/00006454-200005000-00010; WILLIAMSON WA, 1978, LANCET, V1, P1328	13	23	23	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1386	1388		10.1016/S0140-6736(04)16052-2	http://dx.doi.org/10.1016/S0140-6736(04)16052-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110499				2022-12-28	WOS:000220996300025
J	Hakkinen, S; Rhines, PB				Hakkinen, S; Rhines, PB			Decline of subpolar North Atlantic circulation during the 1990s	SCIENCE			English	Article							DECADAL VARIABILITY; OCEAN; OSCILLATION; TOPEX/POSEIDON; TRANSPORT; MODEL; WATER; DEPTH; GYRE	Observations of sea surface height reveal that substantial changes have occurred over the past decade in the mid- to high-latitude North Atlantic Ocean. TOPEX/Poseidon altimeter data show that subpolar sea surface height increased during the 1990s, and the geostrophic velocity derived from altimeter data exhibits declining subpolar gyre circulation. Combining the data from earlier satellites, we find that subpolar circulation may have been weaker in the late 1990s than in the late 1970s and 1980s. Direct current-meter observations in the boundary current of the Labrador Sea support the weakening circulation trend of the 1990s and, together with hydrographic data, show that the mid- to late 1990s decline extends deep in the water column. Analysis of the local surface forcing suggests that the 1990s buoyancy forcing has a dynamic effect consistent with altimetric and hydrographic observations: A weak thermohaline forcing allows the decay of the domed structure of subpolar isopycnals and weakening of circulation.	NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Washington, Seattle, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Washington; University of Washington Seattle	Hakkinen, S (corresponding author), NASA, Goddard Space Flight Ctr, Code 971, Greenbelt, MD 20771 USA.	sirpa.hakkinen@nasa.gov	Hakkinen, Sirpa/E-1461-2012					Belkin IM, 1998, PROG OCEANOGR, V41, P1, DOI 10.1016/S0079-6611(98)00015-9; Bower AS, 2002, NATURE, V419, P603, DOI 10.1038/nature01078; Cuny J, 2002, J PHYS OCEANOGR, V32, P627, DOI 10.1175/1520-0485(2002)032<0627:LSBCAT>2.0.CO;2; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; DESER C, 1993, J CLIMATE, V6, P1743, DOI 10.1175/1520-0442(1993)006<1743:SCVOTN>2.0.CO;2; Dickson B, 2002, NATURE, V416, P832, DOI 10.1038/416832a; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; DICKSON RR, 1988, PROG OCEANOGR, V20, P103, DOI 10.1016/0079-6611(88)90049-3; DOSCHER R, 1994, J PHYS OCEANOGR, V24, P2306, DOI 10.1175/1520-0485(1994)024<2306:ROCAHT>2.0.CO;2; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Flatau MK, 2003, J CLIMATE, V16, P2355, DOI 10.1175/2787.1; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; GREATBATCH RJ, 1989, J PHYS OCEANOGR, V19, P572, DOI 10.1175/1520-0485(1989)019<0572:SVIALB>2.0.CO;2; Hakkinen S, 2001, J GEOPHYS RES-OCEANS, V106, P13837, DOI 10.1029/1999JC000155; Han GQ, 2001, J PHYS OCEANOGR, V31, P199, DOI 10.1175/1520-0485(2001)031<0199:IVOVTI>2.0.CO;2; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Lazier J, 2002, DEEP-SEA RES PT I, V49, P1819, DOI 10.1016/S0967-0637(02)00064-X; Pickart RS, 2003, NATURE, V424, P152, DOI 10.1038/nature01729; Reverdin G, 1997, J GEOPHYS RES-OCEANS, V102, P8505, DOI 10.1029/96JC03943; RHINES PB, 1969, J FLUID MECH, V37, P161, DOI 10.1017/S0022112069000474; Smethie WM, 2001, DEEP-SEA RES PT I, V48, P189, DOI 10.1016/S0967-0637(00)00048-0; Verbrugge N, 2003, J PHYS OCEANOGR, V33, P964, DOI 10.1175/1520-0485(2003)033<0964:COHATT>2.0.CO;2; White MA, 1995, J GEOPHYS RES-OCEANS, V100, P24931, DOI 10.1029/95JC02123	24	446	456	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					555	559		10.1126/science.1094917	http://dx.doi.org/10.1126/science.1094917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15087505				2022-12-28	WOS:000220975100040
J	Robinson, JC				Robinson, JC			Reinvention of health insurance in the consumer era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; PLANS	The private health insurance industry in the United States has fundamentally changed its strategic focus, product design, and pricing policy as a result of the backlash against managed care. Rather than seek to influence the behavior of physicians through capitation and utilization review, the major health plans now seek to influence the behavior of patients through benefit designs that cover a broad range of services but with high co-payments, tiered network designs that cover a broad range of physicians but with variable coinsurance, and medical management programs that provide incentives for patients to better manage their own health care. Premium prices are carefully adjusted to cover the expected costs of care for each type of product and each class of patient, with a commensurate willingness to abandon enrollment where insurance premiums cannot outrun medical costs. The contemporary product and pricing policies reflect a retreat by the insurance industry from previous efforts to transform the health care system and embody a delegation to individual consumers of responsibility for setting priorities and making financial tradeoffs.	Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robinson, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 418 Warren Hall, Berkeley, CA 94720 USA.	jamie@socrates.berkeley.edu						Baker L, 2003, HEALTH AFFAIR, V22, pW537; Berk ML, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.2.9; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Christianson JB, 2002, HEALTH AFFAIR, V21, P49, DOI 10.1377/hlthaff.21.1.49; Danzon PM, 2002, J LAW ECON, V45, P587, DOI 10.1086/368005; Draper DA, 2002, HEALTH AFFAIR, V21, P11, DOI 10.1377/hlthaff.21.1.11; Enthoven AC, 1980, HLTH PLAN ONLY PRACT; FELDSTEIN PJ, 1988, NEW ENGL J MED, V318, P1310, DOI 10.1056/NEJM198805193182006; Gabel J, 2003, HEALTH AFFAIR, V22, P117, DOI 10.1377/hlthaff.22.5.117; Gabel JR, 2001, HEALTH AFFAIR, V20, P47, DOI 10.1377/hlthaff.20.2.47; GABEL JR, 2003, HLTH AFF MILLWOOD S, pW395; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Kaiser Family Foundation, 2003, EMPL HLTH BEN 2003 A; LEE JS, 2002, HLTH AFF MILLWOOD S, pW229; Luft HS, 1999, J HEALTH POLIT POLIC, V24, P957; MANNING WG, 1987, AM ECON REV, V77, P251; Newhouse JP, 1996, J ECON LIT, V34, P1236; RASKIN JR, 2004, HLTH CARE MAN CARE 2; Robinson JC, 2004, HEALTH AFFAIR, V23, P43, DOI 10.1377/hlthaff.23.2.43; Robinson JC, 2001, JAMA-J AM MED ASSOC, V285, P2622, DOI 10.1001/jama.285.20.2622; Robinson JC, 2003, HLTH AFF MILLWOOD S; ROBINSON JC, 2002, HLTH AFF MILLWOOD S, pW139; ROBINSON JC, IN PRESS HLTH AFF MI; ROTHSCHILD M, 1976, Q J ECON, V90, P629, DOI 10.2307/1885326; STRUNK BC, 2003, HLTH AFF MILLWOOD S, pW266; Thorpe KE, 1999, J HEALTH POLIT POLIC, V24, P949; Weinick RM, 2000, HEALTH AFFAIR, V19, P178, DOI 10.1377/hlthaff.19.3.178; Wong MD, 2001, AM J PUBLIC HEALTH, V91, P1889, DOI 10.2105/AJPH.91.11.1889	28	57	57	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1880	1886		10.1001/jama.291.15.1880	http://dx.doi.org/10.1001/jama.291.15.1880			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812XC	15100208	Green Published			2022-12-28	WOS:000220871200030
J	Lai, C; Vummidi, DR				Lai, C; Vummidi, DR			Lemierre's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cannock Chase Hosp, Cannock WS11 2XY, England		Lai, C (corresponding author), Cannock Chase Hosp, Cannock WS11 2XY, England.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					E14	E14		10.1056/ENEJMicm030003	http://dx.doi.org/10.1056/ENEJMicm030003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812DI	15084710				2022-12-28	WOS:000220819800012
J	Zwart, SFP; Baumgardt, H; Hut, P; Makino, J; McMillan, SLW				Zwart, SFP; Baumgardt, H; Hut, P; Makino, J; McMillan, SLW			Formation of massive black holes through runaway collisions in dense young star clusters	NATURE			English	Article							X-RAY SOURCE; LUMINOSITY FUNCTION; M82; DISCOVERY; EVOLUTION; ECOLOGY; GROWTH; MASSES; CORE	A luminous X-ray source is associated with MGG 11-a cluster of young stars similar to200 pc from the centre of the starburst galaxy M 82 (refs 1, 2). The properties of this source are best explained(3,4) by invoking a black hole with a mass of at least 350 solar masses (350M.), which is intermediate between stellar-mass and supermassive black holes. A nearby but somewhat more massive cluster ( MGG 9) shows no evidence of such an intermediate-mass black hole(1,3), raising the issue of just what physical characteristics of the clusters can account for this difference. Here we report numerical simulations of the evolution and motion of stars within the clusters, where stars are allowed to merge with each other. We find that for MGG 11 dynamical friction leads to the massive stars sinking rapidly to the centre of the cluster, where they participate in a runaway collision. This produces a star of 800-3,000 M., which ultimately collapses to a black hole of intermediate mass. No such runaway occurs in the cluster MGG 9, because the larger cluster radius leads to a mass segregation timescale a factor of five longer than for MGG 11.	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Inst Comp Sci, NL-1012 WX Amsterdam, Netherlands; RIKEN, Inst Adv Phys & Chem Res, Wako, Saitama 351019, Japan; Inst Adv Study, Princeton, NJ 08540 USA; Univ Tokyo, Dept Astron, Tokyo 113, Japan; Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA	University of Amsterdam; University of Amsterdam; RIKEN; Institute for Advanced Study - USA; University of Tokyo; Drexel University	Zwart, SFP (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1012 WX Amsterdam, Netherlands.	spz@science.uva.nl	Makino, Junichiro/A-9525-2014; Makino, Junichiro/K-5260-2019; Baumgardt, Holger/A-5444-2012	Makino, Junichiro/0000-0002-0411-4297; 				Aarseth SJ, 1999, PUBL ASTRON SOC PAC, V111, P1333, DOI 10.1086/316455; Baumgardt H, 2003, MON NOT R ASTRON SOC, V340, P227, DOI 10.1046/j.1365-8711.2003.06286.x; CAMPBELL B, 1992, ASTRON J, V104, P1721, DOI 10.1086/116355; Ebisuzaki T, 2001, ASTROPHYS J, V562, pL19, DOI 10.1086/338118; GURKAN MA, 2003, IN PRESS ASTORPHYS J; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Heggie D., 2003, GRAVITATIONAL MILLIO, DOI [10.1017/CBO9781139164535, DOI 10.1017/CBO9781139164535]; HOPMAN C, 2003, UNPUB ASTORPHYS J LE; HUT P, 1985, STARLAB; Ishii M, 1999, PUBL ASTRON SOC JPN, V51, P417, DOI 10.1093/pasj/51.4.417; Kaaret P, 2001, MON NOT R ASTRON SOC, V321, pL29, DOI 10.1046/j.1365-8711.2001.04064.x; KING IR, 1966, ASTRON J, V71, P64, DOI 10.1086/109857; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Matsumoto H, 1999, PUBL ASTRON SOC JPN, V51, P567, DOI 10.1093/pasj/51.4.567; Matsumoto H, 2001, ASTROPHYS J, V547, pL25, DOI 10.1086/318878; MATSUSHITA S, 2000, APJ, V545, P107; McCrady N, 2003, ASTROPHYS J, V596, P240, DOI 10.1086/377631; Mengel S, 2002, ASTRON ASTROPHYS, V383, P137, DOI 10.1051/0004-6361:20011704; MOFFAT AFJ, 1994, ASTROPHYS J, V436, P183, DOI 10.1086/174891; Piatti AE, 1998, ASTRON ASTROPHYS SUP, V127, P423, DOI 10.1051/aas:1998111; Portegies Zwart S, 1999, ASTRON ASTROPHYS, V348, P117; Portegies Zwart S, 2002, ASTROPHYS J, V576, P899, DOI 10.1086/341798; Portegies Zwart S, 2001, MON NOT R ASTRON SOC, V321, P199, DOI 10.1046/j.1365-8711.2001.03976.x; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SINGER D, 2004, 8297 IAU; SPITZER L, 1971, ASTROPHYS J, V164, P399, DOI 10.1086/150855; Stothers RB, 1997, ASTROPHYS J, V489, P319, DOI 10.1086/304771; Strohmayer TE, 2003, ASTROPHYS J, V586, pL61, DOI 10.1086/374732; Whitmore BC, 1999, ASTRON J, V118, P1551, DOI 10.1086/301041; Zezas A, 2002, ASTROPHYS J, V577, P710, DOI 10.1086/342160	30	506	507	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					724	726		10.1038/nature02448	http://dx.doi.org/10.1038/nature02448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085124	Green Submitted			2022-12-28	WOS:000220823800031
J	Adams, T; Budden, M; Hoare, C; Sanderson, H				Adams, T; Budden, M; Hoare, C; Sanderson, H			Lessons from the central Hampshire electronic health record pilot project: issues of data protection and consent	BRITISH MEDICAL JOURNAL			English	Article									Hampshire & Isle Wight Strateg Hlth Author, Southampton SO16 4GX, Hants, England; W Pk Hosp, E Surrey Hlth Informat Serv, Surrey & Sussex Strateg Hlth Author, Surrey K19 8PB, England; Winchester & Eastleigh Healthcare Trust, Winchester SO22 5DG, Hants, England		Adams, T (corresponding author), Hampshire & Isle Wight Strateg Hlth Author, Southampton SO16 4GX, Hants, England.	trina.adams@hiowha.nhs.uk						Chalmers J, 2003, BMJ-BRIT MED J, V326, P725, DOI 10.1136/bmj.326.7392.725; *INF COMM, 2002, US DISCL HLTH DAT GU; *NHS INF AUTH, 2002, BUILD INF COR IMPL N; *NHS INF AUTH, 2002, SHAR WITH CAR; *NHS INF AUTH, 1998, INF HLTH; 2003, NATL PROGRAMME INF 3; 2002, S STAFFORDSHIRE PATI	7	21	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					871	874		10.1136/bmj.328.7444.871	http://dx.doi.org/10.1136/bmj.328.7444.871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073070	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000220871400018
J	Schmidt-Hieber, C; Jonas, P; Bischofberger, J				Schmidt-Hieber, C; Jonas, P; Bischofberger, J			Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; RAT DENTATE GYRUS; MEMBRANE-PROPERTIES; NEURONS; NEUROGENESIS; DEPRESSION; INDUCTION; SEQUENCES; CURRENTS; CHANNELS	Neural stem cells in various regions of the vertebrate brain continuously generate neurons throughout life(1-4). In the mammalian hippocampus, a region important for spatial and episodic memory(5,6), thousands of new granule cells are produced per day(7), with the exact number depending on environmental conditions and physical exercise(1,8). The survival of these neurons is improved by learning and conversely learning may be promoted by neurogenesis(8-10). Although it has been suggested that newly generated neurons may have specific properties to facilitate learning(2,10,11), the cellular and synaptic mechanisms of plasticity in these neurons are largely unknown. Here we show that young granule cells in the adult hippocampus differ substantially from mature granule cells in both active and passive membrane properties. In young neurons, T-type Ca2+ channels can generate isolated Ca2+ spikes and boost fast Na+ action potentials, contributing to the induction of synaptic plasticity. Associative long-term potentiation can be induced more easily in young neurons than in mature neurons under identical conditions. Thus, newly generated neurons express unique mechanisms to facilitate synaptic plasticity, which may be important for the formation of new memories.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Bischofberger, J (corresponding author), Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany.	josef.bischofberger@uni-freiburg.de		Schmidt-Hieber, Christoph/0000-0002-5328-9704; Bischofberger, Josef/0000-0002-4006-1663; Jonas, Peter/0000-0001-5001-4804				BLAXTER TJ, 1989, J PHYSIOL-LONDON, V412, P93, DOI 10.1113/jphysiol.1989.sp017605; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; ELIOT LS, 1994, J NEUROPHYSIOL, V72, P762, DOI 10.1152/jn.1994.72.2.762; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Liu SH, 2003, J NEUROSCI, V23, P732; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; LUBBERS K, 1988, ANAT EMBRYOL, V178, P119, DOI 10.1007/BF02463645; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Normann C, 2000, J NEUROSCI, V20, P8290, DOI 10.1523/JNEUROSCI.20-22-08290.2000; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RIHN LL, 1990, DEV BRAIN RES, V54, P115, DOI 10.1016/0165-3806(90)90071-6; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seki T, 2002, J NEUROSCI RES, V69, P772, DOI 10.1002/jnr.10366; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a	30	919	954	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2004	429	6988					184	187		10.1038/nature02553	http://dx.doi.org/10.1038/nature02553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819ZU	15107864				2022-12-28	WOS:000221356300042
J	Goren-Inbar, N; Alperson, N; Kislev, ME; Simchoni, O; Melamed, Y; Ben-Nun, A; Werker, E				Goren-Inbar, N; Alperson, N; Kislev, ME; Simchoni, O; Melamed, Y; Ben-Nun, A; Werker, E			Evidence of hominin control of fire at Gesher Benot Ya'aqov, Israel	SCIENCE			English	Article							MIDDLE PLEISTOCENE; SEDIMENTS; MINERALS; AFRICA; KENYA	The presence of burned seeds, wood, and flint at the Acheulian site of Gesher Benot Ya'aqov in Israel is suggestive of the control of. re by humans nearly 790,000 years ago. The distribution of the site's small burned flint fragments suggests that burning occurred in specific spots, possibly indicating hearth locations. Wood of six taxa was burned at the site, at least three of which are edible-olive, wild barley, and wild grape.	Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Bot, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, GIS Ctr, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Goren-Inbar, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Mt Scopus, IL-91905 Jerusalem, Israel.	goren@cc.huji.ac.il						[Anonymous], 1997, FOREST ECOLOGY; Belitzky S, 2002, QUATERNARY RES, V58, P372, DOI 10.1006/qres.2002.2347; BELLOMO RV, 1994, J HUM EVOL, V27, P173, DOI 10.1006/jhev.1994.1041; Bird MI, 1998, NATURE, V394, P767, DOI 10.1038/29507; CALLOW P, 1986, COTTE BRELADE 1961; Clark JD, 1985, AFR ARCHAEOL REV, V3, P3, DOI DOI 10.1007/BF01117453; FAHN A, 1986, ANATOMY IDENTIFICATI; Garrod D.A.E., 1937, STONE AGE MOUNT CARM, VI; GERAADS D, 1983, ANTHROPOLOGIE, V87, P138; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N, 2002, ACHEULIAN SITE GESHE; GOWLETT JAJ, 1981, NATURE, V294, P125, DOI 10.1038/294125a0; JAMES SR, 1989, CURR ANTHROPOL, V30, P1, DOI 10.1086/203705; Karkanas P, 2002, J ARCHAEOL SCI, V29, P721, DOI 10.1006/jasc.2001.0742; Kislev Mordechai, 1997, Lagascalia, V19, P289; Klein R. G., 1999, HUMAN CAREER HUMAN B; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meignen L., 2000, PALEORIENT, V26, P9; MERCIER N, 1995, J ARCHAEOL SCI, V22, P495, DOI 10.1006/jasc.1995.0048; OAKLEY KP, 1961, SOCIAL LIFE EARLY MA, P176; Olive M., 1989, NATURE FONCTION FOYE; Purdy B. A, 1975, LITHIC TECHNOLOGY MA, P133; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; TURVILLE-PETRE F, 1927, RES PREHISTORIC GALI; Weiner S, 1998, SCIENCE, V281, P251, DOI 10.1126/science.281.5374.251; Weiner S, 2002, J ARCHAEOL SCI, V29, P1289, DOI 10.1006/jasc.2001.0790; Whelan R.J.., 1995, ECOLOGY FIRE	30	307	322	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					725	727		10.1126/science.1095443	http://dx.doi.org/10.1126/science.1095443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118160				2022-12-28	WOS:000221105300042
J	Paushkin, SV; Patel, M; Furia, BS; Peltz, SW; Trotta, CR				Paushkin, SV; Patel, M; Furia, BS; Peltz, SW; Trotta, CR			Identification of a human endonuclease complex reveals a link between tRNA splicing and Pre-mRNA 3 ' end formation	CELL			English	Article							CANCER SUSCEPTIBILITY GENE; SACCHAROMYCES-CEREVISIAE; INTERVENING SEQUENCES; PROTEIN INTERACTIONS; RIBONUCLEASE-P; XENOPUS-LAEVIS; YEAST; CLEAVAGE; POLYADENYLATION; TRANSCRIPTION	tRNA splicing is a fundamental process required for cell growth and division. The first step in tRNA splicing is the removal of introns catalyzed in yeast by the tRNA splicing endonuclease. The enzyme responsible for intron removal in mammalian cells is unknown. We present the identification and characterization of the human tRNA splicing endonuclease. This enzyme consists of HsSen2, HsSen34, HsSen15, and HsSen54, homologs of the yeast tRNA endonuclease subunits. Additionally, we identified an alternatively spliced isoform of SEN2 that is part of a complex with unique RNA endonuclease activity. Surprisingly, both human endonuclease complexes are associated with pre-mRNA3' end processing factors. Furthermore, siRNA-mediated depletion of SEN2 exhibited defects in maturation of both pre-tRNA and pre-mRNA. These findings demonstrate a link between pre-tRNA splicing and pre-mRNA 3' end formation, suggesting that the endonuclease subunits function in multiple RNA-processing events.	PTC Therapeut, S Plainfield, NJ 07080 USA		Trotta, CR (corresponding author), PTC Therapeut, 100 Corp Court, S Plainfield, NJ 07080 USA.	ctrotta@ptcbio.com						Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; BALDI MI, 1986, CELL, V47, P965, DOI 10.1016/0092-8674(86)90811-1; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; Bujnicki JM, 2000, FEBS LETT, V486, P328, DOI 10.1016/S0014-5793(00)02322-X; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; DEROBERTIS EM, 1979, NATURE, V278, P137, DOI 10.1038/278137a0; Fabbri S, 1998, SCIENCE, V280, P284, DOI 10.1126/science.280.5361.284; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; GANDINIATTARDI D, 1990, METHOD ENZYMOL, V181, P510; HO CK, 1990, EMBO J, V9, P1245, DOI 10.1002/j.1460-2075.1990.tb08232.x; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacobson MR, 1997, J CELL SCI, V110, P829; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; MATTOCCIA E, 1979, CELL, V18, P643, DOI 10.1016/0092-8674(79)90119-3; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; OCONNOR JP, 1992, MOL CELL BIOL, V12, P3843, DOI 10.1128/MCB.12.9.3843; OGDEN RC, 1984, NUCLEIC ACIDS RES, V12, P9367, DOI 10.1093/nar/12.24.9367; OTSUKA A, 1981, MOL CELL BIOL, V1, P269, DOI 10.1128/MCB.1.3.269; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; Simard J, 2002, ENDOCRINOLOGY, V143, P2029, DOI 10.1210/en.143.6.2029; STANDRING DN, 1981, P NATL ACAD SCI-BIOL, V78, P5963, DOI 10.1073/pnas.78.10.5963; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; TROTTA CR, 1998, RNA WORLD, V2, P561; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; WESTAWAY SK, 1988, J BIOL CHEM, V263, P3171; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733	45	165	180	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					311	321		10.1016/S0092-8674(04)00342-3	http://dx.doi.org/10.1016/S0092-8674(04)00342-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109492	Bronze			2022-12-28	WOS:000221176400006
J	Rosenblatt, J; Cramer, LP; Baum, B; McGee, KM				Rosenblatt, J; Cramer, LP; Baum, B; McGee, KM			Myosin II-dependent cortical movement is required for centrosome separation and positioning during mitotic spindle assembly	CELL			English	Article							CAENORHABDITIS-ELEGANS; CHROMOSOME MOVEMENT; CYTOPLASMIC DYNEIN; CELL-DIVISION; CYTOKINESIS; MITOSIS; FLOW; MICROTUBULES; DROSOPHILA; INHIBITOR	The role of myosin II in mitosis is generally thought to be restricted to cytokinesis. We present surprising new evidence that cortical myosin II is also required for spindle assembly in cells. Drug- or RNAi-mediated disruption of myosin II in cells interferes with normal spindle assembly and positioning. Time-lapse movies reveal that these treatments block the separation and positioning of duplicated centrosomes after nuclear envelope breakdown (NEBD), thereby preventing the migration of the microtubule asters to opposite sides of chromosomes. Immobilization of cortical movement with tetravalent lectins produces similar spindle defects to myosin II disruption and suggests that myosin II activity is required within the cortex. Latex beads bound to the cell surface move in a myosin II-dependent manner in the direction of the separating asters. We propose that after NEBD, completion of centrosome separation and positioning around chromosomes depends on astral microtubule connections to a moving cell cortex.	UCL, MRC, Mol Cell Biol Lab, London SC1E 6BT, England; UCL, Ludwig Inst Canc Res, London W1W 7BS, England	University of London; University College London; Ludwig Institute for Cancer Research; University of London; University College London	Rosenblatt, J (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London SC1E 6BT, England.	jody.rosenblatt@uci.ac.uk	Rosenblatt, Jody/AAD-4260-2019; McGee, Karen/B-4937-2009	Rosenblatt, Jody/0000-0001-9460-5868; McGee, Karen/0000-0001-6431-8729; Baum, Buzz/0000-0002-9201-6186				Benink HA, 2000, MOL BIOL CELL, V11, P2553, DOI 10.1091/mbc.11.8.2553; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Canman JC, 1997, J CELL SCI, V110, P1907; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; KIEHART DP, 1982, J CELL BIOL, V94, P165, DOI 10.1083/jcb.94.1.165; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; MEEUSEN RL, 1980, J CELL BIOL, V86, P858, DOI 10.1083/jcb.86.3.858; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Silverman-Gavrila RV, 2001, CELL MOTIL CYTOSKEL, V50, P180, DOI 10.1002/cm.10006; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TENCER R, 1978, EXP CELL RES, V116, P253, DOI 10.1016/0014-4827(78)90446-9; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; WANG YL, 1994, J CELL BIOL, V127, P963, DOI 10.1083/jcb.127.4.963; Whitehead CM, 1996, CELL MOTIL CYTOSKEL, V35, P298, DOI 10.1002/(SICI)1097-0169(1996)35:4<298::AID-CM3>3.0.CO;2-3	27	215	223	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 30	2004	117	3					361	372		10.1016/S0092-8674(04)00341-1	http://dx.doi.org/10.1016/S0092-8674(04)00341-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109496	Bronze			2022-12-28	WOS:000221176400010
J	Koralnik, IJ; Schellingerhout, D; Frosch, MP; Harris, NL; Buonanno, F; Black-Schaffer, RM				Koralnik, IJ; Schellingerhout, D; Frosch, MP; Harris, NL; Buonanno, F; Black-Schaffer, RM			Case 14-2004: A 66-year-old man with progressive neurologic deficits - Progressive multifocal leukoencephalopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLYMERASE CHAIN-REACTION; HUMORAL IMMUNE-RESPONSE; JC VIRUS EPITOPE; CEREBROSPINAL-FLUID; PROLONGED SURVIVAL; AIDS; BRAIN; DNA; TRANSPLANTATION; AMPLIFICATION		Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Koralnik, IJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.		Black-Schaffer, Randie/AAY-4671-2021; Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861	NCI NIH HHS [2PO1CA6924605, 1-R24-CA92782-01] Funding Source: Medline; NIAID NIH HHS [P30-AI 28691] Funding Source: Medline; NINDS NIH HHS [R01NS/AI 41198, R01 NS 047029, R21 NS 046243] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA092782, P01CA069246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041198, R21NS046243, R01NS047029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aksamit AJ, 2001, J NEUROVIROL, V7, P386, DOI 10.1080/13550280152537292; Antinori A, 1997, NEUROLOGY, V48, P687, DOI 10.1212/WNL.48.3.687; ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; BERGER JR, 1989, NEUROLOGY, V39, P324, DOI 10.1212/WNL.39.3.324; Berger JR, 1998, ANN NEUROL, V44, P341, DOI 10.1002/ana.410440309; Berner B, 1999, NEPHROL DIAL TRANSPL, V14, P462, DOI 10.1093/ndt/14.2.462; Bofill-Mas S, 2001, J NEUROVIROL, V7, P345, DOI 10.1080/13550280152537210; Chang L, 1997, NEUROLOGY, V48, P836, DOI 10.1212/WNL.48.4.836; Cinque P, 2003, J NEUROVIROL, V9, P88, DOI 10.1080/13550280390195298; Cinque P, 1996, AIDS, V10, P951, DOI 10.1097/00002030-199610090-00004; Du Pasquier RA, 2003, J VIROL, V77, P11918, DOI 10.1128/JVI.77.22.11918-11926.2003; Du Pasquier RA, 2003, J NEUROVIROL, V9, P25, DOI 10.1080/13550280390195315; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; HALLERVORDEN J, 1930, HDB GEITESKRANHEITEN, V2, P1063; Herrlinger U, 2002, ANN NEUROL, V52, P390, DOI 10.1002/ana.10297; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Koralnik IJ, 1999, NEUROLOGY, V52, P253, DOI 10.1212/WNL.52.2.253; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; MANZ HJ, 1971, ANN INTERN MED, V75, P77, DOI 10.7326/0003-4819-75-1-77; Marra CM, 2002, AIDS, V16, P1791, DOI 10.1097/00002030-200209060-00012; MARTINEZ AJ, 1993, MODERN PATHOL, V6, P25; Moussouttas M, 2002, ARCH NEUROL-CHICAGO, V59, P640, DOI 10.1001/archneur.59.4.640; PADGETT BL, 1971, LANCET, V1, P1257; Phan TG, 2000, NEURO-ONCOLOGY, V2, P229, DOI 10.1093/neuonc/2.4.229; POST MJD, 1988, AM J ROENTGENOL, V151, P373, DOI 10.2214/ajr.151.2.373; Power C, 2000, NEUROLOGY, V54, P743, DOI 10.1212/WNL.54.3.743; RHEIN GMZ, 1965, SCIENCE, V148, P1477, DOI 10.1126/science.148.3676.1477; Richardson E P Jr, 1975, Acta Neuropathol Suppl, VSuppl 6, P247; Singh N, 2000, TRANSPLANTATION, V69, P467, DOI 10.1097/00007890-200002270-00001; Tateishi U, 2001, AM J NEURORADIOL, V22, P1283; Warach S, 1996, J CEREBR BLOOD F MET, V16, P53, DOI 10.1097/00004647-199601000-00006; WEBER T, 1994, AIDS, V8, P49, DOI 10.1097/00002030-199401000-00008; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032	33	46	46	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1882	1893		10.1056/NEJMcpc030038	http://dx.doi.org/10.1056/NEJMcpc030038			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115835				2022-12-28	WOS:000221080300013
J	Rutter, M; Caspi, A; Fergusson, D; Horwood, LJ; Goodman, R; Maughan, B; Moffitt, TE; Meltzer, H; Carroll, J				Rutter, M; Caspi, A; Fergusson, D; Horwood, LJ; Goodman, R; Maughan, B; Moffitt, TE; Meltzer, H; Carroll, J			Sex differences in developmental reading disability - New findings from 4 epidemiological studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; POPULATION	Context An influential article published in 1990 claimed that the increased rate of reading disability in boys was a consequence of referral bias. Objectives To summarize the history of research on sex differences in reading disability and to provide new evidence from 4 independent epidemiological studies about the nature, extent, and significance of sex differences in reading disability. Design, Setting, and Participants The Dunedin Multidisciplinary Health and Development Study comprised 989 individuals (52.1% male) in a cohort born between April 1972 and March 1973 in Dunedin, New Zealand, and followed up from age 3 years; reading performance and IQ were assessed at ages 7, 9, and 11 years using the Burt Word Reading Test and the Wechsler Intelligence Scale for Children-Revised (WISC-R), respectively. The Christchurch Health and Development Study comprised 895 individuals (50% male) in a prospectively studied cohort born in the Christchurch, New Zealand, region during a 4-month period in 1977; reading performance and IQ were assessed at ages 8 to 10 years using the Burt Word Reading Test and the WISC-R. The Office for National Statistics (ONS) Study comprised a UK nationally representative sample of 5752 children (50.1% male) aged 9 to 15 years in 1999; reading was assessed on the British Ability Scales II and IQ on the British Picture Vocabulary Scales II. The Environmental Risk Longitudinal Twin Study (E-Risk) comprised 2163 twin children from England and Wales (49.1% male) identified at birth in 1994 and 1995 and included administration of the Test of Word Reading Efficiency at age 7 years and the Wechsler Preschool and Primary Scale of Intelligence-Revised as a test of IQ at age 5 years. Main Outcome Measure Reading performance by sex in the lowest 15% of the distribution for all 4 studies, with and without taking IQ into account. Results In all 4 studies, the rates of reading disability were significantly higher in boys. For non-IQ-referenced reading disability: Dunedin study, 21.6% in boys vs 7.9% in girls (odds ratio [OR], 3.19; 95% confidence interval [Cl], 2.15-4.17); Christchurch study, 20.6% in boys vs 9.8% in girls (OR, 2.38; 95% Cl, 1.62-3.50); ONS study, 17.6% in boys vs 13.0% in girls (OR, 1.43; 95% Cl, 1.23-1.65); and E-Risk, 18.0% in boys vs 13.0% in girls (OR, 1.39; 95% Cl, 1.04-1.86). The rates for IQ-referenced reading disabilities were similar. Conclusion Reading disabilities are clearly more frequent in boys than in girls.	Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; Christchurch Sch Med, Christchurch, New Zealand; Off Natl Stat, London, England; Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of London; King's College London; University of London; King's College London; University of Otago; University of Warwick	Rutter, M (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, Box P080,De Crespigny Pk, London SE5 8AF, England.	j.wickham@iop.kcl.ac.uk	caspi, avshalom/AAJ-5874-2020; Rutter, Michael/C-8570-2013; Meltzer, Herbert Y/E-8131-2013; Moffitt, Terrie E/D-5295-2011; Carroll, Julia/D-6259-2011; caspi, avshalom/D-5294-2011	caspi, avshalom/0000-0003-0082-4600; Moffitt, Terrie E/0000-0002-8589-6760; Carroll, Julia/0000-0002-3614-6883; caspi, avshalom/0000-0003-0082-4600; Fergusson, David/0000-0002-8117-017X; Rutter, Michael Llewellyn/0000-0003-1577-7405; Goodman, Robert/0000-0001-5596-1667; Horwood, L./0000-0003-4881-1956	NIMH NIH HHS [MH49414, MH45070] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045070, R29MH049414, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; DUNN LM, 1997, BRIT PICTURE VOCABUL, V2; Elliot C. D., 1996, BRIT ABILITY SCALES, V2; Fergusson D M, 1989, Paediatr Perinat Epidemiol, V3, P302; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 1996, DEV PSYCHOL, V32, P132, DOI 10.1037/0012-1649.32.1.132; Flannery KA, 2000, J INT NEUROPSYCH SOC, V6, P433, DOI 10.1017/S1355617700644016; Gould W, 1999, MAXIMUM LIKELIHOOD E; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Meltzer H., 2000, MENTAL HLTH CHILDREN; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Reid, 1981, BURT WORD READING TE; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; SATTLER JM, 1992, ASSESSMENT CHILDRE S; *SCOTT COUNC RES E, 1976, BURT WORD READING TE; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; SNOWLING MJ, 2002, CHILD ADOLESCENT PSY, P682; *STATA CORP, 2001, STATA REL 7 0 COMP P; Torgesen J.K., 1999, TOWRE TEST WORD READ; *UNESCO ORG EC COO, 2003, KNOWL SKILLS LIF 1 R; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, 1990, WECHSLER PRESCHOOL P; YULE W, 1974, BRIT J EDUC PSYCHOL, V44, P1, DOI 10.1111/j.2044-8279.1974.tb00760.x; [No title captured]	24	294	302	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					2007	2012		10.1001/jama.291.16.2007	http://dx.doi.org/10.1001/jama.291.16.2007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815SM	15113820				2022-12-28	WOS:000221062000033
J	Hare, JM				Hare, JM			Spatial confinement of isoforms of cardiac nitric-oxide synthase: unravelling the complexities of nitric oxide's cardiobiology	LANCET			English	Editorial Material							CALCIUM-RELEASE CHANNEL; S-NITROSYLATION		Johns Hopkins Univ, Inst Med, Div Cardiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Inst Med, Inst Cellular Engn, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Hare, JM (corresponding author), Johns Hopkins Univ, Inst Med, Div Cardiol, Baltimore, MD 21287 USA.	jhare@mail.jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065455] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL-65455] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; DEBELDER AJ, 1993, LANCET, V341, P84, DOI 10.1016/0140-6736(93)92559-C; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Hare JM, 2003, J MOL CELL CARDIOL, V35, P719, DOI 10.1016/S0022-2828(03)00143-3; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zhang YH, 2004, CIRCULATION, V110, P293	13	27	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1338	1339		10.1016/S0140-6736(04)16083-2	http://dx.doi.org/10.1016/S0140-6736(04)16083-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110487				2022-12-28	WOS:000220996300004
J	Handelsman, J; Ebert-May, D; Beichner, R; Bruns, P; Chang, A; DeHaan, R; Gentile, J; Lauffer, S; Stewart, J; Tilghman, SM; Wood, WB				Handelsman, J; Ebert-May, D; Beichner, R; Bruns, P; Chang, A; DeHaan, R; Gentile, J; Lauffer, S; Stewart, J; Tilghman, SM; Wood, WB			Scientific teaching	SCIENCE			English	Editorial Material							LECTURES		Univ Wisconsin, Dept Plant Pathol, Howard Hughes Med Inst, Madison, WI 53706 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Amer Soc Microbiol, Washington, DC 20036 USA; CNR, Washington, DC 20007 USA; Hope Coll, Holland, MI 49423 USA; Univ Wisconsin, Dept Curriculum & Instruct, Madison, WI 53706 USA; Princeton Univ, Princeton, NJ 08544 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; University of North Carolina; North Carolina State University; Howard Hughes Medical Institute; Hope College; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of Colorado System; University of Colorado Boulder	Handelsman, J (corresponding author), Univ Wisconsin, Dept Plant Pathol, Howard Hughes Med Inst, Madison, WI 53706 USA.	joh@plantpath.wisc.edu	Beichner, Robert/C-1160-2012	Beichner, Robert/0000-0002-9651-4393; Miller, Sarah/0000-0003-3348-4470				American Association for the Advancement of Sciences [AAAS], 1989, SCI ALL AM PROJ 2061; EbertMay D, 1997, BIOSCIENCE, V47, P601, DOI 10.2307/1313166; Handelsman J, 1997, BIOL BROUGHT LIFE GU; LAWS PW, 1991, PHYS TODAY, V44, P24, DOI 10.1063/1.881276; Springer L, 1999, REV EDUC RES, V69, P21, DOI 10.3102/00346543069001021; Trempy Janine E, 2002, Microbiol Educ, V3, P26; Udovic D, 2002, BIOSCIENCE, V52, P272, DOI 10.1641/0006-3568(2002)052[0272:WBDTEO]2.0.CO;2; Wright JC, 1998, J CHEM EDUC, V75, P986; [No title captured]	9	593	607	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					521	522		10.1126/science.1096022	http://dx.doi.org/10.1126/science.1096022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105480				2022-12-28	WOS:000220975100025
J	Stairs, IH				Stairs, IH			Pulsars in binary systems: Probing binary stellar evolution and general relativity	SCIENCE			English	Review							WHITE-DWARF COMPANION; ACCRETING MILLISECOND PULSAR; STRONG EQUIVALENCE PRINCIPLE; GEODETIC SPIN PRECESSION; X-RAY BINARY; NEUTRON-STAR; RADIO PULSAR; LOW-MASS; TIMING OBSERVATIONS; LORENTZ INVARIANCE	Radio pulsars in binary orbits often have short millisecond spin periods as a result of mass transfer from their companion stars. They therefore act as very precise, stable, moving clocks that allow us to investigate a large set of otherwise inaccessible astrophysical problems. The orbital parameters derived from high-precision binary pulsar timing provide constraints on binary evolution, characteristics of the binary pulsar population, and the masses of neutron stars with different mass-transfer histories. These binary systems also test gravitational theories, setting strong limits on deviations from general relativity. Surveys for new pulsars yield new binary systems that increase our understanding of all these fields and may open up whole new areas of physics, as most spectacularly evidenced by the recent discovery of an extremely relativistic double-pulsar system.	Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Stairs, IH (corresponding author), Univ British Columbia, Dept Phys & Astron, 6224 Agr Rd, Vancouver, BC V6T 1Z1, Canada.	stairs@astro.ubc.ca						ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Anderson SB, 1997, ASTROPHYS J, V482, P870, DOI 10.1086/304162; ANDERSON SB, 1992, THESIS CALTECH; ARZOUMANIAN Z, 1994, ASTROPHYS J, V426, pL85, DOI 10.1086/187346; Arzoumanian Z, 2003, ASTR SOC P, V302, P69; Arzoumanian Z, 1995, THESIS PRINCETON U; Backer DC, 1997, PUBL ASTRON SOC PAC, V109, P61, DOI 10.1086/133859; BACKER DC, 1993, NATURE, V365, P817, DOI 10.1038/365817a0; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Bailes M, 2003, ASTROPHYS J, V595, pL49, DOI 10.1086/378939; BAILES M, 1994, ASTROPHYS J, V425, pL41, DOI 10.1086/187306; Bassa CG, 2003, ASTRON ASTROPHYS, V403, P1067, DOI 10.1051/0004-6361:20030384; Bell JF, 1996, CLASSICAL QUANT GRAV, V13, P3121, DOI 10.1088/0264-9381/13/12/003; BERTOTTI B, 1983, MON NOT R ASTRON SOC, V203, P945, DOI 10.1093/mnras/203.4.945; Bethe HA, 1998, ASTROPHYS J, V506, P780, DOI 10.1086/306265; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bisnovatyi-Kogan G. S., 1974, Soviet Astronomy, V18, P217; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Callanan PJ, 1998, MON NOT R ASTRON SOC, V298, P207, DOI 10.1046/j.1365-8711.1998.01634.x; Camilo F, 2001, ASTROPHYS J, V548, pL187, DOI 10.1086/319120; CANAL R, 1980, ASTROPHYS J, V241, pL33, DOI 10.1086/183354; Chakrabarty D, 1998, NATURE, V394, P346, DOI 10.1038/28561; Chakrabarty D, 2003, NATURE, V424, P42, DOI 10.1038/nature01732; CHAMPION DJ, IN PRESS MON NOT R A; D'Amico N, 2001, ASTROPHYS J, V561, pL89, DOI 10.1086/324562; DAMOUR T, 1986, ANN I H POINCARE-PHY, V44, P263; Damour T, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.042001; DAMOUR T, 1992, PHYS REV D, V45, P1840, DOI 10.1103/PhysRevD.45.1840; DAMOUR T, 1992, PHYS REV D, V46, P4128, DOI 10.1103/PhysRevD.46.4128; DAMOUR T, 1991, PHYS REV LETT, V66, P2549, DOI 10.1103/PhysRevLett.66.2549; Damour T, 1996, PHYS REV D, V53, P5541, DOI 10.1103/PhysRevD.53.5541; Dewi JDM, 2003, MON NOT R ASTRON SOC, V344, P629, DOI 10.1046/j.1365-8711.2003.06844.x; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; Edwards RT, 2001, ASTROPHYS J, V553, P801, DOI 10.1086/320986; Ergma E, 1998, MON NOT R ASTRON SOC, V300, P352, DOI 10.1046/j.1365-8711.1998.01761.x; ESPOSITOFARESE G, 2004, 10 M GROSSM M RIO DE; Freire PC, 2003, MON NOT R ASTRON SOC, V340, P1359, DOI 10.1046/j.1365-8711.2003.06392.x; FREIRE PC, IN PRESS ASTROPHYS J; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Galloway DK, 2002, ASTROPHYS J, V576, pL137, DOI 10.1086/343841; GERARD JM, 2002, PHYS REV D, V66, P1; GRINDLAY JE, 1987, IAU SYMP, P173; Hankins T. H., 1975, METHODS COMPUTATIONA, V14, P55; HULSE RA, 1975, ASTROPHYS J, V195, pL51, DOI 10.1086/181708; HULSE RA, 1994, REV MOD PHYS, V66, P699, DOI 10.1103/RevModPhys.66.699; ILLARIONOV AF, 1975, ASTRON ASTROPHYS, V39, P185; IVANOVA N, IN PRESS REV MEX A A; Jacoby BA, 2003, ASTROPHYS J, V599, pL99, DOI 10.1086/381260; Jaffe AH, 2003, ASTROPHYS J, V583, P616, DOI 10.1086/345443; JOHNSTON S, 1992, ASTROPHYS J, V387, pL37, DOI 10.1086/186300; Kalogera V, 2004, ASTROPHYS J, V601, pL179, DOI 10.1086/382155; KASPI VM, 1994, ASTROPHYS J, V423, pL43, DOI 10.1086/187231; KASPI VM, 1994, ASTROPHYS J, V428, P713, DOI 10.1086/174280; Kaspi VM, 1996, NATURE, V381, P584, DOI 10.1038/381584a0; Kaspi VM, 2000, ASTROPHYS J, V543, P321, DOI 10.1086/317103; KASPI VM, ASTROPH0401614; Kim C, 2003, ASTROPHYS J, V584, P985, DOI 10.1086/345740; King AR, 2003, MON NOT R ASTRON SOC, V345, P678, DOI 10.1046/j.1365-8711.2003.06990.x; Kramer M, 1998, ASTROPHYS J, V509, P856, DOI 10.1086/306535; Kramer M., COMMUNICATION; Kuiper L, 2002, ASTROPHYS J, V577, P917, DOI 10.1086/342220; Lange C, 2001, MON NOT R ASTRON SOC, V326, P274, DOI 10.1046/j.1365-8711.2001.04606.x; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Lommen A N, 2001, THESIS U CALIFORNIA THESIS U CALIFORNIA; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; LYNE AG, 1993, NATURE, V361, P47, DOI 10.1038/361047a0; Lyne AG, 2000, MON NOT R ASTRON SOC, V316, P491, DOI 10.1046/j.1365-8711.2000.03517.x; Manchester RN, 2004, SCIENCE, V304, P542, DOI 10.1126/science.1097649; MANCHESTER RN, 1995, ASTROPHYS J, V445, pL137, DOI 10.1086/187908; MARKWARDT CB, 2003, 8095 IAU; Nice DJ, 2003, ASTR SOC P, V302, P75; Nice DJ, 2001, ASTROPHYS J, V549, P516, DOI 10.1086/319079; Nice DJ, 1996, ASTROPHYS J, V466, pL87, DOI 10.1086/310178; NICE DJ, COMMUNICATION; NORDTVEDT K, 1968, PHYS REV, V170, P1186, DOI 10.1103/PhysRev.170.1186; Pfahl E, 2003, ASTROPHYS J, V597, P1036, DOI 10.1086/378632; PHINNEY ES, 1992, PHILOS T ROY SOC A, V341, P39, DOI 10.1098/rsta.1992.0084; PHINNEY ES, 1994, ANNU REV ASTRON ASTR, V32, P591, DOI 10.1146/annurev.aa.32.090194.003111; PHINNEY ES, 1991, MON NOT R ASTRON SOC, V248, pP21, DOI 10.1093/mnras/248.1.21P; Portegies Zwart S, 1998, ASTRON ASTROPHYS, V332, P173; PYLYSER E, 1988, ASTRON ASTROPHYS, V191, P57; Ransom SM, 2004, ASTROPHYS J, V604, P328, DOI 10.1086/381730; RAPPAPORT S, 1995, MON NOT R ASTRON SOC, V273, P731, DOI 10.1093/mnras/273.3.731; Rasio FA, 2000, ASTROPHYS J, V532, pL47, DOI 10.1086/312555; RYBA MF, 1991, ASTROPHYS J, V371, P739, DOI 10.1086/169938; Sigurdsson S, 2003, SCIENCE, V301, P193, DOI 10.1126/science.1086326; SMARR LL, 1976, ASTROPHYS J, V207, P574, DOI 10.1086/154524; Splaver EM, 2002, ASTROPHYS J, V581, P509, DOI 10.1086/344202; SPLAVER EM, THESIS PRINCETON U; SPLAVER EM, UNPUB; Stairs IH, 2000, MON NOT R ASTRON SOC, V314, P459, DOI 10.1046/j.1365-8711.2000.03306.x; Stairs IH, 2002, ASTROPHYS J, V581, P501, DOI 10.1086/344157; Stairs IH, 2001, MON NOT R ASTRON SOC, V325, P979, DOI 10.1046/j.1365-8711.2001.04447.x; Stairs Ingrid H, 2003, Living Rev Relativ, V6, P5, DOI 10.12942/lrr-2003-5; Strohmayer TE, 2003, ASTROPHYS J, V596, pL67, DOI 10.1086/379158; Taam RE, 2000, ASTROPHYS J, V541, P329, DOI 10.1086/309392; Tauris TM, 1999, ASTRON ASTROPHYS, V350, P928; TAURIS TM, 2003, COMPACT STELLAR XRAY; TAYLOR JH, 1994, REV MOD PHYS, V66, P711, DOI 10.1103/RevModPhys.66.711; TAYLOR JH, 1982, ASTROPHYS J, V253, P908, DOI 10.1086/159690; TAYLOR JH, 1989, ASTROPHYS J, V345, P434, DOI 10.1086/167917; Thorsett SE, 1999, ASTROPHYS J, V523, P763, DOI 10.1086/307771; Thorsett SE, 1996, PHYS REV LETT, V77, P1432, DOI 10.1103/PhysRevLett.77.1432; Thorsett SE, 1999, ASTROPHYS J, V512, P288, DOI 10.1086/306742; THORSETT SE, 1993, ASTROPHYS J, V405, pL29, DOI 10.1086/186758; van Kerkwijk MH, 1999, ASTROPHYS J, V516, pL25, DOI 10.1086/311991; van Straten W, 2001, NATURE, V412, P158, DOI 10.1038/35084015; VANDENHEUVEL EPJ, 1994, ASTRON ASTROPHYS, V291, pL39; WEISBERG JM, 1989, ASTROPHYS J, V347, P1030, DOI 10.1086/168193; Weisberg JM, 2003, ASTR SOC P, V302, P93; Wex N, 2000, ASTR SOC P, V202, P113; Wex N, 1998, MON NOT R ASTRON SOC, V298, P997, DOI 10.1046/j.1365-8711.1998.01700.x; Wex N, 1997, ASTRON ASTROPHYS, V317, P976; Wijnands R, 1998, NATURE, V394, P344, DOI 10.1038/28557; Wijnands R, 2003, NATURE, V424, P44, DOI 10.1038/nature01754; Will Clifford M, 2001, Living Rev Relativ, V4, P4, DOI 10.12942/lrr-2001-4; Willems B, 2003, MON NOT R ASTRON SOC, V343, P949, DOI 10.1046/j.1365-8711.2003.06750.x; Willems B, 2002, MON NOT R ASTRON SOC, V337, P1004, DOI 10.1046/j.1365-8711.2002.05985.x; Wolszczan A, 2000, ASTROPHYS J, V528, P907, DOI 10.1086/308206; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; Zwart SEP, 1999, MON NOT R ASTRON SOC, V309, P26, DOI 10.1046/j.1365-8711.1999.02792.x; [No title captured]; [No title captured]	128	174	177	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2004	304	5670					547	552		10.1126/science.1096986	http://dx.doi.org/10.1126/science.1096986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105492				2022-12-28	WOS:000220975100037
J	Mulliken, JB; Anupindi, S; Ezekowitz, RAB; Mihm, MC; Harris, NL; Kerzner, LS; Avram, MM				Mulliken, JB; Anupindi, S; Ezekowitz, RAB; Mihm, MC; Harris, NL; Kerzner, LS; Avram, MM			A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia - Kaposiform hemangioendothelioma with the Kasabach-Merritt phenomenon.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONGENITAL HEMANGIOMA; RADIATION-THERAPY; SUCCESSFUL MANAGEMENT; INTERFERON ALPHA-2A; VASCULAR TUMORS; TUFTED ANGIOMA; INFANT; MALFORMATIONS; DIFFERENTIATION; ANGIOGENESIS		Childrens Hosp, Div Plast Surg, Craniofacial Ctr, Boston, MA 02115 USA; Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Serv Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Div Dermatopathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mulliken, JB (corresponding author), Childrens Hosp, Div Plast Surg, Craniofacial Ctr, Boston, MA 02115 USA.							ALRASHID RA, 1971, CANCER, V27, P364, DOI 10.1002/1097-0142(197102)27:2<364::AID-CNCR2820270219>3.0.CO;2-V; Barlow CF, 1998, J PEDIATR-US, V132, P527, DOI 10.1016/S0022-3476(98)70034-4; Berenguer B, 2003, PEDIATR DEVEL PATHOL, V6, P495, DOI 10.1017/s10024-003-2134-6; Boon LM, 1996, J PEDIATR-US, V128, P329, DOI 10.1016/S0022-3476(96)70276-7; BROUTYBOYE D, 1980, SCIENCE, V208, P516, DOI 10.1126/science.6154315; Castello MA, 1997, MED PEDIATR ONCOL, V28, P213, DOI 10.1002/(SICI)1096-911X(199703)28:3<213::AID-MPO12>3.3.CO;2-M; Drolet BA, 2001, J PEDIATR-US, V138, P756, DOI 10.1067/mpd.2001.112650; DVORAK HF, 1989, J NATL CANCER I, V81, P497, DOI 10.1093/jnci/81.7.497; ELDESSOUKY M, 1988, J PEDIATR SURG, V23, P109, DOI 10.1016/S0022-3468(88)80135-0; Enjolras O, 1997, Adv Dermatol, V13, P375; Enjolras O, 1997, J PEDIATR-US, V130, P631, DOI 10.1016/S0022-3476(97)70249-X; Enjolras O, 2001, PLAST RECONSTR SURG, V107, P1647, DOI 10.1097/00006534-200106000-00002; Enjolras O, 2000, J AM ACAD DERMATOL, V42, P225, DOI 10.1016/S0190-9622(00)90130-0; ESTERLY NB, 1983, J AM ACAD DERMATOL, V8, P504, DOI 10.1016/S0190-9622(83)70056-3; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23; Folpe AL, 2000, MODERN PATHOL, V13, P180, DOI 10.1038/modpathol.3880033; Frieden IJ, 1996, ARCH DERMATOL, V132, P307, DOI 10.1001/archderm.132.3.307; George M, 2002, PEDIATR DERMATOL, V19, P340, DOI 10.1046/j.1525-1470.2002.t01-1-00097.x; Haisley-Royster C, 2002, J PEDIAT HEMATOL ONC, V24, P794; Haisley-Royster C, 2002, J PEDIAT HEMATOL ONC, V24, P459, DOI 10.1097/00043426-200208000-00010; HATLEY RM, 1993, J PEDIATR SURG, V28, P1356, DOI 10.1016/S0022-3468(05)80327-6; JONES EW, 1989, J AM ACAD DERMATOL, V20, P214, DOI 10.1016/S0190-9622(89)70025-6; Kaban LB, 1999, PEDIATRICS, V103, P1145, DOI 10.1542/peds.103.6.1145; Kasabach HH, 1940, AM J DIS CHILD, V59, P1063, DOI 10.1001/archpedi.1940.01990160135009; Komiyama M, 2000, PEDIATR NEUROSURG, V33, P26, DOI 10.1159/000028971; Mazoyer E, 2002, CLIN LAB HAEMATOL, V24, P243, DOI 10.1046/j.1365-2257.2002.00447.x; Mitsuhashi N, 1997, INT J RADIAT ONCOL, V39, P467, DOI 10.1016/S0360-3016(97)00140-5; Nako Y, 1997, J Perinatol, V17, P244; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; North PE, 2001, ARCH DERMATOL, V137, P559; NORTH PE, 1999, HEMANGIOMAS VASCULAR, P93; Ogino I, 2001, RADIOLOGY, V218, P834, DOI 10.1148/radiology.218.3.r01mr04834; Penny R., 1997, CLIN APPL INTERFERON, P255; Sarkar M, 1997, PLAST RECONSTR SURG, V100, P1377, DOI 10.1097/00006534-199711000-00001; Seo SK, 1999, PEDIATR DERMATOL, V16, P392, DOI 10.1046/j.1525-1470.1999.00103.x; SIDKY YA, 1987, CANCER RES, V47, P5155; TSANG WYW, 1991, AM J SURG PATHOL, V15, P982, DOI 10.1097/00000478-199110000-00009; WHITE CW, 1989, NEW ENGL J MED, V320, P1197, DOI 10.1056/NEJM198905043201807; ZUKERBERG LR, 1993, AM J SURG PATHOL, V17, P321, DOI 10.1097/00000478-199304000-00001	40	51	55	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1764	1775		10.1056/NEJMcpc049002	http://dx.doi.org/10.1056/NEJMcpc049002			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15103004				2022-12-28	WOS:000220947300013
J	Zufall, RA; Rausher, MD				Zufall, RA; Rausher, MD			Genetic changes associated with floral adaptation restrict future evolutionary potential	NATURE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; SUBSTRATE-SPECIFICITY; IPOMOEA; FLOWERS; GLYCOSIDES	A commonly accepted evolutionary principle is that adaptive change constrains the potential directions of future evolutionary change(1-3). One manifestation of this is Dollo's law, which states that character elimination is irreversible(4,5). Although the common occurrence of irreversibility has been documented by phylogenetic analyses of phenotypic transitions, little is known about the underlying causes of this phenomenon(4). One explanation for evolutionary irreversibility relies on the fact that many characteristics result from interactions between multiple gene products(4,6). Such characteristics may often be eliminated by inactivation of just one gene in the network. If they serve no other functions, other genes of the network are then free to accumulate mutations or evolve new functions. Evolutionary change after character loss results in the accumulation of redundant loss-of-function mutations. Such pathway degeneration makes it very unlikely that the characteristic will re-evolve, because multiple simultaneous mutations would be required(4). Here we describe what appear to be the initial stages of such degeneration in the anthyocyanin pigment pathway associated with an adaptive change from blue to red flowers in the morning glory Ipomoea quamoclit.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Zufall, RA (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	bzufall@smith.edu						An G, 1988, PLANT MOL BIOL MAN A, V3, P1; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; BULL JJ, 1985, EVOLUTION, V39, P1149, DOI 10.2307/2408742; Clegg MT, 2003, NAT REV GENET, V4, P206, DOI 10.1038/nrg1023; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; FAEGRI DT, 1966, PRINCIPLES POLLINATI; FORKMANN G, 1987, Z NATURFORSCH C, V42, P1146; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Grant V., 1977, ORGANISMIC EVOLUTION; Harbourne J. B., 1967, COMP BIOCH FLAVONOID; Hoshino A, 2003, PLANT CELL PHYSIOL, V44, P990, DOI 10.1093/pcp/pcg143; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; LAVA C, 2001, OECOLOGIA, V128, P263; MACHADO I C S, 1987, Revista Brasileira de Biologia, V47, P425; Manos PS, 2001, SYST BOT, V26, P585; MCDONALD A, 1991, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V62, P65; Miller RE, 1999, SYST BOT, V24, P209, DOI 10.2307/2419549; MILLER RE, IN PRESS AM J BOT; SAITO N, 1995, PHYTOCHEMISTRY, V40, P1283, DOI 10.1016/0031-9422(95)00369-I; Saito N, 1996, PHYTOCHEMISTRY, V43, P1365, DOI 10.1016/S0031-9422(96)00501-8; STAFFORD HA, 1982, PLANT PHYSIOL, V70, P695, DOI 10.1104/pp.70.3.695; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; WAGNER GP, 1982, J THEOR BIOL, V96, P337, DOI 10.1016/0022-5193(82)90114-X; Zufall RA, 2003, J HERED, V94, P442, DOI 10.1093/jhered/esg098; ZUFALL RA, 2003, THESIS DUKE U	29	126	143	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					847	850		10.1038/nature02489	http://dx.doi.org/10.1038/nature02489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103375				2022-12-28	WOS:000220952300038
J	Kerr, SM				Kerr, SM			Keeping the fire alive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												drkerr@the-doctors-inn.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1813	1814		10.1001/jama.291.15.1813	http://dx.doi.org/10.1001/jama.291.15.1813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100182				2022-12-28	WOS:000220871200001
J	Buesseler, KO; Andrews, JE; Pike, SM; Charette, MA				Buesseler, KO; Andrews, JE; Pike, SM; Charette, MA			The effects of iron fertilization on carbon sequestration in the Southern Ocean	SCIENCE			English	Article							PARTICULATE ORGANIC-CARBON; EXPORT; BLOOM; PHYTOPLANKTON; ENRICHMENT; TH-234	An unresolved issue in ocean and climate sciences is whether changes to the surface ocean input of the micronutrient iron can alter the flux of carbon to the deep ocean. During the Southern Ocean Iron Experiment, we measured an increase in the flux of particulate carbon from the surface mixed layer, as well as changes in particle cycling below the iron-fertilized patch. The flux of carbon was similar in magnitude to that of natural blooms in the Southern Ocean and thus small relative to global carbon budgets and proposed geoengineering plans to sequester atmospheric carbon dioxide in the deep sea.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Charette, Matthew/I-9495-2012					Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bidigare RR, 1999, PALEOCEANOGRAPHY, V14, P589, DOI 10.1029/1999PA900026; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; BOYD P, 1995, DEEP-SEA RES PT I, V42, P619, DOI 10.1016/0967-0637(95)00017-Z; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BRZEZINSKI MA, 2002, AM GEOPH SOC FALL M; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2003, DEEP-SEA RES PT II, V50, P579, DOI 10.1016/S0967-0645(02)00585-4; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; Buesseler KO, 2001, DEEP-SEA RES PT II, V48, P4275, DOI 10.1016/S0967-0645(01)00089-3; Buesseler KO, 2001, MAR CHEM, V74, P15, DOI 10.1016/S0304-4203(00)00092-X; BUESSELER KO, UNPUB; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; COALE KH, 1985, LIMNOL OCEANOGR, V30, P22, DOI 10.4319/lo.1985.30.1.0022; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; Morrison JM, 2001, DEEP-SEA RES PT II, V48, P3943, DOI 10.1016/S0967-0645(01)00075-3; Nodder SD, 2001, GEOPHYS RES LETT, V28, P2409, DOI 10.1029/2001GL013008; RIEBESELL U, COMMUNICATION; Smetacek V, 1998, NATURE, V391, P224, DOI 10.1038/34528; Smetacek V., 2001, US JGOFS NEWS, V11, P11; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000	30	178	190	5	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					414	417		10.1126/science.1086895	http://dx.doi.org/10.1126/science.1086895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087543				2022-12-28	WOS:000220845400040
J	O'Doherty, J; Dayan, P; Schultz, J; Deichmann, R; Friston, KJ; Dolan, RJ				O'Doherty, J; Dayan, P; Schultz, J; Deichmann, R; Friston, KJ; Dolan, RJ			Dissociable roles of ventral and dorsal striatum in instrumental conditioning	SCIENCE			English	Article							BASAL GANGLIA; DOPAMINE NEURONS; TEMPORAL PREDICTION; PREFRONTAL CORTEX; REWARD; ORGANIZATION; MOTIVATION; RESPONSES; PATHWAYS; MODELS	Instrumental conditioning studies how animals and humans choose actions appropriate to the affective structure of an environment. According to recent reinforcement learning models, two distinct components are involved: a "critic," which learns to predict future reward, and an " actor," which maintains information about the rewarding outcomes of actions to enable better ones to be chosen more frequently. We scanned human participants with functional magnetic resonance imaging while they engaged in instrumental conditioning. Our results suggest partly dissociable contributions of the ventral and dorsal striatum, with the former corresponding to the critic and the latter corresponding to the actor.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Gatsby Computat Neurosci Unit, London WC1N 3BG, England	University of London; University College London; University of London; University College London	O'Doherty, J (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England.	j.odoherty@fil.ion.ucl.ac.uk	anand, amit/A-7222-2009; O'Doherty, John P/F-1204-2013; Schultz, Johannes/B-8613-2012; Friston, Karl/D-9230-2011	Schultz, Johannes/0000-0003-4117-232X; Friston, Karl/0000-0001-7984-8909; Dolan, Ray/0000-0001-9356-761X; Dayan, Peter/0000-0003-3476-1839				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baird III L. C., 1993, WLTR931146; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BARTO AG, 1996, MODELS INFORMATION P, pCH11; Brown J, 1999, J NEUROSCI, V19, P10502; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Dayan P, 2002, ADV NEUR IN, V14, P11; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOUK JC, 1996, MODELS INFORMATION P, P249; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; MACKINTOSH NJ, 1983, CONDITINING ASS LEAR; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9	32	1487	1489	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					452	454		10.1126/science.1094285	http://dx.doi.org/10.1126/science.1094285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087550	Green Submitted			2022-12-28	WOS:000220845400052
J	Ely, EW; Shintani, A; Truman, B; Speroff, T; Gordon, SM; Harrell, FE; Inouye, SK; Bernard, GR; Dittus, RS				Ely, EW; Shintani, A; Truman, B; Speroff, T; Gordon, SM; Harrell, FE; Inouye, SK; Bernard, GR; Dittus, RS			Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONFUSION ASSESSMENT METHOD; MINI-MENTAL-STATE; AGITATION-SEDATION SCALE; CRITICALLY-ILL PATIENTS; RISK-FACTORS; SEPTIC ENCEPHALOPATHY; OLDER PERSONS; SEVERE SEPSIS; SOFA SCORE; INFLAMMATION	Context In the intensive care unit (ICU), delirium is a common yet underdiagnosed form of organ dysfunction, and its contribution to patient outcomes is unclear. Objective To determine if delirium is an independent predictor of clinical outcomes, including 6-month mortality and length of stay among ICU patients receiving mechanical ventilation. Design, Setting, and Participants Prospective cohort study enrolling 275 consecutive mechanically ventilated patients admitted to adult medical and coronary ICUs of a US university-based medical center between February 2000 and May 2001. Patients were followed up for development of delirium over 2158 ICU days using the Confusion Assessment Method for the ICU and the Richmond Agitation-Sedation Scale. Main Outcome Measures Primary outcomes included 6-month mortality, overall hospital length of stay, and length of stay in the post-ICU period. Secondary outcomes were ventilator-free days and cognitive impairment at hospital discharge. Results Of 275 patients, 51 (18.5%) had persistent coma and died in the hospital. Among the remaining 224 patients, 183 (81.7%) developed delirium at some point during the ICU stay. Baseline demographics including age, comorbidity scores, dementia scores, activities of daily living, severity of illness, and admission diagnoses were similar between those with and without delirium (P>.05 for all). Patients who developed delirium had higher 6-month mortality rates (34% vs 15%, P=.03) and spent 10 days longer in the hospital than those who never developed delirium (P<.001). After adjusting for covariates (including age, severity of illness, comorbid conditions, coma, and use of sedatives or analgesic medications), delirium was independently associated with higher 6-month mortality (adjusted hazard ratio [HR], 3.2; 95% confidence interval [CI], 1.4-7.7; P=.008), and longer hospital stay (adjusted HR, 2.0; 95% Cl, 1.4-3.0; P<.001). Delirium in the ICU was also independently associated with a longer post-ICU stay (adjusted HR, 1.6; 95% Cl, 1.2-2.3; P=.009), fewer median days alive and without. mechanical ventilation (19 [interquartile range, 4-23] vs 24 [19261; adjusted P=.03), and a higher incidence of cognitive impairment at hospital discharge (adjusted HR, 9.1; 95% Cl, 2.3-35.3; P=.002). Conclusion Delirium was an independent predictor of higher 6-month mortality and longer hospital stay even after adjusting for relevant covariates including coma, sedatives, and analgesics in patients receiving mechanical ventilation.	Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Div Allergy Pulm Crit Care Med,Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; Vanderbilt University; Vanderbilt University; Vanderbilt University; Yale University	Ely, EW (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Div Allergy Pulm Crit Care Med,Sch Med, 6th Floor,Med Ctr E 6109, Nashville, TN 37232 USA.	wes.ely@vanderbilt.edu	Inouye, Sharon/R-7216-2019; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172	NATIONAL INSTITUTE ON AGING [K23AG001023, K24AG000949] Funding Source: NIH RePORTER; NIA NIH HHS [K24AG00949, K23 AG01023-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; *AM PSYCH ASS, WHAT IS DELIRIUM; AM. PSYCHIATRIC ASS'N, 1994, DIAGN STAT MAN MENT, P123; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 1999, Am J Psychiatry, V156, P1; Axell AIRG, 2002, ACTA ANAESTH SCAND, V46, P726, DOI 10.1034/j.1399-6576.2002.460616.x; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; CAMMARANO WB, 1998, PRINCIPLES CRITICAL, P90; Camus V, 2000, INT J GERIATR PSYCH, V15, P313, DOI 10.1002/(SICI)1099-1166(200004)15:4<313::AID-GPS115>3.0.CO;2-M; COX DR, 1972, J R STAT SOC B, V34, P187; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Eilers H, 2001, ANESTH ANALG, V93, P213, DOI 10.1097/00000539-200107000-00042; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2004, CRIT CARE MED, V32, P106, DOI 10.1097/01.CCM.0000098033.94737.84; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2003, CLIN INFECT DIS, V37, P187, DOI 10.1086/375775; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Ely EW, 2001, SEMIN RESP CRIT CARE, V22, P115, DOI 10.1055/s-2001-13826; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; Geary S M, 1994, Crit Care Nurs Q, V17, P51; GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P760, DOI 10.1111/j.1532-5415.1991.tb02697.x; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Inouye SK, 1999, AM J MED, V106, P565, DOI 10.1016/S0002-9343(99)00070-4; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kiely DK, 2003, J GERONTOL A-BIOL, V58, P441, DOI 10.1093/gerona/58.5.M441; Kleinbaum David G., 1988, APPL REGRESSION ANAL, V2a, P210; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; Litaker D, 2001, GEN HOSP PSYCHIAT, V23, P84, DOI 10.1016/S0163-8343(01)00117-7; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; Luhr OR, 2000, INTENS CARE MED, V26, P508, DOI 10.1007/s001340051197; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; McGuire BE, 2000, ARCH INTERN MED, V160, P906, DOI 10.1001/archinte.160.7.906; McNicoll L, 2003, J AM GERIATR SOC, V51, P591, DOI 10.1034/j.1600-0579.2003.00201.x; Meagher DJ, 2001, BMJ-BRIT MED J, V322, P144, DOI 10.1136/bmj.322.7279.144; Meagher DJ, 2000, J NEUROPSYCH CLIN N, V12, P51, DOI 10.1176/jnp.12.1.51; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Nicholson TE, 2002, DRUG METAB DISPOS, V30, P42, DOI 10.1124/dmd.30.1.42; OCONNOR DW, 1989, J PSYCHIAT RES, V23, P87, DOI 10.1016/0022-3956(89)90021-6; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Peterson JF, 2003, J AM GERIATR SOC, V51, pS174; PETO R, 1972, J BIOMETRICS, V26, P579; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; Rahkonen T, 2001, INT J GERIATR PSYCH, V16, P415, DOI 10.1002/gps.356; Renton KW, 2000, J PHARMACOL EXP THER, V294, P524; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551; Rolfson DB, 1999, CAN J CARDIOL, V15, P771; Rothwell NJ, 1996, PHARMACOL THERAPEUT, V69, P85, DOI 10.1016/0163-7258(95)02033-0; Sanders AB, 2002, ANN EMERG MED, V39, P338, DOI 10.1067/mem.2002.122273; Schmitz R., 1998, FUTURE NEEDS PULMONA; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; SCHOR JD, 1992, JAMA-J AM MED ASSOC, V267, P827, DOI 10.1001/jama.267.6.827; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; Shimamoto Y, 1999, ARCH TOXICOL, V73, P41, DOI 10.1007/s002040050584; Shimamoto Y, 1998, ARCH TOXICOL, V72, P492, DOI 10.1007/s002040050533; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Tangalos EG, 1996, MAYO CLIN PROC, V71, P829, DOI 10.4065/71.9.829; Therneau TM, 2000, MODELING SURVIVAL DA; TRUJILLO KA, 1991, NEW BIOL, V3, P915; TRUMAN B, 2003, AM J RESP CRIT CARE, V167, pA969; Truman Brenda, 2003, Crit Care Nurse, V23, P25; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 2002, CRIT CARE, V6, pS1, DOI 10.1186/cc1860; Vinik HR, 1998, ANESTH ANALG, V86, P1307, DOI 10.1097/00000539-199806000-00033; WIJDICKS EFM, 2002, NEUROLOGIC COMPLICAT; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, BRAIN RES, V816, P563, DOI 10.1016/S0006-8993(98)01238-4; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016	101	1842	1948	4	82	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1753	1762		10.1001/jama.291.14.1753	http://dx.doi.org/10.1001/jama.291.14.1753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811RJ	15082703	Bronze, Green Published			2022-12-28	WOS:000220788700033
J	Breen, J				Breen, J			Road safety advocacy	BRITISH MEDICAL JOURNAL			English	Article												j_breen@btopenworld.com						ALLSOP RE, 2001, 12 WESTM LECT TRANSP; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2004, PREV ROAD TRAFF INJ; Beaglehole R., 2003, WORLD HLTH REPORT 20; Breen J, 2002, BRIT MED J, V324, P1109, DOI 10.1136/bmj.324.7346.1109; BREEN J, 1999, P 2 EUR ROAD RES C; Chapman S. L. D., 1994, FIGHT PUBLIC HLTH; Compton R. P., 2002, P INT COUNC ALC DRUG, V2002, P39; European Transport Safety Council, 2003, TRANSP SAF PERF EU S; *HC TRANSP LOC GOV, 2002, 5571 HC TRANSP LOC G, V1; Kopits E., 2003, 3035 WORLD BANK; NADER R, 1972, UNSAFE ANY SPEED; Peden M., 2004, WORLD REPORT ROAD TR; RUTHERFORD D, 2002, GLOBE, V1, P8; Streat S., 1998, PREVENTATIVE CRITICA; Trinca G. W., 1988, REDUCING TRAFFIC INJ; WEBSTER B, 2003, TIMES           0627; World Health Organization (WHO), 1995, ADV STRAT HLTH DEV D; [No title captured]	19	12	13	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					888	890		10.1136/bmj.328.7444.888	http://dx.doi.org/10.1136/bmj.328.7444.888			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073075	Green Published			2022-12-28	WOS:000220871400025
J	Westerlund, H; Ferrie, J; Hagberg, J; Jeding, K; Oxenstierna, G; Theorell, T				Westerlund, H; Ferrie, J; Hagberg, J; Jeding, K; Oxenstierna, G; Theorell, T			Workplace expansion, long-term sickness absence, and hospital admission	LANCET			English	Article							FACTORY CLOSURE; HEALTH; EMPLOYEES; JOB; UNEMPLOYMENT; DISEASE; DEATH; WOMEN	Background Downsizing has in previous studies, as well as in public debate, been associated with increased sickness absence. No studies have, however, looked at the long-term relation between workplace expansion and morbidity. Methods We investigated exposure to personnel change during 1991-96 in relation to long-term (90 days or longer) medically certified sickness absence and hospital admission for specified diagnoses during 1997-99 in 24 036 participants with a complete employment record in the biennial national Swedish Work Environment Surveys from 1989 to the end of 1999. Findings Accumulated exposure to large expansion (greater than or equal to18% per year) was related to an increased risk of long-term sickness absence (odds ratio 1.07 [95% Cl 1.01-1.13], p=0.013) and hospital admission (1.09 [1.02-1.16], p=0.017). In this context, odds ratio signifies the change in odds for each additional year of exposure, varying from 0 to 6. Moderate expansion (greater than or equal to8% and <18% per year), was associated with a decreased risk of admission (0.91 [0.84-0.98], p=0.012). Moderate downsizing (>= 8% and <18% per year) was associated with an increased risk of sickness absence (1.07 (1.02-1.12], p=0.003). The strongest association between large expansion and sickness absence was in women in the public sector (1.18 [1.08-1.30], p=0.0002), corresponding to an odds ratio of 2.77 [1.62-4.74] between full exposure (all 6 years) and no exposure. Interpretation This study confirms earlier findings that downsizing is associated with health risks. It also shows that repeated exposure to rapid personnel expansion, possibly connected with centralisation of functions, statistically predicts long-term sickness absence and hospital admission. Although no conclusions about causal pathways can be drawn from our results, this exposure should be considered in future studies, policy making, and occupational health care practice.	Natl Inst Psychosocial Med, Stockholm, Sweden; UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Stockholm, Dept Stat, S-10691 Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of London; University College London; Stockholm University; Karolinska Institutet	Westerlund, H (corresponding author), Natl Inst Psychosocial Med, Mosseberg Res Stn, Mossebergspk 2, S-52132 Falkoping, Sweden.	hugo.westerlund@ipm.ki.se	Ferrie, Jane/AAZ-2009-2020; Westerlund, Hugo/A-3049-2012	Westerlund, Hugo/0000-0002-8806-5698; Hagberg, Jan/0000-0001-6851-265X				Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; BEALE N, 1985, J ROY COLL GEN PRACT, V35, P510; Bjorkelund C, 2001, Lakartidningen, V98, P3314; De Witte H., 1999, EUR J WORK ORGAN PSY, V8, P155, DOI [DOI 10.1080/135943299398302, https://doi.org/10.1080/135943299398302]; EYER J, 1977, INT J HEALTH SERV, V7, P625, DOI 10.2190/15F1-N58K-D38Y-2X0P; EYER J, 1977, INT J HEALTH SERV, V7, P125, DOI 10.2190/9WA2-RVL3-MT9D-EL9D; Ferrie JE, 1998, SOC SCI MED, V46, P243, DOI 10.1016/S0277-9536(97)00158-5; Ferrie JE, 2001, BMJ-BRIT MED J, V322, P647, DOI 10.1136/bmj.322.7287.647; Ferrie JE, 1998, AM J PUBLIC HEALTH, V88, P1030, DOI 10.2105/AJPH.88.7.1030; Grunberg L, 2001, J Occup Health Psychol, V6, P15, DOI 10.1037/1076-8998.6.1.15; IVERSEN L, 1989, BRIT MED J, V299, P1073, DOI 10.1136/bmj.299.6707.1073; KASL SV, 1975, PSYCHOSOM MED, V37, P106, DOI 10.1097/00006842-197503000-00002; Kivimaki M, 2001, OCCUP ENVIRON MED, V58, P811, DOI 10.1136/oem.58.12.811; Kuper H, 2002, OCCUP ENVIRON MED, V59, P777, DOI 10.1136/oem.59.11.777; Landsbergis P A, 1999, J Occup Health Psychol, V4, P108, DOI 10.1037/1076-8998.4.2.108; MORRIS JK, 1991, BRIT J IND MED, V48, P1; PLATT S, 1998, CHANGING LABOUR MARK; Theorell T, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e9; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; WESTERLUND H, IN PRESS EUR J PUBLI; WESTIN S, 1989, J CLIN EPIDEMIOL, V42, P435, DOI 10.1016/0895-4356(89)90133-9	21	77	79	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1193	1197		10.1016/S0140-6736(04)15949-7	http://dx.doi.org/10.1016/S0140-6736(04)15949-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081652				2022-12-28	WOS:000220748100010
J	Mount, AS; Wheeler, AP; Paradkar, RP; Snider, D				Mount, AS; Wheeler, AP; Paradkar, RP; Snider, D			Hemocyte-mediated shell mineralization in the eastern oyster	SCIENCE			English	Article							NUCLEATION; CALCITE; APLACOPHORA; MORPHOLOGY; GROWTH	The growth of molluscan shell crystals is usually thought to be initiated from solution by extracellular organic matrix. We report a class of granulocytic hemocytes that may be directly involved in shell crystal production for oysters. On the basis of scanning electron microscopy (SEM) and x-ray microanalysis, these granulocytes contain calcium carbonate crystals, and they increase in abundance relative to other hemocytes following experimentally induced shell regeneration. Hemocytes are observed at the mineralization front using vital fluorescent staining and SEM. Some cells are observed releasing crystals that are subsequently remodeled, thereby at least augmenting matrix-mediated crystal-forming processes in this system.	Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; Clemson Univ, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA	Clemson University; Clemson University	Mount, AS (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	mount@clemson.edu		Mount, Andrew/0000-0002-3376-1135				ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; CARRIKER M R, 1980, Proceedings National Shellfisheries Association, V70, P139; Carriker Melbourne R., 1996, P75; Cheng T.C., 1981, INVERTEBRATE BLOOD C, P233; Cheng Thomas C., 1996, P299; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Eble Albert F., 1996, P271; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; FORD SE, 1993, J INVERTEBR PATHOL, V61, P49, DOI 10.1006/jipa.1993.1009; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Gosling E, 2003, BIVALVE MOLLUSCS BIO; GREENFIELD EM, 1984, AM ZOOL, V24, P925; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; JODREY LH, 1953, BIOL BULL, V104, P398, DOI 10.2307/1538493; JUSTUS M, 2002, 6 INT C SHELLF REST; KINGSLEY RJ, 1984, AM ZOOL, V24, P833; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; MCCORMICKRAY MG, 1991, J INVERTEBR PATHOL, V58, P219, DOI 10.1016/0022-2011(91)90066-Y; MOUNT AS, 1999, THESIS CLEMSON U; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2000, BIOL BULL, V198, P121, DOI 10.2307/1542810; Sikes CS, 2000, BIOL BULL, V198, P50, DOI 10.2307/1542803; Simkiss K, 1989, BIOMINERALIZATION CE; WATABE N, 1983, MOLLUSCA 1, V4, P289; Wheeler A.P., 1992, P179; WHEELER AP, 1975, BIOL BULL, V148, P472, DOI 10.2307/1540523; Wilbur K. M., 1983, MOLLUSCA 1, P236; WILBUR KM, 1952, BIOL BULL, V103, P269, DOI 10.2307/1538451; WILBUR KM, 1964, PHYSL MOLLUSCA, V1, P242; [No title captured]	32	324	345	10	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					297	300		10.1126/science.1090506	http://dx.doi.org/10.1126/science.1090506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073378				2022-12-28	WOS:000220719400049
J	Stern, RS				Stern, RS			Treatment of photoaging	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACTINIC SKIN DAMAGE; TOXIN TYPE-A; DOUBLE-BLIND; SUNSCREEN USE; SOLAR KERATOSES; HAIRLESS MICE; BASAL-CELL; CLINICAL-TRIAL; GLYCOLIC ACID		Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Stern, RS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Dermatol, 330 Brookline Ave, Boston, MA 02215 USA.	rstern@bidmc.harvard.edu						*AM SOC AESTH PLAS, 2003, ASAPS COMM; Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; BOYD AS, 1995, J AM ACAD DERMATOL, V33, P941, DOI 10.1016/0190-9622(95)90284-8; Brooke RCC, 2001, ARCH DERMATOL, V137, P751; Carruthers JA, 2002, J AM ACAD DERMATOL, V46, P840, DOI 10.1067/mjd.2002.121356; *CTR FOOD SAF APPL, 2000, OFF COSM COL FACT SH; Darlington S, 2003, ARCH DERMATOL, V139, P451, DOI 10.1001/archderm.139.4.451; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Drake LA, 1996, J AM ACAD DERMATOL, V34, P698; DRAKE LA, 1995, J AM ACAD DERMATOL, V33, P497; Drake LA, 1996, J AM ACAD DERMATOL, V35, P462; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P654; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P648; Drake Lynn A., 1995, Journal of the American Academy of Dermatology, V32, P95; Dunn LB, 1997, ARCH DERMATOL, V133, P339, DOI 10.1001/archderm.133.3.339; *FDA, 2003, T0385 FDA; FOLEY P, 1993, BRIT J DERMATOL, V128, P512, DOI 10.1111/j.1365-2133.1993.tb00227.x; *FOOD DRUG ADM, 1999, P DERM OPHTH DRUGS A; Foote JA, 2001, INT J CANCER, V95, P7, DOI 10.1002/1097-0215(20010120)95:1<7::AID-IJC1001>3.0.CO;2-X; Frost C, 2000, J INVEST DERMATOL, V115, P273, DOI 10.1046/j.1523-1747.2000.00048.x; Fulton JE, 1999, DERMATOL SURG, V25, P729, DOI 10.1046/j.1524-4725.1999.99035.x; Gebauer Kurt, 2003, Australas J Dermatol, V44, P40, DOI 10.1046/j.1440-0960.2002.00635.x; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green A, 1999, LANCET, V354, P723; GRIFFITHS CEM, 1993, NEW ENGL J MED, V329, P530, DOI 10.1056/NEJM199308193290803; Hecker D, 1999, J AM ACAD DERMATOL, V41, P927, DOI 10.1016/S0190-9622(99)70248-3; Hernandez-Perez E, 2001, DERMATOL SURG, V27, P637, DOI 10.1046/j.1524-4725.2001.00291.x; HOLMAN CDJ, 1984, BRIT J DERMATOL, V110, P129, DOI 10.1111/j.1365-2133.1984.tb07458.x; HOLMAN CDJ, 1984, AM J EPIDEMIOL, V120, P414, DOI 10.1093/oxfordjournals.aje.a113906; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Kang SW, 2001, ARCH DERMATOL, V137, P1597; Kennedy C, 2003, J INVEST DERMATOL, V120, P548, DOI 10.1046/j.1523-1747.2003.12092.x; Klein AW, 2001, DERMATOL CLIN, V19, P491, DOI 10.1016/S0733-8635(05)70290-4; KLIGMAN LH, 1985, J INVEST DERMATOL, V84, P272, DOI 10.1111/1523-1747.ep12265353; KLIGMAN LH, 1982, J INVEST DERMATOL, V78, P181, DOI 10.1111/1523-1747.ep12506359; KLIGMAN LH, 1983, J INVEST DERMATOL, V81, P98, DOI 10.1111/1523-1747.ep12542169; Kurwa HA, 1999, J AM ACAD DERMATOL, V41, P414, DOI 10.1016/S0190-9622(99)70114-3; Leveque JC, 2001, CLIN GERIATR MED, V17, P673, DOI 10.1016/S0749-0690(05)70093-8; Lowe NJ, 1996, J AM ACAD DERMATOL, V35, P569, DOI 10.1016/S0190-9622(96)90682-9; MAHEUX R, 1994, AM J OBSTET GYNECOL, V170, P642, DOI 10.1016/S0002-9378(94)70242-X; Malvy DJM, 2000, J AM ACAD DERMATOL, V42, P47, DOI 10.1016/S0190-9622(00)90008-2; Matarasso SL, 2003, DERMATOL SURG, V29, P7, DOI 10.1046/j.1524-4725.2003.29017.x; Memon AA, 2000, BRIT J DERMATOL, V142, P1154, DOI 10.1046/j.1365-2133.2000.03541.x; Neale R, 2002, ARCH DERMATOL, V138, P1319, DOI 10.1001/archderm.138.10.1319; PRESTON DS, 1992, NEW ENGL J MED, V327, P1649, DOI 10.1056/NEJM199212033272307; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; STERN RS, 1986, ARCH DERMATOL, V122, P537, DOI 10.1001/archderm.122.5.537; STERN RS, 1994, J AM ACAD DERMATOL, V30, P985; Stiller MJ, 1996, ARCH DERMATOL, V132, P631, DOI 10.1001/archderm.132.6.631; Stockfleth E, 2002, ARCH DERMATOL, V138, P1498, DOI 10.1001/archderm.138.11.1498; Thibault PK, 1998, DERMATOL SURG, V24, P573, DOI 10.1111/j.1524-4725.1998.tb04209.x; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P527, DOI 10.1001/jama.259.4.527; Weiss JS, 1988, JAMA-J AM MED ASSOC, V260, P926; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P3274; Witheiler DD, 1997, DERMATOL SURG, V23, P191, DOI 10.1111/j.1524-4725.1997.tb00020.x; 2003, PHYS DESK REFERENCE, P1	57	44	49	1	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1526	1534		10.1056/NEJMcp023168	http://dx.doi.org/10.1056/NEJMcp023168			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071127				2022-12-28	WOS:000220682000008
J	Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; Ali, Z; Del Turco, D; Bentivoglio, AR; Healy, DG; Albanese, A; Nussbaum, R; Gonzalez-Maldonaldo, R; Deller, T; Salvi, S; Cortelli, P; Gilks, WP; Latchman, DS; Harvey, RJ; Dallapiccola, B; Auburger, G; Wood, NW				Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S; Ali, Z; Del Turco, D; Bentivoglio, AR; Healy, DG; Albanese, A; Nussbaum, R; Gonzalez-Maldonaldo, R; Deller, T; Salvi, S; Cortelli, P; Gilks, WP; Latchman, DS; Harvey, RJ; Dallapiccola, B; Auburger, G; Wood, NW			Hereditary early-onset Parkinson's disease caused by mutations in PINK1	SCIENCE			English	Article							ALPHA-SYNUCLEIN; NEURODEGENERATION; APOPTOSIS; NEURONS	Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.	IRCCS, CSS, Mendel Inst, I-00198 Rome, Italy; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00187 Rome, Italy; Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Goethe Univ Frankfurt, Inst Expt Neurobiol, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Sect Mol Neurogenet, Neurol Clin, D-60590 Frankfurt, Germany; Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy; Natl Neurol Inst Carlo Besta, I-20133 Milan, Italy; NHGRI, NIH, Bethesda, MD 20892 USA; Hosp Univ San Cecilio, Dept Neurol, Granada 18012, Spain; Univ Modena & Reggio Emilia, Dept Neurosci, I-41100 Modena, Italy; Univ London Birkbeck Coll, London WC1E 7HX, England	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of London; University College London; Sapienza University Rome; University of London; University College London; University of London; University College London; University of London School of Pharmacy; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Neurologico Besta; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hospital Universitario San Cecilio; Universita di Modena e Reggio Emilia; University of London; Birkbeck University London	Valente, EM (corresponding author), IRCCS, CSS, Mendel Inst, Viale Regina Margherita 261, I-00198 Rome, Italy.	e.valente@css-mendel.it; auburger@em.uni-frankfurt.de; n.wood@ion.ucl.ac.uk	Harvey, Robert/D-3994-2016; Bentivoglio, Anna Rita/K-3752-2018; Valente, Enza Maria/G-2942-2017; Albanese, Alberto/K-7396-2016; Cortelli, Pietro/K-6063-2016; Wood, Nicholas W/C-2505-2009; Gilks, William/P-9137-2015; Dallapiccola, Bruno/K-8692-2016	Harvey, Robert/0000-0001-5956-6664; Valente, Enza Maria/0000-0002-0600-6820; Albanese, Alberto/0000-0002-5864-0006; Wood, Nicholas W/0000-0002-9500-3348; Gilks, William/0000-0001-7814-3173; Cortelli, Pietro/0000-0002-3633-8818; Bentivoglio, Anna Rita/0000-0002-9663-095X; Dallapiccola, Bruno/0000-0002-5031-1013; Ali, Zeeshan/0000-0002-1668-8634; Muqit, Miratul/0000-0001-9733-2404	Parkinson&apos;s UK [G-4029] Funding Source: Medline; Telethon [GGP02089] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER	Parkinson&apos;s UK(Parkinson&apos;s UK); Telethon(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Sherer TB, 2002, J NEUROSCI, V22, P7006; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2002, ANN NEUROL, V51, P14, DOI 10.1002/ana.10053; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522	16	2457	2546	10	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2004	304	5674					1158	1160		10.1126/science.1096284	http://dx.doi.org/10.1126/science.1096284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822FP	15087508				2022-12-28	WOS:000221524500043
J	Doran, T; Drever, F; Whitehead, M				Doran, T; Drever, F; Whitehead, M			Is there a north-south divide in social class inequalities in health in Great Britain? Cross sectional study using data from the 2001 census	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine individual social class inequalities in self rated general health within and between the constituent countries of Great Britain and the regions of England. Design Cross sectional study using data from the 2001 national census. Setting Great Britain. Participants Adults aged between 25 and 64 in Great Britain and enumerated in the 2001 population census (n = 25.6 million). Main outcome measures European age standardised rates of self rated general health, for men and women classified by the government social class scheme. Results In each of the seven social classes, Wales and the North East and North West regions of England had high rates of poor health. There were large social class inequalities in self rated health, with rates of poor health generally increasing from class I (higher professional occupations) to class 7 (routine occupations). The size of the health divide varied between regions: the largest rate ratios for routine versus higher professional classes were for Scotland (2.9 for men, 2.8 for women) and London (2.9 for men; 2.4 for women). Women had higher rates of poor health compared to men in the same social class, except in class 6 (semi-routine occupations). Conclusions A northwest-southeast divide in social class inequalities existed in Great Britain at the start of the 21st century, with each of the seven social classes having higher rates of poor health in Wales, the North East and North West regions of England than elsewhere. The widest health gap between social classes, however, vas in Scotland and London, adding another dimension to the policy debate on resource allocation and targets to tackle the health divide.	Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Doran, T (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.	timdoran@liverpool.ac.uk						ACHESON D, 1998, REPORT INDEPENDENT I; Armitage P., 1998, ENCY BIOSTATISTICS; Armitage P., 2002, STAT METHODS MED RES; *DEP HLTH, 2003, KEY NHS INT SUPP ACH; Department of Health, 2003, TACKL HLTH IN PROGR; *GEN REG OFF SCOTL, SCOTL CENS; Office for National Statistics, 2003, CENS 2001 CD SUPPL N; Townsend PP., 1988, HLTH DEPRIVATION INE; 2000, ONS STANDARD OCCUPAT, V2; 1999, SAVING LIVES OUR HLT; 2000, ONS STANDARD OCCUPAT, V1	11	57	57	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1043	1045		10.1136/bmj.328.7447.1043	http://dx.doi.org/10.1136/bmj.328.7447.1043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15117791	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000221174500015
J	You, J; Croyle, JL; Nishimura, A; Ozato, K; Howley, PM				You, J; Croyle, JL; Nishimura, A; Ozato, K; Howley, PM			Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes	CELL			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; NUCLEAR ANTIGEN; BROMODOMAIN PROTEIN; EPISOMAL MAINTENANCE; VIRUS PLASMIDS; REPLICATION; CHROMATIN; CELLS; TRANSACTIVATION; TRANSCRIPTION	The papillomavirus E2 protein tethers viral genomes to host mitotic chromosomes to ensure genome maintenance. We have identified the bromodomain protein Brd4 as a major cellular interacting partner of the bovine papillomavirus E2. Brd4 associates with mitotic chromosomes and colocalizes with E2 on mitotic chromosomes. The site of E2 binding maps to the C-terminal domain of Brd4. Expression of this C-terminal Brd4 domain functions in a dominant-negative manner to abrogate the colocalization of E2 with Brd4 on mitotic chromosomes, to block association of the viral episomes with Brd4, and to inhibit BPV-1 DNA-mediated cellular transformation. Brd4 also associates with HPV16 E2, indicating that Brd4 binding may be a shared property of all papillomavirus E2 proteins. The interaction of E2 with Brd4 is required to ensure the tethering of viral genomes to the host mitotic chromosomes for persistence of viral episomes in PV-infected cells.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Howley, PM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	peter_howley@hms.harvard.edu		Howley, Peter/0000-0002-8668-9579	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA050661, R01CA077385] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA77385, P01 CA50661] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bastien N, 2000, VIROLOGY, V270, P124, DOI 10.1006/viro.2000.0265; BEDELL MA, 1991, J VIROL, V65, P2254, DOI 10.1128/JVI.65.5.2254-2260.1991; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Kapoor P, 2003, J VIROL, V77, P6946, DOI 10.1128/JVI.77.12.6946-6956.2003; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Kurg R, 1999, J VIROL, V73, P4670, DOI 10.1128/JVI.73.6.4670-4677.1999; LAW MF, 1981, P NATL ACAD SCI-BIOL, V78, P2727, DOI 10.1073/pnas.78.5.2727; Lehman CW, 1998, P NATL ACAD SCI USA, V95, P4338, DOI 10.1073/pnas.95.8.4338; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Niki H, 1997, CELL, V90, P951, DOI 10.1016/S0092-8674(00)80359-1; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Piirsoo M, 1996, EMBO J, V15, P1; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Sakai H, 1996, J VIROL, V70, P1602, DOI 10.1128/JVI.70.3.1602-1611.1996; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Stubenrauch F, 1998, J VIROL, V72, P8115, DOI 10.1128/JVI.72.10.8115-8123.1998; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	36	297	332	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					349	360		10.1016/S0092-8674(04)00402-7	http://dx.doi.org/10.1016/S0092-8674(04)00402-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109495	Bronze			2022-12-28	WOS:000221176400009
J	Engel, A; Thoms, S; Riebesell, U; Rochelle-Newall, E; Zondervan, I				Engel, A; Thoms, S; Riebesell, U; Rochelle-Newall, E; Zondervan, I			Polysaccharide aggregation as a potential sink of marine dissolved organic carbon	NATURE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; MATTER; FLUXES; PARTICULATE; RESPIRATION; NITROGEN; TEP	The formation and sinking of biogenic particles mediate vertical mass fluxes and drive elemental cycling in the ocean(1). Whereas marine sciences have focused primarily on particle production by phytoplankton growth, particle formation by the assembly of organic macromolecules has almost been neglected(2,3). Here we show, by means of a combined experimental and modelling study, that the formation of polysaccharide particles is an important pathway to convert dissolved into particulate organic carbon during phytoplankton blooms, and can be described in terms of aggregation kinetics. Our findings suggest that aggregation processes in the ocean cascade from the molecular scale up to the size of fast-settling particles, and give new insights into the cycling and export of biogeochemical key elements such as carbon, iron and thorium.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Stn Zool, Lab Oceanog Villefrance Mer, F-06234 Villefranche Sur Mer, France	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; UDICE-French Research Universities; Sorbonne Universite	Engel, A (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	anja.engel@stonybrook.edu; sthoms@awi-bremerhaven.de	Riebesell, Ulf/AAC-9717-2020	Rochelle-Newall, Emma/0000-0003-0951-8650; Riebesell, Ulf/0000-0002-9442-452X; Engel, Anja/0000-0002-1042-1955				AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; ASPER VL, 1992, NATURE, V357, P670, DOI 10.1038/357670a0; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; Biddanda B, 1997, LIMNOL OCEANOGR, V42, P506, DOI 10.4319/lo.1997.42.3.0506; CARLSON CA, 2002, BIOGEOCHEMISTRY MARI, P59; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Engel A, 2004, AQUAT MICROB ECOL, V34, P93, DOI 10.3354/ame034093; Engel A, 2000, J PLANKTON RES, V22, P485, DOI 10.1093/plankt/22.3.485; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Mari X, 1999, MAR ECOL PROG SER, V183, P59, DOI 10.3354/meps183059; MCCAVE IN, 1975, DEEP-SEA RES, V22, P491, DOI 10.1016/0011-7471(75)90022-4; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; Myklestad SM, 1997, MAR CHEM, V56, P279, DOI 10.1016/S0304-4203(96)00074-6; Nanninga HJ, 1996, J MARINE SYST, V9, P67, DOI 10.1016/0924-7963(96)00017-6; Nielsen MV, 1997, J PHYCOL, V33, P818, DOI 10.1111/j.0022-3646.1997.00818.x; PAKULSKI JD, 1994, LIMNOL OCEANOGR, V39, P930, DOI 10.4319/lo.1994.39.4.0930; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Ruiz J, 2002, DEEP-SEA RES PT I, V49, P495, DOI 10.1016/S0967-0637(01)00072-3; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129; WELLS ML, 1992, MAR CHEM, V40, P5, DOI 10.1016/0304-4203(92)90045-C; Wells ML, 1998, NATURE, V391, P530, DOI 10.1038/35248; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251; ZIFF RM, 1980, J CHEM PHYS, V73, P3492, DOI 10.1063/1.440502	30	277	284	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					929	932		10.1038/nature02453	http://dx.doi.org/10.1038/nature02453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118723	Green Published			2022-12-28	WOS:000221083000037
J	Gheorghiade, M; Gattis, WA; O'Connor, CM; Adams, KF; Elkayam, U; Barbagelata, A; Ghali, JK; Benza, RL; McGrew, FA; Klapholz, M; Ouyang, J; Orlandi, C				Gheorghiade, M; Gattis, WA; O'Connor, CM; Adams, KF; Elkayam, U; Barbagelata, A; Ghali, JK; Benza, RL; McGrew, FA; Klapholz, M; Ouyang, J; Orlandi, C		ACTIV CHF Investigators	Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	76th Annual Scientific Session of the American-Heart-Association	NOV 07-12, 2003	ORLANDO, FL	Amer Heart Assoc			LEFT-VENTRICULAR DYSFUNCTION; PLASMA ARGININE VASOPRESSIN; V-2-RECEPTOR ANTAGONIST; DOUBLE-BLIND; DEATH; MULTICENTER; FUROSEMIDE; OPC-41061; BLOCKADE; THERAPY	Context Nearly 1 million hospitalizations for chronic heart failure occur yearly in the United States, with most related to worsening systemic congestion. Diuretic use, the mainstay therapy for congestion, is associated with electrolyte abnormalities and worsening renal function. In contrast to diuretics, the vasopressin antagonist tolvaptan may increase net volume loss in heart failure without adversely affecting electrolytes and renal function. Objective To evaluate the short- and intermediate-term effects of tolvaptan in patients hospitalized with heart failure. Design, Setting, and Participants Randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, phase 2 trial conducted at 45 centers in the United States and Argentina and enrolling 319 patients with left ventricular ejection fraction of less than 40% and hospitalized for heart failure with persistent signs and symptoms of systemic congestion despite standard therapy. Intervention After admission, patients were randomized to receive 30, 60, or 90 mg/d of oral tolvaptan or placebo in addition to standard therapy, including diuretics. The study drug was continued for up to 60 days. Main Outcome Measures In-hospital outcome was change in body weight at 24 hours after randomization; outpatient outcome was worsening heart failure (defined as death, hospitalization, or unscheduled visits for heart failure) at 60 days after randomization. Results Median (Interquartile range) body weight at 24 hours after randomization decreased by -1.80 (-3.85 to -0.50), -2.10 (-3.10 to -0.85), -2.05 (-2.80 to -0.60), and -0.60 (-1.60 to 0.00) kg in the groups receiving tolvaptan 30, 60, and 90 mg/d, and placebo, respectively (Pless than or equal to008 for all tolvaptan groups vs placebo). The decrease in body weight with tolvaptan was not associated with changes in heart rate or blood pressure, nor did it result in hypokalemia or worsening renal function. There were no differences in worsening heart failure at 60 days between the tolvaptan and placebo groups (P = .88 for trend). In post hoc analysis, 60-day mortality was lower in tolvaptan-treated patients with renal dysfunction or severe systemic congestion. Conclusion Tolvaptan administered in addition to standard therapy may hold promise for management of systemic congestion in patients hospitalized for heart failure.	Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; Duke Clin Res Inst, Durham, NC USA; Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; Univ So Calif, Div Cardiol, Los Angeles, CA USA; Italian Hosp, Div Cardiol, Buenos Aires, DF, Argentina; Cardiac Ctr Louisiana, Div Cardiol, Shreveport, LA USA; Univ Alabama, Div Cardiol, Birmingham, AL USA; Stern Cardiovasc Ctr, Div Cardiol, Memphis, TN USA; St Vincents Hosp, Div Cardiol, New York, NY USA; Otsuka Maryland Res Inst, Rockville, MD USA	Northwestern University; Feinberg School of Medicine; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Hospital Italiano de Buenos Aires; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Alabama System; University of Alabama Birmingham; Saint Vincents Hospital Manhattan	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Cardiol, Galter 10-240,201 E Huron St, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Benza, Raymond Louis/AAD-4885-2019; Stough, Wendy G/R-4287-2016	Benza, Raymond Louis/0000-0001-9627-6236; Stough, Wendy G/0000-0001-8290-1205				Adamson PB, 2003, J AM COLL CARDIOL, V41, P565, DOI 10.1016/S0735-1097(02)02896-6; Burnett JC, 2003, J CARD FAIL, V9, P36; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Domanski M, 2003, J AM COLL CARDIOL, V42, P705, DOI 10.1016/S0735-1097(03)00765-4; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; GATTIS WA, IN PRESS J AM COLL C; Gheorghiade M, 2003, AM HEART J, V145, pS51, DOI 10.1067/mhj.2003.154; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2001, CIRCULATION, V104, P438; GOLDSMITH SR, 1983, J AM COLL CARDIOL, V1, P1385, DOI 10.1016/S0735-1097(83)80040-0; GOLDSMITH SR, 1986, AM J CARDIOL, V58, P295, DOI 10.1016/0002-9149(86)90065-2; Goldsmith Steven R, 2002, Congest Heart Fail, V8, P251, DOI 10.1111/j.1527-5299.2002.01158.x; Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495; HALL MJ, 2003, 2001 NATL HOSP DISCH; Havranek EP, 2001, J CARD FAIL, V7, P153, DOI 10.1054/jcaf.2001.24121; Hirano T, 2000, J PHARMACOL EXP THER, V292, P288; IKRAM H, 1980, CLIN SCI, V59, P443, DOI 10.1042/cs0590443; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; Lee CR, 2003, AM HEART J, V146, P9, DOI 10.1016/S0002-8703(02)94708-3; LEE DCS, 1982, NEW ENGL J MED, V306, P699, DOI 10.1056/NEJM198203253061202; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Licata G, 2003, AM HEART J, V145, P459, DOI 10.1067/mhj.2003.166; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; NASS O, 1995, AM J CARDIOL, V76, P402, DOI 10.1016/S0002-9149(99)80111-8; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; SZATALOWICZ VL, 1981, NEW ENGL J MED, V305, P263, DOI 10.1056/NEJM198107303050506; Udelson JE, 2002, J AM COLL CARDIOL  S, V39, P810; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	33	470	519	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1963	1971		10.1001/jama.291.16.1963	http://dx.doi.org/10.1001/jama.291.16.1963			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113814	Bronze			2022-12-28	WOS:000221062000027
J	Blumenthal, D				Blumenthal, D			New steam from an old cauldron - The physician-supply debate.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROJECTED WORKFORCE; MEDICAL-SCHOOLS; SURPLUS; CARE; SHORTAGE; AFFORD; TRENDS											AARON HJ, 2003, SHOULD PUBLIC POLICY; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], [No title captured]; Barzansky B, 2003, JAMA-J AM MED ASSOC, V290, P1190, DOI 10.1001/jama.290.9.1190; Blumenthal D, 2003, HEALTH AFFAIR, V22, P85, DOI 10.1377/hlthaff.22.4.85; Chernew ME, 2003, HEALTH AFFAIR, V22, P15, DOI 10.1377/hlthaff.22.4.15; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Cooper RA, 2003, HEALTH AFFAIR, V22, P71, DOI 10.1377/hlthaff.22.4.71; Cooper RA, 2003, HEALTH SERV RES, V38, P675, DOI 10.1111/1475-6773.00139; COOPER RA, 1995, JAMA-J AM MED ASSOC, V274, P1534, DOI 10.1001/jama.274.19.1534; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; *COUNC GRAD MED ED, 1994, 4 COUNC GRAD MED ED; *COUNC GRAD MED ED, 1992, 3 COUNC GRAD MED ED; Council on Graduate Medical Education, 1996, 8 COUNC GRAD MED ED; CROASDALE M, 2003, AMA NEWS        1103; GINZBERG E, 1989, HEALTH AFFAIR, V8, P84, DOI 10.1377/hlthaff.8.2.84; Goodman DC, 1997, JAMA-J AM MED ASSOC, V277, P966; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; *GRAD MED ED NAT A, 1981, DHHS PUBL; GRUMBACH K, 1991, JAMA-J AM MED ASSOC, V265, P2369; Grumbach K, 2002, HEALTH AFFAIR, V21, P155, DOI 10.1377/hlthaff.21.1.155; Hallock JA, 2003, HEALTH AFFAIR, V22, P94, DOI 10.1377/hlthaff.22.4.94; JACOBSEN SJ, 1987, HEALTH AFFAIR, V6, P48, DOI 10.1377/hlthaff.6.2.48; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, P442, DOI 10.1001/jama.289.4.442; Ludmerer K., 1999, TIME HEAL AM MED ED; MCNUTT DR, 1981, AM J PUBLIC HEALTH, V71, P1116, DOI 10.2105/AJPH.71.10.1116; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; PAULY MV, 2003, SHOULD WE BE WORRIED; SALSBERG E, 2003, COUNC GRAD MED ED M; Salsberg ES, 2002, HEALTH AFFAIR, V21, P165, DOI 10.1377/hlthaff.21.5.165; SCHWARTZ WB, 1988, NEW ENGL J MED, V318, P892, DOI 10.1056/NEJM198804073181405; Starr P, 1982, SOCIAL TRANSFORMATIO; *SUNY ALB SCH PUBL, 2003, PHYS SUPPL DEM IND N; *SUNY ALB SCH PUBL, 2002, RES TRAIN OUTC SPEC; Tarlov A R, 1986, Health Aff (Millwood), V5, P23, DOI 10.1377/hlthaff.5.1.23; Weeks WB, 2002, ACAD MED, V77, P312, DOI 10.1097/00001888-200204000-00010; Weiner JP, 2002, HEALTH AFFAIR, V21, P160, DOI 10.1377/hlthaff.21.1.160; WEINER JP, 1994, JAMA-J AM MED ASSOC, V272, P222; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	39	81	81	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1780	1787		10.1056/NEJMhpr033066	http://dx.doi.org/10.1056/NEJMhpr033066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814AJ	15103006				2022-12-28	WOS:000220947300015
J	Snow, V; Aronson, MD; Hornbake, ER; Mottur-Pilson, C; Weiss, KB				Snow, V; Aronson, MD; Hornbake, ER; Mottur-Pilson, C; Weiss, KB		Clin Efficacy Assess Subcomm Am Co	Lipid control in the management of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; PRIMARY-PREVENTION; SUBGROUP ANALYSIS; EVENTS; AVERAGE; TRIAL; MEN; INTERVENTION; HYPERTENSION; GEMFIBROZIL	In an effort to provide internists and other primary care physicians with effective management strategies for diabetes care, the Clinical Efficacy Assessment Subcommittee (CEAS) of the American College of Physicians (ACP) decided to develop guidelines on the management of dyslipidemia, particularly hypercholesterolemia, in people with type 2 diabetes mellitus. The CEAS commissioned a systematic review of the currently available evidence on the management of lipids in type 2 diabetes mellitus. The evidence review is presented in a background paper in this issue. On the basis of this systematic review, the CEAS developed recommendations that the ACP Board of Regents then approved as policy. The target audience for this guideline is all clinicians who care for patients with type 2 diabetes. The target patient population is all persons with type 2 diabetes, including those who already have some form of microvascular complication and, of particular importance, premenopausal women. The recommendations are as follows. Recommendation 1: Lipid-lowering therapy should be used for secondary prevention of cardiovascular mortality and morbidity for all patients (both men and women) with known coronary artery disease and type 2 diabetes. Recommendation 2: Statins should be used for primary prevention against macrovascular complications in patients (both men and women) with type 2 diabetes and other cardiovascular risk factors. Recommendation 3: Once lipid-lowering therapy is initiated, patients with type 2 diabetes mellitus should be taking at least moderate doses of a statin. Recommendation 4: For those patients with type 2 diabetes who are taking statins, routine monitoring of liver function tests or muscle enzymes is not recommended except in specific circumstances.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Edward Hines Jr VA Hosp, Chicago, IL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	American College of Physicians; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; Feinberg School of Medicine	Snow, V (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	vincenza@acponline.org						*AG HEALTHC RES QU, DIAB DISP RAC ETHN M; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS32; American Association of Clinical Endocrinologists, 2000, Endocr Pract, V6, P43; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; *CAN MED ASS, 1998, CMAJ S, V159; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Hoogwerf BJ, 1999, DIABETES, V48, P1289, DOI 10.2337/diabetes.48.6.1289; KOSKINEN P, 1992, DIABETES CARE, V15, P820, DOI 10.2337/diacare.15.7.820; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Snow V, 2003, ANN INTERN MED, V138, P587, DOI 10.7326/0003-4819-138-7-200304010-00017; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2003, ANN INTERN MED, V138, P593, DOI 10.7326/0003-4819-138-7-200304010-00018; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013	28	109	119	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					644	649		10.7326/0003-4819-140-8-200404200-00012	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096336				2022-12-28	WOS:000220851700008
J	Boisen, KA; Kaleva, M; Main, KM; Virtanen, HE; Haavisto, AM; Schmidt, M; Chellakooty, M; Damgaard, N; Mau, C; Reunanen, M; Skakkebaek, NE; Toppari, J				Boisen, KA; Kaleva, M; Main, KM; Virtanen, HE; Haavisto, AM; Schmidt, M; Chellakooty, M; Damgaard, N; Mau, C; Reunanen, M; Skakkebaek, NE; Toppari, J			Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries	LANCET			English	Article; Proceedings Paper	4th International Symposium on Pediatric Andrology	NOV 10-11, 2000	BASEL, SWITZERLAND				SEMEN QUALITY; UNDESCENDED TESTIS; TESTICULAR CANCER; RISK-FACTORS; TRENDS; HYPOSPADIAS; ORCHIDOPEXY; POPULATION; FREQUENCY; MEN	Background Several investigators have shown striking differences in semen quality and testicular cancer rate between Denmark and Finland. Since maldescent of the testis is a shared risk factor for these conditions we undertook a joint prospective study for the prevalence of congenital cryptorchidism. Methods 1068 Danish (1997-2001) and 1494 Finnish boys (1997-99) were consecutively recruited prenatally. We also established prevalence data for all newborns at Turku University Central Hospital, Finland (1997-99, n=5798). Testicular position was assessed by a standardised technique. All subtypes of congenital cryptorchidism were included, but retractile testes were considered normal. Findings Prevalence of cryptorchidism at birth was 9.0% (95% CI 7.3-10.8) in Denmark and 2.4% (1.7-3.3) in Finland. At 3 months of age, prevalence rates were 1.9% (1.2-3.0) and 1.0% (0.5-1.7), respectively. Significant geographic differences were still present after adjustment for confounding factors (birthweight, gestational age, being small for gestational age, maternal age, parity, mode of delivery); odds ratio (Denmark vs Finland) was 4.4 (2.9-6.7, p<0.0001) at birth and 2.2 (1.0-4.5, p=0.039) at three months. The rate in Denmark was significantly higher than that reported 40 years ago. Interpretation Our findings of increasing and much higher prevalence of congenital cryptorchidism in Denmark than in Finland contribute evidence to the pattern of high frequency of reproductive problems such as testicular cancer and impaired semen quality in Danish men. Although genetic factors could account for the geographic difference, the increase in reproductive health problems in Denmark is more likely explained by environmental factors, including endocrine disrupters and lifestyle.	GR5064 Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; Univ Turku, Dept Physiol, Turku, Finland; Univ Turku, Dept Paediat, Turku, Finland; Univ Turku, Dept Paediat Surg, Turku, Finland	Rigshospitalet; University of Turku; University of Turku; University of Turku	Toppari, J (corresponding author), GR5064 Rigshosp, Univ Dept Growth & Reprod, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	jorma.toppari@utu.fi		Main, Katharina Maria/0000-0001-7259-1039; Boisen, Kirsten A./0000-0002-3374-6621				ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; BUEMANN B, 1961, Acta Chir Scand Suppl, VSuppl 283, P289; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; CHILVERS C, 1984, LANCET, V2, P330; CHILVERS CED, 1992, ARCH DIS CHILD, V67, P892; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Guillette LJ, 2000, GROWTH HORM IGF RES, V10, P45, DOI 10.1016/S1096-6374(00)80009-X; Hack WWM, 2003, BJU INT, V92, P293, DOI 10.1046/j.1464-410X.2003.04317.x; HJERTKVIST M, 1989, J EPIDEMIOL COMMUN H, V43, P324, DOI 10.1136/jech.43.4.324; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ivell R, 2003, MOL HUM REPROD, V9, P175, DOI 10.1093/molehr/gag025; Jensen TK, 2000, EUR J ENDOCRINOL, V142, P47, DOI 10.1530/eje.0.1420047; Jorgensen N, 2002, HUM REPROD, V17, P2199, DOI 10.1093/humrep/17.8.2199; Kaleva Marko, 2003, Hormones (Athens), V2, P211; Larsen T, 2001, DAN MED BULL, V48, P256; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Moller H, 2001, HUM REPROD, V16, P1007, DOI 10.1093/humrep/16.5.1007; Moller H, 1999, EPIDEMIOLOGY, V10, P352, DOI 10.1097/00001648-199907000-00003; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Pihkala J, 1989, Duodecim, V105, P1540; SCORER CG, 1964, ARCH DIS CHILD, V39, P605, DOI 10.1136/adc.39.208.605; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Thong MK, 1998, PEDIATR SURG INT, V13, P37; Toledano MB, 2003, ENVIRON HEALTH PERSP, V111, P129, DOI 10.1289/ehp.5446; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412; Toppari J, 2001, HUM REPROD UPDATE, V7, P282, DOI 10.1093/humupd/7.3.282; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Weidner IS, 1999, J UROLOGY, V161, P1606, DOI 10.1016/S0022-5347(05)68992-6	32	357	373	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1264	1269		10.1016/S0140-6736(04)15998-9	http://dx.doi.org/10.1016/S0140-6736(04)15998-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	813KB	15094270				2022-12-28	WOS:000220904900007
J	Gallegos, AM; Bevan, MJ				Gallegos, AM; Bevan, MJ			Driven to autoimmunity: The NOD mouse	CELL			English	Editorial Material							TOLERANCE		Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gallegos, AM (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.							Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Tian J, 2001, J IMMUNOL, V166, P7144, DOI 10.4049/jimmunol.166.12.7144; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3	8	31	33	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 16	2004	117	2					149	151		10.1016/S0092-8674(04)00340-X	http://dx.doi.org/10.1016/S0092-8674(04)00340-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084253	Bronze			2022-12-28	WOS:000220913400003
J	Reis, T; Edgar, BA				Reis, T; Edgar, BA			Negative regulation kinases of dE2F1 by cyclin-dependent kinases cell cycle timing	CELL			English	Article							RETINOBLASTOMA FAMILY PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; DROSOPHILA EMBRYOGENESIS; S-PHASE; TRANSCRIPTION FACTOR; DNA-REPLICATION; IMAGINAL DISCS; FISSION YEAST; G(1)-S TRANSITION; E2F	Many types of cells compensate for induced alterations in the length of one cell cycle phase (G1, S, or G2) by altering the lengths of the other phases. Here we show that, when cells in Drosophila wing discs are delayed in G1, they maintain normal division rates by accelerating passage through S and G2. Similarly, when G2-M progression is retarded, G1-S progression accelerates. This compensation mechanism employs negative feedback in which the cyclin-dependent kinases Cdk1 and Cdk2 downregulate the transcription factor dE2F1. dE2F1, in turn, positively regulates cyclin E and string/cdc25, which activate the Cdks to drive cell cycle progression. This homeostatic mechanism coordinates rates of G1-S and G2-M progression, maintaining normal rates of proliferation when cell cycle controls are perturbed (e.g., by ectopic Dacapo, dWee1, dMyc, or Rheb). Without dE2F1, the compensatory mechanism fails, and treatments that alter Cdk activity cause aberrant cell cycle timing and cell death.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Gulbenkian Inst Sci, Programa Gulbenkian Doutoramento Biol & Med, P-2781901 Oeiras, Portugal	Fred Hutchinson Cancer Center	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bedgar@fhcrc.org		Reis, Tania/0000-0001-6879-1265	NIGMS NIH HHS [GM51186] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Bartkova J, 1996, CANCER RES, V56, P5475; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Brook A, 1996, EMBO J, V15, P3676, DOI 10.1002/j.1460-2075.1996.tb00737.x; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DESALLE LM, 1996, FEBS LETT, V490, P1237; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Duronio RJ, 1996, GENE DEV, V10, P2505, DOI 10.1101/gad.10.19.2505; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Heriche JK, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-9; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Johnston LA, 1996, DEVELOPMENT, V122, P3519; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Kylsten P, 1997, DEV BIOL, V192, P509, DOI 10.1006/dbio.1997.8770; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Martelli F, 1999, P NATL ACAD SCI USA, V96, P2858, DOI 10.1073/pnas.96.6.2858; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NURSE P, 1980, GENETICS, V96, P627; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Pignoni F, 1997, DEVELOPMENT, V124, P271; Price D, 2000, GENETICS, V155, P159; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Thacker SA, 2003, CURR BIOL, V13, P53, DOI 10.1016/S0960-9822(02)01400-8; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4	65	103	104	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					253	264		10.1016/S0092-8674(04)00247-8	http://dx.doi.org/10.1016/S0092-8674(04)00247-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084262	Bronze			2022-12-28	WOS:000220913400012
J	Willis, KJ; Gillson, L; Brncic, TM				Willis, KJ; Gillson, L; Brncic, TM			How "virgin" is virgin rainforest?	SCIENCE			English	Editorial Material							AGRICULTURE; ECOLOGY		Univ Oxford, Sch Geog & Environm, Biodivers Res Grp, Oxford Long Term Ecol Lab, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog & Environm, Biodivers Res Grp, Oxford Long Term Ecol Lab, Oxford OX1 3TB, England.	kathy.willis@geog.ox.ac.uk	Gillson, Lindsey/AAR-6531-2020	Gillson, Lindsey/0000-0001-9607-6760; Willis, Katherine/0000-0002-6763-2489				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bayliss-Smith T, 2003, AMBIO, V32, P346, DOI 10.1639/0044-7447(2003)032[0346:RCAHOH]2.0.CO;2; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Foster DR, 2002, J BIOGEOGR, V29, P1269, DOI 10.1046/j.1365-2699.2002.00791.x; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; KEALHOFER L, 2003, ASIAN PERSPECT, V42, P72; Mbida VM, 2000, J ARCHAEOL SCI, V27, P151, DOI 10.1006/jasc.1999.0447; MYERS N, 2002, PROTECTING PROTECT M, P46; Oslisly R., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P101; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3	13	191	205	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2004	304	5669					402	403		10.1126/science.1093991	http://dx.doi.org/10.1126/science.1093991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087539				2022-12-28	WOS:000220845400036
J	Zipfel, C; Robatzek, S; Navarro, L; Oakeley, EJ; Jones, JDG; Felix, G; Boller, T				Zipfel, C; Robatzek, S; Navarro, L; Oakeley, EJ; Jones, JDG; Felix, G; Boller, T			Bacterial disease resistance in Arabidopsis through flagellin perception	NATURE			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-5; GENOME-WIDE ANALYSIS; EXTRACELLULAR ALKALINIZATION; SUBNANOMOLAR CONCENTRATIONS; CAENORHABDITIS-ELEGANS; ELICITOR FLAGELLIN; DEFENSE RESPONSES; TOMATO CELLS; PLANT	Plants and animals recognize microbial invaders by detecting pathogen-associated molecular patterns (PAMPs)(1-5) such as flagellin(6-10). However, the importance of flagellin perception for disease resistance has, until now, not been demonstrated(7-11). Here we show that treatment of plants with flg22, a peptide representing the elicitor-active epitope of flagellin(6), induces the expression of numerous defence-related genes and triggers resistance to pathogenic bacteria in wild-type plants, but not in plants carrying mutations in the flagellin receptor gene FLS2. This induced resistance seems to be independent of salicylic acid, jasmonic acid and ethylene signalling. Wild-type and fls2 mutants both display enhanced resistance when treated with crude bacterial extracts, even devoid of elicitor-active flagellin, indicating the existence of functional perception systems for PAMPs other than flagellin. Although fls2 mutant plants are as susceptible as the wild type when bacteria are infiltrated into leaves, they are more susceptible to the pathogen Pseudomonas syringae pv. tomato DC3000 when it is sprayed on the leaf surface. Thus, flagellin perception restricts bacterial invasion, probably at an early step, and contributes to the plant's disease resistance.	John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Friedrich Miescher Institute for Biomedical Research	Boller, T (corresponding author), Univ Basel, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	thomas.boller@unibas.ch	ZIPFEL, CYRIL B/D-7103-2011; Robatzek, Silke/B-6844-2013; Bruening, Stefan/B-8505-2011; Boller, Thomas/G-3500-2012; ZIPFEL, CYRIL/ABD-5076-2021; Jones, Jonathan DG/J-5129-2012	ZIPFEL, CYRIL B/0000-0003-4935-8583; Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL/0000-0003-4935-8583; Jones, Jonathan DG/0000-0002-4953-261X				Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; GRANADO J, 1995, PLANT PHYSIOL, V107, P485, DOI 10.1104/pp.107.2.485; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Katagiri F., 2002, ARABIDOPSIS BOOK; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; NAVARRO L, IN PRESS PLANT PHYSL; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1	30	1180	1233	14	366	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					764	767		10.1038/nature02485	http://dx.doi.org/10.1038/nature02485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085136				2022-12-28	WOS:000220823800043
J	Landon, BE; Zaslavsky, AM; Bernard, SL; Cioffi, MJ; Cleary, PD				Landon, BE; Zaslavsky, AM; Bernard, SL; Cioffi, MJ; Cleary, PD			Comparison of performance of traditional Medicare vs Medicare managed care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH MAINTENANCE ORGANIZATIONS; INFLUENZA VACCINATION; CONSUMER ASSESSMENTS; PLAN PERFORMANCE; PLUS CHOICE; QUALITY; DIMENSIONS	Context Since 2000, the Centers for Medicare & Medicaid Services (CMS) has been collecting information on beneficiaries' experiences with health care for Medicare managed care (MMC) and traditional fee-for-service (FFS) Medicare. Objectives To compare beneficiary experiences with managed care and FFS arrangements throughout the country and to assess the stability of those differences over time. Design, Setting, and Participants CMS administered managed care and FFS versions of the Consumer Assessment of Health Plans Study (CAHPS) survey to samples of beneficiaries (aged greater than or equal to65 years) from Medicare + Choice MMC organizations and from geographic strata within the traditional FFS Medicare program. We analyzed responses collected in 2000 and 2001 from 497869 respondents: 299058 beneficiaries enrolled in MMC plans (response rate, 82%) and 198811 enrolled in,FFS Medicare (response rate, 68%). Differences between MMC and FFS within states were assessed after adjustment for case mix and nonresponse. For estimates at the regional and national level, state estimates were combined after weighting by the MMC enrollment in the state. Main Outcome Measures Four overall ratings (of the plan, personal physician, care received overall, and care received from specialists), 5 measures summarizing beneficiaries' experiences with care (getting care needed; getting care quickly; communication with clinicians; courtesy and respect of physician's office staff; and paperwork, information, and customer service), and reports of receipt of 3 preventive services (flu shots, pneumococcal vaccinations, and being advised to quit smoking) were assessed. Results Respondents in MMC and FFS plans were similar to each other and to the Medicare population as a whole. Nationally, FFS Medicare beneficiaries rated experiences with care measured by the CAHPS survey higher than did MMC beneficiaries; for instance, in ratings of care received overall (scale of 1-10) (8.91 FFS vs 8.86 MMC, P<.001, in 2000; and 8.88 FFS vs 8.78 MMC, P<.001, in 2001). Differences between FFS and MMC varied across states, however. Managed care enrollees reported significantly fewer problems with paperwork, information, and customer service (2.62 FFS vs 2.55 MMC, P<.001, in 2000; and 2.59 FFS vs 2.51 MMC, P<.001, in 2001). Enrollees in MMC were also more likely to report having received immunizations for influenza and pneumococcus (from any source) (in 2000, 77% of MMC vs 63% of FFS respondents; P<.001), and smokers were more likely to report having received counseling to quit smoking. Conclusions Our data suggest that managed care was better at delivering preventive services, whereas traditional Medicare was better in other aspects of care related to access and beneficiary experiences. These relative strengths should be considered when policy decisions are made that affect the availability of choice or influence beneficiaries to choose one model of care over another.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Research Triangle Institute	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu	Cleary, Paul/AAF-7048-2019		AHRQ HHS [R01-HS09205-07] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERENSON RA, 2002, HLTH AFF MILLWOOD S, pW65; BERNARD SL, 2002, SUBGROUP ANAL IMPLEM; Bloom HG, 1999, J AM GERIATR SOC, V47, P106, DOI 10.1111/j.1532-5415.1999.tb01910.x; Brown RS, 1999, HEALTH AFFAIR, V18, P140, DOI 10.1377/hlthaff.18.6.140; CLEMENT DG, 1994, HMOS ELDERLY; *CTR MED MED SERV, 2002 DAT COMP; *CTR MED MED SERV, 2004, MED MAN CAR CONTR MM; Gawande AA, 1998, HEALTH AFFAIR, V17, P184, DOI 10.1377/hlthaff.17.5.184; Glavin MPV, 2002, INQUIRY-J HEALTH CAR, V39, P341, DOI 10.5034/inquiryjrnl_39.4.341; Gold M, 2001, HEALTH AFFAIR, V20, P120, DOI 10.1377/hlthaff.20.4.120; GOLDSTEIN E, 2001, MED CARE, V22, P101; GROSSMAN J, 2002, REVERSAL FORTUNE MED; Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003; *HLTH CAR FIN ADM, 1998, PROF MED CHART BOOK; IANNACCHIONE V, 2001, IMPLEMENTATION MEDIC; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; LIED TR, IN PRESS HLTH CARE F; McLaughlin CG, 1999, MED CARE RES REV, V56, P24, DOI 10.1177/107755899773743855; *MED, MED PERS PLAN FIND; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; Miller RH, 2002, HEALTH AFFAIR, V21, P63, DOI 10.1377/hlthaff.21.4.63; *NAT COMM QUAL ASS, 1998, ACCR 99 STAND ACCR M; Newhouse JP, 1997, HEALTH AFFAIR, V16, P26, DOI 10.1377/hlthaff.16.5.26; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; PEAR R, 2001, NY TIMES        0605, P19; *PHYS PAYM REV COM, 1997, ANN REP C 1996; RETCHIN SM, 1992, HEALTH SERV RES, V27, P651; ROSS MN, 2002, HLTH AFF MILLWOOD S, pW90; ROSSITER LF, 1989, JAMA-J AM MED ASSOC, V262, P57, DOI 10.1001/jama.262.1.57; Safran DG, 2002, ARCH INTERN MED, V162, P757, DOI 10.1001/archinte.162.7.757; Schnaier JA, 1999, MED CARE, V37, pMS69, DOI 10.1097/00005650-199903001-00008; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Thorpe KE, 2002, HEALTH AFFAIR, V21, pW242; Waltzer KB, 1998, GERIATRICS, V53, P65; Wilensky GR, 1999, HEALTH AFFAIR, V18, P92, DOI 10.1377/hlthaff.18.1.92; Zaslavsky AM, 2000, INQUIRY-J HEALTH CAR, V37, P146; Zaslavsky AM, 2002, MED CARE, V40, P485, DOI 10.1097/00005650-200206000-00006; Zaslavsky AM, 2002, MED CARE, V40, P951, DOI 10.1097/00005650-200210000-00012; Zaslavsky AM, 2000, MED CARE, V38, P162, DOI 10.1097/00005650-200002000-00006; Zaslavsky AM, 2001, HEALTH CARE FINANC R, V22, P109	40	108	108	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1744	1752		10.1001/jama.291.14.1744	http://dx.doi.org/10.1001/jama.291.14.1744			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811RJ	15082702				2022-12-28	WOS:000220788700032
J	Sibley, LD				Sibley, LD			Intracellular parasite invasion strategies	SCIENCE			English	Review							CELL PLASMA-MEMBRANE; GONDII MYOSIN-A; TOXOPLASMA-GONDII; GLIDING MOTILITY; PARASITOPHOROUS VACUOLE; ACTIN CYTOSKELETON; MICRONEME PROTEINS; MAMMALIAN-CELLS; DOMAIN; MIC2	Intracellular parasites use various strategies to invade cells and to subvert cellular signaling pathways and, thus, to gain a foothold against host defenses. Efficient cell entry, ability to exploit intracellular niches, and persistence make these parasites treacherous pathogens. Most intracellular parasites gain entry via host-mediated processes, but apicomplexans use a system of adhesion-based motility called "gliding" to actively penetrate host cells. Actin polymerization - dependent motility facilitates parasite migration across cellular barriers, enables dissemination within tissues, and powers invasion of host cells. Efficient invasion has brought widespread success to this group, which includes Toxoplasma, Plasmodium, and Cryptosporidium.	Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Infect Dis, St Louis, MO 63110 USA	Washington University (WUSTL)	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Infect Dis, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu	Sibley, L. David/C-4616-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI034036] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JC, 2000, DEV DYNAM, V218, P280; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BECKERS C, COMMUNICATION; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Brossier F, 2003, J BIOL CHEM, V278, P6229, DOI 10.1074/jbc.M209837200; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Di Cristina M, 2000, MOL CELL BIOL, V20, P7332, DOI 10.1128/MCB.20.19.7332-7341.2000; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Gantt S, 2000, INFECT IMMUN, V68, P3667, DOI 10.1128/IAI.68.6.3667-3673.2000; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Harper JM, 2004, MOL BIOCHEM PARASIT, V134, P201, DOI 10.1016/j.molbiopara.2003.12.001; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Jewett TJ, 2004, J BIOL CHEM, V279, P9362, DOI 10.1074/jbc.M312590200; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; MOTA MM, 2002, NAT MED, V11, P1318; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Preston TM, 1996, ACTA PROTOZOOL, V35, P3; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sibley LD, 2003, TRAFFIC, V4, P581, DOI 10.1034/j.1600-0854.2003.00117.x; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711	53	327	353	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					248	253		10.1126/science.1094717	http://dx.doi.org/10.1126/science.1094717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073368				2022-12-28	WOS:000220719400035
J	Smith, AE; Helenius, A				Smith, AE; Helenius, A			How viruses enter animal cells	SCIENCE			English	Review							NUCLEAR-PORE COMPLEX; SEMLIKI-FOREST-VIRUS; EPIDERMAL-GROWTH-FACTOR; L1 CAPSID PROTEIN; DC-SIGN; HEPARAN-SULFATE; INFLUENZA-VIRUS; MEMBRANE-FUSION; STRUCTURAL BASIS; HIV-1 ENTRY	Viruses replicate within living cells and use the cellular machinery for the synthesis of their genome and other components. To gain access, they have evolved a variety of elegant mechanisms to deliver their genes and accessory proteins into the host cell. Many animal viruses take advantage of endocytic pathways and rely on the cell to guide them through a complex entry and uncoating program. In the dialogue between the cell and the intruder, the cell provides critical cues that allow the virus to undergo molecular transformations that lead to successful internalization, intracellular transport, and uncoating.	Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch						Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bantel-Schaal U, 2002, J VIROL, V76, P2340, DOI 10.1128/JVI.76.5.2340-2349.2002; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057; Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484; Bousarghin L, 2003, J VIROL, V77, P3846, DOI 10.1128/JVI.77.6.3846-3850.2003; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Cullen BR, 2001, CELL, V105, P697, DOI 10.1016/S0092-8674(01)00392-0; DALES S, 1973, BACTERIOL REV, V37, P103, DOI 10.1128/MMBR.37.2.103-135.1973; DAMM EM, UNPUB; Drobni P, 2003, VIROLOGY, V310, P163, DOI 10.1016/S0042-6822(03)00114-4; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FITZGERALD DJP, 1983, CELL, V32, P607, DOI 10.1016/0092-8674(83)90480-4; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gilbert JM, 2003, J VIROL, V77, P2615, DOI 10.1128/JVI.77.4.2615-2622.2003; Greber UF, 2003, TRAFFIC, V4, P136, DOI 10.1034/j.1600-0854.2003.00114.x; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Heinz FX, 2001, CURR OPIN MICROBIOL, V4, P450, DOI 10.1016/S1369-5274(00)00234-4; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kasamatsu H, 1998, ANNU REV MICROBIOL, V52, P627, DOI 10.1146/annurev.micro.52.1.627; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lanier LM, 1996, VIROLOGY, V216, P380, DOI 10.1006/viro.1996.0073; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lonberg-Holm K, 1974, Monogr Virol, V9, P1; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marsh M, 1997, J CELL SCI, V110, P95; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Medina-Kauwe LK, 2003, ADV DRUG DELIVER REV, V55, P1485, DOI 10.1016/j.addr.2003.07.010; Merle E, 1999, J CELL BIOCHEM, V74, P628, DOI 10.1002/(SICI)1097-4644(19990915)74:4<628::AID-JCB12>3.0.CO;2-I; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nelson LM, 2000, J CELL BIOCHEM, V79, P225, DOI 10.1002/1097-4644(20001101)79:2<225::AID-JCB60>3.0.CO;2-A; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Norkin LC, 2001, ADV DRUG DELIVER REV, V49, P301, DOI 10.1016/S0169-409X(01)00143-0; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Poranen MM, 2002, ANNU REV MICROBIOL, V56, P521, DOI 10.1146/annurev.micro.56.012302.160643; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SCHMID S, 1989, J CELL BIOL, V108, P1291, DOI 10.1083/jcb.108.4.1291; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Stewart PL, 2003, ADV PROTEIN CHEM, V64, P455; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Trybala E, 1996, VIROLOGY, V218, P35, DOI 10.1006/viro.1996.0163; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Whittaker GR, 2003, ADV DRUG DELIVER REV, V55, P733, DOI 10.1016/S0169-409X(03)00051-6; Whittaker GR, 2000, ANNU REV CELL DEV BI, V16, P627, DOI 10.1146/annurev.cellbio.16.1.627; [No title captured]	109	582	612	0	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					237	242		10.1126/science.1094823	http://dx.doi.org/10.1126/science.1094823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073366				2022-12-28	WOS:000220719400033
J	Little, P; Kelly, J; Barnett, J; Dorward, M; Margetts, B; Warm, D				Little, P; Kelly, J; Barnett, J; Dorward, M; Margetts, B; Warm, D			Randomised controlled factorial trial of dietary advice for patients with a single high blood pressure reading in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE ADVICE; GENERAL-PRACTICE; CLINICAL-TRIAL; HYPERTENSION; POTASSIUM; SODIUM; FRUIT	Objective To assess the effect of brief interventions during the "watchful waiting" period for hypertension. Design Factorial trial. Setting General practice. Methods 296 patients with blood pressure > 160/90 mm Hg were randomised to eight groups defined by three factors: an information booklet; low sodium, high potassium salt; prompt sheets for high fruit, vegetable, fibre, mid low fat. Main outcome measures Blood pressure (primary outcome); secondary outcomes of diet, weight, and dietary biomarkers (urinary sodium:potassium (Na:K) ratio; carotenoid concentrations). Results Blood pressure was not affected by the booklet (mean difference (diastolic blood pressure) at one month 0.2, 95% confidence interval 1.6 to 2.0), salt (0.13; 1.7 to 2.0), or prompts (0.52; 1.3 to 2.4). The salt decreased Na:K ratio (difference 0.32; 0.08 to 056, P = 0.01), and the prompts helped control weight (difference 0.39 (0.85 to 0.05) kg at one month, P = 0.085; 1.2 (0.1 to 2.25) kg at six months, P = 0.03). Among those with lower fruit and vegetable consumption (< 300 g per day), prompts increased fruit and vegetable consumption and also carotenoid concentrations (difference 143 (16 to 269) mmol/l, P < 0.03) but did not decrease blood pressure. Conclusion During watchful waiting, over and above the effect of brief advice and monitoring, an information booklet, lifestyle prompts, and low sodium salt do not reduce blood pressure. Secondary analysis suggests that brief interventions-particularly lifestyle prompts-can make useful changes in diet and help control weight, which previous research indicates are likely to reduce the long term risk of stroke.	Univ Southampton, Div Community Clin Sci, Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Univ Southampton, Southampton Gen Hosp, Community Clin Sci Div, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton	Little, P (corresponding author), Univ Southampton, Div Community Clin Sci, Primary Med Care Grp, Southampton SO16 5ST, Hants, England.	psl3@soton.ac.uk		Little, Paul/0000-0003-3664-1873				Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BREARLEY CJ, 1993, J HYPERTENS, V11, P147, DOI 10.1097/00004872-199302000-00006; Burkill S. L., 1995, Proceedings of the Nutrition Society, V54, p201A; BURKILLSL, 1995, P NUTR SOC, V54, pA201; CAPPUCCIO FP, 1991, J HYPERTENS, V9, P465, DOI 10.1097/00004872-199105000-00011; COX D, 1996, P NUTR SOC; DAY SJ, 1989, BMJ-BRIT MED J, V299, P663, DOI 10.1136/bmj.299.6700.663; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI [DOI 10.1002/14651858.CD000484.PUB2, DOI 10.2188/JEA.JE20110120]; FODOR JG, 1999, CAN MED ASSOC J, V160, P29; GATENBY SJ, 1995, APPETITE, V25, P241, DOI 10.1006/appe.1995.0059; GELEIJNSE JM, 1994, BRIT MED J, V309, P436, DOI 10.1136/bmj.309.6952.436; HALBERT J, 2003, J HUM HYPERTENS, V11, P641; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; LAHER M, 1981, BRIT MED J, V282, P1360, DOI 10.1136/bmj.282.6273.1360-a; LAHER M, 2001, BRIT MED J, V282, P1360; Little P, 2002, BMJ-BRIT MED J, V325, P254, DOI 10.1136/bmj.325.7358.254; Little P, 1999, J EPIDEMIOL COMMUN H, V53, P165, DOI 10.1136/jech.53.3.165; Little P, 1999, BRIT J GEN PRACT, V49, P806; MACMAHON S, 1987, EUR HEART J, V8, P57, DOI 10.1093/eurheartj/8.suppl_B.57; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; ROBINSON R, 1993, BRIT MED J, V307, P859, DOI 10.1136/bmj.307.6908.859; SILAGY C, 1992, BRIT MED J, V305, P871, DOI 10.1136/bmj.305.6858.871; STEPTOE A, 2003, BRIT MED J, V328, P855; THOROGOOD M, 2001, CLIN EVIDENCE, P16	26	45	47	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1054	1057		10.1136/bmj.38037.435972.EE	http://dx.doi.org/10.1136/bmj.38037.435972.EE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15082472	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000221174500019
J	Sandri, M; Sandri, C; Gilbert, A; Skurk, C; Calabria, E; Picard, A; Walsh, K; Schiaffino, S; Lecker, SH; Goldberg, AL				Sandri, M; Sandri, C; Gilbert, A; Skurk, C; Calabria, E; Picard, A; Walsh, K; Schiaffino, S; Lecker, SH; Goldberg, AL			Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy	CELL			English	Article							NF-KAPPA-B; GENE-EXPRESSION; PROTEASOME PATHWAY; MAMMALIAN-CELLS; GROWTH; HYPERTROPHY; DAF-16; FKHR; DIFFERENTIATION; IDENTIFICATION	Skeletal muscle atrophy is a debilitating response to fasting, disuse, cancer, and other systemic diseases. In atrophying muscles, the ubiquitin ligase, atrogin-1 (MAFbx), is dramatically induced, and this response is necessary for rapid atrophy. Here, we show that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogrin-1 induction. IGF-1 treatment or AKT overexpression inhibits Foxo and atrogin-1 expression. Moreover, constitutively active Foxo3 acts on the atrogin-1 promoter to cause atrogin-1 transcription and dramatic atrophy of myotubes and muscle fibers. When Foxo activation is blocked by a dominant-negative construct in myotubes or by RNAi in mouse muscles in vivo, atrogin-1 induction during starvation and atrophy of myotubes induced by glucocorticoids are prevented. Thus, forkhead factor(s) play a critical role in the development of muscle atrophy, and inhibition of Foxo factors is an attractive approach to combat muscle wasting.	Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Venetian Inst Mol Med, Dept Biomed Sci, I-35129 Padua, Italy; Boston Univ, Sch Med, Inst Cardiovasc Res, Boston, MA 02118 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Veneto Institute Molecular Medicine; Boston University	Lecker, SH (corresponding author), Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA 02215 USA.	slecker@bidmc.harvard.edu; alfred_goldberg@hms.harvard.edu	Calabria, Elisa/K-3849-2014	Calabria, Elisa/0000-0001-6557-0379; Schiaffino, Stefano/0000-0002-5607-6421; Walsh, Kenneth/0000-0001-7580-2276	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002707, R01DK062307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015052] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR040197] Funding Source: Medline; NIA NIH HHS [R01 AG015052] Funding Source: Medline; NIDDK NIH HHS [R01 DK062307, DK62307, DK02707] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SACHECK J, 2004, AM J PHYSL; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; STITT TN, 2004, IN PRESS MOL CELL; TRAN H, 2003, SCI STKE; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293	41	2079	2182	10	156	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					399	412		10.1016/S0092-8674(04)00400-3	http://dx.doi.org/10.1016/S0092-8674(04)00400-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109499	Green Accepted, Bronze			2022-12-28	WOS:000221176400013
J	Serhan, CN				Serhan, CN			Clues for new therapeutics in osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIPID MEDIATORS; INFLAMMATION; MICE		Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Serhan, CN (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Goh J, 2003, GASTROENTEROLOGY, V124, P1043, DOI 10.1053/gast.2003.50154; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; Krieg P, 2001, GENOMICS, V73, P323, DOI 10.1006/geno.2001.6519; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856	5	4	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1902	1903		10.1056/NEJMcibr040318	http://dx.doi.org/10.1056/NEJMcibr040318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115837				2022-12-28	WOS:000221080300016
J	Coker, RJ; Atun, RA; McKee, M				Coker, RJ; Atun, RA; McKee, M			Health-care system frailties and public health control of communicable disease on the European Union's new eastern border	LANCET			English	Article							RUSSIA; HIV	In May, 2004, the border of the European Union (EU) will shift eastward such that the new frontier will be made up by Ukraine, Belarus, and a considerably longer Russian border. Here, we discuss three issues: first, the factors that have contributed to the growth of communicable disease in Russia, Ukraine, and Belarus; second, how public health systems have responded to these challenges; and third, the implications for the EU as a whole. Since the break-up of the Soviet Union, Russia, Ukraine, and Belarus have witnessed substantial political, social, and economic changes. These events have been reflected in changes in the epidemiology of communicable diseases, including tuberculosis and HIV (ie, HIV-1). Moreover, public health systems, rooted in Soviet traditions, are struggling to respond effectively to the challenges of resurgent infectious diseases, such as tuberculosis, and newly emergent challenges such as HIV. The changing patterns of communicable diseases east of the EU's new border has implications for how the EU aids the strengthening of public health systems east of the new frontier. Transborder spread of communicable diseases also challenges communicable disease control systems within the EU. Concerted action is needed by member states and the EU, building on models of cooperation between institutions that have been successful in areas beyond health, if public health systems are to meet the emerging challenges to communicable disease control.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, ECOHOST, London WC1E 7HT, England; Univ London Imperial Coll Sci Technol & Med, Tanaka Business Sch, London SW7 2AZ, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Coker, RJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, ECOHOST, Keppel St, London WC1E 7HT, England.	Richard.coker@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Atun, Rifat/AAH-5537-2021	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Atun, Rifat/0000-0002-1531-5983				Atlani L, 2000, SOC SCI MED, V50, P1547, DOI 10.1016/S0277-9536(99)00464-5; BALLARD J, 1998, POLITICS AIDS POLICE; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Brand H., 2000, EVALUATION ARRANGEME; CHERVYAKOV V, 1998, POLITICS AIDS POLICI; Coker RJ, 2003, INT J TUBERC LUNG D, V7, P920; European Commission, 2003, COM20030449 EUR COMM; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Frost L, 2002, AIDS EDUC PREV, V14, P7, DOI 10.1521/aeap.14.7.7.23857; Gilmore A, 2002, LANCET, V360, P1255, DOI 10.1016/S0140-6736(02)11262-1; KLUGMAN J, 2002, 91 UNICEF INN RES CT; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; LEKHAN V, 2004, COPENHAGEN EUROPEAN; MacLehose L, 2002, SCIENCE, V295, P2047, DOI 10.1126/science.1070025; MALINOWSKASEMPR.K, 2003, UNINTENDED CONSEQUEN; MCKEE M, 2000, EUROHEALTH, V6, P6; Niemann S, 1997, J CLIN MICROBIOL, V35, P3015, DOI 10.1128/JCM.35.12.3015-3020.1997; Ofer G., 2000, SLAVIC REV, V60, P674; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 1999, AIDS, V13, pS259; Rivkin-Fish M, 1999, SOC SCI MED, V49, P801, DOI 10.1016/S0277-9536(99)00168-9; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Stern V., 1999, SENTENCED DIE PROBLE; Tchoudomirova K, 1997, INT J STD AIDS, V8, P187, DOI 10.1258/0956462971919697; TRAGAKES E, 2003, COPENHAGEN EUROPEAN; *UNAIDS, 2002, REP GLOB HIV AIDS EP; Uuskula A, 1997, INT J STD AIDS, V8, P446, DOI 10.1258/0956462971920505; Vlassov V, 2000, J EPIDEMIOL COMMUN H, V54, P740, DOI 10.1136/jech.54.10.740; World Health Organization, 2003, GLOB TUB CONTR SURV; [No title captured]	31	64	65	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1389	1392		10.1016/S0140-6736(04)16053-4	http://dx.doi.org/10.1016/S0140-6736(04)16053-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	814TF	15110500				2022-12-28	WOS:000220996300026
J	Papadakis, MA				Papadakis, MA			Becoming a physician - The step 2 clinical-skills examination.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Papadakis, MA (corresponding author), Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA.							Hubbard JP, 1985, NATL BOARD MED EXAMI; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Tamblyn R, 2002, JAMA-J AM MED ASSOC, V288, P3019, DOI 10.1001/jama.288.23.3019; US MED LICENSING EXA	4	58	59	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1703	1705		10.1056/NEJMp038246	http://dx.doi.org/10.1056/NEJMp038246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102993				2022-12-28	WOS:000220947300001
J	Studd, RC; Stewart, PJ				Studd, RC; Stewart, PJ			Intraabdominal abscess after acupuncture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Concord Hosp, Sydney, NSW, Australia	Concord Repatriation General Hospital	Studd, RC (corresponding author), Concord Hosp, Sydney, NSW, Australia.								0	10	11	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1763	1763		10.1056/NEJMicm010431	http://dx.doi.org/10.1056/NEJMicm010431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15103003				2022-12-28	WOS:000220947300011
J	Fischer, MA; Avorn, J				Fischer, MA; Avorn, J			Economic implications of evidence-based prescribing for hypertension - Can better care cost less?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIHYPERTENSIVE THERAPY; SYSTOLIC HYPERTENSION; DRUG COVERAGE; PRESCRIPTION; OUTCOMES; MEDICATIONS; PREVENTION; MANAGEMENT; ACCURACY; LOSARTAN	Context Deviation from evidence-based guidelines in hypertension treatment is common, but its economic impact has not been rigorously studied. Suboptimal prescribing patterns contribute to the high cost of medications for elderly patients as well as the difficulty in providing affordable prescription drug benefits for older. Americans. Objective To calculate the potential savings from the perspective of healthcare payers that would result from increased adherence to evidence-based recommendations for managing hypertension in patients older than 65 years. Design Comparative analysis of medications prescribed vs potential regimens suggested by evidence-based guidelines tailored to each patient's medical history, with calculation of the costs of both the actual and the evidence-based regimens. Setting and Patients A total of 133624 patients being treated for hypertension during 2001 who were enrolled in a large state pharmaceutical assistance program that provides prescription drug insurance for elderly persons. Main Outcome Measure Cost difference between medications actually prescribed and regimens suggested by evidence-based guidelines. Results The patients studied filled more than 2.05 million prescriptions for antihypertensive medications in 2001, at an annual program cost of $48.5 million ($363 per patient). We identified 815316 prescriptions (40%) for which an alternative regimen appeared more appropriate according to evidence-based recommendations. Such changes would have reduced the costs to payers in 2001 by $11.6 million (nearly a quarter of program spending on anti hypertensive medications), as well as being more clinically appropriate overall. Replacement of calcium channel blockers resulted in the largest potential savings. Use of pricing limits similar to those in the Medicaid program would have resulted in even larger potential savings of $20.5 million (42% of program costs). Conclusions Adherence to evidence-based prescribing guidelines for hypertension could result in substantial savings in prescription costs for elderly patients with hypertension that would amount to savings of about $1.2 billion nationally. Identification of similar areas in which prescribing can be improved will be critical for the affordability of prescription drug benefit programs.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fischer, MA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mfischer@partners.org			NATIONAL INSTITUTE ON AGING [R03AG018395] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM HEART ASS, 2001, 2002 HEART STROK STA; [Anonymous], HLTH US 2000 AD HLTH; Avorn J, 2004, POWERFUL MED BENEFIT; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHRISTENSEN DB, 1994, ANN PHARMACOTHER, V28, P99, DOI 10.1177/106002809402800119; Cutler Jeffrey A, 2003, J Clin Hypertens (Greenwich), V5, P192, DOI 10.1111/j.1524-6175.2003.02521.x; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Davis BR, 2002, ANN INTERN MED, V137, P313, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00006; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; Franse LV, 2000, HYPERTENSION, V35, P1025, DOI 10.1161/01.HYP.35.5.1025; Freid V.M., 2003, CHARTBOOK TRENDS HLT; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giles TD, 1999, AM J CARDIOL, V84, p25K; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; *HJ KAIS FAM FDN, 2001, MED PRESCR DRUGS; Hodgson TA, 2001, MED CARE, V39, P599, DOI 10.1097/00005650-200106000-00008; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Knight EL, 2001, ANN INTERN MED, V135, P703, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00009; LASCHOBER MA, 2002, HLTH AFF MILLWOOD, pW127; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; MARRE M, 1988, BMJ-BRIT MED J, V297, P1092, DOI 10.1136/bmj.297.6656.1092; Maselli JH, 2001, J CLIN EPIDEMIOL, V54, P196, DOI 10.1016/S0895-4356(00)00269-9; Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805, DOI 10.2105/AJPH.86.12.1805; Monane M, 1997, AM J HYPERTENS, V10, P697, DOI 10.1016/S0895-7061(97)00056-3; *NAT PHARM COUNC, 2001, PHARM BEN STAT MED A; PEAR R, 2004, NY TIMES        0130, pA1; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Ramsey S D, 1999, J Am Board Fam Pract, V12, P105; *SAS I INC, 2003, SAS VERS 8 2 COMP PR; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Solomon DH, 2003, AM J MED, V115, P398, DOI 10.1016/S0002-9343(03)00357-7; Solomon DH, 2003, AM J MED, V115, P715, DOI 10.1016/j.amjmed.2003.08.025; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	48	141	147	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1850	1856		10.1001/jama.291.15.1850	http://dx.doi.org/10.1001/jama.291.15.1850			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100203	Bronze			2022-12-28	WOS:000220871200025
J	Christian, KM; Poulos, AM; Lavond, DG; Thompson, RF				Christian, KM; Poulos, AM; Lavond, DG; Thompson, RF			Comment on "Cerebellar LTD and learning-dependent timing of conditioned eyelid responses"	SCIENCE			English	Editorial Material							MUTANT MICE; NICTITATING-MEMBRANE; INTERPOSITUS NUCLEUS; NEURONAL RESPONSES; MOTOR COORDINATION; LESIONS; ACQUISITION		Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	University of Southern California	Christian, KM (corresponding author), Univ So Calif, Neurosci Program, 3641 Watt Way, Los Angeles, CA 90089 USA.	thompson@neuro.usc.edu			NIA NIH HHS [AG14751] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bao SW, 1998, LEARN MEMORY, V5, P355; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen L, 1996, J NEUROSCI, V16, P2829; Chen L, 1999, BEHAV NEUROSCI, V113, P204, DOI 10.1037/0735-7044.113.1.204; CHRISTIAN KM, 2003, LEARN MEMORY, V11, P427; CLARK GA, 1984, BRAIN RES, V291, P125, DOI 10.1016/0006-8993(84)90658-9; Garcia KS, 1999, J NEUROSCI, V19, P10940, DOI 10.1523/JNEUROSCI.19-24-10940.1999; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; LAVOND DG, 1990, BRAIN RES, V514, P238, DOI 10.1016/0006-8993(90)91419-H; LEE K, 2003, SOC NEUR ABSTR; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1982, PHYSIOL BEHAV, V28, P769, DOI 10.1016/0031-9384(82)90192-5; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1	15	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073358				2022-12-28	WOS:000220719400022
J	Rosenthal, Y; Broccoli, AJ				Rosenthal, Y; Broccoli, AJ			In search of paleo-ENSO	SCIENCE			English	Editorial Material							LAST GLACIAL MAXIMUM; EL-NINO/SOUTHERN-OSCILLATION; SURFACE TEMPERATURE; EQUATORIAL PACIFIC; MODEL SIMULATION; CLIMATE-CHANGE; NINO; VARIABILITY		Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Rosenthal, Y (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	rosentha@imcs.marine.rutgers.edu	Broccoli, Anthony J/D-9186-2014	Broccoli, Anthony J/0000-0003-2619-1434				Broccoli AJ, 2000, J CLIMATE, V13, P951, DOI 10.1175/1520-0442(2000)013<0951:TCATLG>2.0.CO;2; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Clement AC, 2001, J CLIMATE, V14, P2369, DOI 10.1175/1520-0442(2001)014<2369:AODTSF>2.0.CO;2; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P605, DOI 10.1029/1999PA900032; Dannenmann S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000390; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Hewitt CD, 2003, CLIM DYNAM, V20, P203, DOI 10.1007/s00382-002-0272-6; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Martinez I, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000877; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Otto-Bliesner BL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018553; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Trenberth KE, 2003, SCIENCE, V300, P589, DOI 10.1126/science.1083122; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Yin JH, 2001, J CLIMATE, V14, P565, DOI 10.1175/1520-0442(2001)014<0565:TIOTSS>2.0.CO;2	21	33	36	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					219	221		10.1126/science.1095435	http://dx.doi.org/10.1126/science.1095435			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073362				2022-12-28	WOS:000220719400028
J	Fairman, ME; Maroney, PA; Wang, W; Bowers, HA; Gollnick, P; Nilsen, TW; Jankowsky, E				Fairman, ME; Maroney, PA; Wang, W; Bowers, HA; Gollnick, P; Nilsen, TW; Jankowsky, E			Protein displacement by DExH/D "RNA helicases" without duplex unwinding	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; SINGLE-STRANDED-DNA; SPLICEOSOME; TRANSLATION; REQUIREMENT; INITIATION; DISRUPTION; UPSTREAM; MOTORS; ATPASE	Members of the DExH/D superfamily of nucleic acid-activated nucleotide triphosphatases are essential for virtually all aspects of RNA metabolism, including pre-messenger RNA splicing, RNA interference, translation, and nucleocytoplasmic trafficking. Physiological substrates for these enzymes are thought to be regions of double-stranded RNA, because several DExH/D proteins catalyze strand separation in vitro. These "RNA helicases" can also disrupt RNA-protein interactions, but it is unclear whether this activity is coupled to duplex unwinding. Here we demonstrate that two unrelated DExH/D proteins catalyze protein displacement independently of duplex unwinding. Therefore, the essential functions of DExH/D proteins are not confined to RNA duplexes but can be exerted on a wide range of ribonucleoprotein substrates.	Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	Case Western Reserve University; Case Western Reserve University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nilsen, TW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	twn@po.cwru.edu; exj13@po.cwru.edu		Jankowsky, Eckhard/0000-0001-7677-7412	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067700] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Hesson T, 2000, BIOCHEMISTRY-US, V39, P2619, DOI 10.1021/bi992127a; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kadare G, 1997, J VIROL, V71, P2583; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Maroney PA, 2000, RNA, V6, P1905, DOI 10.1017/S1355838200001308; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAUSE A, 1993, CURR OPIN STRUC BIOL, V3, P953, DOI 10.1016/0959-440X(93)90161-D; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Will CL, 2001, SCIENCE, V291, P1916, DOI 10.1126/science.1059682	26	200	203	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					730	734		10.1126/science.1095596	http://dx.doi.org/10.1126/science.1095596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118161				2022-12-28	WOS:000221105300044
J	Morris, MR				Morris, MR			Glimpsing matter at the brink	SCIENCE			English	Editorial Material									Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Morris, MR (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	morris@astro.ucla.edu		Morris, Mark/0000-0002-6753-2066				Bower GC, 2004, SCIENCE, V304, P704, DOI 10.1126/science.1094023; Melia F, 2001, ANNU REV ASTRON ASTR, V39, P309, DOI 10.1146/annurev.astro.39.1.309; Melia F., 2003, BLACK HOLE CTR OUR G	3	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2004	304	5671					689	+		10.1126/science.1095954	http://dx.doi.org/10.1126/science.1095954			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118150				2022-12-28	WOS:000221105300030
J	McVean, GAT; Myers, SR; Hunt, S; Deloukas, P; Bentley, DR; Donnelly, P				McVean, GAT; Myers, SR; Hunt, S; Deloukas, P; Bentley, DR; Donnelly, P			The fine-scale structure of recombination rate variation in the human genome	SCIENCE			English	Article							HIGH-RESOLUTION ANALYSIS; CLASS-II REGION; LINKAGE-DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HAPLOTYPE DIVERSITY; GC-CONTENT; HOTSPOT; BLOCKS; CROSSOVER; EVOLUTION	The nature and scale of recombination rate variation are largely unknown for most species. In humans, pedigree analysis has documented variation at the chromosomal level, and sperm studies have identified specific hotspots in which crossing-over events cluster. To address whether this picture is representative of the genome as a whole, we have developed and validated a method for estimating recombination rates from patterns of genetic variation. From extensive single-nucleotide polymorphism surveys in European and African populations, we find evidence for extreme local rate variation spanning four orders in magnitude, in which 50% of all recombination events take place in less than 10% of the sequence. We demonstrate that recombination hotspots are a ubiquitous feature of the human genome, occurring on average every 200 kilobases or less, but recombination occurs preferentially outside genes.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Wellcome Trust Sanger Institute	McVean, GAT (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	mcvean@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Deloukas, Panos/B-2922-2013; Peng, Bo/A-6920-2009	Myers, Simon R/0000-0002-2585-9626; Deloukas, Panos/0000-0001-9251-070X; Peng, Bo/0000-0001-8225-2284; Donnelly, Peter/0000-0001-9495-3408; Hunt, Sarah/0000-0002-8350-1235				Aquadro CF, 1997, CURR OPIN GENET DEV, V7, P835, DOI 10.1016/S0959-437X(97)80048-2; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cullen M, 1997, AM J HUM GENET, V60, P397; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Fearnhead P, 2001, GENETICS, V159, P1299; Filatov DA, 2003, GENE, V317, P67, DOI 10.1016/S0378-1119(03)00697-8; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galtier N, 2001, GENETICS, V159, P907; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; MCVEAN GAT, UNPUB; Myers S. L., UNPUB; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; SMITH GR, 1994, EXPERIENTIA, V50, P234, DOI 10.1007/BF01924006; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	39	700	722	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					581	584		10.1126/science.1092500	http://dx.doi.org/10.1126/science.1092500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105499				2022-12-28	WOS:000220975100047
J	Kono, T; Obata, Y; Wu, QL; Niwa, K; Ono, Y; Yamamoto, Y; Park, ES; Seo, JS; Ogawa, H				Kono, T; Obata, Y; Wu, QL; Niwa, K; Ono, Y; Yamamoto, Y; Park, ES; Seo, JS; Ogawa, H			Birth of parthenogenetic mice that can develop to adulthood	NATURE			English	Article							MAMMALIAN DEVELOPMENT; IMPRINTED GENES; OOCYTE GROWTH; MOUSE; H19; EXPRESSION; GENOME; DELETION; METHYLATION; IGF2	Only mammals have relinquished parthenogenesis, a means of producing descendants solely from maternal germ cells. Mouse parthenogenetic embryos die by day 10 of gestation(1-4). Bi-parental reproduction is necessary because of parent-specific epigenetic modification of the genome during gametogenesis(5-8). This leads to unequal expression of imprinted genes from the maternal and paternal alleles(9). However, there is no direct evidence that genomic imprinting is the only barrier to parthenogenetic development. Here we show the development of a viable parthenogenetic mouse individual from a reconstructed oocyte containing two haploid sets of maternal genome, derived from non-growing and fully grown oocytes. This development was made possible by the appropriate expression of the Igf2 and H19 genes with other imprinted genes, using mutant mice with a 13-kilobase deletion in the H19 gene(10) as non-growing oocytes donors. This full-term development is associated with a marked reduction in aberrantly expressed genes. The parthenote developed to adulthood with the ability to reproduce offspring. These results suggest that paternal imprinting prevents parthenogenesis, ensuring that the paternal contribution is obligatory for the descendant.	Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; Tokyo Univ Agr, Dept Appl Sci, Setagaya Ku, Tokyo 1568502, Japan; Biooriented Technol Res Adv Inst, Minato Ku, Tokyo 1050001, Japan; MacroGen Inc, Seoul 110061, South Korea; Seoul Natl Univ, Coll Med, Dept Biochem, Seoul 110799, South Korea	Tokyo University of Agriculture; Tokyo University of Agriculture; Macrogen, Inc.; Seoul National University (SNU)	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp	Seo, Jeong-Sun/J-2763-2012					Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEIL R, 1994, DEVELOPMENT, V120, P2933; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; Kono T, 2002, DEV BIOL, V243, P294, DOI 10.1006/dbio.2001.0561; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Mann JR, 2001, STEM CELLS, V19, P287, DOI 10.1634/stemcells.19-4-287; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 1998, DEVELOPMENT, V125, P1553; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Schmidt JV, 2000, GENE DEV, V14, P1997; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SURANI MAH, 1983, SCIENCE, V222, P1034, DOI 10.1126/science.6648518; THEILER K, 1989, HOUSE MOUSE ATLAS EM, P122; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0	30	349	387	5	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					860	864		10.1038/nature02402	http://dx.doi.org/10.1038/nature02402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103378				2022-12-28	WOS:000220952300042
J	Ko, DT; Mamdani, M; Alter, DA				Ko, DT; Mamdani, M; Alter, DA			Lipid-lowering therapy with statins in high-risk elderly patients - The treatment-risk paradox	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY EVENTS; HEART-FAILURE; OLDER; AGE; ONTARIO; CARE; MEN; PRAVASTATIN	Context The benefits of cardiovascular therapies such as statins for secondary prevention have been well documented, although they may not be optimally used in patients most likely to benefit. ideally, aggressiveness in the use of these beneficial therapies should correlate with baseline cardiovascular risk. Objective To examine the association between physicians' treatment aggressiveness and baseline cardiovascular risk. Design, Setting, and Patients Retrospective cohort study incorporating the use of multiple linked health care administrative databases covering more than 1.4 million elderly residents of Ontario. We included 396 077 patients aged 66 years or older who had a history of cardiovascular disease or diabetes while undergoing medical treatment and who were alive on April 1, 1998. Baseline cardiovascular risk was derived using a risk-adjustment index in which we modeled probability of death after 3 years of follow-up. Main Outcome Measure Likelihood of statin use, stratified by baseline cardiovascular risk, after adjusting for age, sex, socioeconomic status, and rural or urban residence. Results Only 75617 patients (19.1%)in this secondary prevention cohort were prescribed statins. In patients 66 to 74 years old, the adjusted probabilities of statin prescription were 37.7%, 26.7%, and 23.4% in the categories of low, intermediate, and high baseline risk, respectively. The likelihood of statin prescription was 6.4% lower (adjusted odds ratio, 0.94; 95% confidence interval, 0.93-0.95) for each year of increase in age and each 1% increase in predicted 3-year mortality risk. The influence of age also interacted synergistically with baseline risk on the prescription of statins (P<.001). Conclusions We found that prescription of statins diminished progressively as baseline cardiovascular risk and future probability of death increased. Since the benefits of a therapy are dependent on the baseline risk, the maximum benefits of statins may not be fully realized until implementation of therapy includes patients at highest risk.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Alter, DA (corresponding author), Inst Clin Evaluat Sci, G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca		Ko, Dennis/0000-0001-6840-8051				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2004, AM J MED, V116, P540, DOI 10.1016/j.amjmed.2003.10.039; Alter DA, 2003, DIABETES CARE, V26, P1427, DOI 10.2337/diacare.26.5.1427; Anderson RT, 2000, CONTROL CLIN TRIALS, V21, p171S, DOI 10.1016/S0197-2456(00)00075-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Elad Y, 2002, J AM COLL CARDIOL, V39, P826, DOI 10.1016/S0735-1097(01)01817-4; Fonarow GC, 2001, CIRCULATION, V103, P38; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 1996, ANN INTERN MED, V124, P292, DOI 10.7326/0003-4819-124-3-199602010-00002; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lemaitre RN, 1998, ARCH INTERN MED, V158, P1761, DOI 10.1001/archinte.158.16.1761; Levy AR, 2003, CAN J CARDIOL, V19, P665; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; PEDERSEN TR, 1994, LANCET, V344, P1383; Rathore SS, 2003, AM J MED, V114, P307, DOI 10.1016/S0002-9343(02)01531-0; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rochon PA, 2000, LANCET, V356, P639, DOI 10.1016/S0140-6736(00)02606-4; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Wang TJ, 2001, AM HEART J, V141, P957, DOI 10.1067/mhj.2001.115587; Whincup PH, 2002, HEART, V88, P25, DOI 10.1136/heart.88.1.25	36	319	324	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2004	291	15					1864	1870		10.1001/jama.291.15.1864	http://dx.doi.org/10.1001/jama.291.15.1864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XC	15100205	Bronze			2022-12-28	WOS:000220871200027
J	Grimes, DA; Creinin, MD				Grimes, DA; Creinin, MD			Induced abortion: An overview for internists	ANNALS OF INTERNAL MEDICINE			English	Review							VAGINAL MISOPROSTOL; PREGNANCY TERMINATION; MIFEPRISTONE RU-486; MEDICAL ABORTION; RANDOMIZED-TRIAL; UNITED-STATES; INDUCTION; WOMEN	Internists care for many women who have had abortions and many who will seek abortions in the future. Each year, about 2% of all women of reproductive age have an abortion. Women having abortions tend to be young, white, unmarried, and early in pregnancy. Most abortions are done by suction curettage under local anesthesia in a freestanding clinic. However, medical abortion is growing in popularity as a nonsurgical alternative. The regimen approved by the U.S. Food and Drug Administration specifies mifepristone, 600 mg orally, followed 2 days later by misoprostol, 400 mug orally (within 49 days from last menses). Recent studies have recommended alternative approaches, such as mifepristone, 200 mg orally, followed in 1 to 3 days by misoprostol, 800 mug vaginally (up to 63 days). Medical abortion can be provided by a broader variety of physicians than can surgical abortion. The overall case-fatality rate for abortion is less than 1 death per 100000 procedures. Infection, hemorrhage, acute hematometra, and retained tissue are among the more common complications. Referral back to the original abortion provider for management is advisable. Overall, induced abortion does not lead to late sequelae, either medical or psychiatric. Of importance, no link exists between induced abortion and later breast cancer. For physicians who are asked to help with a referral, the National Abortion Federation and Planned Parenthood Federation of America have helpful Web sites and networks of high-quality clinics. The cost of abortion (currently about $372 at 10 weeks) has decreased in recent decades. Provision of ongoing contraception and encouragement of emergency contraception can reduce unintended pregnancies and the need for abortion.	Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Grimes, DA (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, CB 7570, Chapel Hill, NC 27599 USA.		Creinin, Mitchell/AAH-3488-2020	Creinin, Mitchell/0000-0001-5967-8180				*A GUTTM I, 2003, STAT POL BRIEF STAT; ADLER NE, 1990, SCIENCE, V248, P41, DOI 10.1126/science.2181664; [Anonymous], 2000, STEDMANS MED DICT; ATRASH HK, 1990, BAILLIERE CLIN OB GY, V4, P391, DOI 10.1016/S0950-3552(05)80234-2; Aubeny E, 1995, Int J Fertil Menopausal Stud, V40 Suppl 2, P85; Bartholomew L L, 1998, Obstet Gynecol Surv, V53, P708, DOI 10.1097/00006254-199811000-00024; BYGDEMAN M, 1985, CONTRACEPTION, V32, P45, DOI 10.1016/0010-7824(85)90115-5; Cates W, 2000, AM J PREV MED, V19, P12, DOI 10.1016/S0749-3797(00)00168-9; Creinin MD, 1997, CONTRACEPTION, V56, P165, DOI 10.1016/S0010-7824(97)00120-0; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Dajani AS, 1997, CIRCULATION, V96, P358; Davis A, 2000, J Am Med Womens Assoc (1972), V55, P141; de Groot ANJA, 1998, DRUGS, V56, P523, DOI 10.2165/00003495-199856040-00002; Elam-Evans Laurie D., 2002, Morbidity and Mortality Weekly Report, V51, P1; ELAMEVANS LD, 2002, MMWR SURVEILL SUMM, V51, P11; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Forrest J D, 1993, Womens Health Issues, V3, P152, DOI 10.1016/S1049-3867(05)80249-X; GRIMES DA, 1981, FAM PLANN PERSPECT, V13, P30, DOI 10.2307/2134768; HAKIMELAHI E, 1990, OBSTET GYNECOL, V76, P129; Harwood B, 2001, CONTRACEPTION, V63, P255, DOI 10.1016/S0010-7824(01)00205-0; Henshaw K, 2003, PERSPECT SEX REPRO H, V35, P16; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Herndon Joy, 2002, MMWR Surveill Summ, V51, P1; Jain JK, 2002, HUM REPROD, V17, P1477, DOI 10.1093/humrep/17.6.1477; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P226, DOI 10.2307/3097821; LAWSON HW, 1994, AM J OBSTET GYNECOL, V171, P1365, DOI 10.1016/0002-9378(94)90162-7; Lichtenberg ES, 2001, CONTRACEPTION, V64, P345, DOI 10.1016/S0010-7824(01)00279-7; MCKINLEY C, 1993, HUM REPROD, V8, P1502, DOI 10.1093/oxfordjournals.humrep.a138287; MERTUS JA, 1990, WOMEN HEALTH, V16, P95, DOI 10.1300/J013v16n01_07; Paul M, 2002, OBSTET GYNECOL, V99, P567, DOI 10.1016/S0029-7844(01)01782-3; PEYRON R, 1993, NEW ENGL J MED, V328, P1509, DOI 10.1056/NEJM199305273282101; Sawaya GF, 1996, OBSTET GYNECOL, V87, P884; Schaff EA, 2001, CONTRACEPTION, V64, P81, DOI 10.1016/S0010-7824(01)00229-3; Schaff EA, 1999, CONTRACEPTION, V59, P1, DOI 10.1016/S0010-7824(98)00150-4; Schaff EA, 1997, J FAM PRACTICE, V44, P353; Schaff EA, 2000, CONTRACEPTION, V61, P41, DOI 10.1016/S0010-7824(99)00119-5; Schaff EA, 2000, JAMA-J AM MED ASSOC, V284, P1948, DOI 10.1001/jama.284.15.1948; SHELTON JD, 1976, FAM PLANN PERSPECT, V8, P260, DOI 10.2307/2134397; Singh K, 1998, OBSTET GYNECOL, V92, P795, DOI 10.1016/S0029-7844(98)00281-6; Spitz IM, 1998, NEW ENGL J MED, V338, P1241, DOI 10.1056/NEJM199804303381801; STOTLAND NL, 1992, JAMA-J AM MED ASSOC, V268, P2078, DOI 10.1001/jama.268.15.2078; Stubblefield Phillip G., 1999, CLIN GUIDE MED SURG; THONG KJ, 1992, BRIT J OBSTET GYNAEC, V99, P1004, DOI 10.1111/j.1471-0528.1992.tb13707.x; VANLOOK PFA, 1993, BRIT MED J, V307, P532; Westhoff C, 2003, CONTRACEPTION, V67, P41, DOI 10.1016/S0010-7824(02)00444-4; Wiebe E, 2002, OBSTET GYNECOL, V99, P813, DOI 10.1016/S0029-7844(02)01944-0; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7	49	30	35	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					620	626		10.7326/0003-4819-140-8-200404200-00009	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096333				2022-12-28	WOS:000220851700005
J	Chiu, CH; Su, LH; Chu, C; Chia, JH; Wu, TL; Lin, TY; Lee, YS; Ou, JT				Chiu, CH; Su, LH; Chu, C; Chia, JH; Wu, TL; Lin, TY; Lee, YS; Ou, JT			Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin	LANCET			English	Article							BETA-LACTAMASE; EMERGENCE		Chang Gung Univ Coll Med, Dept Microbiol & Immunol, Taoyuan 333, Taiwan; Chang Gung Childrens Hosp, Dept Paediat, Div Paediat Infect Dis, Taoyuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Ou, JT (corresponding author), Chang Gung Univ Coll Med, Dept Microbiol & Immunol, 259 Wenhua 1st Rd, Taoyuan 333, Taiwan.	jontou@mail.cgu.edu.tw						BERGSTROM S, 1983, J BACTERIOL, V155, P1297; Chiu CH, 2002, NEW ENGL J MED, V346, P413, DOI 10.1056/NEJMoa012261; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Koeck JL, 1997, FEMS MICROBIOL LETT, V152, P255, DOI 10.1111/j.1574-6968.1997.tb10436.x; Morosini MI, 2000, ANTIMICROB AGENTS CH, V44, P3137, DOI 10.1128/AAC.44.11.3137-3143.2000	5	58	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1285	1286		10.1016/S0140-6736(04)16003-0	http://dx.doi.org/10.1016/S0140-6736(04)16003-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094275				2022-12-28	WOS:000220904900012
J	Sharp, D				Sharp, D			Four up, one back - and no-one off	LANCET			English	Editorial Material							FALL INJURIES; LADDER; PATTERNS		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P276; CLIFT L, 2004, EVALUATING PERFORMAN, P287; Faergemann C, 2000, ACCIDENT ANAL PREV, V32, P745, DOI 10.1016/S0001-4575(99)00124-4; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Partridge RA, 1998, ACAD EMERG MED, V5, P31, DOI 10.1111/j.1553-2712.1998.tb02571.x; *ROYAL SOC PREV AC, 2003, 24 ROSPA; Tsipouras S, 2001, MED J AUSTRALIA, V174, P516, DOI 10.5694/j.1326-5377.2001.tb143403.x; *US CONS PROD SAF, CONS PROD SAF AL CPS; YOUNG R, 2004, TIMES LONDON    0402, P25	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1252	1252		10.1016/S0140-6736(04)16031-5	http://dx.doi.org/10.1016/S0140-6736(04)16031-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094268				2022-12-28	WOS:000220904900005
J	Hamrahian, AH; Oseni, TS; Arafah, BM				Hamrahian, AH; Oseni, TS; Arafah, BM			Measurements of serum free cortisol in critically ill patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	82nd Annual Meeting of the Endocrine-Society	JUN 21-24, 2000	TORONTO, CANADA	Endocrine Soc			CORTICOSTEROID-BINDING GLOBULIN; SEPTIC SHOCK; ADRENAL INSUFFICIENCY; PLASMA-LEVELS; INFLAMMATION; TRANSCORTIN; MODULATION; SURGERY; CORTICOTROPIN; SENSITIVITY	Background: Because more than 90 percent of circulating cortisol in human serum is protein-bound, changes in the binding proteins can alter measured serum total cortisol concentrations without influencing free concentrations of this hormone. We investigated the effect of decreased amounts of cortisol-binding proteins on serum total and free cortisol concentrations during critical illness, when glucocorticoid secretion is maximally stimulated. Methods: Base-line serum total cortisol, cosyntropin-stimulated serum total cortisol, aldosterone, and free cortisol concentrations were measured in 66 critically ill patients and 33 healthy volunteers in groups that were similar with regard to sex and age. Of the 66 patients, 36 had hypoproteinemia (albumin concentration, 2.5 g per deciliter or less), and 30 had near-normal serum albumin concentrations (above 2.5 g per deciliter). Results: Base-line and cosyntropin-stimulated serum total cortisol concentrations were lower in the patients with hypoproteinemia than in those with near-normal serum albumin concentrations (P<0.001). However, the mean (+/- SD) base-line serum free cortisol concentrations were similar in the two groups of patients (5.1 +/- 4.1 and 5.2 +/- 3.5 microg per deciliter [140.7 +/- 113.1 and 143.5 +/- 96.6 nmol per liter]) and were several times higher than the values in controls (0.6 +/- 0.3 microg per deciliter [16.6 +/- 8.3 nmol per liter], P<0.001 for both comparisons). Cosyntropin-stimulated serum total cortisol concentrations were subnormal (18.5 microg per deciliter [510.4 nmol per liter] or less) in 14 of the patients, all of whom had hypoproteinemia. In all 66 patients, including these 14 who had hypoproteinemia, the base-line and cosyntropin-stimulated serum free cortisol concentrations were high-normal or elevated. Conclusions: During critical illness, glucocorticoid secretion markedly increases, but the increase is not discernible when only the serum total cortisol concentration is measured. In this study, nearly 40 percent of critically ill patients with hypoproteinemia had subnormal serum total cortisol concentrations, even though their adrenal function was normal. Measuring serum free cortisol concentrations in critically ill patients with hypoproteinemia may help prevent the unnecessary use of glucocorticoid therapy.	Univ Hosp Cleveland, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University Hospitals of Cleveland; Case Western Reserve University	Arafah, BM (corresponding author), Univ Hosp Cleveland, Div Clin & Mol Endocrinol, 11100 Euclid Ave, Cleveland, OH 44106 USA.	bxa@po.cwru.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR000080] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; ARAFAH BM, 1990, J CLIN ENDOCR METAB, V71, P60, DOI 10.1210/jcem-71-1-60; BAXTER JD, 1979, MONOGRAPHS ENDOCRINO, V12, P25; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Bernier J, 1998, CRIT CARE MED, V26, P452, DOI 10.1097/00003246-199803000-00014; BRIEN TG, 1981, CLIN ENDOCRINOL, V14, P193, DOI 10.1111/j.1365-2265.1981.tb00616.x; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; EKINS RP, 1982, MONOCLONAL ANTIBODIE, P73; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Garrel DR, 1996, HORM RES, V45, P245, DOI 10.1159/000184796; GEISELER D, 1983, ANAL BIOCHEM, V132, P174, DOI 10.1016/0003-2697(83)90444-X; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; HAMANAKA Y, 1970, ACTA ENDOCRINOL-COP, V64, P439, DOI 10.1530/acta.0.0640439; KEANE PM, 1969, J ENDOCRINOL, V43, P571, DOI 10.1677/joe.0.0430571; KEHLET H, 1974, ACTA ENDOCRINOL-COP, V75, P119, DOI 10.1530/acta.0.0750119; KIDESS AI, 1993, MAYO CLIN PROC, V68, P435, DOI 10.1016/S0025-6196(12)60188-8; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; le Roux CW, 2003, J CLIN ENDOCR METAB, V88, P2045, DOI 10.1210/jc.2002-021532; MILLS IH, 1962, BRIT MED BULL, V18, P127, DOI 10.1093/oxfordjournals.bmb.a069953; MOLIJN GJ, 1995, J CLIN ENDOCR METAB, V80, P1799, DOI 10.1210/jc.80.6.1799; MUELLER UW, 1981, BIOCHEM PHARMACOL, V30, P727, DOI 10.1016/0006-2952(81)90158-1; Nasrallah MP, 2003, J CLIN ENDOCR METAB, V88, P5293, DOI 10.1210/jc.2003-030449; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; OGAWA K, 1983, J CLIN ENDOCR METAB, V56, P121, DOI 10.1210/jcem-56-1-121; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PUGEAT M, 1989, CLIN CHEM, V35, P1675; ROSNER W, 1983, CLIN CHEM, V29, P1389; SAVU L, 1981, BIOCHEM BIOPH RES CO, V102, P411, DOI 10.1016/0006-291X(81)91536-9; SMITH JB, 1980, CLIN CHIM ACTA, V108, P435, DOI 10.1016/0009-8981(80)90351-4; TAYLOR KM, 1976, J THORAC CARDIOV SUR, V72, P57; ZOUAGHI H, 1983, ACTA ENDOCRINOL-COP, V102, P277, DOI 10.1530/acta.0.1020277	38	492	512	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2004	350	16					1629	1638		10.1056/NEJMoa020266	http://dx.doi.org/10.1056/NEJMoa020266			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	812DI	15084695				2022-12-28	WOS:000220819800007
J	Yasuda, S; Oceguera-Yanez, F; Kato, T; Okamoto, M; Yonemura, S; Terada, Y; Ishizaki, T; Narumiya, S				Yasuda, S; Oceguera-Yanez, F; Kato, T; Okamoto, M; Yonemura, S; Terada, Y; Ishizaki, T; Narumiya, S			Cdc42 and mDia3 regulate microtubule attachment to kinetochores	NATURE			English	Article							MITOTIC SPINDLE; MAMMALIAN HOMOLOG; RHO-GTPASES; HELA-CELLS; CENP-A; CYTOKINESIS; CHECKPOINT; PROTEINS; MGCRACGAP; PATHWAY	During mitosis, the mitotic spindle, a bipolar structure composed of microtubules (MTs) and associated motor proteins(1,2), segregates sister chromatids to daughter cells. Initially some MTs emanating from one centrosome attach to the kinetochore at the centromere of one of the duplicated chromosomes. This attachment allows rapid poleward movement of the bound chromosome. Subsequent attachment of the sister kinetochore to MTs growing from the other centrosome results in the bi-orientation of the chromosome, in which interactions between kinetochores and the plus ends of MTs are formed and stabilized(2). These processes ensure alignment of chromosomes during metaphase and their correct segregation during anaphase. Although many proteins constituting the kinetochore have been identified and extensively studied, the signalling responsible for MT capture and stabilization is unclear(1,2). Small GTPases of the Rho family regulate cell morphogenesis by organizing the actin cytoskeleton and regulating MT alignment and stabilization(3). We now show that one member of this family, Cdc42, and its effector, mDia3, regulate MT attachment to kinetochores.	Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Horizontal Med Res Org, Kyoto 6068501, Japan; RIKEN, Lab Cellular Morphogenesis, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Kyoto University; Kyoto University; RIKEN; University of Minnesota System; University of Minnesota Twin Cities	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp						Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; ANDREASSEN PR, 1991, J CELL SCI, V99, P523; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Eda M, 2001, J CELL SCI, V114, P3273; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kato T, 2001, J CELL SCI, V114, P775; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Pellman D, 2001, SCIENCE, V291, P2555, DOI 10.1126/science.1057337; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Van de Putte T, 2001, MECH DEVELOP, V102, P33, DOI 10.1016/S0925-4773(01)00279-9; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518	30	147	148	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2004	428	6984					767	771		10.1038/nature02452	http://dx.doi.org/10.1038/nature02452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812EW	15085137				2022-12-28	WOS:000220823800044
J	Sanderson, H; Adams, T; Budden, M; Hoare, C				Sanderson, H; Adams, T; Budden, M; Hoare, C			Lessons from the central Hampshire electronic health record pilot project: evaluation of the electronic health record for supporting patient care and secondary analysis	BRITISH MEDICAL JOURNAL			English	Article									Winchester & Eastleigh Healthcare Trust, Southampton SO22 5DG, Hants, England; Hampshire & Isle Wight Strateg Hlth Author, Southampton SO16 4GX, Hants, England; W Pk Hosp, E Surrey Hlth Informat Serv, Surrey & Sussex Strateg Hlth Author, Surrey K19 8PB, England		Sanderson, H (corresponding author), Winchester & Eastleigh Healthcare Trust, Southampton SO22 5DG, Hants, England.	hugh.sanderson@hiowha.nhs.uk						ADAMS T, 2004, BMJ; *DEP HLTH, NAT PAT REC AN SERV; Gardner M, 2003, BRIT MED J, V326, P1101, DOI 10.1136/bmj.326.7399.1101; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; MORRIS L, 2003, BMJ              JUN; *NHS NAT DES AUTH, 2003, INT CAR REC SERV OUT; Rosen A K, 1999, Jt Comm J Qual Improv, V25, P111; Wyatt J, 1998, BRIT MED J, V317, P900; 2003, T40NSF	9	14	14	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 10	2004	328	7444					875	878		10.1136/bmj.328.7444.875	http://dx.doi.org/10.1136/bmj.328.7444.875			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073071	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000220871400019
J	Farmer, P				Farmer, P			Political violence and public health in Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Clin Bon Sauveur, Cange, Haiti; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Farmer, P (corresponding author), Clin Bon Sauveur, Cange, Haiti.							DIEDERICH B, 1986, PAPA DOC TONTONS MAC, P366; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Mukherjee JS, 2003, LANCET, V362, P994, DOI 10.1016/S0140-6736(03)14373-5; MUKHERJEE JS, 2003, BRIT MED J, V237, P1104; *PAN AM HLTH ORG, HAIT CRIS HLTH RISKS	5	26	26	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1483	1486		10.1056/NEJMp048081	http://dx.doi.org/10.1056/NEJMp048081			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810CI	15071121				2022-12-28	WOS:000220682000001
J	Danesh, J; Wheeler, JG; Hirschfield, GM; Eda, S; Eiriksdottir, G; Rumley, A; Lowe, GDO; Pepys, MB; Gudnason, V				Danesh, J; Wheeler, JG; Hirschfield, GM; Eda, S; Eiriksdottir, G; Rumley, A; Lowe, GDO; Pepys, MB; Gudnason, V			C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; CARDIOVASCULAR RISK-FACTORS; VON-WILLEBRAND-FACTOR; NESTED CASE-CONTROL; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; CHOLESTEROL LEVELS; FOLLOW-UP; MEN; MORTALITY	BACKGROUND: C-reactive protein is an inflammatory marker believed to be of value in the prediction of coronary events. We report data from a large study of C-reactive protein and other circulating inflammatory markers, as well as updated meta-analyses, to evaluate their relevance to the prediction of coronary heart disease. METHODS: Measurements were made in samples obtained at base line from up to 2459 patients who had a nonfatal myocardial infarction or died of coronary heart disease during the study and from up to 3969 controls without a coronary heart disease event in the Reykjavik prospective study of 18,569 participants. Measurements were made in paired samples obtained an average of 12 years apart from 379 of these participants in order to quantify within-person fluctuations in inflammatory marker levels. RESULTS: The long-term stability of C-reactive protein values (within-person correlation coefficient, 0.59; 95 percent confidence interval, 0.52 to 0.66) was similar to that of both blood pressure and total serum cholesterol. After adjustment for base-line values for established risk factors, the odds ratio for coronary heart disease was 1.45 (95 percent confidence interval, 1.25 to 1.68) in a comparison of participants in the top third of the group with respect to base-line C-reactive protein values with those in the bottom third, and similar overall findings were observed in an updated meta-analysis involving a total of 7068 patients with coronary heart disease. By comparison, the odds ratios in the Reykjavik Study for coronary heart disease were somewhat weaker for the erythrocyte sedimentation rate (1.30; 95 percent confidence interval, 1.13 to 1.51) and the von Willebrand factor concentration (1.11; 95 percent confidence interval, 0.97 to 1.27) but generally stronger for established risk factors, such as an increased total cholesterol concentration (2.35; 95 percent confidence interval, 2.03 to 2.74) and cigarette smoking (1.87; 95 percent confidence interval, 1.62 to 2.16). CONCLUSIONS: C-reactive protein is a relatively moderate predictor of coronary heart disease. Recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.	Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London, England; Roche Diagnost, Tokyo, Japan; Iceland Heart Assoc, Kopavogur, Iceland; Univ Glasgow, Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland	University of Cambridge; University of London; University College London; UCL Medical School; Roche Holding; Icelandic Heart Association; Royal Infirmary of Edinburgh; University of Glasgow	Danesh, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Strangeways Site, Cambridge CB1 8RN, England.		Hirschfield, Gideon M/M-2143-2015; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015	Hirschfield, Gideon M/0000-0002-6736-2255; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084				Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Danesh J, 2000, EUR HEART J, V21, P515, DOI 10.1053/euhj.1999.1699; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Erikssen G, 2000, EUR HEART J, V21, P1614, DOI 10.1053/euhj.2000.2148; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Gram J, 2000, J INTERN MED, V247, P205, DOI 10.1046/j.1365-2796.2000.00604.x; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P3071, DOI 10.1161/01.ATV.19.12.3071; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kayaba K, 2000, JPN CIRC J, V64, P303, DOI 10.1253/jcj.64.303; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Koenig W, 2003, AM J EPIDEMIOL, V158, P357, DOI 10.1093/aje/kwg135; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; LOWE GDO, 1999, BLOOD COAGUL FIBRI S, V10, pS92; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Ockene IS, 2001, CLIN CHEM, V47, P444; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C; Pirro M, 2001, ARCH INTERN MED, V161, P2474, DOI 10.1001/archinte.161.20.2474; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Roberts WL, 2001, CLIN CHEM, V47, P980; Roberts WL, 2001, CLIN CHEM, V47, P418; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K.J., 1986, MODERN EPIDEMIOLOGY, P237; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355	42	2279	2402	3	123	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1387	1397		10.1056/NEJMoa032804	http://dx.doi.org/10.1056/NEJMoa032804			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070788				2022-12-28	WOS:000220562500005
J	Darouiche, RO				Darouiche, RO			Current concepts - Treatment of infections associated with surgical implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROSTHETIC JOINT INFECTION; RANDOMIZED CONTROLLED-TRIAL; VENTRICULAR ASSIST DEVICE; FLUID SHUNT INFECTIONS; CARDIOVERTER-DEFIBRILLATOR; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-THERAPY; VALVE ENDOCARDITIS; GRAFT INFECTIONS; MEDICAL PROGRESS		Baylor Coll Med, Ctr Prostheses Infect, Houston, TX 77030 USA; Vet Affairs Med Ctr, Ctr Prostheses Infect, Houston, TX 77030 USA; Vet Affairs Med Ctr, Infect Dis Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Darouiche, RO (corresponding author), Baylor Coll Med, Ctr Prostheses Infect, 1333 Moursund Ave,Suite A221, Houston, TX 77030 USA.	rdarouiche@aol.com						Ako J, 2003, CIRC J, V67, P3, DOI 10.1253/circj.67.3; Akowuah EF, 2003, HEART, V89, P269, DOI 10.1136/heart.89.3.269; Boxma H, 1996, LANCET, V347, P1133, DOI 10.1016/S0140-6736(96)90606-6; Brandt CM, 1997, CLIN INFECT DIS, V24, P914, DOI 10.1093/clinids/24.5.914; Chiesa R, 1998, ANN VASC SURG, V12, P457, DOI 10.1007/s100169900184; Cochrane DD, 2002, EUR J PEDIATR SURG, V12, pS6; Coselli JS, 1999, ANN THORAC SURG, V67, P1990, DOI 10.1016/S0003-4975(99)00355-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crockarell JR, 1998, J BONE JOINT SURG AM, V80A, P1306, DOI 10.2106/00004623-199809000-00009; Darling RC, 1997, J VASC SURG, V25, P106, DOI 10.1016/S0741-5214(97)70326-4; Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Ferguson TB, 1996, J THORAC CARDIOV SUR, V111, P742, DOI 10.1016/S0022-5223(96)70334-3; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Gassel HJ, 2002, VASA-J VASCULAR DIS, V31, P48, DOI 10.1024/0301-1526.31.1.48; Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107; GRIMER RJ, 2002, CLIN ORTHOP RELAT R, V395, P193; John MDV, 1998, CLIN INFECT DIS, V26, P1302, DOI 10.1086/516378; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Kulkarni AV, 2001, PEDIATR NEUROSURG, V35, P66, DOI 10.1159/000050393; Lentino JR, 2000, INFECTION, V28, P355, DOI 10.1007/s150100070005; Lerakis S, 2001, AM J MED SCI, V321, P152; Lin PH, 2002, AM J SURG, V184, P31, DOI 10.1016/S0002-9610(02)00894-2; McCarthy PM, 1996, ANN THORAC SURG, V61, P359, DOI 10.1016/0003-4975(95)00990-6; Meehan AM, 2003, CLIN INFECT DIS, V36, P845, DOI 10.1086/368182; Mela T, 2001, AM J CARDIOL, V88, P750, DOI 10.1016/S0002-9149(01)01845-8; Mulcahy JJ, 2000, INT J IMPOT RES, V12, pS108, DOI 10.1038/sj.ijir.3900587; Naradzay JFX, 1999, J EMERG MED, V17, P311, DOI 10.1016/S0736-4679(98)00168-1; Reilly LM, 2002, CARDIOVASC SURG, V10, P372, DOI 10.1016/S0967-2109(02)00045-5; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Sasaki Y, 2001, Jpn J Thorac Cardiovasc Surg, V49, P224; Schreffler RT, 2002, PEDIATR INFECT DIS J, V21, P632, DOI 10.1097/00006454-200207000-00006; Segreti J, 1998, CLIN INFECT DIS, V27, P711, DOI 10.1086/514951; Sierra J, 2003, CARDIOVASC SURG, V11, P185, DOI 10.1016/S0967-2109(03)00004-8; Sinha P, 2000, CIRCULATION, V102, P194; Stein A, 1998, ANTIMICROB AGENTS CH, V42, P3086, DOI 10.1128/AAC.42.12.3086; Tattevin P, 1999, CLIN INFECT DIS, V29, P292, DOI 10.1086/520202; Turkisher V, 1997, PACE, V20, P2268, DOI 10.1111/j.1540-8159.1997.tb04247.x; Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Whitehead WE, 2001, PEDIATR NEUROSURG, V35, P205, DOI 10.1159/000050422; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; WILSON SK, 1995, J UROLOGY, V153, P659, DOI 10.1016/S0022-5347(01)67678-X; WUNDERLY D, 1990, PACE, V13, P1360, DOI 10.1111/j.1540-8159.1990.tb04007.x; Yeager RA, 1999, J VASC SURG, V30, P76, DOI 10.1016/S0741-5214(99)70178-3; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	49	1586	1672	15	292	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2004	350	14					1422	1429		10.1056/NEJMra035415	http://dx.doi.org/10.1056/NEJMra035415			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808IJ	15070792				2022-12-28	WOS:000220562500009
J	Reissman, DB; Whitney, EAS; Taylor, TH; Hayslett, JA; Dull, PM; Arias, I; Ashford, DA; Bresnitz, EA; Tan, C; Rosenstein, N; Perkins, BA				Reissman, DB; Whitney, EAS; Taylor, TH; Hayslett, JA; Dull, PM; Arias, I; Ashford, DA; Bresnitz, EA; Tan, C; Rosenstein, N; Perkins, BA			One-year health assessment of adult survivors of Bacillus anthracis infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; SOMATIC SYMPTOMS; LYME-DISEASE; PREVALENCE	Context Little is known about potential long-term health effects of bioterrorism-related Bacillus anthracis infection. Objective To describe the relationship between anthrax infection and persistent somatic symptoms among adults surviving bioterrorism-related anthrax disease approximately 1 year after illness onset in 2001. Design, Setting, and Participants Cross-sectional study of 15 of 16 adult survivors from September through December 2002 using a clinical interview, a medical review-of-system questionnaire, 2 standardized self-administered questionnaires, and a review of available medical records. Main Outcome Measures Health complaints summarized by the body system affected and by symptom categories; psychological distress measured by the Revised 90-Item Symptom Checklist; and health-related quality-of-life indices by the Medical Outcomes Study 36-Item Short-Form Health Survey (version 2). Results The anthrax survivors reported symptoms affecting multiple body systems, significantly greater overall psychological distress (P<.001), and significantly reduced health-related quality-of-life indices compared with US referent populations. Eight survivors (53%) had not returned to work since their infection. Comparing disease manifestations, inhalational survivors reported significantly lower overall physical health than cutaneous survivors (mean scores, 30 vs 41; P = .02). Available medical records could not explain the persisting health complaints. Conclusion The anthrax survivors continued to report significant health problems and poor life adjustment 1 year after onset of bioterrorism-related anthrax disease.	CDCP, Off Director, Atlanta, GA 30341 USA; CDCP, Epidemiol & Surveillance Branch, Atlanta, GA 30341 USA; CDCP, Epidemiol & Surveillance Branch, Atlanta, GA 30341 USA; CDCP, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; CDCP, Bioterrorism Preparedness & Response Program, Off Director, Natl Ctr Infect Dis, Atlanta, GA 30341 USA; CDCP, Meningitis & Special Pathogens Branch, Atlanta, GA 30341 USA; CDCP, Biostat Informat Branch, Atlanta, GA 30341 USA; CDCP, Div Bacterial & Mycot Dis,Natl Ctr Infect Dis, Epidem Intelligence Serv Program, Div Appl Publ Hlth Training,Epidemiol Program Off, Atlanta, GA 30341 USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services	Reissman, DB (corresponding author), CDCP, Off Director, 4770 Buford Hwy NE,Mailstop K68, Atlanta, GA 30341 USA.	DReissman@cdc.gov						Bales ME, 2002, EMERG INFECT DIS, V8, P1163, DOI 10.3201/eid0810.020223; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Bromet EJ, 2002, ENVIRON HEALTH PERSP, V110, P625, DOI 10.1289/ehp.02110s4625; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90; ENGEL CC, 2003, TRAUMA HLTH PHYS HLT, P191; ESCOBAR JI, 1992, AM J PSYCHIAT, V149, P965; FALLON BA, 1994, AM J PSYCHIAT, V151, P1571, DOI 10.1176/ajp.151.11.1571; Friedman Matthew J., 1995, P507; Hall Molly J, 2003, Biosecur Bioterror, V1, P139, DOI 10.1089/153871303766275817; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; McCarroll JE, 2002, PSYCHOSOM MED, V64, P29, DOI 10.1097/00006842-200201000-00005; Miller TR, 1994, CRIME US VICTIM COST; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Pfefferbaum B, 2001, Public Health Rev, V29, P271; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Ware J.E., 2000, SF 36 HLTH SURVEY MA	21	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1994	1998		10.1001/jama.291.16.1994	http://dx.doi.org/10.1001/jama.291.16.1994			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113818	Bronze			2022-12-28	WOS:000221062000031
J	Yaziji, H; Goldstein, LC; Barry, TS; Werling, R; Hwang, H; Ellis, GK; Gralow, JR; Livingston, RB; Gown, AM				Yaziji, H; Goldstein, LC; Barry, TS; Werling, R; Hwang, H; Ellis, GK; Gralow, JR; Livingston, RB; Gown, AM			HER-2 testing in breast cancer using parallel tissue-based methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-SITU HYBRIDIZATION; SURGICAL ADJUVANT BREAST; UNITED-STATES FOOD; GENE AMPLIFICATION; TRASTUZUMAB THERAPY; MONOCLONAL-ANTIBODY; BOWEL PROJECT; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION; CARCINOMA	Context Testing for HER-2 oncogene in breast cancer has increased because of its role as a prognostic and predictive factor. Some advocate gene testing by fluorescence in situ hybridization (FISH) vs protein testing by immunohistochemistry as the method which most accurately evaluates and predicts response to the anti-HER-2 antibody, trastuzumab. However, critical examination of FISH on a screening basis has yet to be performed. Objectives To determine the correlation between FISH and immunohistochemistry results by determining HER-2/neu gene status on tumor sections with indeterminate immunohistochemistry results (2+ score), confirm gene amplification on tumor sections with positive results (3+ score), and verify gene status on tumor sections with negative results (0 or 1 + score). Design, Setting, and Patients A quality control and quality assurance program for HER-2 testing by FISH, which used tumor specimens from 2963 patients (median age, 56 years) with breast cancer received from 135 hospitals and cancer centers in 29 states, was performed at a reference laboratory from January 1, 1999, to May 15, 2003. Every specimen evaluated by FISH was parallel tested with immunohistochemistry tests. Main Outcome Measures With FISH as the presumed standard testing method, the positive and negative predictive values and sensitivity and specificity of immunohistochemistry were calculated. Results A total of 3260 clinical HER-2 tests by FISH were performed on 2963 serially referred breast cancer specimens. Of these, 2933 tests were successful and 2913 breast cancer specimens had both FISH and immunohistochemistry results available. With FISH as the standard testing method, the positive predictive value of positive immunohistochemistry score (3+) was 91.6%, and the negative predictive value of negative immunohistochemistry score (0 or 1+) was 97.2%. The sensitivity of immunohistochemistry tests, including tumor sections with scores of 2+ or 3+, was 92.6% and the specificity of immunohistochemistry tests with scores of 3+ was 98.8%. The FISH test had a significantly higher failure rate (5% vs 0.08%) and reagent cost ($140 vs $10), and longer testing (36 hours vs 4 hours) and interpretation times (7 minutes vs 45 seconds) vs immunohistochemistry tests. Conclusions A testing algorithm for HER-2 determination is most efficient by using immunohistochemistry as the method of choice, with FISH performed for cancers with indeterminate results (2+ score). Successful quality control and quality assurance programs are a prerequisite for such approaches.	Phenopath Labs, Seattle, WA 98103 USA; Univ Washington, Sch Med, Div Med Oncol, Seattle, WA USA	PhenoPath Laboratories; University of Washington; University of Washington Seattle	Gown, AM (corresponding author), Phenopath Labs, 551 N 34th St,Suite 100, Seattle, WA 98103 USA.	gown@phenopath.com						Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Baselga J, 1999, SEMIN ONCOL, V26, P78; Bilous M, 2003, MODERN PATHOL, V16, P173, DOI 10.1097/01.MP.0000052102.90815.82; Birner P, 2001, CLIN CANCER RES, V7, P1669; Cianciulli AM, 2002, CANCER GENET CYTOGEN, V133, P66, DOI 10.1016/S0165-4608(01)00559-3; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Couturier J, 2000, MODERN PATHOL, V13, P1238, DOI 10.1038/modpathol.3880228; *CTR BIOL EV RES, 2001, HER 2 NEU BRIEFING D; Field AS, 2001, PATHOLOGY, V33, P278; Fornier M, 2002, ONCOLOGY-NY, V16, P1340; FORNIER M, 2002, ONCOLOGY, V16, P1351; Hanna WM, 2001, MODERN PATHOL, V14, P677, DOI 10.1038/modpathol.3880372; Jacobs TW, 1999, J CLIN ONCOL, V17, P1974, DOI 10.1200/JCO.1999.17.7.1974; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Kakar S, 2000, MOL DIAGN, V5, P199, DOI 10.2165/00066982-200005030-00006; Larsimont D, 2002, ANTICANCER RES, V22, P2485; Lebeau A, 2001, J CLIN ONCOL, V19, P354, DOI 10.1200/JCO.2001.19.2.354; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Onody P, 2001, ARCH PATHOL LAB MED, V125, P746; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; PAIK S, 2002, SAN ANT BREAST CANC; Paik SM, 1998, JNCI-J NATL CANCER I, V90, P1361, DOI 10.1093/jnci/90.18.1361; Pauletti G, 2000, J CLIN ONCOL, V18, P3651, DOI 10.1200/JCO.2000.18.21.3651; Pauletti G, 1996, ONCOGENE, V13, P63; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Ridolfi RL, 2000, MODERN PATHOL, V13, P866, DOI 10.1038/modpathol.3880154; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Sjogren S, 1998, J CLIN ONCOL, V16, P462; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Tsuda H, 2001, PATHOL INT, V51, P26, DOI 10.1046/j.1440-1827.2001.01163.x; Tubbs RR, 2001, J CLIN ONCOL, V19, P2714, DOI 10.1200/JCO.2001.19.10.2714; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; YARDLEY DA, 2002, ANN M AM SOC CLIN ON	40	351	375	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1972	1977		10.1001/jama.291.16.1972	http://dx.doi.org/10.1001/jama.291.16.1972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113815	Bronze			2022-12-28	WOS:000221062000028
J	Young, T; Skatrud, J; Peppard, PE				Young, T; Skatrud, J; Peppard, PE			Risk factors for obstructive sleep apnea in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSITIVE AIRWAY PRESSURE; HEART-FAILURE; PUBLIC-HEALTH; MEN; PREVALENCE; WOMEN; ASSOCIATION; THERAPY		Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Young, T (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, 502 Walnut St, Madison, WI 53705 USA.	tbyoung@wisc.edu			NATIONAL INSTITUTE ON AGING [R01AG014124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62265] Funding Source: Medline; NIA NIH HHS [R01 AG14124] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Chen W, 2003, OTOLARYNG CLIN N AM, V36, P437, DOI 10.1016/S0030-6665(02)00175-5; Dempsey JA, 2002, CHEST, V122, P840, DOI 10.1378/chest.122.3.840; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; IP M, 2002, SLEEP BREATH, V6, P49; Iranzo A, 2002, NEUROLOGY, V58, P911, DOI 10.1212/WNL.58.6.911; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Kaneko Y, 2003, SLEEP, V26, P293, DOI 10.1093/sleep/26.3.293; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; Li KK, 2000, LARYNGOSCOPE, V110, P1689, DOI 10.1097/00005537-200010000-00022; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; McNicholas WT, 2002, EUR RESPIR J, V20, P1594, DOI 10.1183/09031936.02.00404502; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Pack AI, 2001, ANN INTERN MED, V134, P1065, DOI 10.7326/0003-4819-134-11-200106050-00013; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Polo-Kantola N, 2003, OBSTET GYNECOL, V102, P68, DOI 10.1016/S0029-7844(03)00374-0; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Quan SF, 1997, SLEEP, V20, P1077; Redline S, 2000, SLEEP MED REV, V4, P583, DOI 10.1053/smrv.2000.0120; Riley RW, 2000, OTOLARYNG HEAD NECK, V122, P415, DOI 10.1016/S0194-5998(00)70058-1; SCHWAB RJ, 1995, AM J RESP CRIT CARE, V152, P1673, DOI 10.1164/ajrccm.152.5.7582313; Shahar E, 2003, AM J RESP CRIT CARE, V167, P1186, DOI 10.1164/rccm.200210-1238OC; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Strollo PJ, 2003, CLIN CHEST MED, V24, P307, DOI 10.1016/S0272-5231(03)00025-X; SULLIVAN CE, 1981, LANCET, V1, P862; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1998, THORAX, V53, pS16, DOI 10.1136/thx.53.2008.S16; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young T, 1997, J ALLERGY CLIN IMMUN, V99, P757	38	674	702	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					2013	2016		10.1001/jama.291.16.2013	http://dx.doi.org/10.1001/jama.291.16.2013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113821				2022-12-28	WOS:000221062000034
J	Roderick, P				Roderick, P			Commentary: Liver function tests: defining what's normal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMINOTRANSFERASE LEVELS		Univ Southampton, Southampton Gen Hosp, Community Clin Sci Res Div, Southampton SO16 6YD, Hants, England	University of Southampton	Roderick, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Community Clin Sci Res Div, B Floor,S Acad Block, Southampton SO16 6YD, Hants, England.	pjr@soton.ac.uk						Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; *DEP HLTH, 2002, STAT PUBL HLTH ANN R; Kaplan MM, 2002, ANN INTERN MED, V137, P49, DOI 10.7326/0003-4819-137-1-200207020-00012; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Kyrlagkitsis L, 2003, AM J GASTROENTEROL, V98, P1588, DOI [10.1016/S0002-9270(03)00368-X, 10.1111/j.1572-0241.2003.07539.x]; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707	7	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2004	328	7446					987	987		10.1136/bmj.328.7446.987	http://dx.doi.org/10.1136/bmj.328.7446.987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816SR	15105324	Green Submitted, Green Published			2022-12-28	WOS:000221130100014
J	Browning, AC; Amoaku, WM; Vernon, SA; Morgan, J; Thirkill, CE				Browning, AC; Amoaku, WM; Vernon, SA; Morgan, J; Thirkill, CE			Cachexia and poor night vision	LANCET			English	Editorial Material									Univ Nottingham Hosp, Queens Med Ctr, Eye Ear Nose & Throat Ctr, Dept Ophthalmol & Visual Sci, Nottingham NG7 2UH, England; Univ Calif, Sacramento, CA USA	University of Nottingham	Browning, AC (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Eye Ear Nose & Throat Ctr, Dept Ophthalmol & Visual Sci, Nottingham NG7 2UH, England.			Amoaku, Winfried/0000-0001-5028-7984					0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1305	1305		10.1016/S0140-6736(04)16005-4	http://dx.doi.org/10.1016/S0140-6736(04)16005-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094277				2022-12-28	WOS:000220904900022
J	Ren, SJ; Rollins, BJ				Ren, SJ; Rollins, BJ			Cyclin C/Cdk3 promotes Rb-dependent G0 exit	CELL			English	Article							RNA-POLYMERASE-II; CELL-CYCLE REENTRY; RETINOBLASTOMA PROTEIN; KINASE PARTNER; E2F FAMILY; C-MYC; PHOSPHORYLATION; G1; YEAST; P130	G0 is a physiological state occupied by resting or terminally differentiated cells that have exited the cell cycle. In contrast to the well-characterized cyclin/cdk-mediated inactivation of pRb that controls the G1/S transition, little is known about regulation of the G0/G1 transition. However, pRb is likely to participate in this process because its acute somatic inactivation is sufficient for G0-arrested cells to reenter the cell cycle. One physiological regulator of this event may be cyclin C because its highest mRNA levels occur during G0 exit. Here we show that a non-cdk8-associated cellular pool of cyclin C combines with cdk3 to stimulate pRb phosphorylation at S807/811 during the G0/G1 transition, and that this phosphorylation is required for cells to exit G0 efficiently. Thus, G1 entry is regulated in an analogous fashion to S phase entry, but involves a distinct cyclin/cdk combination.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rollins, BJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.	barrett_rollins@dfci.harvard.edu			NCI NIH HHS [CA72573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072573] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Brantey MA, 2000, CANCER RES, V60, P4320; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DARZYNKIEWICZ Z, 1990, FLOW CYTOMETRY SORTI, P469; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KUCHIN S, 1995, P NATL ACAD SCI USA, V92, P4006, DOI 10.1073/pnas.92.9.4006; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; LAJTHA LG, 1963, J CELL COMPAR PHYSL, V62, P143; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LEOPOLD P, 1991, CELL, V66, P1207, DOI 10.1016/0092-8674(91)90043-X; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Liu ZJ, 1998, BLOOD, V92, P4700; Liu ZJ, 1998, MOL CELL BIOL, V18, P3445, DOI 10.1128/MCB.18.6.3445; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mayol X, 1996, ONCOGENE, V13, P237; MAYOL X, 1995, ONCOGENE, V11, P801; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Moberg K, 1996, MOL CELL BIOL, V16, P1436; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pan WJ, 1998, CARCINOGENESIS, V19, P765, DOI 10.1093/carcin/19.5.765; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Rickert P, 1996, ONCOGENE, V12, P2631; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Sherr CJ, 2000, CANCER RES, V60, P3689; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	48	218	230	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					239	251		10.1016/S0092-8674(04)00300-9	http://dx.doi.org/10.1016/S0092-8674(04)00300-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084261	Bronze			2022-12-28	WOS:000220913400011
J	Cotton, PB; Durkalski, VL; Benoit, PC; Palesch, YY; Mauldin, PD; Hoffman, B; Vining, DJ; Small, WC; Affronti, J; Rex, D; Kopecky, KK; Ackerman, S; Burdick, JS; Brewington, C; Turner, MA; Zfass, A; Wright, AR; Iyer, RB; Lynch, P; Sivak, MV; Butler, H				Cotton, PB; Durkalski, VL; Benoit, PC; Palesch, YY; Mauldin, PD; Hoffman, B; Vining, DJ; Small, WC; Affronti, J; Rex, D; Kopecky, KK; Ackerman, S; Burdick, JS; Brewington, C; Turner, MA; Zfass, A; Wright, AR; Iyer, RB; Lynch, P; Sivak, MV; Butler, H			Computed tomographic colonography (virtual colonoscopy) - A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CT COLONOGRAPHY; CONVENTIONAL COLONOSCOPY; PREOPERATIVE EVALUATION; ASYMPTOMATIC ADULTS; MISS RATES; CANCER; POLYPS; COLON; SCREEN; FEASIBILITY	Context Conventional colonoscopy is the best available method for detection of colorectal cancer; however, it is invasive and not without risk. Computed tomographic colonography (CTC), also known as virtual colonoscopy, has been reported to be reasonably accurate in the diagnosis of colorectal neoplasia in studies performed at expert centers. Objective To assess the accuracy of CTC in a large number of participants across multiple centers. Design, Setting, and Participants A nonrandomized, evaluator-blinded, noninferiority study design of 615 participants aged 50 years or older who were re routine, clinically indicated colonoscopy in 9 major hospital centers between April 17, 2000, and October 3, 2001. The CTC was performed by using multislice scanners immediately before standard colonoscopy; findings at colonoscopy were reported before and after segmental unblinding to the CTC results. Main Outcome Measures The sensitivity and specificity of CTC and conventional colonoscopy in detecting participants with lesions sized at least 6 mm. Secondary outcomes included detection of all lesions, detection of advanced lesions, possible technical confounders, participant preferences, and evidence for increasing accuracy with experience. Results A total of 827 lesions were detected in 308 of 600 participants who underwent both procedures; 104 participants had lesions sized at least 6 mm. The sensitivity of CTC for detecting participants with 1 or more lesions sized at least 6 mm was 39.0% (95% confidence interval [Cl], 29.6%-48.4%) and for lesions sized at least 10 mm, it was 55.0% (95% Cl, 39.9%-70.0%). These results were significantly lower than those for conventional colonoscopy, with sensitivities of 99.0% (95% Cl, 97.1%->99.9%) and 100%, respectively. A total of 496 participants were without any lesion sized at least 6 mm. The specificity of CTC and conventional colonoscopy for detecting participants without any lesion sized at least 6 mm was 90.5% (95% Cl, 87.9%-93.1%) and 100%, respectively, and without lesions sized at least 10 mm, 96.0% (95% Cl, 94.3%-97.6%) and 100%, respectively. Computed tomographic colonography missed 2 of 8 cancers. The accuracy of CTC varied considerably between centers and did not improve as the study progressed. Participants expressed no clear preference for either technique. Conclusions Computed tomographic colonography by these methods is not yet ready for widespread clinical application. Techniques and training need to be improved.	Med Univ S Carolina, Ctr Digest Dis, Dept Gastroenterol, Charleston, SC 29425 USA; Med Univ S Carolina, Ctr Digest Dis, Dept Radiol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pharm & Clin Sci, Charleston, SC 29425 USA; Med Univ S Carolina, Clin Innovat Grp, Charleston, SC 29425 USA; Wake Forest Univ, Sch Med, Dept Gastroenterol, Winston Salem, NC 27109 USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; Emory Univ Hosp, Dept Radiol, Atlanta, GA 30322 USA; Emory Univ Hosp, Dept Gastroenterol, Atlanta, GA 30322 USA; Indiana Univ Hosp, Dept Gastroenterol, Indianapolis, IN 46202 USA; Indiana Univ Hosp, Dept Radiol, Indianapolis, IN 46202 USA; Univ Texas SW, Dept Gastroenterol, Dallas, TX USA; Univ Texas SW, Dept Radiol, Dallas, TX USA; Virginia Commonwealth Univ, Med Coll Virginia, Med Ctr, Dept Radiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Med Ctr, Dept Gastroenterol, Richmond, VA 23298 USA; St Marys Hosp, Dept Radiol, London, England; Univ Texas, MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gastroenterol, Houston, TX 77030 USA; Univ Hosp Cleveland, Dept Gastroenterol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Radiol, Cleveland, OH 44106 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Wake Forest University; Wake Forest University; Emory University; Emory University; Indiana University System; Indiana University System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Virginia Commonwealth University; Virginia Commonwealth University; Imperial College London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University Hospitals of Cleveland; University Hospitals of Cleveland	Cotton, PB (corresponding author), Med Univ S Carolina, Ctr Digest Dis, Dept Gastroenterol, Suite 210,Clin Sci Bldg,96 Jonathan Lucas St,POB, Charleston, SC 29425 USA.	cottonp@musc.edu						Akerkar GA, 2001, GASTROINTEST ENDOSC, V54, P310, DOI 10.1067/mge.2001.117595; Bond JH, 1999, NEW ENGL J MED, V341, P1540, DOI 10.1056/NEJM199911113412010; Callstrom MR, 2001, RADIOLOGY, V219, P693, DOI 10.1148/radiology.219.3.r01jn22693; Cash BD, 2003, CLIN GASTROENTEROL H, V1, P136, DOI 10.1053/cgh.2003.50021; Durkalski VL, 2002, CONTROL CLIN TRIALS, V23, P570, DOI 10.1016/S0197-2456(02)00232-5; Edwards JT, 2001, AM J GASTROENTEROL, V96, P3009; Fenlon HM, 1999, RADIOLOGY, V210, P423, DOI 10.1148/radiology.210.2.r99fe21423; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; Ferrucci JT, 2001, AM J ROENTGENOL, V177, P975, DOI 10.2214/ajr.177.5.1770975; Fletcher JG, 2000, RADIOLOGY, V216, P704, DOI 10.1148/radiology.216.3.r00au41704; Gluecker TM, 2002, EUR J CANCER, V38, P2070, DOI 10.1016/S0959-8049(02)00384-2; Johnson CD, 2002, ABDOM IMAGING, V27, P232, DOI 10.1007/s00261-001-0163-z; Johnson CD, 2003, GASTROENTEROLOGY, V125, P311, DOI 10.1016/S0016-5085(03)00894-1; Laghi A, 2002, AM J SURG, V183, P124, DOI 10.1016/S0002-9610(01)00857-1; Lauenstein TC, 2002, RADIOLOGY, V223, P248, DOI 10.1148/radiol.2231010887; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LU Y, 1995, STAT MED, V14, P1831, DOI 10.1002/sim.4780141611; Macari M, 2002, RADIOLOGY, V224, P383, DOI 10.1148/radiol.2242011382; Masutani Y, 2001, J COMPUT ASSIST TOMO, V25, P629, DOI 10.1097/00004728-200107000-00020; Mendelson RM, 2000, MED J AUSTRALIA, V173, P472, DOI 10.5694/j.1326-5377.2000.tb139298.x; Morrin MM, 2000, DIS COLON RECTUM, V43, P303, DOI 10.1007/BF02258293; Neri E, 2002, RADIOLOGY, V223, P615, DOI 10.1148/radiol.2233010928; Pickhardt PJ, 2003, AM J ROENTGENOL, V181, P799, DOI 10.2214/ajr.181.3.1810799; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pineau BC, 2001, J GASTROINTEST CANC, V30, P133, DOI 10.1385/IJGC:30:3:133; Pineau BC, 2003, GASTROENTEROLOGY, V125, P304, DOI 10.1016/S0016-5085(03)00885-0; Postic G, 2002, AM J GASTROENTEROL, V97, P3182; Rex DK, 2003, GASTROENTEROLOGY, V125, P608, DOI 10.1016/S0016-5085(03)00960-0; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex Douglas K, 2002, Rev Gastroenterol Disord, V2 Suppl 1, pS2; Ristvedt SL, 2003, AM J GASTROENTEROL, V98, P578, DOI 10.1016/S0002-9270(02)06024-0; SCHROCK TR, 1993, GASTROINTEST ENDOSC, V3, P585, DOI DOI 10.1016/S1052-5157(18)30533-6; Sonnenberg A, 1999, AM J GASTROENTEROL, V94, P2268; Spinzi G, 2001, AM J GASTROENTEROL, V96, P394; Summers RM, 2001, RADIOLOGY, V219, P51, DOI 10.1148/radiology.219.1.r01ap0751; tenBerge J, 2002, GASTROINTEST ENDOSC, V55, P859, DOI 10.1067/mge.2002.124557; Vining DJ, 1996, RADIOLOGY, V200, P30, DOI 10.1148/radiology.200.1.8657938; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1297, DOI 10.1001/jama.289.10.1297; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yee J, 2001, RADIOLOGY, V219, P685, DOI 10.1148/radiology.219.3.r01jn40685; Zalis ME, 2001, AM J ROENTGENOL, V176, P646, DOI 10.2214/ajr.176.3.1760646	41	491	506	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2004	291	14					1713	1719		10.1001/jama.291.14.1713	http://dx.doi.org/10.1001/jama.291.14.1713			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811RJ	15082698	Bronze			2022-12-28	WOS:000220788700028
J	Richard, S; Graff, J; Lindau, J; Resche, F				Richard, S; Graff, J; Lindau, J; Resche, F			Von Hippel-Lindau disease	LANCET			English	Editorial Material							TUMOR-SUPPRESSOR GENE; MUTATIONS		CHU Bicetre, Genet Oncol EPHE, UPRES 1602, F-94276 Le Kremlin Bicetre, France; CHU Bicetre, Serv Urol, F-94276 Le Kremlin Bicetre, France; Hop Necker Enfants Malad, Serv Nephrol, Paris, France; von Hippel Lindau Family Alliance, Brookline, MA USA; Hop Laennec, Serv Neurochirurg, St Herblain, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes	Richard, S (corresponding author), CHU Bicetre, Genet Oncol EPHE, UPRES 1602, F-94276 Le Kremlin Bicetre, France.	stephane.richard@kb.u-psud.fr	RICHARD, Stephane/O-1005-2017	RICHARD, Stephane/0000-0002-9859-9773				Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; [Anonymous], 1931, Proc R Soc Med, V24, P363; BAURMANN H, 1939, KLIN MONATSBL AUGENH, V103, P632; Brandt R, 1921, ALBRECHT VONGRAEFES, V106, P127; Davison C., 1936, B NEUROL I NEW YORK, V5, P72; GALEZOWSKI X, 1986, DIAGNOSTIC TRAITEMEN; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; LAMIELL JM, 1989, MEDICINE, V68, P1; Lee JY, 1998, CANCER RES, V58, P504; Lindau, 1926, ACTA PATH MICROBIO S, V1, P1; LINDAU ARVID, 1927, ACTA OPHTHALMOL, V4, P193; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; NEUMANN HPH, 1993, GEBURSTAG PATHOL, V14, P178; Resche F, 1993, Adv Tech Stand Neurosurg, V20, P197; Richard Stephane, 2003, Expert Rev Anticancer Ther, V3, P215, DOI 10.1586/14737140.3.2.215; von Hippel E., 1911, GRAEFES ARCH OPHTHAL, V79, P350, DOI [10.1007/BF01966371, DOI 10.1007/BF01966371]; Von Hippel E, 1896, 24 VERS OPHTH GES HE, P269; Von-Hippel E, 1904, ARCH OPHTHALMOL-CHIC, V59, P23, DOI [10.1007/BF01994821, DOI 10.1007/BF01994821]	20	74	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1231	1234		10.1016/S0140-6736(04)15957-6	http://dx.doi.org/10.1016/S0140-6736(04)15957-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081659				2022-12-28	WOS:000220748100027
J	Hemker, KJ				Hemker, KJ			Understanding how nanocrystalline metals deform	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hemker, KJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	hemker@jhu.edu	Hemker, Kevin J/A-3315-2010					Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Legros M, 2000, PHILOS MAG A, V80, P1017, DOI 10.1080/01418610008212096; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Ungar T, 2001, MAT SCI ENG A-STRUCT, V309, P14, DOI 10.1016/S0921-5093(00)01685-3; Van Swygenhoven H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024101; Weertman Jr, 2002, MA SC PR TE, P397; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	9	56	57	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					221	+		10.1126/science.1097058	http://dx.doi.org/10.1126/science.1097058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073363				2022-12-28	WOS:000220719400029
J	Jen, JC; Chan, WM; Bosley, TM; Wan, JJ; Carr, JR; Rub, U; Shattuck, D; Salamon, G; Kudo, LC; Ou, J; Lin, DDM; Salih, MAM; Kansu, T; al Dhalaan, H; al Zayed, Z; MacDonald, DB; Stigsby, B; Plaitakis, A; Dretakis, EK; Gottlob, I; Pieh, C; Traboulsi, EI; Wang, Q; Wang, LJ; Andrews, C; Yamada, K; Demer, JL; Karim, S; Alger, JR; Geschwind, DH; Deller, T; Sicotte, NL; Nelson, SF; Baloh, RW; Engle, EC				Jen, JC; Chan, WM; Bosley, TM; Wan, JJ; Carr, JR; Rub, U; Shattuck, D; Salamon, G; Kudo, LC; Ou, J; Lin, DDM; Salih, MAM; Kansu, T; al Dhalaan, H; al Zayed, Z; MacDonald, DB; Stigsby, B; Plaitakis, A; Dretakis, EK; Gottlob, I; Pieh, C; Traboulsi, EI; Wang, Q; Wang, LJ; Andrews, C; Yamada, K; Demer, JL; Karim, S; Alger, JR; Geschwind, DH; Deller, T; Sicotte, NL; Nelson, SF; Baloh, RW; Engle, EC			Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis	SCIENCE			English	Article							HORIZONTAL GAZE PALSY; PROGRESSIVE SCOLIOSIS; CONGENITAL FIBROSIS; GUIDANCE RECEPTORS; SLIT; EXPRESSION; PARALYSIS; MIDLINE; FAMILY; ORGANIZATION	The mechanisms controlling axon guidance are of fundamental importance in understanding brain development. Growing corticospinal and somatosensory axons cross the midline in the medulla to reach their targets and thus form the basis of contralateral motor control and sensory input. The motor and sensory projections appeared uncrossed in patients with horizontal gaze palsy with progressive scoliosis (HGPPS). In patients affected with HGPPS, we identified mutations in the ROBO3 gene, which shares homology with roundabout genes important in axon guidance in developing Drosophila, zebrafish, and mouse. Like its murine homolog Rig1/Robo3, but unlike other Robo proteins, ROBO3 is required for hindbrain axon midline crossing.	Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; Childrens Hosp Boston, Dept Neurol, Div Genet, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; King Khalid Eye Specialist Hosp, Neuroophthalmol Div, Riyadh 11462, Saudi Arabia; Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia; Hacettepe Univ Hosp, Neuroophthalmol Unit, Ankara, Turkey; King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia; Univ Crete, Dept Neurol, Iraklion, Crete, Greece; Univ Crete, Dept Orthopaed Traumatol, Iraklion, Crete, Greece; Univ Leicester, Dept Ophthalmol, Leicester, Leics, England; Univ Freiburg, Univ Eye Clin, Freiburg, Germany; Cleveland Clin Fdn, Cleveland, OH 44195 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Khaled Eye Specialist Hospital; Goethe University Frankfurt; Johns Hopkins University; King Saud University; King Khalid University Hospital; Hacettepe University; King Faisal Specialist Hospital & Research Center; University of Crete; University of Crete; University of Leicester; University of Freiburg; Cleveland Clinic Foundation	Jen, JC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA.	jjen@ucla.edu; engle@enders.tch.harvard.edu	Nelson, Stanley F/D-4771-2009; Kansu, Tulay/P-6437-2019; Traboulsi, Elias/AAY-7443-2020; Kansu, Tulay/B-6280-2012; Salih, Mustafa/C-1222-2014	Nelson, Stanley F/0000-0002-2082-3114; Kansu, Tulay/0000-0002-1986-4680; Kansu, Tulay/0000-0002-1986-4680; Carr-Ascher, Janai/0000-0002-2074-4643; Salih, Mustafa/0000-0002-4379-2111; Sicotte, Nancy/0000-0002-5131-3352	NEI NIH HHS [R01 EY012498, EY12498, R01 EY008313, R01 EY015298, EY15311, EY15298, R01 EY008313-14, R01 EY013583, EY13583] Funding Source: Medline; NHLBI NIH HHS [R01 HL066251] Funding Source: Medline; NICHD NIH HHS [P30 HD018655, P30 HD 18655] Funding Source: Medline; NIDCD NIH HHS [DC00162, DC05524] Funding Source: Medline; NIMH NIH HHS [MH60233] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008313, R01EY015311, R01EY015298, R01EY013583, R01EY012498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060233, R37MH060233, R56MH060233] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; BOSLEY TM, UNPUB; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Camurri L, 2004, GENE EXPR PATTERNS, V4, P99, DOI 10.1016/S1567-133X(03)00142-X; DEMER JL, UNPUB; DRETAKIS EK, 1974, J BONE JOINT SURG AM, VA 56, P1747, DOI 10.2106/00004623-197456080-00034; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Jen J, 2002, NEUROLOGY, V59, P432, DOI 10.1212/WNL.59.3.432; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KUYPERS HGJ, 1982, BRAIN STEM CONTROL S, P29; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; Lanza F, 2002, BRIT J HAEMATOL, V118, P260, DOI 10.1046/j.1365-2141.2002.03544.x; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LESSER RP, 1987, NEUROLOGY, V37, P82, DOI 10.1212/WNL.37.1.82; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Pieh C, 2002, NEUROLOGY, V59, P462, DOI 10.1212/WNL.59.3.462; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SHARPE JA, 1975, NEUROLOGY, V25, P1035, DOI 10.1212/WNL.25.11.1035; Steffen H, 1998, NEUROPEDIATRICS, V29, P220, DOI 10.1055/s-2007-973565; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; YEE RD, 1982, ARCH OPHTHALMOL-CHIC, V100, P1449; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141	28	264	269	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2004	304	5676					1509	1513		10.1126/science.1096437	http://dx.doi.org/10.1126/science.1096437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825YR	15105459	Green Accepted			2022-12-28	WOS:000221795800047
J	Frank, MH; Sayegh, MH				Frank, MH; Sayegh, MH			Immunomodulatory functions of mesenchymal stem cells	LANCET			English	Editorial Material							T-CELLS; INDUCTION; IL-10		Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Sayegh, MH (corresponding author), Brigham & Womens Hosp, Transplantat Res Ctr, 75 Francis St, Boston, MA 02115 USA.	msayegh@rics.bwh.harvard.edu	Frank, Markus/O-1625-2014	Frank, Markus/0000-0002-1312-0488; Sayegh, Mohamed/0000-0002-2847-588X	NIAID NIH HHS [K08 AI050783, K08 AI050783-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050783] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZM, 2003, BLOOD, V101, P5076, DOI 10.1182/blood-2002-09-2798; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Frassoni F, 2002, BONE MARROW TRANSPL, V29, pS2; Gurevitch O, 1999, TRANSPLANTATION, V68, P1362, DOI 10.1097/00007890-199911150-00024; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rothstein DM, 2003, IMMUNOL REV, V196, P85, DOI 10.1046/j.1600-065X.2003.00088.x; Zeller JC, 1999, J IMMUNOL, V163, P3684	12	58	76	2	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1411	1412		10.1016/S0140-6736(04)16134-5	http://dx.doi.org/10.1016/S0140-6736(04)16134-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121399				2022-12-28	WOS:000221130300003
J	Yekta, S; Shih, IH; Bartel, DP				Yekta, S; Shih, IH; Bartel, DP			MicroRNA-directed cleavage of HOXB8 mRNA	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; GENES; TRANSLATION; INITIATION; TARGETS; INHIBIT; MIRNA; TIME	MicroRNAs (miRNAs) are endogenous similar to22-nucleotide RNAs, some of which are known to play important regulatory roles in animals by targeting the messages of protein-coding genes for translational repression. We find that miR-196, a miRNA encoded at three paralogous locations in the A, B, and C mammalian HOX clusters, has extensive, evolutionarily conserved complementarity to messages of HOXB8, HOXC8, and HOXD8. RNA fragments diagnostic of miR-196-directed cleavage of HOXB8 were detected in mouse embryos. Cell culture experiments demonstrated down-regulation of HOXB8, HOXC8, HOXD8, and HOXA7 and supported the cleavage mechanism for miR-196-directed repression of HOXB8. These results point to a miRNA-mediated mechanism for the posttranscriptional restriction of HOX gene expression during vertebrate development and demonstrate that metazoan miRNAs can repress expression of their natural targets through mRNA cleavage in addition to inhibiting productive translation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; CHEN X, IN PRESS SCIENC 0731; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	24	1356	1517	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2004	304	5670					594	596		10.1126/science.1097434	http://dx.doi.org/10.1126/science.1097434			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814LB	15105502				2022-12-28	WOS:000220975100051
J	Perondi, MBM; Reis, AG; Paiva, EF; Nadkarni, VM; Berg, RA				Perondi, MBM; Reis, AG; Paiva, EF; Nadkarni, VM; Berg, RA			A comparison of high-dose and standard-dose epinephrine in children with cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEDIATRIC CARDIOPULMONARY-RESUSCITATION; CRITICALLY ILL CHILDREN; MYOCARDIAL PERFUSION; BLOOD-FLOW; SWINE MODEL; CPR; PHARMACOKINETICS; PRESSURE; TRIAL; DOGS	Background: When efforts to resuscitate a child after cardiac arrest are unsuccessful despite the administration of an initial dose of epinephrine, it is unclear whether the next dose of epinephrine (i.e., the rescue dose) should be the same (standard) dose or a higher dose. Methods: We performed a prospective, randomized, double-blind trial to compare high-dose epinephrine (0.1 mg per kilogram of body weight) with standard-dose epinephrine (0.01 mg per kilogram) as rescue therapy for in-hospital cardiac arrest in children after failure of an initial, standard dose of epinephrine. The trial included 68 children, and Utstein-style reporting guidelines were used. The primary outcome measure was survival 24 hours after the arrest. Results: The rate of survival at 24 hours was lower in the group assigned to a high dose of epinephrine as rescue therapy than in the group assigned to a standard dose: 1 of the 34 patients in the high-dose group survived for 24 hours, as compared with 7 of the 34 patients in the standard-dose group (unadjusted odds ratio for death with the high dose, 8.6; 97.5 percent confidence interval, 1.0 to 397.0; P=0.05). After adjustment by multiple logistic-regression analysis for differences in the groups at the time of arrest, the high-dose group tended to have a lower 24-hour survival rate (odds ratio for death, 7.9; 97.5 percent confidence interval, 0.9 to 72.5; P=0.08). The two treatment groups did not differ significantly in terms of the rate of return of spontaneous circulation (which occurred in 20 patients in the high-dose group and 21 of those in the standard-dose group; odds ratio, 1.1; 97.5 percent confidence interval, 0.4 to 3.0). None of the patients in the high-dose group, as compared with four of those in the standard-dose group, survived to hospital discharge. Among the 30 patients whose cardiac arrest was precipitated by asphyxia, none of the 12 who were assigned to high-dose epinephrine were alive at 24 hours, as compared with 7 of the 18 who were assigned to a standard dose (P=0.02). Conclusions: We did not find any benefit of high-dose epinephrine rescue therapy for in-hospital cardiac arrest in children after failure of an initial standard dose of epinephrine. The data suggest that high-dose therapy may be worse than standard-dose therapy.	Univ Sao Paulo, Sch Med, Childrens Inst, Dept Pediat, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; Univ Penn, Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Arizona, Coll Med, Steele Mem Childrens Res Ctr, Tucson, AZ USA; Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Arizona; University of Arizona	Berg, RA (corresponding author), 1501 N Campbell Ave,POB 245073, Tucson, AZ 85724 USA.	rberg@peds.arizona.edu	Paiva, Edison F/H-8225-2015; Paiva, Edison F/J-7106-2014					[Anonymous], 1992, JAMA, V268, P2262; Behringer W, 1998, ANN INTERN MED, V129, P450, DOI 10.7326/0003-4819-129-6-199809150-00004; Berg RA, 1997, CIRCULATION, V96, P4364; Berg RA, 1996, CRIT CARE MED, V24, P1695, DOI 10.1097/00003246-199610000-00016; BERG RA, 1993, J PHARMACOL EXP THER, V265, P1232; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; BERG RA, 1993, CRIT CARE MED, V21, P678, DOI 10.1097/00003246-199305000-00010; BROWN CG, 1987, CIRCULATION, V75, P491, DOI 10.1161/01.CIR.75.2.491; BROWN CG, 1992, NEW ENGL J MED, V327, P1051, DOI 10.1056/NEJM199210083271503; BROWN CG, 1986, ANN EMERG MED, V15, P1138, DOI 10.1016/S0196-0644(86)80853-8; CALLAHAM M, 1992, JAMA-J AM MED ASSOC, V268, P2667, DOI 10.1001/jama.268.19.2667; Carpenter TC, 1997, PEDIATRICS, V99, P403, DOI 10.1542/peds.99.3.403; Chameides L, 1997, PEDIAT ADV LIFE SUPP; CHASE PB, 1993, CRIT CARE MED, V21, P413, DOI 10.1097/00003246-199303000-00020; CHOUX C, 1995, RESUSCITATION, V29, P3, DOI 10.1016/0300-9572(94)00810-3; DIECKMANN RA, 1995, PEDIATRICS, V95, P901; DITCHEY RV, 1994, AM HEART J, V127, P324, DOI 10.1016/0002-8703(94)90120-1; DITCHEY RV, 1988, CIRCULATION, V78, P382, DOI 10.1161/01.CIR.78.2.382; Fish SS, 1999, EMERG MED CLIN N AM, V17, P461, DOI 10.1016/S0733-8627(05)70072-9; FISHER DG, 1993, CRIT CARE MED, V21, P111, DOI 10.1097/00003246-199301000-00021; GOETTING MG, 1991, ANN EMERG MED, V20, P22, DOI 10.1016/S0196-0644(05)81112-6; GONZALEZ ER, 1989, ANN EMERG MED, V18, P920, DOI 10.1016/S0196-0644(89)80453-6; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Hornchen U, 1993, J Cardiothorac Vasc Anesth, V7, P184, DOI 10.1016/1053-0770(93)90214-6; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; KOEHLER RC, 1985, ANN EMERG MED, V14, P744, DOI 10.1016/S0196-0644(85)80050-0; LINDNER KH, 1991, ACTA ANAESTH SCAND, V35, P253, DOI 10.1111/j.1399-6576.1991.tb03283.x; LIPMAN J, 1993, ANAESTH INTENS CARE, V21, P192, DOI 10.1177/0310057X9302100210; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; PARADIS NA, 1991, JAMA-J AM MED ASSOC, V265, P1139, DOI 10.1001/jama.265.9.1139; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; SANDERS AB, 1984, CRIT CARE MED, V12, P871, DOI 10.1097/00003246-198410000-00007; Sherman BW, 1997, PHARMACOTHERAPY, V17, P242; STIELL IG, 1992, NEW ENGL J MED, V327, P1045, DOI 10.1056/NEJM199210083271502; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Torres A, 1997, PEDIATR EMERG CARE, V13, P369, DOI 10.1097/00006565-199712000-00002; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; 2000, CIRCULATION S1, V102, P291	40	182	189	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1722	1730		10.1056/NEJMoa032440	http://dx.doi.org/10.1056/NEJMoa032440			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102998				2022-12-28	WOS:000220947300006
J	Tudosa, I; Stamm, C; Kashuba, AB; King, F; Siegmann, HC; Stohr, J; Ju, G; Lu, B; Weller, D				Tudosa, I; Stamm, C; Kashuba, AB; King, F; Siegmann, HC; Stohr, J; Ju, G; Lu, B; Weller, D			The ultimate speed of magnetic switching in granular recording media	NATURE			English	Article							FIELD PULSES; REVERSAL	In magnetic memory devices, logical bits are recorded by selectively setting the magnetization vector of individual magnetic domains either 'up' or 'down'. In such devices, the fastest and most efficient recording method involves precessional switching(1-4): when a magnetic field B-p is applied as a write pulse over a period tau, the magnetization vector precesses about the field until B(p)tau reaches the threshold value at which switching occurs. Increasing the amplitude of the write pulse B-p might therefore substantially shorten the required switching time tau and allow for faster magnetic recording. Here we use very short pulses of a very high magnetic field(5) to show that under these extreme conditions, precessional switching in magnetic media supporting high bit densities no longer takes place at well-defined field strengths; instead, switching occurs randomly within a wide range of magnetic fields. We attribute this behaviour to a momentary collapse of the ferromagnetic order of the spins under the load of the short and high-field pulse, thus establishing an ultimate limit to the speed of deterministic switching and magnetic recording.	Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; LD Landau Theoret Phys Inst, Moscow 117940, Russia; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford, CA 94309 USA; Seagate Technol LLC, Pittsburgh, PA 15222 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Russian Academy of Sciences; Landau Institute for Theoretical Physics; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Seagate Technology	Stohr, J (corresponding author), Stanford Synchrotron Radiat Lab, POB 20450, Stanford, CA 94309 USA.	stohr@slac.stanford.edu	Ju, Ganping/AAB-1161-2021; TUDOSA, IOAN/D-3846-2013; Stamm, Christian/G-4814-2013	Ju, Ganping/0000-0002-3909-680X; TUDOSA, IOAN/0000-0002-5127-578X; Stamm, Christian/0000-0001-5611-9084				Back CH, 1998, PHYS REV LETT, V81, P3251, DOI 10.1103/PhysRevLett.81.3251; EBELS U, 2002, SPIN DYNAMICS CONFIN, V1, P178; Gerrits T, 2002, NATURE, V418, P509, DOI 10.1038/nature00905; Hiebert WK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.140404; Hillebrands B., 2002, SPIN DYNAMICS CONFIN; Kaka S, 2002, APPL PHYS LETT, V80, P2958, DOI 10.1063/1.1470704; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Lu B, 2003, J APPL PHYS, V93, P6751, DOI 10.1063/1.1557715; Rhie HS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.247201; Safonov VL, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094419; Schumacher HW, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.017201; SIEGMANN HC, 1995, J MAGN MAGN MATER, V151, pL8, DOI 10.1016/0304-8853(95)00602-8; Urazhdin S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146803; Weller D, 1999, IEEE T MAGN, V35, P4423, DOI 10.1109/20.809134	14	218	219	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2004	428	6985					831	833		10.1038/nature02438	http://dx.doi.org/10.1038/nature02438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103370				2022-12-28	WOS:000220952300033
J	Selkoe, DJ				Selkoe, DJ			Alzheimer disease: Mechanistic understanding predicts novel therapies	ANNALS OF INTERNAL MEDICINE			English	Review							AMYLOID-PRECURSOR-PROTEIN; PAIRED HELICAL FILAMENTS; CENTRAL-NERVOUS-SYSTEM; BETA-PROTEIN; GAMMA-SECRETASE; APOLIPOPROTEIN-E; MOUSE MODEL; TRANSGENIC MICE; SENILE PLAQUES; IN-VIVO		Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur,HIM 730, Boston, MA 02115 USA.							Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Berezovska O, 2001, J BIOL CHEM, V276, P30018, DOI 10.1074/jbc.M008268200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARRIS ME, 1995, EXP NEUROL, V131, P193, DOI 10.1016/0014-4886(95)90041-1; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jain KK, 2000, EXPERT OPIN INV DRUG, V9, P1397, DOI 10.1517/13543784.9.6.1397; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mann DMA, 1996, ANN NEUROL, V40, P149, DOI 10.1002/ana.410400205; Markesbery WR, 1999, ARCH NEUROL-CHICAGO, V56, P1449, DOI 10.1001/archneur.56.12.1449; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mayeux R, 1999, NEW ENGL J MED, V341, P1670, DOI 10.1056/NEJM199911253412207; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Price DL, 2000, ANN NY ACAD SCI, V920, P179; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; *SELKOE DJ, 2003, ANN M SOC NEUR NEW O; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VERBEEK MM, 2000, CEREBRAL AMYLOID ANG, P357; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zajaczkowski W, 1999, NEUROTOX RES, V1, DOI 10.1007/BF03033259; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	92	332	363	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2004	140	8					627	638		10.7326/0003-4819-140-8-200404200-00047	http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00047			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812PP	15096334				2022-12-28	WOS:000220851700006
J	van Leth, F; Phanuphak, P; Ruxrungtham, K; Baraldi, E; Miller, S; Gazzard, B; Cahn, P; Lalloo, UG; van der Westhuizen, IP; Malan, DR; Johnson, MA; Santos, BR; Mulcahy, F; Wood, R; Levi, GC; Reboredo, G; Squires, K; Cassetti, I; Petit, D; Raffi, F; Katlama, C; Murphy, RL; Horban, A; Dam, JP; Hassink, E; van Leeuwen, R; Robinson, P; Wit, FW; Lange, JMA				van Leth, F; Phanuphak, P; Ruxrungtham, K; Baraldi, E; Miller, S; Gazzard, B; Cahn, P; Lalloo, UG; van der Westhuizen, IP; Malan, DR; Johnson, MA; Santos, BR; Mulcahy, F; Wood, R; Levi, GC; Reboredo, G; Squires, K; Cassetti, I; Petit, D; Raffi, F; Katlama, C; Murphy, RL; Horban, A; Dam, JP; Hassink, E; van Leeuwen, R; Robinson, P; Wit, FW; Lange, JMA		2NN Study Team	Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study	LANCET			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; STEADY-STATE PHARMACOKINETICS; COMBINATION THERAPY; HIV-1-INFECTED INDIVIDUALS; PROTEASE INHIBITOR; NAIVE PATIENTS; HEPATITIS-B; DIDANOSINE; COHORT	Background The 2NN Study was a randomised comparison of the non-nucleoside reverse-transcriptase inhibitors (NNRTI) nevirapine and efavirenz. Methods In this multicentre, open-label, randomised trial, 1216 antiretroviral-therapy-naive patients were assigned nevirapine 400 mg once daily, nevirapine 200 mg twice daily, efavirenz 600 mg once daily, or nevirapine (400 mg) and efavirenz (800 mg) once daily, plus stavudine and lamivudine, for 48 weeks. The primary endpoint was the proportion of patients with treatment failure (less than 1 log(10) decline in plasma. HIV-1 RNA in the first 12 weeks or two consecutive measurements of more than 50 copies per mL from week 24 onwards, disease progression [new Centers for Disease Control and Prevention grade C event or death], or change of allocated treatment). Analyses were by intention to treat. Findings Treatment failure occurred in 96 (43.6%) of 220 patients assigned nevirapine once daily, 169 (43.7%) of 387 assigned nevirapine twice daily, 151 (37.8%) of 400 assigned efavirenz, and 111 (53.1%) of 209 assigned nevirapine plus efavirenz. The difference between nevirapine twice daily and efavirenz was 5.9% (95% CI -0.9 to 12.8). There were no significant differences among the study groups in the proportions with plasma HIV-1 RNA concentrations below 50 copies per mL at week 48 (p=0.193) or the increases in CD4-positive cells (p=0.800). Nevirapine plus efavirenz was associated with the highest frequency of clinical adverse events, and nevirapine once daily with significantly more hepatobiliary laboratory toxicities than efavirenz. Of 25 observed deaths, two were attributed to nevirapine. Interpretation Antiretroviral therapy with nevirapine or efavirenz showed similar efficacy, so triple-drug regimens with either NNRTI are valid for first-line treatment. There are, however, differences in safety profiles. Combination of nevirapine and efavirenz did not improve efficacy but caused more adverse events.	Univ Amsterdam, Acad Med Ctr, Int Antiviral Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands; Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; Chulalongkorn Univ, Bangkok, Thailand; Embassy Dr Med Ctr, Pretoria, South Africa; Innovir Inst, Johannesburg, South Africa; Chelsea & Westminster Hosp, London, England; Fdn Huesped, Buenos Aires, DF, Argentina; Univ Natal, Nelson R Mandela Sch Med, Natal, South Africa; Royal Free Hosp, London NW3 2QG, England; Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; St James Hosp, Dublin 8, Ireland; Somerset Hosp, Cape Town, South Africa; Univ Cape Town, ZA-7925 Cape Town, South Africa; Inst Infectol Emilio Ribas, Sao Paulo, Brazil; Hosp Clin Buenos Aires, Buenos Aires, DF, Argentina; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; FUNCEI, Buenos Aires, DF, Argentina; Listowell RD Woodstock, Cape Town, South Africa; Univ Hosp Nantes, Nantes, France; Hop La Pitie Salpetriere, Paris, France; Northwestern Univ, Chicago, IL 60611 USA; Wojewodzki Szpital Zakazny, Warsaw, Poland; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	University of Amsterdam; Academic Medical Center Amsterdam; Thai Red Cross Society; Chulalongkorn University; Imperial College London; University of Kwazulu Natal; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Trinity College Dublin; University of Cape Town; University of Buenos Aires; University of Southern California; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Northwestern University; Boehringer Ingelheim	Lange, JMA (corresponding author), Univ Amsterdam, Acad Med Ctr, Int Antiviral Therapy Evaluat Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.lange@amc.uva.nl	Wit, Ferdinand/AAC-3803-2019; baraldi, eugenio/AAC-5233-2022; Wood, Robin/G-8509-2011	van Leth, Frank/0000-0002-5490-8968; Murphy, Robert/0000-0003-3936-2052				*AIDS CLIN TRIAL G, 1996, TABL GRAD SEV AD ADV; Albrecht MA, 2001, NEW ENGL J MED, V345, P398, DOI 10.1056/NEJM200108093450602; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bissell DM, 2001, HEPATOLOGY, V33, P1009, DOI 10.1053/jhep.2001.23505; Cozzi-Lepri A, 2002, J INFECT DIS, V185, P1062, DOI 10.1086/339821; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; DOLAN P A, 1989, Journal of Emergency Medicine, V7, P65, DOI 10.1016/0736-4679(89)90412-5; Flandre P, 2002, ANTIVIR THER, V7, P113; Friedl AC, 2001, AIDS, V15, P1793, DOI 10.1097/00002030-200109280-00008; Garcia F, 2000, AIDS, V14, P2485, DOI 10.1097/00002030-200011100-00010; Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7; HAVLIR D, 1995, J INFECT DIS, V171, P537, DOI 10.1093/infdis/171.3.537; Keiser Philip, 2002, HIV Clin Trials, V3, P296; King RW, 2002, ANTIMICROB AGENTS CH, V46, P1640, DOI 10.1128/AAC.46.6.1640-1646.2002; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Kollmann C, 2001, ANTIVIR THER, V6, P143; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; MATTHEWS G, 2003, 9 ANN C BRIT HIV ASS; Matthews GV, 2002, AIDS, V16, P53, DOI 10.1097/00002030-200201040-00008; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Nunez Marina, 2002, HIV Clin Trials, V3, P186; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; Podzamczer D, 2002, ANTIVIR THER, V7, P81; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Raboud JM, 1999, J ACQ IMMUN DEF SYND, V22, P260; Raffi F, 2000, ANTIVIR THER, V5, P267; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Schiodt Frank Vinholt, 2003, Clin Liver Dis, V7, P331; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; van Heeswijk RPG, 2000, AIDS, V14, pF77, DOI 10.1097/00002030-200005260-00001; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; Veldkamp AI, 2001, J INFECT DIS, V184, P37, DOI 10.1086/320998; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003	35	550	562	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2004	363	9417					1253	1263		10.1016/S0140-6736(04)15997-7	http://dx.doi.org/10.1016/S0140-6736(04)15997-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094269				2022-12-28	WOS:000220904900006
J	Killworth, PD				Killworth, PD			Comment on "Oceanic Rossby waves acting as a 'hay rake' for ecosystem floating by-products"	SCIENCE			English	Editorial Material							TRAJECTORIES; PROPAGATION; FIELDS		Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Killworth, PD (corresponding author), Southampton Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.							Chelton DB, 1996, SCIENCE, V272, P234, DOI 10.1126/science.272.5259.234; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Cipollini P, 1997, GEOPHYS RES LETT, V24, P889, DOI 10.1029/97GL00758; COX SM, 1990, J FLUID MECH, V214, P517, DOI 10.1017/S0022112090000246; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; de Vries P, 2001, J ATMOS OCEAN TECH, V18, P1092; DEWAR WK, 1985, DYNAM ATMOS OCEANS, V9, P215, DOI 10.1016/0377-0265(85)90021-1; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Fu L -L, 2001, SATELLITE ALTIMETRY, P133; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Killworth PD, 1997, J PHYS OCEANOGR, V27, P1946, DOI 10.1175/1520-0485(1997)027<1946:TSOOAT>2.0.CO;2; Killworth PD, 2003, J PHYS OCEANOGR, V33, P784, DOI 10.1175/1520-0485(2003)33<784:LEPWPI>2.0.CO;2; KILLWORTH PD, UNPUB J GEOPHYS RES; Robinson AR, 1997, P ROY SOC A-MATH PHY, V453, P2295, DOI 10.1098/rspa.1997.0123; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659	15	13	13	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087530				2022-12-28	WOS:000220845400025
J	Genuis, SJ; Genuis, SK				Genuis, SJ; Genuis, SK			Partner reduction is crucial for balanced "ABC" approach to FRV prevention - Commentary: adolescent behaviour should be priority	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Genuis, SJ (corresponding author), 2935-66 St, Edmonton, AB T6K 4C1, Canada.	sgenuis@ualberta.ca						Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P856; Dehne KL, 2001, REPROD HEALTH MATTER, V9, P170, DOI 10.1016/S0968-8080(01)90021-7; HOGLE JA, 2002, WHAT HAPPENED UGANDA; KAY LE, 1995, POSTGRAD MED, V97, P121, DOI 10.1080/00325481.1995.11946008; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Santelli JS, 1998, FAM PLANN PERSPECT, V30, P271, DOI 10.2307/2991502	6	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					894	894		10.1136/bmj.328.7444.894	http://dx.doi.org/10.1136/bmj.328.7444.894			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073077	Green Published			2022-12-28	WOS:000220871400027
J	Parmar, MS				Parmar, MS			Lesson of the week - Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DRUG		Timmins & Dist Hosp, Dept Internal Med, Timmins, ON P4N 8R1, Canada		Parmar, MS (corresponding author), 108,707 Ross Ave E, Timmins, ON P4N 8R1, Canada.	atbeat@ntl.sympatico.ca	Parmar, Malvinder S/Q-1532-2019	Parmar, Malvinder S/0000-0003-3182-0530				Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Haviv YS, 2000, RENAL FAILURE, V22, P219, DOI 10.1081/JDI-100100866; MANN JFE, 1993, CLIN NEPHROL, V39, P1; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; Parmar MS, 2002, BMJ-BRIT MED J, V325, P85, DOI 10.1136/bmj.325.7355.85; SHERWIN RS, 2000, CECIL TXB MED, P1279; Venturini CM, 1998, CURR OPIN NEPHROL HY, V7, P79, DOI 10.1097/00041552-199801000-00013; WEINRAUCH LA, 1978, ARCH INTERN MED, V138, P399, DOI 10.1001/archinte.138.3.399	8	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2004	328	7444					883	884		10.1136/bmj.328.7444.883	http://dx.doi.org/10.1136/bmj.328.7444.883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812XE	15073073	Green Published, Green Submitted			2022-12-28	WOS:000220871400021
J	Budrovic, Z; Van Swygenhoven, H; Derlet, PM; Van Petegem, S; Schmitt, B				Budrovic, Z; Van Swygenhoven, H; Derlet, PM; Van Petegem, S; Schmitt, B			Plastic deformation with reversible peak broadening in nanocrystalline nickel	SCIENCE			English	Article							GRAIN-BOUNDARIES; X-RAY; NI; MECHANISM; SURFACES; BEHAVIOR; SIZE	Plastic deformation in coarse-grained metals is governed by dislocation-mediated processes. These processes lead to the accumulation of a residual dislocation network, producing inhomogeneous strain and an irreversible broadening of the Bragg peaks in x-ray diffraction. We show that during plastic deformation of electrodeposited nanocrystalline nickel, the peak broadening is reversible upon unloading; hence, the deformation process does not build up a residual dislocation network. The results were obtained during in situ peak pro. le analysis using the Swiss Light Source. This in situ technique, based on well-known peak pro. le analysis methods, can be used to address the relationship between microstructure and mechanical properties in nanostructured materials.	Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Budrovic, Z (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.		Van Petegem, Steven/D-5908-2014; Van Petegem, Steven/E-9807-2016; Schmitt, Bernd/H-9365-2013; Van Swygenhoven, Helena/GZL-0225-2022; Van Petegem, Steven/AAQ-8248-2021	Van Petegem, Steven/0000-0002-3015-7725; Schmitt, Bernd/0000-0002-5778-0680; Van Petegem, Steven/0000-0002-3015-7725				Barabash R, 2001, MAT SCI ENG A-STRUCT, V309, P49, DOI 10.1016/S0921-5093(00)01663-4; Champion Y, 2003, SCIENCE, V300, P310, DOI 10.1126/science.1081042; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; Dalla Torre F, 2002, ACTA MATER, V50, P3957, DOI 10.1016/S1359-6454(02)00198-2; Derlet PM, 2003, SCRIPTA MATER, V49, P629, DOI 10.1016/S1359-6462(03)00400-7; Derlet PM, 2002, PHILOS MAG A, V82, P1, DOI 10.1080/01418610110058310; Hasnaoui A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.184112; Hasnaoui A, 2003, SCIENCE, V300, P1550, DOI 10.1126/science.1084284; Hasnaoui A, 2002, ACTA MATER, V50, P3927, DOI 10.1016/S1359-6454(02)00195-7; Hugo RC, 2003, ACTA MATER, V51, P1937, DOI 10.1016/S1359-6454(02)00599-2; Jia D, 2001, APPL PHYS LETT, V79, P611, DOI 10.1063/1.1384000; Klug H.P., 1974, XRAY DIFFRACTION PRO; Krivoglaz M. A., 1983, XRAY NEUTRON DIFFRAC; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Legros M, 2000, PHILOS MAG A, V80, P1017, DOI 10.1080/01418610008212096; MCFADDEN SX, 2001, MRS S SER, V634; MUGHRABI H, 1991, MAT SCI TECHNOLOGY, V6, P1; Reimann K, 1997, J APPL PHYS, V81, P7186, DOI 10.1063/1.365307; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Ungar T, 1998, J APPL CRYSTALLOGR, V31, P554, DOI 10.1107/S0021889897019559; Ungar T, 2001, J APPL CRYSTALLOGR, V34, P298, DOI 10.1107/S0021889801003715; van Swygenhoven H, 2003, Z METALLKD, V94, P1106, DOI 10.3139/146.031106; Van Swygenhoven H, 2002, SCIENCE, V296, P66; Van Swygenhoven H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024101; Van Swygenhoven H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.224105; Wang YM, 2004, ACTA MATER, V52, P1699, DOI 10.1016/j.actamat.2003.12.022; Weertman JR, 2002, MECH BEHAV NANOCRYST; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	29	426	445	1	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					273	276		10.1126/science.1095071	http://dx.doi.org/10.1126/science.1095071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073373				2022-12-28	WOS:000220719400041
J	Hauert, C; Doebeli, M				Hauert, C; Doebeli, M			Spatial structure often inhibits the evolution of cooperation in the snowdrift game	NATURE			English	Article							PRISONERS-DILEMMA; POPULATION; ALTRUISM	Understanding the emergence of cooperation is a fundamental problem in evolutionary biology(1). Evolutionary game theory(2,3) has become a powerful framework with which to investigate this problem. Two simple games have attracted most attention in theoretical and experimental studies: the Prisoner's Dilemma(4) and the snowdrift game (also known as the hawk-dove or chicken game)(5). In the Prisoner's Dilemma, the non-cooperative state is evolutionarily stable, which has inspired numerous investigations of suitable extensions that enable cooperative behaviour to persist. In particular, on the basis of spatial extensions of the Prisoner's Dilemma, it is widely accepted that spatial structure promotes the evolution of cooperation(6-8). Here we show that no such general predictions can be made for the effects of spatial structure in the snowdrift game. In unstructured snowdrift games, intermediate levels of cooperation persist. Unexpectedly, spatial structure reduces the proportion of cooperators for a wide range of parameters. In particular, spatial structure eliminates cooperation if the cost-to-benefit ratio of cooperation is high. Our results caution against the common belief that spatial structure is necessarily beneficial for cooperative behaviour.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Hauert, C (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	hauert@zoology.ubc.ca	Hauert, Christoph/E-5369-2011; Doebeli, Michael/D-5391-2012	Hauert, Christoph/0000-0002-1239-281X; 				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Doebeli M, 1998, P NATL ACAD SCI USA, V95, P8676, DOI 10.1073/pnas.95.15.8676; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hauert C, 2001, P ROY SOC B-BIOL SCI, V268, P761, DOI 10.1098/rspb.2000.1424; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; MATSUDA H, 1992, PROG THEOR PHYS, V88, P1035, DOI 10.1143/PTP.88.1035; Maynard Smith J., 1982, pi; Milinski M, 1997, P ROY SOC B-BIOL SCI, V264, P831, DOI 10.1098/rspb.1997.0116; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sugden R, 1986, EC RIGHTS COOPERATIO; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szathmary E, 1995, MAJOR TRANSITIONS EV; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON PF, 1976, ANIM BEHAV, V24, P756, DOI 10.1016/S0003-3472(76)80004-8; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	29	1057	1097	9	232	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2004	428	6983					643	646		10.1038/nature02360	http://dx.doi.org/10.1038/nature02360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810IE	15074318				2022-12-28	WOS:000220697200041
J	James, J; Thomas, P; Cavan, D; Kerr, D				James, J; Thomas, P; Cavan, D; Kerr, D			Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERVENTION; CHILDREN	Objective To determine if a school based educational programme aimed at reducing consumption of carbonated drinks can prevent excessive weight gain in children. Design Cluster randomised controlled trial. Setting Six primary schools in south west England. Participants 644 children aged 7-11 years. Intervention Focused educational programme on nutrition over one school year. Main outcome measures Drink consumption and number of overweight and obese children. Results Consumption of carbonated drinks over three days decreased by 0.6 glasses (average glass size 250 ml) in the intervention group but increased by 0.2 glasses in the control group (mean difference 0.7, 95% confidence interval 0.1 to 1.3). At 12 months the percentage of over-weight and obese children increased in the control group by 7.6%, compared with a decrease in the intervention group of 0.2% (mean difference 7.7%,2.2% to 13.1%). Conclusion A targeted, school based education programme produced a modest reduction in the number of carbonated drinks consumed, which was associated with a reduction in the number of overweight and obese children.	Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England; Bournemouth Univ, Inst Hlth & Community Studies, Poole BH12 5BB, Dorset, England; Poole Hosp, Dorset Res & Dev Unit, Poole, Dorset, England	Bournemouth University; Poole Hospital	James, J (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.	janet.james@rbch-tr.swest.nhs.uk	James, Janet/F-9995-2019	James, Janet/0000-0002-9308-6362; Thomas, Peter/0000-0003-2478-4324				Atkinson RL, 2001, BRIT MED J, V323, P1018, DOI 10.1136/bmj.323.7320.1018; Bates CJ, 2000, NATL DIET NUTR SURVE; Butte NF, 2003, SCIENCE, V301; Campisi J, 2001, ADV CELL AGING GERON, V4, P1; *CHILD GROWTH FDN, 2002, BOYS GIRLS WAIST CIR; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Donner A, 2000, DESIGN ANAL CLUSTER, P6; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Goran MI, 2001, AM J CLIN NUTR, V73, P158; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; JAMES J, 2002, DIABETES PRIMARY CAR, V4, P75; Kapp C, 2003, LANCET, V361, P1707, DOI 10.1016/S0140-6736(03)13382-X; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; MATAYKA K, 2002, OBES PRAC, V4, P2; *NHS CTR REV DISS, 2002, EFF HLTH CAR PREV TR, V7; Sahota P, 2001, BRIT MED J, V323, P1027, DOI 10.1136/bmj.323.7320.1027; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; *U YORK NHS CTR RE, 2002, EFF HLTH CAR PREV TR, V7; Ukoumunne OC, 2002, STAT MED, V21, P3757, DOI 10.1002/sim.1330; Who J, 2003, WHO TECH REP SER, V916; World Health Organization, 2003, WHO TECHN REP SER, P916	27	528	537	2	92	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2004	328	7450					1237	1239		10.1136/bmj.38077.458438.EE	http://dx.doi.org/10.1136/bmj.38077.458438.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HL	15107313	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000221677200025
J	Spiegel, W; Maier, H; Maier, M				Spiegel, W; Maier, H; Maier, M			A non-infectious airborne disease	LANCET			English	Editorial Material							PROCESSIONARY CATERPILLAR		Med Univ Vienna, Dept Gen Practice, Inst Med Educ, A-1090 Vienna, Austria; Med Univ Vienna, Div Special & Environm Dermatol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Spiegel, W (corresponding author), Med Univ Vienna, Dept Gen Practice, Inst Med Educ, A-1090 Vienna, Austria.	spiwo@aon.at						Maier H, 2003, BRIT J DERMATOL, V149, P990, DOI 10.1111/j.1365-2133.2003.05673.x; MAKSYMOV J. K., 1978, FORSTSCHADLINGE EURO, P391; MOLNAR M, 1992, DAIRY S FREUD 1929 1, P96; Vega JM, 2003, ALLERGY, V58, P87, DOI 10.1034/j.1398-9995.2003.23710_4.x; WERNO J, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91989-Y	5	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2004	363	9419					1438	1438		10.1016/S0140-6736(04)16103-5	http://dx.doi.org/10.1016/S0140-6736(04)16103-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816ST	15121407				2022-12-28	WOS:000221130300011
J	Artsimovitch, I; Patlan, V; Sekine, SI; Vassylyeva, MN; Hosaka, T; Ochi, K; Yokoyama, S; Vassylyev, DG				Artsimovitch, I; Patlan, V; Sekine, SI; Vassylyeva, MN; Hosaka, T; Ochi, K; Yokoyama, S; Vassylyev, DG			Structural basis for transcription regulation by alarmone ppGpp	CELL			English	Article							COLI RNA-POLYMERASE; 3.3 ANGSTROM RESOLUTION; ELECTRON-DENSITY MAPS; GROWTH-RATE CONTROL; ESCHERICHIA-COLI; STRINGENT CONTROL; CRYSTAL-STRUCTURE; ELONGATION COMPLEX; IN-VITRO; PROMOTER	Guanosine-tetraphosphate (ppGpp) is a major regulator of stringent control, an adaptive response of bacteria to amino acid starvation. The 2.7 Angstrom resolution structure of the Thermus thermophilus RNA polymerase (RNAP) holoenzyme in complex with ppGpp reveals that ppGpp binds to the same site near the active center in both independent RNAP molecules in the crystal but in strikingly distinct orientations. Binding is symmetrical with respect to the two diphosphates of ppGpp and is relaxed with respect to the orientation of the nucleotide base. Different modes of ppGpp binding are coupled with asymmetry of the active site configurations. The results suggest that base pairing of ppGpp with cytosines in the nontemplate DNA strand might be an essential component of transcription control by ppGpp. We present experimental evidence highlighting the importance of base-specific contacts between ppGpp and specific cytosine residues during both transcription initiation and elongation.	RIKEN, Harima Inst SPring 8, Structurome Res Grp, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Cellular Signalling Lab, Sayo, Hyogo 6795148, Japan; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; University System of Ohio; Ohio State University; RIKEN; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; University of Tokyo	Yokoyama, S (corresponding author), RIKEN, Harima Inst SPring 8, Structurome Res Grp, 1-1-1 Kouto Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp; yumiyoshi@harima.riken.go.jp	Artsimovitch, Irina/L-3467-2019; Vassylyev, Dmitry/A-9005-2008; Sekine, Shun-ichi/N-5450-2015; Hosaka, Takeshi/AAV-9938-2020; Patlan, Vsevolod/K-1825-2013; Yokoyama, Shigeyuki/N-6911-2015	Sekine, Shun-ichi/0000-0001-8174-8704; Hosaka, Takeshi/0000-0002-2284-1308; Yokoyama, Shigeyuki/0000-0003-3133-7338	NIGMS NIH HHS [GM067153] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067153] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P653; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chatterji D, 1998, GENES CELLS, V3, P279, DOI 10.1046/j.1365-2443.1998.00190.x; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DaCosta XJ, 1997, J BACTERIOL, V179, P5211, DOI 10.1128/jb.179.16.5211-5217.1997; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Figueroa-Bossi N, 1998, EMBO J, V17, P2359, DOI 10.1093/emboj/17.8.2359; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jores L, 2003, J BIOL CHEM, V278, P16834, DOI 10.1074/jbc.M300196200; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krohn M, 1996, J BIOL CHEM, V271, P23884, DOI 10.1074/jbc.271.39.23884; LAMOND AI, 1985, CELL, V40, P319, DOI 10.1016/0092-8674(85)90146-1; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIZUSHIMASUGANO J, 1985, EMBO J, V4, P1053, DOI 10.1002/j.1460-2075.1985.tb03738.x; OKI T, 1975, BIOCHIM BIOPHYS ACTA, V410, P262, DOI 10.1016/0005-2744(75)90228-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JW, 2002, BIOCHEM BIOPH RES CO, V290, P1183, DOI 10.1006/bbrc.2001.6331; Potrykus K, 2002, J BIOL CHEM, V277, P43785, DOI 10.1074/jbc.M208768200; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Toulokhonov II, 2001, J BIOL CHEM, V276, P1220, DOI 10.1074/jbc.M007184200; TRAVERS AA, 1978, FEBS LETT, V94, P345, DOI 10.1016/0014-5793(78)80973-9; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Wagner R, 2002, J MOL MICROB BIOTECH, V4, P331; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; ZACHARIAS M, 1990, NUCLEIC ACIDS RES, V18, P6271, DOI 10.1093/nar/18.21.6271; ZACHARIAS M, 1989, EMBO J, V8, P3357, DOI 10.1002/j.1460-2075.1989.tb08498.x; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	49	221	235	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2004	117	3					299	310		10.1016/S0092-8674(04)00401-5	http://dx.doi.org/10.1016/S0092-8674(04)00401-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	817KM	15109491	Bronze			2022-12-28	WOS:000221176400005
J	Pfeffer, S; Zavolan, M; Grasser, FA; Chien, MC; Russo, JJ; Ju, JY; John, B; Enright, AJ; Marks, D; Sander, C; Tuschl, T				Pfeffer, S; Zavolan, M; Grasser, FA; Chien, MC; Russo, JJ; Ju, JY; John, B; Enright, AJ; Marks, D; Sander, C; Tuschl, T			Identification of virus-encoded microRNAs	SCIENCE			English	Article							HOMOLOG; SYSTEM; BCL-2; BHRF1	RNA silencing processes are guided by small RNAs that are derived from double-stranded RNA. To probe for function of RNA silencing during infection of human cells by a DNA virus, we recorded the small RNA profile of cells infected by Epstein-Barr virus (EBV). We show that EBV expresses several microRNA (miRNA) genes. Given that miRNAs function in RNA silencing pathways either by targeting messenger RNAs for degradation or by repressing translation, we identified viral regulators of host and/or viral gene expression.	Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Univ Klin Homburg, Inst Mikrobiol & Hyg, Abt Virol, D-66421 Homburg, Germany; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Rockefeller University; University of Basel; Universitatsklinikum des Saarlandes; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10021 USA.	ttuschl@rockefeller.edu	Pfeffer, Sébastien/H-3212-2019; Enright, Anton/F-3094-2011; Pfeffer, Sebastien/A-6512-2010; Zavolan, Mihaela/S-3888-2016; Sander, Chris/H-1452-2011	Pfeffer, Sébastien/0000-0002-8458-348X; Enright, Anton/0000-0002-6090-3100; Pfeffer, Sebastien/0000-0002-8458-348X; Sander, Chris/0000-0001-6059-6270; Zavolan, Mihaela/0000-0002-8832-2041	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068476] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM068476-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Enright AJ, 2004, GENOME BIOL, V5; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; KIEFF E, 2001, FIELDS VIROLOGY, P2511; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Middeldorp JM, 2003, CRIT REV ONCOL HEMAT, V45, P1, DOI 10.1016/S1040-8428(02)00078-1; Murray PG, 1996, BLOOD, V87, P706, DOI 10.1182/blood.V87.2.706.bloodjournal872706; OUDEJANS JJ, 1995, BLOOD, V86, P1893, DOI 10.1182/blood.V86.5.1893.bloodjournal8651893; TORSTEINSDOTTIR S, 1989, INT J CANCER, V43, P273, DOI 10.1002/ijc.2910430219; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; ZHANG CX, 1995, VIROLOGY, V208, P180, DOI 10.1006/viro.1995.1141	13	1200	1343	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2004	304	5671					734	736		10.1126/science.1096781	http://dx.doi.org/10.1126/science.1096781			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816JD	15118162				2022-12-28	WOS:000221105300045
J	Hujoel, PP; Bollen, AM; Noonan, CJ; del Aguila, MA				Hujoel, PP; Bollen, AM; Noonan, CJ; del Aguila, MA			Antepartum dental radiography and infant low birth weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE OUTCOMES; RADIATION-EXPOSURE; CHILDHOOD-CANCER; POOLED ANALYSIS; THYROID-CANCER; PREGNANCY; CHILDREN; AUTOANTIBODIES; ABNORMALITIES; EPIDEMIOLOGY	Context Both high- and low-dose radiation exposures in women have been associated with low-birth-weight offspring. It is unclear if radiation affects the hypothalamus-pituitary-thyroid axis and thereby indirectly birth weight, or if the radiation directly affects the reproductive organs. Objective To investigate whether antepartum dental radiography is associated with low-birth-weight offspring. Design A population-based case-control study. Participants and Setting Enrollees of a dental insurance plan with live singleton births in Washington State between January 1993 and December 2000. Cases were 1117 women with low-birth-weight infants (<2500 g), of whom 336 were term low-birth-weight infants (1501-2499 g and gestation &GE;37 weeks). Four control pregnancies resulting in normal-birth-weight infants (&GE;2500 g) were randomly selected for each case (n = 4468). Main Outcome Measures Odds of low birth weight and term low birth weight by dental radiographic dose during gestation. Results An exposure higher than 0.4 milligray (mGy) during gestation occurred in 21 (1.9%) mothers of low-birth-weight infants and, when compared with women who had no known dental radiography, was associated with an adjusted odds ratio (OR) for a low-birth-weight infant of 2.27 (95% confidence interval [CI], 1.11-4.66, P = .03). Exposure higher than 0.4 mGy occurred in 10 (3%) term low-birth-weight pregnancies and was associated with an adjusted OR for a term low-birth-weight infant of 3.61 (95% Cl, 1.46-8.92, P = .005). Conclusion Dental radiography during pregnancy is associated with low birth weight, specifically with term low birth weight.	Univ Washington, Dept Dent Publ Hlth Sci, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Orthodont, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Washington, Dept Gen Internal Med, Sch Med, Seattle, WA 98195 USA; Washington Dent Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hujoel, PP (corresponding author), Univ Washington, Dept Dent Publ Hlth Sci, Sch Dent, Box 357475, Seattle, WA 98195 USA.	hujoel@u.washington.edu	Bollen, Anne-Marie/ABC-4207-2021	Hujoel, Philippe/0000-0002-4040-104X				BANKVALL G, 1982, ORAL SURG ORAL MED O, V53, P532, DOI 10.1016/0030-4220(82)90472-8; Chang TC, 2001, INT J RADIAT BIOL, V77, P1117, DOI 10.1080/09553000110073420; Chiarelli AM, 2000, EPIDEMIOLOGY, V11, P161, DOI 10.1097/00001648-200003000-00013; Del Aguila MA, 2002, J AM DENT ASSOC, V133, P343, DOI 10.14219/jada.archive.2002.0174; Dietz PM, 1998, AM J EPIDEMIOL, V148, P1048; Gibbs S J, 1988, Dentomaxillofac Radiol, V17, P15; Gibbs S J, 1987, Dentomaxillofac Radiol, V16, P67; Gibbs S J, 1988, Dentomaxillofac Radiol, V17, P25; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; Goldberg MS, 1998, EPIDEMIOLOGY, V9, P271, DOI 10.1097/00001648-199805000-00010; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; Grossman CM, 1999, EPIDEMIOLOGY, V10, P202, DOI 10.1097/00001648-199903000-00024; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HAMILTON PM, 1984, PUBLIC HEALTH REP, V99, P146; Iijima T, 1997, OBSTET GYNECOL, V90, P364, DOI 10.1016/S0029-7844(97)00283-4; KESSNER DM, 1973, INFANT DEATH ANAL MA; Lazarus JH, 2002, THYROID, V12, P861, DOI 10.1089/105072502761016485; Longstreth WT, 2004, CANCER-AM CANCER SOC, V100, P1026, DOI 10.1002/cncr.20036; MATTESON S R, 1991, General Dentistry, V39, P264; MILLER RW, 1972, LANCET, V2, P784; Pacini F, 1998, LANCET, V352, P763, DOI 10.1016/S0140-6736(97)11397-6; PARSHKOV E, 1999, EFF LOW VER LOW DOS; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Rothman K., 1998, MODERN EPIDEMIOLOGY; Suleiman OH, 1999, J AM DENT ASSOC, V130, P1104, DOI 10.14219/jada.archive.1999.0345; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Taylor JMG, 2002, AM J EPIDEMIOL, V156, P774, DOI 10.1093/aje/kwf110; *US DEP HHS, 1993, NAT EV XRAY TRENDS N; Usenko V, 1999, EXP TOXICOL PATHOL, V51, P223, DOI 10.1016/S0940-2993(99)80100-6; WEBER J, 1989, DEUT ZAHNAERZTL Z, V44, P340; Wingren G, 1997, EUR J CANCER PREV, V6, P550, DOI 10.1097/00008469-199712000-00010; YAMAZAKI JN, 1990, JAMA-J AM MED ASSOC, V264, P605, DOI 10.1001/jama.264.5.605	33	70	71	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2004	291	16					1987	1993		10.1001/jama.291.16.1987	http://dx.doi.org/10.1001/jama.291.16.1987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815SM	15113817				2022-12-28	WOS:000221062000030
J	Pas, MFWT; Claes, F				Pas, MFWT; Claes, F			Functional genomics and proteomics for infectious diseases in the post-genomics era	LANCET			English	Editorial Material									Univ Wageningen & Res Ctr, Anim Sci Grp, Div Anim Resource Dev, Anim Genom Grp, NL-8200 AB Lelystad, Netherlands; Catholic Univ Louvain, Dept Anim Sci, Fac Agr & Appl Biol Sci, B-3000 Louvain, Belgium; Inst Trop Med Prince Leopold, Dept Parasitol, B-2000 Antwerp, Belgium	Animal Sciences Group of Wageningen UR; Wageningen University & Research; Universite Catholique Louvain; Institute of Tropical Medicine (ITM)	Pas, MFWT (corresponding author), Univ Wageningen & Res Ctr, Anim Sci Grp, Div Anim Resource Dev, Anim Genom Grp, NL-8200 AB Lelystad, Netherlands.	marinus.tepas@wur.nl						Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Lejon V, 2003, LANCET INFECT DIS, V3, P804, DOI 10.1016/S1473-3099(03)00834-X; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; SILVA RAM, 1996, 136 FAO; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; World Health Organization, 2002, WORLD HLTH REP	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1337	1337		10.1016/S0140-6736(04)16082-0	http://dx.doi.org/10.1016/S0140-6736(04)16082-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110486				2022-12-28	WOS:000220996300003
J	Wolk, A				Wolk, A			The growth hormone and insulin-like growth factor I axis, and cancer	LANCET			English	Editorial Material							PROSTATE-CANCER; IGF-I; RECEPTOR		Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Wolk, A (corresponding author), Karolinska Inst, Natl Inst Environm Med, Div Nutr Epidemiol, S-17177 Stockholm, Sweden.	Alicja.WoIk@imm.ki.se						Baserga R, 1997, ENDOCRINE, V7, P99, DOI 10.1007/BF02778073; FOWLKES JL, 1994, J BIOL CHEM, V269, P25742; LeRoith D, 1997, ENDOCRINE, V7, P103, DOI 10.1007/BF02778074; Rosen CJ, 1999, TRENDS ENDOCRIN MET, V10, P136, DOI 10.1016/S1043-2760(98)00126-X; Rosen CJ, 1999, CLIN CHEM, V45, P1384; Ruotolo G, 2000, J AM COLL CARDIOL, V35, P647, DOI 10.1016/S0735-1097(99)00591-4; SALMON WD, 1957, J LAB CLIN MED, V49, P825; Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; Wolk A, 2000, LANCET, V356, P1902, DOI 10.1016/S0140-6736(00)03266-9; WRIGHT AD, 1970, Q J MED, V39, P1	11	13	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2004	363	9418					1336	1337		10.1016/S0140-6736(04)16081-9	http://dx.doi.org/10.1016/S0140-6736(04)16081-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110485				2022-12-28	WOS:000220996300002
J	Lowdon, D; McMurdo, M				Lowdon, D; McMurdo, M			Interactive case report - A 66 year old woman with breathlessness: case outcome	BRITISH MEDICAL JOURNAL			English	Review							HEART-FAILURE		Royal Victoria Hosp, Dundee DD2 1SP, Scotland; Univ Dundee, Ninewells Hosp, Div Med & Therapeut, Dundee DD1 9SY, Scotland	University of Dundee	Lowdon, D (corresponding author), Royal Victoria Hosp, Dundee DD2 1SP, Scotland.	douglas.lowdon@tpct.scot.nhs.uk						HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2004	328	7445					944	944		10.1136/bmj.328.7445.944	http://dx.doi.org/10.1136/bmj.328.7445.944			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087344	Green Published			2022-12-28	WOS:000220994400028
J	Parrott, S; Godfrey, C				Parrott, S; Godfrey, C			ABC of smoking cessation - Economics of smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Review								Smoking imposes a huge economic burden on society - currently up to 15% of total healthcare costs in developed countries. Smoking cessation can save years of life, at a very low cost compared with alternative interventions. This chapter reviews some of the economic aspects of smoking cessation.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK				Parrott, Steven James/0000-0002-0165-1150; Godfrey, Christine/0000-0001-6290-5532				*ACT SMOK HLTH, 2002, SMOK DIS BAS FACTS 2; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Nielsen K, 2000, PREV MED, V30, P209, DOI 10.1006/pmed.1999.0627; Parrott S, 1998, THORAX, V53, pAS1; Stapleton JA, 1999, LANCET, V354, P210, DOI 10.1016/S0140-6736(99)90001-6	5	88	87	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2004	328	7445					947	949		10.1136/bmj.328.7445.947	http://dx.doi.org/10.1136/bmj.328.7445.947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814SM	15087348	Green Published, Green Accepted			2022-12-28	WOS:000220994400033
J	Bishop, JKB; Wood, TJ; Davis, RE; Sherman, JT				Bishop, JKB; Wood, TJ; Davis, RE; Sherman, JT			Robotic observations of enhanced carbon biomass and export at 55 degrees S during SOFeX	SCIENCE			English	Article							SOUTHERN-OCEAN; IRON FERTILIZATION; PACIFIC; VERTEX	Autonomous. oats pro. ling in high-nitrate low-silicate waters of the Southern Ocean observed carbon biomass variability and carbon exported to depths of 100 m during the 2002 Southern Ocean Iron Experiment (SOFeX) to detect the effects of iron fertilization of surface water there. Control and "in-patch" measurements documented a greater than fourfold enhancement of carbon biomass in the iron-amended waters. Carbon export through 100 m increased two- to sixfold as the patch subducted below a front. The molar ratio of iron added to carbon exported ranged between 10(4) and 10(5). The biomass buildup and export were much higher than expected for iron-amended low-silicate waters.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Diego; Scripps Institution of Oceanography	Bishop, JKB (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, 1 Cyclotron Rd,MS 90-1116, Berkeley, CA 94720 USA.	JKBishop@lbl.gov		Davis, Russ/0000-0003-1903-6313; Bishop, James/0000-0002-8036-3017				Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; BISHOP JL, UNPUB; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Honjo S, 2000, DEEP-SEA RES PT II, V47, P3521, DOI 10.1016/S0967-0645(00)00077-1; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000	14	91	96	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					417	420		10.1126/science.1087717	http://dx.doi.org/10.1126/science.1087717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087544				2022-12-28	WOS:000220845400041
J	Hunten, DM				Hunten, DM			An iron deficiency in polar mesospheric clouds	SCIENCE			English	Editorial Material							TEMPERATURE LIDAR; MESOPAUSE REGION; TWILIGHT		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Hunten, DM (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	dhunten@lpl.arizona.edu						BILLS RE, 1991, J GEOPHYS RES-ATMOS, V96, P22701, DOI 10.1029/91JD02206; BROADFOOT AL, 1976, J GEOPHYS RES-SPACE, V81, P1331, DOI 10.1029/JA081i007p01331; Chu XZ, 2002, APPL OPTICS, V41, P4400, DOI 10.1364/AO.41.004400; DONAHUE TM, 1972, J ATMOS SCI, V29, P1205, DOI 10.1175/1520-0469(1972)029<1205:NCIDCP>2.0.CO;2; HUNTEN DM, 1967, SPACE SCI REV, V6, P493; NEUBER R, 1988, J GEOPHYS RES-ATMOS, V93, P11093, DOI 10.1029/JD093iD09p11093; Perrin MD, 2004, SCIENCE, V303, P1345, DOI 10.1126/science.1094602; Plane JMC, 2004, SCIENCE, V304, P426, DOI 10.1126/science.1093236; PLANE JMC, IN PRESS ADV SPACE R; THOMAS GE, 1989, J GEOPHYS RES-ATMOS, V94, P14673, DOI 10.1029/JD094iD12p14673; THOMAS GE, 1991, REV GEOPHYS, V29, P553, DOI 10.1029/91RG01604	11	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2004	304	5669					395	396		10.1126/science.1097150	http://dx.doi.org/10.1126/science.1097150			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812NE	15087534				2022-12-28	WOS:000220845400031
J	McLean, D				McLean, D			Computed tomography doses in children	LANCET			English	Editorial Material							RADIATION; CT; CANCER; RISKS		Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney	McLean, D (corresponding author), Westmead Hosp, Sydney, NSW 2145, Australia.	rdmc@imag.wsahs.nsw.gov.au						Almen A., 1996, Journal of Radiological Protection, V16, P81, DOI 10.1088/0952-4746/16/2/004; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430; International Electrotechnical Commission, 2002, MED EL EQ 2 44; McLean Donald, 2003, Australas Radiol, V47, P135, DOI 10.1046/j.0004-8461.2003.01141.x; Pages J, 2003, BRIT J RADIOL, V76, P803, DOI 10.1259/bjr/92706933; Shrimpton PC, 2000, RADIAT PROT DOSIM, V90, P249, DOI 10.1093/oxfordjournals.rpd.a033130; UNSCEAR, 2000, SOURC EFF ION RAD UN, VI; Wall BF, 2003, BRIT J RADIOL, V76, P763, DOI 10.1259/bjr/13405318; Wise K. N., 2003, Australasian Physical & Engineering Sciences in Medicine, V26, P53, DOI 10.1007/BF03178458; ZANKL M, 1993, TOMOGRAPHIC ANTHR 2	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1178	1178		10.1016/S0140-6736(04)15984-9	http://dx.doi.org/10.1016/S0140-6736(04)15984-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081647				2022-12-28	WOS:000220748100005
J	Geremia, JM; Stockton, JK; Mabuchi, H				Geremia, JM; Stockton, JK; Mabuchi, H			RETRACTED: Real-time quantum feedback control of atomic spin-squeezing (Retracted Article. See vol 321, pg 489, 2008)	SCIENCE			English	Article; Retracted Publication							NONDEMOLITION MEASUREMENT; STATES; ENTANGLEMENT; SPECTROSCOPY; GENERATION	Real-time feedback performed during a quantum nondemolition measurement of atomic spin-angular momentum allowed us to influence the quantum statistics of the measurement outcome. We showed that it is possible to harness measurement backaction as a form of actuation in quantum control, and thus we describe a valuable tool for quantum information science. Our feedback-mediated procedure generates spin-squeezing, for which the reduction in quantum uncertainty and resulting atomic entanglement are not conditioned on the measurement outcome.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Geremia, JM (corresponding author), CALTECH, Pasadena, CA 91125 USA.	jgeremia@caltech.edu						BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; Geremia JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250801; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Silberfarb A, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013817; Smith GA, 2003, J OPT B-QUANTUM S O, V5, P323, DOI 10.1088/1464-4266/5/4/301; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Thomsen LK, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.061801; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; WISEMAN HM, 1994, PHYS REV A, V49, P2133, DOI 10.1103/PhysRevA.49.2133; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520	13	215	217	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					270	273		10.1126/science.1095374	http://dx.doi.org/10.1126/science.1095374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073372				2022-12-28	WOS:000220719400040
J	Steinbrook, R				Steinbrook, R			Disparities in health care - From politics to policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Agency for Healthcare Research and Quality, 2003, NAT HEALTHC DISP REP; *COMM GOV REF, 2004, CAS STUD POL SCI CHA; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875	3	29	29	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2004	350	15					1486	1488		10.1056/NEJMp048060	http://dx.doi.org/10.1056/NEJMp048060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810CI	15071122				2022-12-28	WOS:000220682000002
J	Greenberg, D; Rosen, AB; Olchanski, NV; Stone, PW; Nadai, J; Neumann, PJ				Greenberg, D; Rosen, AB; Olchanski, NV; Stone, PW; Nadai, J; Neumann, PJ			Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Harvard Univ, Sch Publ Hlth, Harvard Ctr Risk Anal, Dept Hlth Policy & Management, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Columbia Univ, New York, NY 10032 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; Harvard University; Massachusetts General Hospital	Greenberg, D (corresponding author), Harvard Clin Res Inst, 930 Commonwealth Ave, Boston, MA 02215 USA.	dan.greenberg@hcri.harvard.edu		Greenberg, Dan/0000-0002-6759-3985	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010919] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10919] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; Drummond MF, 2015, METHODS EC EVALUATIO; Gold MR, 1996, COST EFFECTIVENESS H; Smith R, 2002, BMJ-BRIT MED J, V325, P1124, DOI 10.1136/bmj.325.7373.1124	4	16	16	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2004	328	7455					1536	1537		10.1136/bmj.38079.502326.AE	http://dx.doi.org/10.1136/bmj.38079.502326.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834DV	15100148	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000222392700020
J	Haynes, RB; Wilczynski, NL				Haynes, RB; Wilczynski, NL		Hedges Team	Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL LITERATURE; ACCESS; CARE	Objective To develop optimal search strategies in Medline for retrieving sound clinical studies on the diagnosis of health disorders. Design Analytical survey. Setting Medline, 2000. Participants 170 journals for 2000 of which 161 were indexed in Medline. Main outcome measures The sensitivity, specificity, precision ("positive predictive value"), and accuracy of 4862 unique terms in 17 287 combinations were determined by comparison with a hand search of all articles (the "gold standard") in 161 journals published during 2000 (49 028 articles). Results Only 147 (18.9%) of 778 articles about diagnostic tests met basic criteria for scientific merit. Combinations of search terms reached peak sensitivities of 98.6% at a specificity of 74.3%. Compared with best single terms, best multiple terms increased sensitivity for sound studies by 6.8% (absolute increase), while also increasing specificity (absolute increase 6.0%) when sensitivity was maximised. When terms were combined to maximise specificity, the single term, specificity.tw. (98.4%), outperformed combinations of terms. The strategies newly reported in this paper outperformed other validated search strategies except for one strategy that had slightly higher sensitivity (99.3% v 98.6%) but lower specificity (54.7% v 74.3%). Conclusion New empirical search strategies in Medline can optimise retrieval of articles reporting high quality clinical studies of diagnosis.	McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hlth Informat Res Unit, Hamilton, ON L8N 3Z5, Canada	McMaster University	Haynes, RB (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hlth Informat Res Unit, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	bhaynes@mcmaster.ca		Haynes, Robert Brian/0000-0002-1453-3196	NATIONAL LIBRARY OF MEDICINE [R01LM006866] Funding Source: NIH RePORTER; NLM NIH HHS [1 R01 LM06866] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bachmann LM, 2002, J AM MED INFORM ASSN, V9, P653, DOI 10.1197/jamia.M1124; Balas EA, 1997, J MED SYST, V21, P21, DOI 10.1023/A:1022887224126; Deville WLJM, 2000, J CLIN EPIDEMIOL, V53, P65, DOI 10.1016/S0895-4356(99)00144-4; Devine KJ, 2001, NEMATOLOGY, V3, P65, DOI 10.1163/156854101300106900; Ely JW, 2002, BRIT MED J, V324, P710, DOI 10.1136/bmj.324.7339.710; Green ML, 2000, AM J MED, V109, P218, DOI 10.1016/S0002-9343(00)00458-7; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; HAYNES RB, 1990, ANN INTERN MED, V112, P78, DOI 10.7326/0003-4819-112-1-78; HAYNES RB, 1986, ANN INTERN MED, V105, P810, DOI 10.7326/0003-4819-105-5-810; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; *NLM, NLM FACT SHEET; Tomlin Z, 1999, BMJ-BRIT MED J, V318, P1532, DOI 10.1136/bmj.318.7197.1532; vanderWeijden T, 1997, FAM PRACT, V14, P204, DOI 10.1093/fampra/14.3.204; Veness Michael, 2003, Australas Radiol, V47, P409, DOI 10.1046/j.1440-1673.2003.01211.x; Vincent Sam, 2003, Health Info Libr J, V20, P150, DOI 10.1046/j.1365-2532.2003.00427.x; Wilczynski N L, 1993, Proc Annu Symp Comput Appl Med Care, P601; Wilczynski Nancy L, 2003, AMIA Annu Symp Proc, P719; Wilczynski NL, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P904; Wilczynski NL, 2001, STUD HEALTH TECHNOL, V84, P390; WONG SSL, 2003, P AMIA ANN S, P728	21	159	161	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2004	328	7447					1040	1042B		10.1136/bmj.38068.557998.EE	http://dx.doi.org/10.1136/bmj.38068.557998.EE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	817JT	15073027	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000221174500014
J	Gloyn, AL; Pearson, ER; Antcliff, JF; Proks, P; Bruining, GJ; Slingerland, AS; Howard, N; Srinivasan, S; Silva, JMCL; Molnes, J; Edghill, EL; Frayling, TM; Temple, IK; Mackay, D; Shield, JPH; Sumnik, Z; van Rhijn, A; Wales, JKH; Clark, P; Gorman, S; Aisenberg, J; Ellard, S; Njolstad, PR; Ashcroft, FM; Hattersley, AT				Gloyn, AL; Pearson, ER; Antcliff, JF; Proks, P; Bruining, GJ; Slingerland, AS; Howard, N; Srinivasan, S; Silva, JMCL; Molnes, J; Edghill, EL; Frayling, TM; Temple, IK; Mackay, D; Shield, JPH; Sumnik, Z; van Rhijn, A; Wales, JKH; Clark, P; Gorman, S; Aisenberg, J; Ellard, S; Njolstad, PR; Ashcroft, FM; Hattersley, AT			Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLETE GLUCOKINASE DEFICIENCY; K-ATP; SULFONYLUREA RECEPTOR; E23K VARIANT; COMMON-CAUSE; IDENTIFICATION; OVERACTIVITY; ASSOCIATION; INHIBITION; SEQUENCE	BACKGROUND Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K-ATP) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K ATP channels was greatly reduced. CONCLUSIONS Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5AX, Devon, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Sophia Childrens Univ Hosp, Rotterdam, Netherlands; Childrens Hosp Westmead, Inst Endocrinol & Diabet, Westmead, NSW, Australia; Piaui State Univ, Sch Med, Teresina, Piaui, Brazil; Univ Bergen, Inst Clin Med & Mol Med, Bergen, Norway; Southampton Univ & Hosp, Wessex Clin Genet Serv, Natl Hlth Serv Trust, Southampton, Hants, England; Southampton Univ & Hosp, Div Human Genet, Natl Hlth Serv Trust, Southampton, Hants, England; Salisbury Dist Hosp, Wessex Reg Genet Labs, Salisbury, England; Royal Hosp Children, Bristol, Avon, England; Charles Univ, Dept Pediat 2, Prague, Czech Republic; Charles Univ, Fac Med 2, Prague, Czech Republic; Meander Med Ctr, Amersfoort, Netherlands; Sheffield Childrens Hosp, Acad Unit Child Hlth, Sheffield, S Yorkshire, England; Reg Endocrine Lab, Birmingham, W Midlands, England; St Lukes Hosp, Bradford BD5 0NA, W Yorkshire, England; Hackensack Univ, Med Ctr, Div Pediat Endocrinol & Diabet, Hackensack, NJ USA	University of Exeter; University of Oxford; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; University of Sydney; Universidade Estadual do Piaui (UESPI); University of Bergen; University of Southampton; University of Southampton; Salisbury District Hospital; Bristol Royal Hospital For Children; Charles University Prague; Charles University Prague; Meander Medisch Centrum; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Hackensack University Medical Center	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Barrack Rd, Exeter EX2 5AX, Devon, England.	a.t.hattersley@ex.ac.uk	Shield, Julian PH/D-6297-2014; temple, isabel K/K-2391-2015; Mackay, Deborah JG/B-2879-2015; Wales, Jerry/A-6797-2011	Shield, Julian PH/0000-0003-2601-7575; Mackay, Deborah JG/0000-0003-3088-4401; Temple, Isabel Karen/0000-0002-6045-1781; Sumnik, Zdenek/0000-0002-6462-6462; Gloyn, Anna/0000-0003-1205-1844; Wales, Jerry/0000-0002-8769-648X; Pearson, Ewan/0000-0001-9237-8585; Proks, Peter/0000-0001-6097-3646; Ellard, Sian/0000-0002-7620-5526; Hattersley, Andrew/0000-0001-5620-473X				Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gloyn AL, 2002, DIABETOLOGIA, V45, P290, DOI 10.1007/s00125-001-0746-9; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hernandez-Sanchez C, 2001, P NATL ACAD SCI USA, V98, P3549, DOI 10.1073/pnas.051012898; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inoue H, 1997, DIABETES, V46, P502, DOI 10.2337/diabetes.46.3.502; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Nichols CG, 2002, AM J PHYSIOL-ENDOC M, V283, pE403, DOI 10.1152/ajpendo.00168.2002; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; Novelli G, 2003, TRENDS MOL MED, V9, P370, DOI 10.1016/S1471-4914(03)00162-X; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Ribalet B, 2003, BIOPHYS J, V84, P266, DOI 10.1016/S0006-3495(03)74847-4; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Shield JPH, 2000, HORM RES, V53, P7, DOI 10.1159/000053198; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Temple IK, 2000, DIABETES, V49, P1359, DOI 10.2337/diabetes.49.8.1359; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Vaxillaire M, 2002, DIABETOLOGIA, V45, P454; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829	35	832	881	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1838	1849		10.1056/NEJMoa032922	http://dx.doi.org/10.1056/NEJMoa032922			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115830	Green Accepted, Bronze			2022-12-28	WOS:000221080300007
J	Ramaswamy, S				Ramaswamy, S			Translating cancer genomics into clinical oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Broad Inst, Program Canc Gen, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.								0	60	67	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1814	1816		10.1056/NEJMp048059	http://dx.doi.org/10.1056/NEJMp048059			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115827				2022-12-28	WOS:000221080300003
J	Thayer, DW				Thayer, DW			Irradiation of food - Helping to ensure food safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	13	14	2	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2004	350	18					1811	1812		10.1056/NEJMp048014	http://dx.doi.org/10.1056/NEJMp048014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	815ZN	15115825				2022-12-28	WOS:000221080300001
J	Wang, KLC; Yoshida, H; Lurin, C; Ecker, JR				Wang, KLC; Yoshida, H; Lurin, C; Ecker, JR			Regulation of ethylene gas biosynthesis by the Arabidopsis ETO1 protein	NATURE			English	Article							1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; UBIQUITIN LIGASES; RESPONSE PATHWAY; GENE FAMILY; KEY ENZYME; PHOSPHORYLATION; MUTATIONS; ADAPTERS; BTB/POZ; MUTANTS	Ethylene gas is used as a hormone by plants, in which it acts as a critical growth regulator. Its synthesis is also rapidly evoked in response to a variety of biotic and abiotic stresses(1,2). The Arabidopsis ethylene-overproducer mutants eto2 and eto3 have previously been identified as having mutations in two genes, ACS5 and ACS9, respectively; these encode isozymes of 1-aminocyclopropane-1- carboxylic acid synthase (ACS), which catalyse the rate-limiting step in ethylene biosynthesis(3,4). Here we report that another ethylene-overproducer mutation, eto1, is in a gene that negatively regulates ACS activity and ethylene production. The ETO1 protein directly interacts with and inhibits the enzyme activity of full-length ACS5 but not of a truncated form of the enzyme, resulting in a marked accumulation of ACS5 protein and ethylene. Overexpression of ETO1 inhibited induction of ethylene production by the plant growth regulator cytokinin, and promoted ACS5 degradation by a proteasome-dependent pathway. ETO1 also interacts with CUL3, a constituent of ubiquitin ligase complexes in which we propose that ETO1 serves as a substrate-specific adaptor protein. ETO1 thus has a dual mechanism, inhibiting ACS enzyme activity and targeting it for protein degradation. This permits rapid modulation of the concentration of ethylene.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	Salk Institute; University of Pennsylvania	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	/AAD-1735-2020; Ecker, Joseph R/B-9144-2008	/0000-0003-3516-4438; Ecker, Joseph R/0000-0001-5799-5895				Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Capitani G, 1999, J MOL BIOL, V294, P745, DOI 10.1006/jmbi.1999.3255; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; ROMAN G, 1995, GENETICS, V139, P1393; SPANU P, 1994, PLANT PHYSIOL, V106, P529, DOI 10.1104/pp.106.2.529; Tarun AS, 1998, J BIOL CHEM, V273, P12509, DOI 10.1074/jbc.273.20.12509; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; Tatsuki M, 2001, J BIOL CHEM, V276, P28051, DOI 10.1074/jbc.M101543200; Tsuchisaka A, 2004, P NATL ACAD SCI USA, V101, P2275, DOI 10.1073/pnas.0308515101; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103	30	294	326	7	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2004	428	6986					945	950		10.1038/nature02516	http://dx.doi.org/10.1038/nature02516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816AO	15118728				2022-12-28	WOS:000221083000042
J	Durrheim, DN; Speare, R				Durrheim, DN; Speare, R			Communicable disease surveillance and management in a globalised world	LANCET			English	Editorial Material							HEALTH		James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	James Cook University	Durrheim, DN (corresponding author), James Cook Univ N Queensland, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia.	David.Durrheim@jcu.edu.au		Speare, Rick/0000-0002-9993-1213				Durrheim DN, 2001, B WORLD HEALTH ORGAN, V79, P22; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; Van Damme W, 2004, TROP MED INT HEALTH, V9, P281, DOI 10.1046/j.1365-3156.2003.01189.x; Walt G, 1998, LANCET, V351, P434, DOI 10.1016/S0140-6736(97)05546-3; WHO, 2002, WHOCDSCSRGAR20024, P6	7	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 24	2004	363	9418					1339	1340		10.1016/S0140-6736(04)16084-4	http://dx.doi.org/10.1016/S0140-6736(04)16084-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814TF	15110488	Bronze, Green Published			2022-12-28	WOS:000220996300005
J	Roy, CJ; Milton, DK				Roy, CJ; Milton, DK			Airborne transmission of communicable infection - The elusive pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									USA, Ctr Aerobiol Sci, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Epidemiol & Risk Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Roy, CJ (corresponding author), USA, Ctr Aerobiol Sci, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.		Milton, Donald K/G-3286-2010	Milton, Donald K/0000-0002-0550-7834; Roy, Chad/0000-0002-1710-6974					0	206	217	2	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2004	350	17					1710	1712		10.1056/NEJMp048051	http://dx.doi.org/10.1056/NEJMp048051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	814AJ	15102996				2022-12-28	WOS:000220947300004
J	Worobey, M; Santiago, ML; Keele, BF; Ndjango, JBN; Joy, JB; Labamall, BL; Dhed'a, BD; Rambaut, A; Sharp, PM; Shaw, GM; Hahn, BH				Worobey, M; Santiago, ML; Keele, BF; Ndjango, JBN; Joy, JB; Labamall, BL; Dhed'a, BD; Rambaut, A; Sharp, PM; Shaw, GM; Hahn, BH			Origin of AIDS - Contaminated polio vaccine theory refuted	NATURE			English	Editorial Material									Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; Univ Kisangani, Fac Med, Kisangani, DEM REP CONGO; Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1A6, Canada; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England	University of Arizona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Simon Fraser University; University of Oxford; University of Nottingham	Worobey, M (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	worobey@email.arizona.edu	Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Sharp, Paul/Y-3787-2019; Rambaut, Andrew/B-2481-2009	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Rambaut, Andrew/0000-0003-4337-3707; Joy, Jeffrey/0000-0002-7013-1482; Hahn, Beatrice/0000-0002-9400-9887; Santiago, Mario L./0000-0001-7792-2706				Berry N, 2001, NATURE, V410, P1046, DOI 10.1038/35074176; Blancou P, 2001, NATURE, V410, P1045, DOI 10.1038/35074171; Butler D, 2004, NATURE, V428, P109, DOI 10.1038/428109b; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Hooper E., 1999, RIVER JOURNEY BACK S; Hooper E, 2003, ATTI CONVEGNI LINCEI, V187, P27; KORHER B, 2000, SCIENCE, V288, P1789; Plotkin SA, 2001, PHILOS T R SOC B, V356, P815, DOI 10.1098/rstb.2001.0861; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Santiago ML, 2003, J VIROL, V77, P2233, DOI 10.1128/JVI.77.3.2233-2242.2003; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Trivers R, 2000, NATURE, V404, P828, DOI 10.1038/35009190	13	61	65	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2004	428	6985					820	820		10.1038/428820a	http://dx.doi.org/10.1038/428820a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	814CH	15103367	Bronze			2022-12-28	WOS:000220952300030
J	Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G				Choi, HK; Atkinson, K; Karlson, EW; Willett, W; Curhan, G			Alcohol intake and risk of incident gout in men: a prospective study	LANCET			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ADENINE-NUCLEOTIDE TURNOVER; CORONARY-HEART-DISEASE; URIC-ACID; CONSUMPTION; WOMEN; REPRODUCIBILITY; HYPERURICEMIA; ACTIVATION; METABOLISM		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Rheumatol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Choi, HK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Rheumatol Unit, Bulfinch 165,55 Fruit St, Boston, MA 02114 USA.	hchoi@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NIDDK NIH HHS [DK58573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Becker C, 2001, EUR J NUTR, V40, P1, DOI 10.1007/PL00007380; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Curhan GC, 1998, ANN INTERN MED, V128, P534, DOI 10.7326/0003-4819-128-7-199804010-00003; Djousse L, 2002, STROKE, V33, P907, DOI 10.1161/hs0402.105245; DRUM DE, 1981, ARCH INTERN MED, V141, P477, DOI 10.1001/archinte.141.4.477; EASTMOND CJ, 1995, BRIT J RHEUMATOL, V34, P756; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Fam AG, 2002, J RHEUMATOL, V29, P1350; GIBSON T, 1984, BRIT J RHEUMATOL, V23, P203; Gibson T, 1977, Adv Exp Med Biol, V76B, P46; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; MACHLACHLAN MJ, 1967, AM J MED, V42, P38; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; *NUTR DAT LAB, 1999, USDA NUTR DAT STAND; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Shadick NA, 2000, J RHEUMATOL, V27, P1708; SHARPE CR, 1984, CAN MED ASSOC J, V131, P563; VANDENBERG MK, 1994, J RHEUMATOL, V21, P700; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WHITEHEAD TP, 1978, LANCET, V1, P978; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YU TF, 1957, P SOC EXP BIOL MED, V96, P809	30	449	495	3	66	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 17	2004	363	9417					1277	1281		10.1016/S0140-6736(04)16000-5	http://dx.doi.org/10.1016/S0140-6736(04)16000-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	813KB	15094272				2022-12-28	WOS:000220904900009
J	Agashe, VR; Guha, S; Chang, HC; Genevaux, P; Hayer-Hartl, M; Stemp, M; Georgopoulos, C; Hartl, FU; Barral, JM				Agashe, VR; Guha, S; Chang, HC; Genevaux, P; Hayer-Hartl, M; Stemp, M; Georgopoulos, C; Hartl, FU; Barral, JM			Function of trigger factor and DnaK in multidomain protein folding: Increase in yield at the expense of folding speed	CELL			English	Article							NASCENT POLYPEPTIDE-CHAINS; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; BETA-GALACTOSIDASE; FIREFLY LUCIFERASE; LIVING CELLS; IN-VIVO; HSP70; RIBOSOME	Trigger factor and DnaK protect nascent protein chains from misfolding and aggregation in the E. coli cytosol, but how these chaperones affect the mechanism of de novo protein folding is not yet understood. Upon expression under chaperone-depleted conditions, multidomain proteins such as bacterial beta-galactosidase (beta-gal) and eukaryotic luciferase fold by a rapid but inefficient default pathway, tightly coupled to translation. Trigger factor and DnaK improve the folding yield of these proteins but markedly delay the folding process both in vivo and in vitro. This effect requires the dynamic recruitment of additional trigger factor molecules to translating ribosomes. While beta-galactosidase uses this chaperone mechanism effectively, luciferase folding in E. coli remains inefficient. The efficient co-translational domain folding of luciferase observed in the eukaryotic system is not compatible with the bacterial chaperone system. These findings suggest important differences in the coupling of translation and folding between bacterial and eukaryotic cells.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Ctr Med Univ Geneva, Dept Biochim Med, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Genevaux, Pierre/A-4851-2015; Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; zhang, hong jun/0000-0003-0030-8323; GENEVAUX, Pierre/0000-0001-7539-3126				Ausubel FM, 2003, CURRENT PROTOCOLS MO; Ayling A, 1996, PROTEIN SCI, V5, P478; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bremer H, 1996, ESCHERICHIA COLI SAL; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; KOLB VA, 1994, EMBO J, V13, P3631, DOI 10.1002/j.1460-2075.1994.tb06670.x; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nichtl A, 1998, J MOL BIOL, V282, P1083, DOI 10.1006/jmbi.1998.2075; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SANCHEZ IE, 2004, IN PRESS J MOL BIOL; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x	38	165	171	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2004	117	2					199	209		10.1016/S0092-8674(04)00299-5	http://dx.doi.org/10.1016/S0092-8674(04)00299-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	813NI	15084258	hybrid			2022-12-28	WOS:000220913400008
J	Druss, B				Druss, B			Understanding errors in the research process	LANCET			English	Editorial Material									Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Druss, B (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 10	2004	363	9416					1230	1230		10.1016/S0140-6736(04)15956-4	http://dx.doi.org/10.1016/S0140-6736(04)15956-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811BT	15081658				2022-12-28	WOS:000220748100026
J	Stephenson, J; Obasi, A				Stephenson, J; Obasi, A			HIV risk-reduction in adolescents	LANCET			English	Editorial Material							RURAL UGANDA; SEXUAL RISK; PREVENTION; INTERVENTIONS; BEHAVIOR; TRANSMISSION; TRIALS		UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England; London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; UCL Medical School; University of London; London School of Hygiene & Tropical Medicine	Stephenson, J (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England.	jstephen@gum.ucl.ac.uk	Obasi, Angela/AAK-4395-2021	Obasi, Angela/0000-0001-6801-8889				Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chesney MA, 2003, AM J PUBLIC HEALTH, V93, P933, DOI 10.2105/AJPH.93.6.933; Cowan FM, 2002, AIDS, V16, P1673, DOI 10.1097/00002030-200208160-00013; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; GRUNSEIT A, 1997, UNAIDS 97 GEN UNAIDS; Hawkes S, 2000, TROP MED INT HEALTH, V5, pA37, DOI 10.1046/j.1365-3156.2000.00594.x; Johnson BT, 2003, ARCH PEDIAT ADOL MED, V157, P381, DOI 10.1001/archpedi.157.4.381; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Mullen PD, 2002, J ACQ IMMUN DEF SYND, V30, pS94, DOI 10.1097/01.QAI.0000019980.12814.DF; OBASI A, 1997, 12 M INT SOC SEX TRA, pS44; Stephenson JM, 2000, AIDS, V14, pS115; *UNAIDS, 2000, UNAIDS0013E	13	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2004	363	9416					1177	1178		10.1016/S0140-6736(04)15983-7	http://dx.doi.org/10.1016/S0140-6736(04)15983-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811BT	15081646				2022-12-28	WOS:000220748100004
J	Laitinen, T; Polvi, A; Rydman, P; Vendelin, J; Pulkkinen, V; Salmikangas, P; Makela, S; Rehn, M; Pirskanen, A; Rautanen, A; Zucchelli, M; Gullsten, H; Leino, M; Alenius, H; Petays, T; Haahtela, T; Laitinen, A; Laprise, C; Hudson, TJ; Laitinen, LA; Kere, J				Laitinen, T; Polvi, A; Rydman, P; Vendelin, J; Pulkkinen, V; Salmikangas, P; Makela, S; Rehn, M; Pirskanen, A; Rautanen, A; Zucchelli, M; Gullsten, H; Leino, M; Alenius, H; Petays, T; Haahtela, T; Laitinen, A; Laprise, C; Hudson, TJ; Laitinen, LA; Kere, J			Characterization of a common susceptibility locus for asthma-related traits	SCIENCE			English	Article							BRONCHIAL HYPERRESPONSIVENESS; LINKAGE DISEQUILIBRIUM; POSITIONAL CLONING; GENE	Susceptibility to asthma depends on variation at an unknown number of genetic loci. To identify susceptibility genes on chromosome 7p, we adopted a hierarchical genotyping design, leading to the identification of a 133-kilobase risk-conferring segment containing two genes. One of these coded for an orphan G protein coupled receptor named GPRA ( G protein - coupled receptor for asthma susceptibility), which showed distinct distribution of protein isoforms between bronchial biopsies from healthy and asthmatic individuals. In three cohorts from Finland and Canada, single nucleotide polymorphism - tagged haplotypes associated with high serum immunoglobulin E or asthma. The murine ortholog of GPRA was up-regulated in a mouse model of ovalbumin-induced inflammation. Together, these data implicate GPRA in the pathogenesis of atopy and asthma.	Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; GeneOS Ltd, Helsinki 00251, Finland; Univ Helsinki, Biomedicum, Dept Anat, FIN-00014 Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, S-14157 Huddinge, Sweden; Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki 00251, Finland; Univ Helsinki, Cent Hosp, Dept Allergol Dis, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Dept Med, Helsinki 00029, Finland; Univ Quebec, Community Gen Med Ctr, Chicoutimi, PQ G7H 2B1, Canada; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Quebec; University of Quebec Chicoutimi; McGill University	Kere, J (corresponding author), Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.	juha.kere@biosci.ki.se	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Laprise, Catherine/0000-0001-5526-9945; Alenius, Harri/0000-0003-0106-8923				Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Illig Thomas, 2002, Paediatr Respir Rev, V3, P47, DOI 10.1053/prrv.2002.0185; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Leaves NI, 2002, EUR J HUM GENET, V10, P177, DOI 10.1038/sj.ejhg.5200787; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; PULKKINEN V, UNPUB; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	14	341	365	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2004	304	5668					300	304		10.1126/science.1090010	http://dx.doi.org/10.1126/science.1090010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073379				2022-12-28	WOS:000220719400050
J	Muller, UK; Kranenbarg, S				Muller, UK; Kranenbarg, S			Power at the tip of the tongue	SCIENCE			English	Editorial Material									Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands	Wageningen University & Research	Muller, UK (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	ulrike.muller@wur.nl						Askew GN, 2001, J EXP BIOL, V204, P3587; BIEWENER AA, 1988, J EXP BIOL, V140, P243; Burrows M, 2003, NATURE, V424, P509, DOI 10.1038/424509a; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Deban SM, 1997, NATURE, V389, P27, DOI 10.1038/37898	5	23	23	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2004	304	5668					217	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810QS	15073361				2022-12-28	WOS:000220719400027
